Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemical synaptic transmission (GO:0007268),0.5606476161136155,2.6636965087686564,0.0,0.0,0.0,103/284,15.12%,KCND2;NRXN1;GRID2;GRM5;GRIA3;KCNQ3;NLGN1;GRIK5;GRIK2;GRID1;ASIC2;SYT1;SYT5;DLG2;GLRA3;GABRG3;CHRM2;GABRB1;HTR2C;RIT2;AMPH;ERC2;DLGAP1;GRIN2B;CDH8;SNAP25;GRIA4;HCRTR1;GABRB3;SNPH;DLGAP2;RIMS1;PTPRN2;HTR3A;GAD2;CACNA1B;PCDHB5;PNOC;CDK5;GLRA1;GRIN2A;GABRB2;APBA2;GABRA2;PLP1;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;CHRM3;MTNR1B;CACNB3;SNCG;CNP;SLC1A2;NPTX2;RAPSN;GRM1;NPY;GRIK1;HOMER1;CACNB4;STXBP2;SLC12A5;CACNA1E;HTR4;GRIA2;GRM7;TSPOAP1;SLC6A2;SLC6A5;SYN2;GABRA3;GABRA1;MINK1;PDLIM4;KIF5A;PENK;RAB3A;LIN7C;SLC17A6;CBLN1;MBP;NAAA;DTNA;HTR1D;PRKAR1B;DLG4;SLC12A4;NLGN2;UTS2;PPFIA3;SLC1A3;PTCHD1;NOVA1;GABRE;KCNC4;SCN2B;APOE;GRM4;UNC13A;HTR1F
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5728891070034454,2.6320934408629575,0.0,0.0,0.0,84/224,15.12%,KCND2;NRXN1;GRM5;GRIA3;KCNQ3;NLGN1;GRIK2;ASIC2;SYT1;SYT5;DLG2;GLRA3;GABRG3;CHRM2;GABRB1;HTR2C;RIT2;AMPH;DLGAP1;GRIN2B;SNAP25;GRIA4;HCRTR1;GABRB3;HTR3A;GAD2;CACNA1B;PCDHB5;PNOC;CDK5;GLRA1;GRIN2A;GABRB2;APBA2;GABRA2;PLP1;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;CHRM3;MTNR1B;CACNB3;SNCG;CNP;SLC1A2;NPTX2;RAPSN;GRM1;NPY;GRIK1;HOMER1;CACNB4;SLC12A5;CACNA1E;HTR4;GRIA2;GRM7;SLC6A2;SLC6A5;SYN2;GABRA3;GABRA1;MINK1;KIF5A;PENK;CBLN1;MBP;DTNA;HTR1D;PRKAR1B;DLG4;SLC12A4;NLGN2;UTS2;SLC1A3;PTCHD1;NOVA1;GABRE;KCNC4;SCN2B;GRM4;HTR1F
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.557013636439822,2.4539104644699883,0.0,0.0,0.0,59/159,11.59%,KIRREL3;PTPRD;GRID2;CDH18;LRRC4C;IL1RAPL1;TENM4;ROBO2;NLGN1;UNC5D;L1CAM;LRFN5;CNTN6;CNTN4;DSCAML1;CDH8;TENM1;PCDHGB4;CDH20;CDH9;CDH10;DSCAM;ADGRL3;ROBO1;IGSF11;TENM3;PCDHB5;CD177;NTNG1;MMP24;CLDN18;PTPRT;IGSF21;CEACAM5;DCHS1;CDH19;TENM2;CXADR;CLDN14;CDH12;NECTIN3;MYPN;CLDN11;SDK1;VSTM2L;CDH7;SLITRK1;EMB;CNTN2;CDH17;PTPRS;CDH24;CDHR3;MAG;LRFN4;LRRC4B;CBLN1;CELSR2;CDH2
prerank,neurotransmitter secretion (GO:0007269),0.6917890135403693,2.44203077799022,0.0,0.0,0.0,22/44,18.02%,NRXN1;SYT1;PCLO;RIMS2;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;GRM4;UNC13A;SNAPIN;GAD1;SLC32A1
prerank,signal release from synapse (GO:0099643),0.6834710844926284,2.3933775122153236,0.0,0.0,0.0,21/43,18.02%,NRXN1;SYT1;PCLO;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;GRM4;UNC13A;SNAPIN;GAD1;SLC32A1
prerank,glutamate receptor signaling pathway (GO:0007215),0.6800060351209462,2.329623988666678,0.0,0.00010883061206696992,0.001,15/37,8.90%,GRID2;GRM5;GRIA3;GRIK2;GRIN2B;GRIA4;GRM8;GRIN2A;CLN3;GRM1;GRIK1;HOMER1;TRPM1;GRIA2;GRM7
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5571026339036906,2.3265447352125603,0.0,9.32833817716885e-05,0.001,43/107,15.07%,GRID2;GRM5;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;SYT1;DGKI;DLGAP1;ATP1A2;RIMS2;CNTNAP4;DLGAP2;RIMS1;TMEM108;GRM8;PSMC5;CACNA1B;CDK5;CLN3;NPTXR;CACNA1A;SYN1;SLC8A2;NPTX2;GRM1;GRIK1;HOMER1;GRM7;MCTP2;CLSTN2;CDH2;SLC8A3;DLG4;DLGAP3;BDNF;NLGN2;CACNG5;BEGAIN;GRM4;UNC13A
prerank,regulation of endothelial cell migration (GO:0010594),-0.5942506529973751,-2.2878213571619006,0.0,0.0,0.0,47/85,22.67%,FOXP1;TEK;DAB2IP;PTPRM;SP100;NRP2;ACVRL1;BMPER;ETS1;RAC1;RHOJ;BMPR2;THBS1;KDR;ANXA3;PRKD2;ABL1;SLIT2;PTK2;FGF1;BMP4;PRKD1;FLT4;SCARB1;ADAMTS9;RRAS;BCAR1;PIK3CD;AKT1;EDN1;BCAS3;RIN2;FGF2;CEACAM1;PRCP;PIK3CB;ROCK2;SMOC2;ANGPT1;SASH1;EPHA2;ITGB3;NF1;NR2F2;DLL4;PTK2B;PTN
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.6050171741923,-2.278723192617674,0.0,0.0,0.0,31/67,15.36%,FLT1;DAB2IP;WASF2;NRP2;DOCK1;ABI1;RAC1;CLEC14A;ELMO1;CRK;PAK2;KDR;PRKD2;NCK1;PXN;PIK3R1;PTK2;MAPKAPK2;ROCK1;PRKD1;SHB;FLT4;BCAR1;VEGFC;NCK2;RHOA;NCF2;PIK3CB;ELMO2;NCKAP1;ROCK2
prerank,regulation of cell junction assembly (GO:1901888),-0.7421849182057293,-2.2723110942681966,0.0,0.0,0.0,16/27,15.36%,TJP1;PRKCH;RAPGEF2;CLDN5;CBFB;F11R;PDLIM5;RAP1A;MEF2C;SETD5;RAP1B;ROCK1;OCLN;RAPGEF1;FLOT1;ROCK2
prerank,neurotransmitter transport (GO:0006836),0.5893695719562158,2.258743890495389,0.0,0.0003264918362009097,0.004,35/73,18.02%,NRXN1;SYT1;ATP1A2;SNAP25;PPFIA2;SNPH;RIMS1;PTPRN2;SLC22A1;GAD2;SLC6A15;GABRA2;SYN1;SLC1A2;STXBP2;SLC29A4;TSPOAP1;SLC6A2;SYN2;SLC28A2;RAB3A;LIN7C;SLC17A6;NAAA;GLS2;GLS;PPFIA3;SLC1A3;GRM4;UNC13A;SNAPIN;SLC6A4;GAD1;PPFIA4;SLC32A1
prerank,establishment of endothelial barrier (GO:0061028),-0.716287222917197,-2.2425866281267886,0.0,0.0,0.0,15/29,11.03%,TJP1;RAPGEF2;PECAM1;F11R;RAB1A;ICAM1;MSN;AFDN;PDE2A;ROBO4;RAP1A;EZR;TJP2;RAP1B;RAPGEF1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6159032066632677,2.241966331739567,0.0,0.0002902149655119198,0.004,29/57,14.09%,GRIA3;NLGN1;DLG2;LRRC7;DLGAP1;GRIN2B;GRIA4;DLGAP2;OPRM1;LYNX1;GRIN2A;SHANK1;NPTXR;GRIA1;CACNG8;NPTX2;CAMK2B;NETO1;CACNG3;GRIA2;MINK1;CACNG2;CACNG4;PRRT1;DLG4;DLGAP3;NLGN2;CACNG5;BEGAIN
prerank,neuron cell-cell adhesion (GO:0007158),0.842739583183601,2.2289629276087415,0.0,0.0003264918362009097,0.005,7/14,4.93%,NRXN3;NRXN1;NLGN1;NCAM2;CNTN4;ASTN2;ASTN1
prerank,presynapse assembly (GO:0099054),0.8192851820972362,2.2224951201002856,0.0,0.00041553506425570327,0.007,5/16,0.55%,PTPRD;IL1RAPL1;NLGN1;PCLO;LRRTM3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6162897417959421,2.2095680513229827,0.0,0.00043532244826787966,0.007,24/46,15.07%,NRXN1;GRM5;NLGN1;SYT1;DGKI;ATP1A2;GRM8;CDK5;CLN3;CACNG8;GRM1;ATAD1;GRIK1;HOMER1;CACNG3;GRM7;CACNG2;CACNG4;CDH2;CCL2;NLGN2;CACNG5;GRM4;UNC13A
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6414075496616877,2.1786999778812906,0.0,0.0008036722121868547,0.014,13/37,6.66%,PTPRD;GRID2;IL1RAPL1;TENM4;NLGN1;TENM1;TENM3;IGSF21;CEACAM5;DCHS1;TENM2;CXADR;NECTIN3
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.5684742232495624,-2.1736428396160754,0.0,0.0010200847051645362,0.004,35/84,16.14%,FOXP1;TEK;NRP2;NOS3;ETS1;RAC1;BMPR2;THBS1;TMSB4X;KDR;ANXA3;PLCG1;PRKD2;SP1;ABL1;FGF1;BMP4;PRKD1;AKT3;FLT4;SCARB1;RRAS;BCAR1;PIK3CD;AKT1;EDN1;BCAS3;RIN2;FGF2;CD40;PIK3CB;ROCK2;SMOC2;LGMN;ANGPT1
prerank,regulation of synapse assembly (GO:0051963),0.6068235752163227,2.133946460485662,0.0,0.0020055927080913027,0.04,19/46,13.33%,PTPRD;NRXN1;GRID2;IL1RAPL1;ROBO2;NLGN1;LRFN5;IL1RAPL2;MUSK;EPHB1;SYNDIG1;MDGA1;SLITRK1;SLIT1;LRFN4;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,positive regulation of nervous system development (GO:0051962),0.6080420484803489,2.115617186673275,0.0,0.002960192648221582,0.062,14/42,13.33%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;OPRM1;MME;EPHB1;SYNDIG1;GPER1;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,neuropeptide signaling pathway (GO:0007218),0.562784533146662,2.1128013756089357,0.0,0.0030200494848584146,0.066,16/58,11.23%,GLRA3;HCRTR1;OPRM1;SORCS1;SORCS3;NXPH3;PNOC;GLRA1;GPR37;CPE;NXPH4;NPY;KISS1R;SORL1;PENK;NMUR2
prerank,calcium ion transport into cytosol (GO:0060402),0.7021322882145656,2.1084396159859295,0.0,0.0029960427321965833,0.07,10/21,11.91%,GRIN2B;MS4A1;ATP2B4;CACNA2D1;GRIN2A;CACNB3;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6418633635130923,2.106419786616649,0.0,0.0029747033964971775,0.074,15/35,10.12%,CDH18;NLGN1;CDH8;PCDHGB4;CDH20;CDH9;CDH10;PCDHB5;DCHS1;CDH19;CDH12;CDH7;CDH17;CDH24;CDHR3
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.5394427869732403,-2.1052735328993166,0.0,0.0053129411727319605,0.023,42/92,17.07%,FOXP1;TEK;RREB1;NRP2;DOCK1;ETS1;RAC1;PRKCE;BMPR2;THBS1;KDR;ANXA3;MTOR;PLCG1;PRKD2;ADAM9;ABL1;TGFB2;FGF1;BMP4;PPM1F;PRKD1;FLT4;PLCG2;SCARB1;RRAS;BCAR1;PIK3CD;FGF7;AKT1;EDN1;BCAS3;RIN2;FGF2;PIK3CB;MAP4K4;ROCK2;SMOC2;ANGPT1;RAB11A;CTSH;HDAC6
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4994613347618882,-2.097016396261125,0.0,0.005829055458083065,0.03,40/128,12.22%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;BMPR2;SMURF2;GCNT2;BMP5;F11R;RNF111;ID1;SMURF1;TGFBR3;ADAM9;TGFBR2;BMP6;CBL;PXN;ITGB5;PDCD4;HIVEP1;TGFB2;PTK2;BMP4;PTPRK;CDH5;JUN;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE;RHOA
prerank,regulation of cation channel activity (GO:2001257),0.5242174172258218,2.095027799570367,0.0,0.003368021047125174,0.086,39/89,17.85%,GRIA3;FGF14;NLGN1;DLG2;LRRC7;ANK3;GRIN2B;GRIA4;FGF12;OPRM1;GRIN2A;SHANK1;HPCA;GRIA1;CALM2;CACNB3;CACNG8;CAMK2B;HOMER1;NETO1;CACNG3;CACNB4;GRIA2;STAC;MINK1;CACNG2;CACNG4;PRRT1;HRC;DLG4;NLGN2;CACNG5;KCNS2;SHISA9;SELENON;NEFL;EPO;CACNB1;CNIH2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.8088914156750763,-2.0888113576031326,0.0,0.0057379764665505175,0.033,9/14,11.47%,GHR;LYN;PTPN1;PXN;PIK3R1;PTK2;STAT6;SOCS2;JAK2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.5336238046402313,-2.0856706665241447,0.0,0.005242101957095535,0.034,29/87,12.22%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;GCNT2;F11R;ID1;SMURF1;TGFBR3;ADAM9;TGFBR2;CBL;PXN;ITGB5;TGFB2;PTK2;PTPRK;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;RHOA
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.7651737062722338,-2.075259215666377,0.0,0.00561046587840495,0.04,9/17,12.19%,PBX1;CREBBP;MAML2;KAT2B;NOTCH3;PLXND1;MAML1;NOTCH4;NOTCH1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.5052438209741286,-2.066982240636875,0.0,0.005911854541294472,0.047,35/112,12.80%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;LIMS1;GCNT2;F11R;ID1;NR3C1;SMURF1;TGFBR3;PDE3A;ADAM9;TGFBR2;CBL;PXN;ITGB5;PDE2A;TGFB2;PTK2;PTPRK;MEF2C;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;RHOA;WWOX
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.6347238676090955,-2.066734777248572,0.0,0.0054191999961866,0.047,16/33,14.15%,TJP1;SEMA6A;KLF4;BMPER;RHOJ;KLF2;THBS1;JAK1;FGF1;SMAD1;CEMIP2;ADAMTS9;FGF2;S100A1;CEACAM1;PIK3CB
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6283423556020304,2.053194932747406,0.0,0.006595135091258376,0.175,10/33,4.29%,GRID2;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;PSMC5;CACNA1B;CACNA1A
prerank,positive regulation of synapse assembly (GO:0051965),0.6502787791169548,2.0486311731662723,0.0,0.006996253632876638,0.193,11/27,13.33%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,Notch signaling pathway (GO:0007219),-0.5668461863338495,-2.0478698104962074,0.0,0.0069640398141040455,0.061,27/59,17.95%,PBX1;ZNF423;CREBBP;MAML2;GMDS;KAT2B;DTX3L;NOTCH3;HES1;JAG2;PSEN2;SORBS2;PLXND1;MAML1;NOTCH2;ADAM10;MIB1;NOTCH4;PSEN1;GALNT11;NOTCH1;DTX3;JAG1;NLE1;APH1A;HEY1;HEY2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6662824959072706,-2.0431720171467864,0.0,0.006830924364941091,0.065,21/26,29.65%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;CDK10;AKT1;RGCC;RPTOR;UBE2E2;LSM11;ANXA1;LSM10;CCND1;MTBP;TFDP1;ADAM17;FGF10;RDX;CCND2
prerank,protein localization to cell-cell junction (GO:0150105),-0.7777803105781157,-2.034206924330306,0.0,0.007990663523788868,0.081,11/15,16.15%,TJP1;MPP7;F11R;JAK1;PAK2;CGNL1;LSR;CDH5;TJP2;ACTB;ARHGEF18
prerank,axon development (GO:0061564),0.518832325586987,2.027865303620792,0.0,0.009023047109552415,0.243,30/78,10.41%,CTNNA2;L1CAM;DCC;ANK3;CNTN4;DSCAML1;SHTN1;CDK5;NTNG2;NTNG1;PLPPR4;PLP1;NRCAM;ATL1;PAX2;PAK3;MAP1S;FGFR2;SLITRK1;MAPT;POU4F1;RTN4;NEFH;S100A6;GRM7;SPTBN4;SLITRK4;MAP1B;CCK;RAB3A
prerank,regulation of cation transmembrane transport (GO:1904062),0.6367688903221165,2.018234326727895,0.0,0.010135442219454328,0.273,12/29,8.21%,KCNIP4;DPP10;KCNIP1;FGF12;DPP6;ATP2B4;KCNN2;CD63;WNK3;CACNA1D;HOMER1;SCN5A
prerank,regulation of cellular component biogenesis (GO:0044087),-0.6006050889243111,-2.017910015973768,0.0,0.010200847051645364,0.11,22/39,23.60%,TJP1;DAB2IP;RAPGEF2;SNCAIP;TIE1;MSN;IRGM;RAP1A;EZR;RAP1B;ROCK1;SPTY2D1;HJURP;RAPGEF1;NOTCH1;HCFC1;ROCK2;NCLN;CCL19;PTPN11;HSP90AA1;GFAP
prerank,regulation of DNA binding (GO:0051101),-0.5902209047190446,-2.0164567933157183,0.0,0.00967580345339891,0.111,21/44,20.11%,LEF1;SP100;SMO;HES1;NFKBIA;ZBTB7A;NGF;JUN;HJURP;DOT1L;JAK2;MAPK8;FOXC1;ILRUN;IGF1;SKI;SUMO1;TFAP4;CEBPG;TXN;PPARG
prerank,regulation of potassium ion transport (GO:0043266),0.6264119356002853,2.0163486630843663,0.0,0.010039623963177974,0.281,10/31,9.31%,KCNIP4;DPP10;KCNIP1;ANK3;DPP6;KCNA5;KCNN2;CD63;CACNA1D;ADRA2A
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.6336941600485901,-2.0160576047494616,0.0,0.009279937248371825,0.112,10/29,11.47%,GHR;PKD2;IL15;IFNAR1;NMI;STAT6;STAMBP;SOCS2;STAT2;JAK2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5018148065304517,-2.013434944835648,0.0,0.009328406185386221,0.115,34/100,14.48%,FLT1;TEK;DAB2IP;IGF1R;GAB1;ROR1;INSR;LYN;PDGFD;KDR;EGFR;PIP4K2A;CBL;PIK3R1;TGFB2;NEDD4;PTK2;PIP4K2B;STAMBP;PIP5K1B;MAPK1;HAX1;IER3;WNT16;PIK3CD;JAK2;MAZ;FGF2;CEACAM1;PTPN13;MYOC;HGF;PIK3CB;PIK3IP1
prerank,potassium ion transport (GO:0006813),0.4764912329970815,2.011070002517662,0.0,0.010552216146013402,0.296,20/120,5.25%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;KCNMA1;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;SLC9A9
prerank,negative regulation of DNA binding (GO:0043392),-0.6411479795083276,-2.0049422039221825,0.0,0.010264602345718146,0.131,13/28,17.95%,LEF1;SP100;SMO;NFKBIA;JUN;SIN3A;JAK2;ILRUN;MAD2L2;SUMO1;TFAP4;HEY1;HEY2
prerank,receptor clustering (GO:0043113),0.6409414033405951,2.002516775133,0.0,0.011427214267031839,0.325,6/27,3.18%,NRXN1;MAGI2;NLGN1;DLG2;LRRC7;MUSK
prerank,sprouting angiogenesis (GO:0002040),-0.5702291086117515,-1.9991346816984163,0.0,0.010929478983905746,0.146,29/51,24.90%,TEK;ENG;ACVRL1;RSPO3;ADGRA2;BMPER;PARVA;THBS1;KDR;RNF213;OTULIN;SLIT2;BMP4;FLT4;RAMP2;AKT1;VEGFC;NAXE;FGF2;JMJD6;ANGPT1;PIK3R3;SEMA3E;PTK2B;RECK;ESM1;E2F7;SEMA5A;EGR3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5905967809340352,-1.9986148860182846,0.0,0.010606562559381258,0.148,17/42,14.75%,UTRN;TEK;FERMT2;RAC1;LIMS1;GSK3B;CCL25;KDR;PTPRJ;ABL1;ROCK1;PPM1F;RRAS;RIN2;MYOC;CDK6;MAP4K4
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5697585683719221,-1.990990401711034,0.0,0.011475952933101033,0.167,30/48,30.81%,JCAD;NOS3;ETS1;RHOJ;THBS1;TMSB4X;KDR;PLCG1;PRKD2;SP1;PIK3C2A;PRKD1;AKT3;AKT1;MAP3K3;FGF2;CD40;ANGPT1;ANXA1;GATA2;HDAC7;MAP2K3;HMGB1;ADAM17;HMOX1;ANGPT4;FGF18;FOXC2;MAPK14;TGFB1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.7024580929548145,-1.9829859921526627,0.0,0.01200724705037423,0.181,11/19,14.75%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;ABL1;ROCK1;PPM1F;MYOC;MAP4K4
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.616412661707536,-1.9818807319933764,0.0,0.01188398681516685,0.187,17/32,21.76%,JCAD;KLF4;RHOJ;THBS1;KDR;MEOX2;PIK3C2A;AKT3;STARD13;MAP3K3;NOTCH1;RHOA;FGF2;ANXA1;GATA2;DLL4;HDAC7
prerank,synaptic vesicle exocytosis (GO:0016079),0.5693402790748106,1.980735504477658,0.0,0.015623238976725013,0.423,10/40,6.17%,SYT1;PCLO;SYT5;RIMS2;SNAP25;SNPH;RIMS1;CDK5;STX2;PRRT2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5974468151531189,-1.977276082406398,0.0,0.012260633475535292,0.199,15/38,15.15%,SP100;NOS3;GSK3B;THBS1;BMP5;DDX3X;TNFSF10;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;GPX1;TNFAIP3;FEM1B
prerank,positive regulation of synaptic transmission (GO:0050806),0.5110673605464053,1.9754489875875685,0.0,0.016301270964602564,0.449,25/72,13.44%,NRXN1;NLGN1;GRIK2;SYT1;MPP2;SLC24A2;GRIN2B;RIMS2;RIMS1;ADCY8;GRIN2A;CACNG8;SLC8A2;CACNG3;GPER1;CACNG2;PRKCZ;ADRA1A;CACNG4;CLSTN2;SLC8A3;DLG4;CCL2;NLGN2;CACNG5
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7624419846960974,-1.9746809595177544,0.0,0.012326023520738149,0.21,7/14,11.79%,NOS3;ACE;ECE1;ENPEP;EDN1;EDN3;AGTR1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.662287946227798,-1.973723640481056,0.0,0.011976887386530044,0.211,10/23,12.30%,ENG;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5285434542873559,-1.965330410639265,0.0,0.01376234968605603,0.245,37/66,28.03%,RB1;DCUN1D3;KLF4;PKD2;ANKRD17;KMT2E;DDX3X;EGFR;DLG1;PLCB1;CCND3;PSME2;FAM107A;AKT1;RGCC;RPTOR;CDC73;UBE2E2;LSM11;CDK6;ANXA1;LSM10;CDK2AP2;PSME1;CCND1;PTEN;CDKN2C;FHL1;E2F7;TFDP1;INO80;ADAM17;APC;FGF10;KIF14;CDKN2B;RDX
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6312367924453129,-1.9653087535646487,0.0,0.013303604696520829,0.245,13/30,9.39%,TJP1;PECAM1;CLDN5;ITGB1;JAM2;ESAM;F11R;LSR;SLC12A2;CDH5;TJP2;MFSD2A;OCLN
prerank,synapse assembly (GO:0007416),0.5156798667299279,1.9597341822247811,0.0,0.019724610242206682,0.525,19/67,9.51%,KIRREL3;NRXN1;GRID2;NLGN1;LRRTM3;GABRB3;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;GABRB2;GABRA2;NRCAM;GPM6A;SDK1;SLITRK1;POU4F1;GABRA1
prerank,endothelial cell proliferation (GO:0001935),-0.7146190898543967,-1.9528481953145551,0.0,0.016082787085457004,0.297,8/17,7.35%,TEK;ACVRL1;BMPER;CD34;BMPR2;DLG1;BMP4;ERN1
prerank,synaptic membrane adhesion (GO:0099560),0.7167506702004174,1.9479238846041929,0.0,0.022484404453035987,0.582,8/14,10.44%,PTPRD;LRRC4C;LRFN5;NTNG1;SLITRK1;PTPRS;LRFN4;LRRC4B
prerank,neuronal action potential (GO:0019228),0.6527399918889324,1.945740769792182,0.004662004662004662,0.022117188903932595,0.59,8/22,9.96%,ANK3;SCN8A;SCN1A;SCN3A;KCNA2;SCN2A;SCN5A;GPER1
prerank,calcium ion import into cytosol (GO:1902656),0.684464609398655,1.9259634299041661,0.0,0.027527342939689198,0.675,7/15,11.91%,SLC24A2;MS4A1;ATP2B4;CACNA2D1;SLC8A2;SLC8A3;SLC8A1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.5988986790771538,-1.9211448800831898,0.0,0.02769370586286534,0.45,11/30,12.30%,ENG;XIAP;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,secondary palate development (GO:0062009),-0.7358781586898655,-1.9174527214780104,0.0,0.028245527252851364,0.466,7/14,13.26%,LEF1;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD4;WNT11
prerank,blood vessel morphogenesis (GO:0048514),-0.5372657345561667,-1.9124580731490115,0.0,0.029889981985887333,0.493,20/54,12.04%,FLT1;ENG;CAV1;LRP5;ID1;TBX1;KDR;SOX17;TGFBR3;TGFBR2;HES1;RASIP1;COL4A1;FLT4;RAMP2;LAMA1;CUL7;SMAD7;ADM;RASA1
prerank,synapse organization (GO:0050808),0.4502253250106677,1.9122378686225583,0.0,0.03179832610756739,0.741,38/125,11.77%,KIRREL3;PTPRD;NRXN1;GRM5;LRRC4C;NLGN1;L1CAM;LRFN5;ANK3;ARHGAP39;CTNND2;PPFIA2;WNT7B;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;MUSK;NTNG1;NRCAM;CACNB3;SNCG;PAK3;SLC8A2;GPM6A;SDK1;CACNB4;SLITRK1;CNTN2;MAPT;POU4F1;PTPRS;LRFN4;LRRC4B;CBLN1;CDH2;SLC8A3
prerank,central nervous system neuron differentiation (GO:0021953),0.5856107524134995,1.911671224142409,0.0,0.031112751449733748,0.743,14/33,10.91%,GRID2;MDGA2;SPOCK1;CHD5;LHX1;TOX;MDGA1;MAP2;PROX1;NPY;NTRK2;MAPT;FAIM2;CBLN1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5647866317338395,-1.9111614375490424,0.0,0.02972818283622363,0.498,21/39,24.42%,TEK;THBS1;KDR;ICAM1;PLCG1;GAS6;PDCD4;CDH5;RAMP2;RGCC;ANO6;ITGA4;ECSCR;CD40;TNFAIP3;ANGPT1;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6406998616681856,-1.9092132630705472,0.001736111111111111,0.02968163135166255,0.505,11/24,13.14%,SEC31A;SEC24B;ACE;SEC24A;ABCB9;SEC24D;TAP2;SEC13;BCAP31;HFE;PDIA3
prerank,regulation of NMDA receptor activity (GO:2000310),0.5901495048446612,1.9076088165447957,0.0021413276231263384,0.03180963318414577,0.762,11/32,8.83%,GRIA3;NLGN1;DLG2;LRRC7;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA1;CAMK2B;GRIA2
prerank,sensory perception of smell (GO:0007608),0.7551607628140612,1.8941942484068177,0.0022172949002217295,0.03696613123208078,0.819,5/11,16.20%,SLC24A4;BBS4;UBR3;ADCY3;MKKS
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5268102650059082,-1.8868586265757228,0.0,0.0402864533897751,0.608,24/54,16.67%,TEK;ACVRL1;FERMT2;RAC1;LIMS1;CORO1C;THBS1;KDR;PTPRJ;ABL1;MACF1;PTK2;ROCK1;PPM1F;LDB1;FAM107A;BCAS3;RHOA;LIMCH1;DUSP3;MYOC;MAP4K4;ROCK2;SLK
prerank,protein localization to synapse (GO:0035418),0.7481836398854725,1.8865533333671998,0.0,0.03944374345454233,0.847,6/12,13.33%,NRXN1;NLGN1;PCLO;SHANK1;DLG4;NLGN2
prerank,sensory perception of chemical stimulus (GO:0007606),0.6932158762080424,1.885827878487718,0.0022675736961451248,0.0387322420419395,0.849,6/15,16.20%,SLC24A4;GNAL;BBS4;UBR3;ADCY3;MKKS
prerank,regulation of angiogenesis (GO:0045765),-0.42572340615251386,-1.8843043995485702,0.0,0.04100472071417972,0.629,66/192,20.79%,FLT1;TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;SP100;ITGB1;GAB1;COL4A2;NOS3;TIE1;ADGRA2;KLF4;BMPER;ETS1;CD34;RHOJ;THBS1;KDR;ANXA3;PLCG1;PRKD2;SP1;TGFB2;FGF1;ISM1;CDH5;PLXND1;ROCK1;HSPG2;PRKD1;CEMIP2;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;RGCC;STAB1;NAXE;FGF2;MTDH;CEACAM1;ECSCR;CD40;MECP2;AGO2;TNFAIP3;FOXC1;ROCK2;SMOC2;FOXO4;NPR1;HIPK1;GTF2I;CTSH;CTNNB1;SASH1;SEMA3E;GATA2;EPHA2;PPARG;F3;BRCA1;NF1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6244922071744532,-1.883048769802753,0.0,0.040541828025770034,0.632,13/24,14.75%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;PIK3R1;ABL1;ROCK1;PPM1F;DUSP3;MYOC;MAP4K4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.4547155471225197,-1.881747402903089,0.0,0.04026146820696279,0.637,48/122,21.67%,SORBS1;INSR;KLF4;THBS1;STN1;EIF3E;METTL14;DDX3X;KDR;MTOR;PRKD2;NIBAN1;EGFR;PLD1;EIF3C;NFKB1;IRS1;TGFB2;UPF3B;SAMD4A;ABCB10;LDB1;NAMPT;RPL26;AKT1;ZCCHC4;RGCC;EEF2;JAK2;FGF2;DNA2;CTC1;LARP4B;HGF;RPS4X;SMOC2;RPL5;METTL5;IGF1;NLRC5;CCL19;NOD2;SOX4;PRKDC;FGFR4;IGF2;RBM3;PDGFRB
prerank,mesenchymal cell differentiation (GO:0048762),-0.5280909312607222,-1.8794624779104832,0.0,0.04083448835003159,0.654,24/51,20.86%,LEF1;ENG;LIMS1;GSK3B;FBXL17;LOXL3;TGFBR3;LRP6;TGFB2;MEF2C;ROCK1;HNRNPAB;CUL7;NOTCH4;NOTCH1;FOXF2;HGF;FOXC1;ROCK2;BMP7;CTNNB1;HEY2;AKNA;TRIM28
prerank,artery morphogenesis (GO:0048844),-0.5821337142306862,-1.8765252394218659,0.0,0.041714178121906934,0.668,21/30,28.96%,ENG;PKD2;BMPR2;TBX1;HES1;TGFB2;BMP4;TBX2;ADAMTS9;SMAD7;NOTCH1;JAG1;HEY2;NF1;PDGFRB;FOXF1;GJA5;LRP1;STRA6;TGFBR1;LRP2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.7036698605884153,-1.8764364005732113,0.0017825311942959,0.040922002707181986,0.668,9/15,15.65%,THBS1;TMSB4X;PRKD2;FGF1;PRKD1;NOTCH1;FGF2;SMOC2;LGMN
prerank,regulation of gastrulation (GO:0010470),0.7070040733812553,1.875134179996788,0.0,0.04292949066764783,0.878,5/14,6.40%,TENM4;LHX1;OSR1;PHLDB1;PHLDB2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.5408647922122756,-1.874954622565766,0.0,0.040455632057093543,0.67,22/47,20.86%,LEF1;ENG;LIMS1;GSK3B;LOXL3;TGFBR3;TGFB2;ROCK1;HNRNPAB;TASOR;CUL7;NOTCH4;NOTCH1;FOXF2;HGF;ROCK2;BMP7;CTNNB1;HEY1;HEY2;AKNA;TRIM28
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7064836716163266,1.874720285823944,0.0,0.042035823910867125,0.88,6/15,8.90%,GRM5;GRM8;GRM1;HOMER1;TRPM1;GRM7
prerank,sodium ion transmembrane transport (GO:0035725),0.47005353815244927,1.8726653006168326,0.0,0.04201392506819512,0.887,22/84,9.21%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SCN1B;SCN1A;ATP12A;SLC6A15;SLC9A7;SLC4A4;SCN3A;ATP1B1;SLC6A11;SLC9A9;SCN2A;SLC8A2;SCN5A;ATP4A;SLC6A2;SLC6A5
prerank,positive regulation of glucose import (GO:0046326),-0.6348995129772217,-1.872355845561373,0.0052173913043478265,0.04117175212789087,0.683,9/21,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;CREBL2;IGF1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.5785239103781008,-1.8701104611878727,0.0,0.04146866084038441,0.687,23/33,29.65%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;STXBP4;PLCG2;AKT1;RGCC;RPTOR;CDC73;UBE2E2;LSM11;ANXA1;LSM10;CCND1;TFDP1;CRNN;ADAM17;FGF10;RDX;CCND2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5796829866747238,-1.867938504655417,0.0017857142857142857,0.04245831286123669,0.709,21/34,25.48%,FLT1;DAB2IP;SEMA6A;GAB1;KDR;PRKD2;ERN1;MAPKAPK2;PRKD1;FLT4;RAMP2;VEGFC;NOTCH1;FOXC1;ANXA1;DLL4;MAP2K3;RELA;EGR3;PIK3CA;MT1G
prerank,sodium ion export across plasma membrane (GO:0036376),0.723004208531369,1.8639876906495312,0.0022727272727272726,0.045242440159268926,0.908,5/13,8.72%,ATP1A2;ATP12A;SLC4A4;ATP1B1;ATP4A
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4956122296537037,-1.8635791080639696,0.0,0.044416188204039184,0.732,23/72,14.15%,FLT1;TEK;IGF1R;GAB1;ROR1;INSR;LYN;PDGFD;KDR;CBL;PIK3R1;TGFB2;NEDD4;PTK2;HAX1;WNT16;PIK3CD;JAK2;MAZ;FGF2;MYOC;HGF;PIK3CB
prerank,positive regulation of cell communication (GO:0010647),0.582768935480215,1.858058473505195,0.0023094688221709007,0.047060381413331125,0.918,9/28,12.35%,GRIK2;SYT1;ANK3;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;DLG4
prerank,endothelial cell development (GO:0001885),-0.6098856800718335,-1.8537116102583817,0.0017985611510791368,0.049312768272622355,0.765,11/25,11.76%,RAPGEF2;PECAM1;ICAM1;MSN;PDE2A;ROBO4;RAP1A;EZR;RAP1B;RAPGEF1;COL15A1
prerank,hemopoiesis (GO:0030097),-0.4637901369042132,-1.8533484604409098,0.0,0.048581534083461046,0.765,29/87,14.85%,MECOM;FLT1;TEK;KITLG;ETV6;ZBTB16;SNRK;CD34;CDK13;KDR;KAT6A;TGFBR3;TGFBR2;TET2;TGFB2;BMP4;NOTCH2;FLT4;RRAS;TAL1;TP53;FUT10;NOTCH4;PRRC2C;ZFPM1;ASH2L;MKNK2;ATF4;JAG1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5895705661118068,-1.8496375468261403,0.0,0.050104160518375754,0.778,15/30,23.22%,NOS3;GSK3B;BMP5;DDX3X;TNFSF10;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;GPX1;TNFAIP3;BRCA1;SERPINE1;RIPK1
prerank,sodium ion transport (GO:0006814),0.45779347960815275,1.8490073661811945,0.0,0.050977248061369315,0.933,27/85,15.60%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SLC5A12;SCN1B;SCN1A;CATSPER4;SLC6A15;SLC4A4;SCN3A;ATP1B1;SLC6A11;SCN2A;SLC8A2;SCN5A;SLC6A2;SLC6A5;SLC8A3;SLC8A1;SGK1;SCN2B;ASIC1;SLC4A11;SLC6A4
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.573143200452886,-1.8474183484397457,0.0,0.05044024611835219,0.789,10/33,9.23%,PTPRG;DAB2IP;PTPRM;SP100;ACVRL1;CORO1C;THBS1;MCC;SLIT2;ADAMTS9
prerank,tight junction assembly (GO:0120192),-0.5366365327680512,-1.846073715709149,0.0017985611510791368,0.05028247721211983,0.795,14/49,9.78%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;LSR;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,regulation of epithelial cell migration (GO:0010632),-0.5205662243415713,-1.844824900656386,0.0,0.05024861695810494,0.8,16/51,9.00%,PTPRG;DAB2IP;RREB1;DOCK1;BMPER;RHOJ;PRKCE;BMPR2;CORO1C;MCC;PLCG1;TGFB2;MACF1;PTK2;PPM1F;PLCG2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.6041783977445102,-1.842884732002733,0.0,0.050795581568534066,0.81,9/25,11.47%,GHR;PKD2;IFNAR1;NMI;STAT6;STAMBP;SOCS2;STAT2;JAK2
prerank,BMP signaling pathway (GO:0030509),-0.4988757188489323,-1.8423835074176824,0.0,0.0503211428217327,0.814,20/62,11.78%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;TGFB2;BMP4;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.47980776172664963,-1.8420203313517485,0.0,0.04977386993401521,0.816,28/72,17.77%,AKAP13;BCR;HEG1;EPS8;RAC1;ARHGEF3;NET1;ARHGEF28;STARD8;ITGA3;RALBP1;F11R;SCAI;EPS8L2;RASIP1;ABL1;CUL3;ARHGDIA;PRAG1;ARHGEF2;RAF1;STARD13;TNFAIP1;MYOC;ARHGEF18;KCTD10;ARHGAP35;ADGRG1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7756025922564921,-1.8399042764765718,0.0,0.05014683647586869,0.824,6/11,7.60%,TJP1;RAPGEF2;F11R;RAB1A;AFDN;TJP2
prerank,positive regulation of protein modification process (GO:0031401),-0.4123758724390251,-1.8395511183358513,0.0,0.04953462169993892,0.825,59/203,13.69%,TEK;PECAM1;ENG;TRABD2B;PPP2R5A;DYRK1A;INSR;DAB2;RAC1;FAM20A;LYN;RAB3GAP1;DVL3;APP;ATG7;RALBP1;LIMK2;RAMP1;TBX1;LRRK2;ATG10;DDX3X;ALG10B;KDR;NIBAN1;SLCO3A1;EGFR;ACE;TFRC;GAS6;ABL1;FAS;IL34;CCND3;PTK2;IRGM;PRKCD;FGF1;SPPL3;BMP4;CDH5;NOS1AP;FLT4;ACVR2A;ASPSCR1;FGF7;AKT1;VEGFC;AXIN2;RAB3GAP2;ILK;FGF2;LIMCH1;CSNK1D;KAT5;FLOT1;CHP1;CD40;HGF
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4721336331513153,1.839207866195235,0.0024875621890547263,0.055851870112768966,0.953,30/75,12.35%,CTNNA2;DCC;ANK3;CNTN4;DSCAML1;SHTN1;CDK5;NTNG2;NTNG1;PLPPR4;NRCAM;ATL1;DCDC2;PAX2;PAK3;MAP2;MAP1S;FGFR2;SLITRK1;POU4F1;NEFH;S100A6;MINK1;SPTBN4;SLITRK4;MAP1B;CCK;RAB3A;CELSR2;LLGL1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6839305467620582,-1.8361023671382235,0.0,0.05077046584662662,0.836,8/14,13.55%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40
prerank,apical junction assembly (GO:0043297),-0.5216554878721108,-1.8355979029067422,0.001763668430335097,0.05006358337846444,0.836,17/53,14.01%,CTNNA1;PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2;RHOA;RHOC;PKN2
prerank,positive regulation of cell motility (GO:2000147),-0.4154500078392678,-1.8336891248585696,0.0,0.05034611609360453,0.84,76/205,22.76%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;SEMA3C;ITGB1;PODXL;FERMT2;INSR;CAV1;DAB2;CBLL1;NTN1;PDGFD;SEMA7A;THBS1;GCNT2;ATM;SPOCK2;SYNE2;KDR;SMO;EGFR;ADAM9;PTK2;FGF1;CDH5;PPM1F;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;EDN1;MAZ;TWIST2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;ACTN4;NEDD9;WNT11;MYOC;RHOC;HGF;NUMB;MAP4K4;ROCK2;VSIR;CAVIN1;SEMA5B;PIK3R3;IGF1;RIPOR1;CTSH;SEMA4A;SEMA3E;CCL19;WASHC1;CXCL12;F3;FERMT3;LAMB1;SEMA4G;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;PTK2B;CCN1;MIEN1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6352900973704734,-1.8310977823639019,0.0036231884057971015,0.05153046943152598,0.853,8/21,17.13%,DAB2IP;CD2AP;CGNL1;SLIT2;TGFB2;STAMBP;SPRY4;ARHGAP12
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.7439679317872709,-1.8309811350991454,0.0018315018315018315,0.05082492349364712,0.853,4/12,7.28%,IGF1R;INSR;IRGM;BNIP3
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.46942017724598933,-1.8275896203913344,0.0,0.052220490098999914,0.862,52/91,31.94%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;SRPRA;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;SIL1;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8;SEC63
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.584025644442814,-1.8272052507921122,0.003669724770642202,0.05158382884070666,0.865,16/27,24.82%,ACVRL1;BMPR2;ATM;PRKD2;PARP4;DACH1;HMBOX1;RGCC;FGF2;HGF;SMOC2;TERF2;FGFR4;PDGFRB;SMG6;PINX1
prerank,stress fiber assembly (GO:0043149),-0.7020159058845752,-1.8260251782497685,0.0,0.05077921657326405,0.871,9/15,12.22%,SORBS1;ITGB1;FAM171A1;ITGB5;CUL3;PDLIM1;TNFAIP1;PHACTR1;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),-0.7020159058845752,-1.8260251782497685,0.0,0.05077921657326405,0.871,9/15,12.22%,SORBS1;ITGB1;FAM171A1;ITGB5;CUL3;PDLIM1;TNFAIP1;PHACTR1;RHOA
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6433187977122807,-1.8210264697247152,0.005555555555555556,0.05342508845345424,0.888,10/19,19.29%,TJP1;PRKCH;CLDN5;CBFB;F11R;ROCK1;OCLN;ROCK2;IKBKB;EPHA2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.5254988673794869,-1.8210163187568689,0.0,0.05269830450073221,0.888,21/46,23.27%,PIEZO2;F11R;NFKB1;PDE2A;FAS;BNIP3;IRF1;CASP8;CRADD;CD40;MAPK8;TNFRSF1A;MAP2K4;CASP8AP2;MAP3K14;CHEK1;PIEZO1;CASP2;LTBR;GADD45A;CASP1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7501059457020476,-1.8206709127090959,0.0018726591760299626,0.05222546342638154,0.891,3/11,1.78%,MECOM;ETV6;CD34
prerank,neuron projection morphogenesis (GO:0048812),0.42720298975291515,1.820131857176718,0.0,0.06734249004074416,0.974,48/137,13.10%,CNTNAP2;NLGN1;CTNNA2;DCC;ANK3;CNTN4;DSCAML1;CTNND2;DOCK10;EPB41L3;SHTN1;CDK5;EPHB1;NTNG2;NTNG1;PLPPR4;SHANK1;NBL1;NRCAM;TNIK;ATL1;DCDC2;IMPACT;PAX2;PAK3;MAP2;MAP1S;GPM6A;PAK1;FGFR2;SLITRK1;NYAP2;POU4F1;NEFH;S100A6;MINK1;SPTBN4;CPNE1;SLITRK4;MAP1B;CCK;RAB3A;SRGAP2;CELSR2;LLGL1;DLG4;SGK1;BDNF
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6891653934523565,-1.8190189683754654,0.0017667844522968198,0.0525981176100464,0.897,6/15,5.93%,IGF1R;DYRK1A;KDR;EGFR;BMX;ABL1
prerank,potassium ion transmembrane transport (GO:0071805),0.42548995572608755,1.8175282068094698,0.0,0.06781304904241023,0.978,34/135,15.23%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;ATP12A;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;ATP1B1;SLC9A9;SLC12A5;ATP4A;KCNJ6;KCNN3;KCND1;SLC12A4;SLC1A3;KCNS2;KCNC4;KCNK12;KCNK10;KCNA4;KCNK9
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.5207498714865318,-1.8153984728046875,0.0,0.05420073356379377,0.911,24/47,27.56%,RREB1;ZBTB16;LRP5;SOX13;TRPM4;SIX1;NAPEPLD;PPARD;AKT1;LPL;TMEM64;CREBL2;BMP7;CARM1;CMKLR1;PPARG;AAMDC;CREB1;SYAP1;PIM1;BMP2;ZFP36L1;FRZB;HNRNPU
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6961494278075735,-1.8139543153733022,0.0017699115044247787,0.05438154272802833,0.912,10/14,22.63%,SEC31A;SEC24B;RAB1A;SEC24A;SEC24D;SEC13;SEC23B;TBC1D20;SEC24C;SAR1A
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6307123784421819,1.8130014747792875,0.002304147465437788,0.0694883458047603,0.983,8/18,10.73%,GRID2;GRIK5;GRIK2;GRID1;CDH8;GRIK1;GRIA2;SLC17A6
prerank,bicellular tight junction assembly (GO:0070830),-0.534348699244735,-1.8124272251378057,0.0018281535648994515,0.0546595387850664,0.918,13/46,9.78%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.528651990660503,-1.8118165575956844,0.0035149384885764497,0.05447722101429687,0.918,16/43,16.77%,FOXP1;THBS1;LDLRAP1;MMP2;IL6R;BMP4;ERN1;JUN;AKT1;EDN1;FGF2;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.5026840372664964,-1.8108031918673146,0.0,0.054316198586683094,0.918,32/54,30.81%,ACVRL1;NOS3;ETS1;THBS1;TMSB4X;KDR;PLCG1;PRKD2;SP1;MEF2C;PRKD1;AKT3;AKT1;RGCC;FGF2;PRCP;CD40;MECP2;ANGPT1;GATA2;EPHA2;PPARG;NF1;MAP2K3;GADD45A;HMGB1;ADAM17;ANGPT4;FGF18;JUP;MAPK14;TGFB1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.49038024351762904,-1.8078953029229712,0.0,0.05554884339982523,0.929,21/67,13.68%,UTRN;RREB1;DOCK1;RSU1;FERMT2;RAC1;LIMS2;LIMS1;GSK3B;VIT;CRK;CCL25;ABL1;PPM1F;FBLN2;FLNA;ILK;JAK2;NEDD9;MYOC;CDK6
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.37346518797680806,-1.8068367390493179,0.0,0.05558816019915606,0.93,159/476,22.69%,MECOM;LEF1;RREB1;SMARCA2;FLI1;ZBTB16;NFIB;SP100;ZNF423;ACVRL1;FOXO1;AFAP1L2;CREBBP;NSD1;DYRK1A;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;LRP5;ESR1;MLLT3;ZFHX3;KLF2;DVL3;RXRA;TRIM56;NFATC1;PRDM16;RNF111;BICRA;TEAD1;KMT2E;ARID1B;TBX1;DTX3L;MITF;MAP3K5;KAT6A;SOX17;EGFR;CD38;NAA16;SP1;FZD4;CRLF3;CTCF;HDAC1;NFKB1;HES1;PPARA;SIX1;SMARCC1;RYBP;TASP1;FOXO3;DNM2;LRP6;PLCB1;NSD3;MED1;BMP4;CREB3L2;MEF2C;JUN;SMAD2;ZFP90;ACTA2;SETD3;MDFIC;HNRNPAB;YAP1;CDH1;PPARD;PHF5A;IRF1;GLI3;PICALM;SMAD4;SP3;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;NOTCH4;ETS2;MED13;KDM3A;RGMB;ILK;SMARCC2;PSEN1;MAZ;ARHGEF11;MED17;YAF2;NOTCH1;FOXF2;FGF2;RPS6KA1;HDAC4;KAT5;WNT11;RHOG;FBXW11;XPC;SMARCD3;ZIC3;ATF4;NR1D2;HCFC1;TCF3;FOXC1;MRPL12;TADA3;JMJD6;TRIM16;MAD2L2;CREBL2;PCBD2;BMP7;IGF1;SIX4;RARA;CTNNB1;GPATCH3;TFAP4;HEY1;HEY2;WBP2;ZIC1;CITED2;RNF10;EDRF1;IKBKB;SOX4;NCOA6;RNF4;TCF4;TBL1X;PPARG;BRCA1;NR2F2;TRIM28;FOXL2;BLM;CAND2;CREB1;MAP2K3;ELF4;NOS1;ATAD2;RELA;MYOCD;KCNH2
prerank,mesoderm formation (GO:0001707),-0.644717546352098,-1.8056639092461209,0.005535055350553505,0.05584963760775836,0.932,8/17,20.64%,ITGB1;BMPR2;ITGA3;ITGB4;SMAD2;KDM6B;ITGA2;ITGB3
prerank,Ras protein signal transduction (GO:0007265),-0.42776592963117316,-1.8055531021279152,0.0,0.05525458819641239,0.932,63/137,20.86%,RREB1;RAPGEF2;GNB1;RB1;EPS8;BRAP;RAC1;ARHGEF3;NTN1;ELMO1;PLEKHG5;PLD1;EPS8L2;ARHGAP5;GNA12;SHOC2;PHACTR4;RAP1A;ARHGDIA;JUN;PLCE1;PLK2;RAP1B;ROCK1;RASGRP2;PRKD1;RRAS;RASSF1;TP53;GRAP;RAPGEF1;ARHGAP1;AGTR1;ARHGEF11;GDI1;RHOA;FGF2;RTKN;TAX1BP3;RHOG;CDC42EP3;KSR1;GRB2;NCKAP1;ROCK2;RERG;IGF1;DNMT1;RIPOR1;DBNL;ARHGAP29;ADGRG1;RAP2A;CFL1;WASF1;RRAS2;RAP2C;KRAS;NRAS;RGL2;CDC42EP1;NF1;TRIM28
prerank,synaptic vesicle cycle (GO:0099504),0.5721885037609936,1.8046692552923813,0.004454342984409799,0.07469333640433057,0.989,8/30,10.73%,NLGN1;PCLO;SNAP25;RIMS1;CDK5;SYNDIG1;RAB3A;SLC17A6
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.631866695801232,-1.8039845567858899,0.007207207207207207,0.05557595634539715,0.936,12/19,26.17%,CBFB;ELF1;KLF4;IFIH1;LIFR;IRAK1;IRAK2;MAVS;MAPK7;TAF9;DHX9;PARP9
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7684443950520154,-1.8027753253909877,0.0017985611510791368,0.055597688975759896,0.936,5/10,11.47%,GHR;LYN;PTPN1;STAT6;JAK2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.644780987130775,-1.8016267478569545,0.0,0.05567962349023094,0.939,8/18,12.19%,ENG;ACVRL1;NOS3;TGFBR2;TGFB2;BMP4;TBX2;NOTCH1
prerank,positive regulation of angiogenesis (GO:0045766),-0.44466688880603805,-1.800943028801154,0.0017953321364452424,0.055504608957482125,0.941,32/108,14.23%,FLT1;TJP1;TEK;ITGB1;GAB1;NOS3;TIE1;KLF4;BMPER;ETS1;CD34;THBS1;JAK1;KDR;ANXA3;PLCG1;PRKD2;SP1;FGF1;CDH5;SMAD1;PRKD1;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;FGF2;MTDH;S100A1;CD40;AGO2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7201604345424784,-1.7991437245500534,0.00528169014084507,0.0561046587840495,0.941,5/12,13.05%,FOXP1;DAB2;HDAC1;ZBTB7A;PIAS2
prerank,regulation of presynapse organization (GO:0099174),0.6429129860726731,1.7991331285421912,0.00684931506849315,0.07561806998441463,0.991,8/18,10.44%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,regulation of presynapse assembly (GO:1905606),0.6429129860726731,1.7991331285421912,0.00684931506849315,0.07561806998441463,0.991,8/18,10.44%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.6204988088899233,-1.7940885954362644,0.007067137809187279,0.05915318778798949,0.954,15/20,30.39%,ENG;ACVRL1;TGFBR3;PDCD4;TGFB2;BMP4;NOTCH1;HEY1;HEY2;TBX3;HAS2;BMP2;SNAI2;TGFBR1;SPRY1
prerank,regulation of glucose import (GO:0046324),-0.5640064532891003,-1.7936679156693278,0.005235602094240838,0.05875629942389481,0.954,11/30,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;GRB10;GSK3A;OCLN;AKT1;CREBL2;IGF1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.740063274385456,1.7898995468882752,0.0,0.08148482788875781,0.996,7/10,18.61%,GABRG3;GABRB2;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,regulation of sodium ion transport (GO:0002028),0.5455362206277151,1.789145192108916,0.0,0.08055108019175652,0.996,13/34,9.75%,NKAIN2;ANK3;FGF12;SCN1B;ATP2B4;NKAIN3;PKP2;NKAIN4;GPD1L;WNK2;WNK3;SCN5A;SPTBN4
prerank,membrane depolarization (GO:0051899),0.5466047076614579,1.7885443996455384,0.002197802197802198,0.0794947159698067,0.996,13/32,10.99%,SCN8A;SCN1B;CACNA1B;SCN1A;SCN3A;CACNA1A;SCN2A;CACNB3;CACNB4;CACNA1E;SCN5A;CACNG2;CACNG4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.5648182871831233,-1.7871217833835598,0.0018656716417910447,0.06355471561952082,0.967,17/33,24.42%,TEK;CAST;KDR;ICAM1;PPARA;GAS6;CDH5;YAP1;RAMP2;TNFAIP3;ANGPT1;GATA2;TCF7L2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4841250403265792,1.7852908822289013,0.009029345372460496,0.08044758843990416,0.996,20/57,15.12%,CHRM2;GNAI2;OPRM1;GRM8;ADCY8;GNAI1;GNAL;CHRM3;GPR37;GNAT3;MTNR1A;HTR4;ADCY7;GRM7;ADRA2A;HTR1D;GABBR1;ADCY3;GRM4;HTR1F
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.5152025620596309,-1.7842928505842184,0.0035778175313059034,0.06493122505234819,0.969,23/44,27.32%,TNRC6B;ZC3HAV1;METTL14;GIGYF2;FTO;PUM1;ROCK1;POLR2G;CELF1;AGO2;RC3H1;BTG2;ROCK2;MOV10;TNRC6A;TOB1;METTL16;RBM24;CNOT8;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,regulation of autophagosome assembly (GO:2000785),-0.5535184721256261,-1.7826963956792665,0.0018018018018018018,0.06554884959834754,0.971,16/33,23.46%,RAB3GAP1;MTMR3;LRRK2;PIP4K2A;PIP4K2B;RAB5A;TBC1D14;SCFD1;CHMP4B;CHMP4A;RAB3GAP2;PHF23;IFT20;TBC1D12;SEC22B;RALB
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.6450890168151723,-1.7809035605277783,0.005535055350553505,0.0662916459891573,0.974,10/17,21.48%,CLDN5;F11R;CDH5;ROCK1;PPP1R12A;ROCK2;TNFRSF1A;IKBKB;VCL;S1PR3
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5842319312792114,-1.7807053265745818,0.003552397868561279,0.06577078401443925,0.974,10/25,12.19%,ZNF423;ENG;ACVRL1;BMPR2;BMP4;CDH5;SMAD2;ACVR2A;SMAD4;NOTCH1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.5952576529809936,-1.7803702972133644,0.005291005291005291,0.06535595890269597,0.976,9/23,11.10%,LYN;THBS1;BMP5;MSN;IL34;SLIT2;PTK2;MAPK1;STK10
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6766990606322307,-1.7803345823750991,0.0018450184501845018,0.06469484577490875,0.976,6/14,12.22%,KLF4;THBS1;MEOX2;STARD13;NOTCH1;RHOA
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5484543779509828,-1.7795583808894244,0.0017857142857142857,0.06477803524853441,0.978,12/34,13.32%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;LIMS1;CRK;ABL1;FLNA;ILK;NEDD9;MYOC
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5760927594625939,1.778665759972053,0.0,0.08433983754432786,0.999,13/26,13.33%,NRXN1;NLGN1;RIMS2;RIMS1;TMEM108;SHANK1;SLC8A2;MTMR2;PRKCZ;CBLN1;SLC8A3;DLG4;NLGN2
prerank,regulation of interleukin-8 production (GO:0032677),-0.4675438836711969,-1.7782611615910182,0.0,0.0650698362186141,0.98,39/69,37.59%,AFAP1L2;KLF4;NOD1;TMSB4X;RAB1A;PRKD2;LBP;ANXA4;ANXA1;MAVS;HYAL2;NOD2;PTPRC;F3;RELA;SERPINE1;RIPK1;ARRB1;HSPA1B;HMGB1;F2R;LGALS9;CACTIN;DDIT3;STAT3;TLR6;TLR1;C5AR2;NOS2;TLR5;CD14;PARK7;CD74;TLR2;CD33;TLR8;MAPKBP1;SYK;CRP
prerank,regulation of Notch signaling pathway (GO:0008593),-0.46320070093589116,-1.7772383116369064,0.0,0.06516051279928568,0.981,32/76,21.17%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;EGFR;IL6ST;NOTCH3;JAG2;ZBTB7A;TGFB2;PRAG1;AAK1;MAML1;TSPAN14;ARRDC1;YAP1;AKT1;NOTCH4;MFNG;GALNT11;TSPAN5;NOTCH1;TCIM;JAG1;CCN3;HEY1;NOD2;GATA2;RITA1;WWP2;DLL4
prerank,receptor internalization (GO:0031623),-0.5181437753739992,-1.7765751475374552,0.0018181818181818182,0.06500464023946231,0.981,18/44,14.62%,ITGB1;CALCRL;CAV1;DNM3;RAMP1;LDLRAP1;TFRC;DNM2;NEDD4;RAB5A;PICALM;RAMP2;ADM;CEACAM1;LMBRD1;ACKR3;SAG;GRB2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.45729361920950273,-1.7764101561444825,0.0,0.06448210442521325,0.981,29/86,16.38%,DAB2IP;AKAP13;BCR;EPS8;LYN;ARHGEF28;STARD8;EPS8L2;SHOC2;TGFB2;STAMBP;ARHGDIA;NGF;PLCE1;DENND3;NOTCH2;ARHGEF2;RAF1;ARHGAP17;STARD13;GABARAP;RAPGEF1;JAK2;NOTCH1;SPRY4;GRB2;DENND4C;ARHGEF18;IGF1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7686482263258733,-1.7754981606714801,0.0034602076124567475,0.06441178422957258,0.982,7/10,12.67%,RAPGEF2;CD34;KDR;RAP1A;RRAS;RIN2;CEACAM1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.48008484478491154,1.7752696634318257,0.004750593824228029,0.08586162499388836,0.999,20/59,8.84%,KIRREL3;ROBO2;L1CAM;CNTN6;CNTN4;DSCAML1;DSCAM;ROBO1;IGSF11;TENM3;PTPRT;IGSF21;CEACAM5;NECTIN3;MYPN;SDK1;VSTM2L;EMB;CNTN2;CDH17
prerank,lipid modification (GO:0030258),0.5169140011660925,1.7717790591427012,0.0022026431718061676,0.08739848704922973,0.999,15/37,16.66%,DGKK;DGKI;DGKQ;PLPPR4;PLPPR1;PLPP2;PLA2G7;SGPP1;PLPP4;PLPPR5;ALOX12;MBOAT7;ALOX5;CYP1A1;MBOAT2
prerank,negative regulation of angiogenesis (GO:0016525),-0.4548543017045694,-1.7709410485802013,0.0,0.06765561794547145,0.985,27/84,17.12%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;KLF2;THBS1;SLC12A2;TGFB2;ISM1;ROCK1;HSPG2;ADAMTS9;RGCC;STAB1;NAXE;ECSCR;MECP2;PIK3CB;FOXC1;ROCK2;FOXO4;NPR1;GTF2I;CTNNB1
prerank,dendrite self-avoidance (GO:0070593),0.6391998166220267,1.770147295611871,0.0022675736961451248,0.0874998121018438,0.999,8/16,8.42%,CNTN6;CNTN4;DSCAML1;DSCAM;MYPN;VSTM2L;EMB;CNTN2
prerank,neuromuscular process controlling balance (GO:0050885),0.6963192645937512,1.768739687516237,0.01160092807424594,0.08708625577598933,0.999,4/12,3.86%,NRXN1;PCDH15;SHANK1;CLN3
prerank,inorganic cation transmembrane transport (GO:0098662),0.37804444130896014,1.7647512059055466,0.0,0.08942664916794754,0.999,65/268,15.68%,TRPM3;KCND2;KCNC2;KCNQ3;ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;SCN8A;KCNH7;SCN1B;RYR3;KCNA5;SCN1A;ATP12A;ATP2B4;SLC6A15;KCNH4;SLC9A7;KCNH5;SLC4A4;KCNN2;SCN3A;CACNA1A;KCNA2;ATP1B1;SLC46A1;SLC6A11;SLC9A9;SCN2A;CACNA1D;SLC8A2;UCP3;TMCO1;SLC36A2;TRPM1;ATP6V0C;SCN5A;ATP4A;SLC6A2;SLC6A5;SLC39A2;KCNN3;P2RX3;SLC8A3;SLC8A1;KCND1;SLC1A3;CACNA2D4;SLC39A7;KCNS2;KCNC4;KCNK12;SCN2B;ASIC1;KCNK10;KCNA4;KCNK9;SLC4A11;SLC6A4;ATP6V0D1
prerank,endothelial tube morphogenesis (GO:0061154),-0.7380892362808409,-1.7645803753422142,0.010471204188481676,0.07254485888670126,0.991,6/10,17.12%,ACVRL1;PRKD2;BMP4;STARD13;RHOA;CTNNB1
prerank,response to laminar fluid shear stress (GO:0034616),-0.7335633290028716,-1.7619818512804928,0.00186219739292365,0.07394388049095335,0.992,6/10,22.38%,KLF4;KLF2;SMAD7;SMAD6;MAPK7;NFE2L2
prerank,calcium ion import across plasma membrane (GO:0098703),0.6484746483561347,1.76121206294537,0.009302325581395349,0.0911228182842023,1.0,6/14,11.91%,SLC24A2;ATP2B4;CACNA2D1;SLC8A2;SLC8A3;SLC8A1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4785283171927563,-1.759503929263263,0.005272407732864675,0.07563199456862776,0.994,15/56,11.78%,RBPMS;ENG;ACVRL1;BMPER;DAB2;BMPR2;BMP5;BMP6;LDLRAD4;TGFB2;BMP4;ACVR2A;SMAD4;SMAD7;HFE
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.5392554755983556,-1.7579211354349893,0.0,0.07641011848119263,0.994,11/35,11.85%,TJP1;TEK;ESAM;BAIAP2L1;F11R;ABL1;ARHGDIA;NOTCH2;HAX1;BCAS3;ABI3
prerank,endocardial cushion development (GO:0003197),-0.6090030687437363,-1.7575373995431902,0.0018115942028985507,0.0761250128106432,0.994,8/21,12.19%,ENG;ACVRL1;NOS3;BMPR2;TGFB2;BMP4;TBX2;NOTCH1
prerank,nervous system development (GO:0007399),0.3562243724985898,1.7573921719065104,0.0,0.09315900392932625,1.0,102/429,13.66%,LSAMP;KIRREL3;RBFOX1;NRXN1;ROBO2;NLGN1;NRG1;L1CAM;NAV3;ASIC2;ERBB4;MYT1L;CHRM2;CNTN6;IL1RAPL2;CNTN4;DSCAML1;ADAM23;TENM1;ADAM22;SCN8A;FGF12;SH3GL2;DSCAM;ADGRL3;APC2;MOBP;CYP46A1;ROBO1;NPAS1;SPOCK1;GPM6B;DNER;PCDHB5;KALRN;CDK5;ZEB2;LHX1;VLDLR;EPHB1;APBA2;TYRO3;SRRM4;NBL1;NRCAM;GFRA1;NELL1;DCHS1;PCDHA4;CHRM3;LIMK1;SCN2A;ATXN10;DPYSL5;EFNB3;NFASC;PTPRZ1;CYP51A1;MAP1S;PROX1;HPCAL4;TMOD2;PCDHA5;GSN;GPM6A;GRIK1;SCRG1;SDK1;MSI1;SLITRK1;AHI1;LRCH4;NCAN;ACVR1B;POU4F1;FGF5;KLK6;NRSN1;VEGFA;DCX;DPF1;POU3F3;SDHA;HAPLN2;RBFOX3;MOG;CBLN1;MBP;ALDH1A2;NMUR2;ARNT2;CDH2;DLG4;ESS2;FZD9;GDF11;FKTN;BDNF;RPS6KA6;NLGN2;SCD5;CAPG
prerank,actomyosin structure organization (GO:0031032),-0.46526154777377543,-1.7562733429239483,0.0,0.07652996595921903,0.995,24/75,12.82%,TJP1;FRMD6;PGM5;SORBS1;ITGB1;MYH9;FAM171A1;F11R;ITGB5;TMOD3;CUL3;CDC42BPA;MYO18A;EPB41L2;ROCK1;PDLIM1;CSRP2;EPB41L5;TNFAIP1;PHACTR1;FRMD5;RHOA;LMOD1;TPM1
prerank,receptor metabolic process (GO:0043112),-0.4860805383304217,-1.755505873157301,0.0,0.07654144754462798,0.995,31/53,30.86%,ITGB1;CALCRL;CAV1;DNM3;RAMP1;LDLRAP1;SMURF1;TFRC;DNM2;NEDD4;PICALM;RAMP2;ADM;ACKR3;REP15;GRB2;LGMN;AP2M1;SNX25;KIF16B;ARFGEF2;BECN1;GRK3;LRP1;FCER1G;GRK4;PHETA2;CD9;RAB31;TGFB1;LILRB1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7329474469612421,-1.7527071957736526,0.0071174377224199285,0.07850015481107091,0.996,7/11,9.84%,IGF1R;GHR;GIGYF2;PIK3R1;IRS1;PLCB1;AKT1
prerank,cytoplasmic translation (GO:0002181),-0.44537923189761786,-1.752253979816639,0.0017574692442882249,0.07820649406261446,0.997,51/91,31.11%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;RPL26;RPS11;RPL13;RPL38;DRG1;RPL27;RWDD1;RPS16;RPS4X;GSPT1;RPL10;RPL7A;RPL5;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;EIF3I;RPS2;RPL39;RPS26;RPS15A;RPL15;RPL34;RPL22L1;RPL18;RPL19;RPS13;EIF4A2;RPL8
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.6083889029284666,1.7521981697991307,0.004366812227074236,0.09645793185760626,1.0,8/18,13.33%,NRXN1;NLGN1;RIMS2;RIMS1;SHANK1;PRKCZ;DLG4;NLGN2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.7260144786102483,-1.7513030136920051,0.0017211703958691911,0.07836208733981588,0.998,8/10,23.46%,RXRA;TBX1;RARG;ACTN4;RARA;PPARG;RARB;RXRG
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.6134657385690134,-1.7481598872444275,0.0,0.08067019421704945,0.998,5/19,5.38%,KLF4;SLCO1C1;KLF2;APP;NFKB1
prerank,blood vessel diameter maintenance (GO:0097746),-0.5461622958134554,-1.7478949645321002,0.0017543859649122807,0.08025337455653013,0.998,17/34,26.87%,NOS3;EDNRA;KLF2;ACE;ECE1;ROCK1;SCPEP1;EDN1;EDN3;AGTR1;ROCK2;NPR1;KCNMB2;GCLC;NOS1;ACE2;ADCY6
prerank,cellular response to BMP stimulus (GO:0071773),-0.46786057576590906,-1.7475860763796585,0.0,0.07987706756527521,0.998,20/66,11.78%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;TGFB2;BMP4;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5895218129557772,1.7458100440348054,0.0045662100456621,0.10081063311618858,1.0,8/21,12.82%,ATP1A2;AKAP6;CALM2;RYR2;SLC8A1;SRI;HRC;CASQ1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.6598801992835607,-1.7444547687005878,0.0018248175182481751,0.08199150663601591,0.998,8/15,12.53%,TJP1;KLF4;BMPER;JAK1;FGF1;SMAD1;FGF2;S100A1
prerank,myeloid cell development (GO:0061515),-0.6291941614919964,-1.7440064783942073,0.00546448087431694,0.0816285730948972,0.998,6/18,8.14%,FOXP1;ALAS1;ANXA2;APP;MED1;ABCB10
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.648730582962199,-1.7423484172023687,0.007272727272727273,0.08214707551547464,0.998,9/15,24.95%,GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;TCF7L2;RAPGEF3
prerank,positive regulation of cell migration (GO:0030335),-0.3878580712220355,-1.7423345388053486,0.0,0.08146747913199548,0.998,89/253,22.06%,FLT1;TJP1;LEF1;DAB2IP;IGF1R;RREB1;ITGA6;RAPGEF2;SEMA6A;PECAM1;SEMA3C;DOCK1;ITGB1;GAB1;PODXL;FERMT2;INSR;CAV1;DAB2;PRKCE;BMPR2;CBLL1;SMURF2;PDGFD;SEMA7A;THBS1;GCNT2;ATM;SYNE2;KDR;MTOR;PLCG1;SMO;EGFR;ADAM9;NIPBL;TGFB2;PTK2;FGF1;CDH5;PPM1F;ARHGEF2;PLCG2;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;EDN1;MAZ;TWIST2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;ACTN4;NEDD9;WNT11;MYOC;RHOC;HGF;AGO2;NUMB;MAP4K4;ROCK2;VSIR;SEMA5B;PIK3R3;IGF1;RAB11A;RIPOR1;CTSH;HDAC6;SEMA4A;SEMA3E;WASHC1;PTPRC;CXCL12;F3;FERMT3;LAMB1;SEMA4G;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;SYDE1;PTK2B
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4789393023964267,-1.741211906975945,0.0035087719298245615,0.08189367523649044,0.999,26/59,23.73%,LEF1;CBFB;TNRC6B;MED15;MED26;MITF;NFKB1;MED1;JUN;TP53;MED13;MED17;MECP2;CCNC;MOV10;CTNNB1;PPM1D;TNRC6A;CCND1;MED10;TCF7L2;PTEN;TRIM28;MED27;RELA;MED20
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4607176581866539,-1.740638141131925,0.0,0.08155408608748292,0.999,27/70,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5735188831650408,-1.7401559590210522,0.0035842293906810036,0.08147090447497501,0.999,14/26,27.14%,DAB2IP;IQGAP1;PLCG1;EGFR;PTPN12;MED1;DUSP3;ZPR1;FOXC1;DUSP22;PTPN11;SYAP1;ZFP36L1;SNAI2
prerank,regulation of monooxygenase activity (GO:0032768),-0.5821386794175181,-1.7366207702469076,0.0017667844522968198,0.08421918846297452,0.999,9/23,9.84%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;CYGB;WASL;NOS1AP;AKT1
prerank,regulation of tube diameter (GO:0035296),-0.7007640072861051,-1.7356132914109377,0.0,0.08391216784683475,0.999,10/13,26.87%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;ROCK2;NPR1;GCLC;ACE2;ADCY6
prerank,vascular process in circulatory system (GO:0003018),-0.7007640072861051,-1.7356132914109377,0.0,0.08391216784683475,0.999,10/13,26.87%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;ROCK2;NPR1;GCLC;ACE2;ADCY6
prerank,clathrin-dependent endocytosis (GO:0072583),-0.5684212833372486,-1.7354865520062719,0.0036231884057971015,0.08338787669202162,0.999,12/26,13.61%,FCHO2;FNBP1L;AP2B1;AP2A2;AP2S1;ITSN1;GPR107;PICALM;GAK;FCHSD2;ITSN2;LMBRD1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6707768108587167,-1.7345109903082847,0.01073345259391771,0.0835244553372419,0.999,6/13,11.47%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2
prerank,regulation of catecholamine secretion (GO:0050433),0.533746709779804,1.7327587442456562,0.006696428571428571,0.11223404211706424,1.0,10/29,16.94%,SYT1;SYT5;SYT12;SYT11;KCNA2;CHGA;SYT4;FGF20;SYT3;SYT9
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.6187144921455892,-1.7320538603196864,0.0017452006980802793,0.08505354699897277,0.999,10/19,16.00%,TJP1;BMP6;AFDN;PPM1F;DENND6A;NOTCH4;RGCC;NOTCH1;FLOT1;MAD2L2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5943350288712637,1.732052778693996,0.011467889908256881,0.11131909710706837,1.0,10/21,18.82%,GCK;PGLS;H6PD;TKT;RPIA;HK1;PGD;PGM2;PGM2L1;HK3
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.41341501148875615,-1.7311491743729237,0.0,0.08528382593177924,0.999,57/132,27.44%,ZBTB20;FOXO1;INSR;DAPK1;SH3BP4;GSK3B;PTPN1;APP;ZC3HAV1;DTX3L;LRRK2;MSN;VGLL4;ADAM9;PPARA;TNFRSF1B;IRS1;FOXO3;IRGM;PRKCD;BNIP3;EZR;PIK3C2A;SNX9;PLK2;ROCK1;PRKD1;GSK3A;PRKAA1;PFKFB3;PSEN1;TRIM14;MTDH;KAT5;PIK3CB;RC3H1;IGF1;MOV10;ARNT;RNF152;DAGLB;ORMDL3;AMER1;HSP90AA1;ATF6;PFKFB4;TRIM68;HMGB1;PNPLA2;PLEKHF1;CNOT8;TPCN1;DXO;VPS35;CNOT1;TRIM6;PFKFB2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.45514298195043906,-1.7307083605575109,0.0,0.08504956229309321,0.999,27/71,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,axonogenesis (GO:0007409),0.37446369450708133,1.7302103552722177,0.0,0.11120888103066867,1.0,61/237,10.41%,NRXN3;NRXN1;ROBO2;UNC5D;CTNNA2;L1CAM;DAB1;DCC;ANK3;NCAM1;CNTN6;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;SHTN1;CDK5;VLDLR;EPHB1;NTNG2;NTNG1;PLPPR4;NRCAM;TNR;DOK5;UNC5C;ATL1;GFRA1;SEMA6D;EPHA5;EFNA3;EFNB3;SEMA3B;DOK6;PAX2;PAK3;GPC1;MAP1S;MYPN;SHC3;FGFR2;VSTM2L;SLITRK1;EMB;CNTN2;POU4F1;NEFH;S100A6;SHC1;SPTBN2;SPTBN4;SLITRK4;SLIT3;SLIT1;KIF5A;MAP1B;CCK;RAB3A
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4612675102012603,-1.7301481704689174,0.0,0.08499408058680087,0.999,29/74,23.22%,ITGA6;NOS3;EYA4;MCL1;GSK3B;THBS1;BMP5;DDX3X;TNFSF10;ICAM1;FAS;BMP4;BIRC6;ARHGEF2;SH3RF1;CASP8;CFLAR;AKT1;GPX1;TNFAIP3;IGF1;ZMYND11;TCF7L2;BRCA1;TERT;MAPK7;RELA;SERPINE1;RIPK1
prerank,regulation of defense response (GO:0031347),-0.45533660543910853,-1.726745043670667,0.0,0.08773114860136666,0.999,31/76,25.00%,FOXP1;IL1R1;XIAP;CASP12;SEMA7A;TMSB4X;BIRC3;SAMHD1;IRF1;CELF1;CASP8;AREL1;JAK2;AGTR1;MGLL;USP18;NR1D2;N4BP1;ANXA1;ZMPSTE24;ERAP1;NOD2;DAGLB;TKFC;BCL6;AKNA;RELA;CASP1;SHPK;ACE2;BRD4
prerank,I-kappaB phosphorylation (GO:0007252),-0.7270105214575777,-1.7262376013806462,0.007104795737122558,0.08760840259204447,0.999,2/10,1.49%,DAB2IP;ERC1
prerank,neuron differentiation (GO:0030182),0.3884836799783969,1.7259053278709828,0.0,0.11399770025727995,1.0,28/165,9.25%,PTPRD;IL1RAPL1;TENM4;PHOX2A;MYT1L;TENM1;ATP8A2;SNPH;WNT7B;IRX4;NIF3L1;SPOCK1;TENM3;ATP2B2;FUT9;CDK5;LHX1;ITM2C;TENM2;EPHA5;RUNX2;NTRK2;IRX3;ADNP2;INSM1;ACSL3;LMX1B;VEGFA
prerank,embryonic limb morphogenesis (GO:0030326),-0.5341254173026543,-1.7252035565746908,0.0017513134851138354,0.087896664380642,0.999,11/34,9.10%,MBNL1;MAP3K20;CREBBP;NIPBL;HDAC1;RARG;LRP6;TGFB2;ECE1;TBX2;GLI3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.443382796785547,-1.7244759383761137,0.0,0.08795397013418668,0.999,51/87,32.77%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8;SEC63;RPL41
prerank,protein targeting to ER (GO:0045047),-0.4385414799058218,-1.7232897368429583,0.0,0.08838546429766622,0.999,54/99,31.11%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;SRPRA;RPL26;CHMP4B;CHMP4A;RPS11;SRP9;RPL13;RPL38;SGTA;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;ZFAND2A;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5357893848156796,-1.7227982540364384,0.005263157894736842,0.08815914532224899,0.999,17/34,22.06%,FLT1;TEK;DAB2IP;PIK3R1;IRS1;AMBRA1;PTK2;PRKD1;FGF2;PIK3IP1;TNFAIP8L3;PIK3R3;CCL19;WASHC1;NOD2;PDGFRB;PTK2B
prerank,limb development (GO:0060173),-0.5404425044706164,-1.722598551354039,0.0018552875695732839,0.08773282858276515,0.999,8/28,12.31%,MAP3K20;KAT2B;SMOC1;ZNRF3;KREMEN1;GLI3;PCSK5;COMP
prerank,regulation of vasculogenesis (GO:2001212),-0.6770682358898894,-1.7214457835705146,0.0034965034965034965,0.08814742744537797,0.999,9/14,17.95%,RAPGEF2;CD34;KDR;RAP1A;RRAS;RIN2;CEACAM1;HEY1;HEY2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7183299622432409,-1.720897946400714,0.0035650623885918,0.08798230582044125,0.999,6/11,13.83%,RSPO3;DAB2;MLLT3;NKD1;CSNK1D;PLEKHA4
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.6624166310728283,-1.720835329859934,0.003484320557491289,0.08742162096476572,0.999,6/13,7.18%,ABHD2;NR3C2;ESR1;NR3C1;MED1;BMP4
prerank,regulation of GTPase activity (GO:0043087),-0.3966172690963012,-1.7195050586477914,0.0,0.0882247555302955,0.999,49/177,13.86%,DAB2IP;DOCK9;CHN2;PRKG1;ITGA6;RAPGEF2;RSU1;ITGB1;FGD5;FERMT2;FGD6;RAB3GAP1;LIMS1;SH3BP4;NET1;GSK3B;DVL3;RALBP1;F11R;LRCH1;PKP4;CRK;CCL25;LRRK2;AFDN;RASIP1;CHN1;PTK2;RAP1A;SNX9;PLXND1;TGM2;USP6NL;AGRN;RASGRP2;EPHA4;TBC1D30;PLXNA4;PICALM;RASA4;RAB3GAP2;RAPGEF1;ARAP1;BCAS3;ARFGEF1;WNT11;CD40;LARS1;GPR137B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4881324439267593,-1.7179630031169153,0.0018050541516245488,0.08905232474194251,0.999,24/46,26.64%,UBR5;GSK3B;YWHAE;EMD;GAS6;PIK3R1;NEDD4;PRKCD;CDH1;TP53;FLNA;PSEN1;ZPR1;TPR;XPO4;MAVS;ZIC1;HYAL2;TCF7L2;TRIM28;KHDRBS1;DHX9;RAPGEF3;RAN
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5926762448600361,-1.7173465557836447,0.0054249547920434,0.0890360391530331,0.999,6/21,3.24%,FOXP1;PRKCH;CBFB;ELF1;LYN;SLC39A10
prerank,regulation of dopamine secretion (GO:0014059),0.5534018686581328,1.7155935424543078,0.011655011655011656,0.12301279554232562,1.0,10/25,19.28%,SYT1;SYT5;SYT12;SYT11;KCNA2;SYT4;FGF20;SYT3;SYT9;SYT17
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.42750494060368754,-1.7140853161108947,0.0,0.09165812829249967,0.999,34/95,20.88%,ENG;CREBBP;CAV1;DAB2;SMURF2;IL17RD;THBS1;ITGA3;PRDM16;RNF111;SPRED2;SMURF1;TGFBR3;TGFBR2;NREP;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD4;LATS2;SMAD7;LTBP4;SMAD6;SKI;GIPC1;CITED2;PMEPA1;HTRA3;DAND5;SNX25;STRAP
prerank,positive regulation of lipid transport (GO:0032370),0.6795477907761684,1.7116008185630942,0.015521064301552107,0.12552001635126805,1.0,5/12,14.63%,ABCA12;PRELID1;TRIAP1;SPP1;APOE
prerank,cellular response to growth factor stimulus (GO:0071363),-0.4002443643099436,-1.7103707949982252,0.0,0.09507399058579745,0.999,65/151,24.99%,FLT1;DAB2IP;RAPGEF2;SEMA6A;ACVRL1;KLF4;BMPR2;LIMS1;IQGAP1;TBX1;NR3C1;KDR;PLCG1;PRKD2;EGFR;EMD;PTPN12;PDE3A;TGFBR2;BMP6;DSTYK;PDE2A;MED1;BMP4;RAP1A;ERN1;MEF2C;MAPKAPK2;PRKD1;FLT4;ACVR2A;SMAD4;MTSS2;BCAR1;RAMP2;AKT1;RAPGEF1;EHD1;SMAD7;NOTCH1;WWOX;DUSP3;ZPR1;HGF;HAS1;FOXC1;LGMN;BMP7;ANXA1;CTNNB1;HYAL2;DUSP22;SMAD9;DLL4;PTPN11;MAP2K3;MAPK7;NOS1;RELA;SYAP1;HAS2;ADAMTS7;ACVR2B;EGR3;BMP2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4878178635749368,-1.709820741839738,0.0035211267605633804,0.09504309621163116,0.999,12/45,11.78%,RBPMS;ENG;ACVRL1;DAB2;BMPR2;BMP5;BMP6;TGFB2;BMP4;ACVR2A;SMAD4;HFE
prerank,myelination in peripheral nervous system (GO:0022011),-0.6723219110577336,-1.7091840260811895,0.008849557522123894,0.09508154397124852,0.999,9/13,20.79%,PARD3;ADGRG6;CNTNAP1;DICER1;MYOC;ARHGEF10;SKI;SOD1;NF1
prerank,negative regulation of binding (GO:0051100),-0.4448646866401124,-1.7087169502816288,0.0018050541516245488,0.09481995413777737,0.999,29/81,19.99%,LEF1;SP100;CAV1;DAB2;BTAF1;GSK3B;LRRK2;SMO;NFKBIA;PRKCD;JUN;ROCK1;NES;WAPL;AKT1;JAK2;ZFPM1;ARHGAP28;ACTB;MAPK8;ILRUN;CTSZ;MITD1;PEX14;SUMO1;TFAP4;PLN;TFIP11;CTNNBIP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4337351779591034,-1.7072927266271047,0.0017985611510791368,0.09551393122690609,0.999,24/80,14.71%,XIAP;KLF4;DAPK1;NOD1;UACA;THBS1;MAP3K5;DDX3X;TNFSF10;YWHAE;GAS6;NGF;DNAJB6;PPM1F;RAF1;ARL6IP5;SH3RF1;AKT1;BCAP31;SOX7;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4485985723697376,-1.7064240746219888,0.0017543859649122807,0.09569205197785204,0.999,29/76,18.97%,NFAT5;NR3C2;NOD1;UACA;LIMS1;TMSB4X;APP;DDX3X;EGFR;NFKBIA;DLG1;NMI;PDCD4;RASSF2;EZR;PPM1B;ILK;RHOA;IRAK1;ACTN4;TCIM;IFI35;CCN3;C1QTNF3;BMP7;SASH1;RPS3;CCL19;NOD2
prerank,positive regulation of vascular permeability (GO:0043117),-0.692211937663067,-1.7042394555522282,0.008710801393728223,0.09737782284169356,0.999,9/12,18.49%,TJP1;PDE3A;BMP6;PDE2A;TJP2;OCLN;FGFBP3;ANGPT1;TRPV4
prerank,regulation of protein import into nucleus (GO:0042306),-0.5115343948383804,-1.703349398692558,0.005385996409335727,0.09768311134994714,0.999,17/36,20.86%,UBR5;PIK3R1;PRKCD;BMP4;MDFIC;CDH1;FLNA;PSEN1;CHP1;UFM1;ZPR1;RAB23;TPR;MAVS;ZIC1;HYAL2;TRIM28
prerank,regulation of ion transport (GO:0043269),0.4341632271814919,1.7022281630589735,0.002257336343115124,0.13455091338546382,1.0,13/76,4.61%,NKAIN2;SYT1;SYT5;ANK3;CA2;KCNA5;STC1;KCNJ3;NKAIN3;SYT12;SYT11;NKAIN4;KCNA2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.547877731133261,1.7014656889678674,0.006741573033707865,0.13363802829702992,1.0,6/27,3.43%,SYT1;SYT5;RIMS2;RIMS1;SYT12;SYT11
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.5730011145587023,-1.7006483747627585,0.005649717514124294,0.09989709389456275,0.999,8/22,14.94%,DAB2IP;MFHAS1;LYN;WDFY1;LBP;FLOT1;TNFAIP3;IFI35
prerank,regulation of developmental growth (GO:0048638),-0.5457624052969714,-1.6991003976101693,0.0033613445378151263,0.10069223218720906,0.999,15/29,18.07%,GHR;INSR;GSK3B;APP;NIPBL;SIX1;ABL1;DNM2;PLCB1;MFSD2A;LATS2;SIN3A;IGF1;SIX4;SOD1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5699690674505986,-1.698767090682681,0.009025270758122744,0.10046363069853619,0.999,13/24,24.42%,TEK;KDR;ICAM1;GAS6;CDH5;RAMP2;TNFAIP3;ANGPT1;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,protein-containing complex assembly (GO:0065003),-0.3751807408369822,-1.6986058122110455,0.0,0.10000241221887687,0.999,95/259,23.81%,LEF1;FBXL7;SLC2A1;PARD3;MNAT1;SEC31A;CREBBP;SEC24B;FERMT2;CSNK1A1;CD2AP;CTSC;GSK3B;TRAPPC3;TRAPPC9;RANBP9;TEAD1;SH3PXD2B;LRRK2;MITF;RAB1A;HDAC1;HES1;RBX1;AFDN;SEC24A;TRRAP;FAS;KPNA3;CUL3;SEC16B;SNX9;WASL;SEC24D;KLHL12;SEC13;YAP1;SCFD1;AFG3L2;PICALM;DET1;OCLN;CASP8;ADAM10;SAMM50;TP53;AXIN2;HFE;ANO6;CDC73;PPP6R3;CDC123;CSNK1D;KAT5;ASH2L;CD40;TCF7L1;CTSZ;TBC1D20;PEX14;TUBGCP4;TNFRSF1A;F5;TFG;CTNNB1;TFAP4;DBNL;FANCC;DNAJB12;IKBKG;VAMP3;WASF1;MDN1;MAGI1;TCF7L2;AP2M1;CXCL12;FERMT3;TERT;MDM2;BLM;CAND2;VAMP2;PTK2B;PREB;SEC24C;AMER1;SEC22B;PPIH;TSPAN33;BET1;RIPK1;NDUFAF1;CD247;RBBP5
prerank,regulation of actin filament-based movement (GO:1903115),0.7129532060344178,1.6985466164596525,0.01839080459770115,0.13516762018717662,1.0,5/10,12.08%,PDE4B;PDPN;STC1;SCN5A;SRI
prerank,chloride transmembrane transport (GO:1902476),0.4743179105924272,1.695613765694527,0.0022727272727272726,0.13684796483749065,1.0,15/48,14.23%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;ANO4;SLC12A5;GABRA3;GABRA1;SLC12A4;SLC1A3;GABRE
prerank,mesenchyme morphogenesis (GO:0072132),-0.6233207839015985,-1.6954891000394279,0.0036429872495446266,0.10282356984573858,0.999,7/17,12.19%,ENG;ACVRL1;NOS3;TGFB2;SMAD2;TBX2;NOTCH1
prerank,monocarboxylic acid transport (GO:0015718),-0.47839544039304815,-1.6953767733126557,0.0017271157167530224,0.10234529093797022,0.999,15/51,12.67%,ABCC4;ABCG2;ATP8B1;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SLC16A12;SLC5A6;SLC16A9;SLC16A1;SLCO2B1;SLC16A6;SLC27A4;CEACAM1
prerank,collagen fibril organization (GO:0030199),-0.4283769592838997,-1.6949168500982303,0.0017271157167530224,0.1021439505163583,0.999,26/88,11.76%,TLL1;COL8A1;ITGA6;COL12A1;COL4A2;COL25A1;PLOD1;PLOD2;ADAMTS2;COL4A6;P3H2;COL5A1;ITGB4;LOXL3;LAMA3;COL4A5;COL4A1;TGFB2;COL8A2;COL5A2;COLGALT2;LOXL1;DST;P4HA1;COL6A3;COL15A1
prerank,cell differentiation in hindbrain (GO:0021533),0.6736593975765985,1.6943087213768302,0.011013215859030838,0.13667120101178606,1.0,6/11,13.24%,GRID2;LHX1;PROX1;FAIM2;CBLN1;KNDC1
prerank,heart morphogenesis (GO:0003007),-0.4774954886833838,-1.6941123225380281,0.003472222222222222,0.10237278648258383,0.999,17/50,17.95%,ENG;ACVRL1;NOS3;INSR;TBX1;SOX17;TGFBR3;NIPBL;HES1;TGFB2;PTK2;TBX2;ZFPM1;NOTCH1;FLRT2;HEY1;HEY2
prerank,sulfur compound transport (GO:0072348),-0.5515379187553666,-1.6935306131095,0.0037174721189591076,0.10249647400194903,0.999,8/27,10.75%,ABCG2;SLC6A6;SLC26A7;SLC13A4;SLC5A6;SLC19A2;LRRC8D;SLC25A11
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.4404671009892756,-1.6932255319231788,0.0,0.10221186163864901,1.0,24/75,18.35%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;THBS1;TGFB2;ISM1;ROCK1;HSPG2;RGCC;STAB1;NAXE;ECSCR;MECP2;FOXC1;ROCK2;FOXO4;NPR1;GTF2I;CTNNB1;SEMA3E
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6510183409500263,1.6930302319976398,0.01059322033898305,0.13638030415020858,1.0,4/12,6.37%,ANK3;ATP1B1;WNK2;WNK3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3465633347387047,-1.6910438976725788,0.0,0.10403775487657516,1.0,168/572,21.32%,FOXP1;KLF12;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ETV6;ZBTB16;NFIB;SP100;MEF2A;CREBBP;NSD1;RB1;CBFB;ZEB1;KLF4;CAV1;USP9X;DAB2;ESR1;NEDD4L;MIER1;CUX1;ZFHX3;NRIP1;PRDM5;SMURF2;KLF2;IRF2;RXRA;PRDM16;WWC2;NFATC4;ID1;MITF;NR3C1;THRB;SOX13;NFIX;ZHX2;ZNF148;CTCF;NIPBL;BMP6;HDAC1;NFKB1;HES1;PPARA;RARG;RPS14;DLG1;ZBTB7A;FOXO3;PDE2A;HIVEP1;NEDD4;MED1;SPEN;GTF2IRD1;BMP4;MAX;MEF2C;EZR;SKIL;JUN;ZBTB4;SMAD2;ZFP90;PHF21A;TBX2;SUV39H1;DACH1;YAP1;LDB1;PRDM2;PPARD;GLI3;ZNF25;USP2;SMAD4;CTBP2;UBE2D3;GLIS2;TP53;FRK;KLF10;EDN1;HMBOX1;PER3;NOTCH4;ETS2;DICER1;NFIC;SIN3A;FNIP2;PSEN1;MAZ;SMAD7;ZFPM1;PRDM6;CHD3;NOTCH1;MTDH;CDC73;RTF1;HDAC4;SFPQ;LRRFIP1;WWOX;KAT5;ZHX1;MECP2;ATF4;MZF1;RPL10;KMT5A;NR1D2;HCFC1;TCF3;FOXC1;PHF6;BCOR;NR2C1;DR1;TPR;MIER2;MAD2L2;TAF7;TRPS1;HIC1;SKI;ORC2;SUMO1;RARA;ZNF692;ARID5B;TAF3;IGBP1;HDAC10;HEY1;HEY2;MIER3;VPS72;ELK4;KDM1B;CITED2;NCOA5;RNF2;CCND1;DUSP22;LIN37;ATRX;RITA1;TCF7L2;TBL1X;PPARG;WWP2;PRDM1;BCL6;RARB;NR2F2;IGF2;GLIS1;DLL4;MDM2;NKAP
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.3880071997623443,-1.690894221161286,0.0,0.10349995800203511,1.0,58/186,16.35%,NXN;DAB2IP;TRABD2B;CSNK1A1;CAV1;DAB2;MLLT3;FZD6;GSK3B;DVL3;MCC;NFATC1;PSMA2;IGFBP4;ZNRF3;SOX13;SOX17;EMD;KREMEN1;VGLL4;RNF213;FZD4;LIMD1;HDAC1;FRMD8;RBX1;STK3;RNF43;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;GRB10;PSMB4;GLI3;GSK3A;LATS2;UBAC2;AXIN2;HMGXB4;WWOX;DKK2;TMEM64;NOTUM;TAX1BP3;WNT11;APCDD1;PSMC2;LMBR1L;TMEM170B;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2;HIC1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5119930731041094,1.690609671376333,0.002183406113537118,0.13721865864536184,1.0,11/34,12.08%,PDE4B;STC1;ATP1B1;CHGA;CALM2;RNF207;RYR2;SCN5A;ADRA1A;SLC8A1;SRI
prerank,response to lipid (GO:0033993),-0.4176128262363813,-1.689717161730401,0.0,0.10419765832497692,1.0,33/105,17.12%,FOXP1;FOXO1;PELI1;NOS3;SRR;ESR1;ACER2;ASXL1;RXRA;IFNAR1;HNRNPA0;PPARA;RARG;STRN3;GGT5;FOXO3;ALPL;GCH1;LBP;RBP4;MAPKAPK2;PPARD;SOCS2;JAK2;IRAK1;RPS6KA3;TRIM16;SMAD6;TAB2;RARA;ANXA1;CTSH;CTNNB1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.4131580288878556,-1.6874315562207904,0.0017123287671232876,0.10613920274320524,1.0,40/110,23.54%,DAB2IP;WWP1;FOXO1;KLF4;NEDD4L;SMURF2;KLF2;GSK3B;APP;ATG7;RANBP9;RAB7A;RAB1A;SMURF1;TIPARP;CDKN1B;NFKBIA;NEDD4;NKD1;PLK2;ABCB10;LDB1;GSK3A;AKT1;AREL1;PSEN1;AGTR1;MAPK8;TNFAIP3;ROCK2;PAEP;OAZ2;GPC3;WWP2;HUWE1;MAPK7;HACE1;SEC22B;MTPN;FZR1
prerank,cell-substrate junction assembly (GO:0007044),-0.5222695238630386,-1.686476380201991,0.0,0.10653965034519788,1.0,9/33,8.83%,ITGA6;SORBS1;THSD1;BCR;FERMT2;ITGB4;LAMA3;PTPRK;DST
prerank,regulation of protein export from nucleus (GO:0046825),-0.5651859441614044,-1.6861603765565223,0.005494505494505495,0.1062412184424692,1.0,10/23,19.87%,SP100;PTPN14;GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;TCF7L2
prerank,cilium movement (GO:0003341),0.46393940263704586,1.6851244731891342,0.004357298474945534,0.1421851282614696,1.0,18/48,18.49%,TEKT1;TTC29;ADCY10;CFAP54;CCDC63;ODAD2;DNAAF5;DNAAF1;ROPN1L;DNAI4;CFAP70;GAS8;SPAG17;ODAD1;CABYR;DNAAF2;CAMSAP3;ODAD3
prerank,cardiac muscle cell contraction (GO:0086003),0.5909064904405551,1.6811487430733691,0.023758099352051837,0.14527254251759478,1.0,8/19,8.21%,FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;CACNA1D;GSN;SCN5A
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3515709087502582,-1.680257699649275,0.0,0.11192429390047949,1.0,135/417,21.81%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;FOXO1;ZHX3;RB1;ZEB1;KAT6B;KLF4;CBFA2T3;BTAF1;FOXN3;PRDM5;SMURF2;LIMS1;RBFOX2;SPINDOC;PRDM16;RPS6KA5;UIMC1;ID1;NR3C1;SOX13;KAT6A;RCOR1;LOXL3;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;HDAC1;HES1;GAS6;ZBTB7A;PDCD4;PLCB1;SPEN;BMP4;PTPRK;MIDEAS;JUN;ZBTB4;SMAD2;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;LDB1;PPARD;IRF1;GLI3;SMAD4;CTBP2;SP3;GLIS2;TP53;EHMT1;KLF10;HMBOX1;SMARCC2;SIN3A;SOX7;SCMH1;TWIST2;YAF2;NOTCH1;HDAC4;SFPQ;PA2G4;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;KMT5A;SAMD1;NR1D2;DAP;BCOR;PHC1;PEX14;TAF7;BMP7;SUMO1;SIX4;RARA;ARID5B;HDAC6;ZBTB14;CTNNB1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;CITED2;BAP1;PIAS4;SCML4;TCF7L2;NONO;TIMELESS;PPARG;WWP2;BCL6;BRCA1;NR2F2;TRIM28;FOXL2;MDM2;NKAP;NACC1;CBFA2T2;GCLC;PHC3;TSHZ3
prerank,positive regulation of GTPase activity (GO:0043547),-0.38174540498436726,-1.6772084094241642,0.0,0.11464022117835951,1.0,76/188,25.64%,DOCK9;ITGA6;TBC1D4;RAPGEF2;RSU1;ITGB1;BCR;FERMT2;RALGAPA1;RAB3GAP1;LIMS1;NET1;CORO1C;GSK3B;DVL3;RALBP1;F11R;PKP4;CCL25;TBC1D1;AFDN;TBC1D2B;ARHGEF15;RAP1A;TBC1D8B;SNX9;TGM2;USP6NL;SIPA1L3;AGRN;RASGRP2;TBC1D30;TBC1D14;PICALM;MTSS2;TBC1D22B;RAPGEF1;ARAP1;TBC1D22A;BCAS3;SLC27A4;TAX1BP3;WNT11;ARHGEF10;RHOG;CD40;LARS1;MAP4K4;TBC1D20;ARHGAP22;ABR;ALS2;ARHGAP29;CCL19;TBC1D8;NDEL1;EPHA2;TBC1D17;TBC1D25;ARHGAP42;NF1;ARHGEF5;ASAP3;SYDE1;SNX13;TBC1D12;EVI5;ARHGAP11A;PIP5K1A;SNX18;ADRB1;PLXNB1;RAPGEF3;FZD10;SIPA1;SIPA1L1
prerank,action potential (GO:0001508),0.48045572847651913,1.6754206182226061,0.009411764705882352,0.15080698221754119,1.0,12/44,12.08%,KCND2;ANK3;SCN8A;SCN1A;AKAP6;CLN3;SCN3A;KCNA2;SCN2A;SCN5A;GPER1;SRI
prerank,clathrin coat assembly (GO:0048268),-0.6348750493443321,-1.6752867421807474,0.012522361359570662,0.11620514355707927,1.0,6/15,9.18%,HIP1;FCHO2;EPS15;AP2S1;PIK3C2A;PICALM
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5777791197557428,-1.67523919753381,0.00927643784786642,0.11557029029609776,1.0,10/22,16.38%,MEF2A;IL6ST;ROCK1;SMAD4;LMCD1;EDN1;PDE9A;NOTCH1;ROCK2;IGF1
prerank,positive regulation of neuron migration (GO:2001224),-0.69448986943368,-1.6747636693805537,0.00530035335689046,0.11547036421894827,1.0,5/11,8.58%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.4762735350701721,-1.674629455243338,0.009487666034155597,0.11493440099475284,1.0,27/49,36.91%,AFAP1L2;NOD1;RAB1A;PRKD2;LBP;MAVS;HYAL2;NOD2;F3;RELA;SERPINE1;RIPK1;HSPA1B;HMGB1;F2R;LGALS9;DDIT3;STAT3;TLR1;NOS2;TLR5;CD14;PARK7;CD74;TLR2;TLR8;SYK
prerank,plasma membrane tubulation (GO:0097320),-0.6592139112996915,-1.6740262112027855,0.009242144177449169,0.11502034644312627,1.0,6/13,10.04%,CAVIN2;FNBP1L;EHD2;SNX9;BIN3;CHMP4A
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5468811691491956,-1.6729999667240902,0.0034965034965034965,0.1155591720024317,1.0,12/27,22.06%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;FGF2;TNFAIP8L3;CCL19;NOD2;PDGFRB;PTK2B
prerank,regulation of cellular component size (GO:0032535),-0.5211046270994136,-1.6723105463940593,0.01444043321299639,0.11566929588688038,1.0,19/30,28.88%,RIN3;EPS8;RAC1;MTOR;MSN;RARG;EZR;PICALM;RPTOR;LARS1;PEX11A;AP2M1;PTEN;VAV2;MTPN;PPP1CA;RAB22A;RDX;PEX11B
prerank,heme catabolic process (GO:0042167),-0.6418475730146693,-1.6715728189079053,0.015706806282722512,0.11529790736984717,1.0,4/14,12.52%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6418475730146693,-1.6715728189079053,0.015706806282722512,0.11529790736984717,1.0,4/14,12.52%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5015253786717264,-1.669530278471038,0.003616636528028933,0.1170349945227793,1.0,15/35,18.35%,SEMA6A;SEMA3C;NRP2;RAC1;SEMA7A;ARHGDIA;PLXND1;PLXNA4;FLNA;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,Rho protein signal transduction (GO:0007266),-0.4615029875639623,-1.6694693134383927,0.0036363636363636364,0.11644098763622662,1.0,24/53,18.29%,EPS8;RHOJ;ARHGEF3;NTN1;PLEKHG5;EPS8L2;ARHGAP5;GNA12;PHACTR4;ARHGDIA;ROCK1;ARHGAP1;AGTR1;ARHGEF11;RHOA;RTKN;TAX1BP3;RHOG;CDC42EP3;ROCK2;RIPOR1;ARHGAP29;ADGRG1;CFL1
prerank,aorta morphogenesis (GO:0035909),-0.5976994832980738,-1.6693157761195652,0.005235602094240838,0.11599282846225435,1.0,11/17,21.67%,ENG;ACVRL1;TBX1;TBX2;ADAMTS9;MYLK;JAG1;HEY1;HEY2;DLL4;PDGFRB
prerank,regulation of peptide hormone secretion (GO:0090276),0.4347689113439622,1.6688160765801945,0.0,0.15765574080745393,1.0,20/67,18.05%,KCNC2;HTR2C;SNAP25;GIP;GCK;KCNA5;CACNA1A;MTNR1B;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;EIPR1;CCL5;ALOX5;SLC8B1;GLP1R;ABCC8;KCNG2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.4187464888476169,-1.6686240960040786,0.0,0.11609007459861624,1.0,38/101,22.46%,KLF4;THBS1;ATG7;EIF3E;METTL14;ATG10;DDX3X;MTOR;NIBAN1;MSN;PLD1;VGLL4;EIF3C;NFKBIA;UPF3B;SAMD4A;EZR;ASPH;ASPSCR1;CASP8;RPL26;AKT1;ZCCHC4;PERP;EEF2;AGTR1;FBXW11;LARP4B;RPS4X;RPL5;METTL5;SOX4;PRKDC;FGFR4;RBM3;OGT;AMER1;HSP90AA1
prerank,epithelial tube morphogenesis (GO:0060562),-0.5236466352878191,-1.6685134039447387,0.006993006993006993,0.11564176475169317,1.0,11/32,7.35%,ACVRL1;PODXL;PKD2;PRKD2;SOX17;HES1;RASIP1;COL4A1;SLIT2;BMP4;MEF2C
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5969768116882597,-1.6664531112456458,0.009057971014492754,0.11735772894967537,1.0,10/18,15.01%,CTNNA1;MFHAS1;GSK3B;MDFIC;LATS2;SIN3A;CHP1;UFM1;RAB23;ILRUN
prerank,regulation of regulated secretory pathway (GO:1903305),0.49695958710836335,1.6651968521089116,0.007058823529411765,0.16031929248438886,1.0,14/34,17.38%,SYT1;SYT5;RIMS2;RIMS1;RAB15;SYT12;SYT11;SYN1;RAB3A;SYT4;SYT3;SNAPIN;SYT9;RIMS3
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5460828509267939,-1.6651769768712712,0.012367491166077738,0.11819617833771438,1.0,11/24,9.29%,SEMA3C;NRP2;ENG;BMPR2;PARVA;TBX1;TGFBR2;TGFB2;BMP4;TBX2;SMAD4
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6328105729082771,-1.6647653230496393,0.0071301247771836,0.11801511881557801,1.0,7/15,16.38%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;IGF1
prerank,positive regulation of vasculature development (GO:1904018),-0.41814710866194826,-1.6636677398390627,0.0018181818181818182,0.11859159356734271,1.0,39/94,25.22%,FLT1;TEK;ITGB1;GAB1;NOS3;TIE1;ETS1;CD34;THBS1;KDR;ANXA3;PLCG1;PRKD2;SP1;FGF1;CDH5;PRKD1;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;FGF2;MTDH;CD40;AGO2;SMOC2;HIPK1;CTSH;SASH1;GATA2;F3;BRCA1;SERPINE1;CYP1B1;PTGIS;SEMA5A;RAPGEF3;TNFSF12
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3920884476546056,-1.6631858953664564,0.0,0.11858484697537736,1.0,48/136,24.18%,DAB2IP;SP100;RB1;KLF4;PKD2;ESR1;CD200;FZD6;TMSB4X;ID1;SIK1;TAX1BP1;HES1;GAS6;NFKBIA;OTULIN;ANXA4;GLIS2;FLNA;NFKBIL1;SMAD7;IRAK1;HDAC4;CHP1;TNFAIP3;DAP;PEX14;MAD2L2;MTURN;BMP7;SUMO1;IRAK2;TAF3;NLRC5;CDK5RAP3;CEBPG;CMKLR1;RNF2;USP7;TCF7L2;CTNNBIP1;WWP2;KEAP1;SFRP4;PIM1;CYP1B1;ARRB1;PTGIS
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5614034179052261,-1.6624892700056404,0.018050541516245487,0.11867831023370395,1.0,9/22,21.82%,SORBS1;ZBTB20;MTOR;PPARA;PPARD;AKT1;CREBL2;PPARG;CREB1
prerank,circulatory system development (GO:0072359),-0.4057902433977706,-1.6603975624214626,0.0,0.12035139991531073,1.0,45/118,19.09%,NXN;TEK;ACVRL1;MEF2A;AKAP13;HEG1;PKD2;KAT2B;MICAL2;SH3PXD2B;TBX1;SOX17;CDKN1B;PDLIM5;TGFBR2;TGFB2;SMYD4;RBP4;MTHFD1;ECE1;MEF2C;WDR11;CDH5;PLCE1;HSPG2;PDLIM1;KDM6A;FLT4;PCSK5;CASP8;RAMP2;KDM6B;NOTCH4;ZFPM1;NOTCH1;PDLIM3;RBM20;FOXC1;BCOR;TAB2;HEY1;HEY2;CITED2;SOX4;NCOA6
prerank,positive regulation of protein catabolic process (GO:0045732),-0.43008263826824367,-1.6596044980950868,0.005291005291005291,0.12056027007669985,1.0,22/84,10.67%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;MSN;VGLL4;ADAM9;TNFRSF1B;NEDD4;NKD1;EZR;SNX9;PLK2;GSK3A;AREL1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.47850391610251886,-1.659284318190361,0.003656307129798903,0.12031346989714457,1.0,15/45,11.38%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;SLC30A10;CBL;PIK3R1;PTK2;PIK3C2A;PLCE1;BCAR1;AKT1;NCK2;BRAF
prerank,DNA double-strand break processing (GO:0000729),-0.5800357810469122,-1.6588411164400112,0.017889087656529516,0.12016074706476616,1.0,9/18,21.31%,ATM;MRE11;RBBP8;DNA2;KAT5;UBE2V2;SMARCAD1;BRCA1;BLM
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.392504231596225,-1.6587995348563265,0.0,0.11958671588223536,1.0,47/140,17.60%,CHN2;ARHGAP31;AKAP13;BCR;CD2AP;RAC1;RHOJ;ARHGEF3;NET1;STARD8;RALBP1;MCF2L;ARHGAP10;CGNL1;ARAP3;PLEKHG5;ARHGAP5;RASGRF2;CHN1;ARHGEF12;SLIT2;RHOQ;ARHGDIA;PLCE1;TGM2;ITSN1;ARHGEF2;ARHGAP17;SOS2;STARD13;ARAP1;ARHGAP1;ARHGEF11;RHOA;ARHGAP28;FAM13A;RHOC;RHOG;TRIO;ARHGAP22;ABR;ARHGEF18;DEPDC7;PREX1;ARHGAP12;ARHGAP29;ARHGAP35
prerank,renal filtration (GO:0097205),-0.6939184596218614,-1.6586548077894143,0.013059701492537313,0.11916738265726065,1.0,5/10,10.92%,CD34;XPNPEP3;ITGA3;TBC1D8B;MCAM
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.510819999699015,-1.6579400170275926,0.0017699115044247787,0.11931255891782429,1.0,14/35,18.86%,UBR5;ZMIZ1;NR3C2;ESR1;RBFOX2;NR3C1;NEDD4;MED1;YAP1;KDM3A;NCOA4;TADA3;WBP2;PMEPA1
prerank,pharyngeal system development (GO:0060037),-0.6359278922338212,-1.6562205162654509,0.009074410163339383,0.12068652903124398,1.0,8/15,16.91%,BMPR2;BMP5;TBX1;HES1;TGFB2;BMP4;BMP7;SIX4
prerank,regulation of hydrolase activity (GO:0051336),-0.43871527491266926,-1.6558387829409662,0.0,0.1205166323857827,1.0,28/71,22.47%,DAB2IP;CHN2;PRKG1;FGD5;FGD6;CAV1;RAB3GAP1;RALBP1;CRK;RASIP1;CHN1;PTK2;PLXND1;EPHA4;PLXNA4;RAB3GAP2;PAFAH1B1;FBXW11;GPR137B;ARHGAP12;CDK5RAP3;SOD1;WRN;NF1;ARHGEF5;VAV2;NOS1;EPHB3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.694295115828051,1.6547707717791635,0.01873536299765808,0.1720767449081747,1.0,7/10,14.09%,DLGAP1;DLGAP2;NPTXR;NPTX2;DLGAP3;CACNG5;BEGAIN
prerank,regulation of inflammatory response (GO:0050727),-0.3752211836867684,-1.654120637213774,0.0,0.12215006839516883,1.0,66/190,25.00%,FOXP1;TEK;IL1R1;XIAP;RB1;KLF4;ETS1;MFHAS1;CASP12;CD200;SEMA7A;TMSB4X;APP;IL15;BIRC3;PPARA;TNFRSF1B;NFKBIA;OTULIN;NMI;PDE2A;PDCD4;PRKCD;NAPEPLD;CDH5;PPARD;CELF1;FEM1A;AREL1;JAK2;AGTR1;MGLL;USP18;LPL;IL17RA;NR1D2;TNFAIP3;IFI35;CCN3;C1QTNF3;IL16;TNFRSF1A;ANXA1;VAMP3;HYAL2;NOD2;DAGLB;PPARG;BCL6;AKNA;LPCAT3;VAMP2;GPR4;MAPK7;RELA;SERPINE1;RIPK1;CASP1;CEBPA;PTGIS;SHPK;ACE2;DDT;GPS2;DHX9;BRD4
prerank,negative regulation of MAPK cascade (GO:0043409),-0.42288078584579825,-1.6538816283439761,0.001841620626151013,0.12174736205760155,1.0,31/87,20.79%,DAB2IP;SEMA6A;FOXO1;CAV1;LYN;PTPN1;RANBP9;SPRED2;PTPRJ;DLG1;PPEF2;PRKCD;BMP4;EZR;SMAD4;PEBP1;STK38;TIMP3;CNKSR3;DUSP3;SPRY4;PIK3CB;ABCA7;BMP7;IGBP1;CDK5RAP3;HYAL2;PTPRC;UCHL1;PTEN;NF1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.32952215966531945,-1.6537291031098142,0.0,0.12130465410183207,1.0,241/807,21.82%,FOXP1;MECOM;KLF12;LEF1;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ETV6;ZBTB16;ATP8B1;SP100;WWP1;ZNF423;FOXO1;MEF2A;ZHX3;CREBBP;NSD1;RB1;CBFB;ZEB1;KAT6B;KLF4;CAV1;USP9X;CBFA2T3;DAB2;ESR1;NEDD4L;BTAF1;MIER1;CUX1;FOXN3;ZFHX3;NRIP1;PRDM5;SMURF2;LIMS1;RBFOX2;KLF2;IRF2;RXRA;SPINDOC;PRDM16;RPS6KA5;UIMC1;WWC2;ID1;MITF;NR3C1;THRB;KDM2A;SOX13;NFIX;KAT6A;RCOR1;LOXL3;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;BMP6;HDAC1;NFKB1;HES1;PPARA;RARG;GAS6;RPS14;DLG1;ZBTB7A;FOXO3;PDE2A;PDCD4;HIVEP1;PLCB1;MED1;SPEN;GTF2IRD1;BMP4;MAX;PTPRK;MEF2C;EZR;MIDEAS;SKIL;JUN;ZBTB4;SMAD2;ZFP90;PHF21A;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;YAP1;LDB1;PRDM2;PPARD;IRF1;GLI3;ZNF25;USP2;SMAD4;CTBP2;SP3;UBE2D3;GLIS2;TP53;FLNA;EHMT1;FRK;KLF10;EDN1;HMBOX1;PER3;NOTCH4;ETS2;DICER1;NFIC;SMARCC2;SIN3A;FNIP2;PSEN1;SOX7;MAZ;SMAD7;ZFPM1;PRDM6;SCMH1;CHD3;TWIST2;YAF2;NOTCH1;MTDH;CDC73;RTF1;HDAC4;SFPQ;PA2G4;LRRFIP1;WWOX;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;ATF4;MZF1;RPL10;KMT5A;SAMD1;NR1D2;HCFC1;TCF3;FOXC1;PHF6;DAP;BCOR;NR2C1;NAB2;PHC1;DR1;PEX14;TPR;MIER2;MAD2L2;TAF7;TRPS1;BMP7;HIC1;SKI;ORC2;SUMO1;SIX4;RARA;ZNF692;ARID5B;HDAC6;ZBTB14;CTNNB1;TAF3;IGBP1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;MIER3;VPS72;ELK4;KDM1B;CITED2;NCOA5;BAP1;RNF2;CCND1;DUSP22;LIN37;PIAS4;RITA1;SCML4;TCF7L2;NONO;TIMELESS;TBL1X;PPARG;WWP2;PRDM1;BCL6;RARB;BRCA1;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;DLL4;MDM2;NKAP;NACC1;CBFA2T2;HSF4;GCLC;PHC3;TSHZ3;CREB1
prerank,positive regulation of sodium ion transport (GO:0010765),0.6468860566637643,1.652695358009598,0.008438818565400843,0.1729100764520018,1.0,6/12,8.21%,ANK3;SCN1B;PKP2;GPD1L;WNK3;SCN5A
prerank,purine-containing compound salvage (GO:0043101),-0.6557709449074525,-1.6486617574004117,0.01971326164874552,0.12689803728094617,1.0,9/12,31.65%,ADK;AMPD2;HPRT1;AMPD3;ADA;PNP;GMPR2;APRT;DCK
prerank,regulation of T cell cytokine production (GO:0002724),-0.6168254143392827,-1.648252602345476,0.015817223198594025,0.12678906481752383,1.0,7/15,24.75%,TRPM4;TNFRSF1B;CD55;SMAD7;HFE;FZD5;MAP3K7
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4376591133798655,-1.646843226832538,0.0017889087656529517,0.12800577489564693,1.0,25/64,22.06%,UTRN;ACER2;CORO1C;GSK3B;THBS1;CCL25;MACF1;PTK2;ROCK1;LDB1;RASA1;RHOA;LIMCH1;DUSP3;MYOC;CDK6;PIK3CB;MAP4K4;JAG1;ROCK2;SLK;SEMA3E;NF1;VCL;PTK2B
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4974415079932507,-1.6466677846000977,0.0035335689045936395,0.1276091470542786,1.0,17/39,15.43%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;IL6ST;JAG2;TGFB2;AAK1;MAML1;TSPAN14;YAP1;NOTCH4;TSPAN5;NOTCH1;JAG1;CCN3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.49102594530095334,-1.6463711723776095,0.009380863039399626,0.12733893927690954,1.0,14/43,12.27%,NFIB;KLF4;ETS1;TEAD1;NFATC4;NR3C1;PPARA;FOXO3;TGFB2;BMP4;JUN;PPARD;TP53;FGF2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.4336093607903259,-1.646027336074528,0.0,0.12720553889163028,1.0,31/75,26.25%,TEK;JCAD;NRP2;BMPR2;KDR;PLCG1;PRKD2;SP1;BMP4;PRKD1;AKT3;FLT4;PIK3CD;AKT1;VEGFC;AGTR1;FGF2;ITGA4;ARNT;GATA2;NRAS;F3;ITGB3;IGF2;SEMA5A;HMGB1;EGR3;BMP2;THBS4;TNFSF12;ADAM17
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.32775390167573804,-1.6458237790765955,0.0,0.12683660360822618,1.0,278/834,25.05%,LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;ITGA6;NFIB;ENG;ERG;ACVRL1;FOXO1;MEF2A;CREBBP;MLLT10;MRTFB;SENP1;NFAT5;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;PKD2;DAB2;LRP5;ESR1;BMPR2;TCF12;ASXL1;ZFHX3;NRIP1;MAML2;KLF2;IRF2;CDK13;DVL3;RXRA;APP;KAT2B;NFATC1;BMP5;ATM;RPS6KA5;FOSL2;RNF111;LMO2;TEAD1;MICAL2;ZSCAN21;TBX1;MITF;NR3C1;THRB;DDX3X;KANSL3;NFIX;KAT6A;PRKD2;PLAGL1;SOX17;CDK12;EGFR;NOTCH3;RTRAF;SP1;CRLF3;ELK3;BMP6;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;NCK1;NFKBIA;PIK3R1;ABL1;FOXO3;LMO7;HIVEP1;LRP6;TGFB2;RHOQ;MED1;AATF;STAT6;PRPF6;E2F4;FGF1;GABPB2;BMP4;MAX;MEF2C;JUN;WASL;SMAD1;SMAD2;PLXND1;AGRN;MAML1;SETD3;PRKD1;ARHGEF2;ATAD2B;YAP1;LDB1;PRDM2;PPARD;IRF1;GLI3;ACVR2A;HAX1;SMAD4;AKIRIN2;NAMPT;CTBP2;SP3;TAL1;GLIS2;TP53;KDM6B;BCLAF3;KLF10;EDN1;DOT1L;NOTCH4;MED13;NCK2;POGZ;HELZ2;NFIC;PPP1R12A;RGCC;SIN3A;SMAD7;ZFPM1;BCAS3;MED17;NOTCH1;FOXF2;FOXJ3;FGF2;CDC73;RPS6KA1;HDAC4;SFPQ;TCEA1;GABPB1;WWOX;KAT5;EIF5A;CREBRF;CD40;HGF;PLSCR1;SMARCD3;ZIC3;ATF4;MZF1;AGO2;GRHL1;RPS6KA3;NR1D2;HCFC1;JAG1;TCF3;FOXC1;MYBL2;ZNF462;JMJD6;KMT2C;DR1;RUVBL2;ETV1;TNFRSF1A;FOXO4;TAF7;IGF1;SKI;CCNC;GCN1;RARA;CTNNB1;NLRC5;ARNT;CEBPG;MAVS;HEY1;HEY2;THAP3;NRF1;WBP2;ELK4;KDM1B;IKBKG;HLF;EPAS1;ZNF507;CITED2;RNF10;IKBKB;HYAL2;NOD2;GATA2;SOX4;NCOA6;RNF4;PRKDC;ATRX;SMAD9;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;RARB;LPIN2;CKAP2;BRCA1;AKNA;NR2F2;IGF2;GLIS1;OGT;PCGF5;TERT;PBX2;CAPRIN2;TET3;CREB1;ELF4;MAPK7;NOS1;NFE2L2;GABPA;CCN1;ATAD2;RELA;MYOCD;YY1;SERPINE1;GLMP;TBX3;USP16;ATF6;RIPK1;RXRG;CRTC1;RFXANK;PCBP1;SUPT4H1;CEBPA;FZD5;ARRB1;SSBP4;THRAP3;ATF5;CCNK;E2F7;E2F3;TAF9;SMARCB1;TFDP1;HMGB1;GPS2;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.6493872413097914,-1.6443188397883954,0.015817223198594025,0.12800008376830596,1.0,5/13,8.91%,NFIB;NFATC4;PPARA;BMP4;PPARD
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5832250156962603,-1.6432690650587611,0.01618705035971223,0.12866540101933818,1.0,10/19,18.14%,CYTH3;PARD3;MSN;CYTH1;EZR;MYO18A;SIPA1L3;RHOA;GOLPH3;RAP2A
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.5745299373127615,-1.6431197500709345,0.013307984790874524,0.1282289576562463,1.0,11/21,26.50%,CSNK1A1;CAV1;GSK3B;DVL3;LRP6;CTNNB1;AMER1;PPP1CA;FZD5;FZD1;APC
prerank,long-term memory (GO:0007616),0.5647200699103154,1.6412172891812475,0.021929824561403508,0.18714815764372145,1.0,8/19,14.63%,RASGRF1;SHANK1;CAMK4;SLC2A4;CPEB3;SGK1;LDLR;APOE
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.675832726615605,-1.640954151342827,0.01289134438305709,0.13012634273416068,1.0,3/11,2.75%,CD34;CD200;THBS1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4272315214696123,-1.6406798796906703,0.0074487895716946,0.12984729380739743,1.0,20/73,12.19%,ZNF423;ENG;ACVRL1;XIAP;BMPER;CRIM1;BMPR2;SMURF2;ITGA3;SMURF1;BMP4;SKIL;CDH5;SMAD1;SMAD2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1
prerank,regulation of chromatin organization (GO:1902275),-0.636667716308177,-1.6397637245523398,0.014388489208633094,0.13024970448350887,1.0,9/14,27.56%,MLLT3;TLK2;TLK1;METTL4;SETD5;HPF1;IGF2;ALKBH4;HNRNPU
prerank,protein K48-linked ubiquitination (GO:0070936),-0.4586150245041276,-1.6392458497157714,0.0035026269702276708,0.13031347065918159,1.0,36/54,37.73%,PELI1;UBR5;NEDD4L;ZNRF1;UBE2K;DTX3L;RBX1;CUL3;RNF115;UBE2D3;UBE2E2;TNFAIP3;KLHL3;RNF152;RNF4;UBE2R2;RNF216;HACE1;RNF146;FBXO38;ARIH2;RNF34;RNF187;CDC34;UBE2H;TRIM32;UBE2A;IFI27;UBE2T;TOPORS;UBE2G2;UBE2C;ITCH;UBE3A;KBTBD7;RNF5
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.6199052359047628,-1.6388878539835339,0.018083182640144666,0.13010759278486206,1.0,7/15,11.66%,PRKCE;LDLRAP1;PPARA;IRS1;PPARD;AKT1;ADM
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.46580541539808396,-1.6378435539545595,0.005199306759098787,0.1308177120755525,1.0,16/47,14.08%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;LIMS1;CORO1C;CRK;ABL1;PTK2;FLNA;ILK;ACTN4;NEDD9;MYOC;SPRY4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.47484494412730177,-1.6376472268948947,0.017208413001912046,0.13046071948038948,1.0,16/44,14.71%,CAST;XIAP;KLF4;THBS1;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;SH3RF1;AKT1;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,myeloid cell differentiation (GO:0030099),-0.4657797008194271,-1.6374938298224333,0.012773722627737226,0.13003195135912415,1.0,12/47,11.57%,ZBTB16;SNRK;MFHAS1;LYN;KMT2E;KAT6A;TET2;RPS14;ACIN1;TAL1;JAK2;ZFPM1
prerank,Rap protein signal transduction (GO:0032486),-0.6928451291830204,-1.6361794773283451,0.020477815699658702,0.13122677510638606,1.0,9/10,27.58%,RAPGEF2;RAP1A;PLK2;RAP1B;RAPGEF1;RAP2A;RAP2C;RAPGEF3;RAP2B
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.49440229938123764,-1.6359944821904684,0.008865248226950355,0.13086703277522838,1.0,17/37,20.17%,PRKG1;LDLRAP1;MMP2;CDKN1B;PDCD4;ERN1;MEF2C;JUN;FGF2;TPM1;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1;PPARG;PTEN
prerank,presynaptic endocytosis (GO:0140238),0.5330084406540023,1.6358363250893284,0.02237136465324385,0.19270523895306568,1.0,6/24,6.00%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.5151168820708903,-1.6357270300034463,0.003527336860670194,0.13062435116858603,1.0,14/29,26.45%,LEF1;CREBBP;HDAC1;TRRAP;AXIN2;CDC73;KAT5;ASH2L;TCF7L1;CTNNB1;TCF7L2;TERT;RBBP5;LEO1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.4354497110250194,-1.6351611201259606,0.006837606837606838,0.13071818782958441,1.0,19/67,12.16%,FLT1;TEK;IGF1R;GHR;DYRK1A;INSR;ABI1;LYN;IL15;KDR;EGFR;BMX;ABL1;PTK2;EPHA4;FLT4;JAK2;ABI3;PKDCC
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5359063008977517,-1.6348014531523491,0.01818181818181818,0.13067014254209436,1.0,10/26,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;BRAF;CREBL2;IGF1
prerank,positive regulation of phosphorylation (GO:0042327),-0.35838441781948893,-1.6331766629332953,0.0,0.13216725235581703,1.0,85/240,23.46%,FLT1;TEK;IGF1R;ITGA6;PECAM1;ENG;ZBTB20;TIE1;ROR1;INSR;DAB2;RAC1;FAM20A;LYN;THBS1;DVL3;APP;RALBP1;LIMK2;TBX1;LRRK2;KDR;NIBAN1;MERTK;SLCO3A1;EGFR;TFRC;GAS6;ABL1;DSTYK;FAS;LMO4;IL34;CCND3;PTK2;IRGM;FGF1;BMP4;MRE11;EPHA4;FLT4;ACVR2A;FGF7;AKT1;VEGFC;AXIN2;PRKAA1;ILK;PFKFB3;PSEN1;FGF2;LIMCH1;CSNK1D;FLOT1;CD40;HGF;PTGES3;MIF;ROCK2;ANGPT1;PELI2;PIK3R3;IGF1;ARNT;MAVS;RAP2A;AKTIP;CCND1;BRAT1;EPHA2;KRAS;FGFR4;ITGB3;IGF2;P2RY1;ROR2;PDGFRB;EPHB6;CCN1;HSP90AA1;EPHB3;PFKFB4;RIPK1;FZD7;RALB
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5418291547896369,-1.6328211950950657,0.010714285714285714,0.132040569566528,1.0,8/24,8.07%,PECAM1;ITGB1;F11R;ICAM1;NT5E;MSN;EZR;ROCK1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.3360172401791187,-1.6324898182976144,0.0,0.13191499317714536,1.0,153/497,21.81%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;ACVRL1;FOXO1;ZHX3;RB1;ZEB1;KAT6B;KLF4;CBFA2T3;DAPK1;BTAF1;FOXN3;BMPR2;PRDM5;SMURF2;LIMS1;RBFOX2;GSK3B;SPINDOC;PRDM16;RPS6KA5;RNF139;UIMC1;ID1;NR3C1;DDX3X;SOX13;KAT6A;RCOR1;LOXL3;GIGYF2;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;HDAC1;LARP1;HES1;GAS6;ZBTB7A;PDCD4;PLCB1;SPEN;BMP4;PTPRK;SAMD4A;MIDEAS;JUN;ZBTB4;SMAD2;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;LDB1;PPARD;IRF1;GLI3;GSK3A;SMAD4;CTBP2;SP3;WAPL;GLIS2;TP53;EHMT1;KLF10;HMBOX1;SMARCC2;SIN3A;SOX7;SCMH1;TWIST2;YAF2;PDS5A;NOTCH1;HDAC4;SFPQ;PA2G4;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;KMT5A;SAMD1;NR1D2;IGFBP5;DAP;SYNCRIP;BCOR;BTG2;PHC1;PEX14;TAF7;BMP7;SUMO1;SIX4;RARA;ARID5B;HDAC6;ZBTB14;CTNNB1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;RPS3;CITED2;BAP1;PIAS4;SCML4;TCF7L2;NONO;TIMELESS;CAPRIN1;PPARG;WWP2;BCL6;BRCA1;TOB1;NR2F2;TRIM28;FOXL2;MDM2;NKAP;NACC1;CBFA2T2;GCLC;PHC3;TSHZ3
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.6068510836825176,-1.6324609204579945,0.00927643784786642,0.13136362548300917,1.0,8/18,19.79%,ABL1;RFK;EDN1;EDN3;AGTR1;SIRT3;NOD2;POR
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.3121237601967872,-1.6322106938618592,0.0,0.13100470945708842,1.0,521/1667,25.05%,FOXP1;MECOM;KLF12;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ETV6;BAZ2B;ITGA6;ZBTB16;NFIB;SP100;TEF;ENG;ERG;MNAT1;ZBTB20;ACVRL1;FOXO1;MEF2A;ZHX3;CREBBP;MLLT10;NSD1;MRTFB;RB1;CBFB;SENP1;ZEB1;NFAT5;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;CAV1;USP9X;CHD1;PKD2;DAB2;LRP5;NR3C2;DACH2;PKNOX2;ESR1;NEDD4L;VGLL3;MIER1;CUX1;BMPR2;TCF12;ASXL1;HIVEP2;ZFHX3;TEAD4;TNRC6B;NRIP1;PRDM5;MED15;SMURF2;ZNF260;MED26;MAML2;KLF2;CHD2;IRF2;CDK13;DVL3;RXRA;PRRX1;APP;KLF3;TRAK1;KAT2B;NFATC1;BMP5;ATM;TBX15;PRDM16;DEK;RPS6KA5;FOSL2;RNF111;LMO2;TEAD1;CRK;WWC2;NFATC4;ZSCAN21;ARID1B;ID1;TBX1;MITF;NR3C1;THRB;DDX3X;KDM2A;ZBTB37;KANSL3;SOX13;NFIX;KAT6A;PBX3;PRKD2;PLAGL1;RCOR1;SOX17;CDK12;EGFR;MKX;ZHX2;ZBTB46;RTRAF;SP1;ZNF148;CRLF3;ELK3;CTCF;NIPBL;MGA;BMP6;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;SMARCC1;NCK1;NFKBIA;PIK3R1;RPS14;DLG1;PHF20;ABL1;ZBTB7A;FOXO3;ZIC4;PDE2A;LMO7;IKZF2;HIVEP1;HOXB6;LRP6;BBX;RHOQ;FUS;MED1;AATF;STAT6;NFYC;PRPF6;E2F4;BAZ1A;FGF1;SPEN;BRD2;GTF2IRD1;GABPB2;BMP4;CREB3L2;MAX;MEF2C;EZR;MIDEAS;SKIL;ZNF182;JUN;ZBTB4;WASL;SMAD1;SMAD2;ZFP90;TSHZ2;SRCAP;AGRN;PHF21A;TBX2;SUV39H1;MAML1;SETD3;DACH1;PRKD1;ARHGEF2;BACH2;ANXA4;ATAD2B;SMARCE1;ZBTB39;YAP1;NOP2;LDB1;PRDM2;PPARD;EBF1;IRF1;GLI3;ZNF25;ACVR2A;USP2;HAX1;SMAD4;AKIRIN2;RBBP8;ZIC5;HSF5;NAMPT;CTBP2;HOXC6;SP3;PHF20L1;UBE2D3;TAL1;GLIS2;ELF2;TP53;ZBTB40;FRK;KDM6B;BCLAF3;KLF10;EDN1;HMBOX1;DOT1L;MAMLD1;PER3;NOTCH4;ETS2;MED13;NCK2;KDM3A;POGZ;DICER1;HELZ2;STAT2;NFIC;PPP1R12A;RGCC;SMARCC2;SIN3A;PRRX2;GMEB1;FNIP2;PSEN1;JMJD1C;ZBTB7C;MAZ;SMAD7;ZFPM1;PRDM6;BCAS3;CHD3;TWIST2;HR;MED17;ZSCAN25;NOTCH1;FOXF2;FOXJ3;FGF2;MTDH;CDC73;SP140;RTF1;RPS6KA1;HDAC4;SFPQ;ZNF394;TCEA1;GABPB1;LRRFIP1;WWOX;TIAL1;KAT5;PROX2;PIAS2;ZBTB6;KLF9;EIF5A;CREBRF;CIC;CD40;HGF;ZHX1;PLSCR1;TFCP2L1;SMARCD3;DBX2;MECP2;ZIC3;ATF4;KDM7A;PGBD1;MZF1;ARID3B;AGO2;RPL10;KMT5A;GRHL1;ZBTB25;RPS6KA3;NR1D2;HCFC1;ZBTB34;HIF3A;JAG1;TCF3;TCF7L1;FOXC1;MYBL2;PHF6;MED29;ZKSCAN1;BCOR;TADA3;ZNF32;NR2C1;ZNF462;JMJD6;KMT2C;SMAD6;DR1;RUVBL2;TPR;BRWD3;ETV1;MIER2;TNFRSF1A;FOXO4;MAD2L2;CC2D1B;ZFP1;TAF7;TRPS1;HIC1;IGF1;SKI;CCNC;MOV10;ORC2;ZNF235;SUMO1;KDM5B;SIX4;RARA;MAMSTR;ZNF692;HOXA2;ARID5B;ZNF691;ZBTB14;CTNNB1;FOXQ1;ZBTB8A;TAF3;IGBP1;TFAP4;ZXDB;ZNF250;HDAC10;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;MAVS;HEY1;ZFP28;HEY2;TSHZ1;THAP3;ZSCAN12;NRF1;WBP2;MIER3;VPS72;ELK4;KDM1B;HOXB9;ZIC1;IKBKG;ZBTB12;HLF;EPAS1;ZNF507;CITED2;RNF10;NCOA5;IKBKB;HYAL2;PCGF3;NOD2;GATA2;RNF2;PPM1D;SOX4;ZFX;NCOA6;TNRC6A;CCND1;DUSP22;LIN37;RNF4;PRKDC;ATRX;SMAD9;PIAS4;RITA1;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;WWP2;PRDM1;PTEN;BCL6;RARB;ELOC;LPIN2;CKAP2;BRCA1;ZSCAN26;BAZ1B;AKNA;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;MED27;OGT;DLL4;PCGF5;MDM2;NKAP;NACC1;TOX4;PBX2;HSF4;CAPRIN2;TET3;TSHZ3;CREB1;ZSCAN18;ELF4;MAPK7;NOS1;AASS;NFE2L2;GADD45A;GABPA;MCPH1;CCN1;ATAD2;RELA;MYOCD;YY1;SERPINE1;KDM3B;GLMP;TBX3;SUDS3;USP16;ATF6;RIPK1;MSX1;ZKSCAN8;RXRG;CRTC1;RFXANK;PCBP1;AEBP2;MED20;SUPT4H1;CEBPA;FZD5;ARRB1;BEND3;SSBP4;THRAP3;TRIB3;KLF16;ATF5;ZFP3;ACVR2B;CCNK;E2F7;ZFHX4;GMEB2;CNOT2;ARID3A;E2F3;TAF9;SMARCB1;ZNF276;TFDP1;TLE6;ZKSCAN4;HMGB1;RBAK;GPS2;EGR3;SP110;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,RNA destabilization (GO:0050779),-0.5920808204900858,-1.6297484493027008,0.01730103806228374,0.13365527941913358,1.0,10/18,26.53%,METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;ROCK2;METTL16;RBM24;DXO
prerank,membrane depolarization during action potential (GO:0086010),0.5229142159448859,1.6294463225064102,0.017699115044247787,0.19962007676083804,1.0,12/26,17.93%,ATP1A2;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;CACNA1D;SCN5A;SLC8A1;SCN2B;CACNA1G;CACNA1I
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.3816332034542394,-1.6293772823365769,0.0,0.13357965433670152,1.0,50/153,16.81%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;ATM;MARK1;RPS6KA5;PAK2;LRRK2;NEK6;MTOR;PRKD2;TLK1;CSNK1G3;TGFBR2;RICTOR;GAS6;MAST4;MAST2;PRKCD;ERN1;MAPKAPK2;PLK2;MAPK1;ROCK1;PRKD1;AKT3;LATS2;CLSPN;AKT1;STK32C;IKBKE;STK38;RPS6KA1;CSNK1G1;CSNK1D;ULK2;MKNK2;MAPK8;PKN2;RPS6KA3;MARK2;PKN3;ROCK2;MAPK12;SRPK2;MARK3;HIPK1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.557537558140181,-1.6283666455354169,0.025179856115107913,0.13418037275625824,1.0,8/24,9.84%,SORBS1;INSR;GSK3B;PPP1R3B;IRS1;PPP1R3C;GSK3A;AKT1
prerank,regulation of nervous system process (GO:0031644),0.5711054559092867,1.627847023043153,0.033783783783783786,0.20003311061082252,1.0,11/18,14.09%,HTR2C;DLGAP1;DLGAP2;TMEM108;NPTXR;SLC8A2;NPTX2;SLC8A3;DLGAP3;CACNG5;BEGAIN
prerank,positive regulation of hydrolase activity (GO:0051345),-0.38550848348561273,-1.6278374824084187,0.0017699115044247787,0.13429849222089063,1.0,55/137,25.12%,DOCK9;ITGA6;RAPGEF2;RSU1;ITGB1;FERMT2;RAB3GAP1;CD200;LIMS1;NET1;GSK3B;DVL3;RALBP1;F11R;PKP4;CCL25;AFDN;RAP1A;SNX9;TGM2;USP6NL;AGRN;RASGRP2;TBC1D30;PICALM;RAPGEF1;ARAP1;BCAS3;RHOA;MTCL1;WNT11;RHOC;CD40;LARS1;MAPK8;MAP4K4;MAPK12;TBC1D20;CTSH;ALS2;WRN;RPS3;CCL19;NDEL1;NF1;ASAP3;SNX13;EVI5;ARHGAP11A;SNX18;ADRB1;PLXNB1;RAPGEF3;BMP2;FZD10
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.41400322218588864,-1.6270737848129997,0.0035842293906810036,0.13469656620631298,1.0,31/88,25.22%,TEK;PTPRM;NRP2;ACVRL1;TIE1;CAV1;BMPR2;THBS1;KDR;PRKD2;BMP4;PRKD1;AKT3;FLT4;PIK3CD;AKT1;VEGFC;RGCC;FGF2;ANGPT1;ARNT;NRAS;F3;ITGB3;NF1;NR2F2;SEMA5A;EGR3;BMP2;THBS4;TNFSF12
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.595065885545195,-1.6263655833219828,0.011764705882352941,0.1349244949162249,1.0,10/18,21.76%,JCAD;RHOJ;KDR;PIK3C2A;AKT3;MAP3K3;FGF2;ANXA1;GATA2;HDAC7
prerank,cell junction assembly (GO:0034329),0.39571248869174747,1.624846488963345,0.0,0.20272240878421374,1.0,29/100,10.12%,KIRREL3;NRXN1;CDH18;NLGN1;CDH8;CTNND2;CDH20;CDH9;CDH10;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;NRCAM;PKP2;DCHS1;CDH19;FLNC;FLCN;CDH12;FSCN1;GPM6A;SDK1;CDH7;SLITRK1;POU4F1;CDH24;CDHR3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.4358472197792969,-1.6246614322471187,0.0036968576709796672,0.13674706940451484,1.0,16/66,13.68%,DAB2IP;PTPRM;NFIB;CAV1;THBS1;MCC;TGFBR3;TGFB2;MED1;AQP11;PTPRK;RGCC;CDC73;CEACAM1;KLF9;CDK6
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.42401613253316406,-1.6243850046641974,0.007207207207207207,0.13659104927626808,1.0,29/75,22.61%,DAB2IP;RB1;HEG1;LRP5;LYN;PTPN1;PTPRJ;CDKN1B;RASIP1;ABL1;LRP6;PRKCD;BMP4;LATS2;AKT1;STK38;SPRY4;PIK3CB;PKIG;BMP7;TFAP4;CDK5RAP3;HYAL2;UCHL1;PTEN;NF1;NR2F2;GADD45A;MYOCD
prerank,Wnt signaling pathway (GO:0016055),-0.4159962521821535,-1.624349651587156,0.0,0.13605911049249278,1.0,38/92,26.76%,LEF1;NXN;FERMT2;CSNK1A1;LRP5;FZD6;GSK3B;DVL3;LRRK2;DDX3X;CSNK1G3;FZD4;RBX1;RARG;LRP6;KLHL12;PLCG2;WNT16;VPS26A;CSNK1G1;WNT11;TCF7L1;USP34;CTNNB1;TCF7L2;PTEN;AMER1;FZD7;SFRP4;FZD5;PLPP3;FZD10;WNT2B;WNT5B;FZD1;APC;VPS35;FRZB
prerank,neuron projection organization (GO:0106027),-0.6115079122257628,-1.6241649622690453,0.013961605584642234,0.13571676749053693,1.0,6/15,15.65%,INSR;GSK3B;APP;PSEN1;DCTN1;LGMN
prerank,embryonic organ development (GO:0048568),-0.44108912172140863,-1.6239200529149889,0.0052173913043478265,0.13554586281176498,1.0,27/61,21.46%,PBX1;KITLG;TEAD4;TEAD1;KDR;PBX3;SOX17;TGFBR2;TGFB2;RBP4;TBX2;NES;GLI3;PCSK5;MFSD2A;TAL1;ZFPM1;PKDCC;ATF4;RPL10;ERCC3;TBC1D23;HEY1;HEY2;COL13A1;RARB;PBX2
prerank,regulation of secretion (GO:0051046),0.6155878958532148,1.6238399542349071,0.023758099352051837,0.20198004846996062,1.0,7/13,15.40%,NRG1;POFUT2;ACSL3;OAS2;GPLD1;SGK1;MYO6
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5594588983617765,-1.6229954958355404,0.013961605584642234,0.13626841413795188,1.0,10/21,16.77%,LDLRAP1;MMP2;ERN1;JUN;FGF2;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.655067813905622,-1.6228501417792587,0.01967799642218247,0.1358353572814641,1.0,4/12,7.35%,DAB2IP;PTPN1;PIK3R1;ERN1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.45312257229855346,1.6224829634323181,0.002304147465437788,0.20201327482500633,1.0,16/53,17.27%,CHRM2;HTR2C;OPRM1;CNR1;CHRM3;MTNR1B;MTNR1A;NPY;HTR4;ADRB3;TSHR;HTR1D;CCL2;HTR1F;HRH1;HRH2
prerank,response to histamine (GO:0034776),0.6715045885622815,1.6215497814488433,0.031818181818181815,0.20102067248240957,1.0,3/10,3.54%,GABRB1;GABRB3;GABRB2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4590882056348126,-1.6209404954775637,0.013157894736842105,0.13753448172794916,1.0,17/50,14.71%,XIAP;KLF4;THBS1;PAK2;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;CAAP1;SH3RF1;AKT1;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5947718253651414,-1.6206404942631565,0.01967799642218247,0.13727603318891046,1.0,11/18,26.25%,FLT1;PLCG1;SP1;MEF2C;AKT3;FGF2;ITGA4;PPARG;IGF2;HMGB1;ADAM17
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.49956469493046896,-1.6162571949516735,0.009560229445506692,0.1420839642724875,1.0,19/33,30.81%,ACVRL1;KLF4;THBS1;MEOX2;MEF2C;STARD13;RGCC;NOTCH1;RHOA;FGF2;MECP2;PPARG;DLL4;GADD45A;HMGB1;HDAC5;ANGPT4;JUP;TGFB1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.44349932474095666,-1.6149939750466946,0.007194244604316547,0.14304837029782122,1.0,32/56,31.34%,RB1;ANKRD17;KMT2E;DDX3X;EGFR;CUL3;PLCB1;CCND3;AKT1;RGCC;CDC16;RPTOR;NSMCE2;UBE2E2;LSM11;MECP2;RAB11A;ANXA1;LSM10;CCND1;CDC25A;TFDP1;BRD4;ANAPC7;DTL;ADAM17;FGF10;RDX;ANAPC11;CCND2;STOX1;ANAPC5
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.3865845992204163,-1.6144734314998892,0.0,0.14320616857392698,1.0,59/138,28.94%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;TEAD1;NR3C1;THRB;NOTCH3;HDAC1;PPARA;RARG;MED1;MAML1;POLR2G;NOTCH2;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;NOTCH4;MAZ;MED17;NOTCH1;TAF8;ERCC3;NR1D2;NR2C1;DR1;TAF7;RARA;TAF3;HDAC10;TBL1X;PPARG;RARB;MED27;HDAC7;TAF4B;TAF13;RXRG;POLR2C;E2F3;TAF9;TAF15;POLR2L;POLR2H;HDAC5;GTF2H3;MAML3;E2F2;CCNH;RORC
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.6367146192465859,-1.6143824373308635,0.02018348623853211,0.14275065364072523,1.0,5/12,9.09%,GMDS;CSGALNACT1;GFPT2;FUT8;SLC35A3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.49641518962297254,-1.6143788964754255,0.007285974499089253,0.14218192593697732,1.0,13/35,17.60%,DAB2IP;HEG1;ITGA3;SCAI;RASIP1;CUL3;TGFB2;STAMBP;TNFAIP1;MYOC;SPRY4;KCTD10;ARHGAP35
prerank,regulation of exocytosis (GO:0017157),0.4567627287121342,1.614337710232993,0.006622516556291391,0.21003150356456396,1.0,8/46,5.60%,IL1RAPL1;STXBP5L;SYT1;RIMS2;CADPS;RAB15;RAB3C;RAB27B
prerank,regulation of cell migration (GO:0030334),-0.3421364728855916,-1.613994019604498,0.0,0.14213888617448903,1.0,140/382,22.81%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;CLDN5;SEMA3C;ENG;ITGB1;ACVRL1;PODXL;FERMT2;INSR;CAV1;DAB2;RAC1;CBLL1;CORO1C;PDGFD;SEMA7A;THBS1;TMSB4X;GCNT2;ATM;MITF;ARID2;SYNE2;KDR;PTPRJ;SCAI;SMO;EGFR;ACE;ADAM9;LDLRAD4;GNA12;AFDN;TCAF1;STK24;FOXO3;LMO4;SLIT2;ROBO4;MACF1;PTK2;FGF1;NKD1;PTPRK;CDH5;PLXND1;ROCK1;PPM1F;EPHA4;DACH1;PLXNA4;LDB1;CDH1;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;FGF7;AKT1;FLNA;EDN1;ZMYND8;LMNA;MAZ;SMAD7;PHACTR1;FRMD5;TWIST2;ABI3;NOTCH1;RHOA;FGF2;SEMA3G;LIMCH1;SEMA6B;CEACAM1;SEMA4C;TPM1;ACTN4;DUSP3;NEDD9;WNT11;MYOC;RHOC;HGF;NUMB;MAP4K4;JAG1;IGFBP5;MIF;TBCCD1;ROCK2;FUZ;VSIR;SEMA5B;PIK3R3;IGF1;SLK;RIPOR1;ANXA1;CTSH;TMSB10;ADARB1;SEMA4A;RAP2A;SASH1;SEMA3E;WASHC1;CITED2;DUSP22;RAP2C;CXCL12;PTEN;F3;FERMT3;SPATA13;NF1;LAMB1;SEMA4G;VCL;AMOTL2;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;PTK2B;HACE1;SERPINE2;CCN1;RECK;MIEN1;SERPINE1
prerank,generation of neurons (GO:0048699),0.3586204010087376,1.6131071584363086,0.0,0.20977272313716977,1.0,44/190,14.86%,PTPRD;IL1RAPL1;TAFA1;MYT1L;SNPH;WNT7B;IRX4;ADGRL3;NIF3L1;SPOCK1;DNER;ATP2B2;ASTN2;FUT9;CDK5;LHX1;CDKL5;NRCAM;ITM2C;ASTN1;MDGA1;DCDC2;RUNX2;GPM6A;NTRK2;IRX3;ADNP2;INSM1;MAPT;ACSL3;LMX1B;DCX;MAP1B;CCK;AUTS2;HMGB2;WNT6;FZD3;NRBP2;TUBGCP2;BRSK2;RNF112;WNT4;RACGAP1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4791068887877321,-1.6124710437558518,0.012750455373406194,0.1436837690688526,1.0,14/39,16.00%,PODXL;KLF4;BMP6;PPARA;PTK2;FXYD5;PPM1F;CDH1;AKT1;NOTCH4;RGCC;NOTCH1;JAG1;MAD2L2
prerank,lipid phosphorylation (GO:0046834),0.6552693843439638,1.6124086184368427,0.018306636155606407,0.20853305654682272,1.0,3/10,1.83%,DGKK;DGKI;DGKQ
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.4424004571024308,-1.6120745176938032,0.007042253521126761,0.14363013533200072,1.0,25/60,23.73%,LEF1;CBFB;TNRC6B;MED15;MED26;NFKB1;MED1;TP53;MED13;MED17;MECP2;CCNC;MOV10;CTNNB1;HEY2;PPM1D;TNRC6A;CCND1;MED10;TCF7L2;PTEN;TRIM28;MED27;RELA;MED20
prerank,protein phosphorylation (GO:0006468),-0.33396434648739143,-1.611873798953002,0.0,0.14332190107561735,1.0,134/479,17.01%,FLT1;GRK5;TEK;PRKCH;DAB2IP;IGF1R;PRKG1;SNRK;MAP3K20;ERG;ACVRL1;BCR;DYRK1A;ERC1;INSR;ABI1;CSNK1A1;NEK7;DAPK1;FAM20A;LYN;PRKCE;BMPR2;TLK2;GSK3B;CDK13;PRKACB;APP;ATM;JAK1;MARK1;RPS6KA5;LIMK2;PAK2;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;KDR;MTOR;CDK17;PRKD2;MERTK;CDK12;EGFR;TLK1;CSNK1G3;TGFBR3;TGFBR2;RICTOR;GAS6;STK3;STK24;BMX;ABL1;MAST4;MAST2;TGFB2;PTK2;PRKCD;BRD2;BMP4;CDK10;ERN1;MAPKAPK2;PRAG1;CDC42BPA;SMAD2;AAK1;PLK2;MAPK1;ROCK1;MAML1;BIRC6;EPHA4;PRKD1;AKT3;YWHAZ;FLT4;PXK;GSK3A;ACVR2A;LATS2;CLSPN;PIK3CD;ADAM10;AKT1;MAP3K3;SIK3;FRK;TAOK3;PRKAA1;WNK4;STK10;ILK;STK32C;FNIP2;IKBKE;BRAF;JAK2;SMAD7;USP15;ABI3;STK38;PKDCC;IRAK1;RPS6KA1;CSNK1G1;CSNK1D;CLK3;WNT11;CSK;ULK2;CDK6;MKNK2;MAPK8;PKN2;RPS6KA3;MAP4K4;MARK2;LIPE;GMFB;PKN3;ROCK2;NUAK1;MAPK12;SRPK2;SLK;FYN;MARK3;HIPK1;RARA;CDC42BPB
prerank,muscle tissue development (GO:0060537),-0.6384069536133892,-1.6107451376151805,0.014010507880910683,0.14423639107497385,1.0,5/13,8.49%,PGM5;ENG;SMO;BMP4;CSRP2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3759526589494257,-1.6093069873705264,0.0,0.14536703198743067,1.0,77/168,27.32%,PAN3;TUT7;TENT4B;ATM;CNOT4;RPS21;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;XRN1;RPSA;SAMD4A;UPF2;POLR2G;RPL3;RPLP1;RPL26;RPS11;HELZ2;XRN2;TUT4;RPL13;RPL38;RPL27;RPS16;RPS4X;TENT2;PARN;GSPT1;RPL10;PDE12;RPL7A;RC3H1;RPL5;EXOSC8;RPS27;RPL27A;RPS3;CTIF;RPL36A;RPL35A;PPP2CA;EXOSC5;PELO;DCP1A;RNPS1;RPL37A;RPL32;DIS3L2;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;THRAP3;SMG6;CNOT2;RPS17;EXOSC7;RPS2;CNOT8;ZFP36L1;RPL39;RPS26;RPS15A;DXO;RPL15;RPL34;CNOT1;PABPC1
prerank,heart trabecula morphogenesis (GO:0061384),-0.5812993194505062,-1.6089102818122043,0.015957446808510637,0.14538183956937983,1.0,11/18,17.92%,TEK;ENG;ADGRG6;BMP5;TGFBR3;TGFB2;RBP4;S1PR1;NOTCH1;BMP7;HEY1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5193365845062342,-1.6087960467335802,0.01054481546572935,0.14496329219869583,1.0,15/27,32.99%,TNRC6B;EGFR;LIMD1;BMP4;PUM1;TP53;AGO2;WTIP;RIPK1;AJUBA;DHX9;FXR1;TGFB1;STAT3;PUM2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.40179288858495893,-1.607901048410597,0.003616636528028933,0.1455680491283354,1.0,58/110,31.11%,RPS21;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;RPSA;UPF2;RPL3;RPLP1;RPL26;RPS11;HELZ2;RPL13;RPL38;RPL27;RPS16;RPS4X;GSPT1;RPL10;RPL7A;RPL5;RPS27;RPL27A;RPS3;CTIF;RPL36A;RPL35A;PPP2CA;DCP1A;RNPS1;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;SMG6;RPS17;RPS2;RPL39;RPS26;RPS15A;RPL15;RPL34;PABPC1;SMG1;RPLP2;RPL18;RPL19;RPS13;RPL8
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5718147106590267,1.6077613359183953,0.030837004405286344,0.2138622503972516,1.0,9/18,13.44%,NRXN1;NLGN1;CACNG8;CACNG3;CACNG2;CACNG4;CCL2;NLGN2;CACNG5
prerank,vascular transport (GO:0010232),-0.4150293415727766,-1.6072309636326452,0.005199306759098787,0.14589458596900645,1.0,25/81,11.66%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC16A12;SLC12A2;ABCC9;TFRC;SLC5A6;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLCO2B1;SLC13A3;MFSD2A;SLC2A13;SLC27A4
prerank,regulation of transferase activity (GO:0051338),-0.5932585206775637,-1.6067554342527726,0.020599250936329586,0.14596555571228423,1.0,11/17,29.78%,ATM;PARP4;LDB1;FEM1A;HMBOX1;FEM1B;NLRC5;SMG6;PINX1;BAG5;EMP2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.480727552743591,-1.6067518932471399,0.0053475935828877,0.14541540191064609,1.0,11/38,11.47%,INSR;KLF4;CAV1;PKD2;CD34;RAC1;KLF2;NOS1AP;AKT1;EDN1;JAK2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4280495958977273,-1.606410924812821,0.003738317757009346,0.14531377102073978,1.0,32/65,30.81%,CAV1;SMURF2;IL17RD;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD7;SMAD6;SKI;NRROS;PMEPA1;HTRA3;DAND5;SNX25;STRAP;MTMR4;FBN1;ADAM17;EMILIN1;TGFBR1;ADAMTSL2;BAMBI;LTBP1;SPRY1;TGFB1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.34017207288816426,-1.6047250777042281,0.0,0.14685851550154158,1.0,117/348,22.46%,TEK;RBPMS;RAPGEF2;GHR;PECAM1;ENG;ACVRL1;INSR;CAV1;DAB2;RAC1;FAM20A;LYN;BMPR2;PDGFD;IQGAP1;DVL3;UBE2K;APP;RALBP1;BMP5;RPS6KA5;LIMK2;PAK2;TBX1;LRRK2;IL15;DDX3X;KDR;PRKD2;NIBAN1;PTPRJ;SLCO3A1;EGFR;TFRC;BMP6;IL6R;GAS6;MRNIP;ABL1;FAS;IL34;CCND3;TGFB2;PTK2;IRGM;RASSF2;FGF1;BMP4;RAP1A;SNX9;NGF;MRE11;MAPK1;MMD;PRKD1;ARHGEF2;RAF1;FLT4;PLCG2;ACVR2A;HAX1;SMAD4;CSPG4;FGF7;AKT1;VEGFC;TP53;AXIN2;ILK;FNIP2;BRAF;JAK2;HFE;RPTOR;FGF2;LIMCH1;CSNK1D;MTCP1;FLOT1;CD40;HGF;MIF;ROCK2;MAD2L2;CREBL2;ANGPT1;PELI2;PIK3R3;BMP7;IGF1;TAB2;HDAC6;ALS2;MAVS;CACUL1;RAP2A;CCL19;CENPE;AKTIP;CCND1;BRAT1;PTPRC;RAP2C;TXN;KRAS;ITGB3;IGF2;PTPN11;P2RY1;CAPRIN2;MAP2K3;NOS1;PTK2B;TTK;CCN1;HSP90AA1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5156469217101983,-1.6033294584894975,0.01263537906137184,0.14825263005932152,1.0,11/28,19.26%,FOXP1;XIAP;BIRC3;SAMHD1;CD55;IRF1;CASP8;N4BP1;ZMPSTE24;ERAP1;TKFC
prerank,response to gamma radiation (GO:0010332),-0.5331012081018519,-1.602967950007387,0.010507880910683012,0.14814629044433092,1.0,13/24,21.28%,MAP3K20;DCUN1D3;TLK2;ATM;YAP1;RPL26;TP53;PRKAA1;TRIM13;FANCD2;WRN;LIG4;MDM2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.313464274121078,-1.6025976374530875,0.0,0.1480692915551564,1.0,352/1082,25.05%,MECOM;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;FLI1;ITGA6;ZBTB16;NFIB;SP100;ZNF423;ENG;ERG;ACVRL1;FOXO1;MEF2A;AFAP1L2;CREBBP;MLLT10;NSD1;MRTFB;SENP1;NFAT5;DYRK1A;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;PKD2;DAB2;LRP5;ESR1;BMPR2;TCF12;ASXL1;MLLT3;ZFHX3;NRIP1;MAML2;KLF2;IRF2;DVL3;RXRA;APP;TRIM56;KAT2B;NFATC1;BMP5;ATM;PRDM16;RPS6KA5;FOSL2;RNF111;LMO2;BICRA;TEAD1;KMT2E;ZSCAN21;ARID1B;TBX1;DTX3L;MITF;NR3C1;THRB;MAP3K5;DDX3X;KANSL3;NFIX;MTOR;KAT6A;PRKD2;PLAGL1;SOX17;EGFR;CD38;NAA16;RTRAF;SP1;FZD4;CRLF3;ELK3;CTCF;BMP6;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;SMARCC1;RYBP;NCK1;TASP1;NFKBIA;PIK3R1;WDR75;ABL1;FOXO3;DNM2;LMO7;HIVEP1;LRP6;PLCB1;RHOQ;NSD3;MED1;AATF;STAT6;PRPF6;E2F4;FGF1;GABPB2;BMP4;CREB3L2;MAX;MEF2C;JUN;WASL;SMAD1;SMAD2;ZFP90;ACTA2;AGRN;MAML1;SETD3;PRKD1;MDFIC;ARHGEF2;ATAD2B;HNRNPAB;YAP1;LDB1;PRDM2;CDH1;PPARD;PHF5A;IRF1;GLI3;ACVR2A;PICALM;DDX39B;HAX1;SMAD4;AKIRIN2;NAMPT;CTBP2;SP3;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;KDM6B;BCLAF3;KLF10;EDN1;DOT1L;NOTCH4;ETS2;MED13;NCK2;KDM3A;POGZ;HELZ2;RGMB;NFIC;PPP1R12A;RGCC;ILK;SMARCC2;SIN3A;PSEN1;MAZ;SMAD7;ZFPM1;BCAS3;RPTOR;ICE1;ARHGEF11;MED17;YAF2;NOTCH1;FOXF2;FOXJ3;FGF2;RPS6KA1;HDAC4;SFPQ;TCEA1;GABPB1;WWOX;KAT5;EIF5A;WNT11;CREBRF;ZPR1;RHOG;FBXW11;CD40;HGF;XPC;PLSCR1;SMARCD3;ZIC3;ATF4;MZF1;AGO2;GRHL1;RPS6KA3;NR1D2;HCFC1;JAG1;TCF3;FOXC1;MYBL2;MRPL12;TADA3;ZNF462;JMJD6;TRIM16;KMT2C;DR1;RUVBL2;ETV1;TNFRSF1A;FOXO4;MAD2L2;CREBL2;PCBD2;TAF7;THOC1;BMP7;IGF1;SKI;CCNC;SIX4;RARA;CTNNB1;GPATCH3;TFAP4;NLRC5;ARNT;CEBPG;MAVS;HEY1;HEY2;THAP3;NRF1;WBP2;ELK4;KDM1B;ZIC1;IKBKG;HLF;EPAS1;ZNF507;CITED2;RNF10;EDRF1;IKBKB;HYAL2;NOD2;GATA2;SOX4;NCOA6;RNF4;PRKDC;ATRX;ELOF1;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;RARB;LPIN2;CKAP2;BRCA1;AKNA;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;OGT;PCGF5;BLM;PBX2;CAND2;CAPRIN2;TET3;CREB1;CHEK1;MAP2K3;ELF4;MAPK7;NOS1;UBTF;NFE2L2;GABPA;CCN1;ATAD2;RELA;MYOCD;KCNH2;YY1;SERPINE1;GLMP;TBX3;USP16;ATF6;RIPK1;EIF2AK3;FZD7;RXRG;CRTC1;RFXANK;PCBP1;SUPT4H1;CEBPA;FZD5;ARRB1;SSBP4;THRAP3;ATF5;SERTAD2;CCNK;E2F7;E2F3;TAF9;SMARCB1;TFDP1;TAF15;HMGB1;GPS2;FANK1;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,response to ethanol (GO:0045471),0.6049174414382178,1.6023168313659197,0.033783783783783786,0.2203620001395201,1.0,5/14,13.88%,GRIN2B;GLRA1;GRIN2A;ADCY7;GRIN3A
prerank,phosphorylation (GO:0016310),-0.34007040553812967,-1.6014735839860703,0.0,0.14890771806709452,1.0,106/385,15.38%,GRK5;PRKCH;PRKG1;SNRK;MAP3K20;ERG;ACVRL1;BCR;DYRK1A;INSR;CSNK1A1;NEK7;DAPK1;FAM20A;LYN;PRKCE;BMPR2;TLK2;GSK3B;CDK13;PRKACB;APP;ATM;JAK1;MARK1;RPS6KA5;LIMK2;PAK2;PANK2;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;MTOR;CDK17;PRKD2;MERTK;CDK12;TLK1;TGFBR2;LIMD1;GAS6;STK3;STK24;BMX;ABL1;MAST2;TGFB2;PRKCD;BRD2;CDK10;ERN1;MAPKAPK2;PRAG1;CDC42BPA;AAK1;PLK2;MAPK1;ROCK1;MAML1;BIRC6;PRKD1;AKT3;YWHAZ;PXK;GSK3A;ACVR2A;LATS2;PIK3CD;ADAM10;AKT1;DGKA;SIK3;FRK;DGKZ;TAOK3;PRKAA1;WNK4;STK10;ILK;FNIP2;IKBKE;BRAF;JAK2;STK38;IRAK1;CSNK1D;CLK3;WNT11;CSK;CDK6;PNKP;MKNK2;AGK;MAPK8;PKN2;PIK3CB;GK5;MAP4K4;MARK2;LIPE;GMFB;PKN3;ROCK2;NUAK1
prerank,microtubule-based transport (GO:0099111),0.5957634704812751,1.601375449397859,0.033632286995515695,0.21967294150851108,1.0,8/13,21.02%,ADCY10;ROPN1L;DYNC1I1;HTT;SPAG17;CABYR;DNAAF2;DYNC1I2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4206897957682833,-1.600635100618119,0.005226480836236934,0.14942351884910152,1.0,27/73,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,positive regulation by host of viral transcription (GO:0043923),-0.6047090117941696,-1.6005130940549936,0.01904761904761905,0.14898506505687215,1.0,5/15,9.48%,LEF1;CHD1;SP1;JUN;TAF11
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3401291700708946,-1.5993430530906714,0.0,0.15011090231651478,1.0,112/390,17.16%,PTPRG;FLT1;TEK;IGF1R;RAPGEF2;GHR;SORBS1;WASF2;NRP2;DOCK1;FOXO1;GAB1;COL4A2;TIE1;ROR1;INSR;ABI1;ANKS1A;RAC1;LYN;RBFOX2;ARHGEF28;COL4A6;PDGFD;GSK3B;ELMO1;CRK;PAK2;NFATC4;SPRED2;KDR;PRKD2;MERTK;PTPRJ;MMP2;EGFR;GIGYF2;YES1;AP2B1;CEP57;AP2A2;CBL;NCK1;PXN;PIK3R1;IRS1;PSEN2;SHOC2;CHN1;PLCB1;DDIT4;RHOQ;PTK2;AP2S1;FGF1;PIK3C2A;MAPKAPK2;NGF;WASL;ITSN1;HNRNPM;MAPK1;ROCK1;EPHA4;POLR2G;PRKD1;GRB10;SHB;FLT4;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;FGF7;AKT1;MPZL1;VEGFC;SOCS2;FRK;NCK2;RAPGEF1;PSEN1;JAK2;HNRNPF;RASA1;RHOA;FGF2;ACTB;TIAL1;ATP6V1E1;NEDD9;HGF;NCF2;PIK3CB;GRB2;ELMO2;NCKAP1;HNRNPA1;FOXC1;FLRT2;ROCK2;FOXO4;ANGPTL1;ANGPT1;PIK3R3;ARPC4;IGF1;FYN;UBASH3B;PLAT;APH1A
prerank,neuron development (GO:0048666),0.37164788075117994,1.5993300691525933,0.0,0.22086519735319143,1.0,32/141,9.80%,CNTNAP2;TENM4;NLGN1;L1CAM;RASGRF1;MYT1L;PPP1R9A;CNTN4;BLK;TENM1;ATP8A2;SH3GL2;TMEM108;GPM6B;TENM3;CDK5;SRRM4;PLP1;TENM2;EPHA5;ATXN10;MAP2;NPY;GPM6A;NTRK2;INSM1;MAPT;POU4F1;ARL3;DCX;ZFYVE27;STMN2
prerank,transport across blood-brain barrier (GO:0150104),-0.411508639776264,-1.5993192708971253,0.0035335689045936395,0.14957505768401608,1.0,25/83,11.66%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC16A12;SLC12A2;ABCC9;TFRC;SLC5A6;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLCO2B1;SLC13A3;MFSD2A;SLC2A13;SLC27A4
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5312939705361392,-1.5988872016043902,0.008532423208191127,0.14963414055593294,1.0,5/26,5.93%,FOXP1;DAB2;HDAC1;STRN3;ZBTB7A
prerank,granulocyte differentiation (GO:0030851),-0.5730464408897262,-1.5977718141287636,0.01717557251908397,0.15066187420414218,1.0,7/18,16.92%,LEF1;CBFA2T3;RXRA;DEK;TAL1;LBR;RARA
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.33019411967241413,-1.5967830599789532,0.0,0.15154356204169891,1.0,141/509,18.97%,FLT1;HIP1;TEK;VWF;DAB2IP;IGF1R;KITLG;JCAD;RAPGEF2;ENG;ITGB1;PELI1;GAB1;AKAP13;FERMT2;NFAT5;ROR1;INSR;CAV1;RAC1;TAB3;NR3C2;MFHAS1;ESR1;LYN;MIER1;ANKRD17;NOD1;LIMS1;TRAF5;PDGFD;THBS1;IQGAP1;GCNT2;TRIM25;APP;ADRA1B;TBX1;DDX3X;PLEKHG5;RPL37;NEK6;KDR;TNFSF10;PRKD2;PTPRJ;EGFR;BIRC3;TFRC;RICTOR;CBL;GAS6;PIK3R1;IRS1;NMI;PDCD4;TGFB2;NEDD4;PTK2;FGF1;PUM1;PLK2;TGM2;SEC13;ROCK1;MIOS;PRKD1;NOS1AP;FLT4;PLCG2;HAX1;ALPK1;WNT16;CASP8;PIK3CD;CFLAR;FGF7;MAP3K3;TP53;FLNA;THEM4;BCAP31;DDX60;ILK;IKBKE;TRIM14;JAK2;MAZ;ADGRV1;USP15;RPTOR;RHOA;FGF2;IRAK1;MTDH;ACTN4;TCIM;WNT11;MYOC;RHOC;RHOG;CD40;LARS1;HGF;KSR1;PIK3CB;GRB2;IFI35;BBC3;IAPP;CGAS;TNFRSF19;MIF;ROCK2;GAB2;TNFRSF1A;TNFAIP8L3;ANGPT1;PELI2;BCL2L11;IGF1;TAB2;TFG;TRIM13;MIB2;FYN;GSDME;VAPA;GOLPH3;CDK5RAP3;MAVS;SASH1;RPS3;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;SIAH1;IKBKB;NOD2
prerank,positive regulation of catabolic process (GO:0009896),-0.42908539471258395,-1.596283389303726,0.00865051903114187,0.15151664291737688,1.0,28/65,26.50%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;NEDD4;NKD1;PLK2;GSK3A;AREL1;TNFAIP3;VSIR;OAZ2;GPC3;WWP2;HUWE1;HACE1;SEC22B;FZR1;TNFSF12;DTL;APC
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.555507728892026,-1.5961670160701804,0.016129032258064516,0.15107711339347796,1.0,11/21,17.95%,NOS3;SRGN;TRPM4;GAS6;ASPN;ROCK1;NOTCH1;BCOR;ROCK2;HEY1;HEY2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.530967545328902,-1.5951654337648347,0.023255813953488372,0.1518975594124038,1.0,9/23,17.56%,ZBTB20;INSR;APP;NFKB1;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.5907240700358584,-1.5946613375637415,0.014414414414414415,0.15198806711993926,1.0,5/16,10.04%,CREBBP;KAT2B;NAA16;NAA80;NAA15
prerank,inhibitory synapse assembly (GO:1904862),0.6301298433070179,1.594524687879076,0.03171247357293869,0.22626207507966808,1.0,4/11,9.51%,GABRB3;GABRB2;GABRA2;GABRA1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5219380444662312,-1.5936984624941688,0.01073345259391771,0.1527585921470594,1.0,7/26,10.40%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,membrane assembly (GO:0071709),0.48616931745222935,1.592536569322829,0.014742014742014743,0.2270974783802171,1.0,6/34,3.52%,PTPRD;NRXN1;IL1RAPL1;NLGN1;ANK3;STX2
prerank,extracellular matrix organization (GO:0030198),-0.34702137018347107,-1.5921014239393498,0.0,0.154337549828817,1.0,82/276,15.88%,VWF;TLL1;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;COL12A1;ITGB1;JAM2;BSG;COL4A2;COL25A1;PLOD1;PLOD2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;SH3PXD2B;ITGA1;SMOC1;KDR;P3H2;COL5A1;ICAM1;ITGB4;HTRA1;MMP2;LOXL3;LAMA3;LAMA4;GAS6;ITGB5;COL4A5;COL4A1;TGFB2;COL8A2;COL5A2;SLC39A8;AGRN;HSPG2;COLGALT2;LOXL1;DST;CDH1;ADAMTS9;CAPN2;ADAM10;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;P4HA1;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3;LCP1;NID1;FLOT1;ITGA4;COL26A1;ICAM2;HAS1;FLRT2;EXOC8;SMOC2;ITGA2;COL6A2
prerank,receptor catabolic process (GO:0032801),-0.5316873334588917,-1.5916856862962887,0.017889087656529516,0.1543418797500494,1.0,13/24,23.00%,ZNRF3;SMURF1;AP2B1;AP2A2;RNF43;NEDD4;AP2S1;MYLIP;LGMN;AP2M1;SNX25;KIF16B;BECN1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.42280083845157723,-1.591232073659499,0.01048951048951049,0.1544449549865972,1.0,22/73,13.20%,DOCK1;ITGB1;FERMT2;MYH9;DAB2;ITGBL1;SEMA7A;ITGB4;ADAM9;LAMA3;ITGB5;ABL1;CUL3;PTK2;PRKD1;DST;BCAR1;ADAM10;ILK;LAMA5;CEACAM1;NEDD9
prerank,T-helper cell differentiation (GO:0042093),-0.5911851273266961,-1.5911081081974496,0.022058823529411766,0.1540685829256402,1.0,2/14,0.16%,FOXP1;LEF1
prerank,endothelial cell differentiation (GO:0045446),-0.6297315396566547,-1.5908033111029871,0.026362038664323375,0.15394451391882114,1.0,6/12,14.85%,ACVRL1;TIE1;BMPR2;KDR;KDM6B;JAG1
prerank,embryonic hemopoiesis (GO:0035162),-0.638880077991282,-1.5907203617577284,0.026737967914438502,0.1535147509475184,1.0,6/12,14.04%,KITLG;KDR;TGFBR2;TAL1;ZFPM1;ATF4
prerank,negative regulation of vascular permeability (GO:0043116),-0.6279699219676826,-1.5903015056837657,0.015517241379310345,0.15357941949977189,1.0,9/12,16.14%,CLDN5;FERMT2;PTPRJ;PDE3A;PDE2A;SLIT2;RAMP2;CEACAM1;ANGPT1
prerank,presynapse organization (GO:0099172),0.6762542456139802,1.5902162738253052,0.029213483146067417,0.22890564523701454,1.0,2/10,0.55%,NLGN1;LRRTM3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.37096493031642386,-1.5901260330465259,0.0,0.1532377244596432,1.0,46/161,16.00%,DAB2IP;CSNK1A1;CAV1;DAB2;MLLT3;FZD6;GSK3B;DVL3;MCC;PSMA2;IGFBP4;ZNRF3;SOX13;SOX17;EMD;KREMEN1;FZD4;LIMD1;HDAC1;FRMD8;RBX1;STK3;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;PSMB4;GLI3;GSK3A;LATS2;UBAC2;AXIN2;DKK2;TMEM64;NOTUM;WNT11;PSMC2;LMBR1L;TMEM170B;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5850472425767598,-1.5896879432590576,0.024163568773234202,0.1532589331173064,1.0,5/17,8.91%,CAV1;ADIPOR2;PANK2;PPARA;PPARD
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.48046631679958507,-1.5895210926107284,0.017857142857142856,0.15293383324593063,1.0,14/39,12.27%,ENG;TIE1;PKD2;LRP5;KDR;TGFBR2;SIX1;RASIP1;COL4A1;LRP6;SLIT2;BMP4;NOTCH4;FGF2
prerank,translation (GO:0006412),-0.3602435194777889,-1.5887409008952673,0.0017421602787456446,0.15351925468649158,1.0,95/208,30.54%,YARS1;WARS2;RRBP1;RPS21;RPL37;RPL31;RPL9;RPS14;FARS2;RPSA;PTCD3;RPL3;RPLP1;MRPL32;MRPL47;RPL26;RPS11;EEF2;RPL13;MRPS18A;RPL38;DRG1;RPL27;RWDD1;RPS16;LARS1;RPS4X;MRPL2;GSPT1;AGO2;RPL10;MRPS24;RPL7A;AIMP2;HARS2;N6AMT1;DARS2;RPL5;MRPL24;RPS27;RPL27A;MRPL57;RPS3;NDUFA7;RPL36A;RPL35A;FARSA;MRPS14;RPL37A;IARS2;ABCE1;MRPS21;MRPL35;GFM2;RPL32;WARS1;RPS7;RPS15;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;MRPS2;SRBD1;NOA1;RPS17;MRPS28;RPS2;MRPL43;TUFM;EEF1B2;RPL39;MRPL11;RPS26;TNIP1;RPS15A;TRMT112;RPL15;RPL34;EEF1G;RPL22L1;GATB;RPLP2;RPL18;MRPS17;RPL19;EEF1D;RPS13;COPS5
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.6318661161996575,1.5884589753994827,0.03532008830022075,0.22987536744207127,1.0,4/12,1.29%,SYT1;SYT5;RIMS2;RIMS1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3980137629207172,-1.5878163076992962,0.007352941176470588,0.15407892059023212,1.0,42/103,21.36%,RAPGEF5;RREB1;ARHGAP31;RAPGEF2;GNB1;BCR;RB1;BRAP;RAC1;NTN1;RALBP1;PLD1;SHOC2;JUN;PLCE1;PLK2;RASGRP2;PRKD1;PLD2;RRAS;RASSF1;TP53;GRAP;ARHGAP1;RIN2;FGF2;CHP1;KSR1;GRB2;RERG;ABR;ARHGEF18;IGF1;DNMT1;RGL1;RRAS2;KRAS;NRAS;RGL2;NF1;TRIM28;NUCB2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.5152218812282259,-1.587244262964125,0.008992805755395683,0.15441358740634772,1.0,12/27,26.66%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;CRTC1;PPP1CA;FBXL22;CRY2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.49132864489331357,-1.5870430942672735,0.02018348623853211,0.15409330397930388,1.0,19/33,32.81%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;PTEN;CDKN2C;FHL1;E2F7;PLK3;APC;CDKN2B;JADE1;WEE1;CDK4
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5214695687958726,-1.5868938079065837,0.017761989342806393,0.1537148755675091,1.0,11/26,18.97%,TAB3;NOD1;IFIH1;ALPK1;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2
prerank,positive regulation of cartilage development (GO:0061036),-0.5790084478128389,-1.5866545795609923,0.02531645569620253,0.15353648664181038,1.0,5/17,12.16%,ZBTB16;ACVRL1;BMPR2;BMP4;PKDCC
prerank,regulation of glycolytic process (GO:0006110),-0.4190249757840252,-1.5865397827419794,0.0,0.15314962989617903,1.0,20/68,17.87%,ZBTB20;INSR;CBFA2T3;APP;NUP42;RAE1;RANBP2;PPARA;ZBTB7A;NUP98;SEC13;PRKAA1;PFKFB3;PSEN1;NUP153;HDAC4;TPR;IGF1;ARNT;NUP214
prerank,atrial septum morphogenesis (GO:0060413),-0.6701761815983832,-1.5861013120443246,0.028985507246376812,0.1532899027054317,1.0,6/10,19.06%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;SOX4
prerank,positive regulation of cell differentiation (GO:0045597),-0.35381795593971976,-1.5850133798054147,0.0,0.15417730247974332,1.0,68/237,16.38%,LEF1;PRKCH;KITLG;CTNNA1;SLC6A6;RAPGEF2;ZBTB16;ACVRL1;MEF2A;ZHX3;ZEB1;FERMT2;BOC;CD34;DAB2;LRP5;BMPR2;GCNT2;KDR;MTOR;IL6ST;TRPM4;TGFBR2;BMP6;IL6R;NFKB1;ABL1;PLCB1;TGFB2;BLOC1S5;BMP4;RAP1A;MEF2C;CDON;NGF;SMAD2;MMD;BNIP2;PRKD1;ARHGEF2;YAP1;PPARD;ACVR2A;SMAD4;RRAS;AKT1;AXIN2;RGCC;SIN3A;EDN3;AGTR1;RIN2;PKDCC;RHOA;RPS6KA1;PA2G4;CEACAM1;LPL;TMEM64;HGF;RPS6KA3;SMYD1;TCF3;FOXC1;MAPK12;CREBL2;BMP7;IGF1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.3305623119272744,-1.5848834998840966,0.0,0.1538938420648558,1.0,137/420,22.02%,SGMS1;TEK;VWF;DAB2IP;CHN2;ARHGAP31;MOB3B;AKAP13;PPP1R13B;XIAP;BCR;RAC1;RHOJ;ARHGEF3;LYN;NET1;TRAF5;STARD8;TMSB4X;RALBP1;ATM;MCF2L;ARHGAP10;CRK;PAK2;WWC2;LRRK2;ARAP3;PLEKHG5;MTOR;KAT6A;PRKD2;EGFR;BIRC3;PIP4K2A;TOP3A;RICTOR;HDAC1;ARHGAP5;RASGRF2;GNA12;NFKBIA;DLG1;PHF20;STK3;PDE2A;CHN1;ARHGEF12;DDIT4;PAK1IP1;RHOQ;PIP4K2B;RASSF2;FGF1;PIP5K1B;EZR;ARHGDIA;MRE11;ITSN1;MAPK1;ARHGEF2;NOP2;PLCG2;USP2;IER3;RRAS;RBBP8;TAF11;ARHGAP17;SOS2;STARD13;AKT1;TP53;EHMT1;TAOK3;PRKAA1;ARAP1;ARHGAP1;CHD3;TTI1;ARHGEF11;RHOA;ARHGAP28;CEACAM1;RPA3;DNA2;KAT5;PTPN13;RPA1;FAM13A;MYOC;RHOC;RHOG;KMT5A;TRIO;ZFAND6;MAP4K4;NUAK1;RPL5;ARHGAP22;CASTOR1;ABR;ARHGEF18;DEPDC7;TAF7;PREX1;HIPK1;ARHGAP12;TAF3;ARHGAP29;ARHGAP35;CMKLR1;WRN;IKBKG;RPA2;PRKAB1;ITFG2;ARHGAP26;VRK2;USP7;BOP1;FAM13B;TMEM127;PRDM1;PTEN;BRCA1;ARHGEF5;RRS1;MDM2;BLM;NRK;VAV2;ARHGEF1;RFC4;TAF4B;CHEK1;SYDE1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3393105294064091,-1.5845103979582604,0.0,0.153840257936155,1.0,123/306,27.65%,MEF2A;ST3GAL4;EXT1;ALAS1;RBMS1;RRBP1;ATM;RPS21;THRB;RPL37;RPL31;TOP3A;RPL9;RPS14;RPSA;MRE11;POLR2G;MCM9;ST3GAL2;RPL3;RPLP1;MRPL32;RBBP8;CLSPN;RPL26;MCM4;PWP1;RPS11;TAF1B;ORC5;EEF2;POLD3;RPL13;MRPS18A;RPA3;DNA2;KAT5;RPL38;REV1;DRG1;RPA1;RPL27;RPS16;TBRG1;RPS4X;GSPT1;AGO2;RPL10;B4GALT5;RPL7A;GAL3ST2;HARS2;RPL5;TOP1MT;CREBL2;ORC2;MRPL24;RPS27;POLE2;PTMS;RPL27A;GOLPH3;WRN;RPS3;LARGE1;ORC4;RPA2;RPL36A;RPL35A;MRPS14;TIMELESS;RNPS1;RPL37A;BRCA1;MRPS21;MRPL35;TERT;RPL32;BLM;WARS1;RFC4;CHEK1;PTMA;RPS7;RPS15;MCM3;TOP1;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;MED20;RPS23;POLR2C;SRBD1;RPS17;POLR2L;POLA2;RPS2;MRPL43;MLF1;POLR2H;TUFM;MCM7;EEF1B2;RPL39;MRPL11;RPS26;TNIP1;RPS15A;MMS19;RPL15;RPL34;MCM5;EEF1G;MCM10;POLL;EXO1
prerank,cellular response to cadmium ion (GO:0071276),-0.5256652499530797,-1.5839088575727371,0.014109347442680775,0.1540984394955239,1.0,14/24,25.53%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.4215002029642137,-1.5829097364936335,0.0017793594306049821,0.15495053116031374,1.0,31/66,29.46%,UBR5;FERMT2;LIMK2;DTX3L;TFRC;PIK3R1;PRKCD;TCP1;YAP1;CDH1;AKT1;FLNA;PSEN1;ZPR1;TPR;CDK5RAP3;MAVS;ZIC1;HYAL2;ORMDL3;TRIM28;TERT;EIF2AK3;PINX1;CCT5;CCT2;PARP9;RAN;NMD3;JUP;LARP7
prerank,amino acid import (GO:0043090),-0.5449782254784792,-1.582574288009976,0.01893939393939394,0.15485638345901473,1.0,5/21,2.55%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SH3BP4
prerank,photoperiodism (GO:0009648),-0.5060339102237286,-1.5812472415578025,0.016042780748663103,0.15600878789483283,1.0,12/28,26.66%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;CRTC1;PPP1CA;FBXL22;CRY2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6568003336533379,-1.5792519029579142,0.0364963503649635,0.15833741502558002,1.0,2/10,0.62%,DAB2IP;SEMA6A
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.5100522153696787,-1.5780850192561438,0.014010507880910683,0.15944619454020678,1.0,13/29,22.06%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;DGKZ;FGF2;TNFAIP8L3;CCL19;NOD2;PDGFRB;PTK2B
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5657789597724222,-1.5772960095094013,0.02292768959435626,0.15999071239455598,1.0,8/18,17.28%,ANKRD17;RNF125;BIRC3;PUM1;SEC14L1;DDX60;USP15;GPATCH3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.522753184099067,-1.5763964506479833,0.01079136690647482,0.16079085165156004,1.0,7/25,10.40%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,positive regulation of axon extension (GO:0045773),0.5275258864687832,1.5750343061013516,0.015486725663716814,0.25034150221462137,1.0,9/22,9.72%,L1CAM;DSCAM;SHTN1;CDKL5;LIMK1;MEGF8;MAPT;VEGFA;ZFYVE27
prerank,macrophage activation (GO:0042116),-0.48700545098087494,-1.5744066585309733,0.017482517482517484,0.16295115161599408,1.0,9/34,14.94%,FOXP1;APP;DYSF;NMI;LBP;CD93;PLCG2;JAK2;IFI35
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.4778428255780857,-1.5742629047507737,0.012612612612612612,0.16257599988559798,1.0,18/36,24.96%,DAB2IP;PTPRM;SP100;ACVRL1;THBS1;SLIT2;MEF2C;ADAMTS9;RGCC;NOTCH1;FGF2;MECP2;PPARG;NR2F2;DLL4;GADD45A;HMGB1;ADGRB1
prerank,negative regulation of apoptotic process (GO:0043066),-0.32721742634760653,-1.5742322849311263,0.0,0.16208510449034108,1.0,117/444,17.30%,TJP1;LEF1;GRK5;TEK;PRKCH;IGF1R;ITGB1;FOXO1;XIAP;RB1;ERC1;KLF4;CAV1;MCL1;DAB2;TNFAIP8;GSK3B;THBS1;ARHGAP10;PAK2;NFATC4;TBX1;DDX3X;KDR;YWHAE;MERTK;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;RNF213;SLC30A10;HDAC1;NFKB1;SIX1;CBL;GAS6;NFKBIA;PIK3R1;DSTYK;PSEN2;FAS;PTK2;MED1;AATF;PRKCD;BMP4;BNIP3;MEF2C;ARHGDIA;NGF;RNF144B;MYO18A;PLK2;MRE11;DNAJB6;MAPK1;BIRC6;NOTCH2;BNIP2;ANXA4;RAF1;YAP1;YWHAZ;FLT4;SH3RF1;HAX1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;PRKAA1;AREL1;PSEN1;BRAF;MAZ;RASA1;NOTCH1;SON;IRAK1;COMP;MTDH;RPS6KA1;SFPQ;PA2G4;CAT;TCIM;WNT11;UFM1;BABAM2;HGF;MAPK8;RPL10;RPS6KA3;ZFAND6;GPX1;MAP4K4;MIF;PRDM9;SMAD6;LGMN;ANGPT1;IGF1;SIX4;ANXA1;CTSH;CTNNB1;FOXQ1;IGBP1;API5;PPIF
prerank,canonical Wnt signaling pathway (GO:0060070),-0.4238749782265697,-1.573782117789342,0.005504587155963303,0.1621211850489004,1.0,30/68,26.76%,LEF1;CSNK1A1;CAV1;LRP5;FZD6;GSK3B;DVL3;LRRK2;FZD4;RARG;LRP6;RAB5A;WNT16;WNT11;TCF7L1;CTNNB1;TCF7L2;PTEN;AMER1;FZD7;SFRP4;PPP1CA;FZD5;PLPP3;FZD10;WNT2B;WNT5B;FZD1;APC;FRZB
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5038000069891042,-1.572428171911807,0.025089605734767026,0.16349286173369232,1.0,11/27,13.32%,TJP1;WASF2;SHANK3;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC
prerank,cellular component maintenance (GO:0043954),-0.6345625385689544,-1.5721808059691726,0.030685920577617327,0.1633103963109933,1.0,3/12,2.92%,IGF1R;INSR;ITGA3
prerank,regulation of leukocyte activation (GO:0002694),-0.6073502163962536,-1.571621603498573,0.02527075812274368,0.1636761306697561,1.0,7/14,15.33%,MFHAS1;LYN;CD200;MYO18A;PLSCR1;GPR137B;MIF
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5137524364160336,1.5713078741223483,0.03263403263403263,0.25499628429623505,1.0,7/22,12.08%,PDE4B;STAC2;HPCA;CACNB3;CACNB4;STAC;SRI
prerank,Notch signaling involved in heart development (GO:0061314),-0.6540739487280223,-1.5701308933658986,0.028070175438596492,0.1652184362877341,1.0,8/11,27.14%,NOTCH2;GALNT11;NOTCH1;JAG1;HEY1;HEY2;DLL4;SNAI2
prerank,regulation of cell cycle (GO:0051726),-0.3415597208446037,-1.5694475254720917,0.0,0.16577175898347823,1.0,96/271,26.54%,MECOM;GRK5;APBB2;DAB2IP;TTC28;MAP3K20;PPP1R13B;XIAP;AFAP1L2;RB1;DCUN1D3;NEK7;PKD2;ANKRD17;THBS1;IQGAP1;FBXL12;LIN52;KAT2B;ATM;FBXL17;SIK1;NEK6;PLAGL1;FBXL3;BIRC3;CDKN1B;CRLF3;ABL1;PDCD4;PHACTR4;LRP6;TGFB2;RNF40;CDC14A;BMP4;PTPRK;CDK10;ERN1;PUM1;JUN;UHRF2;NOTCH2;IRF1;RASSF1;ADAM10;TP53;RGCC;NOTCH1;SON;CDC123;CDK6;TBRG1;NUDT6;RNF167;HCFC1;MYBL2;MIF;MAPK12;FOXO4;BMP7;SRPK2;RARA;TFAP4;ADARB1;CDK5RAP3;RAD23A;CITED2;BAP1;CCND1;PTPRC;LIN37;BOP1;TCF7L2;CDK11B;BRCA1;PES1;MDM2;CDKN2C;CHEK1;CDC25A;GADD45A;TBX3;MAEA;BMP2;APBB1;FBXL22;SIPA1;MLF1;DTL;RPS15A;NUPR2;CDKN3;APC;GAS2L1;FGF10
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6201468312114571,-1.5688849917116672,0.04230769230769231,0.16597893870673278,1.0,7/13,15.78%,SP100;MDFIC;NUP153;CHP1;UFM1;RAB23;TPR
prerank,homologous chromosome segregation (GO:0045143),0.5413947920893818,1.5688395696275839,0.0365296803652968,0.2571046926942865,1.0,4/20,3.69%,SYCP1;MAJIN;ZCWPW1;FMN2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5805545179536717,1.5687462898726683,0.043010752688172046,0.2548571088803842,1.0,7/15,15.55%,MELTF;PDPN;DDR2;FSCN1;CST3;DDR1;CLASP2
prerank,positive regulation of hemostasis (GO:1900048),-0.662090629843924,-1.5682631342853268,0.03152364273204904,0.1657479247646228,1.0,7/10,26.84%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,positive regulation of coagulation (GO:0050820),-0.662090629843924,-1.5682631342853268,0.03152364273204904,0.1657479247646228,1.0,7/10,26.84%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,positive regulation of blood coagulation (GO:0030194),-0.5755033010585813,-1.566442313661425,0.03616636528028933,0.16775340348785528,1.0,9/17,26.84%,ST3GAL4;THBS1;ENPP4;ANO6;F3;SERPINE1;HPSE;DMTN;F2R
prerank,erythrocyte development (GO:0048821),-0.6700833572523288,-1.5663920618845089,0.021778584392014518,0.16728287221344051,1.0,4/10,8.14%,ALAS1;ZBTB7A;MED1;ABCB10
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6329319566199004,-1.5663782741001868,0.03723404255319149,0.16681131311338687,1.0,8/11,30.81%,TGFBR3;TGFBR2;TGFB2;SMAD7;USP15;BMP2;TGFBR1;TGFB1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.4175428362678668,-1.5663229339075222,0.007259528130671506,0.1663739379558233,1.0,29/64,28.73%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;CDC73;RTF1;TCEA1;MLLT1;ERCC3;NELFB;ELOF1;ADRM1;ELOC;TCEA2;SUPT4H1;POLR2C;CCNK;POLR1E;POLR2L;POLR2H;LEO1;GTF2H3;CCNH;ELP2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.29887204271797807,-1.56536214574468,0.0,0.1671714502871133,1.0,511/1645,25.19%,FOXP1;MECOM;KLF12;LEF1;PBX1;APBB2;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ETV6;BAZ2B;ZBTB16;ATP8B1;NFIB;SP100;WWP1;ZNF423;TEF;ENG;ERG;MNAT1;ZBTB20;ACVRL1;FOXO1;MEF2A;ZHX3;AFAP1L2;CREBBP;NSD1;RB1;BNC2;CBFB;ZEB1;NFAT5;DYRK1A;ZMIZ1;KAT6B;ELF1;ERC1;INSR;KLF4;ETS1;CHD1;CBFA2T3;LRP5;NR3C2;DACH2;PKNOX2;ESR1;VGLL3;BTAF1;CUX1;FOXN3;TCF12;HIVEP2;MLLT3;ZFHX3;TEAD4;PRDM5;SMURF2;ZNF260;LIMS1;RBFOX2;MED26;KLF2;CHD2;IRF2;ZNF326;DVL3;RXRA;PRRX1;KLF3;TRIM56;TRAK1;NFATC1;TBX15;SPINDOC;PRDM16;DEK;RPS6KA5;FOSL2;RNF111;BICRA;TEAD1;CRK;UIMC1;WWC2;KMT2E;NFATC4;ZSCAN21;ARID1B;ID1;TBX1;DTX3L;MITF;NR3C1;MAP3K5;KDM2A;ZBTB37;SOX13;NFIX;KAT6A;CDK17;PBX3;PLAGL1;RCOR1;SOX17;EGFR;LOXL3;MKX;PSPC1;CD38;ZHX2;CDKN1B;NAA16;ZBTB46;VGLL4;SP1;FZD4;ZNF148;CRLF3;VSX1;ELK3;METTL4;CTCF;NIPBL;LIMD1;MGA;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;SIX1;UBP1;SMARCC1;RYBP;GAS6;TASP1;PHF20;ABL1;ZBTB7A;FOXO3;ZIC4;DNM2;TRRAP;IKZF2;PDCD4;HIVEP1;HOXB6;LRP6;PLCB1;BBX;NSD3;FUS;MED1;AATF;STAT6;NFYC;E2F4;BAZ1A;SPEN;BRD2;GTF2IRD1;BMP4;CREB3L2;MAX;PTPRK;MEF2C;SETD5;MIDEAS;SLC39A8;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;ZFP90;ASCC1;ACTA2;TSHZ2;SRCAP;PBXIP1;TBX2;SUV39H1;PPM1F;SETD3;DACH1;MDFIC;BACH2;ANXA4;HNRNPAB;NAB1;SMARCE1;ZBTB39;YAP1;NOP2;LDB1;PRDM2;CDH1;PPARD;PHF5A;EBF1;IRF1;GLI3;ZNF25;PICALM;SMAD4;RBBP8;ZIC5;GPBP1;SPTY2D1;HSF5;CTBP2;HOXC6;SP3;USP13;PHF20L1;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;ZBTB40;EHMT1;KLF10;HMBOX1;MAMLD1;NOTCH4;ETS2;MED13;KDM3A;HMG20A;RGMB;STAT2;NFIC;ILK;SMARCC2;SIN3A;PRRX2;GMEB1;PSEN1;SOX7;JMJD1C;ZBTB7C;MAZ;SMAD7;SCMH1;CHD3;TWIST2;HR;ARHGEF11;MED17;YAF2;ZSCAN25;NOTCH1;FOXF2;FOXJ3;FGF2;MTDH;SP140;RPS6KA1;HDAC4;SFPQ;PA2G4;ZNF394;OGG1;LRRFIP1;TIAL1;KAT5;PROX2;PIAS2;ZBTB6;TCIM;KLF9;WNT11;CREBRF;RHOG;CIC;FBXW11;TAF5L;XPC;ZHX1;TFCP2L1;SMARCD3;DBX2;MECP2;ZIC3;ATF4;KDM7A;PGBD1;MZF1;ARID3B;GPBP1L1;KMT5A;SAMD1;GRHL1;ZBTB25;RPS6KA3;NR1D2;HCFC1;ZBTB34;HIF3A;TCF3;TCF7L1;POLR3F;FOXC1;MYBL2;PHF6;DAP;MRPL12;MED29;ZKSCAN1;BCOR;TADA3;ZNF32;NR2C1;JMJD6;TRIM16;NAB2;SMAD6;PHC1;RUVBL2;PEX14;BRWD3;UBE2L3;ETV1;FOXO4;MAD2L2;CC2D1B;CREBL2;PCBD2;ZFP1;TAF7;THOC1;TRPS1;BMP7;HIC1;IGF1;CCNC;ZNF235;SUMO1;KDM5B;SIX4;RARA;MAMSTR;ZNF692;HOXA2;ARID5B;HDAC6;ZNF691;ZBTB14;CTNNB1;FOXQ1;HINT1;ZBTB8A;GPATCH3;TFAP4;ZXDB;ZNF250;HDAC10;ZNF83;ARNT;PATZ1;CEBPG;HEY1;ZMYND11;ZFP28;HEY2;TSHZ1;CARM1;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;WTIP;ZIC1;ZBTB12;HLF;EPAS1;CITED2;RNF10;EDRF1;IKBKB;PCGF3;GATA2;BAP1;SOX4;ZFX;NCOA6;PPP2CA;RNF4;UTP4;ATRX;SMAD9;PIAS4;SCML4;TCF4;TCF7L2;NONO;TIMELESS;TBL1X;CDK11B;PPARG;WWP2;PRDM1;BCL6;ELOC;BRCA1;ZSCAN26;BAZ1B;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;MED27;OGT;SRSF10;PCGF5;MDM2;BLM;NKAP;NACC1;TOX4;PBX2;CDK14;CBFA2T2;HSF4;CAND2;GCLC;PHC3;TSHZ3;CREB1;ZSCAN18;MAP2K3;ELF4;NOS1;NFE2L2;GABPA;ATAD2;RELA;MYOCD;KCNH2;YY1;TULP3;ZNHIT3;KDM3B;TBX3;SUDS3;USP16;ATF6;MSX1;ZKSCAN8;TCEA2;FZD7;RXRG;RFXANK;MYCBP;RBM15;AJUBA;AEBP2;MED20;SUPT4H1;CEBPA;ARRB1;THRAP3;CDK18;TRIB3;KLF16;ATF5;ZFP3;ACVR2B;CCNK;E2F7;ZFHX4;GMEB2;CNOT2;ARID3A;E2F3;SMARCB1;ZNF276;MBTD1;TFDP1;TAF15;ZKSCAN4;HMGB1;RBAK;GCFC2;KHDRBS1;SETDB2;EGR3;FANK1;SP110;DHX9;BMP2;BRD4;IRF7;APBB1;POLR2L;HIC2;EID2B;FOXF1
prerank,erythrocyte differentiation (GO:0030218),-0.4468765313703541,-1.5647865396380054,0.009174311926605505,0.16745483488933843,1.0,15/44,18.25%,ALAS1;MFHAS1;LYN;KMT2E;TGFBR3;RPS14;MED1;ACIN1;ABCB10;TAL1;JAK2;ZFPM1;CDK5RAP3;CEBPG;FLVCR1
prerank,negative regulation of programmed cell death (GO:0043069),-0.3326864559534239,-1.5640832981583017,0.0,0.16807368284257326,1.0,96/355,17.30%,MECOM;TJP1;LEF1;GRK5;TEK;IGF1R;FOXO1;XIAP;ERC1;MCL1;DAB2;TNFAIP8;GSK3B;THBS1;ARHGAP10;PAK2;RAB7A;DDX3X;KDR;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;HDAC1;NFKB1;CBL;GAS6;NFKBIA;PIK3R1;DSTYK;PSEN2;FAS;PTK2;MED1;AATF;BMP4;BNIP3;ARHGDIA;NGF;RNF144B;MYO18A;PLK2;MRE11;BIRC6;NOTCH2;BNIP2;ANXA4;RAF1;YWHAZ;FLT4;SH3RF1;HAX1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;PRKAA1;AREL1;PSEN1;BRAF;RASA1;SON;IRAK1;COMP;TM7SF3;MTDH;RPS6KA1;PA2G4;CAT;TCIM;WNT11;UFM1;BABAM2;HGF;MAPK8;RPL10;RPS6KA3;ZFAND6;MAP4K4;MIF;PRDM9;SMAD6;ANGPT1;IGF1;SIX4;ANXA1;CTSH;CTNNB1;API5;PPIF
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.3655793284782034,-1.5636990595837295,0.0,0.1681478261918376,1.0,50/150,23.17%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;RAC1;MFHAS1;ESR1;THBS1;GCNT2;PTPRJ;EGFR;RICTOR;GAS6;PIK3R1;IRS1;PTK2;FGF1;HAX1;PIK3CD;FGF7;THEM4;MAZ;FGF2;MTDH;MYOC;RHOG;HGF;PIK3CB;GRB2;IAPP;GAB2;TNFAIP8L3;ANGPT1;FYN;CCL19;TXN;TCF7L2;F3;FGFR4;IGF2;PTPN11;PDGFRB;HSP90AA1;HPSE;FRS2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.4271567098830693,-1.5635341950049615,0.017271157167530225,0.167859406883835,1.0,26/59,24.02%,PKD2;NET1;MAP3K5;EGFR;PXN;ABL1;PRKCD;PTPRK;JUN;MAPK1;ANKZF1;AKT1;TPM1;MAPK8;TNFAIP3;AGAP3;ANXA1;HDAC6;PPIF;RPS3;ERCC6L2;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,aortic valve development (GO:0003176),-0.4801375713307305,-1.5624910566506698,0.022304832713754646,0.16881710548007225,1.0,17/34,17.95%,ELN;RB1;NOS3;TIE1;BMPR2;NFATC1;TNFRSF1B;SLIT2;BMP4;ROCK1;NOTCH1;JAG1;ROCK2;SMAD6;TNFRSF1A;HEY1;HEY2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.4529887065992737,-1.5621511471147747,0.01841620626151013,0.16886920263686644,1.0,15/44,20.79%,DAB2IP;LYN;PTPN1;PTPRJ;PDCD4;PRKCD;BMP4;STK38;SPRY4;PIK3CB;BMP7;CDK5RAP3;HYAL2;UCHL1;NF1
prerank,sodium-independent organic anion transport (GO:0043252),-0.6675522039521371,-1.5616324066945326,0.034926470588235295,0.16902788293847248,1.0,7/10,29.04%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1;SLCO4A1;SLCO1B1;SLC16A2
prerank,copper ion homeostasis (GO:0055070),-0.5687622975396207,-1.5609555713767094,0.03551401869158879,0.16948631250584503,1.0,4/17,4.50%,XIAP;APP;ATOX1;SLC31A1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5151060125698921,-1.5604497869980118,0.027874564459930314,0.16968395618311724,1.0,11/24,16.15%,TJP1;WASF2;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC;ARHGEF18
prerank,negative regulation of endopeptidase activity (GO:0010951),0.43001799820709613,1.5597983657378767,0.024886877828054297,0.26894540356703933,1.0,12/47,12.71%,VTN;SPOCK3;SPOCK1;SERPIND1;SORL1;TIMP1;ANXA8;ANXA8L1;SERPINA2;SERPING1;PCID2;FETUB
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6068008899469829,-1.5593274412743632,0.039927404718693285,0.17070148914502245,1.0,8/13,21.17%,ENG;KDR;TGFBR2;COL4A1;NOTCH4;CTNNB1;SEMA3E;DLL4
prerank,long-term synaptic potentiation (GO:0060291),0.5223985275544214,1.5588924916195224,0.033482142857142856,0.268150713179409,1.0,7/21,11.77%,MPP2;SLC24A2;GRIN2B;GRIN2A;SLC8A2;PRKCZ;SLC8A3
prerank,histone lysine demethylation (GO:0070076),-0.5064292154138528,-1.5565132436667237,0.0285204991087344,0.17417267290215047,1.0,14/25,31.74%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;KDM5B;KDM1B;KDM3B;KDM4D;RIOX1;KDM4A
prerank,regulation of stress fiber assembly (GO:0051492),-0.4044794145234205,-1.5561320496589253,0.004966887417218543,0.1742644704656083,1.0,28/74,16.66%,TJP1;WASF2;FERMT2;RAC1;F11R;PAK2;CGNL1;PXN;PIK3R1;ABL1;ARHGEF15;PPFIA1;ROCK1;PPM1F;RGCC;ARAP1;RHOA;ARHGAP28;LIMCH1;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2;ARHGEF18;ALMS1
prerank,positive regulation of wound healing (GO:0090303),-0.47129041347525835,-1.5539964769792731,0.013207547169811321,0.17677092859533242,1.0,12/36,11.88%,RREB1;ITGB1;ST3GAL4;FERMT2;PRKCE;THBS1;MTOR;PTK2;ENPP4;OCLN;MYLK;ARFGEF1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6338155894151545,-1.5521554953457477,0.0325497287522604,0.17893736582198885,1.0,8/11,23.09%,CD34;ADIPOR2;KDR;MCAM;PRCP;GATA2;ITGB3;HPSE
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6390852224874541,1.5519374698795274,0.052752293577981654,0.2787946144366399,1.0,7/10,18.86%,GALNT13;GALNT16;MGAT5B;GALNT3;GALNT2;POGLUT1;POGLUT2
prerank,positive regulation of neuron differentiation (GO:0045666),0.4450049485461649,1.5515364443732376,0.029213483146067417,0.2769525302687824,1.0,12/40,9.78%,BRINP3;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;PROX1;BRINP2;ADRA2C;CPNE1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5901588059109542,-1.5511673188379191,0.033628318584070796,0.17986076850088595,1.0,10/15,28.84%,TMSB4X;KDR;PRKD2;PRKD1;FGF2;SMOC2;LGMN;SEMA5A;MET;FGF18
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.5702588938364083,1.5508496180667357,0.041928721174004195,0.2758480405820642,1.0,5/15,13.33%,NLGN1;CNTNAP4;CLN3;ADRA1A;NLGN2
prerank,vasoconstriction (GO:0042310),-0.6437458782335386,-1.549597891366977,0.032432432432432434,0.18161150911590046,1.0,5/11,11.69%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.6010500902388373,-1.5495383498784345,0.034545454545454546,0.18116140944844314,1.0,5/13,15.93%,ALG14;ALG12;ALG8;ALG11;ALG13
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.471580337239927,-1.549304125093082,0.022887323943661973,0.18095785235348139,1.0,17/36,22.46%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;GCH1;CYGB;WASL;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;TERT;GLA;HSP90AA1
prerank,insulin receptor signaling pathway (GO:0008286),-0.41167634327774355,-1.54810229950124,0.005145797598627788,0.18234382632527493,1.0,21/69,16.18%,IGF1R;SORBS1;FOXO1;GAB1;INSR;GSK3B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;AKT1;ATP6V1E1;GRB2;FOXO4;PIK3R3
prerank,positive regulation of binding (GO:0051099),-0.4007294524684301,-1.5478114614025207,0.007104795737122558,0.18227399722722082,1.0,46/84,29.99%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;HES1;STK3;SPPL3;BMP4;NGF;DPH3;HMBOX1;PSEN1;HFE;FLOT1;FOXC1;HIP1R;IGF1;SKI;MARK3;RARA;CEBPG;AKTIP;CLN5;TXN;TCF7L2;PPARG;TERT;CAPRIN2;RALB;TRIB3;HMGB1;DHX9;BMP2;LRP1;PARP9;RAN;NMD3;MET;STMN1;PLAUR;KDM4D;MED25;BAMBI
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4911466074298532,-1.5474437155633027,0.01896551724137931,0.18232182056135832,1.0,9/28,20.17%,DAB2IP;CTSC;RNF139;SMURF1;PTK2;ECSCR;PSMC2;CDK5RAP3;PTEN
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6381542986304649,-1.5474207496443064,0.03333333333333333,0.1818249836576587,1.0,5/11,14.15%,SEMA6A;KLF2;THBS1;ADAMTS9;PIK3CB
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5802829979390861,-1.54656731855739,0.033807829181494664,0.18247858111529036,1.0,5/16,12.29%,ST3GAL4;NFAT5;ETS1;RHOA;IRAK1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5208921647507366,1.5462479616398077,0.03811659192825112,0.2824326220946396,1.0,8/19,16.82%,ADCY10;AQP4;DNAAF1;NEK10;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,regulation of vasculature development (GO:1901342),-0.5104302463825797,-1.5451196478586346,0.0216998191681736,0.18423645235904368,1.0,13/26,29.78%,SP100;ADGRA2;BMPER;ETS1;PLXND1;FGF2;CTNNB1;EPHA2;NF1;WARS1;TSPAN12;HMOX1;EMP2
prerank,positive regulation of gene expression (GO:0010628),-0.32330199223162787,-1.5443745703784502,0.0,0.18497366938855367,1.0,134/442,21.17%,LEF1;CLDN5;UBR5;NOS3;DYRK1A;KLF4;ETS1;CD34;TNRC6B;LIMS1;MED26;GSK3B;THBS1;TENT4B;APP;KAT2B;ATM;DEK;EIF3E;METTL14;MITF;IL15;DDX3X;MTOR;NIBAN1;SMO;EGFR;TFRC;MSN;PLD1;SP1;CTCF;EIF3C;BMP6;AFDN;GAS6;PIK3R1;PDE2A;UPF3B;MED1;SEC16B;FGF1;BMP4;ERN1;MEF2C;SAMD4A;EZR;CDH5;NGF;SMAD1;ACTA2;MAPK1;ROCK1;PPM1F;RAB27A;NOS1AP;YAP1;PLCG2;CELF1;GSK3A;SF3B1;OCLN;WNT16;PIK3CD;TENT4A;RPL26;FGF7;RAMP2;AKT1;MYOM1;TP53;ZCCHC4;PRKAA1;TAF1B;RGCC;PSEN1;BRAF;EEF2;MAZ;HFE;NOTCH1;FGF2;ACTB;FLOT1;WNT11;ZPR1;LARP4B;TAF1C;PLSCR1;MAPK8;RPS4X;ATF4;PIK3CB;AGO2;RBM20;FAM98A;HCFC1;AGPAT1;MIF;ROCK2;TADA3;C1QTNF3;RPL5;VSIR;TERF2;ANGPT1;PIK3R3;METTL5;BMP7;IGF1;MOV10;SRPK2;DNMT1;CTSH;FUBP1;HEY1;HEY2;SOD1;RPS3;WBP2;LURAP1;CITED2;GATA2;SOX4;TNRC6A;PRKAB1;PRKDC;KRAS;F3;FGFR4;BRCA1;BAZ1B;RBM3;DLL4
prerank,actin filament organization (GO:0007015),-0.3661026397545594,-1.5436191898752185,0.0068143100511073255,0.18562001679989387,1.0,44/151,17.13%,HIP1;SHROOM4;MYO1D;EPS8;ABI1;BAIAP2L1;CD2AP;RAC1;SHROOM3;TPM3;RHOBTB1;CORO1C;PLS3;SVIL;ELMO1;RND3;CGNL1;DLG1;TMOD3;WASL;MYO1F;BIN3;ARHGEF2;SHROOM1;ARHGAP17;BCAR1;NEBL;FLNA;SHROOM2;FAT1;RHOA;ACTN1;LCP1;LMOD1;TPM1;NEDD9;RHOC;RHOG;ELMO2;HIP1R;MAD2L2;ARPC4;CORO7;ARHGAP12
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.4029912322844956,-1.542036523236171,0.012704174228675136,0.18756663436452295,1.0,24/78,14.87%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP2R5A;DAB2;PRKCE;ITGA3;PTPN9;LDLRAP1;EGFR;PIK3R1;DLG1;STX3;RHOQ;PPFIA1;STX8;PICALM;AKT1;ABI3;ACTB;RHOG;NUMB;STAC3
prerank,peptide biosynthetic process (GO:0043043),-0.3628461974312552,-1.541338267608646,0.0035650623885918,0.18799370909720656,1.0,68/153,31.11%,RRBP1;RPS21;RPL37;RPL31;RPL9;RPS14;GGT5;RPSA;PCSK5;RPL3;RPLP1;MRPL32;RPL26;RPS11;RPL13;MRPS18A;RPL38;RPL27;RPS16;RPS4X;GSPT1;AGO2;RPL10;RPL7A;HARS2;RPL5;MRPL24;RPS27;RPL27A;RPS3;RPL36A;RPL35A;MRPS14;RPL37A;MRPS21;MRPL35;RPL32;WARS1;RPS7;RPS15;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;SRBD1;RPS17;RPS2;MRPL43;RPL39;MRPL11;RPS26;TNIP1;RPS15A;RPL15;RPL34;RPLP2;RPL18;MRPS17;RPL19;RPS13;COPS5;RPL8
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.49306444169037833,-1.5412425281835083,0.018900343642611683,0.18761607072058836,1.0,9/28,17.78%,DAB2IP;DDX3X;ZDHHC3;NGF;CASP8;CRADD;GABARAP;TNFRSF1A;CASP8AP2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.40800668637023907,-1.5408390486621562,0.009380863039399626,0.1876727267092626,1.0,32/72,25.97%,CBFB;ELF1;PTPN1;JAK1;BIRC3;TAX1BP1;GAS6;OTULIN;LIFR;CASP8;CFLAR;JAK2;IRAK1;USP18;TNFAIP3;AGPAT1;TNFRSF1A;SUMO1;HIPK1;IRAK2;IKBKG;IKBKB;IFNGR2;PTPRC;VRK2;ABCE1;PTPN11;IFNAR2;RIPK1;IL7;PTPN2;TRIM44
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4982242745492902,-1.5400430293074723,0.03008849557522124,0.18834524863512808,1.0,10/29,16.12%,SORBS1;ZBTB20;MTOR;PPARA;ELOVL5;SCARB1;MFSD2A;AKT1;CHP1;CREBL2
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6528873116558929,-1.5389818858021418,0.025044722719141325,0.18951483152320392,1.0,7/10,21.17%,BMP5;PHACTR4;LRP6;NOTCH1;BMP7;ARHGAP12;DLL4
prerank,cytoskeleton organization (GO:0007010),-0.3800173125052056,-1.5378568106045396,0.0018148820326678765,0.19055749006198627,1.0,38/114,18.41%,SEMA6A;FGD5;FGD6;RAC1;PDZD8;RHOBTB1;RANBP9;MARK1;ARHGAP10;RND3;MICAL2;ARAP3;DIAPH1;LIMD1;ZMYM6;CNTNAP1;MAST4;MAST2;PLCE1;PPP2R3C;SIPA1L3;PLD2;DST;LRCH3;CECR2;RHOA;ZMYM4;TPM1;NEDD9;RHOC;RHOG;TNFAIP3;BRWD3;FMNL2;CDC42BPB;CAPZB;CFL1;WTIP
prerank,regulation of cellular component organization (GO:0051128),-0.36335751373523195,-1.537558313399819,0.0017271157167530224,0.1904711486357258,1.0,50/135,20.63%,HIP1;TJP1;DAB2IP;RAPGEF2;SNCAIP;RUFY1;MLLT3;NET1;PTPN1;STON1;MTOR;TFRC;METTL4;RAB5B;ABL1;NEDD4;IRGM;AP2S1;RAP1A;SETD5;PLCE1;RAP1B;ROCK1;RASGRP2;RAB5A;PICALM;FAM107A;RAB4B;BCAR1;SOCS2;HJURP;RAPGEF1;SNX12;AGTR1;RPTOR;ARHGEF11;LTBP4;CEACAM1;HCFC1;HIP1R;ROCK2;MAD2L2;NCLN;ZFYVE16;STON2;BAP1;SLITRK2;CDK11B;RUFY2;DCUN1D5
prerank,amide transport (GO:0042886),-0.49921613218569466,-1.536255667191004,0.024390243902439025,0.19210421149952858,1.0,9/26,7.90%,ABCG2;CERT1;PLTP;SLC25A32;SLC5A6;SLC38A5;AQP11;ABCB9;TAP2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.41762949965259355,-1.5358532475115256,0.01060070671378092,0.19218269388518236,1.0,22/63,23.22%,ITGA6;SP100;CAV1;THBS1;PAK2;TNFSF10;FAS;BMP4;BIRC6;SH3RF1;CASP8;CFLAR;WWOX;FEM1B;IGF1;ZMYND11;HYAL2;TCF7L2;G0S2;LTBR;RELA;RIPK1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.44566672501403287,-1.5355112744868515,0.015957446808510637,0.19215215086672496,1.0,17/47,19.69%,DAB2IP;IGF1R;FOXO1;MID1;EGFR;TGFBR3;FAS;TGFB2;MAPK1;ARL6IP5;TAOK3;SEMA4C;MAP4K4;IGBP1;RAP2A;NOD2;KLHDC10
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5971988716184209,-1.5351422678573348,0.03690685413005272,0.1922300718711773,1.0,8/13,28.54%,CAV1;NEDD4L;CASQ2;NOS1;PTK2B;KCNH2;CAB39;ACTN2
prerank,hemidesmosome assembly (GO:0031581),-0.6286506722296551,-1.5348014373314858,0.041237113402061855,0.19225530864002655,1.0,4/11,8.83%,ITGA6;ITGB4;LAMA3;DST
prerank,Golgi to endosome transport (GO:0006895),-0.5578361552689793,-1.5343139370620424,0.04519774011299435,0.1924784488467648,1.0,7/16,22.11%,VPS13A;EPS15;VPS13C;WIPI1;CORO7;AP4M1;KIF16B
prerank,cellular potassium ion homeostasis (GO:0030007),0.5850411038582238,1.5334566833009933,0.06334841628959276,0.3058178053207791,1.0,5/13,8.72%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.45256488833021596,-1.533439715548245,0.026595744680851064,0.1933413942373504,1.0,15/40,17.12%,LEF1;FERMT2;DAB2;GCNT2;MTOR;TGFBR2;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;NOTCH1;JAG1;FOXC1;CTNNB1
prerank,regulation of neuron projection development (GO:0010975),0.3463129624148506,1.533018193713681,0.0,0.30414403292991643,1.0,35/163,10.54%,MAGI2;CSMD3;LRRC4C;IL1RAPL1;CTNNA2;LRRC7;DCC;RIT2;PPFIA2;SCN1B;CCDC88A;SPOCK1;TENM3;FUT9;CDK5;CDKL5;TOX;NTNG2;NTNG1;ITM2C;KIDINS220;NDRG4;NCS1;PAK3;CAMK2B;NTRK2;PAK1;TANC2;PLA2G3;TSKU;PLPPR5;PTPRS;STMN2;MAG;ABI2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6189964403485815,-1.5328586272494669,0.046263345195729534,0.19366059326401122,1.0,8/12,29.30%,LMO2;THRB;MED1;KLF9;CTSH;GAS2L1;RDX;BRD8
prerank,positive regulation of signaling (GO:0023056),0.44887229664514766,1.5328181934772518,0.0228310502283105,0.30194634738703624,1.0,9/37,12.35%,GRIK2;SYT1;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;INPP5F;DLG4
prerank,positive regulation of cellular component organization (GO:0051130),-0.3787415435463217,-1.5327702316056695,0.001736111111111111,0.1932853742360074,1.0,32/107,18.45%,ATP10A;DAB2IP;IGF1R;SHANK3;RB1;TRABD2B;ASAP1;INSR;MPP7;DAB2;NEDD4L;CBLL1;GSK3B;TFRC;TGFB2;SPIDR;BNIP3;CDH5;TAL1;FNIP2;DCTN1;ICE1;FLOT1;RHOC;ABCB7;SLF2;GPX1;BCL2L11;BMP7;SUMO1;RPS3;CCL19
prerank,regulation of insulin secretion (GO:0050796),0.3722546268691821,1.532481635874177,0.00641025641025641,0.3001400713875414,1.0,31/101,18.05%,KCNC2;ABCA12;BLK;SNAP25;GIP;GCK;NR1D1;KCNA5;CACNA1A;MTNR1B;EPHA5;CHGA;TRH;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;GPER1;EIPR1;CCL5;NLGN2;GLUD1;BRSK2;MCU;BMP8A;ALOX5;SLC8B1;GLP1R;ABCC8;KCNG2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.35914675024264375,-1.5316047940411814,0.0017421602787456446,0.194582532287366,1.0,54/166,21.67%,SORBS1;INSR;KLF4;PKD2;KLF2;THBS1;STN1;EIF3E;METTL14;DDX3X;MTOR;PRKD2;NIBAN1;EGFR;PLD1;SP1;EIF3C;ELOVL5;IRS1;UPF3B;SAMD4A;ABCB10;NOS1AP;LDB1;SCARB1;MFSD2A;RPL26;AKT1;ZCCHC4;EDN1;RGCC;EEF2;FGF2;STARD4;DNA2;CHP1;CTC1;LARP4B;HGF;RPS4X;SMOC2;RPL5;METTL5;IGF1;ARNT;GIPC1;CCL19;STAR;SOX4;PRKDC;FGFR4;IGF2;RBM3;PDGFRB
prerank,phospholipid translocation (GO:0045332),-0.4952014764948385,-1.5311602245649574,0.027422303473491772,0.1947518571684592,1.0,10/28,16.71%,ATP10A;ATP8B1;PLSCR4;PLSCR2;MFSD2A;ATP10B;ANO6;PLSCR1;ABCA7;ATP9B
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6450077973776882,-1.53020373265635,0.045372050816696916,0.19579883234920906,1.0,6/10,16.00%,BMP6;PPM1F;NOTCH4;RGCC;NOTCH1;MAD2L2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5280303101865537,-1.5293693883953632,0.040515653775322284,0.19597187299150964,1.0,8/20,17.56%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),-0.5280303101865537,-1.5293693883953632,0.040515653775322284,0.19597187299150964,1.0,8/20,17.56%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,regulation of JUN kinase activity (GO:0043506),-0.4692247674482988,-1.5291477722210542,0.02830188679245283,0.19581692501865244,1.0,13/33,25.12%,DAB2IP;DVL3;MAP3K5;PPEF2;PDCD4;EDN1;TAOK3;SASH1;RPS3;ARHGEF5;MAP3K7;AIDA;FZD10
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4619663982101034,1.529070746640066,0.03211009174311927,0.3045592669690604,1.0,7/34,3.70%,GRID2;MPP2;GABRG3;GRIN2B;GLRA1;GRIN2A;GABRA2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.43719846569206927,-1.5290683576219044,0.01232394366197183,0.19541927750330432,1.0,19/50,18.97%,NFAT5;NR3C2;NOD1;LIMS1;APP;DDX3X;EGFR;NMI;PDCD4;ILK;RHOA;IRAK1;ACTN4;TCIM;IFI35;SASH1;RPS3;CCL19;NOD2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.47958823956915253,-1.528883768527935,0.025688073394495414,0.19519914533416355,1.0,18/31,32.81%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;PTEN;CDKN2C;FHL1;E2F7;APC;CDKN2B;JADE1;WEE1;CDK4
prerank,"phagocytosis, engulfment (GO:0006911)",-0.46669160277029237,-1.5288624843446144,0.01576182136602452,0.1947278451524347,1.0,7/36,3.40%,GULP1;DOCK1;MYH9;RAC1;RHOBTB1;THBS1;ELMO1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5230316841138687,1.528588812662189,0.05656108597285068,0.3029191256272041,1.0,6/20,12.16%,ATP1A2;ATP1B1;CALM2;RYR2;SLC8A1;HRC
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.407985276731326,-1.5277292873180575,0.010830324909747292,0.1959569296453901,1.0,27/62,28.73%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;CDC73;RTF1;TCEA1;MLLT1;ERCC3;NELFB;ELOF1;ADRM1;ELOC;SUPT4H1;POLR2C;CCNK;POLR2L;POLR2H;LEO1;GTF2H3;CCNH;ELP2
prerank,regulation of cell killing (GO:0031341),-0.5652352142718841,-1.5255547574655322,0.027777777777777776,0.19879938179618972,1.0,8/16,23.43%,RAC1;CR1L;ICAM1;TGFB2;CD55;MAPK8;CFH;FZD7
prerank,glycerolipid catabolic process (GO:0046503),-0.5368463806253754,-1.524939164569392,0.03914590747330961,0.1992970464874143,1.0,6/19,13.54%,GPCPD1;ABHD2;PLA2G4A;GDPD1;MGLL;GDPD3
prerank,response to interferon-beta (GO:0035456),-0.5273992331472418,-1.5249010624364392,0.02029520295202952,0.19885659085991436,1.0,12/22,30.71%,UBE2K;IRGM;IRF1;IKBKE;IFITM3;PLSCR1;IFNAR2;IFITM2;TRIM6;BST2;CDC34;SHFL
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4948574596790555,-1.5246291762328703,0.03914590747330961,0.19868739691901052,1.0,10/27,11.66%,PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4
prerank,positive regulation of protein binding (GO:0032092),-0.4231171525979871,-1.52415422000912,0.010344827586206896,0.1989065816170992,1.0,28/56,27.52%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;STK3;ABL1;SPPL3;BMP4;PSEN1;HFE;FLOT1;HIP1R;PPP2CB;MARK3;AKTIP;PPP2CA;TCF7L2;TERT;CAPRIN2;RALB;TRIB3;BMP2;LRP1;RAN;NMD3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5029307337039807,-1.5241225888331282,0.03770197486535009,0.19842101004019766,1.0,7/26,14.94%,CAV1;MFHAS1;DDX3X;WDFY1;LBP;FLOT1;IFI35
prerank,spinal cord development (GO:0021510),-0.619181653196753,-1.5236649294042164,0.03368794326241135,0.19861009671386654,1.0,6/12,20.79%,PKD2;VIT;LOXL3;ZPR1;SOX4;NF1
prerank,cholesterol biosynthetic process (GO:0006695),0.46579152025219955,1.5224013457235819,0.02850877192982456,0.312833144673232,1.0,12/31,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;SC5D;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,adipose tissue development (GO:0060612),-0.6265922812340904,-1.5211427692933654,0.053003533568904596,0.20190052817812004,1.0,5/11,17.06%,LRP5;SH3PXD2B;NAMPT;DGAT2;ARID5B
prerank,supramolecular fiber organization (GO:0097435),-0.3238329800220293,-1.5206565085783497,0.0,0.2021878688430557,1.0,84/334,17.16%,HIP1;TLL1;COL8A1;ITGA6;PGM5;SHROOM4;COL12A1;COL4A2;SNCAIP;MYO1D;COL25A1;CLIP1;USP9X;CD2AP;RAC1;SHROOM3;PLOD1;TPM3;PLOD2;ADAMTS2;RHOBTB1;CORO1C;COL4A6;APP;CENPJ;ELMO1;RND3;CGNL1;P3H2;COL5A1;ITGB4;LOXL3;LAMA3;COL4A5;DLG1;TMOD3;COL4A1;TGFB2;COL8A2;COL5A2;MYH11;MYO1F;BIN3;DNAJB6;HSPG2;COLGALT2;LOXL1;TSPAN14;ARHGEF2;DST;SHROOM1;ARHGAP17;BCAR1;ADAM10;SHROOM2;FBLN5;P4HA1;COL6A3;FAT1;DCTN1;COL15A1;TSPAN5;RHOA;ACTN1;LMOD1;TPM1;SLAIN2;CHP1;RHOC;RHOG;COL26A1;ELMO2;H3-3A;IAPP;HIP1R;COL6A2;TUBGCP4;MAD2L2;CORO7;SLK;TUBGCP5;COLGALT1;ARHGAP12;APH1A
prerank,nuclear export (GO:0051168),-0.39327322668867476,-1.5206216352991624,0.015228426395939087,0.20171848094402692,1.0,34/80,26.64%,SRSF11;NUP42;SMURF1;RAE1;CSE1L;SARNP;THOC2;XPO7;UPF3B;THOC7;DDX39B;DHX38;NUP153;SLU7;CHP1;HNRNPA1;TPR;THOC3;THOC1;LSG1;XPO4;NUP214;WASHC4;PHAX;SRRM1;RITA1;RNPS1;SRSF3;NUP188;POLDIP3;NXF1;NEMF;ATXN1;RAN
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5346064807187167,1.520260055605703,0.05052631578947368,0.3146739021954735,1.0,6/17,17.93%,NLGN1;RAB15;RAB3A;SYT4;CACNA1G;CACNA1I
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3724383036747055,-1.5202408072375737,0.007220216606498195,0.20176349304291782,1.0,44/108,23.64%,NXN;RSPO3;CBFB;TRABD2B;ESR1;ITGA3;APP;NFATC1;LRRK2;EMD;KREMEN1;VGLL4;OTULIN;RNF43;MACF1;NKD1;MDFIC;GRB10;CCNY;HMGXB4;PSEN1;SOX7;CDC73;WWOX;NOTUM;TAX1BP3;APCDD1;TCF7L1;TNFAIP3;DAAM2;HIC1;SKI;SENP2;CTNNB1;PPP2CA;CTNNBIP1;GPC3;TERT;CDK14;AMER1;RSPO2;FZD7;SFRP4;PPP1CA
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5189465371430202,-1.5193049869128836,0.028933092224231464,0.20278412182609168,1.0,13/21,27.98%,CAV1;NCK1;DDIT4;RASSF2;PPM1F;NCK2;SMAD7;CNKSR3;PTEN;GADD45A;INPP5J;DMTN;NLRP2B
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4464494154484777,-1.5176146387399534,0.024778761061946902,0.2048864788859101,1.0,19/40,31.57%,SORBS1;ZBTB20;MTOR;PPARA;BMP4;RAB27A;PLCG2;AKT1;RGCC;CREBL2;CREB1;MTPN;ADGRB1;SLC5A3;F2R;LARP6;RUNX1;TGFB1;TLR6
prerank,regulation of endocytosis (GO:0030100),-0.41553901920915365,-1.5172367713011972,0.017391304347826087,0.20503637847620307,1.0,24/61,20.16%,HIP1;RUFY1;DAB2;NEDD4L;CBLL1;PTPN1;STON1;RAB5B;ABL1;AP2S1;ROCK1;RAB5A;PRKD1;PICALM;RAB4B;SNX12;FLOT1;HIP1R;ABCA7;ZFYVE16;STON2;CCL19;GPC3;RUFY2
prerank,regulation of response to stress (GO:0080134),0.6172960693859689,1.5169961541693118,0.06345733041575492,0.3189957959941506,1.0,3/10,8.61%,OPRM1;ADCY8;CORO2B
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5348236321231195,-1.5166687510578507,0.03225806451612903,0.20541471532827515,1.0,9/18,17.60%,HEG1;ITGA3;SCAI;RASIP1;CUL3;TNFAIP1;MYOC;KCTD10;ARHGAP35
prerank,peptidyl-lysine modification (GO:0018205),-0.38009792233979284,-1.5166607629271782,0.010507880910683012,0.2049056511927097,1.0,32/99,22.99%,SENP1;PLOD1;PLOD2;IFIH1;KAT2B;NUP42;RAE1;LOXL3;TRPM4;RANBP2;UBA2;SIRT5;NUP98;LOXL1;NSMCE2;NUP153;HDAC4;KAT5;PIAS2;SIRT3;TPR;SUMO1;SENP2;HDAC6;HDAC10;NUP214;PIAS4;CTH;TRIM28;LOX;NUP188;SENP6
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.4454713019030856,-1.516187435711783,0.01601423487544484,0.20510575940523337,1.0,13/39,15.65%,DAB2IP;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;PTPN3;DUSP3;GRB2;LGMN
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.4111296933305473,-1.5153397341393489,0.013961605584642234,0.20583348634643833,1.0,25/62,26.60%,NUP42;RAE1;RANBP2;LIMD1;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;WTIP;TNRC6A;PPARG;NUP188;AJUBA;POLR2C;DHX9;POLR2L;FXR1;POLR2H;NUP88
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5576040481979776,1.5152858464476915,0.04932735426008968,0.31990933950331074,1.0,6/16,8.52%,GPR137C;PIP4P1;RRAGA;FLCN;KLHL22;SEH1L
prerank,positive regulation of cytokinesis (GO:0032467),-0.4737416512444608,-1.515049158470862,0.04151624548736462,0.20572986522453693,1.0,9/32,17.77%,PRKCE;SVIL;PKP4;CUL3;CDC14A;KIF23;RHOA;PKN2;GIPC1
prerank,regulation of lymphocyte migration (GO:2000401),-0.640174900414997,-1.5140209609021886,0.03804347826086957,0.20691780691321893,1.0,5/10,11.10%,JAM2;MSN;WASL;AKT1;STK10
prerank,response to reactive oxygen species (GO:0000302),-0.42251923111612977,-1.5131457362713332,0.014109347442680775,0.20784543849244003,1.0,21/54,20.81%,PKD2;EGFR;ADAM9;PXN;STK24;PTPRK;JUN;MAPK1;AKT1;TPM1;CAT;TXNRD2;MAPK8;GPX1;AGAP3;FYN;SOD1;RPS3;HYAL2;COA8;ERCC6L2
prerank,pulmonary valve development (GO:0003177),-0.5486927621083002,-1.513075979589819,0.04240282685512368,0.20742673909898898,1.0,14/18,17.95%,NOS3;BMPR2;NFATC1;TNFRSF1B;SLIT2;TGFB2;BMP4;NOTCH2;NOTCH1;JAG1;SMAD6;TNFRSF1A;HEY1;HEY2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4324343910636764,-1.513037033632366,0.022181146025878003,0.20696898517037163,1.0,12/46,12.95%,DAB2IP;SEMA6A;LYN;PTPN1;RANBP9;SPRED2;DLG1;EZR;SMAD4;TIMP3;CNKSR3;DUSP3
prerank,regulation of multicellular organism growth (GO:0040014),-0.5653887847849344,-1.5127778852157125,0.04007285974499089,0.20684174242870632,1.0,5/15,18.07%,GHR;APP;MFSD2A;IGF1;SOD1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6347190873638351,-1.5126327496148042,0.042279411764705885,0.20650418460414177,1.0,4/10,9.84%,CD200;LRCH1;WASL;AKT1
prerank,positive regulation of cell division (GO:0051781),-0.45403275482303723,-1.5112878676051502,0.03374777975133215,0.20813433958115451,1.0,10/38,14.01%,PRKCE;SVIL;PKP4;CUL3;FGF1;CDC14A;TAL1;KIF23;RHOA;PKN2
prerank,hippo signaling (GO:0035329),-0.4895009753555513,-1.5111273106598628,0.044169611307420496,0.20784852455384165,1.0,9/26,11.88%,TJP1;TEAD4;TEAD1;YWHAE;STK3;TJP2;YAP1;LATS2;SAV1
prerank,cellular response to oxidative stress (GO:0034599),-0.36607240275892233,-1.5109135859697205,0.0017761989342806395,0.2076828704420923,1.0,40/118,22.38%,FOXO1;PKD2;DAPK1;LRRK2;EGFR;PXN;ABL1;FOXO3;PYROXD1;PRKCD;PTPRK;JUN;MAPK1;PRKD1;WNT16;AKT1;TP53;PRKAA1;ERO1A;TPM1;CAT;NCF2;TXNRD2;MAPK8;ATF4;MSRA;GPX1;AGAP3;NOX4;FANCC;ARNT;CCS;SOD1;RPS3;VRK2;ERCC6L2;TXNRD1;KEAP1;SLC25A24;NFE2L2
prerank,ncRNA processing (GO:0034470),-0.3407171604866507,-1.5105668314127207,0.0017730496453900709,0.2076552015797502,1.0,86/200,30.40%,INTS8;TUT7;UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;FARS2;RPF1;DDX10;SMAD1;SMAD2;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;DICER1;EXOSC3;XRN2;TUT4;RPL13;INTS3;UTP3;RPL38;RRP1;RPL27;RPS16;AGO2;RPL10;RPL7A;RPL5;PUS10;INTS9;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;BOP1;RPL37A;TRPT1;PES1;DROSHA;RPL32;EBNA1BP2;RPS7;RPS15;INTS7;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPP30;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;INTS5;UTP20;RPL18;INTS12;SSB;RPL19;FCF1
prerank,negative regulation of TOR signaling (GO:0032007),-0.44722534042975665,-1.510356603915497,0.0148975791433892,0.20750637712801276,1.0,14/36,20.40%,SH3BP4;SESN1;ATM;DDIT4;GSK3A;UBR2;PRKAA1;KPTN;CASTOR1;UBR1;RNF152;ITFG2;TMEM127;AKT1S1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4643439927073323,-1.5103250610324448,0.02872531418312388,0.20706974927464053,1.0,14/32,28.27%,ZBTB20;INSR;TMSB4X;APP;PPARA;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT;PFKFB4;BEND3;PFKFB2;TREM2
prerank,positive regulation of response to external stimulus (GO:0032103),-0.36485409439146904,-1.5094002095596855,0.00667779632721202,0.20794748586166625,1.0,44/128,28.27%,ETS1;ANKRD17;THBS1;APP;IL15;BMP6;SCARF1;NFKBIA;NMI;PDE2A;PDCD4;STX3;PUM1;NAPEPLD;PPM1F;AKIRIN2;FEM1A;DDX60;USP15;AGTR1;LPL;IL17RA;PLSCR1;POLR3F;IFI35;IL16;TNFRSF1A;GBP5;SASH1;CCL19;HYAL2;PDGFRB;GPR4;PTN;SERPINE1;RIPK1;CEBPA;DDT;DHX9;TNIP1;GPSM3;OASL;RIOK3;TREM2
prerank,response to molecule of bacterial origin (GO:0002237),-0.4075042893910638,-1.509224398131796,0.019927536231884056,0.20770332462239413,1.0,16/69,16.41%,FOXP1;PELI1;NOS3;SRR;IFNAR1;HNRNPA0;GGT5;GCH1;LBP;MAPKAPK2;JAK2;IRAK1;RPS6KA3;TNFAIP3;SMAD6;TAB2
prerank,response to ionizing radiation (GO:0010212),-0.4033008493565995,-1.5090919320426133,0.02185792349726776,0.2073895036903806,1.0,28/70,22.73%,DCUN1D3;NET1;ATM;UIMC1;MRNIP;XRCC4;SPIDR;INIP;NABP1;TP53;PRKAA1;INTS3;KAT5;BABAM2;NHEJ1;RNF168;GRB2;TRIM13;ANXA1;RFWD3;FANCD2;BRCC3;BRAT1;LIG4;BRCA1;BLM;GADD45A;INTS7
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3806699701077651,-1.5088062002240041,0.008726003490401396,0.20732914378039932,1.0,20/86,12.19%,RBPMS;ZNF423;ENG;ACVRL1;CREBBP;DAB2;BMPR2;THBS1;BMP5;RNF111;BMP6;TGFB2;BMP4;CDH5;SMAD2;ACVR2A;SMAD4;JAK2;HFE;NOTCH1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4651943490819715,1.5085627638674903,0.04096385542168675,0.3313291392460624,1.0,11/31,19.28%,SYT1;SYT5;SYT12;SYT11;ADRA2A;SYT4;SYT3;SYT9;CACNA1G;CACNA1I;SYT17
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5435680185244672,-1.5085305817396206,0.04247787610619469,0.20726294374555523,1.0,10/18,33.07%,NR3C1;FAM107A;KLF9;UBE2L3;BCL2L11;ANXA1;ZFP36L1;HNRNPU;SSTR2;AQP1
prerank,axonemal dynein complex assembly (GO:0070286),0.47241033251504555,1.508069914129461,0.03619909502262444,0.329565005389277,1.0,11/28,18.49%,DNAAF3;SPAG1;CCDC63;ODAD2;DNAAF5;DNAAF1;DNAI4;ODAD1;DNAAF2;LRRC49;ODAD3
prerank,regulation of store-operated calcium entry (GO:2001256),0.6266253288054556,1.5079109376099038,0.07296137339055794,0.3272785015700237,1.0,6/10,19.45%,EFHB;HOMER1;CASQ1;SLC8B1;GRAMD2A;CD84
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4847041878596404,-1.507689975939049,0.04056437389770723,0.20807770988320254,1.0,10/28,11.66%,PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4
prerank,positive regulation of programmed cell death (GO:0043068),-0.33107702759432495,-1.507279986245434,0.0,0.20814730793121106,1.0,91/272,25.05%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;ATM;MCF2L;LRRK2;UTP11;MAP3K5;DDX3X;PLEKHG5;TNFSF10;RASGRF2;RARG;RBM5;RYBP;STK3;ABL1;FOXO3;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;RASSF2;BMP4;BNIP3;NGF;JUN;TGM2;ITSN1;ARHGEF2;ARL6IP5;LATS2;SOS2;CASP8;TP53;CRADD;PSEN1;SLC27A4;ARHGEF11;ANO6;CTNNBL1;STPG1;MAPK8;ATF4;TRIO;ERCC3;IAPP;HIP1R;ABR;ARHGEF18;BCL2L11;PREX1;HDAC6;CTNNB1;APH1A;TFAP4;SOD1;SIAH1;SOX4;RNPS1;BCL6;NF1;ARHGEF5;FOXL2;PNMA2;VAV2;ARHGEF1;CASP2;PHLDA3;GADD45A;SUDS3;ATF6;RIPK1;SFRP4;CYP1B1;CALHM2;HMGB1;FANK1;BMP2;APBB1
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.48516818089265235,-1.5067662738780967,0.02292768959435626,0.20841133934513162,1.0,10/27,15.76%,CREBBP;KAT6B;KAT2B;KAT6A;PHF20;TRRAP;SGF29;PHF20L1;KAT5;RUVBL2
prerank,iron ion transmembrane transport (GO:0034755),-0.6403285372716334,-1.5046950092788205,0.04308797127468582,0.21136397968319948,1.0,5/10,16.79%,SLC40A1;SCARA5;SLC39A8;ABCB7;SLC25A28
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.47747921889843137,-1.5042642089596523,0.02531645569620253,0.21156156989444186,1.0,21/34,35.49%,RB1;INSR;LRP5;CUL3;EDN1;RGCC;CDC16;EDN3;NSMCE2;IGF1;IGF2;PDGFRB;ANAPC7;BTC;ANAPC11;ANAPC5;AURKA;PHIP;IL1A;ESPL1;DRD3
prerank,embryonic digit morphogenesis (GO:0042733),-0.5454578718924746,-1.503878600005696,0.042704626334519574,0.21165549000996872,1.0,6/18,9.10%,MAP3K20;CREBBP;HDAC1;ECE1;TBX2;GLI3
prerank,body fluid secretion (GO:0007589),0.5444102555232642,1.503813160261942,0.047520661157024795,0.3334093819804165,1.0,3/15,9.25%,ERBB4;SLC22A4;VEGFA
prerank,purine nucleotide catabolic process (GO:0006195),-0.5912051488291953,-1.5036491253999227,0.045714285714285714,0.21151384015153668,1.0,8/13,27.28%,NT5C2;NT5E;NT5C1A;GPX1;HINT1;GDA;NT5C;PNP
prerank,alpha-amino acid metabolic process (GO:1901605),0.4286156685827256,1.503389195366398,0.029612756264236904,0.33183719091452457,1.0,15/45,14.38%,SLC25A13;ASNS;DDAH2;OAT;GADL1;GNMT;PYCR2;RIMKLA;ASPA;DPEP1;THAP4;GLS2;GLS;GLUD1;GPT2
prerank,negative regulation of growth (GO:0045926),-0.36016750783698953,-1.5033441786877904,0.003430531732418525,0.21151721006203567,1.0,47/121,25.54%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;PTPRJ;SOX17;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;NOTCH2;SMAD4;TP53;DCBLD2;NOTCH1;WNT11;ST7L;CCN3;RERG;NPR1;OSGIN2;HYAL2;PPP2CA;BCL6;CDKN2C;CAPRIN2;FHL1;MSX1;SERTAD2;HSPA1B;GNG4;APBB1;SIPA1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;SERTAD3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4848120428417301,-1.5024054520050978,0.024475524475524476,0.2125316480718983,1.0,10/29,15.88%,TUT7;PUM1;SMAD1;SMAD2;ZC3H7B;SNIP1;DICER1;TUT4;AGO2;PUS10
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.5110277472834166,-1.501893655048009,0.040152963671128104,0.21283193357020058,1.0,10/21,16.67%,CORO1C;MACF1;PTK2;ROCK1;LDB1;RHOA;LIMCH1;DUSP3;ROCK2;SLK
prerank,neuron migration (GO:0001764),0.4163963950601419,1.50079523139549,0.015283842794759825,0.3350760600173306,1.0,18/48,11.64%,ADGRL3;SPOCK1;DNER;ASTN2;CDK5;CDKL5;NRCAM;ASTN1;MDGA1;DCDC2;GPM6A;NTRK2;SOX1;VEGFA;DCX;MAP1B;CCK;AUTS2
prerank,sensory perception (GO:0007600),0.44081687715440454,1.5007681872798768,0.03139013452914798,0.33256807357997703,1.0,15/45,18.13%,PCDH15;OPRM1;MME;PNOC;GNAL;KCNA2;TTC8;BBS4;PENK;CCL2;WHRN;NTSR2;CLRN1;RETREG1;TRPV2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5654011398472035,1.5007228064916078,0.04708520179372197,0.33014755539715934,1.0,5/14,9.76%,ANK3;ATP1B1;WNK2;WNK3;TESC
prerank,vasculogenesis (GO:0001570),-0.4676650441433778,-1.5003207639237457,0.04424778761061947,0.21477620681952267,1.0,12/32,12.19%,ENG;CAV1;KDR;SOX17;TGFBR3;TGFBR2;RASIP1;RAMP2;CUL7;ADM;RASA1;NOTCH1
prerank,response to leucine (GO:0043201),-0.6260505531149088,-1.4996298157961443,0.05065666041275797,0.21492518948265624,1.0,6/10,18.69%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,cellular response to leucine (GO:0071233),-0.6260505531149088,-1.4996298157961443,0.05065666041275797,0.21492518948265624,1.0,6/10,18.69%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5277076551244675,-1.49860307709988,0.05253940455341506,0.2160414860312857,1.0,10/20,23.22%,PELI1;BIRC3;CASP8;CFLAR;FLOT1;ASAH1;PDCD6IP;OGT;HSP90AA1;RIPK1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.543207329015173,1.4983105120694145,0.07192575406032482,0.3326289007911524,1.0,5/16,12.16%,ATP1A2;CALM2;RYR2;SLC8A1;HRC
prerank,positive regulation of chemotaxis (GO:0050921),-0.4429605228484524,-1.4978140621670741,0.02058319039451115,0.21682421101161167,1.0,20/43,28.27%,THBS1;TMSB4X;KDR;PRKD2;IL6R;STX3;PPM1F;PRKD1;EDN3;FGF2;SMOC2;LGMN;CCL19;F3;PDGFRB;PTN;SEMA5A;ADAM17;MET;TREM2
prerank,chloride transport (GO:0006821),0.3804692979587366,1.4971081216459476,0.017467248908296942,0.3327487842260137,1.0,18/74,14.47%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;SLC12A5;GABRA3;GABRA1;SLC12A4;SLC1A3;GABRE;SLC26A8
prerank,gene silencing by miRNA (GO:0035195),-0.46562607860747496,-1.4964739784448773,0.032590051457975985,0.21842386651296544,1.0,15/32,27.03%,TNRC6B;LIMD1;PUM1;ZC3H7B;SNIP1;NOTCH4;DICER1;AGO2;MOV10;WTIP;TNRC6A;AJUBA;CNOT8;RAN;CNOT1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5381085529396712,-1.4963669687213073,0.04151624548736462,0.21809316762264883,1.0,6/18,11.09%,DNAJC13;DAB2;MSN;EZR;MAPK1;SNX12
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3986596200953779,-1.4961347782816723,0.010327022375215147,0.2179520267373871,1.0,19/65,15.35%,HIP1;DAB2IP;AFAP1L2;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;RHBDF2;AKT1;ARAP1;PTPN3;CEACAM1;DUSP3;GRB2;HIP1R
prerank,regulation of complement activation (GO:0030449),0.43959635376518386,1.4960158236060708,0.028824833702882482,0.3324847752387309,1.0,10/40,13.29%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU
prerank,vacuolar acidification (GO:0007035),0.5001376486201117,1.4959479667305347,0.04157043879907621,0.33020328016242884,1.0,7/21,11.39%,TMEM9;CLN3;GRN;CCDC115;ATP6V0D2;ATP6V0A2;DMXL2
prerank,plasma membrane organization (GO:0007009),-0.40016225060941163,-1.4958958292032676,0.02617801047120419,0.21784671011039655,1.0,19/61,16.51%,SPTBN1;PLSCR4;MYOF;MYH9;CAVIN2;FNBP1L;A4GALT;COL5A1;PLSCR2;EHD2;DYSF;AHNAK2;SNX9;BIN3;CHMP4A;ANO6;PLSCR1;ABCA7;TLCD1
prerank,negative regulation of blood pressure (GO:0045776),-0.5832400698532094,-1.4946347389869152,0.047619047619047616,0.2194264201370126,1.0,8/13,35.49%,NOS3;BMPR2;SCPEP1;PRCP;NOS1;APLN;NOS2;DRD3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5972184866087085,-1.4935558193706935,0.0603448275862069,0.22081215717400302,1.0,5/12,14.99%,PRKG1;DOCK4;MEF2C;TPM1;IGFBP5
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6065031813145143,-1.4933398250471455,0.04931972789115646,0.22065445270532544,1.0,4/11,6.09%,FOXO1;CAV1;ATG7;FAS
prerank,negative regulation of cell differentiation (GO:0045596),-0.34416778044320206,-1.4931207948871377,0.005154639175257732,0.22053232153850397,1.0,64/181,25.21%,DAB2IP;ZBTB16;FOXO1;RB1;FERMT2;CRIM1;CAV1;LRP5;ASXL1;IL17RD;BMP5;SPRED2;TBX1;METTL14;COL5A1;EGFR;TRPM4;LIMD1;HES1;PPARA;LDLRAD4;NFKBIA;PDCD4;MED1;SUZ12;COL5A2;BMP4;YAP1;NOTCH4;ANKRD26;SMAD7;ZFPM1;ADGRV1;TWIST2;NOTCH1;CDC73;TMEM64;CDK6;TRIO;JAG1;SMAD6;MAD2L2;BMP7;SKI;HEY1;NELFB;GATA2;PPP2CA;PPARG;PTEN;ITGB3;IGF2;PTPN11;HDAC7;USH2A;PTK2B;MYOCD;TBX3;ADAMTS7;TRIB3;NEPRO;GPS2;EID2B;GDF10
prerank,heart development (GO:0007507),-0.35186612075527546,-1.4928202140821538,0.0033613445378151263,0.2204889906469846,1.0,45/150,16.41%,TEK;ACVRL1;MEF2A;AKAP13;HEG1;INSR;PKD2;BMPR2;KAT2B;BMP5;MICAL2;SH3PXD2B;TBX1;SOX17;CDKN1B;TGFBR3;PDLIM5;TGFBR2;NIPBL;TGFB2;SMYD4;PTK2;RBP4;BMP4;MTHFD1;ECE1;MEF2C;WDR11;PLCE1;TBX2;PDLIM1;KDM6A;PCSK5;CASP8;RAMP2;KDM6B;ZFPM1;NOTCH1;PDLIM3;RBM20;FOXC1;FLRT2;BCOR;BMP7;TAB2
prerank,regulation of humoral immune response (GO:0002920),0.435243401238588,1.4925244589210165,0.02102803738317757,0.33505688480898316,1.0,11/44,13.37%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU;GATA6
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.6274003630991303,-1.4922779043938177,0.034990791896869246,0.2208506517853674,1.0,7/11,24.87%,RESF1;TASOR;TPR;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,response to thyroid hormone (GO:0097066),-0.5848257214092502,-1.491977122951157,0.06044905008635579,0.22078371791756868,1.0,9/13,33.15%,LMO2;THRB;MED1;KLF9;CTSH;GAS2L1;RDX;BRD8;HPN
prerank,positive regulation of innate immune response (GO:0045089),-0.4709974771648297,-1.4918138305444577,0.03893805309734513,0.22057892577759333,1.0,16/30,31.52%,UBE2K;NMI;LBP;AKIRIN2;PLSCR1;POLR3F;IFI35;NLRC5;GBP5;MAVS;DHX9;TRIM6;RIOK3;SPI1;PLA2G5;TRIM62
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5220189360883518,-1.4909395048405771,0.036101083032490974,0.22151231272170896,1.0,10/19,19.06%,BMPR2;TGFBR2;TGFB2;SMAD4;ZFPM1;NOTCH1;SMAD6;HEY1;HEY2;SOX4
prerank,regulation of RNA metabolic process (GO:0051252),-0.40734327576165713,-1.4908515142713963,0.017605633802816902,0.22116066797391687,1.0,18/59,14.59%,MBNL1;MBNL2;ZNF326;MITF;AHNAK;METTL4;TNFRSF1B;NOVA2;FUS;MED1;AHNAK2;CELF1;HNRNPF;RASA1;SON;CLK3;RBM20;RC3H1
prerank,cardiac muscle cell action potential (GO:0086001),0.4773628433185866,1.4905802193035214,0.0379746835443038,0.33670298667223675,1.0,9/30,8.21%,ATP1A2;FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;ATP1B1;CACNA1D;SCN5A
prerank,cardiac atrium morphogenesis (GO:0003209),-0.55242781188921,-1.490535389197111,0.053475935828877004,0.22119370366919802,1.0,9/16,24.99%,ENG;BMPR2;TGFB2;NOTCH2;ZFPM1;NOTCH1;HEY2;DLL4;BMP2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5483271172668149,-1.489978278725508,0.03949730700179533,0.221623100988935,1.0,12/17,34.50%,BMP4;NOTCH2;GALNT11;NOTCH1;JAG1;HEY1;HEY2;DLL4;BMP2;SNAI2;TGFB1;BMPR1A
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.5320215381773261,-1.4896935220371592,0.044142614601018676,0.22156957043232048,1.0,8/18,26.25%,LYN;MTUS1;IL6R;SLIT2;EDN3;PTK2B;PTN;ADAM17
prerank,organelle fission (GO:0048285),-0.5046977857325237,-1.489482763226086,0.03608247422680412,0.2213856438636041,1.0,6/24,6.71%,DNM3;CORO1C;TMCC1;MIEF1;DNM2;SEC16B
prerank,dopamine metabolic process (GO:0042417),-0.5251772227295225,-1.4891519066031518,0.05565529622980251,0.22141788596183898,1.0,4/18,10.24%,SNCAIP;TGFB2;GCH1;MAOA
prerank,negative regulation of hippo signaling (GO:0035331),-0.5932832888860193,-1.4887528363936413,0.07231040564373897,0.22152632179533513,1.0,7/12,23.64%,WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,regulation of fat cell differentiation (GO:0045598),-0.39454306236670883,-1.487541974226127,0.013937282229965157,0.22296580431993765,1.0,30/74,26.76%,ZBTB16;FOXO1;FERMT2;LRP5;ASXL1;TRPM4;FTO;YAP1;PPARD;AKT1;ANKRD26;ZFPM1;LPL;TMEM64;TRIO;TAF8;CREBL2;CARM1;CMKLR1;GATA2;PPARG;AAMDC;CREB1;SYAP1;TRIB3;GPS2;PTPRQ;BMP2;ZFP36L1;FRZB
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.42088595633507186,-1.4873253657762684,0.02146690518783542,0.22282545648519597,1.0,13/52,9.84%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;PIK3R1;DLG1;STX3;EPB41L2;AKT1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6307432022991657,-1.487182087640547,0.047957371225577264,0.22259304301517113,1.0,8/11,32.99%,LIMD1;PUM1;WTIP;AJUBA;DHX9;FXR1;STAT3;PUM2
prerank,amino sugar metabolic process (GO:0006040),-0.6177299445690989,-1.4867318766704376,0.04021937842778794,0.22280723759369905,1.0,5/10,9.09%,ST3GAL1;ST6GAL1;CSGALNACT1;GFPT2;SLC35A3
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5298330312022702,-1.4866190788189344,0.055855855855855854,0.2224947911747035,1.0,11/18,36.42%,CD34;CD200;TGFB2;SMAD4;LGALS9;LRRC32;LTBP1;LILRB1;HIF1A;SMAD3;ITGB6
prerank,regulation of cholesterol storage (GO:0010885),-0.5526531721257391,-1.486598018131846,0.04448398576512456,0.2220274628377133,1.0,6/15,20.11%,PPARA;PPARD;SCARB1;EHD1;LPL;PPARG
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5237971592459718,-1.486160980952249,0.0335195530726257,0.22222756891631676,1.0,9/20,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;PKDCC;CSK;NUMB
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.45669014103626193,-1.4860602661672222,0.04819277108433735,0.22191564951704426,1.0,11/32,21.82%,SORBS1;ZBTB20;ADIPOR2;MTOR;PPARA;AKT1;CEACAM1;ASAH1;CREBL2;STAR;CREB1
prerank,regulation of cellular response to heat (GO:1900034),-0.3904418812080873,-1.4855918987795855,0.016363636363636365,0.22218719984365057,1.0,22/77,15.78%,CREBBP;CD34;GSK3B;ATM;NUP42;MTOR;YWHAE;RAE1;CAMK2G;RANBP2;DNAJC7;NUP98;MAPKAPK2;SEC13;DNAJB6;MAPK1;RPTOR;NUP153;RPA3;RPA1;PTGES3;TPR
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.43527685939809496,-1.4833360697352385,0.02872531418312388,0.22547799642165897,1.0,16/43,21.30%,SORBS1;PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4;TNS2;GKAP1;IGF2;OGT;PTPN11
prerank,endothelial cell migration (GO:0043542),-0.44302362760319314,-1.4831731254318354,0.03790613718411552,0.2252576658460736,1.0,18/37,25.35%,NOS3;ADGRA2;MYH9;ID1;PLEKHG5;PXN;ABL1;CDH5;PLXND1;STARD13;RHOA;CCN3;LGALS8;GIPC1;CYP1B1;EGR3;TNFSF12;PIK3CA
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5395934787643711,-1.483112355836807,0.054673721340388004,0.22483999841883887,1.0,6/16,9.64%,PDGFD;PTPN1;PTPRJ;ABL1;PIK3C2A;BCAR1
prerank,receptor-mediated endocytosis (GO:0006898),-0.35611999477302914,-1.4830716308148435,0.0,0.22443787164734064,1.0,38/132,15.35%,FCHO2;ITGB1;DNAJC13;CALCRL;INSR;CAV1;DAB2;DNM3;EPS15;FNBP1L;RAMP1;LDLRAP1;TFRC;AP2B1;SCARF1;AP2A2;DNM2;LRP6;NEDD4;AP2S1;PI4KB;SNX9;HSPG2;GPR107;SCARB1;PICALM;IGF2R;RAMP2;GAK;STAB1;FCHSD2;ADM;AP1G1;LMBRD1;ACKR3;GRB2;LMBR1L;HIP1R
prerank,external encapsulating structure organization (GO:0045229),-0.333997862538819,-1.4829277546376602,0.0049833887043189366,0.22420748857088169,1.0,55/205,12.36%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;ITGA1;SMOC1;KDR;COL5A1;ICAM1;ITGB4;MMP2;LAMA3;LAMA4;ITGB5;COL4A5;COL4A1;COL8A2;COL5A2;SLC39A8;HRNR;AGRN;HSPG2;LOXL1;CDH1;ADAMTS9;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5626902502010824,-1.481829645770365,0.044444444444444446,0.22555692708187516,1.0,10/15,27.32%,TNRC6B;TENT4B;POLR2G;TENT4A;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5796262526325042,-1.4817024857207666,0.044859813084112146,0.22527598684235872,1.0,3/13,6.52%,DAB2IP;PTPN1;NEDD4
prerank,somite development (GO:0061053),-0.6126761138337321,-1.481561082583736,0.04963235294117647,0.22505618807692584,1.0,4/11,7.20%,SMO;LOXL3;MEOX2;MTHFD1
prerank,response to ketone (GO:1901654),-0.49170653289975486,-1.4810706944019147,0.042704626334519574,0.2254001132240562,1.0,7/24,8.80%,ABHD2;CAV1;THBS1;TGFBR3;SLIT2;TGFB2;YAP1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5585659071655931,-1.480659445814289,0.05103969754253308,0.2255201095784767,1.0,8/15,25.76%,RSPO3;ZNRF3;RNF213;CSNK1D;DAAM2;GPC3;SFRP4;WNT5B
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.48230516250036065,-1.480081538577013,0.04477611940298507,0.22595904967239389,1.0,9/29,11.88%,TJP1;SHANK3;LIMA1;KANK3;SLIT2;PRKCD;KANK4;SMAD4;ARFGEF1
prerank,positive regulation of protein import (GO:1904591),-0.4680263873389274,-1.4800471500972097,0.038817005545286505,0.22554515876451794,1.0,13/30,20.86%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;ZIC1;HYAL2;ARHGEF5;TRIM28
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.614581956703494,1.4800124877980656,0.075,0.3569706712120105,1.0,4/10,12.08%,PDE4B;CACNA2D1;CACNB3;SRI
prerank,regulation of protein phosphorylation (GO:0001932),-0.32450902617821414,-1.4792852898459197,0.001694915254237288,0.22633264185043375,1.0,87/256,24.16%,TEK;DAB2IP;PECAM1;ENG;NSD1;PPP2R5A;INSR;BMPER;DAB2;RAC1;FAM20A;LYN;CORO1C;DVL3;APP;RALBP1;LIMK2;TBX1;LRRK2;KDR;NIBAN1;SLCO3A1;EGFR;TFRC;GAS6;ABL1;FAS;IL34;LRP6;SLIT2;CCND3;PTK2;IRGM;FGF1;BMP4;CDH5;PLCE1;FLT4;ACVR2A;OCLN;FGF7;AKT1;VEGFC;AXIN2;STAT2;ILK;FNIP2;FGF2;LIMCH1;CSNK1D;PTPN13;FLOT1;CHP1;CD40;HGF;ATF4;TRAF3IP1;DNAJC10;ROCK2;ANGPT1;PELI2;PIK3R3;BMP7;FYN;CDK5RAP3;MAVS;SOD1;RAP2A;AKTIP;CCND1;BRAT1;PPP2CA;PRKDC;KRAS;PTEN;ITGB3;IGF2;P2RY1;WARS1;CCN1;HSP90AA1;RIPK1;EIF2AK3;RALB;PLPP3;ARRB1;PPP2R5E
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.37273064901139946,-1.479252611280381,0.014285714285714285,0.22593315963252616,1.0,29/94,17.21%,DAB2IP;ITPR1;PPP1R13B;MCL1;ATM;MAP3K5;DDX3X;FHIT;TNFRSF1B;STK24;ABL1;CUL3;PRKCD;BNIP3;ERN1;CUL2;PPM1F;ATP2A3;ARL6IP5;TP53;FNIP2;IKBKE;ERO1A;ATF4;DNAJC10;BBC3;BCL2L11;HIC1;HINT1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.3161023975049914,-1.478175150965279,0.0,0.22720239260792335,1.0,76/327,16.35%,APBB2;NFIA;RREB1;SMARCA2;ZNF423;ENG;ACVRL1;CREBBP;NSD1;RB1;BNC2;ZMIZ1;KAT6B;ERC1;INSR;ESR1;FOXN3;ZFHX3;IRF2;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;SOX13;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;ABL1;DNM2;TRRAP;NSD3;FUS;NFYC;GTF2IRD1;MEF2C;SLC39A8;ZBTB4;ASCC1;NAB1;LDB1;PRDM2;GPBP1;SPTY2D1;SP3;USP13;TP53;HMG20A;PRRX2;SOX7;JMJD1C;CHD3;YAF2;NOTCH1;SFPQ;OGG1;ACTN4;TAF5L;ATF4;MZF1;GPBP1L1;NR1D2;HCFC1;TCF3;TCF7L1;FOXC1;MYBL2;NAB2;UBE2L3;FOXO4;CREBL2;HIC1
prerank,regulation of response to external stimulus (GO:0032101),-0.35881717302936755,-1.4778714474798953,0.01073345259391771,0.22720993834728373,1.0,32/121,20.85%,FOXP1;IL1R1;XIAP;ADGRA2;CAV1;CASP12;SEMA7A;TMSB4X;BIRC3;STK24;SAMHD1;CD55;IRF1;NMT1;CELF1;CASP8;AREL1;JAK2;AGTR1;MGLL;USP18;SAG;NR1D2;N4BP1;ANXA1;ZMPSTE24;ERAP1;NOD2;DAGLB;TKFC;BCL6;AKNA
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.6321667444032295,-1.477562391009926,0.05650684931506849,0.22726289647344922,1.0,6/10,18.94%,DDX39B;WDR76;FEM1B;THOC1;RFWD3;RPA2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.31799357230476394,-1.477439776508375,0.0,0.22697951724121357,1.0,111/348,22.40%,LEF1;CLDN5;RESF1;UBR5;NOS3;INSR;KLF4;ETS1;CD34;TNRC6B;LIMS1;MED26;KLF2;GSK3B;ANXA2;PTPN1;APP;ATM;DTX3L;MITF;DDX3X;MTOR;SMO;TFRC;MSN;SP1;CTCF;BMP6;AFDN;GAS6;PDE2A;MED1;SEC16B;FGF1;BMP4;ECE1;MEF2C;EZR;CDH5;NGF;SMAD1;ACTA2;MAPK1;ROCK1;PPM1F;RAB27A;NOS1AP;YAP1;PLCG2;CELF1;GSK3A;OCLN;WNT16;PIK3CD;FGF7;RAMP2;AKT1;MYOM1;TASOR;TP53;PRKAA1;RGCC;PSEN1;BRAF;MAZ;HFE;NOTCH1;FGF2;WNT11;ZPR1;PLSCR1;MAPK8;ATF4;PIK3CB;AGO2;FAM98A;HCFC1;ROCK2;TADA3;RPL5;VSIR;TERF2;ANGPT1;PIK3R3;BMP7;IGF1;MOV10;SRPK2;DNMT1;CTSH;FUBP1;PPHLN1;HEY1;HEY2;RPS3;CITED2;VAMP3;GATA2;TNRC6A;PRKAB1;KRAS;F3;FGFR4;BRCA1;TRIM28;DLL4;WARS1;MAPK7;RPS7;NFE2L2;GABPA
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3847768574521484,-1.4769137197623563,0.019332161687170474,0.2273282191203964,1.0,27/82,16.46%,ZHX3;FERMT2;CRIM1;LRP5;BMPR2;SMOC1;IL6ST;TRPM4;LIMD1;BMP6;IL6R;PTK2;BMP4;MEF2C;PRKD1;YAP1;ACVR2A;TWIST2;NOTCH1;TMEM64;CDK6;HGF;ATF4;SMAD6;BMP7;IGF1;SKI
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5046439301432065,-1.4763040551594708,0.039927404718693285,0.22777641395736462,1.0,8/20,13.55%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.47480127666369,-1.4757217013925048,0.042435424354243544,0.2282094904594446,1.0,12/28,20.86%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;ZIC1;HYAL2;TRIM28
prerank,cell-cell junction organization (GO:0045216),0.37525606713581094,1.475604993814119,0.013793103448275862,0.36391712896771117,1.0,24/79,11.59%,CDH18;CADM2;CDH8;CTNND2;CDH20;CDH9;CDH10;CD177;PKP2;DCHS1;CDH19;CXADR;FLCN;CDH12;ANG;FSCN1;NECTIN3;SDK1;CDH7;CDH17;CDH24;CDHR3;CSF1R;CDH2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5306607231080087,-1.4750368825649518,0.058823529411764705,0.2288206604198956,1.0,7/18,17.78%,ITGB1;JAM2;SLC39A8;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,protein localization to chromatin (GO:0071168),-0.52263061382263,-1.4747943825666612,0.05090909090909091,0.2287640270220697,1.0,9/18,17.79%,ESR1;NIPBL;MRNIP;SGF29;MCM9;WAPL;TASOR;RUVBL2;PPHLN1
prerank,transcription by RNA polymerase II (GO:0006366),-0.3200370629849912,-1.4745536673487039,0.0016891891891891893,0.2286575718371529,1.0,98/305,24.63%,RREB1;MNAT1;INTS8;CREBBP;CBFB;NR3C2;ESR1;MLLT3;TEAD4;MED26;MAML2;CDK13;RXRA;PRRX1;KAT2B;SETD2;DEK;TEAD1;NR3C1;THRB;NFIX;CDK12;NOTCH3;SP1;HDAC1;NFKB1;PPARA;RARG;RPRD2;IWS1;MED1;EAF1;MAML1;POLR2G;NOTCH2;NABP1;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;CPSF7;NOTCH4;NFIC;MAZ;ICE1;MED17;NOTCH1;INTS3;CDC73;SNAPC1;RTF1;TCEA1;LSM11;TAF5L;TAF1C;MLLT1;SNRPE;ATF4;TAF8;ERCC3;NR1D2;NR2C1;PIR;INTS9;TAF7;GTF2I;RARA;TAF3;HDAC10;LSM10;NELFB;PHAX;HSF2BP;FIP1L1;ELOF1;ADRM1;TBL1X;PPARG;RARB;ELOC;MED27;HDAC7;TAF4B;INTS7;SNAPC3;TAF13;RXRG;MED20;SUPT4H1;POLR2C;CCNK;GMEB2;E2F3;TAF9;TFDP1;TAF15
prerank,negative regulation of protein kinase activity (GO:0006469),-0.37509107070561726,-1.474373969364389,0.011320754716981131,0.22846216677677286,1.0,30/88,22.40%,PTPRB;DAB2IP;RB1;CAV1;LRP5;CORO1C;PTPN1;CEP85;PAK2;CDKN1B;RTRAF;ABL1;LRP6;PPM1F;SH3BP5L;PRKRIP1;AKT1;CEACAM1;DUSP3;CHP1;TAF7;UBASH3B;ADARB1;CDK5RAP3;HYAL2;PTPRC;AKT1S1;NF1;WARS1;GADD45A
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3238030041049378,-1.4736849977881448,0.0,0.22907303397097648,1.0,69/248,16.07%,DAB2IP;XIAP;UBR5;ADGRA2;CSNK1A1;CAV1;DAB2;MLLT3;SMURF2;FZD6;GSK3B;DVL3;MCC;PSMA2;LRRK2;IGFBP4;DDX3X;ZNRF3;SOX13;SOX17;EGFR;EMD;KREMEN1;CSNK1G3;TRPM4;FZD4;LIMD1;HDAC1;FRMD8;NFKB1;RBX1;STK3;OTULIN;LRRK1;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;PSMB4;GLI3;GSK3A;LATS2;PPM1B;UBAC2;AXIN2;CCNY;ILK;PSEN1;SOX7;CSNK1G1;DKK2;CSNK1D;TMEM64;NOTUM;WNT11;PLEKHA4;PSMC2;LMBR1L;TMEM170B;LYPD6;USP34;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2;DAAM2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5294402222064798,-1.473591692122834,0.048214285714285716,0.22873880906720798,1.0,5/17,11.65%,TEK;BAIAP2L1;ABL1;HAX1;BCAS3
prerank,response to cytokine (GO:0034097),-0.35215931051817356,-1.4729685106869277,0.007029876977152899,0.2293675091925034,1.0,35/141,13.89%,LEF1;IL1R1;OSMR;SP100;NFAT5;PTPN14;MCL1;APP;TRIM56;SETD2;PTPN9;LDLRAP1;MAP4K3;IL6ST;PTPN12;ADAM9;IL6R;GGT5;GCH1;MAPKAPK2;LIFR;HAX1;CASP8;ADAM10;IKBKE;JAK2;IFITM3;TIMP3;RHOA;IRAK1;HDAC4;PTPN13;CD40;PLSCR1;MAPK8
prerank,regulation of protein binding (GO:0043393),-0.36438837896720194,-1.4729288337162736,0.0017857142857142857,0.22895321412975914,1.0,45/114,26.64%,RAPGEF2;CLDN5;CAV1;DAB2;GSK3B;APP;CRK;DTX3L;LRRK2;LDLRAP1;STK3;PRKCD;SPPL3;BMP4;ROCK1;NES;AKT1;PSEN1;ZFPM1;HFE;HDAC4;ACTB;FLOT1;MAPK8;BTBD1;MARK2;HIP1R;CTSZ;MITD1;PEX14;MARK3;AKTIP;PPP2CA;TFIP11;TCF7L2;CTNNBIP1;TERT;CAPRIN2;RALB;PPP1CA;TRIB3;BMP2;LRP1;HDAC5;RAN
prerank,pentose-phosphate shunt (GO:0006098),0.5966255349125308,1.4727263852065802,0.10138248847926268,0.36780115788760637,1.0,6/11,17.50%,PGLS;H6PD;TKT;RPIA;PGD;PGM2
prerank,organic hydroxy compound transport (GO:0015850),-0.4486727290754876,-1.4709738594639945,0.033628318584070796,0.23157744387065626,1.0,8/36,8.86%,ABCC4;ATP8B1;SLCO1C1;RXRA;RALBP1;RBP4;SLC16A1;SLCO2B1
prerank,calcium ion transmembrane transport (GO:0070588),0.36474537734770013,1.4706093874194988,0.015555555555555555,0.37009918947827913,1.0,16/86,8.07%,TRPM3;SLC24A4;SLC24A2;GRIN2B;SLC25A23;RYR3;PHB2;ATP2B4;CACNA2D1;GRIN2A;CACNA1A;CACNB3;CACNA1D;SLC8A2;TMCO1;TRPM1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5657553248354615,1.4699504926101084,0.07488986784140969,0.36905906553048845,1.0,3/12,6.17%,SNAP25;STX2;PRRT2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.43147496587636147,1.469894152368,0.04194260485651214,0.3665868475299159,1.0,11/39,7.33%,FGF14;ANK3;HECW1;FGF12;SCN1B;OSR1;GPD1L;WNK2;HECW2;WNK3;NETO1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.4296936750728746,-1.4696185935265542,0.02304964539007092,0.2334093002311054,1.0,15/43,17.82%,CTNNA1;FERMT2;MFHAS1;GSK3B;LIMK2;DTX3L;TFRC;BMP4;YAP1;LATS2;AKT1;SIN3A;ILRUN;TPR;CDK5RAP3
prerank,negative regulation of cellular process (GO:0048523),-0.3018309008758452,-1.4686450693007282,0.0,0.23451322336438868,1.0,187/521,27.13%,APBB2;DAB2IP;SMARCA2;IGFBP7;RAPGEF2;SP100;ACVRL1;JAM2;PPP1R13B;RB1;PODXL;FERMT2;NOS3;DCUN1D3;PTPN14;KLF4;ETS1;ABI1;PKD2;CBFA2T3;CD34;MYH9;LYN;BMPR2;PDS5B;CBLL1;CD200;SH3BP4;BTG3;APP;KAT2B;BMP5;RNF139;ITGA1;TBX1;ARID2;DDX3X;P3H2;THAP12;PTPRJ;SOX17;CDKN1B;TGFBR3;VGLL4;CRLF3;CTCF;DYSF;TNFRSF1B;RARG;RBM5;NCK1;NMI;PDCD4;SLIT2;TGFB2;SUZ12;AQP11;BMP4;BNIP3;PTPRK;CDK10;ARHGDIA;NGF;PLXND1;PLXNA4;PRKD1;RAF1;IRF1;CELF1;SMAD4;WNT16;CTBP2;ADAM10;VPS13C;CHMP4B;TP53;FRK;UBR2;KLF10;NOTCH4;AXIN2;NCK2;RGCC;LMNA;SOX7;TXNIP;JAK2;ZBTB7C;DCBLD2;RASA1;NOTCH1;FGF2;RAD18;ACTN1;CDC73;CTTNBP2NL;WNT11;CCN5;CDK6;TBRG1;PLSCR1;ST7L;PDE12;NUDT6;RNF167;IFI35;BTG2;MIF;ATG5;CCN3;FUZ;SMAD6;FOXO4;RERG;ANGPT1;BMP7;SKI;NPR1;GSDME;NOX4;PIP4P2;CTNNB1;TFAP4;ADARB1;OSGIN2;TNS2;ADGRG1;VAMP3;TES;HYAL2;BAP1;PPM1D;SOX4;PPP2CA;TGFBI;TMEM127;PTEN;BCL6;TOB1;LPCAT3;DLL4;BLM;WARS1;CDKN2C;ROR2;CAPRIN2;DIS3L2;NOS1;PTK2B;CCN1;FHL1;MYOCD;PARP16;BECN1;TXNDC12;MSX1;EIF2AK3;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;SERTAD2;E2F7;SEMA5A;HSPA1B;PINX1;GNG4;PLXNB1;ADGRB1;BMP2;PLPP1;APBB1;SIPA1;SERTAD3;PTPN2;TPTE;NUPR2;CDKN3;APC;VPS35;EMILIN1;FRZB;RND1;F2R;FABP3;CGREF1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.48455708106465534,-1.4683681555843215,0.06060606060606061,0.2345005067911964,1.0,14/26,25.53%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F
prerank,postsynaptic membrane organization (GO:0001941),0.5234008202979862,1.4683192127189122,0.05530973451327434,0.3676208008908809,1.0,6/17,14.63%,NRXN1;NLGN1;MUSK;DLG4;NLGN2;APOE
prerank,regulation of microglial cell activation (GO:1903978),0.5531283774451873,1.4680468150770267,0.06607929515418502,0.36573794390862185,1.0,5/15,13.14%,NR1D1;SYT11;SPHK1;GRN;LDLR
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5546829134156098,-1.4674855153579243,0.052346570397111915,0.23557710219193254,1.0,5/15,6.37%,EDA;ANKRD11;TBX1;HDAC1;LRP6
prerank,regulation of cell population proliferation (GO:0042127),-0.2942701479904743,-1.4664925092471603,0.0,0.2368373936301329,1.0,231/691,27.21%,FLT1;TJP1;LEF1;GRK5;DAB2IP;IGF1R;SMARCA2;KITLG;IGFBP7;OSMR;RAPGEF2;ELN;CLDN5;ENG;ACVRL1;XIAP;NOS3;PTPN14;INSR;KLF4;ETS1;ABI1;PKD2;CBFA2T3;LRP5;LYN;ACER2;BMPR2;PDS5B;CD200;LIMS1;SH3BP4;RBFOX2;BTG3;PDGFD;THBS1;CDK13;GCNT2;APP;KAT2B;BMP5;RNF139;ITGA1;TBX1;ARID2;IL15;KDR;P3H2;THAP12;PTPRJ;EGFR;IL6ST;TFRC;CDKN1B;TRPM4;TGFBR2;CTCF;BMP6;HDAC1;IL6R;HES1;JAG2;RARG;SIX1;RBM5;IRS1;NMI;STX3;IL34;CUL3;DNAJA2;TGFB2;PTK2;STAT6;AQP11;FGF1;BMP4;STAMBP;PTPRK;CDK10;NGF;JUN;TBX2;BIRC6;ARHGEF2;RAF1;YAP1;NOP2;FLT4;IRF1;LIFR;CELF1;NAMPT;CTBP2;ADAM10;FGF7;AKT1;VEGFC;TP53;FRK;KLF10;EDN1;DOT1L;AXIN2;PTGFR;NCK2;STAT2;RGCC;LMNA;SOX7;JAK2;ZBTB7C;MAZ;EDN3;ACER3;AGTR1;NOTCH1;RHOA;FGF2;CDC73;HDAC4;CDC123;ASH2L;RHOG;CDK6;TBRG1;KSR1;RPS4X;MECP2;NUDT6;FAM98A;COPS9;JAG1;IFI35;BTG2;NUAK1;GAB2;FUZ;SMAD6;LGMN;FOXO4;RERG;IGF1;SKI;SRPK2;COX17;GSDME;NOX4;SIX4;RARA;CTSH;CTNNB1;TFAP4;ADARB1;TNS2;ADGRG1;CACUL1;CLCF1;TNFSF13;TBC1D8;TES;BAP1;PPM1D;SOX4;DUSP22;PRKDC;TCF7L2;TIMELESS;KRAS;TMEM127;PTEN;BCL6;ECRG4;FGFR4;PRC1;IL13RA1;TOB1;IGF2;DLL4;MDM2;NACC1;S1PR3;WARS1;CDKN2C;ROR2;PDGFRB;DIS3L2;LAMC2;PTK2B;TTK;RELA;MYOCD;PTN;ESM1;TBX3;HAS2;CEP131;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;E2F7;HSPA1B;ACE2;PINX1;IL7;MVD;ADGRB1;BMP2;PLPP1;CDCA7;PTPN2;CNOT8;ZFP36L1;ADAM17;TBX6;RPS15A;TPTE;NUPR2;CDKN3;TNFRSF9;APC;FGF10;FRZB;F2R;KIF14;FABP3;CGREF1;HILPDA;IL12RB2
prerank,negative regulation of GTPase activity (GO:0034260),-0.4936167658529792,-1.4664458717814075,0.05698529411764706,0.236424168334581,1.0,8/22,11.88%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;RASA4;BCAS3;ARFGEF1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5878501583148177,-1.466378990126682,0.07806691449814127,0.23606904923617827,1.0,6/11,32.98%,MFHAS1;LYN;TNFAIP3;TREM2;TLR6;TLR1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5911444285341568,-1.4663349117100881,0.03790613718411552,0.23568463087596697,1.0,8/13,26.25%,PLCG1;SP1;AKT3;FGF2;ITGA4;IGF2;HMGB1;ADAM17
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.36992501937733435,1.4655951498764987,0.017857142857142856,0.3687047874854981,1.0,16/76,11.23%,GRM5;CHRM2;HTR2C;OPRM1;CALCA;PTGER3;GRM1;HOMER1;TRHR;C3AR1;ADRA2A;GPR65;ADRA1D;ADRA1A;TACR1;NMUR2
prerank,hepaticobiliary system development (GO:0061008),-0.5066203196046292,-1.46530889170216,0.060550458715596334,0.2370163746062911,1.0,11/20,23.86%,PKD2;LSR;TGFBR3;NIPBL;PRKCSH;ARID5B;CDK5RAP3;CEBPG;CITED2;NF1;CEBPA
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6204850737728484,-1.464649018708126,0.0564373897707231,0.23766953545628536,1.0,3/10,8.04%,LYN;FAS;MAPK1
prerank,extracellular structure organization (GO:0043062),-0.3295834666117527,-1.464616121740079,0.004909983633387889,0.23724859271787072,1.0,54/204,12.36%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;ITGA1;SMOC1;KDR;COL5A1;ICAM1;ITGB4;MMP2;LAMA3;LAMA4;ITGB5;COL4A5;COL4A1;COL8A2;COL5A2;SLC39A8;AGRN;HSPG2;LOXL1;CDH1;ADAMTS9;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3
prerank,synaptic vesicle membrane organization (GO:0048499),0.5212892790152295,1.4642561730926842,0.049217002237136466,0.3692049100693017,1.0,5/17,12.45%,SNAP25;STX2;PRRT2;SYP;SYNGR1
prerank,telomere maintenance (GO:0000723),-0.4083331871791782,-1.46407005426391,0.034990791896869246,0.2375786422513809,1.0,20/50,21.31%,SP100;STN1;ATM;SMC5;MRE11;NSMCE2;POLD3;RPA3;DNA2;RPA1;CTC1;PTGES3;TERF2;TEP1;WRN;RPA2;PRKDC;DCLRE1B;TERT;BLM
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3803451329819707,-1.463820149559605,0.014109347442680775,0.23753219920134744,1.0,21/74,17.12%,LEF1;DAB2IP;FERMT2;DAB2;IL17RD;GCNT2;BMP5;SPRED2;MTOR;TGFBR2;LDLRAD4;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;SMAD7;FOXC1;MAD2L2;MCRIP1;CTNNB1
prerank,regulation of hemopoiesis (GO:1903706),-0.6196803730178904,-1.4635311735184096,0.04945054945054945,0.2375011202810537,1.0,2/10,1.23%,CREBBP;CBFB
prerank,synaptic vesicle recycling (GO:0036465),0.4519111891008785,1.4633084969876855,0.05581395348837209,0.36899274663683485,1.0,6/31,6.00%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,positive regulation of kinase activity (GO:0033674),-0.35847108567760216,-1.4632663835012198,0.010752688172043012,0.23742219016490437,1.0,23/107,8.85%,FLT1;TEK;IGF1R;RAPGEF2;TIE1;ROR1;INSR;IQGAP1;KDR;MERTK;EGFR;GAS6;MRNIP;DSTYK;LMO4;PTK2;RASSF2;RAP1A;SNX9;MRE11;EPHA4;MMD;FLT4
prerank,inositol lipid-mediated signaling (GO:0048017),-0.41607859423332727,-1.462951929379556,0.03197158081705151,0.23746201071409237,1.0,17/50,16.38%,IGF1R;PLCB4;PLCB3;PIK3R1;IRS1;PLCB1;PI4KB;EZR;PIK3C2A;NGF;PLCE1;PIK3CD;RHOA;PIK3CB;GAB2;TNFAIP8L3;IGF1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.39617953322993227,-1.4612636622666062,0.021621621621621623,0.2398909258318889,1.0,19/62,16.58%,ZBTB16;CREBBP;CBFB;LYN;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;CDC73;ASH2L;CDK6;H3-3A;KMT2C;MOV10
prerank,protein acetylation (GO:0006473),-0.4583041040888174,-1.4601479295836381,0.040293040293040296,0.2411481247029343,1.0,8/30,12.91%,FOXO1;CREBBP;KAT2B;KAT6A;NAA16;NAA80;NAA15;KAT5
prerank,regulation of dendrite extension (GO:1903859),0.5118514444381733,1.4598995398077768,0.06206896551724138,0.374329420041067,1.0,8/18,15.07%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A
prerank,axoneme assembly (GO:0035082),0.4475615805047272,1.4592921932181782,0.050808314087759814,0.37332503601621897,1.0,10/31,16.82%,DNAAF3;CFAP74;SPAG1;DNAAF1;DCX;DNAI4;FOXJ1;GAS8;SPAG17;DNAAF2
prerank,metal ion export (GO:0070839),0.45392496502301904,1.4589435786493417,0.04395604395604396,0.37175391496686744,1.0,7/31,8.72%,ATP1A2;KCNA5;ATP12A;ATP2B4;SLC4A4;ATP1B1;ATP4A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.41040506030402946,-1.4587448537344436,0.043557168784029036,0.24303417895760682,1.0,13/52,9.84%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;PIK3R1;DLG1;STX3;CNST;AKT1
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.3389890828071023,-1.458178597243205,0.0049261083743842365,0.2435652250189186,1.0,66/166,28.41%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;TEAD1;NR3C1;THRB;NOTCH3;HDAC1;PPARA;RARG;MED1;MAML1;POLR2G;NOTCH2;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;NOTCH4;TAF1B;BRF1;MAZ;MED17;NOTCH1;TAF1C;TAF8;ERCC3;NR1D2;NR2C1;CAVIN1;TAF7;RARA;TAF3;HDAC10;NCOA6;TBL1X;PPARG;RARB;MED27;HDAC7;TAF4B;UBTF;TAF1D;TAF13;RXRG;POLR2C;E2F3;TAF9;TAF15;POLR1E;POLR2L;POLR2H;HDAC5;RSF1;GTF2H3;MAML3;E2F2;CCNH
prerank,telomere organization (GO:0032200),-0.42160661642199465,-1.4581302449384013,0.040145985401459854,0.24316593550288385,1.0,19/43,21.31%,SP100;STN1;ATM;MRE11;DOT1L;POLD3;RPA3;DNA2;RPA1;CTC1;PTGES3;H3-3A;TERF2;WRN;RPA2;PRKDC;DCLRE1B;TERT;BLM
prerank,peptidyl-tyrosine modification (GO:0018212),-0.404417662678905,-1.458058149194985,0.023608768971332208,0.24281801453501536,1.0,16/56,12.16%,FLT1;TEK;DYRK1A;INSR;ABI1;LYN;KDR;EGFR;ABL1;PTK2;TPST2;EPHA4;FLT4;JAK2;ABI3;PKDCC
prerank,peptidyl-serine modification (GO:0018209),-0.3399545556846503,-1.4579648898132014,0.008605851979345954,0.24248884908977056,1.0,55/166,19.55%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;ATM;MARK1;RPS6KA5;PAK2;LRRK2;NEK6;MTOR;PRKD2;TLK1;CSNK1G3;TGFBR2;RICTOR;GAS6;MAST4;MAST2;PRKCD;MAPKAPK2;PLK2;MAPK1;ROCK1;PRKD1;AKT3;LATS2;CLSPN;AKT1;STK32C;IKBKE;STK38;RPS6KA1;CSNK1G1;CSNK1D;ULK2;MKNK2;MAPK8;PKN2;RPS6KA3;MARK2;PKN3;ROCK2;MAPK12;SRPK2;MARK3;HIPK1;HPF1;IKBKB;GALNT1;VRK2;POGLUT3;PRKDC
prerank,negative regulation of response to stimulus (GO:0048585),-0.3902359092991045,-1.4574675110296533,0.018018018018018018,0.24291759342027375,1.0,16/60,16.88%,KLF7;KLF4;BRAP;CD34;LYN;PTPN1;SLC30A10;SLIT2;AQP11;AKT3;VPS13C;MAP3K3;CDK6;TERF2;UBASH3B;KIF26A
prerank,protein hydroxylation (GO:0018126),-0.5625350603094835,-1.4573386702556579,0.05714285714285714,0.24262665193663488,1.0,5/15,9.07%,PLOD1;PLOD2;P3H2;OGFOD1;ASPH
prerank,regulation of AMPA receptor activity (GO:2000311),0.4752661864716012,1.456989617745832,0.04375,0.37368164316657587,1.0,13/25,19.35%,NLGN1;SHANK1;CACNG8;CACNG3;MINK1;CACNG2;CACNG4;PRRT1;NLGN2;CACNG5;SHISA9;CNIH2;NLGN3
prerank,positive regulation of cell junction assembly (GO:1901890),0.39210816885612104,1.4566768414186082,0.023696682464454975,0.37189964235513756,1.0,15/56,13.33%,CNTNAP2;PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1;NPHP4;IRX3;VEGFA;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.42410702429113045,-1.45648981426194,0.025179856115107913,0.24355510789974974,1.0,12/43,14.62%,DAB2IP;EPS15;RAB7A;ITGA1;PTPRJ;EGFR;CBL;EPS15L1;RNF115;PTPN3;DUSP3;GRB2
prerank,negative regulation of glycolytic process (GO:0045820),-0.6143664903648528,-1.4559047840115922,0.07308377896613191,0.24363876394393136,1.0,3/10,12.48%,CBFA2T3;PPARA;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6143664903648528,-1.4559047840115922,0.07308377896613191,0.24363876394393136,1.0,3/10,12.48%,CBFA2T3;PPARA;HDAC4
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3810964923825751,-1.4558110850208963,0.025547445255474453,0.24329708136568812,1.0,29/76,24.52%,CSNK1A1;CBFA2T3;DAB2;GSK3B;RNF139;LRRK2;SMURF1;RBX1;PTK2;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;CSNK1D;ZER1;ZYG11B;SUMO1;CDK5RAP3;RAD23A;PTEN;MDM2;SH3RF2;KEAP1;CEBPA;RCHY1;TRIB3;HSPA1B
prerank,cellular protein modification process (GO:0006464),-0.28591369826038,-1.4556821773897124,0.0,0.24301801611858503,1.0,227/983,17.01%,PTPRG;PTPRB;GRK5;PRKCH;PTPRM;PRKG1;FBXL7;IGFBP7;ZBTB16;ST3GAL6;KLHL5;SNRK;MAP3K20;ERG;ACVRL1;BCR;DCAF10;ST3GAL4;ST3GAL1;PPP2R5A;DCUN1D3;PTPN14;DYRK1A;INSR;PPM1H;CSNK1A1;NEK7;PTP4A2;DAPK1;FAM20A;LYN;PRKCE;BMPR2;PLOD2;TLK2;ST8SIA4;GSK3B;THBS1;CDK13;PRKACB;FBXL12;GCNT2;MTMR3;PTPN1;APP;ATG7;ZDHHC6;ATM;JAK1;MARK1;RPS6KA5;ZC3HAV1;PSMA2;LIMK2;PAK2;SIK1;LRRK2;ATG10;IGFBP4;MAN2A1;MAP3K5;PTPN9;MAP4K3;RAB1A;ALG10B;NEK6;MTOR;CUL9;CDK17;TIPARP;PRKD2;MERTK;PTPRJ;PARP4;CDK12;FBXL3;TLK1;DAD1;YES1;PTPN12;CSNK1G3;RAB2A;TGFBR2;B3GNT2;RBX1;PIGT;GAS6;STK3;STK24;BMX;ABL1;PPEF2;MAST2;LMO7;CUL3;DCAF5;TGFB2;SIRT5;PRKCD;PPM1L;PARP14;BRD2;BMP4;OGFOD1;ILKAP;PTPRK;CDK10;ERN1;PSME2;MAPKAPK2;PRAG1;CDC42BPA;AAK1;PLK2;PDIA6;TGM2;MAPK1;ROCK1;MTMR6;PHKA2;CUL2;PPM1F;MAML1;NAA80;SETD3;BIRC6;LOXL1;WSB2;RAB5A;PRKD1;AKT3;SPSB1;YWHAZ;PSMB4;ST3GAL2;PXK;GSK3A;ACVR2A;LATS2;PPM1B;PIK3CD;ADAM10;UBE2D3;AKT1;FEM1A;UBA7;SOCS2;FUT10;SIK3;CUL7;FRK;TAOK3;PRKAA1;FBXW8;WIPI1;WNK4;PPP1R12A;UBLCP1;STK10;ILK;KLHL13;FNIP2;PTPN3;IKBKE;ITIH2;BRAF;ERO1A;JAK2;STK38;IRAK1;LRRC41;UBE2E2;CSNK1D;PRKCSH;PTPN13;CTTNBP2NL;CLK3;ANO8;CCDC8;NOTUM;WNT11;FEM1C;CSK;MSLN;ASB1;SIRT3;FBXW11;CDK6;KLHL25;MKNK2;MAPK8;PKN2;BTBD1;B4GALT5;MSRA;PSMC2;MAP4K4;MARK2;HIF3A;LIPE;IGFBP5;SERPINC1;GMFB;PTAR1;FEM1B;PKN3;UBE2M;ROCK2;NUAK1;ATG5;ERCC8;PSMB2;ABCA7;UBE2L3;PSMB1;F5;DCAF13;PPP2CB;SRPK2;RAB11A;FYN;MARK3;HIPK1;RARA;PLAT;ANXA1;CDC42BPB
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.443096924976746,-1.4556110483145202,0.047186932849364795,0.24263233565403503,1.0,17/36,25.25%,LEF1;GNB1;TNRC6B;FZD6;NFATC1;FZD4;PLCB3;PLCB1;WNT11;AGO2;MOV10;CTNNB1;TNRC6A;TCF7L2;FZD5;MAP3K7;GNG2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6046543955096579,-1.4554526571244917,0.08082706766917293,0.2424606505393236,1.0,3/10,14.94%,WDFY1;LBP;IFI35
prerank,regulation of apoptotic process (GO:0042981),-0.2921484897663691,-1.4551382082309907,0.0,0.24249441908478755,1.0,163/676,17.32%,HIP1;TJP1;LEF1;UNC13B;GRK5;TEK;DAB2IP;IGF1R;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;PPP1R13B;XIAP;CREBBP;DCUN1D3;ERC1;MCL1;DAB2;ARHGEF3;DAPK1;ACER2;TNFAIP8;NET1;GSK3B;THBS1;ATG7;ATM;MCF2L;ARHGAP10;PAK2;UTP11;MAP3K5;DDX3X;PLEKHG5;KDR;TNFSF10;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;IER3IP1;HDAC1;NFKB1;RASGRF2;RARG;CBL;RBM5;RYBP;GAS6;NFKBIA;PIK3R1;STK3;ABL1;ZBTB7A;FOXO3;DSTYK;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;PTK2;MED1;AATF;RASSF2;STEAP3;BMP4;BNIP3;MEF2C;ARHGDIA;NGF;JUN;RNF144B;MYO18A;PLK2;TGM2;MRE11;ITSN1;BIRC6;NOTCH2;BNIP2;ARHGEF2;ANXA4;RAF1;YWHAZ;FLT4;ARL6IP5;SH3RF1;HAX1;LATS2;SOS2;CASP8;BCAR1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;CRADD;PRKAA1;AREL1;PERP;PSEN1;BRAF;JAK2;SLC27A4;ARHGEF11;ANO6;RASA1;SON;IRAK1;COMP;ACTN1;MTDH;RPS6KA1;PA2G4;CTNNBL1;ACTN4;CAT;NDRG1;RTKN;TCIM;WNT11;UFM1;STPG1;BABAM2;HGF;MAPK8;ATF4;RPL10;TRIO;RPS6KA3;SPTLC1;ZFAND6;ERCC3;MAP4K4;IAPP;MIF;HIP1R;PRDM9;SMAD6;ABR;ANGPT1;ARHGEF18;BCL2L11;IGF1;PREX1;SLK;SIX4;ANXA1;CTSH;CTNNB1;APH1A;API5;PPIF;TFAP4
prerank,organic anion transport (GO:0015711),-0.3822175713770627,-1.454856347193768,0.013961605584642234,0.24256455986523415,1.0,15/76,9.97%,ABCC4;ABCG2;SLC26A7;LRRC8C;SLCO2A1;SLCO1C1;SLC4A10;SLCO3A1;CA4;ABCC6;SLC39A8;LRRC8D;SLCO2B1;SLC35A3;SLC52A1
prerank,positive regulation of cell adhesion (GO:0045785),-0.38560789408645063,-1.4544519375642322,0.02154398563734291,0.24279959001401993,1.0,20/74,12.82%,RSU1;RAC1;ZFHX3;LIMS1;ATM;VIT;PRKD2;PTPRJ;ADAM9;AFDN;STX3;TGFB2;TGM2;PPM1F;EPHA4;FBLN2;JAK2;SMAD7;FRMD5;TPM1
prerank,sterol biosynthetic process (GO:0016126),0.4415905420749791,1.453762301618506,0.029082774049217,0.376346086389317,1.0,12/33,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;SC5D;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5676947389951257,-1.4533015453652394,0.07880910683012259,0.24428701499249206,1.0,7/13,31.26%,CBFB;TGFBR2;GLI3;NKAP;PNP;RUNX1;SHH
prerank,mitochondrion transport along microtubule (GO:0047497),0.5474304338118579,1.4529523969806242,0.07234042553191489,0.3759218630431731,1.0,7/13,24.89%,SYBU;MAP1S;MAPT;NEFL;RHOT1;UBB;SPAST
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3322202896553839,-1.4528896061916077,0.0017064846416382253,0.24465337989258085,1.0,91/193,35.76%,FBXL7;NEDD4L;SMURF2;UBE2K;TRIM25;CNOT4;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;RNF40;RNF144B;BIRC6;ARRDC1;SPSB1;TRIP12;MIB1;FEM1A;AREL1;NTAN1;CDC16;ANAPC16;ATXN3;UBR4;FEM1C;UBE4A;KLHL25;RNF168;PSMC2;RC3H1;RNF167;MYLIP;UBE2L3;KCTD10;KLHL3;SIAH1;ADRM1;BUB1B;HERPUD1;ELOC;UBE2R2;MDM2;BUB3;KEAP1;NDFIP2;HACE1;FZR1;ARRB1;RCHY1;RNF146;TRPC4AP;ANAPC7;DTL;ARIH2;RNF34;RNF114;UBE2I;UBA1;RNF14;ANAPC11;CDC34;UBE2H;TRIM32;ANAPC10;ANAPC5;PSMD13;RNF11;PLK1;RNF19A;RBBP6;AURKA;FBXL14;UBE2A;RNF20;TOLLIP;KLHL15;WDR81;TOPORS;RNF185;UBE2G2;CDC20;NEDD8;OS9
prerank,positive regulation of autophagy (GO:0010508),-0.37679579975424043,-1.452420688689233,0.01444043321299639,0.24493866292924502,1.0,34/81,26.10%,FOXO1;DAPK1;GNAI3;SH3BP4;GSK3B;SESN1;LRRK2;KDR;LARP1;FOXO3;IRGM;BNIP3;PIK3C2A;PLK2;ROCK1;PRKD1;GSK3A;PRKAA1;TRIM14;MTDH;KAT5;PIK3CB;TRIM13;IKBKG;RNF152;ORMDL3;ATF6;TRIM68;HMGB1;MAP3K7;PLEKHF1;PLK3;EIF2AK4;TPCN1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.36784849355995747,-1.4524025302040666,0.017094017094017096,0.24450215537114817,1.0,26/87,15.36%,EPS8;ESAM;RAC1;RHOBTB1;IQGAP1;F11R;RND3;CRK;MTOR;RICTOR;ABL1;RHOQ;PRKCD;CDK10;EZR;ARHGDIA;ROCK1;NOTCH2;FAM107A;ARHGAP17;ABI3;RHOA;RHOC;RHOG;HIP1R;ROCK2
prerank,regulation of protein neddylation (GO:2000434),-0.615425014034884,-1.451478272069544,0.06766917293233082,0.24556614588713263,1.0,6/10,20.63%,DCUN1D3;COPS9;RPL5;DCUN1D2;EPAS1;DCUN1D5
prerank,regulation of immune effector process (GO:0002697),0.4266209829820139,1.4512966727489691,0.04751131221719457,0.3773081069614539,1.0,10/41,13.29%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5976937015148203,-1.4507736211461593,0.07168458781362007,0.24627313349237134,1.0,6/11,28.54%,CAV1;NEDD4L;CASQ2;KCNH2;CAB39;ACTN2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6045897969052109,1.4506543824532967,0.07708779443254818,0.37632110289805365,1.0,4/10,13.31%,QDPR;ASRGL1;THAP4;PCBD1
prerank,regulation of signal transduction (GO:0009966),-0.3306539784064975,-1.4505437303907107,0.008756567425569177,0.2462368472393765,1.0,51/190,16.88%,GRK5;IGFBP7;SP100;CREBBP;RSPO3;CBFB;RGS3;ELF1;BRAP;ESR1;RGS5;GIT2;ITGA3;PTPN1;APP;CRK;FBXL17;LRRK2;IGFBP4;ZDHHC3;NCK1;PXN;RGS12;PLCB1;CD55;WDR11;PRAG1;TMEM204;PLCE1;PRKD1;MDFIC;LIFR;SOCS2;NCK2;MFNG;ILK;GALNT11;IRAK1;MGLL;CSK;PLSCR1;TCF7L1;IGFBP5;FUZ;CASTOR1;NCLN;FYN;UBASH3B;SENP2;IRAK2;KIF26A
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.40967446149163644,-1.4497986940855494,0.033210332103321034,0.24695666986264053,1.0,23/51,24.99%,BMPER;CRIM1;BMPR2;SMURF2;SMURF1;SKIL;SMAD1;GREM2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;SMAD6;SKI;HTRA3;SMAD9;DAND5;PPARG;CHRDL1;ACVR2B;FBN1;BMP2
prerank,response to estrogen (GO:0043627),-0.4511641071218637,-1.4492254367500754,0.03102189781021898,0.24749470861632458,1.0,11/31,23.81%,CAV1;ESR1;TRIM25;NCOA4;BCAS3;ASH2L;RARA;WBP2;CITED2;BRCA1;RBBP5
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3991444041804358,-1.448508162314844,0.02185792349726776,0.24819757229373673,1.0,20/59,24.75%,DAB2IP;ERC1;TAB3;BIRC3;NFKBIA;ROCK1;AKT1;NFKBIL1;ROCK2;TNFRSF1A;TAB2;IRAK2;IKBKG;MAP3K14;IKBKB;TBKBP1;NKIRAS2;RELA;RIPK1;MAP3K7
prerank,regulation of glycogen metabolic process (GO:0070873),-0.590918408422439,-1.4480852387432992,0.05818181818181818,0.24851718472415685,1.0,3/12,9.84%,PPP1R3B;PPP1R3C;AKT1
prerank,manganese ion transport (GO:0006828),-0.5613645209818843,-1.447823075337519,0.06770833333333333,0.24853404543799276,1.0,5/14,16.74%,SLC30A10;TRPC4;SLC39A8;TRPC6;TRPC3
prerank,gene expression (GO:0010467),-0.307338645973067,-1.4470374944393145,0.0016722408026755853,0.24937800323584422,1.0,132/348,27.02%,RBPMS;MEF2A;SRSF11;RBMS1;RRBP1;NUP42;RPS21;THRB;RPL37;RAE1;SARNP;RPL31;RANBP2;THOC2;RPL9;RBM5;TASP1;RPS14;UPF3B;THOC7;NUP98;RPSA;RBMS2;UPF2;SEC13;AGFG1;TSPAN14;POLR2G;DDX39B;RPL3;RPLP1;MRPL32;RPL26;NOL9;PWP1;RPS11;TAF1B;HNRNPUL1;RBM39;DHX38;HNRNPF;XRN2;TSPAN5;TSPAN17;NUP153;RPL13;SLU7;MRPS18A;RPL38;DRG1;RPL27;RPS16;APOBEC1;MCM3AP;RPS4X;GSPT1;AGO2;RPL10;RPL7A;SYNCRIP;HARS2;TPR;RPL5;THOC3;CREBL2;THOC1;MRPL24;NOX4;RPS27;ADARB1;RPL27A;GOLPH3;NUP214;NXT1;RPS3;RPL36A;RPL35A;FIP1L1;TFIP11;SRRM1;MRPS14;RNPS1;GLE1;RPL37A;SRSF3;MRPS21;DROSHA;MRPL35;RBM3;RPL32;WARS1;RBM6;PTMA;RPS7;NUP188;RPS15;TSPAN33;MRPL34;RPS8;ALKBH5;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;MED20;RPS23;POLR2C;POLDIP3;SMG6;NXF1;SRBD1;RPS17;POLR2L;RPS2;MRPL43;MLF1;POLR2H;ATXN1;RPL39;MRPL11;RPS26;TNIP1;RPS15A;HNRNPL;HNRNPD;NUP88;MMS19;RPL15;RPL34
prerank,anion transport (GO:0006820),-0.43804373684332176,-1.4462790058847759,0.040780141843971635,0.25015022451021157,1.0,8/33,9.05%,ABCG2;SLC26A7;LRRC8C;SLC13A4;LRRC8D;SLCO2B1;SLC17A5;SLC13A3
prerank,positive regulation of cell projection organization (GO:0031346),0.3421529303343352,1.4455599376570378,0.016166281755196306,0.3856299801165462,1.0,22/115,9.80%,PTPRD;MAGI2;IL1RAPL1;ROBO2;LRRC7;GRIP1;RIT2;SCN1B;ROBO1;TENM3;FUT9;CDKL5;TOX;KIDINS220;NDRG4;CAMK2B;NTRK2;CARMIL1;PLA2G3;SLITRK1;PLPPR5;STMN2
prerank,cellular response to cytokine stimulus (GO:0071345),-0.3024006354416917,-1.4450859084095125,0.0,0.25189244426719193,1.0,155/416,29.63%,LEF1;DAB2IP;IL1R1;OSMR;ST3GAL6;GHR;ITGB1;FOXO1;ZEB1;NFAT5;PTPN14;MCL1;DAPK1;GSK3B;UBE2K;JAK1;LRCH1;CRK;CCL25;PTPN9;LDLRAP1;IFNAR1;ICAM1;PTPRJ;MMP2;SLC12A2;IL6ST;CDKN1B;PTPN12;IL6R;NFKB1;TNFRSF1B;CBL;GAS6;PIK3R1;FOXO3;PDE2A;STX3;IL34;STAT6;IRGM;LBP;GBP6;GRB10;ARHGEF2;YWHAZ;GREM2;IRF1;LIFR;GSK3A;S1PR1;HAX1;PIK3CD;AKT1;SOCS2;TP53;MAOA;IL4R;STAT2;RAPGEF1;JAK2;RHOA;LAMA5;FGF2;IRAK1;PTPN13;GBP4;CSK;CD40;HGF;MAPK8;PIK3CB;PDE12;ZFAND6;RC3H1;GRB2;FOXC1;SYNCRIP;GAB2;USP10;ASAH1;TPR;IL16;TNFRSF1A;BCL2L11;VCAM1;FYN;GSDME;IRAK2;ANXA1;GBP5;IL10RB;IL20RB;RPS3;CCL19;CLCF1;IKBKB;HYAL2;CCND1;IFNGR2;CXCL12;BCL6;F3;BRCA1;IL13RA1;INPP5D;PTPN11;ITGAM;IFNAR2;IL3RA;NFE2L2;HSP90AA1;RELA;RIPK1;CASP1;RPL13A;HAS2;MAPK11;PIM1;GBP3;CEBPA;ADAMTS7;PTGIS;SHPK;IL7;DHX9;ERBIN;PIK3CA;MT1X;LCN2;PTPN2;CRNN;IFITM2;ZFP36L1;LGALS9;IL12RB2;BAG4;TRIM6;HNRNPU;IL22;CXCL10;HMOX1;PTPN18;DUSP1;RORC;PLP2;IL2RA;AXL;HYAL3;CACTIN;WNK1;IL2RG;BIRC5;IFNLR1;SHMT1
prerank,cholesterol metabolic process (GO:0008203),0.3702968253613559,1.4447064241449874,0.027253668763102725,0.38516650031416566,1.0,22/68,15.42%,IDI2;AKR1D1;CYP46A1;INSIG1;PIP4P1;SULT2B1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5;FDFT1;DHCR24;ABCA5;IDI1;APOE;CLN8
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2956077787462792,-1.4424872514589653,0.0,0.25602994767239656,1.0,155/532,23.93%,IL1R1;OSMR;GHR;SP100;ITGB1;FOXO1;PELI1;EDA;ZEB1;MCL1;TAB3;NOD1;LIMS1;TRAF5;TMSB4X;IRF2;ANXA2;TRIM25;JAK1;ADIPOR2;RPS6KA5;PSMA2;CRK;PAK2;CCL25;IL15;IFNAR1;ICAM1;PTPRJ;MID1;MMP2;CAMK2G;IL6ST;BIRC3;CDKN1B;MSN;IL6R;NFKB1;RBX1;TNFRSF1B;CBL;NFKBIA;PIK3R1;IRS1;SAMHD1;FOXO3;PDCD4;STX3;IL34;PLCB1;STAT6;PRKCD;LBP;TCP1;PSME2;RAP1B;TXNDC17;GRB10;YAP1;YWHAZ;PSMB4;GREM2;IRF1;LIFR;S1PR1;SMAD4;PIK3CD;AKT1;MAP3K3;SOCS2;TP53;MAOA;IL4R;STAT2;RAPGEF1;ILK;JAK2;HNRNPF;IFITM3;LAMA5;FGF2;IRAK1;CEACAM1;LCP1;ACTN4;IL17RA;EIF5A;CSK;FBXW11;CD40;MAP3K8;ACKR3;HGF;PIK3CB;PSMC2;GRB2;TALDO1;FOXC1;IFI35;IL17RE;MIF;GAB2;PSMB2;IL16;PSMB1;TNFRSF1A;PELI2;BCL2L11;TAB2;VCAM1;TNFRSF11B;FYN;IRAK2;ANXA1;PSMA8;IL10RB;SOD1;IL20RB;CFL1;IKBKG;CCL19;MAP3K14;CLCF1;EDAR;TNFSF13;IKBKB;NOD2;PSME1;CCND1;IFNGR2;CXCL12;TNFRSF25;BCL6;F3;PSMD4;IL13RA1;INPP5D;PTPN11;TNFSF8;PSMA7;ITGAM;PTK2B;LTBR;IFNAR2;IL3RA;HSP90AA1;RELA;FCGR1A;RIPK1;CASP1;PITPNA;PIM1;PSMD5;CEBPA;TRIM68
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5699376000790548,-1.442369160129702,0.07612456747404844,0.25569872332777477,1.0,6/13,17.95%,TMSB4X;SIN3A;PSEN1;MAD2L2;HEY1;HEY2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.608449227129566,-1.4423177036298749,0.07303370786516854,0.2553194054751946,1.0,3/10,12.16%,ZBTB16;ACVRL1;PKDCC
prerank,protein import into mitochondrial matrix (GO:0030150),-0.5084231825332411,-1.4414653380877265,0.06776556776556776,0.2562704987816044,1.0,10/18,36.31%,TOMM40;TIMM17B;DNAJC19;TOMM40L;TIMM50;TOMM20;TOMM70;DNLZ;TIMM23;PAM16
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.49699704995898497,-1.4413827532184003,0.0695970695970696,0.2559500148873504,1.0,4/21,4.26%,FOXP1;PRKCH;SLC39A10;PRKD2
prerank,positive regulation of MAPK cascade (GO:0043410),-0.31960332348514164,-1.4412653736961927,0.0034129692832764505,0.25568675353694886,1.0,63/245,16.73%,FLT1;TEK;DAB2IP;IGF1R;JCAD;RAPGEF2;FERMT2;ROR1;INSR;BMPER;MFHAS1;PDGFD;SEMA7A;IQGAP1;GCNT2;APP;ADRA1B;TBX1;CCL25;LRRK2;KDR;ICAM1;PRKD2;PTPRJ;MID1;EGFR;SLC30A10;GAS6;DSTYK;IL34;TGFB2;FGF1;RAP1A;ROCK1;NOTCH2;FLT4;ARL6IP5;PLCG2;EDN1;TAOK3;HTR2A;TPD52L1;PIK3R6;BRAF;EDN3;NOTCH1;FGF2;IRAK1;SEMA4C;CD40;ACKR3;KSR1;P2RY6;IAPP;MIF;ROCK2;ABCA7;TNFAIP8L3;MTURN;ANGPT1;PELI2;IGF1;GSDME
prerank,endochondral bone morphogenesis (GO:0060350),-0.6036485163466224,-1.4405945230546953,0.06583629893238434,0.256377870300288,1.0,6/11,19.97%,BMPR2;BMP4;MEF2C;FOXC1;TRPV4;COL13A1
prerank,atrial septum development (GO:0003283),-0.569539848438086,-1.4401013103489335,0.059782608695652176,0.2568477421979638,1.0,7/13,26.07%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;DAND5;GJA5
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4826602269083704,-1.4399895872194466,0.0749063670411985,0.25660286500747526,1.0,10/23,25.12%,DAB2IP;DVL3;MAP3K5;EDN1;TAOK3;SASH1;RPS3;ARHGEF5;MAP3K7;FZD10
prerank,positive regulation of signal transduction (GO:0009967),-0.31850915578496836,-1.4395431668907046,0.003246753246753247,0.2569454269849672,1.0,85/238,24.99%,TEK;VWF;DAB2IP;JCAD;SORBS1;SHANK3;CREBBP;RSPO3;NOS3;ZMIZ1;PKD2;LIMS2;ASXL1;LIMS1;MAML2;KLF2;KAT2B;TTC23;LRRK2;PRKD2;SMO;LOXL3;IL6ST;BMP6;JAG2;GAS6;PIK3R1;IRS1;DSTYK;FAS;TGFB2;MACF1;FGF1;ERN1;AAK1;MAML1;TSPAN14;GRB10;YAP1;CTBP2;FLNA;CRADD;NOTCH4;TPD52L1;ILK;JAK2;TSPAN5;NOTCH1;CDC73;P2RY6;JAG1;TNFAIP3;AGPAT1;FGFBP3;CCN3;TRIM16;SMOC2;IGF1;SKI;ARNT;SASH1;RPS3;CITED2;NOD2;PTPRC;KIF7;GKAP1;PTEN;F3;ITGB3;IGF2;DLL4;TERT;PTPN11;TUBD1;PTK2B;ESM1;TRIM39;RSPO2;PTGIS;NEPRO;SMARCB1;GPS2;IL7;BMP2
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4709288583194584,-1.4382547869522782,0.04900181488203267,0.258786325599897,1.0,12/26,24.04%,SETD2;KMT5B;TET2;SETD5;SUV39H1;SETD3;PRDM9;ANTKMT;WDR82;OGT;TET3;BEND3
prerank,Golgi organization (GO:0007030),-0.3505540294468581,-1.437818684808383,0.0136986301369863,0.2590867312754855,1.0,36/112,22.93%,ATP8B1;VTI1A;CSNK1A1;COG1;DYM;LRRK2;SYNE1;RAB1A;GOLPH3L;RAB2A;ATL2;SEC16B;MYO18A;USP6NL;PRKD1;YWHAZ;CUL7;FBXW8;GAK;BCAS3;ARFGEF1;FAM174B;CSNK1D;TRAPPC12;VCPIP1;PI4K2B;TBC1D20;LMAN2;TMED5;GOLPH3;TJAP1;GORASP2;HUWE1;HACE1;SEC22B;BET1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.4537097728781569,1.4375128545891755,0.07531380753138076,0.3992001485931297,1.0,10/30,8.21%,FGF12;SCN1B;KCNA5;SCN1A;CACNA2D1;PKP2;GPD1L;CACNA1D;RYR2;SCN5A
prerank,positive regulation of cell death (GO:0010942),-0.39196229418795525,-1.4374407653244659,0.03007518796992481,0.25917852874007546,1.0,13/59,10.55%,SLC6A6;ACER2;GSK3B;LRRK2;MAP3K5;CDKN1B;RARG;DDIT4;BMP4;BNIP3;CELF1;PICALM;AXIN2
prerank,cellular response to hexose stimulus (GO:0071331),-0.48274271879945063,-1.4371014571296907,0.05688073394495413,0.25933444059049854,1.0,6/23,10.64%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,neurotransmitter uptake (GO:0001504),0.5673867103100213,1.437059990465625,0.06619385342789598,0.39773154870726624,1.0,4/12,13.80%,ATP1A2;SNAP25;SLC29A4;SLC1A3
prerank,organelle organization (GO:0006996),-0.3030037656884004,-1.4368009977565603,0.0,0.25941397348995077,1.0,99/388,18.41%,SEMA6A;ATP8B1;FGD5;SEC31A;NOS3;FGD6;CSNK1A1;CAV1;PKD2;ALAS1;PEX1;PDZD8;RAB3GAP1;COG1;DYM;EPS15;TMCC1;RANBP9;MARK1;ARHGAP10;FNBP1L;RAB7A;MICAL2;LRRK2;ARAP3;SYNE1;DIAPH1;RAB1A;GOLPH3L;RAB2A;LIMD1;ZMYM6;CNTNAP1;MAST4;MAST2;ATL2;TOR1B;SIRT5;SEC16B;ABCD3;WASL;PLCE1;MYO18A;USP6NL;SIPA1L3;PEX7;CEP78;PYROXD2;PRKD1;PLD2;DST;HAX1;VPS13C;CHMP4B;CHMP4A;CECR2;CUL7;TMEM135;FBXW8;AGTPBP1;GAK;BCAS3;ARFGEF1;MTX1;FAM174B;ZMYM4;GABPB1;TPM1;CSNK1D;MIEF2;CHMP2B;NEDD9;SIRT3;MCOLN1;AFG1L;TRAPPC12;HCFC1;RAB32;TNFAIP3;PI4K2B;VPS13D;TBC1D20;PEX14;BRWD3;FMNL2;CHMP5;CDC42BPB;LMAN2;FANCG;TMED5;ZFYVE16;VAPA;CAPZB;GOLPH3;PEX11A;NRF1;CFL1;TJAP1;WTIP
prerank,regulation of hippo signaling (GO:0035330),-0.5197625772838029,-1.4366394945683956,0.07508532423208192,0.2592271910152163,1.0,8/17,23.64%,MOB3B;WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5600943575958345,-1.4364819253028307,0.04317789291882556,0.2590296330208089,1.0,9/13,37.20%,NAMPT;NAXE;NUDT12;NAPRT;PARP16;PTGIS;PARP9;NAXD;NNMT
prerank,inorganic anion transmembrane transport (GO:0098661),0.3821933868471663,1.4363447710792778,0.0400890868596882,0.3969860305767061,1.0,13/63,9.51%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;SLC25A3;ANO4;SLC12A5;GABRA3;GABRA1
prerank,detection of calcium ion (GO:0005513),0.5399350700532254,1.4362733675277113,0.08991228070175439,0.39471668514362424,1.0,3/13,7.41%,SYT1;CALM2;RYR2
prerank,positive regulation of apoptotic process (GO:0043065),-0.31219964556823826,-1.4359411562322335,0.0,0.2596005888116308,1.0,96/293,25.05%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;ATM;MCF2L;SIK1;UTP11;MAP3K5;DDX3X;PLEKHG5;TNFSF10;RASGRF2;RARG;RBM5;RYBP;STK3;ABL1;FOXO3;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;TGFB2;RASSF2;BMP4;BNIP3;NGF;JUN;TGM2;ITSN1;ARHGEF2;ARL6IP5;LATS2;SOS2;CASP8;TP53;CRADD;TPD52L1;PSEN1;SLC27A4;ARHGEF11;ANO6;CTNNBL1;STPG1;MAPK8;ATF4;TRIO;ERCC3;IAPP;HIP1R;ABR;ARHGEF18;BCL2L11;SRPK2;PREX1;CTNNB1;APH1A;TFAP4;SOD1;RPS3;SIAH1;SOX4;RNPS1;BCL6;NF1;ARHGEF5;FOXL2;PNMA2;VAV2;ARHGEF1;CASP2;PHLDA3;GADD45A;SUDS3;TRIM39;ATF6;RIPK1;SFRP4;CYP1B1;PTGIS;CALHM2;HMGB1;FANK1;BMP2;APBB1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5454353973021083,1.435583905284451,0.08486238532110092,0.39383621894795073,1.0,6/13,12.16%,ANK3;CALM2;IRX3;SLC8A1;SRI;HRC
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.39871128301497283,1.4355538173528486,0.041758241758241756,0.39151878251702105,1.0,11/54,6.43%,KCNIP4;DPP10;KCNIP1;KCNMA1;DPP6;KCNJ3;AKAP6;KCNN2;GABBR2;CD63;CACNA1D
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4442403702899406,1.434860955286319,0.052980132450331126,0.39082832330090694,1.0,11/30,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4047207780949798,1.434802048479145,0.035634743875278395,0.3886069080381328,1.0,11/41,11.91%,SLC24A2;HTR2C;GRIN2B;RYR3;ATP2B4;CACNA2D1;GRIN2A;SLC8A2;RYR2;SLC8A3;SLC8A1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5414009965787199,-1.4339468988636845,0.05656934306569343,0.26269234101266437,1.0,8/16,16.74%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;IGF1;TRPC3
prerank,positive regulation of dendrite extension (GO:1903861),0.5179634797144661,1.4336106056121005,0.07075471698113207,0.38921304302989634,1.0,10/17,20.24%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A;SYT17;CPNE5
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.37238085824646133,-1.4330891432064583,0.03896103896103896,0.2637989141000834,1.0,32/78,26.35%,CSNK1A1;CAV1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;BCAP31;GABARAP;SMAD7;CSNK1D;SGTA;ZER1;ZYG11B;SUMO1;RAD23A;HERPUD1;MDM2;SH3RF2;KEAP1;NFE2L2;FZR1;CEBPA;RCHY1;TRIB3;HSPA1B;PLK3;ARIH2
prerank,outer dynein arm assembly (GO:0036158),0.518748005191386,1.4321884919745087,0.0967741935483871,0.3903190696379747,1.0,7/15,18.49%,CCDC63;ODAD2;DNAAF5;DNAAF1;ODAD1;LRRC49;ODAD3
prerank,zinc ion homeostasis (GO:0055069),-0.46359706094070013,-1.4320853226247987,0.06976744186046512,0.2651583816945072,1.0,14/28,25.53%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.43592102354615386,-1.4318584303341158,0.05008944543828265,0.2650972354006441,1.0,18/35,31.42%,ETS1;LYN;FOXO3;MED1;ABCB10;LDB1;ACVR2A;TAL1;ZFPM1;CDK6;ARNT;PRKDC;MAPK11;HSPA1B;ZFP36L1;SPI1;MAPK14;STAT3
prerank,endodermal cell differentiation (GO:0035987),-0.44770989001690814,-1.4315071636389523,0.055944055944055944,0.26520843429253305,1.0,10/31,13.41%,COL8A1;COL12A1;COL4A2;SETD2;MMP2;LAMA3;ITGB5;CDC73;RTF1;ITGA4
prerank,regulation of vasoconstriction (GO:0019229),-0.46891458344569337,-1.4313589173548087,0.0586145648312611,0.26504567891236536,1.0,8/27,11.79%,CAV1;BMPR2;ADRA1B;ACE;TRPM4;ECE1;ADM;AGTR1
prerank,negative regulation of macrophage activation (GO:0043031),0.5120451698264348,1.4311322873798924,0.08979591836734693,0.3904613243884845,1.0,7/16,19.13%,LRFN5;NR1D1;SYT11;GRN;LDLR;FCGR2B;CX3CL1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.44405786915634476,1.4307135225772758,0.04932735426008968,0.38917447233478436,1.0,13/29,16.34%,GRIK2;CLN3;SLC8A2;SYP;CAMK2B;NETO1;RAB3A;DLG4;SYNGR1;PPFIA3;APOE;NCDN;SHISA9
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5737843849651065,-1.4299575849209207,0.07785467128027682,0.2669123849449216,1.0,6/12,24.99%,HES1;EPHA4;NOTCH1;CLCF1;SERPINE2;BMP2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.35525344443627493,-1.429417245631651,0.021778584392014518,0.2674388151932253,1.0,38/100,24.54%,EIF3H;CSNK1A1;CBFA2T3;DAB2;TLK2;GSK3B;LRRK2;FHIT;RBX1;GNA12;RYBP;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;HFE;FOXF2;CSNK1D;ZER1;N4BP1;ZYG11B;SUMO1;GIPC1;RAD23A;USP7;HERPUD1;OGT;MDM2;SH3RF2;KEAP1;TRIM39;CEBPA;RCHY1;TRIB3;HSPA1B;TAF9
prerank,focal adhesion assembly (GO:0048041),-0.49002759174289917,-1.4283250344301492,0.06689536878216124,0.26884044550020836,1.0,6/21,12.35%,SORBS1;THSD1;BCR;FERMT2;PTPRK;ACTN1
prerank,regulation of MAP kinase activity (GO:0043405),-0.3629376553582003,-1.4280266393153973,0.024096385542168676,0.2688385648481053,1.0,25/92,14.15%,FLT1;DAB2IP;LYN;PDGFD;PTPN1;LRRK2;PTPRJ;CDK12;EGFR;PPEF2;IL34;PRKCD;FGF1;BMP4;EDN1;TPD52L1;PIK3R6;EDN3;STK38;FGF2;IRAK1;CD40;KSR1;SPRY4;PIK3CB
prerank,protein deacetylation (GO:0006476),-0.42506909100864276,-1.427574988161407,0.04701627486437613,0.2691885214274482,1.0,18/41,23.74%,MIER1;PRDM5;RCOR1;HDAC1;SIRT5;MIDEAS;FLNA;SIN3A;HDAC4;SIRT3;MIER2;HDAC6;HDAC10;MIER3;TBL1X;HDAC7;SUDS3;MORF4L1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5694170306161409,1.4273724162343113,0.10129310344827586,0.3947871342843694,1.0,5/10,19.33%,LAPTM4B;TSKU;GATA6;HSP90AB1;CD24
prerank,regulation of interleukin-1 production (GO:0032652),-0.5424996278832853,-1.427127569137812,0.0888468809073724,0.26951711683820906,1.0,6/15,26.84%,FOXP1;GAS6;CEACAM1;ANXA1;HMGB1;F2R
prerank,regulation of dendritic spine development (GO:0060998),0.4986671071920356,1.4265211122307804,0.07468879668049792,0.39455975487920975,1.0,9/19,14.63%,NLGN1;PPFIA2;SHANK1;CAMK2B;TANC2;PTPRS;CPEB3;GRIN3A;APOE
prerank,positive regulation of translation (GO:0045727),-0.3596364097260568,-1.425791850262923,0.02443280977312391,0.27140103905904533,1.0,37/94,26.86%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;PLD1;EIF3C;LARP1;UPF3B;SAMD4A;POLR2G;RPL26;ZCCHC4;EEF2;CDC123;EIF5A;EIF5AL1;LARP4B;RPS4X;AGO2;RPUSD4;MRPS27;RPL5;METTL5;MPV17L2;UQCC2;SOX4;PRKDC;RBM3;USP16;POLDIP3;KHDRBS1;DHX9;FXR1;HNRNPD;LARP6
prerank,cellular response to dsRNA (GO:0071359),-0.5476983714103226,-1.4248869775162096,0.10242085661080075,0.27261184151939755,1.0,9/15,28.25%,CAV1;IFIH1;FLOT1;PDE12;CGAS;MAVS;RALB;DHX9;RIOK3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5439929514853574,-1.424557515141602,0.09187279151943463,0.2727124359029536,1.0,6/14,14.92%,GAB1;KDR;FLT4;PIK3CD;VEGFC;FOXC1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.551956297821881,-1.4245031092208469,0.08141592920353982,0.2723595062645862,1.0,6/13,20.98%,AKAP13;RAC1;ROCK1;ROCK2;ALMS1;ASAP3
prerank,regulation of actin filament polymerization (GO:0030833),-0.37808340915800953,-1.4237776073430743,0.026168224299065422,0.27317868404306284,1.0,25/69,22.90%,KANK3;ESAM;BAIAP2L1;PRKCE;NCK1;SLIT2;PRKCD;SNX9;KANK4;HAX1;NCK2;FCHSD2;ARFGEF1;RASA1;ARHGAP28;LMOD1;CDC42EP3;NCKAP1;HIP1R;GBA2;DBNL;FCHSD1;CDC42EP1;PTK2B;MTPN
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4312587199695032,1.4234733430138793,0.05518763796909492,0.39922302330065984,1.0,13/33,16.23%,OMA1;MPV17L;PSMD10;PRELID1;FLCN;TRIAP1;MAPT;TMEM14A;GHITM;FZD9;CLU;ADCK1;SLC35F6
prerank,protein modification by small protein conjugation (GO:0032446),-0.3057926015095819,-1.4232509443954025,0.001658374792703151,0.27370280568975286,1.0,110/361,22.54%,FBXL7;WWP1;DCUN1D3;USP9X;BRAP;NEDD4L;CBLL1;SMURF2;IFIH1;UBE2K;ATG7;NUP42;CNOT4;RNF139;RNF111;FBXL17;DTX3L;ATG10;ZNRF3;SMURF1;CUL9;RAE1;FBXL3;TRPM4;RNF213;RANBP2;UBA2;RBX1;CBL;OTULIN;RNF43;LMO7;CUL3;NEDD4;RNF40;NUP98;CUL2;BIRC6;UHRF2;PDZRN3;ARRDC1;SPSB1;UBE2J2;DET1;UBE2D3;MIB1;UBA7;CUL7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;CDC16;NSMCE2;TSPAN17;NUP153;RAD18;CDC73;RTF1;ANAPC16;PIAS2;UFM1;ASB1;FBXW11;KLHL25;RNF168;MYLIP;DTX3;HIF3A;VCPIP1;UBE2M;UBE2V2;PEX14;TPR;UBE2L3;DCUN1D2;HERC2;TRIM13;MIB2;SUMO1;RFWD3;KCTD10;CDK5RAP3;NUP214;KLHL3;SDE2;EPAS1;UBR1;RNF152;USP7;PRKDC;PIAS4;TRIM47;WWP2;ELOC;HUWE1;BRCA1;DCUN1D5;TRIM28;UBE2R2;MDM2;CAND2;KEAP1;MOCS3;HACE1;NFE2L2;NUP188
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.5030468432740451,-1.4230337571770924,0.06578947368421052,0.2736218109604796,1.0,11/20,30.81%,ADAM9;NFKB1;PSEN2;ADAM10;PSEN1;APH1A;RELA;ADAM17;RHBDD1;MBTPS1;TGFB1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5671193508648799,-1.4217487521165184,0.08614232209737828,0.2754802280984349,1.0,6/12,15.43%,BMP5;SLIT2;PLCB1;WASL;AKT1;CCN3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.4519637708900302,-1.4213829685019757,0.056776556776556776,0.27558143278382863,1.0,10/30,15.97%,ACVRL1;BMPR2;TENT4B;STN1;XRN1;DACH1;TP53;CTC1;HNRNPA1;TERF2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3786257207049302,-1.421228697852782,0.028021015761821366,0.2753964888934292,1.0,23/73,23.39%,HIP1;SENP1;ACER2;NOD1;CASP12;TNFSF10;FAS;NGF;ATP2A3;CASP8;CFLAR;CRADD;JAK2;BBC3;DAP;HIP1R;CASP8AP2;PPARG;F3;CASP2;RIPK1;CASP1;EIF2AK3
prerank,aortic valve morphogenesis (GO:0003180),-0.44839214204076594,-1.421056512026069,0.04945054945054945,0.2752209603409069,1.0,14/30,17.95%,ELN;RB1;NOS3;TIE1;NFATC1;SLIT2;BMP4;ROCK1;NOTCH1;JAG1;ROCK2;SMAD6;HEY1;HEY2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4389810760192283,1.4207808029334779,0.07777777777777778,0.4031543454215847,1.0,11/29,17.17%,HSD17B12;ACSBG1;HACD1;ACLY;ACACA;ACSL3;ACSL6;TECR;SCD5;HACD2;SCD
prerank,regulation of organelle assembly (GO:1902115),-0.37611365534137475,-1.4203623885171062,0.039711191335740074,0.2760187961672013,1.0,27/73,22.99%,MTMR3;CENPJ;STX18;MSN;TBC1D1;TBC1D2B;IFT140;EZR;PLK2;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;TRAPPC12;ATG5;TBC1D20;ALMS1;TBC1D8;TBC1D17;RNF4;PDCD6IP;IFT20;TBC1D12;EVI5;SENP6
prerank,central nervous system myelination (GO:0022010),0.5820816291012819,1.419762829629632,0.0963302752293578,0.4031971272550263,1.0,6/11,16.50%,TENM4;MYRF;PLP1;ABCA2;CLU;B4GALT6
prerank,phospholipid dephosphorylation (GO:0046839),0.41739950529697245,1.4195398920582687,0.05747126436781609,0.40155194249873916,1.0,13/37,12.18%,PIP4P1;PLPPR4;PLPPR1;PLPP2;SGPP1;MTMR2;PLPP4;MTMR10;MTMR11;PLPPR5;MTMR7;OCRL;INPP5F
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.35720732652852955,-1.4191948548955327,0.03735144312393888,0.27755752449442606,1.0,27/98,14.96%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP1R13B;PRKCE;ITGA3;PTPN9;YWHAE;EGFR;MIEF1;PIK3R1;TCAF1;DLG1;STX3;YWHAZ;NMT1;CASP8;AKT1;TP53;MTCL1;MIEF2;CHP1;RHOG;MAPK8;STAC3;BBC3
prerank,apoptotic process (GO:0006915),-0.32291171027147486,-1.4190242953312227,0.010327022375215147,0.27735299642046385,1.0,73/203,25.63%,HIP1;ZBTB16;SEMA6A;FOXO1;DAPK1;PRKCE;YARS1;CASP12;APP;ELMO1;TBX1;MAGI3;MTOR;PLAGL1;KREMEN1;TGFBR2;NFKBIA;STK3;FAS;PDCD4;DDIT4;PRKCD;BNIP3;RFK;NOTCH2;BNIP2;RAF1;PPARD;IRF1;IER3;ERCC2;CASP8;CFLAR;AKT1;TNFAIP1;JAK2;PLSCR1;ERCC3;NCKAP1;BBC3;DAP;IAPP;FEM1B;TNFRSF19;BCL2L11;THOC1;PAEP;IKBKG;SIAH1;RNF152;BRAT1;PPP2CA;CDK11B;TNFRSF25;LIG4;OGT;MDM2;CHEK1;CASP2;PTK2B;GADD45A;BIK;RIPK1;CASP1;AKAP1;AHCYL1;MAP3K7;TNFSF12;PLK3;PIK3CA;FXR1;MAGEH1;DMPK
prerank,cellular response to fluid shear stress (GO:0071498),-0.5625042101328342,-1.41880249187932,0.08490566037735849,0.27729520535539987,1.0,7/12,23.34%,KLF4;PKD2;KLF2;MEF2C;MAPK7;NFE2L2;HAS2
prerank,chromatin organization (GO:0006325),-0.33737358728135103,-1.418044313708969,0.0210896309314587,0.27823637193831935,1.0,43/132,24.98%,MECOM;SMARCA2;BAZ2B;RB1;CHD1;ESR1;KAT2B;SETD2;PRDM16;HDAC1;SMARCC1;ZBTB7A;BAZ1A;SETD5;SUV39H1;KDM6A;SMARCE1;EHMT1;KDM6B;HMG20A;SMARCC2;HDAC4;HMGN3;MCM3AP;SMARCD3;HCFC1;TCF7L1;DR1;RUVBL2;KDM5B;HDAC10;HMGN2;SMARCAD1;ATRX;BAZ1B;PWWP3A;TOP1;NPM3;SUPT4H1;SETD7;SMARCB1;SETDB2;INO80
prerank,heterochromatin organization (GO:0070828),-0.5501340623695302,-1.4175099842687648,0.05989110707803993,0.27870512761227745,1.0,2/14,3.23%,MECOM;PRDM16
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5674554736182357,1.416824598449637,0.09172259507829977,0.4056633705145225,1.0,4/12,9.47%,DGKQ;H6PD;CLCN2;ABCA2
prerank,histone mRNA catabolic process (GO:0071044),-0.53657940709057,-1.4162291147660042,0.08378870673952642,0.2805558221315091,1.0,6/15,13.97%,TUT7;TENT4B;ATM;XRN1;TUT4;TENT2
prerank,neuron projection development (GO:0031175),0.3219834544571207,1.4158989639117454,0.004454342984409799,0.4056189465477346,1.0,36/168,9.80%,CNTNAP2;NLGN1;L1CAM;RASGRF1;PPP1R9A;CNTN4;BLK;CTNND2;SH3GL2;TMEM108;GPM6B;DOCK10;EPB41L3;SHTN1;CDK5;EPHB1;SHANK1;PLP1;NBL1;TNIK;ATXN10;PAK3;MAP2;MAP1S;NPY;GPM6A;PAK1;NYAP2;MAPT;POU4F1;NEFH;TSKU;GRM7;MINK1;ZFYVE27;STMN2
prerank,regulation of gene expression (GO:0010468),-0.28137499155211837,-1.4152926992895243,0.0,0.2818438619808382,1.0,241/903,21.32%,FOXP1;LEF1;MBNL1;APBB2;NFIA;RREB1;SMARCA2;MBNL2;CLDN5;ZNF423;ENG;ACVRL1;AFF1;CREBBP;NSD1;RB1;BNC2;UBR5;NOS3;KAT6B;ERC1;INSR;KLF4;ETS1;CD34;ESR1;LYN;FOXN3;ZFHX3;TNRC6B;PRDM5;SLC7A5;LIMS1;MED26;GSK3B;IRF2;ZNF326;GCNT2;APP;ATM;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;DDX3X;SOX13;AHNAK;KDR;MTOR;TIPARP;SOX17;SMO;HMG20B;PSPC1;TFRC;MSN;SP1;ZNF148;VSX1;METTL4;CTCF;LIMD1;BMP6;HDAC1;LARP1;NFKB1;SIX1;AFDN;RYBP;GAS6;ABL1;PDE2A;NOVA2;DNM2;TRRAP;TGFB2;NSD3;FUS;MED1;AHNAK2;SEC16B;NFYC;PARP14;FGF1;GTF2IRD1;BMP4;MEF2C;PUM1;EZR;SLC39A8;CDH5;NGF;ZBTB4;SMAD1;ASCC1;ACTA2;ZC3H7B;MAPK1;ROCK1;KDM6A;PPM1F;RAB27A;NOTCH2;NOS1AP;HNRNPAB;NAB1;YAP1;LDB1;PRDM2;CDH1;PLCG2;CELF1;GSK3A;PICALM;OCLN;WNT16;GPBP1;SPTY2D1;CASP8;SP3;PIK3CD;USP13;ADAM10;FGF7;RAMP2;AKT1;MYOM1;TP53;KDM6B;PRKAA1;POGZ;HMG20A;DICER1;RGCC;SNX12;PRRX2;PSEN1;SOX7;BRAF;TRIM14;JMJD1C;MAZ;PRDM6;HNRNPF;EDN3;CHD3;HFE;YAF2;NOTCH1;SON;FGF2;HDAC4;SFPQ;OGG1;CLK3;WNT11;ZPR1;TAF5L;CDK6;PLSCR1;MAPK8;MECP2;ATF4;MARF1;MZF1;PIK3CB;AGO2;GPBP1L1;RBM20;ICOSLG;RC3H1;FAM98A;NR1D2;HCFC1;GPX1;TCF3;TCF7L1;FOXC1;MYBL2;MIF;ROCK2;TADA3;ZNF462;PRDM9;NAB2;LGMN;RPL5;UBE2L3;VSIR;FOXO4;TERF2;CREBL2;ANGPT1;PIK3R3;BMP7;HIC1;IGF1;MOV10;SRPK2;DNMT1;CTSH;HDAC6;HINT1;HDAC10;PATZ1;FUBP1;HEY1;HEY2;CARM1;RPS3;WTIP;ZNF507;CITED2;GATA2;SOX4;TNRC6A;PPP2CA;PRKAB1;PTPRC;CAVIN4;UTP4;ATRX;NONO;KRAS;CDK11B;WWP2;PRDM1;BCL6;F3;FGFR4;BRCA1;PTBP3;ZSCAN26;TOB1;IGF2;DLL4;SRSF10;TERT;TRA2B;NKAP
prerank,regulation of fibroblast migration (GO:0010762),-0.4989461244279473,-1.4152451165134134,0.09157509157509157,0.28145260837622366,1.0,9/20,14.73%,ITGB1;RAC1;PRKCE;CORO1C;THBS1;GNA12;PTK2;FGF2;HAS1
prerank,entry into host (GO:0044409),-0.5534620510890345,-1.4142925816128606,0.08303249097472924,0.28275418982790423,1.0,6/13,17.12%,CBLL1;CBL;CTNND1;CDH1;GRB2;CTNNB1
prerank,rRNA metabolic process (GO:0016072),-0.32793039444450206,-1.413453580736898,0.005376344086021506,0.28377352158091745,1.0,69/160,30.40%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;DDX10;XRN1;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;BOP1;RPL37A;PES1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;UTP20;RPL18;RPL19;FCF1
prerank,positive regulation of catalytic activity (GO:0043085),-0.4302603895050501,-1.4134357623963016,0.05851063829787234,0.28332508643885923,1.0,17/37,25.66%,CAV1;ABL1;PSEN2;PHACTR4;XRCC4;PSEN1;BCAS3;MAPK8;NHEJ1;APH1A;SOD1;WRN;NOD2;FGFR4;IGF2;MSH3;SLC5A3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.443063998422973,-1.413406767782846,0.06486486486486487,0.2828888943939245,1.0,16/31,36.31%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;TOMM70;AIFM1;PEX26;DNLZ;TIMM23;PAM16
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3796506494612376,-1.4132124468464435,0.0364963503649635,0.2828549161034807,1.0,21/67,19.31%,ATP8B1;MYO10;PODXL;CAV1;RAC1;PLD1;TBC1D1;TBC1D2B;IFT140;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;TBC1D20;CAPZB;TBC1D8;EPHA2;TBC1D17
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3272235629945102,-1.413049057038527,0.008695652173913044,0.2826734305156551,1.0,68/158,32.09%,PELI1;AKAP13;ROR1;TAB3;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;NEK6;TNFSF10;BIRC3;TFRC;PLK2;PRKD1;ALPK1;CASP8;CFLAR;MAP3K3;FLNA;IKBKE;TRIM14;RHOA;IRAK1;MTDH;RHOC;CD40;TNFRSF19;TNFRSF1A;PELI2;TAB2;TFG;TRIM13;MIB2;VAPA;MAVS;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;IKBKB;NOD2;TMEM9B;LTBR;NDFIP2;RELA;RIPK1;CASP1;TRIM68;MAP3K7;BRD4;F2R;SLC20A1;LGALS9;TRIM6;TIFA;HMOX1;BST2;RNF31;EEF1D;TRIM32;TICAM1;TRIM62;TLR6;TNIP2;LPAR1
prerank,adherens junction organization (GO:0034332),0.4001738410836291,1.412749486776234,0.046296296296296294,0.4107844522543269,1.0,16/48,10.12%,CDH18;CADM2;CDH8;CDH20;CDH9;CDH10;INAVA;DCHS1;CDH19;CDH12;ANG;NECTIN3;CDH7;CDH17;CDH24;CDHR3
prerank,response to interferon-alpha (GO:0035455),-0.5235678712389221,-1.41169036401066,0.0705244122965642,0.28460918596584994,1.0,9/16,29.08%,IFNAR1;GAS6;IFITM3;PDE12;TPR;IFNAR2;IFITM2;BST2;AXL
prerank,regulation of microtubule depolymerization (GO:0031114),0.4549629648243172,1.4115335997743306,0.06794055201698514,0.4113294840998846,1.0,9/25,17.71%,NAV3;APC2;MAP1S;STMN2;MAP1B;HDGFL3;CLASP2;CAMSAP3;MAP1A
prerank,regulation of protein kinase activity (GO:0045859),-0.34853173621580485,-1.4115162180754544,0.026881720430107527,0.28445949033691503,1.0,36/106,22.42%,RAPGEF2;RB1;IQGAP1;CEP85;PAK2;RTRAF;GAS6;MRNIP;LRP6;PTK2;RASSF2;RAP1A;SNX9;PLCE1;PPM1F;MMD;PRKRIP1;AKT1;CEACAM1;CHP1;TAF7;TAB2;UBASH3B;ALS2;CACUL1;SOD1;CCL19;CENPE;PTPRC;RAP2C;AKT1S1;NF1;WARS1;MAP2K3;PTK2B;CCN1
prerank,ribosome biogenesis (GO:0042254),-0.32127289829292127,-1.41073224008925,0.0017857142857142857,0.28547044929337434,1.0,80/187,31.11%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;PAK1IP1;RPF1;DDX10;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;NIP7;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;LSG1;RPL27A;WDR74;RPL36A;MDN1;RPL35A;DDX31;UTP4;EXOSC5;BOP1;RPL37A;PES1;ABCE1;RRS1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;NOP16;RPS17;NOL8;GLUL;EXOSC7;WDR46;RPS2;RPL39;NAF1;RAN;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;UTP20;RPL18;RPL19;FCF1;DHX29;RPL8
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.448174911338991,1.409946681929075,0.08078602620087336,0.4129747065178654,1.0,13/28,19.92%,MAP2;MAP1S;MAPT;STMN2;MAP1B;MAPRE3;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP1A;STMN3
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.4677087396525855,-1.4099219638365519,0.06338028169014084,0.2864992901513364,1.0,8/24,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;GDI1;NUMB
prerank,pore complex assembly (GO:0046931),-0.5043123743730712,-1.4097841421487192,0.07366482504604052,0.2862665744878024,1.0,7/19,15.78%,AFDN;AHCTF1;NUP98;ADAM10;ANO6;NUP153;TPR
prerank,cellular senescence (GO:0090398),-0.46045974139388535,-1.4096539928593017,0.07677902621722846,0.2860494587785828,1.0,18/27,41.97%,KAT6A;SMC5;PRKCD;TBX2;NSMCE2;TERF2;ECRG4;TBX3;CDKN2B;SPI1;MAPK14;MAPKAPK5;HMGA1;CDKN1A;MAP2K1;SIRT1;SMC6;PML
prerank,muscle organ development (GO:0007517),-0.3921800343458779,-1.4095597798542772,0.037037037037037035,0.2857569374635357,1.0,20/54,25.68%,UTRN;MEF2A;TCF12;TEAD4;CHD2;TBX1;MKX;EMD;MEF2C;COL6A3;MAPK12;IGF1;LARGE1;SMTN;ITGA7;FHL1;EGR3;FXR1;POU6F1;ITGA11
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.45037281369043813,-1.409279260398523,0.07216494845360824,0.285788383437384,1.0,13/28,24.75%,TAB3;NOD1;OTULIN;IRGM;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2;RELA;MAP3K7
prerank,cell differentiation in spinal cord (GO:0021515),0.5777195577706237,1.4085373821668448,0.11182795698924732,0.4139774530055274,1.0,3/10,5.07%,MDGA2;LHX1;MDGA1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5676704592898353,-1.4082290452384345,0.07184466019417475,0.28744047987551613,1.0,2/12,1.54%,FOXP1;KLF4
prerank,sensory perception of taste (GO:0050909),0.5727942701068552,1.4081644968219174,0.10046728971962617,0.4126009695626112,1.0,3/10,14.59%,ASIC2;GNAT3;ASIC1
prerank,regulation of ossification (GO:0030278),-0.4277386021738151,-1.407466920310474,0.06129597197898424,0.2883738220451833,1.0,12/36,17.52%,ZBTB16;BMPR2;SGMS2;LRP6;TGFB2;BMP4;MEF2C;S1PR1;NOTCH1;NOTUM;SMAD6;ANKH
prerank,cellular protein catabolic process (GO:0044257),-0.3805168345619232,-1.4074036706782942,0.03350970017636684,0.288016379058884,1.0,22/59,24.08%,DAB2IP;CTSC;RAB7A;AP2B1;AP2A2;AP2S1;BNIP3;DENND3;CASP8;CAPN2;AFG1L;MYLIP;MAGEC2;CTSZ;LGMN;CTSH;AP2M1;MDM2;CTSF;CTSO;RIPK1;ADAMTS7
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3028260978988444,-1.4073853066325166,0.0,0.28757202889980754,1.0,135/336,29.65%,FOXP1;SUSD6;MNAT1;FOXO1;XIAP;UBR5;MCL1;LYN;ACER2;PDS5B;TLK2;ATM;DTX3L;RNF169;PARP4;SMC5;NIPBL;KMT5B;TNFRSF1B;MRNIP;ABL1;SAMHD1;TRRAP;AATF;SPIDR;MAPKAPK2;ZBTB4;MRE11;STXBP4;SUV39H1;INIP;NABP1;MCM9;YAP1;TRIP12;RBBP8;UBA7;TP53;ZBTB40;WDR76;TAOK3;DOT1L;NSMCE3;FNIP2;PSEN1;IKBKE;ENDOV;PDS5A;RAD18;INTS3;OGG1;UBE2E2;RPA1;ASH2L;BABAM2;PNKP;XPC;RNF168;SLF2;ERCC3;GRB2;VCPIP1;CGAS;BTG2;ERCC8;MAPK12;USP10;BCL2L11;HIC1;HERC2;SUMO1;POLE2;RFWD3;FANCC;FANCG;HPF1;WRN;RPS3;IKBKG;AKTIP;NCOA6;CCND1;BRAT1;EPHA2;PRKDC;RAD54L;TIMELESS;BCL6;NSMCE4A;FANCL;BRCA1;DCUN1D5;CBX1;BAZ1B;TRIM28;CHRNA4;BLM;RFC4;CHEK1;CASP2;PWWP3A;GADD45A;YY1;USP16;RBM24;RBBP5;SETD7;MSH3;CCNK;TAF9;LIG1;INO80;IRF7;APBB1;PLK3;DTL;MCM7;NUPR2;APC;MMS19;GTF2H3;MCM10;EXO1;ZBTB38;ALKBH7;GNL1;XRCC2;APLF;UBA1;HINFP;RAD51AP1;BOD1L1;FBXO31;TDP1;CHD1L
prerank,regulation of striated muscle contraction (GO:0006942),0.4498142616172815,1.4061810105336348,0.05627705627705628,0.4148517612045731,1.0,7/27,12.61%,ATP1A2;CALM2;RNF207;RYR2;SLC8A3;SRI;MYL2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4425366747702292,-1.4059711032048023,0.05514705882352941,0.2896479432328645,1.0,16/32,25.94%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TAOK3;BABAM2;CDK5RAP3;BRCC3;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.452399023030689,-1.4056046256311385,0.08208955223880597,0.2898420185424268,1.0,15/25,33.46%,CDK13;CDK12;EAF1;LDB1;CDC73;RNF168;ZMYND11;NELFB;SUPT4H1;BRD4;LEO1;HNRNPU;LARP7;NELFA;NELFCD
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5551368605288544,-1.4051186691130013,0.0780399274047187,0.2903130184536494,1.0,11/13,35.75%,IFIH1;GAS6;AGPAT1;MAVS;TAF9;IL7;DHX9;TRIM44;AXL;TSLP;CD74
prerank,positive regulation of protein acetylation (GO:1901985),-0.5673221371894268,-1.4036307169599231,0.09074410163339383,0.2925847121355202,1.0,8/12,30.00%,DDX3X;DIP2B;PRKAA1;KAT5;RAPGEF3;DIP2A;CEP295;FAM161A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.3960708294058864,-1.4033512744760814,0.04601769911504425,0.29215915426844963,1.0,19/50,26.60%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;TNRC6A;NUP188;POLR2C;POLR2L;POLR2H;NUP88
prerank,regulation of gene silencing by RNA (GO:0060966),-0.3960708294058864,-1.4033512744760814,0.04601769911504425,0.29215915426844963,1.0,19/50,26.60%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;TNRC6A;NUP188;POLR2C;POLR2L;POLR2H;NUP88
prerank,regulation of mRNA stability (GO:0043488),-0.3339995291228559,-1.4028420186003483,0.025906735751295335,0.2925839295502111,1.0,56/145,28.54%,PSMA2;METTL14;GIGYF2;LARP1;FUS;PRKCD;FTO;XRN1;SAMD4A;PUM1;PSME2;MAPKAPK2;ROCK1;YWHAZ;EXOSC2;PSMB4;EXOSC1;CELF1;AKT1;AXIN2;EXOSC3;SERBP1;PARN;PDE12;PSMC2;RC3H1;ROCK2;ZC3H14;PSMB2;PSMB1;EXOSC8;PSMA8;NUP214;TNFSF13;PSME1;EXOSC5;DCP1A;PSMD4;PSMA7;METTL16;RBM24;PSMD5;THRAP3;TAF15;CARHSP1;EXOSC7;FXR1;IGF2BP2;ZFP36L1;PSMB10;HNRNPD;PSMA3;PABPC1;HNRNPU;TENT5C;SET
prerank,nucleotide catabolic process (GO:0009166),-0.518978811770965,-1.4023748617310348,0.08365019011406843,0.2929700661040022,1.0,13/16,42.82%,NT5C2;NT5E;SAMHD1;NT5C1A;GPX1;GDA;NT5C;PNP;DERA;VCP;NUDT15;NUDT3;XDH
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4727156650982967,-1.402284086614319,0.08392857142857142,0.29269776514821405,1.0,11/23,22.61%,UACA;TMSB4X;DDX3X;NMI;PPM1B;IFI35;CCN3;C1QTNF3;BMP7;HDAC7;RELA
prerank,negative regulation of calcium ion transport (GO:0051926),0.5145601981111854,1.4022487050689953,0.07032967032967033,0.42223251176194226,1.0,4/15,9.31%,ATP1A2;STC1;TRIM27;ADRA2A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5643990680866402,-1.4021274811502629,0.09124087591240876,0.292517129662807,1.0,7/11,36.16%,CBFB;VSIR;HMGB1;LGALS9;RUNX1;TWSG1;CD274
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.45339138104999793,1.4019881617897965,0.07816091954022988,0.4206326311837763,1.0,5/25,3.46%,GRID2;MPP2;GRIN2B;GLRA1;GRIN2A
prerank,negative regulation of organelle assembly (GO:1902116),-0.42960935252676974,-1.4016630731894375,0.05226480836236934,0.2929262220498834,1.0,10/35,10.04%,KAT2B;LIMK2;LRRK2;CDK10;TBC1D30;YAP1;SCFD1;SMAD4;CHMP4B;CHMP4A
prerank,positive regulation of vacuole organization (GO:0044090),-0.5894399219214452,-1.4014562366543002,0.0913884007029877,0.29285685838974695,1.0,5/10,11.00%,RAB3GAP1;ANXA2;PIP4K2A;PIP4K2B;RAB3GAP2
prerank,copper ion transport (GO:0006825),-0.5811579184249841,-1.4012200519697244,0.0686456400742115,0.2928616373045746,1.0,8/11,34.80%,ATOX1;SLC31A1;STEAP3;COX17;STEAP2;ATP7B;STEAP4;CUTC
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5557145003726272,-1.4007286026177481,0.08426966292134831,0.2932620526780699,1.0,4/13,14.45%,KPNA4;RANBP2;KPNA3;KPNA1
prerank,positive regulation of receptor internalization (GO:0002092),0.4595660089184292,1.4004942221544618,0.08277404921700224,0.42184472707190346,1.0,5/22,9.25%,MAGI2;CD63;ATAD1;AHI1;VEGFA
prerank,axon guidance (GO:0007411),0.30779887160371755,1.3985993915184844,0.011764705882352941,0.42404416010157103,1.0,42/201,10.15%,NRXN3;NRXN1;ROBO2;UNC5D;L1CAM;DAB1;DCC;NCAM1;CNTN6;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;LHX1;VLDLR;EPHB1;TNR;DOK5;UNC5C;GFRA1;SEMA6D;EPHA5;EFNA3;EFNB3;SEMA3B;DOK6;GPC1;MYPN;SHC3;VSTM2L;EMB;CNTN2;SHC1;VEGFA;SPTBN2;SPTBN4;SLIT3;SLIT1;KIF5A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5370681207476269,1.398268607778165,0.08297872340425531,0.422661630466162,1.0,4/13,17.93%,SYT1;SYT4;CACNA1G;CACNA1I
prerank,cardiac ventricle development (GO:0003231),-0.4877038745699838,-1.3981821017212526,0.07747747747747748,0.2975376682260918,1.0,11/20,26.96%,ENG;HES1;PDE2A;HECTD1;NOTCH1;HEY1;HEY2;DAND5;DLL4;GJA5;STRA6
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4235311196823444,-1.3981578198216547,0.06319702602230483,0.2971098875737342,1.0,10/35,21.17%,FLT1;PTPRM;CAV1;THBS1;MEF2C;RGCC;PPARG;NF1;NR2F2;DLL4
prerank,response to nutrient levels (GO:0031667),-0.5088055934539928,-1.3981527823454352,0.0740072202166065,0.2966385920924368,1.0,5/17,14.04%,MTOR;FAM107A;PRKAA1;RPTOR;ATF4
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3798096523290454,-1.3979748602204722,0.04553415061295972,0.29650692946622614,1.0,31/61,27.26%,USP9X;EYA4;UIMC1;PRKD2;EGFR;MRE11;PPP1R10;RGCC;OTUD4;FGF2;BABAM2;HGF;MECP2;RNF168;ERCC8;SMOC2;CEBPG;BRCC3;WRN;RPS3;USP7;ATRX;FGFR4;BRCA1;TRIM28;PDGFRB;HMGB1;DHX9;ERCC6;FGF10;STPG4
prerank,filopodium assembly (GO:0046847),-0.5076372774306772,-1.3978232166510671,0.11072056239015818,0.29631467696570724,1.0,4/16,7.39%,FGD5;FGD6;DNM3;EZR
prerank,protein kinase A signaling (GO:0010737),-0.5638444013016923,-1.3966801012116705,0.07439446366782007,0.29788747464987947,1.0,4/12,12.71%,PRKACB;EZR;MYOM1;LCP1
prerank,negative regulation of developmental process (GO:0051093),-0.3714924254064792,-1.3963780586640715,0.0392156862745098,0.2979166301092612,1.0,23/69,17.95%,KLF7;NFIB;NOS3;TBX1;TFRC;GAS6;ARHGEF15;SUZ12;BMP4;BNIP3;ROCK1;TBX2;NOTCH4;NOTCH1;WNT11;CDK6;RC3H1;FOXC1;MIF;ROCK2;FUZ;HEY1;HEY2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5369575568523035,1.3959432959509301,0.1053864168618267,0.4259970251963912,1.0,4/12,8.12%,TMEM9;CLN3;GRN;CCDC115
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.46032736828753984,-1.3958282655283756,0.07992895204262877,0.29847597514010754,1.0,11/27,24.75%,MAP3K20;MAP3K5;NFKB1;MAPK1;FBXW11;MAP3K8;MAPK8;IKBKG;IKBKB;MAPK11;MAP3K7
prerank,Golgi localization (GO:0051645),-0.5835619895179034,-1.3956113711259324,0.07871198568872988,0.2984737939915164,1.0,5/11,16.94%,ARCN1;COPG1;YWHAZ;TBCCD1;RIPOR1
prerank,defense response to tumor cell (GO:0002357),-0.5974398667922663,-1.3951690487083501,0.08608058608058608,0.2988872397003258,1.0,3/10,11.85%,KLF4;DAPK1;ABI3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4933903055577705,-1.3949063286461585,0.0776173285198556,0.29885621434225074,1.0,3/19,0.62%,DAB2IP;JCAD;SEMA6A
prerank,mRNA destabilization (GO:0061157),-0.41683406510218945,-1.394497526018357,0.06445993031358885,0.2991088671860706,1.0,17/38,27.03%,TUT7;METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;TUT4;PDE12;RC3H1;ROCK2;MOV10;DIS3L2;METTL16;RBM24;ZFP36L1;CNOT1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4494591864785735,-1.3936991030519639,0.08170515097690942,0.30005550637523853,1.0,8/28,11.47%,RAC1;ADIPOR2;MITF;TNFRSF1B;MED1;SIRT5;NOS1AP;JAK2
prerank,striated muscle tissue development (GO:0014706),-0.4535618957109273,-1.3934342104394741,0.0641025641025641,0.3000869467366695,1.0,10/29,9.75%,PGM5;CAV1;BMPR2;SVIL;BMP5;SIX1;RBP4;MEF2C;TBX2;CFLAR
prerank,regulation of dendrite morphogenesis (GO:0048814),0.42895568156784863,1.3932820837553417,0.06382978723404255,0.4301267733477498,1.0,7/32,6.03%,PTPRD;IL1RAPL1;ADGRB3;HECW1;CDKL5;TNIK;HECW2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.41788936595653614,1.3927914130959869,0.06651884700665188,0.4291045178341153,1.0,17/37,19.92%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT;STMN2;MAPRE3;TPPP;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP6;MAP6D1;STMN3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.520191026461086,-1.3926105338410106,0.08581436077057793,0.3011391737838455,1.0,8/16,21.22%,GCH1;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;TERT
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.4664605238030749,-1.3922447955874264,0.08170515097690942,0.30131071754567135,1.0,9/24,18.97%,TAB3;NOD1;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2
prerank,chromatin remodeling (GO:0006338),-0.3471134969638308,-1.3922088596441387,0.01763668430335097,0.3009070287857712,1.0,35/100,26.74%,SMARCA2;BAZ2B;RB1;ESR1;KAT2B;ARID1B;HDAC1;SMARCC1;ZBTB7A;BAZ1A;SRCAP;KDM6A;SMARCE1;CECR2;KDM6B;SMARCC2;CHD3;HDAC4;ACTB;SMARCD3;HCFC1;DR1;RUVBL2;KDM5B;INO80B;SMARCAD1;ATRX;BAZ1B;TOP1;NPM3;SMARCB1;INO80;ERCC6;HDAC5;RSF1
prerank,protein sumoylation (GO:0016925),-0.3945702452693536,-1.3917295006203931,0.04753199268738574,0.3013294356703124,1.0,18/49,26.60%,IFIH1;NUP42;RAE1;TRPM4;RANBP2;UBA2;NUP98;NSMCE2;NUP153;PIAS2;TPR;SUMO1;NUP214;PIAS4;TRIM28;NUP188;SAE1;NUP88
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4586896432853347,-1.3916965202868141,0.08602150537634409,0.3009090740655793,1.0,12/25,28.04%,ZNF326;SETD5;EAF1;LDB1;DDX39B;THOC1;ZMYND11;TCEA2;SUPT4H1;CCNK;ERCC6;HTATSF1
prerank,RNA 3'-end processing (GO:0031123),-0.37011656563553236,-1.3914440443734308,0.03728813559322034,0.3009051265612102,1.0,21/69,20.24%,SRSF11;TUT7;TENT4B;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;TENT4A;CPSF7;DHX38;TUT4;SLU7;TENT2;THOC3;THOC1;FIP1L1;SRRM1;RNPS1;SRSF3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3689188275504866,-1.3909492073618717,0.035842293906810034,0.30134539618352046,1.0,30/72,27.03%,SP100;ACER2;ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;KAT5;NDRG1;BTG2;USP10;TFAP4;CARM1;SOX4;ATRX;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,vasculature development (GO:0001944),-0.5151714544548647,-1.390768561977522,0.07894736842105263,0.3012219847350574,1.0,11/16,29.92%,ACVRL1;BMPR2;CDH5;FLT4;NOTCH4;PDGFRB;ACVR2B;FOXF1;PIK3CA;STRA6;APLNR
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.34952694825021463,-1.3906608321409355,0.025041736227045076,0.30095464164868835,1.0,27/101,13.55%,FLT1;DAB2IP;RAPGEF2;FERMT2;PKD2;PDGFD;LRRK2;DDX3X;EGFR;IL34;CCND3;IRGM;FGF1;AKT1;EDN1;TPD52L1;CCNY;PIK3R6;RGCC;EDN3;RPTOR;RHOA;FGF2;IRAK1;MTCP1;TCIM;CD40
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.45409234355960687,1.3904916795133968,0.08333333333333333,0.4323823474249627,1.0,15/23,24.35%,CCDC88A;TUBA1C;KIF5A;DYNC1I1;KIF1C;HOOK1;TUBB;MAP6;MAP6D1;HOOK3;DYNC1I2;CCDC88C;F8A1;KIF5C;KIF1B
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5415207910887325,-1.390281983139543,0.09773123909249563,0.30119343136700255,1.0,3/13,5.48%,NOS3;TMSB4X;PPARA
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.527106818260542,1.3902773335343126,0.09772727272727273,0.4306527265970469,1.0,8/13,16.34%,GRIK2;CLN3;SLC8A2;SYP;RAB3A;SYNGR1;PPFIA3;SHISA9
prerank,COPII-coated vesicle budding (GO:0090114),-0.37772675684165197,-1.3897329357312789,0.03776978417266187,0.30168177420356757,1.0,26/68,22.93%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;SEC23B;CTSZ;TBC1D20;F5;TFG;VAPA;PREB;SEC24C;SEC22B;SAR1A;BET1
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.5597594765929876,-1.3895202879117656,0.1099476439790576,0.30160583159604387,1.0,7/12,24.95%,CAV1;IFIH1;FLOT1;CGAS;MAVS;RALB;DHX9
prerank,modulation by host of symbiont process (GO:0051851),-0.4301262965673726,-1.3886195520606681,0.07636363636363637,0.30292114761607897,1.0,7/31,9.48%,LEF1;CHD1;SP1;HDAC1;NAPEPLD;JUN;TAF11
prerank,blood circulation (GO:0008015),-0.40254452461667356,-1.3876687950529403,0.05555555555555555,0.30419514418413296,1.0,21/49,21.72%,ELN;ACVRL1;MYOF;NOS3;ACE;MEOX2;ROCK1;SCPEP1;EDN3;AGTR1;GPX1;ROCK2;F5;NPR1;GUCY1A1;SOD1;PLN;TBC1D8;CXCL12;DLL4;GCLC
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3567965937621952,-1.387553601624587,0.05338078291814947,0.30393549146408716,1.0,27/80,16.85%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;PLD1;SP1;EIF3C;UPF3B;PRKCD;SAMD4A;EPHA4;GSK3A;PICALM;RPL26;ZCCHC4;SLC2A13;EEF2;SIRT3;LARP4B;RPS4X;ROCK2;RPL5;TNFRSF1A;METTL5;SMPD2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5254482699847972,-1.3875160765413483,0.10052910052910052,0.303545604405671,1.0,9/15,30.24%,EHD2;ADAM9;EHD1;FLOT1;CD53;RAPGEF3;ADGRB1;TREM2;MAPK14
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.44910291201563124,-1.3873197558574464,0.09549549549549549,0.30346153096383055,1.0,9/28,14.96%,DAB2IP;ITPR1;MAP3K5;ERN1;ATP2A3;ERO1A;ATF4;DNAJC10;BBC3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5233897515711514,-1.3871571312389104,0.09056603773584905,0.30328802828091483,1.0,5/15,15.35%,DAB2;WASL;AAK1;PIK3CB;HIP1R
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5517925957889477,-1.3871416921491186,0.11496350364963503,0.30285030056820944,1.0,4/12,8.04%,LYN;IL34;PTK2;MAPK1
prerank,response to progesterone (GO:0032570),-0.4978297586949467,-1.386448625443088,0.08064516129032258,0.30382313264129795,1.0,5/18,8.80%,ABHD2;CAV1;THBS1;TGFB2;YAP1
prerank,cation transport (GO:0006812),0.3145658328384064,1.3858157010439272,0.012195121951219513,0.4391199184574651,1.0,29/167,9.62%,TRPM3;KCNMA1;ATP1A2;KCNA6;SLC22A4;SCN8A;SLC22A1;SLC5A12;KCNA5;SCN1A;CATSPER4;KCNJ3;KCNH4;SLC4A4;KCNN2;CLN3;SCN3A;SLC7A8;KCNA2;ATP1B1;SCN2A;SLC8A2;SLC36A2;TRPM1;SCN5A;SLC29A4;KCNJ6;PANX2;SLC7A6
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.35318568036827064,-1.3851837441058987,0.0427807486631016,0.30568577147439174,1.0,25/79,20.11%,DAB2IP;BMPER;CRIM1;BMPR2;SMURF2;THBS1;PTPN1;SMURF1;SLIT2;NEDD4;SKIL;SMAD1;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;FGF2;SPRY4;SMAD6;SKI;HTRA3;SMAD9;DAND5;PPARG
prerank,regulation of receptor internalization (GO:0002090),0.41633907150272503,1.3841733576373607,0.06981981981981981,0.4407375956925452,1.0,10/35,13.02%,MAGI2;ANKRD13B;WDR54;CD63;MTMR2;ATAD1;AHI1;VEGFA;DLG4;RSPO1
prerank,cellular response to chemical stress (GO:0062197),-0.3461101280921607,-1.3840794032768922,0.021314387211367674,0.30723269264988806,1.0,31/96,22.38%,FOXO1;CAV1;PKD2;ATG7;ATM;LRRK2;DDX3X;ABL1;FOXO3;FAS;PYROXD1;LRRC8D;PRKD1;PRKAA1;ERO1A;CAT;NCF2;TXNRD2;ATF4;MSRA;GPX1;NOX4;FANCC;CCS;SOD1;TRPV4;VRK2;TXNRD1;KEAP1;SLC25A24;NFE2L2
prerank,protein autoprocessing (GO:0016540),0.48535854872641304,1.3835578762559335,0.10491071428571429,0.4400223994241788,1.0,5/17,16.86%,OMA1;MYRF;KLK6;HTRA2;CASP4
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.523706289863225,-1.3831713071067906,0.08506944444444445,0.3084711381565839,1.0,6/16,13.27%,BMPR2;ACE;PLCB3;GSK3A;ADM;PRCP
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.384274029753072,-1.3830395390889612,0.04293381037567084,0.30824911892747525,1.0,27/55,31.23%,DAB2IP;CAV1;PAK2;TNFSF10;FAS;TP53;CRADD;TPD52L1;BCAP31;WWOX;BBC3;BCL2L11;GSDME;RPS3;SIAH1;HYAL2;G0S2;LTBR;BECN1;TRIM39;RIPK1;TNFSF12;TNFRSF12A;TGFBR1;DDIT3;PMAIP1;ING5
prerank,protein ADP-ribosylation (GO:0006471),-0.4425052239993209,-1.382824767012942,0.0975177304964539,0.3081840249855922,1.0,12/28,26.17%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;HPF1;ART3;PARP16;PARP6;PARP9
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4710589969315554,-1.3827285442941162,0.072992700729927,0.30791495666976576,1.0,7/21,15.43%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2;CCN3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4578969073652856,1.3827245664205292,0.10262008733624454,0.43982368238296954,1.0,8/22,9.80%,MAGI2;SH3GL2;TMEM108;KIDINS220;NTRK2;MAPT;ACAP2;STMN2
prerank,histone mRNA metabolic process (GO:0008334),-0.4386156321784296,-1.3822262797736202,0.08,0.3083582975738039,1.0,9/27,18.09%,TUT7;TENT4B;ATM;XRN1;TUT4;LSM11;TENT2;SNRPE;LSM10
prerank,steroid metabolic process (GO:0008202),0.355017803595216,1.3818972840470398,0.033707865168539325,0.4395782125009462,1.0,15/72,12.33%,AKR1D1;CYP46A1;AKR1C1;CYP24A1;SULT2B1;CYP26B1;LSS;HSD17B7;CYP51A1;HSD17B14;CYP27A1;GC;CYP11B1;FDFT1;DHCR24
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.3236035839025542,-1.3816360845596252,0.018333333333333333,0.308988496451599,1.0,56/144,25.29%,PPP1R13B;UBR5;GSK3B;YWHAE;EMD;MIEF1;GAS6;PIK3R1;TCAF1;HPS4;SEC16B;PRKCD;YWHAZ;CDH1;NMT1;GSK3A;UBE2J2;CASP8;UBE2D3;TP53;FLNA;PSEN1;BCAS3;ICE1;MTCL1;MIEF2;CHP1;ZPR1;MAPK8;BBC3;TPR;UBE2L3;FYN;RIPOR1;XPO4;MAVS;PCM1;ZIC1;OAZ2;HYAL2;BAP1;NPEPPS;TCF7L2;PPP3CC;HUWE1;TRIM28;VAMP2;ITGAM;PCNT;SAR1A;CEP131;FZD5;TFDP1;SAE1;RAPGEF3;PLK3
prerank,leukocyte tethering or rolling (GO:0050901),-0.5019179172168446,-1.3813967995695189,0.10093457943925234,0.30899171049464197,1.0,6/17,17.78%,ITGB1;JAM2;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,regulation of cellular pH (GO:0030641),0.43830857143076735,1.381251157346696,0.07674418604651163,0.43894726192127853,1.0,7/29,5.56%,CA2;SLC9A7;SLC4A4;SLC4A5;CLN3;SLC9A9;SLC4A2
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3739660849038502,-1.3812349423001322,0.05263157894736842,0.3088015429729506,1.0,27/65,31.27%,FOXP1;LEF1;CBFA2T3;MYH9;RXRA;DEK;IL15;TGFBR2;BMP4;CASP8;PIK3CD;GAB2;PIR;RARA;CCL19;EPHA2;PPARG;CEBPA;MT1G;LGALS9;GLO1;TREM2;SPI1;BATF2;RUNX1;MAPK14;SBNO2
prerank,excitatory postsynaptic potential (GO:0060079),0.4697340692709845,1.3809696468642711,0.11136890951276102,0.4374926271725451,1.0,4/19,3.46%,GRID2;MPP2;GRIN2B;GRIN2A
prerank,regulation of JNK cascade (GO:0046328),-0.34116234003217155,-1.3808568093674647,0.03577817531305903,0.30908604800544864,1.0,35/101,24.93%,MECOM;DAB2IP;IGF1R;MFHAS1;TRAF5;APP;MAP3K5;EGFR;TGFBR3;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TAOK3;TPD52L1;DUSP3;MAP4K4;TNFRSF19;MTURN;ZMYND11;RAP2A;CCL19;EDAR;NOD2;DUSP22;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1;GPS2;AIDA
prerank,smooth muscle cell differentiation (GO:0051145),-0.5543838182176101,-1.3807985847332434,0.10849909584086799,0.3087264217623246,1.0,7/12,22.61%,MRTFB;BMP4;MEF2C;TMEM204;HEY1;HEY2;MYOCD
prerank,superoxide metabolic process (GO:0006801),-0.4463459160054222,-1.3807136395048947,0.07992895204262877,0.30840217841658846,1.0,9/29,18.07%,SH3PXD2A;NOS3;SH3PXD2B;NCF2;PREX1;NOX4;NRROS;CCS;SOD1
prerank,muscle tissue morphogenesis (GO:0060415),-0.5101381408951126,-1.3806532708800276,0.0852575488454707,0.30807129038900993,1.0,7/16,17.95%,TBX1;TGFBR3;BMP4;MYLK;ZFPM1;NOTCH1;HEY2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.47357604911820483,-1.379453741822265,0.08928571428571429,0.3098564301142113,1.0,10/20,21.05%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,thymus development (GO:0048538),-0.5432806995581063,-1.3792811255546307,0.0979381443298969,0.3097520602862343,1.0,8/13,31.26%,TBX1;HES1;SIX1;SOD1;EPHB3;FGF10;TGFBR1;SHH
prerank,regulation of kinase activity (GO:0043549),-0.3506790170930605,-1.378709320758213,0.040492957746478875,0.3103603926143989,1.0,18/89,8.88%,FLT1;TEK;IGF1R;RB1;TIE1;ROR1;INSR;KDR;MERTK;EGFR;CDKN1B;DSTYK;LMO4;PLCE1;MRE11;EPHA4;FLT4;LDB1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5865832105514055,-1.3782398411403254,0.0922242314647378,0.31076638386231026,1.0,3/10,12.91%,CREBBP;KAT2B;KAT5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.4623234022877615,-1.3780940283719774,0.08450704225352113,0.3105874570363468,1.0,9/25,17.95%,NSD1;RB1;ZBTB7A;DOT1L;SIN3A;MAD2L2;IGF1;HEY1;HEY2
prerank,regulation of urine volume (GO:0035809),-0.5837829067065079,-1.3768421908865907,0.11481481481481481,0.31245752849575714,1.0,7/10,41.33%,ADM;NPR1;HYAL2;HAS2;ADCY6;TFAP2B;NPR3
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5438747336819767,-1.3761193447798004,0.09420289855072464,0.313308771141073,1.0,9/12,32.19%,TP53;RFWD3;SDE2;RPA2;CCND1;PRKDC;PLK3;FBXO31;RPS27L
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.42909732811869183,1.3757521845852216,0.06695464362850972,0.44794359836729325,1.0,12/31,16.82%,DSCAML1;COL2A1;OSR1;HOXD3;MEGF8;FGFR2;HOXA4;EIF4A3;HOXA9;PDGFRA;TWIST1;HOXD4
prerank,rRNA processing (GO:0006364),-0.3165646109792921,-1.375716413154911,0.01444043321299639,0.31358389316819624,1.0,72/172,30.40%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;RRP15;DDX10;NOP2;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;PRKDC;BOP1;RPL37A;PES1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RIOK3;RPLP2;UTP20;RPL18;RPL19;FCF1
prerank,negative regulation of signal transduction (GO:0009968),-0.3013505615982701,-1.3755582189458775,0.008319467554076539,0.3133774579792563,1.0,71/249,20.17%,NXN;DAB2IP;SEMA6A;RB1;TRABD2B;BRAP;LYN;ASXL1;NTN1;THBS1;PTPN1;NFATC1;BMP5;LRRK2;PTPRJ;EGFR;NOTCH3;PIP4K2A;PTPN12;VGLL4;NCK1;IRS1;ZBTB7A;RNF43;PHACTR4;HERC4;PALM;DDIT4;NEDD4;PIP4K2B;PRKCD;NKD1;ARRDC1;GRB10;GLI3;GSK3A;GRB14;AKT1;GLIS2;NFKBIL1;HMGXB4;MOSMO;MAZ;OTUD4;SLC27A4;FGF2;WWOX;TCIM;NOTUM;TAX1BP3;APCDD1;SPRY4;PIK3CB;TNFAIP3;IGFBP5;LGMN;GPR108;HIC1;UBASH3B;KIF26A;TNS2;HEY1;SIAH1;GATA2;PTPRC;RITA1;KIF7;CTNNBIP1;GPC3;WWP2;PTEN
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.32664740290555594,1.3745123511174395,0.028169014084507043,0.448698526812462,1.0,26/124,9.80%,CNTNAP2;NLGN1;L1CAM;RASGRF1;PPP1R9A;CNTN4;BLK;SH3GL2;TMEM108;GPM6B;CDK5;TTC29;PLP1;PLEK;ATXN10;MAP2;TSGA10IP;NPY;GPM6A;CARMIL1;MAPT;POU4F1;CATIP;KIFAP3;ZFYVE27;STMN2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5318576817969567,-1.3743608689276823,0.09719626168224299,0.31516117015884915,1.0,3/13,4.94%,CAV1;ADRA1B;TRPM4
prerank,regulation of secretion by cell (GO:1903530),0.3800677087144668,1.374087052371051,0.05405405405405406,0.4475632506057034,1.0,10/54,12.35%,STXBP5L;SYT1;RIMS2;RIMS1;RAB15;SYN1;RAB3C;RAB3A;MCTP2;LLGL1
prerank,regulation of biomineral tissue development (GO:0070167),-0.45486303264123673,-1.3729312396126236,0.0865561694290976,0.31753694012379474,1.0,11/26,17.95%,NOS3;SGMS2;GAS6;ROCK1;S1PR1;NOTCH1;NOTUM;ROCK2;ANKH;HEY1;HEY2
prerank,myelin assembly (GO:0032288),0.5684654094306303,1.3727354445038167,0.14444444444444443,0.44877328101725816,1.0,6/10,17.29%,TENM4;EPB41L3;GPC1;ABCA2;TPPP;NCMAP
prerank,positive regulation of secretion by cell (GO:1903532),-0.3644645453865214,-1.3726494448749058,0.049557522123893805,0.3176023259452165,1.0,17/70,11.69%,UNC13B;CD2AP;GOLPH3L;SLC12A2;ADAM9;IER3IP1;BMP6;RAB2B;TGFB2;EZR;MYO18A;RAB27A;RAB5A;MYOM1;EDN1;RGCC;EDN3
prerank,positive regulation of inflammatory response (GO:0050729),-0.3536765578678432,-1.3724763711492411,0.03616636528028933,0.3174621591771756,1.0,25/86,24.95%,OSMR;ETS1;APP;IL15;IL6ST;NFKBIA;NMI;PDE2A;PDCD4;LBP;NAPEPLD;FEM1A;AGTR1;LPL;IL17RA;IFI35;IL16;TNFRSF1A;HYAL2;GPR4;SERPINE1;RIPK1;CEBPA;DDT;DHX9
prerank,negative regulation of peptidase activity (GO:0010466),0.38174672760551537,1.3710409921373579,0.07142857142857142,0.45071570118619814,1.0,10/47,13.78%,VTN;SPOCK3;SPOCK1;ECM1;SERPIND1;TIMP1;SERPINA2;SERPING1;FETUB;CST3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.47540700225933336,1.3706021910156405,0.10154525386313466,0.44961206384846236,1.0,4/19,6.81%,PTPRD;IL1RAPL1;CDKL5;CAMK2B
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5024303240824306,-1.3704965299803489,0.09945750452079566,0.32072268460403414,1.0,5/17,12.95%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.3187293879259189,-1.3701515138944609,0.01926444833625219,0.3209488040334924,1.0,47/151,22.11%,SGMS1;CERT1;ST3GAL4;ALAS1;ACER2;DEGS2;SGMS2;PLA2G4A;PRKD3;PRKD2;GSTT1;SPNS2;LPCAT1;ELOVL5;CERS4;GCH1;PPM1L;PAM;SLC44A1;PRKD1;STARD7;ST3GAL2;PCSK5;MFSD2A;GSTM2;ACER3;TYW1;MOCS2;B4GALT5;SPTLC1;GAL3ST2;CEPT1;CERS5;PCTP;ESD;VAPA;GOLPH3;HPGDS;LARGE1;DEGS1;ELOVL7;CDO1;LPIN2;GSTO2;LPCAT3;LCAT;MOCS3
prerank,regulation of monocyte differentiation (GO:0045655),-0.530581771212586,-1.3701495629957425,0.09174311926605505,0.32048466614388516,1.0,7/14,26.05%,FOXP1;IL34;ACIN1;CDK6;CTNNBIP1;IRF7;ZFP36L1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3406691121627349,-1.3700225908286832,0.036585365853658534,0.32026316586762354,1.0,33/108,23.39%,HIP1;SENP1;DAPK1;ACER2;NOD1;CASP12;UACA;MAP3K5;DDX3X;TNFSF10;FAS;NGF;PPM1F;ATP2A3;ARL6IP5;CASP8;CFLAR;CRADD;BCAP31;SOX7;JAK2;BBC3;DAP;HIP1R;CASP8AP2;RPS3;PPARG;F3;FOXL2;CASP2;RIPK1;CASP1;EIF2AK3
prerank,protein autophosphorylation (GO:0046777),-0.32359922753369424,-1.369362902283883,0.015280135823429542,0.3210820397193404,1.0,34/157,11.47%,FLT1;GRK5;TEK;IGF1R;DYRK1A;INSR;DAPK1;LYN;GSK3B;ATM;PAK2;SIK1;LRRK2;NEK6;KDR;MTOR;PRKD2;CDK12;EGFR;STK24;BMX;ABL1;PTK2;ERN1;MAPKAPK2;AAK1;EPHA4;PRKD1;FLT4;AKT1;MAP3K3;TAOK3;STK10;JAK2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5579907780506127,-1.3691017055169572,0.09944751381215469,0.32108609611146,1.0,7/12,24.87%,RESF1;TASOR;APOBEC1;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.457548791784566,-1.3687590878165548,0.08561020036429873,0.3213340740449823,1.0,8/25,15.33%,ITGA6;THBS1;APP;EGFR;ILK;PSEN1;PTGES3;MIF
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4739549687852772,-1.3681645902344262,0.08333333333333333,0.3219264063113052,1.0,8/20,23.27%,ENTPD1;APP;NT5E;TXNIP;ANO6;PSTPIP1;TXN;CASP1
prerank,DNA conformation change (GO:0071103),-0.5011528705301176,-1.3681448388555337,0.1154562383612663,0.3214833064041754,1.0,8/17,24.66%,KAT6A;TOP3A;ABL1;TOP3B;ERCC3;TOP1MT;TOP1;HMGB1
prerank,regulation of lipid catabolic process (GO:0050994),0.4724303742033278,1.3680129885930512,0.0949367088607595,0.45364330444783924,1.0,5/19,15.13%,PDE3B;BSCL2;TYSND1;ADRA2A;APOC1
prerank,motile cilium assembly (GO:0044458),0.5451692341808166,1.3679324903190357,0.09403669724770643,0.4517099658346653,1.0,4/12,11.36%,DNAAF3;BBOF1;DNAAF1;BBS5
prerank,water transport (GO:0006833),0.5366622647580344,1.367609056451826,0.10135135135135136,0.4503924079274927,1.0,2/12,4.58%,PDPN;AQP4
prerank,ameboidal-type cell migration (GO:0001667),-0.37655433199554916,-1.3675493370804939,0.06878306878306878,0.3222374720421544,1.0,22/51,21.39%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;PDLIM1;AKT1;SEMA3G;SEMA6B;SEMA4C;PDXDC1;ITGA4;PKN2;PKN3;CCN3;SEMA5B;SEMA4A;SEMA3E;GPC3;SEMA4G;AMOTL2
prerank,negative regulation of cell aging (GO:0090344),-0.5055087283766011,-1.3674809118866473,0.09252669039145907,0.32192748850036784,1.0,7/16,21.22%,SLC30A10;AKT3;MAP3K3;CDK6;MIF;TERF2;TERT
prerank,peroxisome organization (GO:0007031),-0.4525445221774138,-1.3674704355285734,0.09859154929577464,0.3214844650128796,1.0,12/25,31.64%,PEX1;SEC16B;ABCD3;PEX7;TMEM135;PEX14;PEX11A;PEX3;PEX6;PEX11B;PEX19;LONP2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5421004153491591,-1.3669681777738791,0.11172161172161173,0.32198438760303955,1.0,2/12,0.62%,DAB2IP;SEMA6A
prerank,actin filament bundle assembly (GO:0051017),-0.4237020916210693,-1.3669353705871212,0.06148282097649186,0.32158097153503884,1.0,10/33,13.20%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;SHROOM1;FAM107A;SHROOM2;LCP1;NEDD9
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5645870980211497,-1.3665243852233886,0.13176895306859207,0.32192039188538635,1.0,4/11,9.60%,PELI1;BIRC3;ARHGEF2;CASP8
prerank,sulfation (GO:0051923),0.5517533071104719,1.3660414525252373,0.1334841628959276,0.45219885726587034,1.0,2/11,4.15%,HS3ST5;SULT2B1
prerank,mitochondrion distribution (GO:0048311),-0.546844672194144,-1.3656549933288484,0.10676156583629894,0.3230797246906042,1.0,3/12,3.71%,MEF2A;TRAK1;LRRK2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.46792829795327595,1.3652881211115602,0.10065645514223195,0.45188300925549085,1.0,4/21,5.87%,NUDT19;LPIN1;HAO1;CYP26B1
prerank,COPII vesicle coating (GO:0048208),-0.3776148262478813,-1.3651777271836714,0.06537102473498234,0.3226217682998744,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3776148262478813,-1.3651777271836714,0.06537102473498234,0.3226217682998744,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,vesicle coating (GO:0006901),-0.3776148262478813,-1.3651777271836714,0.06537102473498234,0.3226217682998744,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.555666930118484,-1.3647729011668543,0.11423550087873462,0.3229572940577374,1.0,7/12,31.65%,HES1;NOTCH1;JAG1;NELFB;HNRNPU;N4BP2L2;TCF15
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4319040148698931,-1.364010932802377,0.08551483420593368,0.32401635859552447,1.0,17/31,32.86%,CRIM1;LRP5;TRPM4;LIMD1;TWIST2;NOTCH1;TMEM64;CDK6;SMAD6;SKI;PPARG;HDAC7;GDF10;SUFU;BAMBI;RIOX1;PTCH1
prerank,regulation of dendrite development (GO:0050773),0.4023627151013169,1.3636975743840556,0.10328638497652583,0.45373253831846433,1.0,8/37,6.03%,CSMD3;ADGRB3;DCC;HECW1;CDKL5;VLDLR;TNIK;HECW2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5157248822517163,1.3634697118384176,0.12581344902386118,0.45220630850104704,1.0,4/12,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.572002492429968,-1.3632161450680882,0.10805860805860806,0.32505433208665896,1.0,8/11,30.86%,MERTK;GAS6;CCL19;NOD2;CXCL12;IRF7;AXL;LILRB1
prerank,cellular glucan metabolic process (GO:0006073),-0.5612170965845669,-1.3628223773216905,0.1111111111111111,0.3253885987378683,1.0,4/11,13.73%,GBE1;GSK3B;PPP1R3C;PHKB
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.47097797506025185,-1.361788525096265,0.11588785046728972,0.32694652643604516,1.0,5/20,12.38%,LYN;PRKCE;LBP;IRAK1;MTDH
prerank,smooth muscle contraction (GO:0006939),-0.5199763491951644,-1.3616840465796918,0.10784313725490197,0.32669725520380744,1.0,9/14,23.84%,EDNRA;MYH11;PIK3C2A;ACTA2;ROCK1;MYLK;ROCK2;SMTN;TPCN2
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5060418887499424,-1.361526401457098,0.10598290598290598,0.3265314161478906,1.0,8/16,20.15%,IGF1R;INSR;OGFOD1;BNIP3;GSPT1;HDAC6;TBC1D25;GLE1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.46021339459919713,1.361522612175506,0.10176991150442478,0.45499420830343185,1.0,5/20,9.79%,AKR1D1;CYP46A1;AKR1C1;TSPOAP1;CYP11B1
prerank,protein localization to membrane (GO:0072657),0.3022371205541045,1.3611103532457691,0.016355140186915886,0.45394945651303004,1.0,37/187,11.34%,KCNIP4;NRXN1;MAGI2;NLGN1;ABCA12;DLG2;LRRC7;DPP10;MAP7;ANK3;DPP6;CYP46A1;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CPE;CACNB3;WNK3;CD81;MYO5A;HGS;ARL3;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;LIN7C;TSPAN32;PPIL2;NKD2
prerank,regulation of acrosome reaction (GO:0060046),0.5688879466221324,1.360633556690295,0.12614678899082568,0.4530245672772385,1.0,2/10,3.88%,GLRA1;SPINK13
prerank,response to prostaglandin E (GO:0034695),-0.5704408206156876,-1.3589872162969074,0.10460992907801418,0.3311396096427075,1.0,5/10,26.87%,GNB1;TGFBR3;CCL19;GNG2;ADCY6
prerank,activation of GTPase activity (GO:0090630),-0.3441571951259437,-1.3588931859312605,0.050724637681159424,0.3308532115815301,1.0,33/89,22.98%,TBC1D4;BCR;RALGAPA1;CORO1C;TBC1D1;TBC1D2B;ARHGEF15;TBC1D8B;USP6NL;SIPA1L3;TBC1D30;TBC1D14;MTSS2;TBC1D22B;TBC1D22A;BCAS3;SLC27A4;TAX1BP3;ARHGEF10;RHOG;ARHGAP22;ABR;ARHGAP29;TBC1D8;EPHA2;TBC1D17;TBC1D25;ARHGAP42;ARHGEF5;SYDE1;TBC1D12;EVI5;PIP5K1A
prerank,organic acid transport (GO:0015849),-0.34303857973617013,-1.3576329103812337,0.03783783783783784,0.3328814337379974,1.0,23/94,13.79%,ABCC4;ABCG2;SLC6A6;SLC26A7;ATP8B1;SLCO1C1;SLC7A1;RXRA;SLC25A32;SLC5A6;SLC38A5;SLC16A1;SLC1A5;LRRC8D;SLCO2B1;PPARD;SLC13A3;MFSD2A;SLC25A11;SLC27A4;CEACAM1;SLC7A7;SFXN5
prerank,response to lipopolysaccharide (GO:0032496),-0.3229064104475549,-1.3572234309114979,0.02772963604852686,0.3331853456610962,1.0,29/138,16.45%,FOXP1;DAB2IP;PELI1;NOS3;SRR;IFNAR1;ADAM9;HNRNPA0;NFKB1;TNFRSF1B;GGT5;PDCD4;GCH1;IRGM;LBP;MEF2C;MAPKAPK2;SCARB1;NFKBIL1;JAK2;RHOA;IRAK1;CDC73;MAPK8;RPS6KA3;TNFAIP3;SMAD6;TAB2;CHMP5
prerank,neuromuscular process (GO:0050905),0.4855076611368068,1.3569216896679914,0.1079136690647482,0.46004777396029456,1.0,4/16,6.17%,NRXN1;SHANK1;CLN3;PRRT2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3681215324045142,-1.3567040311881902,0.04212454212454213,0.3336884228991485,1.0,28/63,27.03%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;BTG2;RFWD3;CARM1;SDE2;RPA2;SOX4;CCND1;PRKDC;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,protein deacylation (GO:0035601),-0.4633911805773737,-1.356556651781393,0.09895833333333333,0.33353024792655084,1.0,15/23,29.04%,HDAC1;SIRT5;SIN3A;HDAC4;ABHD17A;NOTUM;SIRT3;ABHD17C;HDAC6;HDAC10;HDAC7;LYPLA1;HDAC5;ABHD10;PPT1
prerank,cellular response to starvation (GO:0009267),-0.3184842191265848,-1.3565114909003653,0.013245033112582781,0.33316593338369666,1.0,43/147,19.30%,FOXO1;BMPR2;SESN1;MTMR3;ATG7;SIK1;LRRK2;MAP3K5;MTOR;MAP1LC3B;PPARA;STK24;FOXO3;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;MFSD2A;TP53;KLF10;PRKAA1;WIPI1;GABARAP;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;ZFYVE1;HNRNPA1;DAP;NUAK1;ATG5;CASTOR1;GCN1;RIPOR1;LAMP2;WRN;RNF152;ITFG2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.37474314519649726,-1.3561461508320312,0.06629834254143646,0.33337349836250635,1.0,25/58,25.59%,ATM;UIMC1;KDM2A;SMC5;ZBTB7A;XRCC4;MRE11;NSMCE2;KAT5;BABAM2;NHEJ1;RNF168;UBE2V2;ERCC8;HERC2;SUMO1;BRCC3;PRKDC;PIAS4;LIG4;BRCA1;DCLRE1B;HMGB1;DCLRE1A;ERCC6
prerank,endoderm formation (GO:0001706),-0.4151449569137088,-1.3559392191889088,0.08703374777975133,0.3333336331916225,1.0,8/35,5.77%,COL8A1;COL12A1;COL4A2;SETD2;SOX17;MMP2;LAMA3;ITGB5
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.39098132001490327,-1.3558778713595123,0.07347670250896057,0.332983526297633,1.0,16/46,18.29%,ANXA2;JAK1;PAK2;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;JAK2;HNRNPF;LCP1;TALDO1;MIF;SOD1;CFL1
prerank,T cell differentiation (GO:0030217),-0.4079887862989243,-1.3558491777419002,0.07491289198606271,0.33259365937380253,1.0,24/40,40.88%,SOX13;JAG2;GLI3;PIK3CD;NHEJ1;LMBR1L;ANXA1;SOX4;PTPRC;LIG4;DLL4;PTPN2;ZFP36L1;ADAM17;FCER1G;SPI1;SHH;LFNG;ZAP70;GATA3;GPR89B;GPR89A;LCK;CD28
prerank,negative regulation of synaptic transmission (GO:0050805),0.44616779237298915,1.3552793871824964,0.09817351598173515,0.46201401765816874,1.0,6/23,11.22%,SLC24A2;SYT11;MTMR2;ATAD1;CBLN1;PRRT1
prerank,positive regulation of nervous system process (GO:0031646),0.4774776898070593,1.3552721562952519,0.10329670329670329,0.45994463890605813,1.0,5/18,2.82%,TENM4;MYRF;RIMS2;RIMS1;CARTPT
prerank,limb morphogenesis (GO:0035108),-0.4764662268159038,-1.3547643545826524,0.1128747795414462,0.33426697302088043,1.0,6/20,9.13%,MBNL1;NIPBL;LRP6;TGFB2;GLI3;PCSK5
prerank,histone H3-K9 demethylation (GO:0033169),-0.5690585268714221,-1.354509647635966,0.13320825515947468,0.3343355878370816,1.0,7/11,31.74%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.5567407259874806,-1.3543544645536536,0.14337568058076225,0.33416063164183984,1.0,10/11,43.70%,TENT4B;EXOSC2;EXOSC3;PARN;EXOSC5;LARP7;EXOSC4;FBL;FBLL1;DKC1
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.31112540916674936,-1.3542218441114857,0.01929824561403509,0.3339509348316276,1.0,44/150,20.79%,DAB2IP;PARD3;ENG;RB1;CAV1;LYN;CORO1C;CEP85;PAK2;SPRED2;LRRK2;NIBAN1;RTRAF;LDLRAD4;NCK1;PPEF2;LRP6;SLIT2;DDIT4;PRKCD;RASSF2;PPM1F;PRKRIP1;OCLN;AKT1;NCK2;SMAD7;CNKSR3;CEACAM1;PTPN13;CHP1;TRAF3IP1;DNAJC10;SMAD6;TAF7;UBASH3B;CDK5RAP3;PMEPA1;PTPRC;PRKDC;PTEN;SNX25;AKT1S1;NF1
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.30689877820379124,-1.3540680129248095,0.01384083044982699,0.333799855797565,1.0,65/190,23.64%,DAB2IP;ITPR1;CAV1;MCL1;CD2AP;ESR1;LYN;UACA;SH3BP4;THBS1;TMSB4X;CGNL1;WWC2;DDX3X;PTPRJ;VGLL4;PDE3A;LIMD1;PPARA;PPEF2;NMI;PDE2A;SLIT2;DDIT4;STAMBP;GSK3A;PPM1B;CASP8;AKT1;UBR2;THEM4;PRKAA1;PEBP1;DUSP3;PIK3CB;PIK3IP1;TRIM59;TNFAIP3;IFI35;CCN3;ABCA7;USP10;C1QTNF3;BMP7;MARK3;ARHGAP12;PPIF;ZMYND11;WTIP;UBR1;HYAL2;EPHA2;TMEM127;PTEN;HERPUD1;AKT1S1;NF1;MDM2;HDAC7;MAP2K3;PHLDA3;RELA;TRIM39;RIPK1;AJUBA
prerank,cellular response to ionizing radiation (GO:0071479),-0.39032208057573337,-1.3537477560005284,0.06927175843694494,0.33390561921083106,1.0,23/47,30.42%,MAP3K20;NET1;TLK2;ATM;NIPBL;SPIDR;YAP1;RPL26;TP53;GRB2;WRN;LIG4;MDM2;BLM;GADD45A;INTS7;INO80;TMEM109;KDM4D;RAD51AP1;SWI5;MAPK14;EEF1D
prerank,negative regulation of histone methylation (GO:0031061),-0.57529476744815,-1.353243777178336,0.12138728323699421,0.3345162230189151,1.0,6/10,30.94%,BCOR;DNMT1;BRCA1;AASS;WDR5;DNMT3B
prerank,T cell homeostasis (GO:0043029),-0.5808415467760688,-1.3524194543047598,0.09885931558935361,0.33560856860675964,1.0,3/10,9.84%,FAS;PPP2R3C;AKT1
prerank,mitochondrion localization (GO:0051646),-0.47780395188444835,-1.352265849537523,0.11538461538461539,0.33546129204184033,1.0,4/19,3.71%,MEF2A;TRAK1;MARK1;LRRK2
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.39592737442803594,-1.351532829455906,0.06429780033840947,0.33635022416299365,1.0,15/42,14.15%,RSU1;RAC1;LIMS1;CORO1C;GCNT2;VIT;FZD4;PTK2;PPM1F;FBLN2;JAK2;NOTCH1;RHOA;ATXN3;PIK3CB
prerank,response to estradiol (GO:0032355),-0.4210456711159535,-1.3508419915402017,0.08303249097472924,0.33719486024393186,1.0,10/31,17.12%,ESR1;NRIP1;EGFR;STRN3;GGT5;SOCS2;KAT5;RUVBL2;ANXA1;CTNNB1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4244572317572766,1.3503903968553392,0.0935412026726058,0.47002233247947467,1.0,7/29,13.72%,SYCP1;MAJIN;ZCWPW1;REC8;SYCP2;RAD21;SIRT7
prerank,substrate-dependent cell migration (GO:0006929),-0.5206587197885792,-1.3500435407636786,0.11913357400722022,0.3382897710252105,1.0,6/14,19.32%,ANKS1A;CD2AP;NTN1;VEGFC;ITGA2;PTPRC
prerank,mesonephric tubule development (GO:0072164),0.4858363579960036,1.349876673314018,0.13245033112582782,0.4693640807012917,1.0,6/15,7.54%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.36060501199287415,-1.3497859874433897,0.05653710247349823,0.3383205557365703,1.0,14/70,11.47%,DAB2IP;MCL1;GSK3B;DDX3X;IL6R;TNFRSF1B;FAS;TGFB2;NGF;GSK3A;CASP8;CRADD;GABARAP;JAK2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3097573139154607,-1.3496051535819122,0.015570934256055362,0.3382279152612734,1.0,44/182,16.77%,FOXP1;CLDN5;ENG;ACVRL1;RB1;RIN3;KLF4;CD34;ESR1;TNRC6B;SLC7A5;APP;KDR;TIPARP;SMO;ZNF148;HDAC1;NFKB1;TGFB2;PARP14;BMP4;MEF2C;NOTCH2;YAP1;CELF1;PICALM;OCLN;ADAM10;PRKAA1;DICER1;SNX12;PSEN1;NOTCH1;FGF2;APOBEC1;MECP2;AGO2;MIF;ROCK2;LGMN;TERF2;IGF1;MOV10;DNMT1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.32898156764210024,-1.3495461751311089,0.0415944540727903,0.33786142247533774,1.0,32/108,15.36%,TJP1;RAC1;RHOBTB1;GSK3B;IQGAP1;F11R;RND3;CRK;PAK2;DIAPH1;MTOR;RICTOR;ABL1;RHOQ;PTK2;PRKCD;CDK10;EZR;MAPK1;ROCK1;FAM107A;ARHGAP17;CAPN2;PRKAA1;RHOA;RHOC;RHOG;TRAF3IP1;SORBS3;MARK2;HIP1R;ROCK2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5332341370744669,-1.3494015974872475,0.0994671403197158,0.33766917367543126,1.0,5/13,13.52%,GFPT2;GNPDA2;SLC35A3;GNPNAT1;UAP1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.39835476165300465,-1.3493387285313472,0.06371681415929203,0.3373217348731759,1.0,17/42,25.59%,SMARCA2;ARID1B;HDAC1;SMARCC1;SRCAP;SMARCE1;SPTY2D1;CECR2;SMARCC2;CHD3;ACTB;INO80B;VPS72;SMARCAD1;SMARCB1;INO80;ERCC6
prerank,positive regulation of defense response (GO:0031349),-0.34363671483582886,-1.3492285949487366,0.04864864864864865,0.33705298799811556,1.0,30/89,28.25%,ETS1;APP;IL15;NFKBIA;NMI;PDE2A;PDCD4;MEF2C;NAPEPLD;AKIRIN2;FEM1A;AGTR1;LPL;IL17RA;PLSCR1;POLR3F;IFI35;IL16;TNFRSF1A;GBP5;HYAL2;GPR4;SERPINE1;RIPK1;CEBPA;DDT;DHX9;TNIP1;GPSM3;RIOK3
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.40616931714334237,-1.3490709727958656,0.08547008547008547,0.3369247297159484,1.0,12/38,18.16%,ANKRD17;BMP6;NMI;PUM1;AKIRIN2;DDX60;USP15;PLSCR1;POLR3F;IFI35;GBP5;SASH1
prerank,RNA stabilization (GO:0043489),-0.4118791180154255,-1.348880651073208,0.10301953818827708,0.3368812507645321,1.0,14/33,28.15%,LARP1;FUS;AXIN2;TENT2;PARN;TRDMT1;PHAX;RBM24;THRAP3;TAF15;NAF1;PABPC1;HNRNPU;TENT5C
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4247044747549824,-1.3483117942871146,0.09169550173010381,0.3375382509651473,1.0,14/31,23.50%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;TCF3;MAPK12;CTNNB1;IGF2;SPAG9;MYOCD;MAPK11
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.466804533337196,-1.3480678223951612,0.12121212121212122,0.33751640248962395,1.0,8/21,18.01%,MYH9;ADAM9;PSEN2;SPPL3;ADAM10;PSEN1;APH1A;ERAP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.456176162275844,1.348031536180229,0.11238532110091744,0.47165155765066175,1.0,6/20,11.91%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,regulation of innate immune response (GO:0045088),-0.3666684089677432,-1.3480097027887334,0.06896551724137931,0.33717369115692536,1.0,28/57,32.73%,XIAP;PTPN1;BIRC3;SAMHD1;NMI;IRF1;AKIRIN2;CASP8;USP18;PLSCR1;POLR3F;TNFAIP3;IFI35;N4BP1;GBP5;ERAP1;TKFC;ABCE1;PTPN11;IFNAR2;DHX9;PARP9;RIOK3;TREM2;CACTIN;LRP8;FGR;TRAFD1
prerank,plasma membrane invagination (GO:0099024),-0.4297906033931287,-1.347953431044563,0.1073943661971831,0.33681304871934703,1.0,11/29,24.25%,GULP1;DOCK1;MYH9;ELMO1;SNX9;RHOA;ARHGAP12;ITGAM;FCGR1A;ALKBH4;SNX18
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3396258420334956,-1.3477901333661513,0.03873239436619718,0.33672037648630854,1.0,38/93,25.77%,NSD1;CAV1;APP;PRKD2;EGFR;TFRC;GAS6;NCK1;DDIT4;IRGM;RASSF2;NGF;PPM1F;PRKD1;RAF1;HAX1;AKT1;NCK2;FNIP2;BRAF;SMAD7;RPTOR;CNKSR3;MTCP1;MIF;MAD2L2;CREBL2;HDAC6;TXN;PTEN;CAPRIN2;NOS1;HSP90AA1;AKAP9;SH2D3C;INPP5J;RAPGEF3;DMTN
prerank,protein-containing complex subunit organization (GO:0043933),-0.3350112996736433,-1.3470713859052172,0.03546099290780142,0.33767914589075176,1.0,38/109,23.77%,SLC2A1;PARD3;MNAT1;CREBBP;CD2AP;RANBP9;TEAD1;MITF;HES1;FAS;KPNA3;NUP98;SNX9;WASL;YAP1;AFG3L2;PICALM;DET1;OCLN;TP53;HFE;CD40;PEX14;TPR;TUBGCP4;TFAP4;FANCC;IKBKG;VAMP3;WASF1;MDN1;MAGI1;MDM2;VAMP2;PTK2B;PPIH;NDUFAF1;CD247
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5866350308379754,-1.3469598905404403,0.12717770034843207,0.33746436753952225,1.0,4/10,16.50%,ST3GAL1;ST6GAL1;GNPDA2;GNE
prerank,protein monoubiquitination (GO:0006513),-0.40768031577528957,-1.3468210334131723,0.0931899641577061,0.33728255251509776,1.0,13/36,21.22%,TRIM25;DTX3L;RBX1;CUL3;RNF40;KLHL12;UBE2D3;RAD18;CDC73;OBI1;HUWE1;FANCL;UBE2R2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4354344070523637,-1.346780681692731,0.10442477876106195,0.336912255350763,1.0,6/26,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,cellular response to interleukin-7 (GO:0098761),-0.4883854085157071,-1.3467192644711725,0.11231884057971014,0.33614066190805497,1.0,9/17,35.34%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;TSLP;IL7R
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4883854085157071,-1.3467192644711725,0.11231884057971014,0.33614066190805497,1.0,9/17,35.34%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;TSLP;IL7R
prerank,negative regulation of cell population proliferation (GO:0008285),-0.28544581871534136,-1.3463089415886216,0.0034071550255536627,0.3365567366843221,1.0,113/351,25.03%,DAB2IP;SMARCA2;IGFBP7;RAPGEF2;ACVRL1;NOS3;PTPN14;KLF4;ETS1;ABI1;PKD2;CBFA2T3;LYN;BMPR2;PDS5B;CD200;SH3BP4;BTG3;APP;MCC;KAT2B;BMP5;RNF139;ITGA1;ARID2;P3H2;THAP12;PTPRJ;EMD;CDKN1B;TGFBR3;VGLL4;CTCF;HES1;RARG;RBM5;NMI;TGFB2;RBP4;AQP11;BMP4;PTPRK;CDK10;NGF;RAF1;IRF1;CELF1;CTBP2;TP53;FRK;KLF10;AXIN2;NCK2;RGCC;LMNA;SOX7;JAK2;ZBTB7C;NOTCH1;CDC73;CDK6;TBRG1;NUDT6;TNFAIP3;IFI35;IGFBP5;BTG2;CCN3;FUZ;SMAD6;FOXO4;RERG;SKI;GSDME;NOX4;CTNNB1;TFAP4;ADARB1;TNS2;ADGRG1;TES;GATA2;BAP1;PPM1D;SOX4;TMEM127;CTNNBIP1;PPARG;PTEN;NF1;TOB1;DLL4;WARS1;CDKN2C;ROR2;DIS3L2;PTK2B;MYOCD;TBX3;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;E2F7;HSPA1B;E2F3;TFDP1;PINX1;PLXNB1;ADGRB1;BMP2;PLPP1
prerank,negative regulation of gene expression (GO:0010629),-0.2900424484097092,-1.345967304307799,0.006745362563237774,0.3367922093716293,1.0,99/302,27.43%,FOXP1;CLDN5;ENG;ACVRL1;RB1;KLF4;CD34;DAPK1;ESR1;TNRC6B;SLC7A5;APP;KAT2B;RPS6KA5;RNF139;DDX3X;KDR;SRGN;TIPARP;SMO;GIGYF2;ZNF148;HDAC1;LARP1;NFKB1;TGFB2;SUZ12;PARP14;BMP4;ERN1;MEF2C;SAMD4A;NOTCH2;YAP1;CELF1;PICALM;OCLN;ADAM10;TASOR;PRKAA1;DICER1;RGCC;SNX12;PSEN1;NOTCH1;FGF2;ASB1;MECP2;AGO2;H3-3A;IGFBP5;N4BP1;SYNCRIP;BTG2;MIF;ROCK2;LGMN;TERF2;IGF1;MOV10;DNMT1;PPHLN1;HEY2;RPS3;CITED2;NUDT12;GATA2;PPM1D;TNRC6A;CAPRIN1;WWP2;PTBP3;TOB1;DLL4;TERT;DIS3L2;METTL16;NDFIP2;YY1;RPL13A;MRPL13;EIF2AK3;AEBP2;HSPA1B;SETDB2;BMP2;DIP2A;FXR1;IGF2BP2;CNOT8;PARP9;RPS26;DXO;EMILIN1;NANOS1;LGALS9;CNOT1;SLC24A3;TRIM6
prerank,protein-DNA complex disassembly (GO:0032986),-0.5061211969873127,-1.345527381300914,0.10902896081771721,0.33725028554829656,1.0,5/16,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,regulation of autophagy (GO:0010506),-0.305289418944562,-1.3444733567060645,0.019400352733686066,0.33893665434661474,1.0,70/216,24.66%,ITPR1;FOXO1;MCL1;TAB3;DAPK1;ACER2;SH3BP4;TLK2;GSK3B;MTMR3;ATM;LRRK2;EXOC4;MTOR;PIP4K2A;RASIP1;ABL1;FOXO3;NEDD4;PIP4K2B;IRGM;BNIP3;ERN1;PIK3C2A;PLK2;ROCK1;PRKD1;TBC1D14;DAPL1;GSK3A;HAX1;USP13;AKT1;PRKAA1;TRIM14;RPTOR;VPS26A;MTDH;KAT5;ATP6V1E1;HGF;GPR137B;MAPK8;PIK3CB;DAP;EXOC8;USP10;TAB2;HDAC6;RAB39B;ATP6V0A1;WASHC1;RNF152;DRAM2;PRKAB1;UCHL1;WDR41;ORMDL3;CTSA;KEAP1;MTMR4;ATP6V1H;ATF6;GFAP;TPCN2;FZD5;TRIM68;TRIB3;RHEB;HMGB1
prerank,intracellular pH reduction (GO:0051452),0.40582281823612326,1.3435292760761783,0.10416666666666667,0.48074911622684224,1.0,12/33,19.06%,TMEM9;ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;DMXL2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,actin filament bundle organization (GO:0061572),-0.41214019678098923,-1.3434582839171572,0.08912655971479501,0.3404701368285774,1.0,10/33,13.20%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;SHROOM1;FAM107A;SHROOM2;LCP1;NEDD9
prerank,heart contraction (GO:0060047),0.39416947765941696,1.3433022001237123,0.09777777777777778,0.47918933524102336,1.0,11/41,14.49%,SGCZ;ATP1A2;SCN1B;ATP1B1;RYR2;SCN5A;TNNC1;SLC8A1;MYL2;TNNI2;SCN2B
prerank,regulation of cellular catabolic process (GO:0031329),-0.3711694162113797,-1.342774416905351,0.06428571428571428,0.3413881234057418,1.0,22/62,24.23%,ITPR1;DAPK1;ACER2;MTMR3;ATM;LRRK2;PIP4K2A;ABL1;PIP4K2B;ROCK1;USP13;RPTOR;GPR137B;USP10;HDAC6;RAB39B;DRAM2;WDR41;KEAP1;MTMR4;TPCN2;TRIB3
prerank,endomembrane system organization (GO:0010256),-0.3085154425676988,-1.3424893808254732,0.02982456140350877,0.3415113727225896,1.0,47/178,18.82%,SPTBN1;ATP8B1;SEC31A;MYOF;DNAJC13;CSNK1A1;COG1;DYM;TMCC1;A4GALT;LRRK2;SYNE1;RAB1A;SRGN;GOLPH3L;RAB2A;DYSF;ATL2;TOR1B;SEC16B;ALS2CL;MYO18A;USP6NL;PRKD1;REEP3;CUL7;FBXW8;GAK;BCAS3;ARFGEF1;FAM174B;CSNK1D;CHMP2B;TRAPPC12;EXOC8;PI4K2B;TBC1D20;SUN1;TLCD1;LMAN2;ALS2;TMED5;VAPA;GOLPH3;WASHC4;TJAP1;AKTIP
prerank,negative regulation of cytokine production (GO:0001818),-0.31041095346553704,-1.3420909431368384,0.025684931506849314,0.34187453461178846,1.0,37/163,18.05%,LEF1;KLF4;CD34;RAC1;CD200;THBS1;TMSB4X;IFIH1;TRIM25;RPS6KA5;SRGN;RNF125;TAX1BP1;PPARA;GAS6;PDCD4;EZR;ANXA4;UBA7;RGCC;IKBKE;ZFPM1;CEACAM1;KAT5;ASB1;TRAF3IP1;TNFAIP3;N4BP1;ILRUN;C1QTNF3;VSIR;RARA;ANXA1;GPATCH3;NLRC5;MAVS;CMKLR1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.49665056024621546,-1.3414743135812885,0.11937716262975778,0.34266960570314153,1.0,5/16,12.16%,RB1;PDS5B;NIPBL;POGZ;PDS5A
prerank,regulation of protein kinase B signaling (GO:0051896),-0.3037890573174629,-1.3402706287604034,0.010238907849829351,0.34460029670425235,1.0,57/193,23.17%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;RAC1;MFHAS1;ESR1;THBS1;GCNT2;PTPRJ;EGFR;RICTOR;PPARA;GAS6;PIK3R1;IRS1;PTK2;FGF1;HAX1;RRAS;PIK3CD;FGF7;AKT1;THEM4;MAZ;FGF2;MTDH;MYOC;RHOG;HGF;PIK3CB;GRB2;IAPP;GAB2;TNFAIP8L3;ANGPT1;FYN;CCL19;HYAL2;EPHA2;TXN;TCF7L2;PTEN;F3;FGFR4;IGF2;PTPN11;PDGFRB;PHLDA3;HSP90AA1;HPSE;FRS2
prerank,GPI anchor metabolic process (GO:0006505),0.43160269451076855,1.3399244550958318,0.12931034482758622,0.48585421982865906,1.0,7/26,12.14%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3;GPLD1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4668819140187877,-1.3397635934398724,0.12874779541446207,0.3452206937820856,1.0,14/19,49.59%,PRKCE;NMI;LBP;IRAK1;ITGAM;LGALS9;PIK3AP1;CD14;TNIP3;TLR4;TICAM2;SCIMP;RAB11FIP2;LY96
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.29892914678512944,-1.3394773523454993,0.02120141342756184,0.34531972949256823,1.0,62/214,22.42%,TEK;DAB2IP;RAPGEF2;SEMA6A;FERMT2;ROR1;BMPER;MFHAS1;LYN;PDGFD;SEMA7A;GCNT2;PTPN1;APP;RANBP9;SPRED2;CCL25;KDR;ICAM1;PRKD2;EGFR;TGFBR3;SLC30A10;GAS6;DLG1;DSTYK;RAP1A;EZR;NOTCH2;YWHAZ;FLT4;SMAD4;RRAS;HTR2A;BRAF;TIMP3;NOTCH1;FGF2;CNKSR3;CEACAM1;DUSP3;ACKR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN;ANGPT1;CCL19;NOD2;EPHA2;PTPRC;PTEN;FGFR4;ARHGEF5;PTPN11;P2RY1;ROR2;PDGFRB;PTK2B;APIP;CCN1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.28135991130837723,-1.3393094156893341,0.0,0.3452098826027853,1.0,115/423,23.40%,FOXP1;FLT1;TJP1;LEF1;GRK5;PRKCH;IGF1R;KITLG;OSMR;CLDN5;INSR;LRP5;LYN;ACER2;PDGFD;THBS1;CDK13;GCNT2;BMP5;TBX1;IL15;KDR;EGFR;IL6ST;TGFBR3;TRPM4;TGFBR2;BMP6;HDAC1;IL6R;HES1;GAS6;IRS1;STX3;IL34;CUL3;DNAJA2;TGFB2;PTK2;AQP11;FGF1;BMP4;STAMBP;MEF2C;TBX2;YAP1;NOP2;FLT4;NES;LIFR;NAMPT;ADAM10;FGF7;AKT1;MAP3K3;VEGFC;EDN1;DOT1L;PTGFR;MAZ;EDN3;ACER3;NOTCH1;FGF2;HDAC4;SAAL1;CDC123;ASH2L;RHOG;CDK6;RPS4X;MECP2;FAM98A;COPS9;MIF;GAB2;LGMN;IGF1;SRPK2;COX17;RARA;CTSH;CACUL1;CLCF1;TNFSF13;TBC1D8;NOD2;SOX4;PTPRC;TCF7L2;KRAS;PTEN;LIG4;FGFR4;PRC1;IL13RA1;IGF2;LAMB1;DLL4;TERT;MDM2;NACC1;S1PR3;PDGFRB;LAMC2;PTK2B;TTK;CCN1;RELA;PTN;ESM1;TBX3;HPSE;HAS2;CEP131
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.42494554082066543,1.3392158589569656,0.09598214285714286,0.48563735901353133,1.0,7/27,7.23%,IL1RAPL1;CTNNA2;CCDC88A;NTNG2;NTNG1;NCS1;HOMER1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4046497460840036,-1.3391467855148298,0.0873440285204991,0.345038651106683,1.0,18/36,29.08%,UBE2K;GAS6;IRGM;PARP14;EDN1;AGPAT1;NLRC5;MAVS;RIPK1;CASP1;HSPA1B;IL7;TRIM44;PARP9;ADAM17;CD300LF;TRIM6;AXL
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5684292855654823,-1.3391374960027966,0.15087719298245614,0.34460651992337926,1.0,3/10,9.10%,BMP4;IRF1;GLI3
prerank,regulation of calcium ion transport (GO:0051924),0.36322570779789626,1.3381937675073832,0.06807511737089202,0.4860299426659004,1.0,15/54,12.82%,STC1;CACNA2D1;BCL2;EFHB;WNK3;CACNA1D;CAMK2B;HOMER1;PLPP4;ADRA2A;LILRA5;SRI;HRC;CCL5;CASQ1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.43759926009252437,-1.3378122938334176,0.11956521739130435,0.34687368614290365,1.0,9/26,21.22%,GCH1;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;POR;TERT
prerank,regulation of cell development (GO:0060284),-0.4102689833055318,-1.3374600913564858,0.0931899641577061,0.34711104975574375,1.0,9/36,17.95%,FOXO1;ADGRA2;HES1;NOTCH2;YAP1;AKT1;CTNNB1;HEY1;HEY2
prerank,melanosome transport (GO:0032402),0.4690586276273125,1.3373621879748123,0.1070615034168565,0.484069180524566,1.0,9/18,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,pigment granule transport (GO:0051904),0.4690586276273125,1.3373621879748123,0.1070615034168565,0.484069180524566,1.0,9/18,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.4170753149996367,-1.3372323858802133,0.08633093525179857,0.34711731526097916,1.0,8/30,10.98%,FLT1;MLLT3;KDR;ACE;BMP4;FLT4;TP53;PRRC2C
prerank,steroid catabolic process (GO:0006706),0.549396668408935,1.336670030724764,0.12445414847161572,0.48375440605854103,1.0,3/10,13.05%,CYP24A1;HSD17B14;SPP1
prerank,regulation of cellular senescence (GO:2000772),-0.43037862410481464,-1.3364369751698062,0.09507042253521127,0.3483042794187696,1.0,10/28,15.97%,NEK6;SLC30A10;AKT3;YPEL3;MAP3K3;ABI3;CDK6;CGAS;NUAK1;TERF2
prerank,embryonic digestive tract development (GO:0048566),-0.48996903696434146,-1.3354394287380003,0.12078152753108348,0.3498553156613429,1.0,9/18,26.96%,NIPBL;TGFB2;GLI3;PCSK5;PKDCC;RARB;FOXF1;RBPMS2;STRA6
prerank,positive regulation of transport (GO:0051050),-0.34026543385402314,-1.3343995366719759,0.058419243986254296,0.351501435168686,1.0,22/85,20.09%,DAB2;NEDD4L;CBLL1;GSK3B;ANXA2;RXRA;IL15;MERTK;GAS6;RAB27A;GSK3A;ACTB;FLOT1;CHP1;HIP1R;ABCA7;ANXA1;LMAN2;TULP1;CCL19;GATA2;GPC3
prerank,cell-cell junction assembly (GO:0007043),0.35101892076213653,1.3338741981412814,0.06164383561643835,0.489065236929361,1.0,21/63,11.59%,CDH18;CDH8;CTNND2;CDH20;CDH9;CDH10;EPB41L3;PKP2;DCHS1;CDH19;FLCN;CDH12;FSCN1;CLDN11;CDH7;GJB2;CDH24;CDHR3;GJB6;PATJ;CDH2
prerank,muscle cell migration (GO:0014812),-0.5727880211840226,-1.3331951215273394,0.14150943396226415,0.3534517623873065,1.0,6/10,25.21%,SIX1;ROCK1;CCN3;PLAT;ITGB3;THBS4
prerank,negative regulation of cell death (GO:0060548),-0.33734345636579316,-1.333119407267046,0.060714285714285714,0.3531532590310177,1.0,26/88,16.68%,MECOM;FERMT2;CD34;CD200;GSK3B;LRRK2;INPP5A;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;WNT16;AKT1;CHMP4B;CHMP4A;FGF2;RAD18;TM7SF3;WNT11;CCN5;PDE12;ATG5;CCN3;BMP7;FYN
prerank,pyroptosis (GO:0070269),-0.495572355026613,-1.3325242613143125,0.11711711711711711,0.3538739654132239,1.0,7/15,29.62%,CASP8;GSDME;APIP;CASP1;DHX9;TREM2;NLRC4
prerank,dorsal/ventral pattern formation (GO:0009953),0.46861862496594875,1.3322316656656952,0.14186046511627906,0.491038164338318,1.0,5/20,8.73%,DSCAML1;LHX1;NBL1;FBXL15;LMX1B
prerank,urogenital system development (GO:0001655),0.5235070989529933,1.3320045324408378,0.13194444444444445,0.48952470454384367,1.0,3/11,6.07%,LHX1;OSR1;PAX2
prerank,positive regulation of cellular process (GO:0048522),-0.27178522529086635,-1.331837187975927,0.0046875,0.3547341275854311,1.0,157/565,23.43%,FLT1;TJP1;LEF1;GRK5;IGF1R;KITLG;OSMR;SLC6A6;CLDN5;PARD3;INSR;ETS1;CAV1;RAC1;LRP5;LYN;ACER2;ANKRD17;ZFHX3;PDGFD;THBS1;CDK13;GCNT2;BMP5;ATM;TBX1;IL15;DDX3X;KDR;PRKD2;MERTK;PTPRJ;EGFR;IL6ST;CDKN1B;SMC5;TRPM4;TGFBR2;BMP6;HDAC1;IL6R;HES1;TNFRSF1B;GAS6;IRS1;STX3;IL34;CUL3;DNAJA2;LRP6;TGFB2;PTK2;PRKCD;LBP;AQP11;FGF1;BMP4;STAMBP;TGM2;TBX2;RAB27A;EPHA4;NOP2;FLT4;EXOSC2;LIFR;CELF1;MFSD2A;NAMPT;ADAM10;FGF7;TAL1;ACACB;AKT1;VEGFC;EDN1;DOT1L;AXIN2;PRKAA1;PTGFR;DICER1;LMNA;MAZ;EDN3;ACER3;FRMD5;RPTOR;NOTCH1;FGF2;RAD18;RPS6KA1;HDAC4;PA2G4;TPM1;CDC123;ACTN4;FLOT1;ASH2L;RHOG;MAPK8;RPS4X;MECP2;RPS6KA3;FAM98A;COPS9;HCFC1;H3-3A;AGPAT1;GAB2;N6AMT1;ABCA7;LGMN;IGF1;TRIM13;SRPK2;COX17;TRPC3;RARA;CTSH;LMAN2;TULP1;ADGRG1;CACUL1;RAD23A;CLCF1;TNFSF13;CITED2;TBC1D8;RNF10;GATA2;SOX4;CCND1;BRAT1;KRAS;CXCL12;PTEN;NSMCE4A;FGFR4;PRC1;IL13RA1;IGF2;MDM2;NACC1;S1PR3;PDGFRB;CHEK1;LAMC2;PTK2B;TTK;RELA;PTN;ESM1;MTPN;TBX3;HAS2;CEP131;FZD7
prerank,negative regulation of cellular senescence (GO:2000773),-0.5223221425392397,-1.330865047672772,0.12979890310786105,0.3561139337035307,1.0,6/13,21.22%,SLC30A10;AKT3;MAP3K3;CDK6;TERF2;TERT
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4755892853943239,1.330818992985873,0.12751677852348994,0.4903990035898728,1.0,9/17,20.73%,GGA3;NTRK2;SORL1;RTN4;CLU;APOE;RTN3;HAP1;RTN1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.3296663988607375,-1.3306418201124093,0.04804270462633452,0.3560823316411592,1.0,22/113,10.05%,TEK;RREB1;NRP2;BMPR2;BMP5;TBX1;KDR;PRKD2;EGFR;BMP6;FGF1;BMP4;STXBP4;NOTCH2;PRKD1;AKT3;YAP1;FLT4;PIK3CD;FGF7;AKT1;VEGFC
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.2812183268152904,-1.330535747075287,0.006589785831960461,0.35586093615372466,1.0,80/366,16.35%,APBB2;NFIA;RREB1;SMARCA2;ZNF423;ENG;ACVRL1;CREBBP;NSD1;RB1;BNC2;KAT6B;ERC1;INSR;ESR1;FOXN3;ANKRD17;ZFHX3;IRF2;APP;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;SOX13;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;ABL1;FOXO3;DNM2;TRRAP;NSD3;FUS;NFYC;GTF2IRD1;MEF2C;SLC39A8;ZBTB4;ASCC1;NAB1;LDB1;PRDM2;GPBP1;SPTY2D1;SP3;USP13;TP53;HMG20A;ORC5;PRRX2;SOX7;JMJD1C;CHD3;YAF2;NOTCH1;SFPQ;OGG1;OBI1;TAF5L;ATF4;MZF1;RPL10;GPBP1L1;NR1D2;HCFC1;TCF3;TCF7L1;FOXC1;MYBL2;NAB2;UBE2L3;FOXO4;CREBL2;HIC1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.42768419650820866,-1.3304740295082584,0.09944751381215469,0.3555501970348731,1.0,11/31,15.35%,PPP1R13B;GSK3B;YWHAE;YWHAZ;NMT1;GSK3A;CASP8;TP53;MAPK8;BBC3;HIP1R
prerank,mammary gland development (GO:0030879),0.44768252347298254,1.330365764047666,0.12387387387387387,0.48948808407368155,1.0,3/21,1.29%,NRG1;ERBB4;WNT7B
prerank,double-strand break repair (GO:0006302),-0.30938228941399104,-1.3291155469102276,0.030716723549488054,0.35792597603795795,1.0,70/158,32.37%,ATM;UIMC1;DTX3L;KDM2A;SMC5;SAMHD1;ZFYVE26;XRCC4;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;TENT4A;RAD54B;NSMCE2;SFPQ;RPA3;DNA2;KAT5;RPA1;BABAM2;MAPK8;NHEJ1;RNF168;UBE2V2;PALB2;MAD2L2;HERC2;SUMO1;RFWD3;HPF1;BRCC3;WRN;RPA2;BAP1;SMARCAD1;PRKDC;PIAS4;LIG4;BRCA1;RAD51AP2;BAZ1B;DCLRE1B;BLM;YY1;MORF4L1;HMGB1;INO80;DCLRE1A;APBB1;PARP9;TRIP13;POLL;XRCC2;AP5Z1;APLF;KDM4D;RAD51AP1;MDC1;TDP1;SWI5;RAD51D;HUS1B;CYREN;KDM4A;RMI1;MEIOB;PARP3
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.576401903897084,-1.3282699511459046,0.13611615245009073,0.35912329891984995,1.0,2/10,14.03%,GNB1;SAG
prerank,histone deacetylation (GO:0016575),-0.38758089398027484,-1.3282145404129793,0.0711743772241993,0.35878515656519844,1.0,17/43,23.74%,MIER1;PRDM5;RCOR1;HDAC1;MIDEAS;SIN3A;HDAC4;SFPQ;MIER2;HDAC6;HDAC10;MIER3;ELK4;SMARCAD1;TBL1X;SUDS3;MORF4L1
prerank,synaptic vesicle endocytosis (GO:0048488),0.4046900243759345,1.3279908959855815,0.1087962962962963,0.49339883430562587,1.0,7/33,6.12%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG;DNM1
prerank,mitochondrial genome maintenance (GO:0000002),-0.5485264156334759,-1.327893614519088,0.13941480206540446,0.3589601961459651,1.0,3/11,8.59%,MEF2A;TOP3A;AKT3
prerank,regulation of centriole replication (GO:0046599),-0.47721510358405245,-1.3278681737651261,0.1359724612736661,0.3585565251879295,1.0,7/18,25.55%,KAT2B;CENPJ;PLK2;ALMS1;PLK4;BRCA1;CEP295
prerank,regulation of translational initiation (GO:0006446),-0.35674155675044256,-1.3276079946867037,0.0626118067978533,0.3586746307309923,1.0,35/63,36.89%,EIF3H;EIF4H;EIF3E;DDX3X;LARP1;NCK1;EIF3B;POLR2G;EIF2B2;NCK2;CDC123;KLHL25;ATF4;AGO2;TPR;CTIF;GLE1;EIF2AK3;KHDRBS1;EIF2AK4;EIF5B;DNAJC3;MTIF2;EIF4G3;BOLL;EIF4A2;CEBPB;ATF3;EIF2B5;PAIP2B;MIF4GD;ALKBH1;EIF4EBP1;EIF4EBP3;PAIP2
prerank,ERBB signaling pathway (GO:0038127),-0.3574854824158278,-1.3267742726728473,0.06293706293706294,0.3598439529271411,1.0,17/64,11.38%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;PTPN12;SLC30A10;CBL;PIK3R1;PTK2;PIK3C2A;PLCE1;MAPK1;BCAR1;AKT1;NCK2;BRAF
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.44569754374153814,-1.3264417587763353,0.12962962962962962,0.36001028771322396,1.0,6/25,7.91%,CAV1;FAM20A;CNNM2;TMTC2;TRPM7;CNNM4
prerank,muscle contraction (GO:0006936),-0.318007956642065,-1.3264415634249695,0.044964028776978415,0.35955400091003864,1.0,35/126,22.04%,UTRN;SORBS1;MYOF;GJC1;EDNRA;TPM3;ITGA1;EMD;DYSF;PXN;ITGB5;TMOD3;SNTB1;MYH11;ACTA2;ROCK1;ASPH;MYLK;CHRNB1;MYOM1;ARHGEF11;LMOD1;TPM1;SORBS3;ROCK2;SSPN;CALD1;CASQ2;MYL6;MYL12B;SMTN;GAMT;VCL;SNTA1;NOS1
prerank,myoblast fusion (GO:0007520),0.5325558978929534,1.3259320966986248,0.14385150812064965,0.4965968036268854,1.0,4/12,6.52%,ADAM12;ADGRB3;ADAMTS15;CD81
prerank,cellular response to gamma radiation (GO:0071480),-0.48061683635568186,-1.3256873060556686,0.1051693404634581,0.36055152153332987,1.0,6/17,10.11%,MAP3K20;TLK2;ATM;YAP1;RPL26;TP53
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.37534662959088433,-1.3251677929608314,0.08170515097690942,0.36119671217239546,1.0,22/54,24.96%,NXN;DCUN1D3;CAV1;IVNS1ABP;AKT1;SMAD7;SPOPL;CHP1;COPS9;TNFAIP3;N4BP1;RPL5;SENP2;CTNNB1;RPS3;SOX4;OGT;SH3RF2;ARRB1;HSPA1B;PINX1;ADGRB1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5150232718692243,-1.3251362589660158,0.13430127041742287,0.36080988495109517,1.0,4/14,10.55%,ZEB1;CAV1;SPRED2;NOTCH4
prerank,apical protein localization (GO:0045176),-0.5512832885451544,-1.325046360240445,0.14160839160839161,0.3605349820176424,1.0,4/10,12.61%,ATP8B1;SHROOM3;SHROOM2;ACTB
prerank,positive regulation of JNK cascade (GO:0046330),-0.3472808708298236,-1.324942608546782,0.06352087114337568,0.360276830802932,1.0,25/70,24.66%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TAOK3;TPD52L1;TNFRSF19;MTURN;CCL19;EDAR;NOD2;DUSP22;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.3017722715344328,-1.3239016996044697,0.026455026455026454,0.36192316636019306,1.0,45/199,17.95%,PTPRG;DAB2IP;KLF7;NFIB;ZNF423;RB1;NOS3;BMPR2;IL17RD;CORO1C;GSK3B;MCC;BMP5;RPS6KA5;WWC2;ID1;SPRED2;IL15;SRGN;EGFR;LDLRAD4;LAMA4;GAS6;NOVA2;BMP4;MEF2C;RAB11FIP3;ROCK1;GSK3A;ADAMTS5;RGCC;SMAD7;ADM;NOTCH1;WNT11;ASB1;ATF4;N4BP1;ROCK2;SMAD6;MAD2L2;PCTP;PAEP;HEY1;HEY2
prerank,calcium ion import (GO:0070509),0.41250662364896556,1.3238935884493235,0.10835214446952596,0.49959753680705016,1.0,10/28,17.93%,MS4A1;SLC25A23;CACNA1B;CACNA1A;CACNA1D;CACNA1E;SLC8A1;MCU;CACNA1G;CACNA1I
prerank,cellular response to ATP (GO:0071318),0.49761179086345414,1.3236079706386246,0.13013698630136986,0.49827780935571064,1.0,4/14,14.11%,RYR3;CIB2;P2RX3;TAF1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3140154923906513,-1.3236064811729413,0.03411131059245961,0.36203876250019057,1.0,33/149,18.97%,PRKCH;EDA;ERC1;ROR1;CAV1;TAB3;NOD1;TRAF5;TRIM25;APP;RPS6KA5;PRKD2;SLCO3A1;TFRC;NFKB1;NFKBIA;ZBTB7A;PRKD1;ARHGEF2;CFLAR;RNF25;TRIM14;IRAK1;MTDH;FLOT1;CD40;TAB2;TRIM13;IRAK2;RPS3;IKBKG;IKBKB;NOD2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.4367527131120019,-1.3234979038887726,0.122040072859745,0.361789295486798,1.0,10/25,24.52%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;ARNT;PRKDC;MAPK11;HSPA1B
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5361479636455668,-1.3234187421774906,0.1258741258741259,0.3615132897942601,1.0,6/12,20.89%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4045061766656522,-1.3231908125436276,0.11208406304728546,0.3615523627876195,1.0,10/34,15.36%,CTNNA1;MFHAS1;NEDD4L;GSK3B;PICALM;LATS2;SIN3A;TAX1BP3;ILRUN;ROCK2
prerank,nucleic acid metabolic process (GO:0090304),-0.3508476737368336,-1.322678422053751,0.05328596802841918,0.3621109437451886,1.0,26/69,27.56%,RBFOX2;METTL14;NT5E;HNRNPA0;HNRNPR;HNRNPM;POLR2G;HNRNPA3;WTAP;HNRNPF;XRN2;DNA2;PDE12;HNRNPA1;WRN;WDR74;PCBP1;POLR2C;POLR2L;POLR2H;HNRNPL;HNRNPD;DXO;RAN;MMS19;HNRNPU
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.42337115444157325,-1.3223736223684956,0.11891891891891893,0.36226538119473845,1.0,10/29,20.17%,DAB2IP;IL17RD;BMP5;SPRED2;LDLRAD4;SMAD7;FUZ;MAD2L2;PPP2CA;PTEN
prerank,regulation of hormone secretion (GO:0046883),-0.5079422011093332,-1.3221071191723295,0.1407942238267148,0.36231131979785675,1.0,9/15,38.26%,EDN1;EDN3;ANXA1;VAMP3;VAMP2;NMB;IL11;LIF;SNX6
prerank,chromatin disassembly (GO:0031498),-0.5200476660188689,-1.3215761551111962,0.1346153846153846,0.36248056585555183,1.0,5/14,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,nucleosome disassembly (GO:0006337),-0.5200476660188689,-1.3215761551111962,0.1346153846153846,0.36248056585555183,1.0,5/14,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,response to glucocorticoid (GO:0051384),-0.43863092931855663,-1.3209674695396174,0.11375212224108659,0.36324994593364535,1.0,10/26,27.56%,NR3C1;ADAM9;SLIT2;FAM107A;UBE2L3;BCL2L11;ANXA1;PDCD7;ZFP36L1;HNRNPU
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3259077654865361,-1.3208204291997132,0.04013961605584642,0.3630634604947737,1.0,33/113,18.94%,UNC13B;DAB2IP;FERMT2;TRABD2B;ASAP1;MPP7;ESR1;GSK3B;ATM;DDX3X;TFRC;RBX1;RASIP1;SPIDR;CDH5;RAP1B;ERCC2;TAL1;TP53;FNIP2;ICE1;LCP1;RPA3;RPA1;RHOC;SLF2;ERCC3;PSMC2;BCL2L11;SUMO1;GBP5;RPS3;RPA2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5265463436072808,-1.3204302789465239,0.11504424778761062,0.3634099163854291,1.0,6/13,20.89%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.33820761103146213,-1.3202035358292734,0.06292517006802721,0.3634604097617113,1.0,33/87,27.78%,FBXL7;RB1;DCUN1D3;KLF4;PKD2;PSMA2;RBX1;DLG1;PSME2;PSMB4;FAM107A;RGCC;CDC73;CDK6;PSMC2;PSMB2;PSMB1;PSMA8;CDK2AP2;PSME1;PTEN;PSMD4;CDKN2C;PSMA7;FHL1;PSMD5;E2F7;PINX1;ZFP36L1;PSMB10;APC;PSMA3;CDKN2B
prerank,cellular metal ion homeostasis (GO:0006875),0.3222099697052477,1.320200016397443,0.050997782705099776,0.5048369940348042,1.0,19/102,12.58%,SLC24A4;SLC24A2;HTR2C;KCNMA1;ATP1A2;STC1;ATP12A;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;ATP4A;CCL13;ATP13A2;SLC8A3;SLC8A1;CCL5
prerank,plasma membrane repair (GO:0001778),-0.5223636104844411,-1.3199315089908228,0.14361702127659576,0.36361953270420844,1.0,4/13,6.64%,MYOF;MYH9;DYSF;AHNAK2
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.28326820998128527,-1.319815159232653,0.01015228426395939,0.3634067504196579,1.0,67/308,18.51%,LEF1;PRKCH;IGF1R;RREB1;ZBTB16;GHR;FERMT2;CAV1;DAB2;BMPR2;SMURF2;GCNT2;ADRA1B;ADIPOR2;PRDM16;IL15;SHLD1;MTOR;SMO;TFRC;TRPM4;TGFBR2;KMT5B;SIX1;GAS6;PLCB1;TGFB2;MED1;STAT6;LBP;BMP4;SMAD2;RBM19;UCP2;ROCK1;GRB10;SMAD4;ACADL;PIK3CD;EHMT1;KDM6B;IL4R;AXIN2;KDM3A;RGCC;JAK2;FGF2;FLOT1;AGO2;B4GALT5;FOXC1;AGPAT1;MIF;ABCA7;TRIM16;C1QTNF3;MAD2L2;NPR1;ALMS1;SIX4;CTNNB1;ACSL1;CMKLR1;SOD1;CFL1;EPAS1;LURAP1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3067219907586031,-1.3196073224436737,0.028380634390651086,0.3633611528305494,1.0,43/173,17.73%,SPTBN1;SPTAN1;SEC31A;SEC24B;VTI1A;COG5;CTSC;COG1;TRAPPC3;ARCN1;RAB1A;PROS1;RAB2A;IER3IP1;GAS6;SEC24A;ATL2;CUL3;SEC16B;CD55;SEC24D;KLHL12;SEC13;COPG1;SCFD1;BET1L;KDELR3;BCAP31;COPA;DCTN1;DCTN3;COPE;TRAPPC12;ERGIC2;USE1;CTSZ;TBC1D20;F5;TFG;LMAN2;TMED5;VAPA;CAPZB
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3889788203666044,-1.319485416236666,0.10233393177737882,0.363179049063475,1.0,12/43,9.17%,ZHX3;FERMT2;LRP5;BMPR2;IL6ST;BMP6;IL6R;BMP4;MEF2C;PRKD1;YAP1;ACVR2A
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3515320209154662,-1.3191376287678738,0.09507042253521127,0.3634271337577202,1.0,26/70,22.47%,TEK;RB1;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;MEF2C;SIPA1L3;ILK;RHOA;LAMA5;ACTN1;LAMC3;ITGA4;ATF4;ATRNL1;VAMP3;EPHA2;FERMT3;ITGB3;LAMB1;USH2A;EPHB3
prerank,regulation of DNA repair (GO:0006282),-0.3837882209415549,-1.3184757470901884,0.1043956043956044,0.3643278265394083,1.0,17/44,20.86%,UBR5;EYA4;DEK;UIMC1;EGFR;TRIP12;AXIN2;BABAM2;RNF168;UBE2V2;ERCC8;CEBPG;BRCC3;RPS3;USP1;BRCA1;TRIM28
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.33641342693984677,-1.3182589164334586,0.05850091407678245,0.36429696805833817,1.0,28/85,20.92%,DAB2IP;ACVRL1;TIE1;LIMS1;MCC;BMP5;TBX1;EGFR;TGFBR3;BMP6;TGFB2;AQP11;FGF1;BMP4;PRKD1;YAP1;FGF7;FGF2;CDC73;CDK6;GPX1;ANGPT1;IGF1;SIX4;NOD2;PRKDC;TCF7L2;LAMB1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5611834942679557,-1.318224202176865,0.14258555133079848,0.3639161561453023,1.0,5/10,31.28%,ACADL;ACAD11;ACADVL;IVD;ACADS
prerank,positive regulation of nuclear division (GO:0051785),-0.4414766316301836,-1.3181971429671966,0.12244897959183673,0.3635284728668061,1.0,13/25,35.49%,INSR;LRP5;EDN1;RGCC;EDN3;IGF1;IGF2;PDGFRB;BTC;AURKA;PHIP;IL1A;DRD3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.45673147325925,-1.3176391775212515,0.1037567084078712,0.3641487281775242,1.0,11/20,30.97%,RPS6KA5;DIP2B;PRKAA1;RUVBL2;SOX4;BRCA1;NOS1;ARRB1;DIP2A;GLYR1;RPS6KA4
prerank,cell projection assembly (GO:0030031),-0.45254147848935544,-1.3173144754462793,0.11713286713286714,0.36435333187030744,1.0,7/22,14.72%,PARVB;RAC1;RHOJ;PARVA;RHOQ;RHOG;NCKAP1
prerank,regulation of actin filament-based process (GO:0032970),-0.3487725564480638,-1.3169897415815122,0.06785714285714285,0.364625856845284,1.0,21/70,15.36%,RAC1;RHOBTB1;IQGAP1;F11R;RND3;CRK;MTOR;RICTOR;ABL1;RHOQ;PRKCD;CDK10;EZR;ROCK1;FAM107A;ARHGAP17;RHOA;RHOC;RHOG;HIP1R;ROCK2
prerank,steroid biosynthetic process (GO:0006694),0.3546688774477259,1.3168441969806985,0.07760532150776053,0.5115163654735203,1.0,12/56,13.40%,AKR1D1;CYP46A1;INSIG1;LSS;CYP51A1;SC5D;OSBPL6;SQLE;CYP27A1;CYP11B1;FDFT1;OSBPL9
prerank,glial cell differentiation (GO:0010001),0.4096005645837742,1.3165461235165983,0.09750566893424037,0.5102041282620731,1.0,9/28,12.81%,MYRF;CDK5;MMP24;PTPRZ1;PAX2;GPC1;CDH2;SLC8A3;TPPP
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.30724950161551684,-1.316264709623906,0.03677758318739054,0.36558885327860136,1.0,58/148,27.65%,PPP1R13B;ATM;RPL37;MTOR;KAT6A;PIP4K2A;TOP3A;RICTOR;HDAC1;PHF20;PAK1IP1;PIP4K2B;MRE11;NOP2;USP2;RBBP8;TAF11;AKT1;TP53;EHMT1;PRKAA1;CHD3;RPA3;DNA2;KAT5;RPA1;KMT5A;NUAK1;RPL5;TAF7;HIPK1;TAF3;CDK5RAP3;WRN;RPA2;PRKAB1;USP7;BOP1;PRDM1;BRCA1;RRS1;MDM2;BLM;RFC4;TAF4B;CHEK1;RPS15;TAF13;MAPK11;CCNG1;TAF9;TAF15;PLK3;PPP1R13L;PRR5;RNF34;PPP2R5C;EXO1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.47696333561796256,-1.3158093631978571,0.13780918727915195,0.3660593199656819,1.0,8/17,19.69%,LYN;MID1;TGFB2;ARL6IP5;TAOK3;SEMA4C;NOD2;KLHDC10
prerank,lipid transport (GO:0006869),-0.32730584538145907,-1.3153119740270258,0.04923599320882852,0.3666123076542503,1.0,36/97,26.99%,ABCC4;PITPNC1;ATP8B1;CERT1;PLTP;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SPNS2;LBP;ABCD3;SLCO2B1;PPARD;SCARB1;MFSD2A;ABCA9;SLC27A4;CEACAM1;ABCA7;TNFAIP8L3;MFSD2B;PCTP;ACSL1;PRELID2;GLTP;OSBPL2;ABCA6;PITPNA;SLC10A3;PEX3;SLC27A3;ABCG4;STARD5;SLCO1B1;FABP3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4960785160515742,-1.3149063405186907,0.1226252158894646,0.3669349292677792,1.0,4/15,12.72%,PRKCH;NFKB1;AGTR1;LPL
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3435781687819977,-1.314854121927122,0.058419243986254296,0.36661071512170135,1.0,29/80,25.90%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;RBX1;CUL3;GSK3A;FAM107A;NSMCE3;SMAD7;MAGEC2;FANCM;UBE2L3;DCUN1D2;ANGPT1;SENP2;CDK5RAP3;PHF23;HUWE1;BRCA1;DCUN1D5;NDFIP2;AMER1;RCHY1;TRIB3;FANCI;RPS2;PEF1
prerank,artery development (GO:0060840),-0.43693937772340974,-1.3146268185380312,0.12607944732297063,0.366625358864644,1.0,9/23,11.55%,ENG;ACVRL1;PKD2;BMPR2;TBX1;HES1;PDE2A;HECTD1;SMAD7
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.45825283758301494,-1.3143640814392756,0.11594202898550725,0.36670164099667046,1.0,7/20,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;NUMB
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3605057332194504,-1.3140362871395457,0.08839779005524862,0.3669502169625846,1.0,23/57,27.63%,PAK1IP1;RPL26;RPL38;NIP7;RPS16;TGS1;RPL5;WDR74;RPL35A;DDX31;BOP1;PES1;RRS1;EBNA1BP2;RPS7;RPS15;NOP16;RPS17;GLUL;NAF1;BYSL;EMG1;WDR12
prerank,alcohol catabolic process (GO:0046164),0.5444616852568452,1.3134098884804035,0.16933638443935928,0.5162074826801896,1.0,4/10,14.63%,AKR1D1;CYP46A1;CYP27A1;APOE
prerank,autophagosome assembly (GO:0000045),-0.3709537332416463,-1.3133618090726458,0.08145580589254767,0.3678888114916372,1.0,22/52,27.26%,ATG7;RAB7A;RAB1A;SMURF1;MAP1LC3B;AMBRA1;IRGM;WIPI1;GABARAP;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;ATG2A;RAB19;ATG2B;UBXN2A;ATG3
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4901150514471118,-1.3125982558222116,0.1478743068391867,0.36895419120741774,1.0,5/16,7.52%,RREB1;SOX13;SIX1;FTO;NAPEPLD
prerank,cytosolic transport (GO:0016482),-0.3281557961905873,-1.311932474665227,0.05090909090909091,0.3698482202536535,1.0,32/108,23.00%,VPS13A;MYO1D;VTI1A;ERC1;EPS15;RAB7A;TMEM87B;HEATR5A;VPS54;RAB5A;STX8;VPS13C;BET1L;GAK;DCTN1;VPS26A;ANKFY1;AP1G1;VPS52;TBC1D23;CORO7;AP4M1;ANKRD27;WASHC1;VAMP3;AKTIP;TBC1D17;CLN5;SPAG9;KIF16B;EVI5;BECN1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3191735598348243,-1.3118669201142046,0.045936395759717315,0.3695600142195848,1.0,45/114,27.42%,EDA;LIMS1;TRAF5;TMSB4X;PSMA2;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;PSMB4;TP53;ILK;JAK2;ACTN4;EIF5A;CD40;PSMC2;PSMB2;PSMB1;TNFRSF1A;TNFRSF11B;PSMA8;MAP3K14;EDAR;TNFSF13;IKBKB;PSME1;TNFRSF25;PSMD4;TNFSF8;PSMA7;PTK2B;LTBR;RELA;RIPK1;PSMD5;TNFSF12;ADAM17;PSMB10;TNFRSF9;TNFRSF12A;PSMA3;BAG4
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.32407308375408284,-1.3118200549882097,0.04990757855822551,0.3692128013220003,1.0,32/104,20.88%,BMPER;CRIM1;CAV1;BMPR2;SMURF2;IL17RD;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD1;SMAD2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;CCN3;SMAD6;SKI;PMEPA1;HTRA3;SMAD9;DAND5;PPARG;SNX25;STRAP
prerank,lysine metabolic process (GO:0006553),-0.5229792746637778,-1.311437893194856,0.15675675675675677,0.36910726646798636,1.0,5/12,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,lysine catabolic process (GO:0006554),-0.5229792746637778,-1.311437893194856,0.15675675675675677,0.36910726646798636,1.0,5/12,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3608314085561647,-1.3111795176071375,0.08185053380782918,0.36915840514411347,1.0,14/58,9.03%,SGMS1;CERT1;ST3GAL4;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ST3GAL2
prerank,regulation of acute inflammatory response (GO:0002673),-0.47078516011775867,-1.3106761262767728,0.13440860215053763,0.36976090111024607,1.0,2/18,4.57%,OSMR;IL6ST
prerank,cellular response to glucose stimulus (GO:0071333),-0.41217888152057663,-1.3106079725922881,0.1068840579710145,0.36945660353055726,1.0,6/30,10.64%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,regulation of lipid kinase activity (GO:0043550),-0.5473709548786495,-1.3100318570131446,0.15302491103202848,0.37019104958876303,1.0,3/11,5.82%,RB1;PPP2R5A;PIK3R1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.522260947342413,-1.3099974860775014,0.13857677902621723,0.3698216911683341,1.0,4/13,7.52%,RREB1;SOX13;SIX1;NAPEPLD
prerank,lipid droplet formation (GO:0140042),0.5510220987499196,1.309818876665996,0.16810344827586207,0.5234417576999508,1.0,4/10,17.75%,BSCL2;SQLE;AUP1;CDS1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.46349964695808676,-1.309611599346934,0.13725490196078433,0.3701976546321329,1.0,9/17,36.26%,KLF4;TMSB4X;ANXA4;ANXA1;ARRB1;CACTIN;TLR6;CD33;MAPKBP1
prerank,ion homeostasis (GO:0050801),0.39664499515087415,1.3095160061838529,0.11007025761124122,0.5221183720561935,1.0,7/30,7.88%,UNC80;SLC4A4;SLC4A5;WNK2;SLC4A2;WNK3;SLC12A5
prerank,sulfate transport (GO:0008272),-0.5022466507703615,-1.3091675429575151,0.15879017013232513,0.3706847890084022,1.0,5/14,16.49%,SLC26A7;SLC26A2;SLC13A4;SLC25A11;SLC26A11
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.4555401273426378,-1.307966967137147,0.13725490196078433,0.3726878865286187,1.0,9/21,24.72%,THBS1;MTUS1;IL34;PTK2;MAPK1;MIF;CMKLR1;PTK2B;DDT
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3978441308979271,-1.3078382600165004,0.10017574692442882,0.3724789747030447,1.0,14/36,21.87%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;PHC3;CHEK1
prerank,cellular response to hydroxyurea (GO:0072711),-0.5538841179271276,-1.307620999414107,0.15934065934065933,0.3725059615060603,1.0,7/10,21.31%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,cellular copper ion homeostasis (GO:0006878),-0.502282023279037,-1.3075240234821723,0.14917127071823205,0.37225706373471135,1.0,3/14,4.50%,APP;ATOX1;SLC31A1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3764269054542358,-1.3074641079867693,0.0925589836660617,0.3719395035371473,1.0,15/48,13.32%,RREB1;DOCK1;FERMT2;RAC1;CUX1;LIMS2;LIMS1;CRK;ABL1;FLNA;CUL7;FBXW8;ILK;NEDD9;MYOC
prerank,diacylglycerol metabolic process (GO:0046339),0.432692035945559,1.3068683712689868,0.12694877505567928,0.5270968121207875,1.0,6/23,12.65%,DGKK;DGKI;DGKQ;ANG;PGS1;MOGAT1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.4353412821454757,1.3064333651337305,0.10550458715596331,0.5260828255072499,1.0,6/20,12.58%,VTN;IGFBP3;NDRG4;SORL1;PDGFA;CCL5
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.44324165406759114,-1.306370701346252,0.1284722222222222,0.3736526368069891,1.0,8/21,20.46%,SLC30A10;PPARA;SIRT5;AATF;ABCB7;HDAC6;COA8;BRCA1
prerank,neural crest cell migration (GO:0001755),-0.38774468942371754,-1.3062702708751164,0.11992945326278659,0.3734363095272835,1.0,12/36,18.35%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,release of cytochrome c from mitochondria (GO:0001836),0.45922129218666896,1.3053202479396333,0.1463963963963964,0.5268979884710363,1.0,9/17,25.59%,BCL2;GGCT;FZD9;CLU;MFF;FIS1;DNM1L;SFN;BOK
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5035714936429371,1.3049005287595312,0.17286652078774617,0.5258876559429431,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,ventricular septum morphogenesis (GO:0060412),-0.41869033038838066,-1.3047373899972885,0.11478260869565217,0.37600472244821453,1.0,15/27,19.06%,BMPR2;TGFBR3;TGFBR2;HES1;SLIT2;TGFB2;BMP4;SMAD4;SMAD7;ZFPM1;NOTCH1;HEY1;HEY2;CITED2;SOX4
prerank,regulation of MAPK cascade (GO:0043408),-0.3043538302860533,-1.304456007238903,0.04421768707482993,0.37616222847657416,1.0,40/157,16.73%,FLT1;TEK;DAB2IP;IGF1R;JCAD;ROR1;INSR;CAV1;LYN;IQGAP1;ADRA1B;PAK2;TBX1;KDR;PTPRJ;EGFR;TGFBR3;STK3;PPEF2;FAS;MAPK1;ROCK1;YWHAZ;FLT4;PLCG2;RRAS;TAOK3;PEBP1;FGF2;CEACAM1;DUSP3;MYOC;KSR1;MAP4K4;IAPP;ROCK2;ABCA7;PELI2;IGF1;GSDME
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.37849455134003984,-1.30389918817491,0.10215053763440861,0.3768701147306603,1.0,10/45,14.33%,DYRK1A;EGFR;NFKB1;PIK3R1;WDR75;BMP4;ERN1;TP53;ZPR1;RBM20
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5063235264156253,-1.3035274042674874,0.15384615384615385,0.3772385054375985,1.0,3/14,5.78%,PKD2;TMSB4X;NFKBIA
prerank,positive regulation of cell cycle (GO:0045787),-0.3495747317589194,-1.3034606511289046,0.0843585237258348,0.37692518061367297,1.0,30/62,27.04%,PKD2;ANKRD17;APP;EGFR;CDKN1B;LRP6;CCND3;TGFB2;USP2;TAL1;AKT1;CCNY;RGCC;DUSP3;PKN2;HCFC1;SMOC2;LGMN;SRPK2;RARA;RAD23A;CITED2;CCND1;MDM2;CHEK1;TBX3;CCNYL1;ADAM17;RPS15A;USP19
prerank,stress-activated MAPK cascade (GO:0051403),-0.36033335439394537,-1.3032417196401673,0.08876811594202899,0.37693621207737754,1.0,25/61,27.01%,MAP3K20;TAB3;NOD1;MAP3K5;MAP4K3;NFKB1;MAPK1;IRAK1;FBXW11;MAP3K8;MAPK8;TNFRSF19;MAP2K4;TAB2;IRAK2;IKBKG;IKBKB;NOD2;MAP2K3;MAPK11;SH2D3C;MAP3K7;GPS2;ZFP36L1;LGALS9
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.4544551186855836,-1.3031006533636944,0.1350844277673546,0.37680272562819817,1.0,12/19,32.44%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;PDCD6IP;HSPA1B;CHMP3;HNRNPU;CCSAP;CHMP1A;PLK1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.40445788547305744,-1.3030486984372212,0.12410071942446044,0.37646571230286824,1.0,13/33,22.61%,KLF4;ETS1;TEAD1;NR3C1;FOXO3;TGFB2;JUN;TP53;FGF2;GATA2;PPARG;TERT;RELA
prerank,axonal fasciculation (GO:0007413),0.5026815755430419,1.3029858876066185,0.16743119266055045,0.5290045273919626,1.0,4/12,8.65%,CNTN4;NRCAM;MEGF8;RTN4
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5137554299200474,-1.3025858754736173,0.14154411764705882,0.37692754033533826,1.0,8/13,27.32%,TNRC6B;POLR2G;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.3583487138460864,-1.3022786749743753,0.08856088560885608,0.377156725558062,1.0,29/57,32.44%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TP53;TAOK3;BABAM2;RFWD3;FANCD2;CDK5RAP3;BRCC3;SDE2;RPA2;CCND1;PRKDC;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL;RINT1;FBXO31;MDC1;HUS1B;RPS27L;PLK1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3423603846394984,-1.302195132634653,0.08394160583941605,0.3768960929769185,1.0,22/73,20.36%,KITLG;CBFB;TCF12;PSMA2;LMO2;METTL14;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;PSMC2;TCF3;FOXC1;PSMB2;PSMB1;PSMA8;PSME1;GATA2;PRKDC;PSMD4
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.46490935839007647,-1.3015033841751449,0.15514018691588785,0.37789636210341865,1.0,4/17,3.37%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,positive regulation of macroautophagy (GO:0016239),-0.3728209600076154,-1.301397173684513,0.09786476868327403,0.37766506101444,1.0,14/48,18.44%,RAB3GAP1;GNAI3;SESN1;KDR;PIP4K2A;LARP1;PIP4K2B;IRGM;BNIP3;RAB3GAP2;SPTLC1;VPS13D;TRIM13;IKBKG
prerank,protein acylation (GO:0043543),-0.39459194656122826,-1.3005797812740978,0.1140819964349376,0.37879657594502103,1.0,7/38,8.25%,FOXO1;CREBBP;KAT2B;ZDHHC6;KAT6A;ZDHHC3;NAA80
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.5263920885427712,-1.3005717871806444,0.1602112676056338,0.37836848470106865,1.0,6/12,20.77%,SRR;MTHFD1;SERINC3;SERINC5;SEPHS2;CTH
prerank,positive regulation of protein processing (GO:0010954),0.44446794365400427,1.300422997938995,0.1415525114155251,0.5336804704917752,1.0,7/19,16.65%,MELTF;CLEC3B;GSN;PLGRKT;NKD2;ADAM8;KLKB1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4826120074686565,1.300093272488111,0.15529411764705883,0.5324659329589989,1.0,5/15,11.91%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,calcium ion transport (GO:0006816),0.3063935818795567,1.2999173720127344,0.05077262693156733,0.5308374649006244,1.0,20/113,8.07%,TRPM3;SLC24A4;SLC24A2;MS4A1;RYR3;CACNA1B;ATP2B4;ATP2B2;CACNA2D1;CACNA1A;CACNB3;CACNG8;CACNA1D;SLC8A2;SELENOK;RYR2;TMCO1;CACNG3;CACNA1E;TRPM1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5304797096634087,-1.2997299923625945,0.16374269005847952,0.3796808340612846,1.0,5/12,16.25%,TAF11;TAF1B;BDP1;DR1;TAF7
prerank,cellular response to interleukin-12 (GO:0071349),-0.3689884525219771,-1.2992265055134793,0.09515260323159784,0.38024364141154854,1.0,16/48,18.29%,ANXA2;JAK1;PAK2;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;JAK2;HNRNPF;LCP1;TALDO1;MIF;SOD1;CFL1
prerank,B cell receptor signaling pathway (GO:0050853),0.3930237641563023,1.2985124502300902,0.12147505422993492,0.5326085461474187,1.0,5/32,3.49%,BLK;MS4A1;BLNK;NFATC2;BCL2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.41860431203483384,-1.2983351164206964,0.1261101243339254,0.38173758084271486,1.0,18/29,36.90%,DCUN1D3;DTX3L;ABL1;FEM1A;SMAD7;MAGEC2;FEM1B;UBE2L3;DCUN1D2;DCUN1D5;TRIB3;RPS2;BAG5;PLK1;PARK7;BMI1;TOPORS;FBXO5
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.2966302135687029,-1.298204192981821,0.040492957746478875,0.3815666209296546,1.0,62/175,26.87%,DAB2IP;EDA;LIMS1;TRAF5;TMSB4X;PSMA2;CCL25;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;ARHGEF2;PSMB4;AKT1;TP53;ILK;JAK2;ACTN4;EIF5A;CD40;ZFAND6;PSMC2;PSMB2;ASAH1;PSMB1;TNFRSF1A;TNFRSF11B;GSDME;PSMA8;RPS3;CCL19;MAP3K14;EDAR;TNFSF13;IKBKB;HYAL2;PSME1;TNFRSF25;PSMD4;BRCA1;TNFSF8;PSMA7;PTK2B;LTBR;NFE2L2;RELA;RIPK1;HAS2;PSMD5;GBP3;ADAMTS7;DHX9;ERBIN;TNFSF12;ZFP36L1;ADAM17;PSMB10;TNFRSF9;TNFRSF12A;PSMA3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5293623730313265,-1.2978028276025857,0.16512059369202226,0.3819815173647266,1.0,6/12,27.56%,CDYL;PCGF3;BRCA1;PCGF5;RBM15;HNRNPU
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.39632813645368065,-1.2970825892135338,0.11206896551724138,0.38309310415233044,1.0,15/37,23.29%,CAV1;NCK1;TP53;BCAP31;SFPQ;EIF5A;BBC3;BCL2L11;GSDME;SOD1;RPS3;SIAH1;RPS7;BECN1;MSX1
prerank,cellular protein metabolic process (GO:0044267),-0.27341069304065047,-1.2967644295018301,0.010221465076660987,0.3833193728916071,1.0,151/396,30.54%,DAB2IP;IGFBP7;ST3GAL6;ST3GAL1;PLOD2;MSRB3;ST8SIA4;APP;RRBP1;RPS21;IGFBP4;RPL37;PARP4;MMP2;RPL31;YES1;CSNK1G3;RPL9;GAS6;RPS14;ABL1;PSEN2;SPPL3;BMP4;RPSA;PDIA6;PHKA2;DENND3;AFG3L2;PCSK5;RPL3;RPLP1;MRPL32;RPL26;ADAM10;UBE2D3;LMCD1;UBA7;RPS11;FDX1;PSEN1;ITIH2;ERO1A;GALNT11;STK38;RPL13;MRPS18A;PRKCSH;RPL38;ANO8;NOTUM;FDXR;MSLN;RPL27;RPS16;RPS4X;GSPT1;AGO2;RPL10;RPL7A;MSRA;IGFBP5;SERPINC1;MAGEC2;UBE2M;HARS2;LGMN;RPL5;UBE2L3;F5;IGF1;MRPL24;RPS27;PLAT;CTSH;APH1A;RPL27A;RPS3;RPL36A;RPL35A;BAP1;CLN5;PRKDC;MRPS14;GPC3;WWP2;RPL37A;MRPS21;MFGE8;IGF2;LAMB1;MRPL35;RPL32;UBL4A;LOX;WARS1;RPS7;CCN1;CHRDL1;KTN1;RPS15;MRPL34;RPS8;RPL28;RIPK1;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;MSRB2;STOML2;FBN1;SRBD1;RPS17;PNPLA2;RPS2;MRPL43;SEC11A;RABGGTB;ADAM17;RPL39;MRPL11;RPS26;TNIP1;RPS15A;RPL15;RPL34;TMEM132A;DNAJC3;ATG3;MANBA;PAPPA;IGFALS;SCG3;RPLP2;UBE2I;LIPT1;DUSP12;YME1L1;RPL18;MRPS17;MBTPS1;CDC34;LTBP1;RPL19;AHSG;RPS13;COPS5
prerank,positive regulation of axonogenesis (GO:0050772),0.3687659670500067,1.2963680257676298,0.11312217194570136,0.5363096634326278,1.0,13/43,13.54%,ROBO2;L1CAM;ROBO1;SHTN1;CDKL5;LIMK1;NTRK2;SLITRK1;MAPT;ZFYVE27;PLXNA2;BDNF;PLXNA1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4752088327771601,-1.2957318870590342,0.13559322033898305,0.38506150431619457,1.0,7/18,15.36%,TEK;CDH5;RAP1B;ROCK1;BCAS3;ARFGEF1;ROCK2
prerank,negative regulation of secretion (GO:0051048),0.5405781851970244,1.2956168912752137,0.16591928251121077,0.5362180901484687,1.0,2/10,5.24%,NRG1;PTGER3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.4058760291059308,1.2947984534999326,0.13169642857142858,0.5362301917763741,1.0,6/27,9.70%,AK9;AK7;TYMS;AK5;AK6;NME2
prerank,stem cell differentiation (GO:0048863),-0.3878200957317678,-1.2947852734392615,0.1172291296625222,0.3865717906315538,1.0,14/39,19.32%,MLLT3;SETD2;FBXL17;ACE;LRP6;TGFB2;MEF2C;PUM1;TP53;LMBR1L;FOXO4;METTL5;NELFB;PTPRC
prerank,establishment of protein localization to membrane (GO:0090150),-0.34718941148779303,-1.2943903609046516,0.10144927536231885,0.3868750026622086,1.0,33/66,36.63%,PARD3;RAB3GAP1;ZDHHC6;ZDHHC3;EGFR;AFDN;COX18;AQP11;RAB3GAP2;BRAF;RAB11A;ZDHHC1;GORASP2;REEP1;ZDHHC4;ZDHHC12;RAB3IP;ATG3;VPS37B;RTP4;RFTN1;GOLGA7B;ZDHHC9;SEC63;NPC1;ZDHHC22;RAB10;SYNE3;NCF1;VPS37C;ICMT;YIF1B;RABGEF1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3624315779162307,-1.2941254812878342,0.10233393177737882,0.3869807910150831,1.0,23/54,27.03%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;BTG2;CARM1;SOX4;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.37915196667529427,-1.2940986796476108,0.11839708561020036,0.38659580053376075,1.0,14/42,21.49%,YARS1;WARS2;NARS2;CARS2;FARS2;TARS3;LARS1;AIMP2;HARS2;DARS2;VARS2;FARSA;IARS2;WARS1
prerank,proton transmembrane transport (GO:1902600),0.39225721853957285,1.2939311969540557,0.10652173913043478,0.5366149767909926,1.0,7/36,8.72%,ATP1A2;ATP12A;SLC46A1;UCP3;SLC36A2;ATP6V0C;ATP4A
prerank,inositol phosphate metabolic process (GO:0043647),-0.37386865193967644,-1.2939084620132246,0.1104868913857678,0.3865460943554002,1.0,12/46,12.27%,PLCB4;INPP1;PLCG1;INPP5A;PLCB3;PLCB1;MINPP1;PLCE1;PLCG2;ITPKB;INPP4A;FGF2
prerank,regulation of cell size (GO:0008361),-0.4315302927074137,-1.293712366979038,0.152753108348135,0.38650521511057667,1.0,13/23,22.90%,RAC1;MTOR;MSN;RARG;EZR;EDN1;RPTOR;RHOA;LARS1;PTEN;AKT1S1;VAV2;MTPN
prerank,response to exogenous dsRNA (GO:0043330),-0.47157737838454866,-1.293548664771494,0.13787085514834205,0.38641800864195675,1.0,10/18,31.57%,CAV1;IFIH1;FLOT1;CGAS;MAVS;SLC3A2;RALB;DHX9;TICAM1;RFTN1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3361703457131359,-1.2933198331086841,0.08955223880597014,0.38643242924679055,1.0,20/76,19.47%,DAB2IP;KLF4;CD200;TMSB4X;TAX1BP1;NFKBIA;OTULIN;ANXA4;NFKBIL1;IRAK1;CHP1;TNFAIP3;DAP;MTURN;BMP7;IRAK2;NLRC5;CDK5RAP3;CMKLR1;USP7
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.37661683819924574,-1.2931932938370116,0.1099290780141844,0.38626879438666545,1.0,17/43,23.54%,FOXN3;ATM;UIMC1;MRNIP;MRE11;NABP1;CLSPN;TAOK3;INTS3;BABAM2;CDK5RAP3;BRCC3;BRCA1;BLM;CHEK1;TRIM39;FZR1
prerank,cellular response to interleukin-6 (GO:0071354),-0.4255219184019041,-1.2931583827159654,0.1223021582733813,0.38591614410618835,1.0,9/26,11.47%,ST3GAL6;JAK1;IL6ST;IL6R;NFKB1;CBL;YAP1;SMAD4;JAK2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4433789416259807,-1.2929767498672398,0.13321492007104796,0.38589931473744243,1.0,11/22,28.90%,ERI3;RPS21;EXOSC2;NOL9;EXOSC3;EXOSC8;PES1;RRS1;EXOSC7;WDR12;UTP20
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4466962197498846,-1.29276671986185,0.14575645756457564,0.38590271742873944,1.0,10/22,26.45%,CDK13;CDK12;DDX39B;CDC73;THOC1;SUPT4H1;CCNK;BRD4;ERCC6;LEO1
prerank,positive regulation of chromatin organization (GO:1905269),-0.5162334281184763,-1.2913922231945971,0.14962121212121213,0.3884981073238287,1.0,6/12,19.64%,MIER1;TAL1;SIN3A;H3-3A;TERF2;ATRX
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5373327223006825,-1.2912903281901198,0.17938931297709923,0.3882841326174893,1.0,6/11,30.81%,MEF2C;MYOCD;FRS2;FZD7;BMP2;TGFB1
prerank,regulation of neuron differentiation (GO:0045664),0.3322531108124351,1.2905310864707702,0.10352941176470588,0.5438456761633628,1.0,13/76,7.42%,BRINP3;NLGN1;CNTN4;YWHAG;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;BRINP2;ADRA2C
prerank,negative regulation of neuron projection development (GO:0010977),0.3519402640820673,1.2899864153997536,0.07242990654205607,0.5433246235083931,1.0,16/56,15.52%,NLGN1;DCC;SPOCK1;ITM2C;EFNB3;RTN4;TSKU;PTPRS;STMN2;MAG;OMG;PAQR3;NGEF;DENND5A;APOE;PTPRO
prerank,miRNA metabolic process (GO:0010586),-0.45770477201666504,-1.2898340597725626,0.15828677839851024,0.39088967378820433,1.0,12/20,35.42%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2;DROSHA;DIS3L2;RAN;SND1;TARBP2;DGCR8
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3210921570101745,-1.28908790539949,0.07329842931937172,0.39196008112323033,1.0,32/96,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,smooth muscle tissue development (GO:0048745),-0.5394197618248603,-1.2887150367049574,0.1888111888111888,0.39228367094740657,1.0,9/10,33.81%,ENG;SMO;BMP4;MYLK;NF1;STRA6;SHH;PTCH1;EFEMP2
prerank,purine nucleotide metabolic process (GO:0006163),-0.4317831207193798,-1.2884390134457693,0.14925373134328357,0.39243604191816517,1.0,11/24,27.28%,NT5C2;FHIT;NT5E;MTHFD1;NT5C1A;GPX1;HPRT1;GDA;PRPS2;NT5C;PNP
prerank,regulation of myoblast fusion (GO:1901739),-0.5408795908108462,-1.2883711979166075,0.1865671641791045,0.3921401380484782,1.0,7/11,30.24%,EHD2;CFLAR;EHD1;FLOT1;CD53;ADGRB1;MAPK14
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.502207772604891,-1.2883444656168879,0.13909774436090225,0.3917634166591683,1.0,6/13,19.30%,SESN1;ATM;KPTN;CASTOR1;RNF152;ITFG2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.47333049308353964,1.2871441849156249,0.16344086021505377,0.5490009694178327,1.0,5/14,9.70%,AK7;AK3;AK5;ENPP3;NME2
prerank,cGMP-mediated signaling (GO:0019934),0.4974760017640422,1.2870977539738513,0.16554809843400448,0.5470869693635532,1.0,2/13,0.78%,KCNC2;HTR2C
prerank,mitochondrion disassembly (GO:0061726),-0.39685966775644455,-1.2868283948495942,0.12886597938144329,0.3944575027591174,1.0,16/34,27.26%,ATG7;MAP1LC3B;AMBRA1;BNIP3;WIPI1;GABARAP;FUNDC1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B;ATG3
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.34767137338888504,-1.28674779454063,0.0954861111111111,0.39416603588528487,1.0,17/66,13.55%,FLT1;DAB2IP;PDGFD;DVL3;LRRK2;MAP3K5;EGFR;IL34;FGF1;EDN1;TAOK3;TPD52L1;PIK3R6;EDN3;FGF2;IRAK1;CD40
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4617221305275137,-1.2865127906670049,0.15664845173041894,0.39419720237788436,1.0,4/17,7.67%,XIAP;ITGA3;SLIT2;TMEM204
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5351215777966742,1.2864291528406573,0.16964285714285715,0.5467928163839325,1.0,4/10,11.42%,ENPP2;PLA2G7;PLA2G6;LIPC
prerank,regulation of neuron apoptotic process (GO:0043523),0.31621631787748633,1.2859383087329925,0.08235294117647059,0.5460582074539545,1.0,28/96,17.26%,GRID2;CDK5;BCL2;TYRO3;CLN3;PTPRZ1;NAE1;NTRK2;VSTM2L;GRN;PLA2G3;POU4F1;BACE1;FAIM2;TRIM2;MAG;FZD9;NRBP2;CCL2;BDNF;FGF20;SIGMAR1;APOE;LANCL1;GRM4;ADAM8;MSH2;RETREG1
prerank,regulation of protein ubiquitination (GO:0031396),-0.3204574572898906,-1.2855369796343266,0.07570422535211267,0.3958477976206081,1.0,39/108,24.96%,NXN;XIAP;CAV1;LRRK2;IVNS1ABP;BIRC3;CUL3;GSK3A;FAM107A;AKT1;NSMCE3;SMAD7;SPOPL;FOXF2;CHP1;TNFAIP3;N4BP1;UBE2L3;ANGPT1;SENP2;CDK5RAP3;SASH1;RPS3;WASHC1;SOX4;PHF23;HUWE1;BRCA1;OGT;SH3RF2;NDFIP2;AMER1;HSP90AA1;ARRB1;RCHY1;HSPA1B;FANCI;PINX1;ADGRB1
prerank,dendritic spine morphogenesis (GO:0060997),0.4800771026451224,1.28531688196151,0.14123006833712984,0.5456580090226114,1.0,5/15,6.15%,CTNND2;DOCK10;EPHB1;SHANK1;PAK3
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.538004432283942,-1.2852964403903608,0.1645101663585952,0.3959310376123991,1.0,7/11,26.17%,TIPARP;PARP4;PARP14;PARP11;PARP16;PARP6;PARP9
prerank,pulmonary valve morphogenesis (GO:0003184),-0.46769918133405564,-1.2850912565227517,0.16725352112676056,0.3959303157701262,1.0,11/17,17.95%,NOS3;NFATC1;SLIT2;TGFB2;BMP4;NOTCH2;NOTCH1;JAG1;SMAD6;HEY1;HEY2
prerank,cellular response to UV-A (GO:0071492),0.5038687978359182,1.2850911163228351,0.16554809843400448,0.5442849517085812,1.0,4/11,13.12%,MME;CERS1;TIMP1;PPID
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.537050248764249,-1.2843211488498611,0.16636851520572452,0.39710967127719216,1.0,4/10,18.97%,KDR;NAMPT;JAK2;NOD2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5373206880676002,-1.2837697696043475,0.1847246891651865,0.3978330350141692,1.0,3/10,5.09%,LRP5;TBX1;TGFBR2
prerank,protein localization to organelle (GO:0033365),-0.3063687716740494,-1.2837055966383455,0.051601423487544484,0.39753867094830597,1.0,41/133,21.65%,ZNF423;APP;LRRK2;DDX3X;YWHAE;EMD;SIX1;ZBTB7A;TOR1B;CEP250;IFT140;BMP4;CNTLN;UBE2J2;UBAC2;CROCC;GAK;LMNA;EHD1;WDR35;TSPAN17;CSNK1D;RPA1;SGTA;LMBRD1;TRAM2;ABCA7;BMP7;RAB11A;SIX4;RIPOR1;LAMP2;TULP1;GBP5;VAPA;RPA2;DCP1A;WDR83OS;MDM2;IFT20;VAMP2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.28423389898319706,-1.2828043263420972,0.03722504230118443,0.3989738448216356,1.0,68/234,24.95%,PRKCH;EDA;ERC1;ROR1;CAV1;TAB3;ESR1;NOD1;CD200;TRAF5;TRIM25;APP;RPS6KA5;ANXA3;PRKD2;SLCO3A1;SMO;TFRC;FZD4;NFKB1;NFKBIA;STK3;ZBTB7A;LRP6;PRKD1;ARHGEF2;PLCG2;CFLAR;AKT1;RNF25;EDN1;RGCC;IKBKE;TRIM14;IRAK1;MTDH;HDAC4;FLOT1;CD40;TCF3;ADCY1;TAB2;TRIM13;IRAK2;ARID5B;CTNNB1;CEBPG;MAVS;RPS3;IKBKG;IKBKB;NOD2;PPARG;PTEN;ARHGEF5;RELA;MYOCD;MTPN;RIPK1;CRTC1;TRIM68;PLPP3;HSPA1B;SMARCB1;TFDP1;MAP3K7;FANK1;DHX9
prerank,protein insertion into membrane (GO:0051205),-0.39106139052018263,-1.2825710715653447,0.1425925925925926,0.3990092954784577,1.0,11/32,21.65%,APP;EGFR;EMD;COX18;UBE2J2;SGTA;TRAM2;VAPA;WDR83OS;REEP1;VAMP2
prerank,atrioventricular valve development (GO:0003171),-0.490676894559096,-1.2824848912355524,0.14647377938517178,0.3987315332956817,1.0,5/14,12.19%,BMPR2;TGFBR2;TGFB2;ZFPM1;NOTCH1
prerank,sensory perception of light stimulus (GO:0050953),0.32415767581815663,1.2823199136684988,0.0815347721822542,0.5493164682629158,1.0,11/87,6.07%,PCDH15;COL2A1;EML2;COL1A1;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3654629210417824,-1.2820609494005,0.10106382978723404,0.39910814089562485,1.0,16/48,22.01%,MCL1;ATM;TNFRSF1B;ABL1;DDIT4;TP53;FNIP2;IKBKE;BCL2L11;HIC1;HIPK1;EPHA2;PRKDC;BRCA1;CASP2;PHLDA3
prerank,regulation of spindle assembly (GO:0090169),-0.4172026903950405,-1.2806598129186992,0.14990859232175502,0.40164146383891425,1.0,14/25,32.44%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;RNF4;PDCD6IP;SENP6;HSPA1B;CHMP3;HNRNPU;CCSAP;CHMP1A;PLK1
prerank,cell chemotaxis (GO:0060326),-0.35112854692764184,-1.2795901708612532,0.08872458410351201,0.40340441826467505,1.0,21/60,24.90%,LEF1;PARVA;DOCK4;CCL25;PLEKHG5;PRKCD;CCR9;BCAR1;AGTR1;RHOG;ACKR3;HGF;ELMO2;CCN3;HOXB9;EPHA2;CXCL12;PDGFRB;PIP5K1A;SEMA5A;EGR3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.39601776348232626,1.2791525904832004,0.14617169373549885,0.556014392283226,1.0,6/27,8.21%,PDE4B;CTNNA3;STC1;PKP2;RYR2;SCN5A
prerank,regulation of necroptotic process (GO:0060544),-0.43624121261134785,-1.2788264522758088,0.15080789946140036,0.4045933430684947,1.0,10/23,23.22%,PELI1;BIRC3;ARHGEF2;CASP8;CFLAR;FLOT1;PDCD6IP;OGT;HSP90AA1;RIPK1
prerank,cellular response to nutrient levels (GO:0031669),-0.34628892893718655,-1.2785276184642695,0.11092436974789915,0.40481876360564245,1.0,19/62,18.18%,FOXO1;BMPR2;ATG7;LRRK2;MTOR;MAP1LC3B;PPARA;STK24;MFSD2A;FAM107A;KLF10;PRKAA1;WIPI1;RPTOR;LPL;ZFYVE1;RIPOR1;LAMP2;WRN
prerank,Rac protein signal transduction (GO:0016601),-0.4560869544588778,-1.2782645868850822,0.15439856373429084,0.4049484060757427,1.0,8/18,22.30%,EPS8;RAC1;ELMO1;RHOG;NCKAP1;DBNL;WASF1;HACE1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5300190170890383,-1.277781732433539,0.20216606498194944,0.40552706029447855,1.0,2/10,9.06%,CBFB;SH3RF1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.40016443330168056,-1.2776306208630321,0.12605042016806722,0.40540117990048447,1.0,13/32,20.17%,ACVRL1;ACER2;CORO1C;THBS1;FAM107A;BCAS3;RASA1;MYOC;MAP4K4;JAG1;SEMA3E;DUSP22;PTEN
prerank,regulation of intracellular pH (GO:0051453),0.3900465254618214,1.2775221858634778,0.1318181818181818,0.5585026966259149,1.0,7/34,5.56%,CA2;SLC9A7;SLC4A4;SLC4A5;CLN3;SLC9A9;SLC4A2
prerank,response to peptide hormone (GO:0043434),-0.37747350419381687,-1.2771869627141754,0.11688311688311688,0.4059068434486656,1.0,14/43,21.82%,CAV1;TGFBR3;IRS1;STAT6;ROCK1;AKT1;EIF2B2;STAT2;IGFBP5;ROCK2;TRIM16;ANXA1;OGT;CREB1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.43462999163090615,-1.276962443412725,0.15901060070671377,0.40587429354886334,1.0,8/22,16.18%,MYH9;ID1;KDR;SLIT2;CDH5;AKT1;FGF2;PIK3R3
prerank,cardiac muscle contraction (GO:0060048),0.39272745696328365,1.2766322734046267,0.15010570824524314,0.558810510680924,1.0,10/34,14.49%,ATP1A2;SCN1B;ATP1B1;GSN;RYR2;SCN5A;TNNC1;SLC8A1;TNNI2;SCN2B
prerank,cellular glucose homeostasis (GO:0001678),-0.37540163231455115,-1.2764109259582832,0.12972972972972974,0.40657343292508713,1.0,9/41,10.64%,UNC13B;IGF1R;ZBTB20;FOXO1;GAS6;PIK3R1;ERN1;LRRC8D;PRKAA1
prerank,regulation of cellular component movement (GO:0051270),-0.36481520411860074,-1.2763035779364666,0.10830324909747292,0.40635230138372014,1.0,19/49,17.28%,SP100;ETS1;LYN;DIAPH1;EGFR;TGFBR3;ABL1;PRAG1;ROCK1;RAF1;ARAP1;RHOA;ACTN1;ACTN4;CDK6;PKN2;ROCK2;HDAC6;IGBP1
prerank,actin filament-based transport (GO:0099515),-0.4374072335750452,-1.2758340756408626,0.16901408450704225,0.4069200763831035,1.0,6/21,12.83%,MYO1D;FNBP1L;SYNE2;WASL;MYO1F;ACTN4
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4193015140790156,1.2755589950875896,0.15789473684210525,0.5597094827881888,1.0,6/22,12.48%,TAFA1;TOX;PTPRZ1;PROX1;INSM1;FZD9
prerank,regulation of cellular response to stress (GO:0080135),-0.31434550891663093,-1.2753226529468402,0.06630824372759857,0.40766023992843803,1.0,28/115,15.78%,CREBBP;MCL1;GSK3B;ATM;NUP42;NEK6;MTOR;YWHAE;RAE1;CAMK2G;RANBP2;ABL1;DNAJC7;NUP98;MAPKAPK2;SEC13;DNAJB6;MAPK1;IER3;RPTOR;NUP153;RPA3;RPA1;ATF4;PTGES3;ROCK2;NUAK1;TPR
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.28637858713966846,-1.2752511277404195,0.04173913043478261,0.40737204800111987,1.0,53/208,18.97%,DAB2IP;PELI1;AKAP13;ROR1;TAB3;ESR1;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;NEK6;TNFSF10;BIRC3;TFRC;PLK2;PRKD1;PLCG2;ALPK1;PPM1B;CASP8;CFLAR;MAP3K3;FLNA;IKBKE;TRIM14;RHOA;IRAK1;MTDH;RHOC;CD40;ZFAND6;TRIM59;TNFAIP3;TNFRSF19;USP10;TNFRSF1A;PELI2;TAB2;TFG;TRIM13;MIB2;VAPA;MAVS;ZMYND11;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;IKBKB;NOD2
prerank,ncRNA export from nucleus (GO:0097064),-0.3821776405333743,-1.275096703707612,0.12477718360071301,0.4072729764909023,1.0,15/36,31.35%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;PHAX;NUP188;NUP88;RAN;SSB;NUP35
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.37753749918657564,-1.2750236794173821,0.12698412698412698,0.40698998430835787,1.0,14/39,18.76%,EFR3B;PIP4K2A;PIK3R1;PIP4K2B;PI4KB;PIK3C2A;ITPKB;PIK3CD;TTC7A;SOCS2;PIK3CB;PI4K2B;PIK3R3;TMEM150A
prerank,odontogenesis (GO:0042476),-0.3929594561022099,-1.274748297984097,0.13237924865831843,0.4071252654019139,1.0,14/35,24.99%,EDA;ANKRD11;TBX1;HDAC1;LRP6;TGFB2;BMP4;AXIN2;FOXC1;BCOR;TUFT1;LAMB1;MSX1;BMP2
prerank,positive regulation of cell growth (GO:0030307),0.31245881397801245,1.2746315480143469,0.0855106888361045,0.5602789868094128,1.0,20/96,11.30%,L1CAM;SYT1;RIMS2;RIMS1;CXCL16;SHTN1;CDKL5;AKAP6;BCL2;PSMD10;LIMK1;EXOSC9;SPHK1;CPNE9;ADNP2;KLHL22;MAPT;ZFYVE27;RNF157;SYT4
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.32260009329343536,-1.2739761892830568,0.07880910683012259,0.4082991261928346,1.0,27/94,19.01%,IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;NFKB1;RBX1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;FBXW11;MAP3K8;PSMC2;PSMB2;PSMB1;PELI2;TAB2;IRAK2;PSMA8;IKBKG;IKBKB;NOD2;PSME1
prerank,tRNA transport (GO:0051031),-0.38628089388961373,-1.2738980121696857,0.1286231884057971,0.40801042232557133,1.0,15/35,31.35%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;TOMM20;SSB;NUP35
prerank,histone lysine methylation (GO:0034968),-0.38922105946118507,-1.2735373728597368,0.13580246913580246,0.408384019248398,1.0,15/33,26.63%,PRDM5;SUV39H1;KDM6A;SETD3;DOT1L;ASH2L;SMYD1;N6AMT1;PRDM9;WDR82;WDR5B;WDR5;RBBP5;SETDB2;TRMT112
prerank,RNA processing (GO:0006396),-0.29218404024896105,-1.2735345715627955,0.037300177619893425,0.40794850780593306,1.0,54/176,21.55%,MBNL1;RBPMS;SRSF11;TUT7;TENT4B;RBMS1;PRPF3;SMU1;CDK12;IVNS1ABP;RSRC1;HNRNPA0;PPIG;RBM5;HNRNPR;FUS;PRPF6;RBMS2;CELF1;DDX39B;SF3B1;TENT4A;NOL9;DICER1;HNRNPUL1;RBM39;HNRNPF;XRN2;TUT4;SON;SFPQ;SLU7;APOBEC1;TENT2;YJU2;SCNM1;SF3A1;SYNCRIP;THOC1;SRPK2;ADARB1;USB1;ZMAT5;PPP2CA;TFIP11;SRRM1;NONO;RNPS1;TSEN34;DROSHA;RBM3;FASTKD5;LSM3;RBM6
prerank,regulation of osteoclast differentiation (GO:0045670),0.38074540743872143,1.2734001237344488,0.12276785714285714,0.5616724229947606,1.0,7/33,15.02%,BGLAP;CARTPT;CAMK4;POU4F1;TMEM178A;TCTA;IL23A
prerank,cytosolic calcium ion transport (GO:0060401),0.3965839073150925,1.2733445524982727,0.15584415584415584,0.5598285973754559,1.0,8/28,11.91%,SLC25A23;CACNA2D1;CACNB3;SLC8A2;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5188080646278979,1.2732728662993524,0.18032786885245902,0.5580238741721045,1.0,2/10,2.53%,UBE2J1;INSIG1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3375685578153956,-1.27320249717638,0.10391822827938671,0.40824846299084916,1.0,23/69,21.67%,IGF1R;PLCB4;PLCB3;PIK3R1;IRS1;PLCB1;PI4KB;EZR;PIK3C2A;NGF;PLCE1;PIK3CD;AKT1;EDN1;HTR2A;RHOA;PIK3CB;GAB2;IGF1;PTEN;NF1;OGT;PDGFRB
prerank,regulation of neuron death (GO:1901214),0.3275733370139274,1.273004501697496,0.07777777777777778,0.5567750708913478,1.0,22/82,15.00%,GRID2;DCC;GRIN2B;CDK5;EPHB1;EGR1;CHGA;NAE1;SNCG;SORL1;MAPT;FAIM2;KIR3DL2;TRIM2;ATP13A2;DHCR24;HTRA2;CCL5;CLU;SIGMAR1;LANCL1;GRM4
prerank,NAD biosynthetic process (GO:0009435),-0.4378297641895017,-1.2728004025116988,0.15669014084507044,0.40863845813029787,1.0,12/20,37.20%,NAMPT;NADSYN1;NAXE;NUDT12;NAPRT;KYNU;PARP16;PTGIS;PARP9;NAXD;NMNAT3;NNMT
prerank,fatty acid biosynthetic process (GO:0006633),0.33840993018831383,1.2727883535555589,0.10093896713615023,0.555399926730456,1.0,19/63,17.17%,FADS1;ACSBG1;HACD1;ELOVL4;ACLY;ACACA;OXSM;ALOX12;LIPC;TECR;OLAH;ACOT7;SCD5;NDUFAB1;ALOX5;CYP1A1;HACD2;ASAH2;SCD
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3255257810122891,-1.2721016065280764,0.08828828828828829,0.40965624498495407,1.0,29/85,24.52%,DAB2IP;CSNK1A1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;USP13;GABARAP;SMAD7;CSNK1D;ATXN3;ECSCR;ZER1;PSMC2;ZYG11B;SUMO1;RAD23A;MDM2;SH3RF2;KEAP1;CEBPA;RCHY1;TRIB3;HSPA1B
prerank,histone modification (GO:0016570),-0.31842906673708743,-1.2714207792894152,0.08185053380782918,0.4107472525382885,1.0,32/109,20.76%,CREBBP;NSD1;KAT6B;EYA4;MIER1;PRDM5;RPS6KA5;KAT6A;RCOR1;HDAC1;PHF20;TRRAP;NSD3;PRKCD;MIDEAS;SGF29;PHF20L1;EHMT1;SIN3A;HDAC4;KAT5;PHC1;RUVBL2;MIER2;HDAC6;HDAC10;CARM1;MIER3;TBL1X;HUWE1;ATXN7;BAZ1B
prerank,embryonic skeletal system development (GO:0048706),0.3891019253279238,1.2712348725878064,0.13704496788008566,0.557659675157709,1.0,12/35,16.82%,DSCAML1;COL1A1;OSR1;HOXD3;UCMA;DEAF1;MEGF8;SLC2A10;HOXA4;HOXA9;PDGFRA;HOXD4
prerank,rRNA 3'-end processing (GO:0031125),-0.5388386726966862,-1.271200963753211,0.17699115044247787,0.41081555773201917,1.0,5/10,16.26%,ERI3;RPS21;EXOSC2;EXOSC3;EXOSC8
prerank,mitotic recombination (GO:0006312),-0.47339456552287296,-1.2710902969616986,0.19366852886405958,0.4106046159190926,1.0,11/15,42.06%,SMC5;DMC1;RAD54B;NSMCE2;TEP1;MSH3;RAD51D;RAD50;RAD52;SMC6;ERCC1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.31913442661000246,-1.2706902599621175,0.06833333333333333,0.4110446626197768,1.0,50/98,36.37%,RB1;PDS5B;NIPBL;CUL3;WRAP73;SMC4;TENT4A;CHMP4B;CHMP4A;POGZ;KIF23;PDS5A;CHMP2B;KMT5A;CHMP5;RAB11A;DSN1;CENPE;PRC1;PDCD6IP;RRS1;NCAPD2;DIS3L2;MCPH1;BECN1;NCAPH;KIF18B;EML4;NCAPH2;PINX1;INO80;RAN;CHMP3;KIF14;SPDL1;TUBG2;CDCA8;SET;TTN;CHMP6;CHMP1A;NUDC;PLK1;BOD1;PSRC1;MIS12;ESPL1;CSNK2A1;CSNK2A2;CHMP1B
prerank,regulation of defense response to virus by host (GO:0050691),-0.40290207362659386,-1.2700133849098796,0.14285714285714285,0.4120653463783826,1.0,16/30,30.86%,DTX3L;SIN3A;TNFAIP3;CGAS;MAVS;ZDHHC1;RNF216;HSP90AA1;DHX9;EIF2AK4;TRIM44;PARP9;TRIM6;TOMM70;IFNLR1;LILRB1
prerank,positive regulation of exocytosis (GO:0045921),0.3834398698982754,1.2691379831840992,0.1425233644859813,0.5613506125863683,1.0,13/35,19.83%,CADPS;RAB15;SMPD3;RAB27B;HGS;TSG101;ATP13A2;RAB3A;SDC4;CLASP2;CHMP2A;VPS4B;EXPH5
prerank,quinone biosynthetic process (GO:1901663),-0.4906053898962137,-1.2690228580993512,0.18006993006993008,0.41375753916150376,1.0,6/14,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,mitotic cell cycle phase transition (GO:0044772),-0.2842132984163921,-1.268896719822868,0.030303030303030304,0.4136070211267495,1.0,74/204,29.14%,FBXL7;MNAT1;RB1;EPS8;FBXL12;CENPJ;FBXL17;PPP1R12B;YWHAE;FBXL3;CDKN1B;CRLF3;CEP57;DNM2;CUL3;PLCB1;CCND3;CEP250;MAX;PLK2;CUL2;CEP78;PPP2R2D;NES;LATS2;HAUS8;CHMP4B;TPD52L1;CCNY;PPP1R12A;CDC16;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CDK6;GSPT1;CEP41;ALMS1;PLK4;PCM1;CACUL1;CETN2;CNTRL;CEP152;CCND1;TACC3;CDK14;CDKN2C;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;CCNG1;CCNE2;E2F3;KHDRBS1;FBXL22;PLK3;ANAPC7;CDKN3;CCNJ;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA;HINFP
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4980023167332862,-1.2684214848697717,0.15789473684210525,0.4142951010205398,1.0,4/14,11.75%,ANKRD17;PUM1;DDX60;USP15
prerank,histone H3-K4 methylation (GO:0051568),-0.41913126575916915,-1.2683722383556655,0.15875912408759124,0.4139608134550968,1.0,12/26,24.04%,TET2;KDM6A;ASH2L;PRDM9;KMT2C;WDR82;WDR5B;OGT;TET3;WDR5;RBBP5;BEND3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3957704995259573,-1.2682072751561568,0.13793103448275862,0.4134205261671554,1.0,14/32,31.35%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;SSB;NUP35
prerank,tRNA export from nucleus (GO:0006409),-0.3957704995259573,-1.2682072751561568,0.13793103448275862,0.4134205261671554,1.0,14/32,31.35%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;SSB;NUP35
prerank,error-prone translesion synthesis (GO:0042276),-0.44336895875245297,-1.2680669614639632,0.1619718309859155,0.413264390782519,1.0,8/21,23.23%,RPA3;REV1;RPA1;MAD2L2;POLE2;RPA2;RFC4;RFC1
prerank,reverse cholesterol transport (GO:0043691),0.47661839579362103,1.2680318306483975,0.2026431718061674,0.562355076343167,1.0,5/13,14.63%,APOM;LIPC;ABCA5;CLU;APOE
prerank,membrane organization (GO:0061024),-0.2818221384261611,-1.2679718178474113,0.048903878583473864,0.413047674194171,1.0,68/227,21.65%,SPTBN1;HIP1;FCHO2;MYOF;CERT1;DAB2;DNM3;CORO1C;EPS15;TMCC1;FNBP1L;STX18;A4GALT;LDLRAP1;EGFR;TFRC;EMD;FZD4;AP2B1;AP2A2;DYSF;CBL;DNM2;TOR1B;COX18;RABEP1;AP2S1;EPS15L1;PIK3C2A;SNX9;WASL;AAK1;ITSN1;AGFG1;RAB5A;PICALM;IGF2R;REEP3;CHRNB1;CHMP4B;CHMP4A;ATP10B;GAK;ACTB;CHP1;CHMP2B;GRB2;HIP1R;MITD1;SUN1;ARPC4;CHMP5;TLCD1;REPS1;MOSPD3;VAPA;STON2;VAMP3;GLTP;AP2M1;HUWE1;M6PR;PDCD6IP;OSBPL2;LPCAT3;REEP1;RABIF;VAMP2
prerank,positive regulation of embryonic development (GO:0040019),0.43362094528027223,1.267966989129457,0.17016806722689076,0.5605267025616013,1.0,3/19,4.20%,TENM4;LHX1;OSR1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5318923756800986,-1.2677065452659728,0.18248175182481752,0.41316270137478733,1.0,3/10,6.37%,CD200;BMP5;SLIT2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5187448940007156,-1.2675899173287142,0.17889087656529518,0.4129492531490955,1.0,5/11,12.19%,FOXO1;GSK3A;SMAD4;LMNA;NOTCH1
prerank,neutrophil activation (GO:0042119),-0.5005419916299501,-1.2675571701655552,0.18181818181818182,0.412589180960835,1.0,4/12,16.59%,KMT2E;IL15;PRKCD;PREX1
prerank,purine-containing compound catabolic process (GO:0072523),-0.5028249882561111,-1.267390280991994,0.16827852998065765,0.41252371049195496,1.0,7/13,27.28%,NT5C2;NT5E;NT5C1A;GPX1;GDA;NT5C;PNP
prerank,positive regulation of ion transport (GO:0043270),0.35659478802551003,1.2673477056498221,0.1300639658848614,0.5601958381389112,1.0,11/48,12.58%,ANK3;SCN1B;PKP2;GPD1L;WNK3;CACNA1D;PLA2G3;SCN5A;ADRA2A;LILRA5;CCL5
prerank,peripheral nervous system development (GO:0007422),0.41261692114057213,1.267330288338621,0.13555555555555557,0.5582782083066185,1.0,4/23,6.31%,ASIC2;SCN8A;NFASC;GPC1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4023744717310497,1.2672045561899237,0.1409090909090909,0.5566264894405322,1.0,7/27,12.34%,LPIN1;ETNK1;PLA2G3;PLA2G4E;PLA2G6;NAAA;CHKA
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4447614316267431,1.2669653001262244,0.1511111111111111,0.5553240692026404,1.0,6/18,11.47%,HSD17B12;ACSBG1;HACD1;ACSL3;ACSL6;TECR
prerank,neutral amino acid transport (GO:0015804),-0.4075834669545346,-1.2668153528074546,0.14828209764918626,0.413372630555753,1.0,11/28,23.45%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.33190355550332806,-1.266494615414681,0.11170212765957446,0.41364273388614176,1.0,28/73,26.59%,KAT2B;DEK;CTCF;SUZ12;SF3B1;TASOR;TAF1B;HDAC4;ACTB;TAF1C;MECP2;GPX1;H3-3A;DNMT1;HDAC6;PPHLN1;WBP2;KDM1B;PPM1D;BAZ1B;IGF2;TAF1D;AEBP2;POLR1E;POLR2L;ERCC6;POLR2H;HDAC5
prerank,homeostasis of number of cells (GO:0048872),-0.5157338057953196,-1.2662916421465955,0.15520282186948853,0.41367578891115947,1.0,7/12,26.84%,NOS3;NAPEPLD;NOTCH1;CCN3;LPCAT3;OCIAD2;F2R
prerank,aspartate family amino acid metabolic process (GO:0009066),0.44051758167824945,1.2662914839099293,0.17391304347826086,0.5551061647728424,1.0,4/18,8.01%,SLC25A13;ASNS;GADL1;ASPA
prerank,polyol metabolic process (GO:0019751),-0.3634810366971355,-1.2662584466990157,0.13172541743970315,0.41331684706519295,1.0,11/46,10.99%,PLCB4;INPP1;PLCG1;INPP5A;PLCB3;PLCB1;MINPP1;PLCE1;PLCG2;ITPKB;INPP4A
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3861539047122868,-1.2661154762678983,0.12121212121212122,0.4132026866641443,1.0,7/36,11.50%,SGMS1;DAB2IP;RB1;FAS;CRADD;TPD52L1;MAZ
prerank,striated muscle contraction (GO:0006941),0.34985206655434636,1.265996192187608,0.11889596602972399,0.5539440626411504,1.0,13/53,14.49%,SMPX;ATP1A2;SCN1B;STAC2;ATP1B1;RYR2;SCN5A;STAC;TNNC1;DTNA;SLC8A1;TNNI2;SCN2B
prerank,positive regulation of behavior (GO:0048520),0.5206336144322756,1.2659510636510776,0.18633540372670807,0.5521414516535798,1.0,3/10,10.11%,NLGN1;NR4A3;SGIP1
prerank,ventricular septum development (GO:0003281),-0.3796112483045877,-1.2656433436175774,0.1413793103448276,0.4137999858679854,1.0,17/37,19.74%,BMPR2;TGFBR3;TGFBR2;HES1;PDE2A;SLIT2;TGFB2;HECTD1;SMAD4;SMAD7;ZFPM1;NOTCH1;HEY1;HEY2;CITED2;SOX4;DAND5
prerank,regulation of cell adhesion (GO:0030155),-0.3053842238408886,-1.265456103114911,0.07861060329067641,0.41373104979219255,1.0,38/129,22.47%,RSU1;ACVRL1;PODXL;LYN;ZFHX3;CBLL1;ATM;PKP4;PRKD2;PTPRJ;ABL1;STX3;PTK2;CYTH1;ARHGDIA;PLXND1;TGM2;ROCK1;EPHA4;PLXNA4;ADAM10;PPP1R12A;FRMD5;RASA1;TPM1;ATXN3;ROCK2;NUAK1;ANGPT1;ADGRG1;PPP2CA;EPHA2;TGFBI;CXCL12;PTPN11;GPR4;PTK2B;EPHB3
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.3050875477921952,-1.2654501059751522,0.06097560975609756,0.41330939874726685,1.0,46/124,26.87%,LEF1;GNB1;RAC1;TNRC6B;SMURF2;FZD6;DVL3;NFATC1;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;PLCB3;PLCB1;AP2S1;PSME2;PSMB4;RHOA;WNT11;AGO2;PSMC2;PSMB2;PSMB1;MOV10;CTNNB1;PSMA8;PSME1;TNRC6A;TCF7L2;AP2M1;PSMD4;ROR2;PSMA7;FZD7;SFRP4;PSMD5;FZD5;MAP3K7;FZD10;GNG2;PSMB10;FZD1;FRZB;PSMA3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.32899159625785085,-1.264945670321405,0.09965635738831616,0.4139701341589579,1.0,27/76,24.76%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;UBA2;CUL3;GSK3A;FAM107A;NSMCE3;SMAD7;HDAC4;UBE2L3;DCUN1D2;ANGPT1;SENP2;CDK5RAP3;PIAS4;PHF23;HUWE1;BRCA1;DCUN1D5;NDFIP2;AMER1;RCHY1;SAE1;FANCI
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4286852279441497,1.2648511634986113,0.16441441441441443,0.5531263679243166,1.0,6/20,14.53%,BICD1;PLEK;RPGRIP1L;RNF157;CCL5;MRAP2
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3126993584930955,-1.2646859753276096,0.07733812949640288,0.41405195501260106,1.0,30/107,20.26%,DAB2IP;ITPR1;GSK3B;THBS1;RNF139;ATG10;MAP3K5;NIBAN1;RASGRF2;NCK1;PIK3R1;CREB3L2;ERN1;JUN;ATP2A3;TP53;BCAP31;ERO1A;FLOT1;PDIA3;UFM1;ATF4;DNAJC10;BBC3;BCL2L11;CDK5RAP3;DNAJB12;DNAJB9;GORASP2;HERPUD1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5044699559855454,-1.2646703634002356,0.1781305114638448,0.4136432820249873,1.0,6/13,22.56%,LRRK2;SCFD1;CHMP4B;CHMP4A;PHF23;SEC22B
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3569405418411277,-1.264598298923873,0.1284722222222222,0.41335658396554437,1.0,19/52,23.66%,SEC31A;PDIA5;ERN1;PDIA6;KLHDC3;GSK3A;SRPRA;CUL7;KDELR3;WIPI1;LMNA;DCTN1;EXTL3;ACADVL;DNAJB9;PREB;PARP16;FKBP14;TLN1
prerank,negative regulation of phosphorylation (GO:0042326),-0.3165319759382936,-1.2635257873941665,0.09523809523809523,0.4152351056883003,1.0,25/85,21.55%,DAB2IP;CBFA2T3;LYN;CORO1C;LRRK2;NIBAN1;CDKN1B;PPARA;LRP6;SLIT2;BMP4;ROCK1;PRKRIP1;OCLN;HDAC4;PTPN13;CHP1;TRAF3IP1;DNAJC10;BMP7;CDK5RAP3;PRKDC;PTEN;WARS1;CDKN2C
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.38209400684116007,-1.2634294153382617,0.14855072463768115,0.41500446088443893,1.0,10/37,11.82%,PARD3;UBE2K;APP;SPRED2;PPEF2;DDIT4;IRGM;MAPK1;SMAD7;RPTOR
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.41015269265360366,-1.2629907313614752,0.14690265486725665,0.4154815088219131,1.0,19/26,45.31%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;CYP1B1;TGFB1;SULF1;IL1A;SARS1;HIF1A;RORA;GATA4;ISL1;CCBE1;NODAL;IL6
prerank,skeletal muscle organ development (GO:0060538),-0.41225622521047245,-1.2627523526688988,0.13884007029876977,0.4155943851300798,1.0,13/26,28.65%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SIX4;MYL6;LARGE1;FOXL2;FXR1;DISP1;STRA6;MSC
prerank,macrophage activation involved in immune response (GO:0002281),-0.4901324396544392,-1.262512263965159,0.18181818181818182,0.41568584145203713,1.0,5/13,14.94%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4549870237198674,-1.2622580454056536,0.1615798922800718,0.4157982716136826,1.0,7/19,11.69%,NFAT5;NFATC1;NFATC4;INPP5A;PLCE1;EDN1;EDN3
prerank,regulation of cytokinesis (GO:0032465),-0.3277282446523624,-1.2615497584001711,0.1265597147950089,0.41692791075812347,1.0,24/78,25.29%,PRKCE;SVIL;SETD2;PKP4;AHCTF1;ZFYVE26;CUL3;CDC14A;RAB11FIP3;PLK2;BIRC6;KLHL13;KIF23;RHOA;PKN2;RAB11A;GIPC1;PLK4;CETN2;PRC1;KIF13A;BECN1;E2F7;PLK3
prerank,regulation of TORC1 signaling (GO:1903432),0.37948138735689313,1.261320115108288,0.14553014553014554,0.5607435999887174,1.0,8/33,8.52%,DGKQ;GPR137C;PIP4P1;RRAGA;STK11;FLCN;KLHL22;SEH1L
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.30356302210511,-1.260846824737693,0.08465608465608465,0.4180288113974733,1.0,36/118,18.41%,SP100;SHANK3;FERMT2;ADGRA2;BMPER;ETS1;NEDD4L;PDZD8;GSK3B;KIF13B;PAK2;TBX1;LRRK2;PDLIM5;ZMYM6;CHN1;NEDD4;MEF2C;PLXND1;EPHA4;FLT4;STAT2;ABI3;FGF2;ZMYM4;CEACAM1;RC3H1;MARK2;TNFAIP3;FMNL2;CTNNB1;ARHGAP35;CAPZB;RAP2A;CFL1;WTIP
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.525393673491991,-1.2602416067222408,0.18333333333333332,0.41880964759141504,1.0,4/10,14.27%,SETD2;SETD3;EHMT1;KMT5A
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4519523118577472,-1.2599882999271057,0.17100371747211895,0.41891048254430574,1.0,7/17,25.58%,ALG14;ALG12;ALG8;DOLPP1;ALG13;MVD;DOLK
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3437433037853653,-1.259524743044475,0.13227513227513227,0.4194532513529892,1.0,18/59,17.01%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;MAPK1;ROCK1;PRKD1;GSK3A;AKT1;MAPK8;MARK2;ROCK2;HIPK1;CDC42BPB
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3627890293066946,-1.259507840310816,0.1306715063520871,0.419056317958604,1.0,10/45,11.47%,SP100;IRF2;TRIM25;JAK1;ICAM1;MID1;CAMK2G;PRKCD;IRF1;JAK2
prerank,nucleotide-excision repair (GO:0006289),-0.3158063312083831,-1.2594223594749783,0.10619469026548672,0.4188217243069663,1.0,40/101,31.32%,MNAT1;RNF111;RBX1;POLR2G;ERCC2;TP53;POLD3;TCEA1;OGG1;RPA3;ATXN3;RPA1;PNKP;XPC;ERCC3;ERCC8;FANCC;CETN2;RAD23A;RPA2;USP7;LIG4;COPS7A;RFC4;RFC1;COPS8;POLR2C;COPS4;LIG1;POLR2L;ERCC6;POLR2H;MMS19;GTF2H3;POLL;CCNH;PPIE;CHD1L;COPS5;HUS1B
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.49736624842422655,-1.2592466787682057,0.18229166666666666,0.41874765751216064,1.0,3/13,10.16%,PKD2;NFKBIA;FLNA
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3609050569218502,-1.259150296087162,0.14051094890510948,0.41853221014016334,1.0,15/49,16.58%,CBFB;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;ASH2L;H3-3A;KMT2C;MTURN;MOV10
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2859595244435342,1.2587705618302032,0.06,0.5657192897873042,1.0,30/152,12.02%,ADGRB3;GNAO1;CHRM2;GNAI2;ADGRL3;GRM8;ADCY8;GNAI1;CALCA;GNAL;ADGRG4;CNR1;PTGER3;GPR37;GNAT3;MTNR1A;CACNA1D;PF4;GIPR;ADCY7;ADRB3;ADRA2A;GPR65;TSHR;GPER1;LGR5;VIPR2;ADRA1D;HTR1D;GABBR1
prerank,eosinophil migration (GO:0072677),0.4687502867057809,1.258746765098526,0.18736842105263157,0.5619476007497725,1.0,5/14,19.13%,CCL13;CCL5;CCL2;CCL7;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.4687502867057809,1.258746765098526,0.18736842105263157,0.5619476007497725,1.0,5/14,19.13%,CCL13;CCL5;CCL2;CCL7;CX3CL1
prerank,response to organophosphorus (GO:0046683),0.456427284533246,1.2586961997778083,0.20044543429844097,0.5602182175545132,1.0,3/16,5.28%,DGKQ;AKR1C1;TYMS
prerank,synaptonemal complex assembly (GO:0007130),0.456997065036199,1.2586927154518364,0.16997792494481237,0.5564905935342542,1.0,4/15,12.99%,SYCP1;REC8;SYCP2;RAD21
prerank,synaptonemal complex organization (GO:0070193),0.456997065036199,1.2586927154518364,0.16997792494481237,0.5564905935342542,1.0,4/15,12.99%,SYCP1;REC8;SYCP2;RAD21
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.39693192650643383,-1.2585065693167048,0.15660377358490565,0.4195530367382257,1.0,6/30,7.55%,AKAP13;RAC1;ARHGEF3;NET1;F11R;PRAG1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4201124947823904,1.258496710838712,0.17598343685300208,0.5551427755413721,1.0,6/21,17.24%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3
prerank,positive regulation of secretion (GO:0051047),0.5002564349209981,1.2583682853915845,0.1935483870967742,0.553591313814571,1.0,3/11,12.14%,TRH;ACSL3;GPLD1
prerank,protein heterooligomerization (GO:0051291),0.4536453873008254,1.257785694959103,0.16071428571428573,0.5532479841340091,1.0,2/17,0.90%,KCNC2;GRIN2B
prerank,histone acetylation (GO:0016573),-0.33814232032228464,-1.2577446394857748,0.10786106032906764,0.4208045578939321,1.0,24/69,25.05%,LEF1;CREBBP;KAT6B;KAT2B;KAT6A;EP400;PHF20;TRRAP;SGF29;PHF20L1;KAT5;TAF5L;ZZZ3;TADA3;TRIM16;DR1;RUVBL2;JADE2;WDR5;MORF4L1;BEND3;TAF9;MAP3K7;APBB1
prerank,recombinational repair (GO:0000725),-0.33470271939181545,-1.2576542727906994,0.10714285714285714,0.42057721359025707,1.0,36/77,33.67%,SMC5;SAMHD1;ZFYVE26;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;RAD54B;NSMCE2;SFPQ;RPA3;RPA1;PALB2;RFWD3;WRN;RPA2;BRCA1;RAD51AP2;BLM;YY1;MORF4L1;INO80;POLL;XRCC2;AP5Z1;KDM4D;RAD51AP1;SWI5;RAD51D;HUS1B;RMI1;MEIOB;RAD50;FAN1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3790022363521956,-1.257573686252951,0.14802065404475043,0.42035033467922,1.0,13/39,14.85%,ACER2;CORO1C;THBS1;GCNT2;FZD4;RASA1;NOTCH1;RHOA;ACTN4;MYOC;SPRY4;MAP4K4;JAG1
prerank,central nervous system development (GO:0007417),0.2705446444784505,1.2572421452492752,0.038834951456310676,0.5528358036223312,1.0,49/250,13.66%,CNTNAP2;ROBO2;ASIC2;CNTN6;IL1RAPL2;CNTN4;GRIN2B;DSCAML1;ADAM23;MYRF;ADAM22;SH3GL2;ADGRL3;NPAS1;SPOCK1;DNER;CDK5;GRIN2A;NRCAM;POMK;MEIS1;NDRG4;MEIS3;MDGA1;PITPNM1;SMG9;PTPRZ1;MAP1S;PROX1;HPCAL4;GSN;GRIK1;AHI1;NCAN;KLK6;DCX;POU3F3;HAPLN2;MOG;MBP;NMUR2;ARNT2;CDH2;SLC8A3;PBX4;TPPP;RPS6KA6;TUBGCP2;CAPG
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5186655250086329,-1.2571658501891365,0.19055944055944055,0.4207914598265955,1.0,6/11,17.00%,RAPGEF2;LYN;MEF2C;PIK3CD;PIK3CB;ANXA1
prerank,regulation of axon guidance (GO:1902667),0.5001769993395604,1.2570228946442692,0.19058823529411764,0.5516358809053226,1.0,5/10,24.18%,VEGFA;ZSWIM5;YTHDF1;ZSWIM8;MYCBP2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5100023691535316,-1.2558640376117232,0.205607476635514,0.4232583076514481,1.0,3/11,10.11%,EGFR;BMP4;TP53
prerank,regulation of axon extension (GO:0030516),0.3665916993477281,1.255824902535922,0.14161220043572983,0.5529744058808156,1.0,14/37,14.63%,L1CAM;SHTN1;CDKL5;NRCAM;LIMK1;MAP2;MAPT;RTN4;PTPRS;ZFYVE27;MAG;TRIM46;OLFM1;APOE
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4124877053766808,-1.255823807293999,0.156140350877193,0.4228992746123768,1.0,8/27,20.64%,PRKCH;NFKB1;PPARA;NFKBIA;AGTR1;LPL;PPARG;ITGB3
prerank,keratan sulfate metabolic process (GO:0042339),-0.3938794246951478,-1.2555329437903833,0.15272727272727274,0.42308819024014643,1.0,6/31,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,positive regulation of locomotion (GO:0040017),-0.41170351279079087,-1.255400950960696,0.1849912739965096,0.42292872887454974,1.0,11/27,30.90%,NTN1;THBS1;SPOCK2;STX3;PPM1F;CAVIN1;CCL19;PDGFRB;TREM2;TGFB1;TRIM32
prerank,regulation of exosomal secretion (GO:1903541),0.43995468247851477,1.2549655875271564,0.17906976744186046,0.5533609836891432,1.0,8/19,18.93%,ATP9A;SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,response to glucose (GO:0009749),-0.35492897435174775,-1.254735684151318,0.14028776978417265,0.42387347303067224,1.0,9/46,12.72%,UNC13B;IGF1R;ZBTB20;THBS1;GAS6;ERN1;EIF2B2;PRKAA1;LPL
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.3654876367032942,-1.254216127100391,0.13932980599647266,0.42456619998818385,1.0,20/46,22.47%,TEK;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;ILK;RHOA;LAMA5;LAMC3;ITGA4;ATRNL1;VAMP3;FERMT3;ITGB3;LAMB1;USH2A;EPHB3
prerank,negative regulation of DNA replication (GO:0008156),0.47965656537686135,1.253913055427499,0.19047619047619047,0.5543235823550494,1.0,4/13,11.18%,GMNN;GTPBP4;TERF1;ATR
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.35251818765950826,-1.2532212840773944,0.1431064572425829,0.42622194057794877,1.0,20/48,25.92%,ZMIZ1;KAT2B;DEK;ARID1B;ATAD2B;SF3B1;TAF1B;ACTB;TAF1C;WBP2;ELOF1;BAZ1B;CHEK1;ATAD2;TAF1D;SERTAD2;POLR1E;POLR2L;ERCC6;POLR2H
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.43502635907136306,-1.2530644660540635,0.17590822179732313,0.42610003740449176,1.0,4/20,3.37%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,negative regulation of cell migration (GO:0030336),-0.29788613486031634,-1.2529605261914307,0.08376963350785341,0.4258801968038375,1.0,44/137,21.11%,PTPRG;DAB2IP;CLDN5;ENG;ACVRL1;RAC1;CORO1C;MCC;MITF;ARID2;PTPRJ;SCAI;LDLRAD4;AFDN;TCAF1;STK24;FOXO3;SLIT2;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;SMAD7;FGF2;LIMCH1;TPM1;DUSP3;WNT11;HAS1;JAG1;IGFBP5;MIF;FUZ;ADARB1;ADGRG1;RAP2A;CITED2;HYAL2;DUSP22;RAP2C;PTEN;NF1;VCL
prerank,methylguanosine-cap decapping (GO:0110156),0.5084247843604622,1.2527272293598957,0.19690265486725664,0.5556276229850534,1.0,2/10,3.94%,PATL2;DCPS
prerank,positive regulation of ATPase activity (GO:0032781),0.35936354828149203,1.2526641041507196,0.14553014553014554,0.5539795136574012,1.0,14/41,20.90%,PFN2;DNAJB11;ATP1B1;UHRF1;PFN1;DNAJC24;RYR2;MSH2;MYL4;DNAJB2;DNAJB1;VMP1;ATP1B2;CHTOP
prerank,cellular calcium ion homeostasis (GO:0006874),0.2941664044733892,1.2525599199446347,0.08053691275167785,0.5524747404265768,1.0,25/133,12.58%,SLC24A4;SLC24A2;HTR2C;HCRTR1;STC1;ATP2B4;ATP2B2;ADCY8;CALCA;BCL2;CLN3;ATP1B1;SLC8A2;SELENOK;RYR2;TMCO1;CCL13;GPER1;TMEM178A;ATP13A2;SLC8A3;SLC8A1;HRC;FZD9;CCL5
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4538168517206145,-1.2524028041829571,0.17689530685920576,0.4266803696926076,1.0,7/17,20.17%,PRKG1;CDKN1B;PDCD4;MEF2C;TPM1;PPARG;PTEN
prerank,protein localization to plasma membrane (GO:0072659),0.291652451326685,1.2516255437643469,0.08428246013667426,0.5531716536923735,1.0,29/129,11.34%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;CCDC88A;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;WNK3;CD81;NECTIN3;MYO5A;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;TSPAN32;PPIL2;NKD2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.41730112578968576,1.2509268665079005,0.166270783847981,0.5532801814737737,1.0,7/23,16.64%,FADS1;ACSBG1;ALOX12;ACOT7;ALOX5;CYP1A1;ASAH2
prerank,ubiquinone metabolic process (GO:0006743),-0.47045256577731875,-1.2509102799183738,0.18229166666666666,0.42957272822921033,1.0,6/15,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.4578728275960562,-1.2505952667688858,0.18587360594795538,0.42984849652461726,1.0,5/18,14.94%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,positive regulation of phospholipase activity (GO:0010518),-0.43654483594228277,-1.25005903997214,0.17793594306049823,0.43059592205706093,1.0,5/22,12.27%,FLT1;ESR1;PLCG1;AGTR1;FGF2
prerank,regulation of translation (GO:0006417),-0.28775971379842996,-1.2500162141714193,0.07093425605536333,0.43025568698376376,1.0,63/173,27.09%,EIF3H;DAPK1;THBS1;EIF4H;APP;RNF139;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;GIGYF2;PLD1;EIF3C;LARP1;FOXO3;UPF3B;LTN1;EIF3B;OGFOD1;SAMD4A;RPL26;EIF2B2;ZCCHC4;EEF2;RPS6KA1;LARP4B;KLHL25;RPS4X;GSPT1;RPL10;RPS6KA3;IGFBP5;SYNCRIP;BTG2;RPL5;METTL5;RPS3;CTIF;RBM4B;SOX4;PRKDC;CAPRIN1;GLE1;TOB1;RBM3;MTPN;RPL13A;MRPL13;EIF2AK3;MTG2;POLDIP3;NEMF;DHX9;FXR1;IGF2BP2;EIF2AK4;CNOT8;HNRNPD;NANOS1;LARP6;CNOT1;EIF5B
prerank,protein glycosylation (GO:0006486),-0.30035044397799837,-1.2499871066463277,0.0941385435168739,0.4298943075702469,1.0,24/125,10.84%,ST3GAL6;EOGT;ST3GAL4;ST3GAL1;PLOD1;PLOD2;ST8SIA4;GCNT2;TRAK1;GALNT10;ALG10B;MAN1C1;DAD1;MGAT4B;B3GNT2;GFPT2;TET2;FUT8;AQP11;SLC39A8;ST3GAL2;FUT10;ALG12;ALG8
prerank,V(D)J recombination (GO:0033151),-0.5123408425166526,-1.2497915829889148,0.19850187265917604,0.4299236272983694,1.0,6/11,24.66%,XRCC4;TCF3;PRKDC;LIG4;LIG1;HMGB1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5175957530353656,1.2497005828002026,0.20704845814977973,0.5547440521673094,1.0,6/10,21.60%,HSF1;CPEB1;CPEB3;DHX36;PAF1;NCBP2
prerank,aminoglycan biosynthetic process (GO:0006023),0.3445214882307397,1.2494620137659447,0.1340909090909091,0.553570027627396,1.0,10/49,7.94%,GPC5;B3GALT1;HS3ST6;HS3ST5;B3GALT5;HS6ST2;GPC1;GALNT5;B4GALT7;HS3ST2
prerank,gas transport (GO:0015669),0.517664988942517,1.249293269328313,0.18820861678004536,0.552283225297262,1.0,2/10,3.98%,CA2;NGB
prerank,positive regulation of transferase activity (GO:0051347),-0.29425090447680213,-1.2490875283853975,0.0905982905982906,0.4310280778758237,1.0,42/142,22.47%,FLT1;TEK;IGF1R;TIE1;DCUN1D3;ROR1;INSR;KLF4;NEK7;CD200;DTX3L;KDR;MERTK;EGFR;DSTYK;LMO4;TCP1;MRE11;MAPK1;EPHA4;FLT4;GSK3A;HMBOX1;PNKP;PARN;PTGES3;MAGEC2;UBE2L3;DCUN1D2;CTNNB1;SERINC1;SERINC5;EPHA2;FGFR4;DCUN1D5;IGF2;ROR2;PDGFRB;RFC4;EPHB6;HSP90AA1;EPHB3
prerank,negative regulation of cell growth (GO:0030308),-0.2993262118297362,-1.2487059241161367,0.0846286701208981,0.4314274661740871,1.0,41/121,25.54%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;PTPRJ;SOX17;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;DIP2B;GSK3A;SMAD4;TP53;DCBLD2;SEMA3G;WNT11;ULK2;ST7L;CCN3;RERG;NPR1;OSGIN2;HYAL2;PPP2CA;BCL6;CDKN2C;CAPRIN2;FHL1;MSX1;SERTAD2;HSPA1B;GNG4;APBB1;SIPA1;SERTAD3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4976263696956598,-1.2485139912224572,0.20074349442379183,0.43139888642721236,1.0,6/12,19.32%,CBFB;ELF1;LYN;ELF2;RC3H1;PTPRC
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3596266462783726,-1.248486476446845,0.12631578947368421,0.4310202847845209,1.0,16/46,25.53%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;AGPAT4;DGKZ;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.36353538312547984,1.2480771825186965,0.12933025404157045,0.5536619628638656,1.0,10/41,12.02%,ANK3;KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;STAC;KCNN3;GABBR1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.3023426794370847,-1.2479633847692884,0.09466437177280551,0.4316903509415897,1.0,34/112,24.95%,FOXP1;CD34;THBS1;IFIH1;APP;PTPRJ;FRMD8;GAS6;LBP;MAPKAPK2;ARHGEF2;PLCG2;NFKBIL1;DICER1;PSEN1;JAK2;LPL;TNFAIP3;ILRUN;MIF;VSIR;IGF1;RARA;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3618893382524737,-1.2477114067242951,0.14695945945945946,0.43178145400204493,1.0,16/44,15.36%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;RHOA;LIMCH1;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2
prerank,regulation of phospholipase C activity (GO:1900274),-0.4777581808394627,-1.246305430776993,0.20176991150442478,0.43437672884753603,1.0,4/15,5.93%,FLT1;ESR1;PLCG1;ABL1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.48553735307733537,1.2462108141169568,0.2113289760348584,0.5568241020703945,1.0,7/12,19.05%,BICD1;NINL;BBS4;KIF3A;CEP19;HOOK3;CCDC120
prerank,membrane protein proteolysis (GO:0033619),-0.38095994703390057,-1.2461123174315438,0.1510791366906475,0.4343707995534458,1.0,11/37,18.01%,MYH9;ADAM9;NFKB1;PSEN2;SPPL3;AFG3L2;ADAM10;PSEN1;CTSH;APH1A;ERAP1
prerank,carboxylic acid metabolic process (GO:0019752),-0.3888966658699854,-1.2460090716451633,0.15636363636363637,0.4341780021576748,1.0,5/33,3.70%,SLC2A1;ST3GAL1;ST6GAL1;PLA2G4A;CSGALNACT1
prerank,negative regulation of cell cycle process (GO:0010948),-0.3411136176239459,-1.2458920304330838,0.13489208633093525,0.4339805087173477,1.0,22/61,24.58%,DAB2IP;MGA;RYBP;SUZ12;BMP4;MAX;RBBP8;WAPL;EHMT1;PPP1R10;YAF2;PHC1;FOXO4;TERF2;BMP7;RNF2;BRCA1;PHC3;CHEK1;TOM1L2;E2F7;TFDP1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.4462533461767529,1.2453738434069415,0.17488789237668162,0.5573503121038008,1.0,8/17,17.51%,ATP1A2;SCN1B;CACNA2D1;CACNA1D;SCN5A;SLC8A1;SCN2B;CACNA1G
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2726866000568713,-1.2449392446076046,0.053082191780821915,0.43557997539147025,1.0,65/260,19.62%,ABCC4;ABLIM1;RAPGEF2;ITGB1;EXOC6;FGD5;ASAP1;FGD6;PARVB;CD2AP;RAC1;DNM3;PARVA;NTN1;CENPJ;FNBP1L;EXOC4;RAB1A;EHD2;PTPDC1;SSX2IP;CEP250;IFT140;CDC14A;RAP1A;WDR11;EZR;RAB11FIP3;FXYD5;RAP1B;EXOC2;S1PR1;MYLK;PDE6D;FLNA;EMP1;EHD1;WDR35;GALNT11;ANO6;RAB8B;NOTCH1;IFT52;CFAP44;RAB23;TRAF3IP1;CEP41;MAP4K4;EXOC8;FUZ;DZIP1L;VSTM5;NUDCD3;EHD4;RAB11A;HDAC6;CFAP298;GOLPH3;PLK4;PCM1;RAP2A;TMEM17;KIF3B;IFT43;RAP2C
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.33954381174324844,-1.2447446382199787,0.14338235294117646,0.43560836362751243,1.0,19/62,17.77%,AKAP13;RAC1;ARHGEF3;LYN;NET1;F11R;SHOC2;PRAG1;NGF;NOTCH2;RAPGEF1;JAK2;NOTCH1;PIK3CB;GRB2;MAP4K4;IGF1;ALS2;ADGRG1
prerank,secretion (GO:0046903),0.4665364936341828,1.2444968566596797,0.21325051759834368,0.5579612427574154,1.0,2/14,1.29%,SLC22A4;RIMS1
prerank,response to interleukin-1 (GO:0070555),-0.3226188848513689,-1.2442756384788256,0.11296296296296296,0.43617991337961454,1.0,22/73,24.54%,DAB2IP;IL1R1;APP;CCL25;NFKB1;IRAK1;HDAC4;CD40;RC3H1;USP10;IRAK2;ANXA1;IGBP1;CCL19;HYAL2;RELA;HAS2;MAPK11;GBP3;ADAMTS7;PTGIS;TAF9
prerank,response to hydrogen peroxide (GO:0042542),-0.36180735565315536,-1.2440687047142187,0.14678899082568808,0.4362139750431835,1.0,21/45,24.02%,NET1;MAP3K5;ADAM9;STK24;ABL1;PRKCD;ANKZF1;CAT;GPX1;TNFAIP3;FYN;ANXA1;HDAC6;PPIF;SOD1;RPS3;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.5398346021622744,-1.2440072815363992,0.19669117647058823,0.43591687133086693,1.0,4/10,15.58%,PRKCH;MED1;FOXC1;TRIM16
prerank,regulation of synapse organization (GO:0050807),0.39527732533051085,1.2431147947318224,0.18976545842217485,0.5599273773626314,1.0,7/26,9.86%,IL1RAPL1;CTNNA2;CDKL5;CLN3;MDGA1;CAMK2B;SLITRK4
prerank,positive regulation of isotype switching (GO:0045830),-0.4687619539765289,-1.2427802056174098,0.21072088724584104,0.43824505408881875,1.0,7/15,18.59%,SHLD1;TFRC;KMT5B;CD40;MAD2L2;CLCF1;TNFSF13
prerank,positive regulation of heart rate (GO:0010460),-0.45162491023625195,-1.2427124792560045,0.18571428571428572,0.4379402229768698,1.0,8/17,17.16%,ADRA1B;TRPM4;KCNQ1;EDN1;ADM;EDN3;TPM1;SCN3B
prerank,mRNA transport (GO:0051028),-0.308238943124646,-1.2422508914165942,0.10052910052910052,0.4385431842531344,1.0,32/101,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5034154285451634,-1.2416149124365976,0.1967799642218247,0.43946593435192466,1.0,4/13,12.29%,NFAT5;ETS1;RHOA;IRAK1
prerank,cellular response to virus (GO:0098586),-0.3928355866969409,-1.2414564536512598,0.1746880570409982,0.4393594862205899,1.0,15/30,30.24%,IFIH1;DDX3X;IRGM;EIF5A;LGALS8;GSDME;CCL19;HSP90AA1;MAPK11;VWCE;LGALS9;CXCL10;RIOK3;TOMM70;MAPK14
prerank,bile acid and bile salt transport (GO:0015721),-0.41879532038039047,-1.2413157467026217,0.16550522648083624,0.439292191959785,1.0,4/24,2.90%,ABCC4;ATP8B1;SLCO1C1;RXRA
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.43992453002218807,-1.2407893293247423,0.18771929824561404,0.4399780454523216,1.0,6/18,20.79%,DAB2IP;EMD;TP53;CDC73;SKI;NF1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.4372772295708435,-1.2407805981275641,0.17889087656529518,0.4395617212940193,1.0,6/18,15.56%,ASH1L;SETD2;SUV39H1;SETD3;EHMT1;PRDM9
prerank,protein K63-linked ubiquitination (GO:0070534),-0.37149535963769503,-1.2407570811440287,0.15625,0.43917627649669105,1.0,12/41,20.14%,PELI1;TRAF5;TRIM56;NEDD4;RNF115;HECTD1;UBE2E2;RNF168;UBE2V2;RNF152;RNF4;WWP2
prerank,regulation of mitochondrial fission (GO:0090140),-0.41312519692288985,-1.2407286233127304,0.19257950530035337,0.4388116095047582,1.0,7/24,12.94%,RALBP1;LRRK2;KDR;MIEF1;BNIP3;STAT2;MIEF2
prerank,peptide catabolic process (GO:0043171),-0.4252566770658971,-1.2401861441420075,0.15862068965517243,0.4395940027356477,1.0,9/23,19.22%,CPQ;ACE;GGT5;ECE1;ENPEP;XPNPEP1;CTSH;ERAP1;NPEPPS
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4222736811893736,-1.2398907368247551,0.18292682926829268,0.4398116187491049,1.0,3/21,4.17%,MFHAS1;GSK3B;YWHAE
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.492532054204345,1.2395036365826766,0.22394678492239467,0.5678822021995449,1.0,4/12,19.15%,IL12RB1;IL23A;ZBTB1;PRKCQ
prerank,respiratory chain complex IV assembly (GO:0008535),-0.4292467858074024,-1.239414570003172,0.18518518518518517,0.44051289997780474,1.0,7/21,19.59%,COX16;COX18;SCO1;COX17;COA6;COX10;COA8
prerank,sphingoid metabolic process (GO:0046519),0.49021791557056754,1.238884545087971,0.2164009111617312,0.5677328009605147,1.0,6/12,16.64%,PLPP2;SPHK1;SGPP1;SPHK2;NAAA;ASAH2
prerank,protein-containing complex disassembly (GO:0032984),-0.34478120583771693,-1.2387723384867357,0.15412844036697249,0.44153813044658524,1.0,17/54,26.82%,CSNK1A1;CAV1;LIX1L;GSK3B;DVL3;MAP1LC3B;LRP6;TECPR1;GABARAP;CTNNB1;LAMP2;AMER1;PPP1CA;FZD5;FZD1;APC;CHMP3
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.49640178558321846,1.238759419363006,0.203125,0.5663329412362257,1.0,3/11,11.42%,PLA2G7;PLA2G3;LIPC
prerank,mRNA export from nucleus (GO:0006406),-0.30497243653900663,-1.2383335761156513,0.10801393728222997,0.4421006268947836,1.0,33/102,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;IWS1;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5209467691438427,-1.2379781589297567,0.21296296296296297,0.44243312873314355,1.0,6/11,24.04%,TET2;PRDM9;WDR82;OGT;TET3;BEND3
prerank,negative regulation of lipid catabolic process (GO:0050995),0.4335245082951782,1.2377820410891132,0.19333333333333333,0.5671505809699642,1.0,6/17,15.13%,PDE3B;BSCL2;SORL1;ADRA2A;GPLD1;APOC1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.3080669548590446,-1.2375979724720156,0.12105263157894737,0.4428209081163269,1.0,31/104,22.21%,ST3GAL6;ST3GAL4;ST3GAL1;SLC26A2;CSGALNACT1;GSTT1;B3GNT2;CHST15;GGT5;B4GALT4;SLC10A7;DSE;ST3GAL2;CHST11;CSPG4;GSTM2;BGN;MAT2B;B4GALT5;ANGPT1;ESD;HPGDS;MAT2A;B4GALT1;CDO1;CHST7;GSTO2;CTH;CHPF2;GCLC;METTL16
prerank,negative regulation of cellular component movement (GO:0051271),-0.47448952691973695,-1.237414728123954,0.1967509025270758,0.44279200197949664,1.0,5/15,12.35%,SP100;CRK;TGFBR3;FRMD5;ACTN1
prerank,positive regulation of phagocytosis (GO:0050766),-0.3514443199544939,-1.237048923606238,0.15567765567765568,0.44318860083256223,1.0,20/47,31.44%,IL15;MERTK;PTPRJ;GAS6;MYO18A;RAB27A;ANO6;ABCA7;LMAN2;TULP1;GATA2;PTPRC;IL15RA;CD300LF;FCER1G;TREM2;IL2RG;AHSG;RAB31;PLA2G5
prerank,protein ubiquitination (GO:0016567),-0.25775250233106783,-1.2365881854921124,0.03215434083601286,0.443823588643271,1.0,157/471,27.43%,FBXL7;WWP1;PELI1;UBR5;CBFB;USP9X;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;FBXL12;UBE2K;TRIM25;CNOT4;RNF139;PSMA2;RNF111;FBXL17;DTX3L;ZNRF3;SMURF1;CUL9;RNF125;FBXL3;RNF213;RBX1;CBL;OTULIN;RNF43;LMO7;UBE4B;CUL3;NEDD4;RNF40;PSME2;RNF115;RNF144B;KLHL12;CUL2;BIRC6;UHRF2;PDZRN3;ARRDC1;SPSB1;PSMB4;SH3RF1;TRIP12;UBE2J2;DET1;ZNRF2;UBE2D3;MIB1;TPP2;CUL7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;RMND5A;CDC16;HERC6;TSPAN17;RAD18;CDC73;RTF1;ANAPC16;UBE2E2;OBI1;UBE4A;ASB1;FBXW11;KLHL25;RNF168;PSMC2;RC3H1;RNF167;MYLIP;DTX3;HIF3A;VCPIP1;UBE2V2;ERCC8;PSMB2;PHC1;PEX14;UBE2L3;PSMB1;PELI2;HERC2;TRIM13;MIB2;CTNNB1;RFWD3;KCTD10;PSMA8;SPOP;SASH1;KLHL3;SDE2;EPAS1;RNF10;UBR1;SIAH1;RNF152;AKTIP;PSME1;TRIM3;NPEPPS;RNF4;USP7;PRKDC;TRIM47;WWP2;ELOC;PSMD4;HUWE1;FANCL;BRCA1;UBE2R2;MDM2;SH3RF2;CAND2;PSMA7;KEAP1;HACE1;NFE2L2;TRIM39;PSMD5;THOP1;TRIM68;ARRB1;RCHY1;TRIM7;RNF146;FBXO32;TRPC4AP;RNF38;FBXL22;FBXO17;ANAPC7;FBXO40;DTL;TRIM44;PSMB10;ARIH2;LEO1;RNF122;RNF103-CHMP3;PSMA3;RNF34;RNF103;ATG3;TRIM6
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.46407840551311874,-1.2358293567179583,0.2136279926335175,0.4450478536674098,1.0,12/15,47.14%,IL17RA;GBP5;NOD2;STAT3;TICAM1;TLR6;HIF1A;CARD9;TLR4;TNF;IL6;MYD88
prerank,response to hydroxyurea (GO:0072710),-0.5085390865181758,-1.2358292810662306,0.23948811700182815,0.44461618746598647,1.0,7/11,21.31%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5015061289872329,-1.2352212748654234,0.20292504570383912,0.44465063152235534,1.0,4/12,11.86%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5015061289872329,-1.2352212748654234,0.20292504570383912,0.44465063152235534,1.0,4/12,11.86%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5015061289872329,-1.2352212748654234,0.20292504570383912,0.44465063152235534,1.0,4/12,11.86%,RB1;CUL3;CDC16;NSMCE2
prerank,nuclear pore complex assembly (GO:0051292),-0.51955010692741,-1.2349816397956703,0.20976491862567812,0.4447655553562501,1.0,4/10,15.78%,AHCTF1;NUP98;NUP153;TPR
prerank,ureteric bud development (GO:0001657),0.43844051568676407,1.2347629636223827,0.19294117647058823,0.5734864263528262,1.0,6/17,7.54%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,positive regulation of phospholipid transport (GO:2001140),0.5121651143340623,1.2345481888284024,0.21689497716894976,0.5723021315295946,1.0,3/10,14.63%,PRELID1;TRIAP1;APOE
prerank,eye development (GO:0001654),-0.34324290407826036,-1.2343273368659207,0.14513274336283186,0.4457676620983126,1.0,17/54,16.81%,PBX1;RAB3GAP1;SH3PXD2B;SMOC1;COL5A1;PBX3;NIPBL;TGFB2;RBP4;COL5A2;SIPA1L3;LAMA1;SHROOM2;FOXC1;SKI;FREM2;HIPK1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5245542647946174,-1.2338305400808862,0.24,0.44638419772321175,1.0,3/10,12.97%,THBS1;AKT1;CTTNBP2NL
prerank,RNA export from nucleus (GO:0006405),-0.30555223804192794,-1.2337254098350732,0.11091854419410745,0.4461629875133122,1.0,33/100,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;HNRNPA1;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,negative regulation of cilium assembly (GO:1902018),-0.4981073266127657,-1.2334459370843869,0.21645796064400716,0.4463815562504587,1.0,5/12,8.80%,LIMK2;MAP4;CDK10;TBC1D30;YAP1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3731905307510115,1.2334331313946816,0.1723404255319149,0.5735353287009668,1.0,10/32,18.37%,NAV3;EML2;APC2;MAP2;STMN2;HDGFL3;MAPRE1;CLASP2;CAMSAP3;TUBB4A
prerank,autophagosome organization (GO:1905037),-0.34974545253611994,-1.232835439430055,0.1384083044982699,0.44724706611061904,1.0,21/50,27.26%,ATG7;RAB7A;RAB1A;MAP1LC3B;AMBRA1;IRGM;WIPI1;GABARAP;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;ATG2A;RAB19;ATG2B;UBXN2A;ATG3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.417382080528909,1.232597541328225,0.18032786885245902,0.5739567216101651,1.0,10/22,20.72%,STAC2;AKAP6;ATP1B1;CALM2;RYR2;STAC;CASQ1;HTT;HAP1;VMP1
prerank,establishment of melanosome localization (GO:0032401),0.4270760881193889,1.2325410346069037,0.21149425287356322,0.5723431659894003,1.0,9/19,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.4355563038314365,-1.231931727390931,0.1863799283154122,0.44884216981468783,1.0,11/20,30.00%,TNRC6B;LIMD1;CELF1;AGO2;MOV10;WTIP;TNRC6A;AJUBA;CNOT8;CNOT1;HELZ
prerank,DNA biosynthetic process (GO:0071897),0.4416853706621243,1.2318687748245467,0.1925754060324826,0.5723777848898178,1.0,5/16,14.05%,WRNIP1;TYMS;POLD4;POLA1;PPIA
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5005252399037263,-1.2318348017607215,0.2385496183206107,0.4486218973020158,1.0,4/11,8.96%,MAP3K5;STK24;PRKCD;ARL6IP5
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.405657196145991,-1.2318196520563176,0.17314487632508835,0.448230892020045,1.0,18/24,45.31%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;CYP1B1;TGFB1;SULF1;IL1A;HIF1A;RORA;GATA4;ISL1;CCBE1;NODAL;IL6
prerank,motor neuron axon guidance (GO:0008045),-0.46771354130976966,-1.2311109276674566,0.20892857142857144,0.44931848839240895,1.0,6/15,13.44%,RAC1;NTN1;CHN1;SLIT2;EPHA4;RHOG
prerank,positive regulation of neurogenesis (GO:0050769),0.3206807580510517,1.2309055682167298,0.12304250559284116,0.5731973532277433,1.0,14/68,13.54%,PTPRD;IL1RAPL1;ROBO2;OPRM1;MME;ROBO1;CDKL5;NTRK2;SLITRK1;VEGFA;GPER1;FZD3;PLXNA2;PLXNA1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5162711232952325,1.2306507251762597,0.24113475177304963,0.572121872029964,1.0,4/10,6.03%,ATP1A2;HECW1;OSR1;HECW2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.48545623106622493,-1.2302538945162165,0.20637898686679174,0.45077616333041803,1.0,5/13,18.97%,KDR;NAMPT;EDN1;JAK2;NOD2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3433471348383646,-1.2301665506859412,0.14695340501792115,0.4505402558521221,1.0,13/57,11.35%,DAPK1;NOD1;UACA;MAP3K5;DDX3X;TNFSF10;PPM1F;ARL6IP5;ASPH;CASP8;PERP;BCAP31;SOX7
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5189185715323166,-1.2300999156850347,0.21964285714285714,0.45026826302379086,1.0,2/10,5.58%,TRPM4;TNFRSF1B
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3140927890369508,-1.2297174362532572,0.1125703564727955,0.45066475980860443,1.0,30/91,25.64%,ABCG2;APP;ATOX1;SLC39A10;SLC40A1;SLC31A1;TFRC;SLC30A10;BMP6;SCARA5;SLC39A8;SMAD4;HFE;HMOX2;ABCB7;SLC30A5;SLC39A6;SOD1;FLVCR1;SLC30A1;GLRX3;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;LCN2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.42918485873181367,-1.2294385863296835,0.19655172413793104,0.45086479802288987,1.0,6/21,14.09%,PAN3;TUT7;CNOT4;SAMD4A;TUT4;PARN
prerank,regulation of phosphorylation (GO:0042325),-0.2957174944227092,-1.2291367496282553,0.0920138888888889,0.451117888220371,1.0,32/120,19.25%,ITGA6;LYN;CORO1C;THBS1;APP;NUP42;RAE1;EGFR;CDKN1B;RANBP2;ZBTB7A;PTK2;NUP98;BMP4;CDH5;SEC13;ROCK1;PRKRIP1;LDB1;STAT2;ILK;FNIP2;PSEN1;NUP153;PTGES3;MIF;TPR;BMP7;NLRC5;NUP214;IKBKB;PPP2CA
prerank,autophagy of peroxisome (GO:0030242),-0.5061850966037384,-1.228984085062952,0.22201492537313433,0.45098590254266996,1.0,2/12,4.77%,ATM;MAP1LC3B
prerank,protein modification by small protein removal (GO:0070646),-0.2720603121259015,-1.2287859216272332,0.06825938566552901,0.4510444640082617,1.0,91/252,27.04%,SENP1;USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;TRRAP;STAMBP;PSME2;SMAD1;SMAD2;JOSD1;PSMB4;USP2;SMAD4;CLSPN;USP13;TP53;OTUD1;USP40;INO80E;SMAD7;OTUD4;USP15;INO80D;RHOA;USP18;ACTB;ATXN3;BABAM2;PSMC2;HCFC1;TNFAIP3;VCPIP1;USP34;TADA3;PSMB2;USP10;PSMB1;FOXO4;SENP2;INO80B;PSMA8;BRCC3;RAD23A;KDM1B;IKBKG;PSME1;BAP1;USP7;JOSD2;ADRM1;UCHL1;PTEN;USP1;PSMD4;BRCA1;ATXN7;COPS7A;EIF3F;OGT;MDM2;PSMA7;CDC25A;KEAP1;YY1;MBD6;SENP6;BECN1;SUDS3;USP16;RIPK1;STAM2;COPS8;PSMD5;USP12;COPS4;MAP3K7;INO80;PSMB10;TNIP1;APC;TOMM20;PSMA3;USP19
prerank,negative regulation of translation (GO:0017148),-0.3122617733125384,-1.2284089571463261,0.11754385964912281,0.4514540830072732,1.0,32/87,27.03%,DAPK1;RNF139;EIF3E;METTL14;DDX3X;GIGYF2;LARP1;FTO;SAMD4A;PUM1;ROCK1;CELF1;AGO2;IGFBP5;SYNCRIP;BTG2;ROCK2;TPR;RPS3;CAPRIN1;TOB1;METTL16;RPL13A;RBM24;MRPL13;EIF2AK3;FXR1;IGF2BP2;EIF2AK4;CNOT8;NANOS1;CNOT1
prerank,microvillus organization (GO:0032528),-0.4855532188768783,-1.2282731215800626,0.2168458781362007,0.4513282029193763,1.0,8/13,19.62%,RAPGEF2;RAP1A;EZR;FXYD5;RAP1B;MAP4K4;RAP2A;RAP2C
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.39535940358550736,-1.2282127036056605,0.17657342657342656,0.4510490653084755,1.0,10/26,18.59%,ST3GAL4;ST3GAL2;ALG8;ALG11;B4GALT5;GK5;GAL3ST2;GOLPH3;GBGT1;LARGE1
prerank,positive regulation of developmental growth (GO:0048639),0.33980231780575904,1.2277220804042408,0.1619718309859155,0.5783454816431695,1.0,15/49,15.07%,L1CAM;SYT1;RIMS2;RIMS1;SHTN1;CDKL5;LIMK1;CPNE9;MAPT;ZFYVE27;RNF157;SYT4;BDNF;SYT3;UNC13A
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4699285299568436,-1.2269083642097411,0.21869158878504674,0.453359307702369,1.0,4/14,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2623464643832925,-1.226789267482093,0.050488599348534204,0.45319820476762984,1.0,122/341,29.34%,FBXL7;WWP1;PELI1;USP9X;NEDD4L;ZNRF1;SMURF2;UBE2K;TRIM25;CNOT4;PSMA2;RNF111;FBXL17;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;RNF40;PSME2;RNF115;RNF144B;BIRC6;ARRDC1;SPSB1;PSMB4;TRIP12;GSK3A;UBE2D3;MIB1;FEM1A;AREL1;NTAN1;TNFAIP1;RMND5A;CDC16;SPOPL;ARMC8;ANAPC16;KAT5;ATXN3;UBR4;FEM1C;UBE4A;FBXW11;KLHL25;APPBP2;RNF168;PSMC2;RC3H1;RNF167;MYLIP;TNFAIP3;FEM1B;ERCC8;PSMB2;UBE2L3;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;KLHL3;RAD23A;SIAH1;PSME1;TRIM3;RNF4;ADRM1;BUB1B;UCHL1;TBL1X;WWP2;HERPUD1;ELOC;PSMD4;HUWE1;UBE2R2;MDM2;BUB3;PSMA7;KEAP1;NDFIP2;RNF216;HACE1;NFE2L2;FZR1;PSMD5;ARRB1;RCHY1;RNF146;TRPC4AP;MAEA;FBXL22;ZFAND2A;ANAPC7;DTL;PSMB10;ARIH2;RNF122;UBXN2A;PSMA3;KIF14;RNF34;PPP2R5C;RNF114;VPS37B;UBE2I;UBA1;ATE1;RNF14;RNF187;ANAPC11
prerank,gland development (GO:0048732),-0.3350776005925161,-1.2267686636199218,0.14285714285714285,0.45281444362665274,1.0,27/59,28.59%,CAV1;PKD2;LSR;TBX1;MSN;TGFBR3;HES1;SIX1;EZR;NOTCH4;PRKCSH;WNT11;ANXA1;ARID5B;ARHGAP35;CDK5RAP3;CEBPG;SOD1;CITED2;NF1;EPHB3;TBX3;CEBPA;FGF10;STRA6;MET;TGFBR1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.47167276155481574,-1.2266620069880307,0.20795660036166366,0.4526264659371184,1.0,2/14,4.57%,OSMR;IL6ST
prerank,positive regulation of cytokine production (GO:0001819),-0.26538418265887687,-1.226123582038777,0.05025125628140704,0.45337231666210154,1.0,116/292,34.60%,FOXP1;SPTBN1;IL1R1;AFAP1L2;CREBBP;CD34;NOD1;CD200;SLC7A5;IFIH1;APP;IL15;RAB1A;PRKD2;IL6ST;IL6R;NFKB1;PLCB1;STAT6;LBP;MRE11;ARHGEF2;FLT4;IRF1;PLCG2;PIK3CD;RGCC;ZFPM1;IRAK1;LPL;LRRFIP1;FLOT1;IL17RA;CD40;ATF4;POLR3F;AGPAT1;CGAS;MIF;ROCK2;C1QTNF3;IL16;RARA;ANXA1;CTNNB1;ARNT;GBP5;PAEP;CEBPG;MAVS;SOD1;RPS3;CCL19;LURAP1;HYAL2;NOD2;PTPRC;PRKDC;F3;BRCA1;PTPN11;RELA;SERPINE1;HPSE;RIPK1;EIF2AK3;MAPK11;CD276;FZD5;CYP1B1;STOML2;HSPA1B;HMGB1;MAP3K7;IL7;DHX9;IRF7;POLR2L;POLR2H;ADAM17;F2R;LGALS9;POLR3GL;HILPDA;IL12RB2;PNP;FCER1G;TRIM6;HMOX1;POLR3K;RUNX1;MAPK14;DDIT3;TNFRSF14;TGFB1;LILRB1;STAT3;TICAM1;TLR6;RFTN1;SULF1;IRF5;CEBPB;FGR;TLR1;NOS2;RAB7B;TLR5;POLR2E;CD14;IL1A;TSLP;NLRP3;POLR3A;PARK7;TBK1
prerank,amino sugar biosynthetic process (GO:0046349),-0.4978878945735812,-1.2258274197381147,0.225177304964539,0.45356754053574144,1.0,4/12,13.52%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.42939967140383334,1.2256555641672358,0.18876404494382024,0.582314807712273,1.0,10/19,20.73%,GGA3;NTRK2;SORL1;RTN4;CLU;APOE;RTN3;FLOT2;HAP1;RTN1
prerank,positive regulation of exosomal secretion (GO:1903543),0.45306305576325323,1.2256468068147024,0.20833333333333334,0.5805921481948607,1.0,7/15,18.93%,SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4439754744057343,-1.2253711160805485,0.19429590017825313,0.45415501410381515,1.0,3/17,6.51%,PODXL;ADAM9;TGFB2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5007126822957553,-1.2252622295123343,0.20426287744227353,0.4539820765993606,1.0,2/12,2.03%,FOXP1;LYN
prerank,retrograde axonal transport (GO:0008090),0.4403319850873342,1.2252349549070014,0.21615720524017468,0.5799699921276041,1.0,7/16,19.24%,DLG2;TMEM108;KIF5A;KIF1C;NEFL;MAP1A;HAP1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.29351184524627116,-1.225135612877183,0.0859106529209622,0.45382384505880297,1.0,48/129,28.79%,FBXL7;MNAT1;FBXL12;CENPJ;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;CDK14;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;KHDRBS1;FBXL22;PLK3;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA
prerank,regulation of endocytic recycling (GO:2001135),0.4932238935815503,1.224372009538911,0.2324561403508772,0.5805625515125304,1.0,6/11,12.18%,ATP9A;PLA2G3;SORL1;PLA2G4E;EIPR1;INPP5F
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4622901800412115,1.224172089285515,0.23194748358862144,0.5793858440473233,1.0,2/13,3.86%,B3GALT1;B3GALT5
prerank,nucleosome organization (GO:0034728),-0.339236042914526,-1.2240970489097673,0.15742397137745975,0.4556725561665091,1.0,16/55,19.64%,KAT6B;SETD2;ARID2;CTCF;SMARCC1;BRD2;SRCAP;SMARCE1;SPTY2D1;SMARCC2;MCM3AP;SMARCD3;H3-3A;PRDM9;VPS72;ATRX
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4792921387968312,-1.2237500284758605,0.2077922077922078,0.45600106870019896,1.0,3/13,8.44%,NRP2;PLXND1;PLXNA4
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.503556321971584,-1.223584324005052,0.209009009009009,0.45594057801313875,1.0,5/11,17.32%,SP100;TP53;KAT5;MAD2L2;TFAP4
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4925532623543507,-1.223420272464901,0.24113475177304963,0.4558551282978608,1.0,5/11,19.06%,TGFB2;BMP4;JAG1;HEY2;SOX4
prerank,bile acid metabolic process (GO:0008206),0.39482428917882906,1.2233905647650742,0.16335540838852097,0.5798129031878728,1.0,5/27,8.86%,AKR1D1;CYP46A1;AKR1C1;OSBPL6;CYP27A1
prerank,protein localization to cell junction (GO:1902414),-0.41527226922607674,-1.223118583070598,0.17437722419928825,0.45609070232584026,1.0,7/22,7.60%,TJP1;FERMT2;HEG1;JAK1;PAK2;CGNL1;TJP2
prerank,regulation of cartilage development (GO:0061035),-0.44331542031547694,-1.223115894168551,0.19718309859154928,0.45566921608397104,1.0,5/18,16.33%,ZBTB16;BMPR2;BMP4;WNT11;TRPS1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4740641199452561,-1.2229425630460233,0.1834862385321101,0.45561759519759676,1.0,7/14,23.02%,KMT2E;SMAD4;PRDM9;DNMT1;CTNNB1;BRCA1;WDR5
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5055778525404199,-1.2228195335308578,0.22592592592592592,0.45546853453463043,1.0,4/12,15.58%,ASXL1;KLF2;CTBP2;TRIM16
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.44351191948167357,-1.222608132005946,0.20357142857142857,0.45548374482503495,1.0,5/17,11.55%,PARD3;SPRED2;PPEF2;DDIT4;SMAD7
prerank,regulation of cell death (GO:0010941),-0.30671535294108393,-1.2225376388490081,0.11208406304728546,0.4552329829198836,1.0,37/94,26.55%,FERMT2;ACER2;LRRK2;CDKN1B;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;CELF1;WNT16;CHMP4B;AXIN2;ACER3;FGF2;RAD18;CHP1;WNT11;CCN5;PDE12;ATG5;CCN3;CTSZ;BMP7;TRIM13;SOX4;RRAS2;SLC25A24;CCN1;PARP16;BECN1;TXNDC12;HSPA1B;NOA1;LRP1;APC;VPS35
prerank,positive regulation of organelle organization (GO:0010638),-0.3767448826743984,-1.2218967071633215,0.161231884057971,0.4561854385845987,1.0,14/32,31.44%,RAB3GAP1;GSK3B;ANXA2;STX18;IRGM;RAB3GAP2;SORBS3;ANXA1;LIG4;KATNBL1;DOC2B;TREM2;SYNJ1;PLA2G5
prerank,protein tetramerization (GO:0051262),0.3151841919788482,1.2215794478249633,0.14942528735632185,0.5829588556975762,1.0,14/67,15.30%,HCN1;GRIN2B;MS4A1;SYCP1;RYR3;AQP4;GNMT;HOMER1;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,glycine transport (GO:0015816),0.5059678130964951,1.2215057606865178,0.21218961625282168,0.5814637686465832,1.0,3/10,9.21%,SLC7A8;SLC36A2;SLC6A5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.49021667872664376,-1.2210376579548892,0.2247191011235955,0.4576646529034028,1.0,5/12,15.49%,RANBP9;ROCK1;PICALM;ROCK2;ABCA7
prerank,ubiquinone biosynthetic process (GO:0006744),-0.4615852561656331,-1.2210138395851786,0.2198581560283688,0.45728351480192686,1.0,6/15,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3366373739914252,-1.2209637607507196,0.17168141592920355,0.45697168877589384,1.0,16/55,24.66%,SLC7A1;IL15;IL6ST;TFRC;NCK1;NCK2;ICOSLG;IGF1;VCAM1;ANXA1;RPS3;CCL19;PTPRC;IGF2;CD276;HMGB1
prerank,regulation of blood coagulation (GO:0030193),-0.39862458032219517,-1.2207612718859497,0.19320214669051877,0.4570055110996634,1.0,12/27,26.84%,ST3GAL4;CAV1;CD34;THBS1;ENPP4;EDN1;TFPI;SERPINE2;SERPINE1;HPSE;DMTN;F2R
prerank,negative regulation of anoikis (GO:2000811),-0.4645287223062098,-1.2205342872723408,0.20913884007029876,0.457103026083573,1.0,5/14,12.19%,ITGB1;CAV1;MCL1;PTK2;NOTCH1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.30542132489081186,-1.2203064341482013,0.12052730696798493,0.4571732307388596,1.0,32/93,24.99%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;MID1;PLCB1;TGFB2;RASSF2;FLT4;ARL6IP5;SH3RF1;WNT16;TAOK3;TPD52L1;SEMA4C;TNFRSF19;MTURN;SASH1;CCL19;EDAR;NOD2;DUSP22;KLHDC10;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1;BMP2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.44524465507947997,-1.2202454924590598,0.2161654135338346,0.45686855177158303,1.0,4/18,10.11%,ESR1;EGFR;BMP4;TP53
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3674191288330071,-1.2201663727232737,0.15761821366024517,0.4566185950836061,1.0,14/37,24.54%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;RPL5;GIPC1;USP7;OGT;RPS7;TRIM39;TAF9
prerank,myoblast differentiation (GO:0045445),-0.46282063246185834,-1.2201337625970914,0.22201834862385322,0.4562667617366709,1.0,8/14,19.87%,MBNL1;RB1;PLEKHM3;JAG1;MAPK12;IGF1;EPAS1;TCF7L2
prerank,"phototransduction, visible light (GO:0007603)",-0.4735763151946874,-1.2196267523378292,0.22375215146299485,0.456934486422838,1.0,8/14,46.72%,GNB1;SAG;GNA11;PDE6G;PDE6B;RP1;GNAQ;RHO
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4318020011583882,1.2192261226108498,0.22093023255813954,0.5858294568295482,1.0,2/16,2.78%,KCNC2;DDAH2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.34635140340613935,-1.218906093804792,0.14444444444444443,0.4580776784556889,1.0,19/51,27.81%,THBS1;IL6R;GAS6;MOSPD2;IL34;PTK2;MAPK1;VEGFC;EDN3;ANO6;LGMN;CMKLR1;CXCL12;PTN;SERPINE1;HMGB1;ADAM17;LGALS9;CXCL10
prerank,protein transport (GO:0015031),-0.2605023067398074,-1.21833287098387,0.06734006734006734,0.4589184661741716,1.0,94/332,22.66%,SPTBN1;TBC1D4;SEC31A;RUFY1;CALCRL;MYH9;ARF3;RAMP1;RAB7A;ARCN1;RAB1A;GOLPH3L;TLK1;TFRC;SCAMP2;SYNRG;TBC1D1;RAB5B;DNM2;STX3;TBC1D2B;MACF1;TANGO6;STEAP3;MON1A;TBC1D8B;WDR11;SNX9;SLC10A7;USP6NL;SEC13;COPG1;RAB5A;TBC1D30;ARRDC1;ARHGEF2;STX8;TBC1D14;SCFD1;ARL6IP5;TVP23A;RAMP2;TBC1D22B;COPA;RAB3GAP2;ARHGAP1;EHD1;TXNIP;TBC1D22A;HFE;VPS26A;RAB8B;ARL4A;GOLGA4;SLU7;ATP6V1E1;CHMP2B;MCOLN1;VPS45;REP15;RAB23;RAB24;RAB32;TOM1;SNX8;HERC2;SIL1;AP4M1;HDAC6;LAMP2;TMED5;GOLPH3;FAM91A1;ATP6V0A1;STX12;TBC1D8;VPS26C;SCAMP1;AP3B1;KIF3B;TBC1D17;TBC1D25;PPARG;ARL5C;KIF13A;CTSA;VAMP2;SNX13;PREB;TBC1D12;ATP6V1H;EVI5;SAR1A;ARL4C
prerank,protein deubiquitination (GO:0016579),-0.27143306737091655,-1.218225117863226,0.06357388316151202,0.45872754465990007,1.0,79/242,23.88%,USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;OTULIN;TRRAP;MINDY1;STAMBP;PSME2;SMAD1;SMAD2;JOSD1;PSMB4;USP2;SMAD4;CLSPN;USP13;TP53;OTUD1;USP40;INO80E;SMAD7;OTUD4;USP15;INO80D;RHOA;USP18;ACTB;ATXN3;BABAM2;PSMC2;HCFC1;TNFAIP3;VCPIP1;USP34;TADA3;PSMB2;USP10;PSMB1;FOXO4;INO80B;PSMA8;BRCC3;RAD23A;KDM1B;IKBKG;PSME1;BAP1;USP7;JOSD2;ADRM1;UCHL1;PTEN;USP1;PSMD4;BRCA1;ATXN7;EIF3F;OGT;MDM2;PSMA7;CDC25A;KEAP1;YY1;MBD6;BECN1;SUDS3;USP16;RIPK1;STAM2;PSMD5;USP12
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4627276454752511,1.216916829854524,0.22954545454545455,0.5901297105125527,1.0,6/13,21.60%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.41297436919187247,-1.21663571650895,0.22201492537313433,0.461795577701294,1.0,8/21,21.08%,NT5C2;NT5E;PDE2A;PDE9A;NT5C1A;HPRT1;HINT1;AMPD3
prerank,regulation of anoikis (GO:2000209),-0.4289245913701736,-1.2165816773364129,0.21492007104795738,0.461515800128558,1.0,5/19,6.61%,ITGB1;CAV1;MCL1;SIK1;PTK2
prerank,primary miRNA processing (GO:0031053),-0.5191333309162713,-1.2164558801575498,0.24029574861367836,0.4613545791545135,1.0,7/10,36.30%,SMAD1;SMAD2;PUS10;DROSHA;MRPL44;DGCR8;SMAD3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3859782411185771,-1.2160377398510707,0.18297101449275363,0.4619117762748311,1.0,15/33,26.42%,IGF1R;PIK3R1;IRS1;PIK3C2A;PIK3CD;AKT1;EDN1;HTR2A;PIK3CB;IGF1;PTEN;NF1;PIK3CA;ZFP36L1;TPTE
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.37705210403546924,-1.2159280025068488,0.19005328596802842,0.4617084900254613,1.0,11/29,26.55%,CAV1;THBS1;PAK2;TNFSF10;WWOX;HYAL2;G0S2;LTBR;RIPK1;TNFSF12;TNFRSF12A
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5098326256117244,-1.215903819068162,0.23958333333333334,0.46133540589108807,1.0,3/10,9.84%,PRKCE;IRS1;AKT1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3428083145046546,-1.2157469813373543,0.16270566727605118,0.46127624837806674,1.0,21/53,26.54%,EYA4;ATM;UIMC1;SPRED2;EGFR;PRKCD;BABAM2;RNF168;ERCC8;HIC1;CEBPG;BRCC3;RPS3;NSMCE4A;BRCA1;TRIM28;MSX1;DHX9;FXR1;ERCC6;FGF10
prerank,heart looping (GO:0001947),-0.3542454160740285,-1.2157438278298471,0.17870036101083034,0.4608611929775459,1.0,10/40,14.01%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2;NOTCH1;ZIC3
prerank,cellular response to interleukin-1 (GO:0071347),-0.2849942870971071,-1.215733022697577,0.08892921960072596,0.4604643296454143,1.0,44/143,24.75%,DAB2IP;IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;CCL25;NFKB1;RBX1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;FBXW11;CD40;MAP3K8;PSMC2;RC3H1;PSMB2;USP10;PSMB1;PELI2;TAB2;IRAK2;PSMA8;IKBKG;CCL19;IKBKB;HYAL2;NOD2;PSME1;PSMD4;PSMA7;RELA;HAS2;MAPK11;PSMD5;GBP3;ADAMTS7;PTGIS;MAP3K7
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.39802524438820075,1.215420802747613,0.19389978213507625,0.5923036460772003,1.0,9/23,16.53%,HSD17B12;FAR1;ACSBG1;HACD1;ACSL3;ACSL6;TECR;ACOT7;HACD2
prerank,epidermal cell differentiation (GO:0009913),-0.36158714253100144,-1.2144394632283042,0.1936026936026936,0.46283788639883455,1.0,15/41,22.98%,BCR;ADAM9;HDAC1;MED1;ERCC2;WNT16;TXNIP;ERCC3;JAG1;ASAH1;ANXA1;CTNNB1;EPHA2;USH2A;PIP5K1A
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.46071460986458546,-1.214397373696218,0.21934369602763384,0.4625292852924673,1.0,8/15,32.49%,NR3C1;FAM107A;UBE2L3;BCL2L11;ANXA1;ZFP36L1;HNRNPU;SSTR2
prerank,carboxylic acid transport (GO:0046942),-0.3400306411548231,-1.214056546467503,0.16518650088809947,0.46285879821974857,1.0,19/55,24.20%,SLC6A6;SLC7A1;SLC7A5;SLC16A12;SLC38A5;SLC16A9;SLC16A1;SLC1A5;SLC17A5;SLC13A3;SLC16A6;SLC36A4;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC38A6;SLC16A13
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.506055941868788,-1.2136615632513315,0.23290203327171904,0.4633127910828541,1.0,3/11,5.09%,LRP5;TBX1;TGFBR2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4476850454766758,-1.213517577224209,0.21551724137931033,0.462790604804735,1.0,7/16,20.17%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4476850454766758,-1.213517577224209,0.21551724137931033,0.462790604804735,1.0,7/16,20.17%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN
prerank,regulation of type I interferon production (GO:0032479),-0.3143409186644336,-1.213170962046455,0.14705882352941177,0.4631233070909876,1.0,30/84,25.92%,CREBBP;IFIH1;TRIM25;TRIM56;RNF125;TAX1BP1;NFKB1;STAT6;MRE11;IRF1;UBA7;IKBKE;IRAK1;LRRFIP1;TRAF3IP1;POLR3F;TNFAIP3;ILRUN;CGAS;CTNNB1;GPATCH3;NLRC5;MAVS;PRKDC;RNF216;RELA;DHX9;IRF7;POLR2L;POLR2H
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3837933005948136,-1.2127557909532412,0.1989051094890511,0.46367119435032594,1.0,12/30,24.54%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;GIPC1;USP7;OGT;TRIM39;TAF9
prerank,regulation of RNA splicing (GO:0043484),-0.32498686059886783,-1.212329076737371,0.15070921985815602,0.4641846567949438,1.0,25/69,22.21%,MBNL1;MBNL2;DYRK1A;ZNF326;AHNAK;METTL4;PIK3R1;FUS;AHNAK2;ERN1;CELF1;RBM39;HNRNPF;SON;CLK3;ZPR1;RBM20;JMJD6;SRPK2;SRSF3;PTBP3;SRSF10;TRA2B;CWC22;METTL16
prerank,cell projection organization (GO:0030030),-0.383188462386793,-1.2121579662058553,0.18312387791741472,0.46415697056450117,1.0,6/30,6.53%,ITGB1;PARVB;RAC1;RHOJ;PARVA;RHOQ
prerank,cellular response to interferon-beta (GO:0035458),-0.46937204937262517,-1.2110320849714056,0.23507462686567165,0.4661524716193111,1.0,7/14,35.23%,UBE2K;IRGM;IRF1;IFITM2;TRIM6;CDC34;UBE2G2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.4382237778110854,-1.2108358347037647,0.21811460258780038,0.4661656027696173,1.0,7/18,11.47%,JAK1;IL6ST;IL6R;CBL;YAP1;SMAD4;JAK2
prerank,positive regulation of type I interferon production (GO:0032481),-0.32237802660254367,-1.2107061703958206,0.15384615384615385,0.46607072832068247,1.0,38/73,37.30%,CREBBP;IFIH1;TRIM56;SETD2;DDX3X;NFKB1;STAT6;MRE11;IRF1;IRAK1;LRRFIP1;FLOT1;POLR3F;CGAS;CTNNB1;MAVS;PRKDC;PTPN11;HSP90AA1;RELA;DHX9;IRF7;POLR2L;POLR2H;POLR3GL;RIOK3;TOMM70;POLR3K;IRF5;POLR2E;CD14;POLR3A;TBK1;TLR2;TLR8;GAPDH;G3BP1;NFKB2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.404572075024515,-1.21038090841148,0.1923743500866551,0.4663490304337377,1.0,13/24,23.50%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;TCF3;MAPK12;CTNNB1;SPAG9;MYOCD;MAPK11
prerank,cortical cytoskeleton organization (GO:0030865),-0.35926789024996775,-1.2102869002186725,0.19597069597069597,0.4661188536711535,1.0,17/41,18.83%,RAC1;RHOBTB1;RND3;DLG1;RHOQ;EZR;PPP2R3C;ROCK1;RHOA;LCP1;RHOC;RHOG;NCKAP1;ROCK2;FMNL2;TRPV4;IKBKB
prerank,organelle transport along microtubule (GO:0072384),0.36817130966385114,1.210107595646033,0.19101123595505617,0.6053291132605643,1.0,15/31,20.86%,BICD1;CLN3;MAP1S;MAPT;DYNC1I1;TMEM201;RAB6A;COPG2;HTT;BORCS5;TRAK2;BICDL1;RHOT1;HAP1;UBB
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2890587389252631,-1.2100379212171564,0.10207612456747404,0.4661881045712694,1.0,48/130,28.79%,FBXL7;MNAT1;FBXL12;CENPJ;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;CDK14;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;KHDRBS1;FBXL22;PLK3;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA
prerank,sodium ion homeostasis (GO:0055078),0.4062068184148154,1.210005376793677,0.21904761904761905,0.6038664670320802,1.0,5/21,11.91%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.47413051721000227,-1.2099471577655037,0.22344322344322345,0.46598481175362344,1.0,2/14,2.95%,DAB2IP;PTPN1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4552653447842797,1.2098293014042414,0.2062780269058296,0.6026060761658854,1.0,5/13,15.63%,INSIG1;CD81;SORL1;BRSK2;SAR1B
prerank,negative regulation of chemotaxis (GO:0050922),-0.37913194958897306,-1.209652699712428,0.18761061946902655,0.4661809974456307,1.0,13/31,18.35%,SEMA6A;SEMA3C;SEMA7A;THBS1;SLIT2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;DUSP3;SEMA5B;SEMA4A;SEMA3E
prerank,bone development (GO:0060348),-0.3596196502955721,-1.2089991355454326,0.17137809187279152,0.4672394703859489,1.0,12/39,13.32%,AKAP13;LRP5;PLS3;DYM;SH3PXD2B;LRP6;SLC10A7;TGM2;TP53;RPL13;NOTUM;MYOC
prerank,cellular protein localization (GO:0034613),-0.26195892436920637,-1.2089694380622067,0.08121827411167512,0.4668862399158119,1.0,90/285,23.83%,TBC1D4;SEC31A;FERMT2;ESAM;ARF3;SH3PXD2B;ID1;ARCN1;LRRK2;RAB1A;SMURF1;EGFR;TLK1;RIC3;SYNRG;NIPBL;TBC1D1;RAB5B;CNTNAP1;STX3;TBC1D2B;COX18;CEP250;TBC1D8B;PTPRK;WDR11;CNTLN;SNX9;ITSN1;USP6NL;SEC13;RAB5A;TBC1D30;ARHGEF2;STX8;TBC1D14;SCFD1;OCLN;FGF7;FLNA;CROCC;TBC1D22B;AXIN2;WIPI1;COPA;FBLN5;RAB3GAP2;EHD1;TBC1D22A;VPS26A;ARL4A;SLU7;ABHD17A;WNT11;VPS45;RAB23;RAB24;RAB32;SNX8;ANGPT1;HERC2;SIL1;AP4M1;HDAC6;CTNNB1;TMED5;FAM91A1;HEY2;RAP2A;STX12;TBC1D8;VPS26C;AP3B1;TBC1D17;TBC1D25;WDR45B;ARL5C;VCL;REEP1;KIF13A;CTSA;SNX13;TBC1D12;EVI5;SAR1A;ARL4C;COPZ1;NPHP1;MYO7A;RAB19
prerank,response to UV (GO:0009411),-0.30061532310109745,-1.2087211117785785,0.1335676625659051,0.46702178563369223,1.0,35/95,26.71%,CREBBP;DCUN1D3;MAP4K3;EGFR;UBE4B;NEDD4;PRKCD;PTPRK;ERCC2;RPL26;AKT1;TP53;NSMCE3;CAT;REV1;MAPK8;ATF4;ERCC3;COPS9;GPX1;N4BP1;ERCC8;RUVBL2;WRN;SDE2;CCND1;USP1;CDC25A;RELA;YY1;INO80;ERCC6;EIF2AK4;DTL;RHBDD1
prerank,negative regulation of type I interferon production (GO:0032480),-0.35631013611042706,-1.2086460157413441,0.18421052631578946,0.4667856105215544,1.0,15/40,22.72%,IFIH1;TRIM25;RNF125;TAX1BP1;PPM1B;UBA7;IKBKE;TRAF3IP1;TNFAIP3;ILRUN;GPATCH3;NLRC5;MAVS;RNF216;YY1
prerank,mRNA 3'-end processing (GO:0031124),-0.31308889600961926,-1.2081985062243992,0.13708260105448156,0.4673946147971526,1.0,21/78,20.24%,SRSF11;TENT4B;APP;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;CPSF7;DHX38;CDC73;SLU7;LSM11;TENT2;THOC3;THOC1;FIP1L1;SRRM1;RNPS1;SRSF3
prerank,endoplasmic reticulum organization (GO:0007029),-0.3165182363220494,-1.2073619689157578,0.15452930728241562,0.468898860309179,1.0,22/72,21.65%,SEC31A;APP;TMCC1;STX18;LRRK2;EMD;ATL2;TOR1B;SEC16B;UBE2J2;REEP3;GAK;SGTA;VCPIP1;TRAM2;LMAN2;MOSPD3;VAPA;WDR83OS;LPCAT3;REEP1;VAMP2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.38453029783817655,1.2073447798164074,0.19402985074626866,0.6077420364096348,1.0,5/27,9.50%,HTR2C;CALCA;GRM1;C3AR1;GPR65
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3643394375695191,-1.2072625343496024,0.19715808170515098,0.46867641766327983,1.0,13/36,28.79%,MECOM;FOXO1;DLG1;EZR;TAOK3;DUSP3;IGBP1;ZMYND11;SH3RF2;GPS2;AIDA;TREM2;DUSP1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.36664711542733364,-1.2067920506362002,0.2110912343470483,0.4692525897279374,1.0,10/34,19.29%,WASF2;RAC1;PIK3R1;SLIT2;PLCE1;OCLN;ABI3;NCKAP1;CAPZB;EPHA2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4965945165529656,-1.2067484561374104,0.24143835616438356,0.4689201879053228,1.0,4/11,20.12%,ATG7;ATG10;WIPI1;WDR45B
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5091999781729999,-1.2066245526245025,0.23665480427046262,0.46880146137991613,1.0,6/10,31.81%,PARD3;PRKD3;DGKH;PLPP1;F2R;DGKD
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3995928226418761,-1.2063315378967208,0.2158671586715867,0.46908042545614514,1.0,10/23,26.17%,JAK1;IRGM;PARP14;JAK2;SUMO1;NLRC5;IFNGR2;PPARG;PTPN2;PARP9
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5011890888741332,-1.2061031322296225,0.2270363951473137,0.4691314798515179,1.0,4/11,13.52%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3373949801565865,-1.2058936761453327,0.16901408450704225,0.46917905248586655,1.0,20/52,24.70%,PPP1R13B;YWHAE;HPS4;YWHAZ;NMT1;GSK3A;UBE2J2;CASP8;UBE2D3;TP53;MAPK8;BBC3;UBE2L3;BAP1;NPEPPS;PPP3CC;HUWE1;FZD5;TFDP1;SAE1
prerank,regulation of wound healing (GO:0061041),-0.34941705550095864,-1.2056396650508754,0.18198198198198198,0.4693293173167996,1.0,11/42,17.00%,ITGB1;CAV1;PRKCE;CRK;PTK2;OCLN;MYLK;ARFGEF1;FGF2;TNFAIP3;ANXA1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4773637363117282,-1.205189173225561,0.2303473491773309,0.46987426049184555,1.0,7/13,22.38%,CAV1;USP13;BCAP31;ATXN3;SGTA;HERPUD1;NFE2L2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.34618403372132134,-1.2050921837877653,0.19090909090909092,0.46968203830266464,1.0,15/46,21.67%,FOXP1;ELN;THBS1;IL6R;BMP4;AKT1;EDN1;TNFAIP3;IGFBP5;IGF1;CTNNB1;PRKDC;TCF7L2;PPARG;PDGFRB
prerank,purine ribonucleotide transport (GO:0015868),-0.4598651800387357,-1.2048362287940668,0.23665480427046262,0.4697942887569213,1.0,4/16,7.79%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,positive regulation of neuron projection development (GO:0010976),0.30258035121278243,1.204500313326832,0.1417910447761194,0.6137691028033389,1.0,15/85,9.80%,MAGI2;LRRC7;RIT2;SCN1B;TENM3;FUT9;TOX;VLDLR;KIDINS220;NDRG4;CAMK2B;NTRK2;PLA2G3;PLPPR5;STMN2
prerank,protein export from nucleus (GO:0006611),-0.3933913598079279,-1.2042597113694187,0.19672131147540983,0.4706952635906943,1.0,9/27,19.14%,NUP42;SMURF1;CSE1L;XPO7;CHP1;TPR;XPO4;NUP214;DUSP16
prerank,mRNA processing (GO:0006397),-0.2607597155312885,-1.2039622876327407,0.06688417618270799,0.4709672163508167,1.0,97/287,28.50%,MNAT1;SRSF11;PRPF3;METTL14;SMU1;SARNP;PSPC1;CWF19L2;RSRC1;HNRNPA0;THOC2;RBM5;RPRD2;NOVA2;HNRNPR;UPF3B;FUS;THOC7;PRPF6;SF3B6;SPEN;ERN1;RBM19;HNRNPM;POLR2G;PHF5A;CELF1;DDX39B;SF3B1;ERCC2;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SON;SFPQ;SLU7;CTNNBL1;SNRPE;ERCC3;SF3A1;HNRNPA1;SYNCRIP;THOC3;SRSF12;THOC1;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;CMTR2;ALKBH5;RBM15;PCBP1;SUPT4H1;POLR2C;GEMIN7;USP39;POLDIP3;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;PRPF18;HNRNPL;HNRNPD;GTF2H3;PABPC1;HNRNPU;SCAF11;TXNL4A;LSM2;CCNH;CWC27
prerank,UV protection (GO:0009650),-0.5106461843801134,-1.2039325751525825,0.226691042047532,0.47062866127027764,1.0,6/10,32.94%,ERCC2;CAT;GPX1;SDF4;MFAP4;SCARA3
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3711620934384228,-1.2034876537761159,0.18994413407821228,0.47122233769657773,1.0,7/32,9.39%,RREB1;WASF2;RAC1;CORO1C;PIK3R1;PLCE1;OCLN
prerank,positive regulation of developmental process (GO:0051094),-0.2774332736197917,-1.2032139057144122,0.10702341137123746,0.47144264340564307,1.0,34/164,14.44%,DAB2IP;RREB1;SLC6A6;ZBTB16;SHANK3;INSR;BMPR2;SMURF2;CORO1C;DVL3;ZDHHC6;RALBP1;BMP5;SHLD1;KDR;TFRC;TRPM4;FZD4;KMT5B;MIEF1;PLCB1;BMP4;BNIP3;RBM19;LMNA;PSEN1;EDN3;RPS6KA1;PA2G4;LLPH;MIEF2;AGO2;B4GALT5;RPS6KA3
prerank,negative regulation of cell activation (GO:0050866),0.4392154102988137,1.2025163004901394,0.2266949152542373,0.6175938230252762,1.0,7/14,15.31%,C1QTNF1;NR1D1;PDGFA;GPER1;LDLR;APOE;PDGFRA
prerank,neuron fate commitment (GO:0048663),0.4500629484198746,1.2021743975834573,0.22850678733031674,0.6168109814440389,1.0,2/14,8.55%,MYT1L;POU4F1
prerank,mesenchyme development (GO:0060485),-0.45908920093711475,-1.201982671572258,0.21505376344086022,0.47371528071700075,1.0,8/15,28.59%,PKD2;BMPR2;BMP4;WNT11;BMP7;BMP2;FOXF1;TGFBR1
prerank,negative regulation of cell motility (GO:2000146),-0.2975161973887775,-1.2018175849659662,0.11599297012302284,0.47369119974930324,1.0,37/108,21.11%,CLDN5;ENG;ACVRL1;CRK;MITF;ARID2;PTPRJ;SCAI;LDLRAD4;AFDN;TCAF1;STK24;FOXO3;SLIT2;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;SMAD7;FRMD5;LIMCH1;TPM1;DUSP3;WNT11;JAG1;IGFBP5;MIF;FUZ;ADARB1;RAP2A;CITED2;DUSP22;RAP2C;PTEN;NF1;VCL
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.389420484569953,-1.2018017333270266,0.20557491289198607,0.47330699954310274,1.0,10/26,15.65%,APP;HES1;CUL3;USP2;TAL1;PPP1R10;DUSP3;PKN2;SMOC2;LGMN
prerank,icosanoid secretion (GO:0032309),-0.48704870103262776,-1.201644843295827,0.24048442906574394,0.47322967699854224,1.0,2/12,4.51%,ABCC4;ACE
prerank,cellular response to retinoic acid (GO:0071300),0.34240540796330754,1.2012752319662359,0.1912442396313364,0.6175722936447787,1.0,9/42,12.40%,BRINP3;WNT7B;BRINP1;PAX2;BRINP2;ADNP2;TESC;WNT6;HTRA2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.443150160005246,-1.2011298849314196,0.23467600700525393,0.4739318453036711,1.0,7/17,18.37%,ABHD2;NR3C1;MED1;BMP4;UBE2L3;BMP7;TFPI
prerank,negative regulation of protein binding (GO:0032091),-0.32326436845550316,-1.2010209865162422,0.16420664206642066,0.47375594050343295,1.0,17/71,15.77%,CAV1;DAB2;GSK3B;LRRK2;PRKCD;ROCK1;ATP2A3;NES;AKT1;ZFPM1;HFE;ACTB;ITGA4;MAPK8;CTSZ;MITD1;PEX14
prerank,protein localization to mitochondrion (GO:0070585),-0.5037446098287915,-1.2009078274943077,0.24368231046931407,0.47358480164124234,1.0,3/11,9.84%,LRRK2;COX18;AKT1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4847224016139691,-1.2006707596549477,0.2522202486678508,0.4737012781459861,1.0,3/12,6.51%,MBNL1;LRP6;TGFB2
prerank,protein localization to cell periphery (GO:1990778),0.2772422094790685,1.200368178438495,0.14553990610328638,0.6183514902071825,1.0,29/133,11.34%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;WNK3;CD81;MYO5A;ARL3;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;LIN7C;TSPAN32;PPIL2;NKD2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3983698830949733,-1.200164823928956,0.2509090909090909,0.4744317385019988,1.0,6/22,12.11%,ADAM9;TNFRSF1B;SNX9;ROCK1;PTPN3;TIMP3
prerank,fluid transport (GO:0042044),0.46267653003704023,1.1997593219332199,0.23717948717948717,0.6183534027247806,1.0,2/12,4.58%,PDPN;AQP4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3250586933417342,-1.19961398800024,0.1917562724014337,0.47527209394731695,1.0,23/60,26.33%,KLF4;NEK7;ATM;PRKD2;TCP1;MAPK1;HMBOX1;RGCC;FGF2;HGF;PNKP;PARN;PTGES3;HNRNPA1;SMOC2;CTNNB1;FGFR4;PDGFRB;RFC4;HSP90AA1;CCT5;CCT2;NAF1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.4799398180802969,-1.1993022606331505,0.24567474048442905,0.47551675047497893,1.0,1/12,0.40%,IL1R1
prerank,proteasomal protein catabolic process (GO:0010498),-0.270857140801425,-1.1992140306646915,0.09415584415584416,0.47528156796535265,1.0,71/201,27.44%,WWP1;PELI1;NEDD4L;ZNRF1;SMURF2;UBE2K;RNF139;PSMA2;FBXL17;SMURF1;DDI2;RBX1;UBE4B;CUL3;NEDD4;PSME2;SPSB1;PSMB4;GSK3A;UBE2D3;AREL1;TNFAIP1;RMND5A;SPOPL;ARMC8;KAT5;ATXN3;FEM1C;FBXW11;APPBP2;PSMC2;FEM1B;ERCC8;PSMB2;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;DNAJB12;RAD23A;SIAH1;PSME1;TRIM3;RNF4;UCHL1;TBL1X;WWP2;PSMD4;HUWE1;MDM2;PSMA7;RNF216;HACE1;NFE2L2;PSMD5;ARRB1;MAEA;FBXL22;ZFAND2A;PSMB10;RNF122;UBXN2A;RHBDD1;PSMA3;KIF14;RNF34;PPP2R5C
prerank,dendrite morphogenesis (GO:0048813),0.3540389948949415,1.1989912021187115,0.1912087912087912,0.618668000874134,1.0,11/35,12.35%,CTNNA2;CTNND2;DOCK10;EPHB1;SHANK1;DCDC2;PAK3;MAP2;MINK1;CELSR2;DLG4
prerank,negative regulation of cell adhesion (GO:0007162),-0.31514989036201113,-1.1985431358612626,0.1619718309859155,0.47641725609442065,1.0,29/72,27.14%,SEMA6A;ACVRL1;PODXL;ACER2;CBLL1;GCNT2;FZD4;PTK2;ARHGDIA;PLXND1;PLXNA4;CDH1;ADAM10;RASA1;NOTCH1;RHOA;JAG1;ANGPT1;PTPRC;TGFBI;SERPINE1;FZD7;CYP1B1;SEMA5A;PLXNB1;SIPA1;DMTN;RND1;SNAI2
prerank,response to ATP (GO:0033198),0.42136945465776454,1.1984366999691387,0.23394495412844038,0.6185332810112268,1.0,5/18,14.11%,DGKQ;RYR3;CIB2;P2RX3;TAF1
prerank,response to cadmium ion (GO:0046686),-0.38806187969953804,-1.1974936235134839,0.2088495575221239,0.47831647748832595,1.0,14/26,25.53%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F
prerank,cation transmembrane transport (GO:0098655),0.34012605328554435,1.1972821567604421,0.17675544794188863,0.6198516100996163,1.0,11/44,11.71%,TRPM3;ASIC2;ATP1A2;SLC7A8;ATP1B1;MFSD12;TRPM1;SLC29A4;SLC6A5;ATP13A2;P2RX3
prerank,lamellipodium organization (GO:0097581),-0.3758283039634722,-1.1972400837274408,0.22144112478031636,0.47846798593781986,1.0,4/29,1.85%,ABLIM1;ITGB1;PARVB;RAC1
prerank,regulation of protein acetylation (GO:1901983),-0.4823362962333827,-1.197105324369666,0.23487544483985764,0.4783759329728998,1.0,7/12,34.57%,GSK3B;DDX3X;KAT5;RAPGEF3;CEP295;FAM161A;PARK7
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5099092575141984,-1.1968199603037017,0.25925925925925924,0.4785669053213095,1.0,3/10,8.35%,DAB2IP;ANXA2;EPHA4
prerank,response to copper ion (GO:0046688),-0.4116277754323934,-1.1962580003249825,0.22540250447227192,0.4793901319774052,1.0,13/20,35.95%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;ATP7B;ATP5F1D;AQP1;IL1A;MT3
prerank,potassium ion homeostasis (GO:0055075),0.39296301016297314,1.1962040853458242,0.21286031042128603,0.6211370385466917,1.0,6/23,8.72%,KCNMA1;ATP1A2;ATP12A;ATP1B1;SLC12A5;ATP4A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4890503002293274,-1.1955687250295408,0.2582897033158813,0.48046342583735874,1.0,10/11,45.42%,TP53;ATF4;ATF6;DDIT3;CEBPB;ATF3;CREB3L1;ATF6B;CREB3L3;MBTPS2
prerank,lamellipodium assembly (GO:0030032),-0.38618820178523794,-1.1954537756376984,0.22898032200357782,0.4803236791169841,1.0,4/26,1.85%,ABLIM1;ITGB1;PARVB;RAC1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.34253474124583244,1.1950629617020423,0.18333333333333332,0.6226353922513338,1.0,11/44,12.02%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;ATP1B1;WNK2;WNK3;KCNJ6;KCNN3;GABBR1
prerank,regulation of protein catabolic process (GO:0042176),-0.2986000468966555,-1.1949576182558637,0.155668358714044,0.48099240149024447,1.0,36/99,26.50%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;EGFR;CDKN1B;NEDD4;NKD1;PLK2;GSK3A;FLNA;AREL1;SNX12;AZIN1;TNFAIP3;MAD2L2;OAZ2;GPC3;WWP2;HUWE1;MDM2;CTSA;HACE1;SEC22B;FZR1;GFAP;ADGRB1;TNFSF12;DTL;APC
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4690676942428884,-1.1946785913476972,0.266199649737303,0.4812121976007791,1.0,8/13,28.11%,PRPF3;PRPF6;PRPF31;SRSF12;CD2BP2;SRSF10;AAR2;LSM2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3552138951677982,-1.1946611139735466,0.19784172661870503,0.48083253483405997,1.0,14/40,23.11%,RNF139;SMURF1;GNA12;PTK2;HFE;FOXF2;SGTA;RPL5;CDK5RAP3;RAD23A;PTEN;PTK2B;RPS7;TRIM39
prerank,lipid translocation (GO:0034204),-0.4118836675266505,-1.1941663073556854,0.2146690518783542,0.48144637339582436,1.0,6/21,16.71%,ATP10A;ATP8B1;RFT1;ATP10B;ABCA7;ATP9B
prerank,regulation of blood circulation (GO:1903522),-0.36962181270497596,-1.1937389289585991,0.22638146167557932,0.4819263776298954,1.0,9/34,18.24%,ACE;KCNQ1;ECE1;TBX2;AGTR1;S100A1;TPM1;KCNMB2;PLN
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.3398975650033848,-1.1937233278477328,0.18356643356643357,0.4815514657073696,1.0,20/50,24.96%,NXN;CAV1;DTX3L;IVNS1ABP;ABL1;AKT1;SMAD7;SPOPL;CHP1;TNFAIP3;N4BP1;SENP2;RPS3;SOX4;OGT;SH3RF2;ARRB1;HSPA1B;PINX1;ADGRB1
prerank,histone H3 acetylation (GO:0043966),-0.35519366769406246,-1.1932680418310264,0.20433996383363473,0.4821970635782117,1.0,14/40,24.75%,LEF1;KAT6B;KAT2B;KAT6A;SGF29;LDB1;TAF5L;TADA3;TRIM16;DR1;JADE2;WDR5;TAF9;MAP3K7
prerank,negative regulation of lipid storage (GO:0010888),-0.42054461944704874,-1.1932407750091178,0.2482394366197183,0.4818597763233822,1.0,8/19,28.27%,PPARA;NFKBIA;PPARD;PPARG;ITGB3;PNPLA2;PTPN2;TREM2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3143539672206155,-1.1931958223093386,0.15630550621669628,0.48156899766334765,1.0,27/73,24.95%,CAV1;APP;PRKD2;EGFR;TFRC;GAS6;IRGM;NGF;PRKD1;RAF1;HAX1;AKT1;FNIP2;BRAF;RPTOR;MTCP1;MIF;MAD2L2;CREBL2;HDAC6;TXN;CAPRIN2;NOS1;HSP90AA1;AKAP9;SH2D3C;RAPGEF3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.30306865787609055,-1.19242783573099,0.17142857142857143,0.48288489184226757,1.0,31/87,26.54%,RBFOX2;SPRED2;TBX1;CEP57;CBL;DSTYK;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;GRB2;HNRNPA1;FLRT2;HYAL2;FGFR4;DLL4;PTPN11;KIF16B;FRS2;POLR2C;EGR3;POLR2L;POLR2H;ZFP36L1;FLRT3;FGF10
prerank,transition metal ion transport (GO:0000041),-0.3704461718908186,-1.1918368118122489,0.19056261343012704,0.4838622891035109,1.0,10/35,16.74%,ATOX1;SLC31A1;TFRC;SLC30A10;TRPC4;SLC39A8;TRPC6;SLC30A5;COX17;TRPC3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.4138879094272125,-1.1913799725936687,0.21746880570409982,0.4844355213820514,1.0,11/21,40.62%,LRRK2;NCK1;BCL2L11;HERPUD1;TXNDC12;EIF2AK3;DDIT3;PMAIP1;PARK7;CREB3L1;TMBIM6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4722265518114944,-1.1911452932413686,0.24118738404452691,0.48458491815071,1.0,5/12,17.87%,PTPN14;NEDD4;BMP4;TPR;NUP214
prerank,glycoprotein metabolic process (GO:0009100),-0.33057586317446364,-1.1910832916531724,0.17625899280575538,0.48431483194934494,1.0,22/53,27.55%,ST3GAL4;ST8SIA4;MAN2A1;MAN1C1;ST6GALNAC3;MGAT4B;FUT8;MAN1A2;ST3GAL2;ADAMTS9;PRKCSH;MAN1B1;B4GALT5;GAL3ST2;GOLPH3;LARGE1;ENGASE;HPSE;FBXO17;TNIP1;ST8SIA6;MANBA
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.30996238336334736,-1.1909583105116963,0.17543859649122806,0.48373582033058254,1.0,24/78,22.23%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.30996238336334736,-1.1909583105116963,0.17543859649122806,0.48373582033058254,1.0,24/78,22.23%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4554355294834611,-1.1908140916590992,0.2534965034965035,0.48366047706220155,1.0,7/14,29.20%,ARID2;MRNIP;FUS;TIMELESS;ERCC6;MMS19;RAD51AP1
prerank,oligodendrocyte differentiation (GO:0048709),0.4194820431131059,1.190295686047685,0.22538293216630198,0.6340961196775968,1.0,7/19,17.62%,MYRF;CDK5;PTPRZ1;SLC8A3;TPPP;EIF2B1;SOX9
prerank,telomere maintenance via recombination (GO:0000722),-0.48469360350873814,-1.1899570275596123,0.23443223443223443,0.48519135285006826,1.0,8/11,42.06%,SMC5;NSMCE2;TEP1;RAD51D;RAD50;ERCC4;SMC6;ERCC1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2757446889100133,-1.1896106143677552,0.1359724612736661,0.48552909257550814,1.0,41/151,22.06%,TEK;RAPGEF2;FERMT2;ROR1;BMPER;MFHAS1;PDGFD;SEMA7A;GCNT2;APP;CCL25;KDR;ICAM1;PRKD2;EGFR;SLC30A10;GAS6;DSTYK;RAP1A;NOTCH2;FLT4;HTR2A;BRAF;NOTCH1;FGF2;ACKR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN;ANGPT1;CCL19;NOD2;PTPRC;FGFR4;PTPN11;P2RY1;ROR2;PDGFRB;PTK2B
prerank,autophagy of nucleus (GO:0044804),-0.43859509992671664,-1.1895626822928302,0.24573378839590443,0.4852173302597901,1.0,10/16,34.25%,ATG7;WIPI1;ULK2;ATG5;WDR45B;ATG2A;ATG2B;ATG3;ATG9A;WIPI2
prerank,cellular response to calcium ion (GO:0071277),0.30341736113901063,1.189562593479697,0.1650943396226415,0.6344903065662622,1.0,15/67,12.14%,NLGN1;SYT1;SYT5;RYR3;ADCY8;SYT12;SYT11;HPCA;CPNE9;DPEP1;SCN5A;ACER1;CPNE1;SYT4;GPLD1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.32523435684440877,-1.189470729821356,0.1828358208955224,0.48499485674450565,1.0,19/54,23.61%,PAK1IP1;RPF1;RRP15;NOP2;RPL3;RPL26;NIP7;RPL10;RPL7A;RPL5;NLE1;WDR74;MDN1;RPL35A;BOP1;PES1;RRS1;EBNA1BP2;NOP16
prerank,relaxation of cardiac muscle (GO:0055119),0.4588114024496793,1.1893085043066103,0.2314410480349345,0.6334158080973583,1.0,5/13,11.91%,ATP1A2;ATP1B1;CHGA;GSN;SLC8A1
prerank,adenine nucleotide transport (GO:0051503),-0.44486938209362215,-1.1891485566973283,0.25354609929078015,0.48529729527293336,1.0,4/17,7.79%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4970452515833309,-1.1890399726768301,0.26640926640926643,0.48512591918006065,1.0,3/10,22.01%,KLF4;PTPRC;MAPK7
prerank,serine family amino acid metabolic process (GO:0009069),-0.4441275706777487,-1.1886527753786844,0.22735042735042735,0.4856134400726865,1.0,6/16,21.72%,SRR;MTHFD1;CDO1;SEPHS2;CTH;GCLC
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4300986051781768,1.1884083338831781,0.23598130841121495,0.6343133761597851,1.0,7/16,20.61%,CHGA;KLK6;GPER1;PRMT5;MRAP2;C3;GRP
prerank,liver development (GO:0001889),-0.36844768897197266,-1.1883283860496432,0.21978021978021978,0.48594155689901847,1.0,13/32,24.40%,PKD2;LSR;TGFBR3;PRKCSH;ZIC3;ANXA1;ARID5B;CDK5RAP3;CEBPG;CITED2;NF1;CEBPA;E2F7
prerank,regulation of cell morphogenesis (GO:0022604),-0.37259455969056954,-1.1882070080429783,0.21311475409836064,0.4858067179715068,1.0,11/30,18.41%,FERMT2;PDZD8;ZMYM6;MACF1;MFSD2A;ZMYM4;FMNL2;MOV10;CAPZB;CFL1;WTIP
prerank,melanosome localization (GO:0032400),0.39948917532904904,1.187696856390165,0.22958057395143489,0.6345924949032935,1.0,9/21,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2920753435811148,-1.1876026680045915,0.159369527145359,0.48677813193091224,1.0,35/110,23.64%,DAB2IP;RB1;TRABD2B;MPP7;GSK3B;DDX3X;TFRC;IRGM;SPIDR;CDH5;RAF1;TAL1;HJURP;FNIP2;ICE1;RHOC;SLF2;TRAF3IP1;HCFC1;IAPP;BCL2L11;NCLN;SUMO1;HDAC6;RPS3;TFIP11;PTPN11;WARS1;PREB;HSP90AA1;SAR1A;BIK;RALB;GFAP;AJUBA
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.376069776874884,-1.187436961640569,0.22540250447227192,0.4867267456292037,1.0,7/30,17.07%,FOXP1;DAB2;HDAC1;ZBTB7A;PIAS2;H3-3A;HDAC6
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4287948111360489,-1.1872152485898508,0.2446043165467626,0.48681198767450035,1.0,5/17,17.30%,CBFA2T3;PPARA;HDAC4;PDE12;PPIF
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.3386720257789363,-1.186964487557443,0.19202898550724637,0.4869293128641551,1.0,9/44,8.09%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;HES1;MEF2C;TBX2
prerank,negative regulation of axonogenesis (GO:0050771),0.37098054962230986,1.1869616686220577,0.2040358744394619,0.634984579996245,1.0,12/27,21.42%,DCC;EFNB3;MAP2;RTN4;PTPRS;MAG;OMG;TRIM46;LINGO1;RTN4R;RUFY3;NGFR
prerank,import into cell (GO:0098657),-0.34551426780973304,-1.1869586659611902,0.21272727272727274,0.4865409061341593,1.0,8/41,7.79%,SLC47A1;SLC6A6;SLC12A7;LRRC8C;SLC7A1;SLC7A5;SLC5A6;LRRC8D
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3081429515143852,-1.186821482486607,0.18563922942206654,0.4864545024034478,1.0,24/79,22.23%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,carbohydrate derivative transport (GO:1901264),-0.4301173609402349,-1.1868018141953818,0.23170731707317074,0.486090720844303,1.0,5/18,9.30%,PLTP;LBP;SLC10A7;SCARB1;MFSD2A
prerank,N-glycan processing (GO:0006491),-0.4288002014007555,-1.1867720144044367,0.23411978221415608,0.4857425388195483,1.0,8/18,13.38%,ST8SIA4;MAN2A1;MAN1C1;MGAT4B;FUT8;MAN1A2;PRKCSH;MAN1B1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.31982977282033753,-1.1865521706362987,0.1705150976909414,0.4858142711149112,1.0,19/63,18.47%,DAB2IP;MCL1;TAB3;TLK2;MTOR;RASIP1;ROCK1;TBC1D14;DAPL1;GSK3A;MFSD2A;AKT1;PTPN3;TIMP3;HGF;DAP;TAB2;CDK5RAP3;WASHC1
prerank,endodermal cell fate commitment (GO:0001711),-0.5031017520792371,-1.1861923475025469,0.26286764705882354,0.48619904830438626,1.0,3/10,12.45%,SOX17;CDC73;RTF1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2942173626986154,-1.1859443424844336,0.16725352112676056,0.4863503726994423,1.0,36/104,26.57%,DAB2IP;MNAT1;RB1;LRP5;DDX3X;CDK12;CDKN1B;ABL1;PPEF2;LRP6;CCND3;IRGM;AKT1;RPTOR;RHOA;ACTB;MTCP1;KSR1;CDK5RAP3;CCND1;PPP2CA;CNPPD1;BLM;CDKN2C;CDC25A;GADD45A;PARP16;SYAP1;RALB;CCNG1;TRIB3;CCNK;CCNE2;CAB39;CDKN3;CCNJ
prerank,telomere capping (GO:0016233),-0.4371701172047154,-1.1854430436696333,0.24162257495590828,0.48702749169765114,1.0,8/16,25.04%,STN1;MRE11;CTC1;TERF2;TFIP11;PRKDC;DCLRE1B;DCLRE1A
prerank,positive regulation of protein kinase activity (GO:0045860),-0.27887560085037155,-1.18470543238303,0.1342512908777969,0.48817577931416134,1.0,50/148,23.46%,DAB2IP;RAPGEF2;INSR;IQGAP1;PTPN1;PAK2;DDX3X;ACE;TGFBR2;IL6R;GAS6;MRNIP;STK3;IL34;TGFB2;PTK2;IRGM;PRKCD;RASSF2;RAP1A;SNX9;EPHA4;MMD;CLSPN;TAOK3;RPTOR;RHOA;MTCP1;NEDD9;MAP4K4;MARK2;NAB2;TAB2;NOX4;ALS2;CACUL1;CCL19;CENPE;PPP2CA;PTPRC;ITGB3;NRK;MAP2K3;PTK2B;CCN1;HSP90AA1;FCGR1A;PARP16;SYAP1;RALB
prerank,regulation of cardiac conduction (GO:1903779),0.32258600138476,1.1844874755129877,0.1707865168539326,0.6400631594085572,1.0,12/54,12.89%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;NPPC;SLC8A2;RYR2;SLC8A3;SLC8A1;CASQ1;FXYD4
prerank,skeletal muscle tissue development (GO:0007519),-0.368002596819834,-1.1843137523363692,0.21467889908256882,0.4886329306896232,1.0,13/32,30.32%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SKI;SIX4;MYL6;FOXL2;KLHL41;MSC;CAV2;MYORG
prerank,transition metal ion homeostasis (GO:0055076),-0.3846624974383009,-1.1837898320120743,0.2333931777378815,0.4893937264551897,1.0,7/28,14.16%,XIAP;SLC40A1;BDH2;PICALM;HFE;HMOX2;ABCB7
prerank,negative regulation of leukocyte activation (GO:0002695),0.43637953562412046,1.1837078011089266,0.24944812362030905,0.6406161260615877,1.0,6/15,19.45%,LRFN5;GRN;GPER1;HAVCR2;FCGR2B;CD84
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.31697132585317606,-1.1833800362061384,0.16605839416058393,0.4898841941310653,1.0,23/69,24.95%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,sphingosine metabolic process (GO:0006670),0.42225661227772593,1.1833048564839945,0.23667377398720682,0.6400446589802051,1.0,7/17,11.24%,PLPP2;SPHK1;SGPP1;ACER1;ABCA2;SPHK2;NAAA
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.32637522121763085,-1.1832452565964928,0.1853146853146853,0.48974904247890116,1.0,14/57,17.30%,GSK3B;ZDHHC6;RALBP1;KDR;TNFSF10;MIEF1;BNIP3;GSK3A;TP53;MIEF2;BBC3;HIP1R;BCL2L11;PPIF
prerank,regulation of membrane repolarization (GO:0060306),-0.468467773419334,-1.1831401669867887,0.24733096085409254,0.4895599690143724,1.0,5/13,6.70%,CAV1;NEDD4L;KCNJ2;YWHAE;KCNQ1
prerank,cellular response to interleukin-15 (GO:0071350),-0.4610573538627984,-1.1828270380993284,0.25183823529411764,0.4894201912941538,1.0,7/13,31.42%,JAK1;IL15;PLCB1;GRB2;IL15RA;IL2RG;STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4610573538627984,-1.1828270380993284,0.25183823529411764,0.4894201912941538,1.0,7/13,31.42%,JAK1;IL15;PLCB1;GRB2;IL15RA;IL2RG;STAT3
prerank,response to amyloid-beta (GO:1904645),0.33608686290200734,1.182703584020431,0.18961625282167044,0.6399346165744725,1.0,7/44,4.29%,GRM5;MMP12;CACNA1B;CDK5;CACNA2D1;GRIN2A;CACNA1A
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4418384124403635,-1.1824590578336407,0.2537878787878788,0.4898387023326587,1.0,7/16,14.52%,CDK13;RSRC1;HNRNPM;PUF60;SFPQ;SLU7;SCNM1
prerank,"transcription, DNA-templated (GO:0006351)",-0.2679956865653244,-1.1821692221947024,0.10380622837370242,0.490061813782562,1.0,68/207,27.24%,RREB1;MNAT1;MEF2A;CBFB;MLLT3;DEK;THRB;NFIX;IVNS1ABP;NFKB1;FOXO3;IWS1;EAF1;POLR2G;GTF2E1;GTF2E2;ERCC2;TAF11;TP53;PWP1;TAF1B;NFIC;BRF1;CDC73;RTF1;TCEA1;DRG1;TAF5L;TAF1C;MLLT1;ATF4;ERCC3;MRPL12;PIR;CREBL2;TAF7;TAF3;NELFB;HSF2BP;NCOA6;RNPS1;ELOC;TAF4B;PTMA;UBTF;SNAPC3;TAF13;TCEA2;MED20;GTF3C4;SUPT4H1;POLR2C;CCNK;GMEB2;TAF9;TFDP1;TAF15;POLR2L;ERCC6;MLF1;POLR2H;TRIP11;LEO1;RSF1;MMS19;POLR3GL;TRIP13;GTF2H3
prerank,myelin maintenance (GO:0043217),0.48564166282275945,1.1806776000938541,0.2660753880266075,0.6441030944571547,1.0,2/10,2.76%,MYRF;EPB41L3
prerank,positive regulation of DNA replication (GO:0045740),-0.43967154732575503,-1.1806589748499685,0.2730696798493409,0.49305362845023687,1.0,4/16,13.51%,STN1;EGFR;DNA2;CTC1
prerank,negative regulation of ion transport (GO:0043271),0.37621674090939095,1.1803450725958284,0.24,0.6432892409527918,1.0,6/24,9.31%,GPM6B;STC1;SYT11;WNK2;WNK3;ADRA2A
prerank,mitotic spindle assembly (GO:0090307),-0.34582464459740164,-1.1802077406410887,0.19516407599309155,0.4936318349662513,1.0,14/42,22.31%,STAG1;CCDC61;TOGARAM1;WRAP73;FLNA;KIF23;RHOA;ARHGEF10;STAG2;KIF11;RAB11A;KIF3B;PRC1;MISP
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2872975157127532,-1.180046439672244,0.16666666666666666,0.49364225317814836,1.0,44/121,27.32%,ZC3HAV1;PSMA2;PRKCD;XRN1;SAMD4A;PUM1;PSME2;MAPKAPK2;YWHAZ;EXOSC2;PSMB4;EXOSC1;AKT1;EXOSC3;SERBP1;PARN;PSMC2;RC3H1;ZC3H14;PSMB2;PSMB1;EXOSC8;MOV10;PSMA8;NUP214;TNFSF13;PSME1;EXOSC5;DCP1A;PSMD4;PSMA7;RBM24;PSMD5;CARHSP1;EXOSC7;FXR1;IGF2BP2;CNOT8;ZFP36L1;PSMB10;HNRNPD;PSMA3;CNOT1;PABPC1
prerank,protein stabilization (GO:0050821),-0.2699893807226557,-1.1800100991743219,0.13274336283185842,0.49333625071108717,1.0,59/168,27.56%,HIP1;USP9X;PARVA;DVL3;SOX17;NAA16;PIK3R1;STK3;HPS4;IRGM;PRKCD;RASSF2;TCP1;AAK1;STXBP4;EPHA4;CTNND1;USP2;USP13;NAA15;FLNA;PER3;SMAD7;FLOT1;CHP1;TBRG1;PTGES3;HCFC1;HIP1R;RPL5;CREBL2;IGF1;NCLN;SUMO1;LAMP2;TMEM88;STX12;SOX4;USP7;COA8;TBL1X;PTEN;CREB1;RPS7;HSP90AA1;GLMP;TRIM39;MSX1;PLPP3;CRTAP;HSPA1B;TAF9;CCT5;PEX6;TRIM44;CCT2;USP19;BAG4;BAG5
prerank,DNA repair (GO:0006281),-0.25959917187411685,-1.1799489949232767,0.09897610921501707,0.49307712151982613,1.0,102/284,29.65%,MNAT1;PDS5B;SETD2;ATM;UIMC1;DTX3L;PARP4;KMT5B;ABL1;TRRAP;XRCC4;FTO;ASCC1;MRE11;INIP;NABP1;ERCC2;RBBP8;TENT4A;TP53;DOT1L;NSMCE3;ENDOV;PDS5A;POLD3;RAD18;INTS3;OGG1;RPA3;DNA2;KAT5;ATXN3;RPA1;BABAM2;PNKP;XPC;MAPK8;RNF168;ERCC3;VCPIP1;FANCM;BTG2;UBE2V2;ERCC8;MAD2L2;HERC2;SUMO1;POLE2;RFWD3;FANCD2;FANCC;FANCG;HPF1;BRCC3;WRN;CETN2;RAD23A;RPA2;BAP1;PRKDC;RAD54L;PIAS4;TIMELESS;USP1;NSMCE4A;HUWE1;LIG4;FANCL;BRCA1;RAD51AP2;BAZ1B;ERCC6L2;TRIM28;CHRNA4;DCLRE1B;BLM;RFC4;CHEK1;PWWP3A;GADD45A;ALKBH5;MSH3;LIG1;FANCI;INO80;DCLRE1A;APBB1;ERCC6;PARP9;ASCC2;MMS19;TRIP13;GTF2H3;POLL;EXO1;XRCC2;APLF;HINFP;RAD51AP1;MDC1;TDP1;CHD1L
prerank,inorganic cation import across plasma membrane (GO:0098659),0.30113341558296186,1.1797832557208043,0.16367713004484305,0.6431818959859813,1.0,16/75,13.06%,SLC24A2;ATP1A2;KCNJ3;ATP12A;ATP2B4;CACNA2D1;SLC9A7;ATP1B1;SLC9A9;SLC8A2;SLC12A5;ATP4A;KCNJ6;SLC8A3;SLC8A1;SLC12A4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4370168601502098,-1.1793474740097982,0.2357142857142857,0.4940366676078605,1.0,6/16,21.17%,JCAD;THBS1;AGTR1;FGF2;GATA2;DLL4
prerank,myelination (GO:0042552),0.3319630187350197,1.1792190053426765,0.2059447983014862,0.6431066378718165,1.0,18/46,18.24%,MYRF;SCN8A;EPB41L3;PLP1;BCAS1;SCN2A;ACSBG1;NFASC;GPC1;KLK6;MBP;SLC8A3;TPPP;GAL3ST1;AMIGO1;B4GALT6;LGI4;CXCR4
prerank,cellular component assembly (GO:0022607),-0.2605113078381503,-1.1790439056800142,0.10427350427350428,0.49438022283207794,1.0,62/253,19.04%,SPTBN1;SLC2A1;PARD3;LIMA1;MNAT1;CREBBP;FERMT2;EPS8;PARVB;BAIAP2L1;CD2AP;RAC1;RHOJ;LIMS2;PARVA;LIMS1;PLS3;RANBP9;TEAD1;MITF;HES1;GAS6;TOGARAM1;FAS;KPNA3;RHOQ;EZR;SNX9;WASL;YAP1;YWHAZ;AFG3L2;PICALM;SHROOM1;FAM107A;DET1;OCLN;TP53;FLNA;SHROOM2;ILK;HFE;RHOA;ACTB;LCP1;NEDD9;RHOG;CD40;NCKAP1;HAS1;VCPIP1;PEX14;TUBGCP4;TLCD1;TFAP4;CALD1;FANCC;IKBKG;VAMP3;WASF1;MDN1;MAGI1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.3800174392390103,-1.1788591272280617,0.22306238185255198,0.4943679059224285,1.0,11/28,20.09%,ESAM;NAA80;HAX1;FCHSD2;RASA1;ARHGAP28;GBA2;DBNL;ARHGAP35;FCHSD1;CXCL12
prerank,protein neddylation (GO:0045116),-0.4661134972338396,-1.1783196297323166,0.251865671641791,0.49512970570837395,1.0,5/13,20.63%,DCUN1D3;RBX1;UBE2M;DCUN1D2;DCUN1D5
prerank,mRNA stabilization (GO:0048255),-0.3409249992547306,-1.1782363468853148,0.2147887323943662,0.49490479930315984,1.0,16/40,30.71%,HNRNPA0;LARP1;FUS;MAPKAPK2;AXIN2;SYNCRIP;ANGEL2;RBM24;THRAP3;TAF15;DHX9;PABPC1;HNRNPU;TENT5C;MAPK14;BOLL
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4644495735833974,-1.1781558007406285,0.2634315424610052,0.4946613878872091,1.0,6/13,18.45%,RAMP1;ALG10B;PLCB1;CHP1;IGF1;CCL19
prerank,microvillus assembly (GO:0030033),-0.460137877028614,-1.1779653158695975,0.26353790613718414,0.49468240827483995,1.0,8/14,19.62%,RAPGEF2;RAP1A;EZR;FXYD5;RAP1B;MAP4K4;RAP2A;RAP2C
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3762749785310948,-1.1779119698724536,0.22851919561243145,0.4943820004634706,1.0,12/28,25.91%,SHANK3;GSK3B;APP;ABL1;EPHA4;FAM107A;LGMN;ADCY1;CALB1;PTN;CALB2;EIF2AK4
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.34754702943097243,-1.1776057791238363,0.2117437722419929,0.49470970122018676,1.0,11/41,19.04%,TJP1;PODXL;GCNT2;JAK1;AFDN;DENND6A;SMAD7;FLOT1;BMP7;CITED2;MAGI1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3950154678349524,-1.1774235959822972,0.22846441947565543,0.4947034559296097,1.0,6/24,8.56%,DAB2IP;PTPN1;PRKD2;NEDD4;TMEM204;GRB10
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.25270394055601,-1.1771815699663657,0.10132890365448505,0.4948235827129369,1.0,103/314,27.44%,FBXL7;WWP1;PELI1;RB1;ECPAS;NEDD4L;ZNRF1;SMURF2;FBXL12;UBE2K;TRIM25;PSMA2;FBXL17;SMURF1;FBXL3;RBX1;UBE4B;CUL3;NEDD4;LTN1;PSME2;CUL2;ANKZF1;SPSB1;PSMB4;GSK3A;UBE2J2;UBE2D3;FEM1A;UBR2;AREL1;TNFAIP1;RMND5A;CDC16;SPOPL;ARMC8;ANAPC16;KAT5;ATXN3;FEM1C;SGTA;MAN1B1;UBE4A;FBXW11;ERLIN2;APPBP2;DNAJC10;PSMC2;FEM1B;ERCC8;PSMB2;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;DNAJB12;DMAC2;RAD23A;UBR1;SIAH1;PSME1;TRIM3;DNAJB9;RNF4;BUB1B;UCHL1;TBL1X;WWP2;HERPUD1;ECRG4;PSMD4;HUWE1;MDM2;BUB3;PSMA7;RNF216;HACE1;NFE2L2;FZR1;PSMD5;ARRB1;NEMF;MAEA;FBXL22;ZFAND2A;FBXO17;ANAPC7;FBXO38;PSMB10;TMUB1;RNF122;UBXN2A;RNF103-CHMP3;PSMA3;KIF14;USP19;RNF34;RNF103;PPP2R5C
prerank,regulation of axonogenesis (GO:0050770),0.3259146035089174,1.1770401043579066,0.21495327102803738,0.6473617274148304,1.0,21/51,19.75%,LRRC4C;ROBO2;ROBO1;EFNB3;PAK3;NTRK2;PAK1;SLITRK1;RTN4;MAG;CDH2;OMG;PLXNA2;PLXNA1;BRSK2;AMIGO1;PLXNA3;LINGO1;MAP6;RTN4R;RUFY3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3480699811774986,1.1769739995765278,0.22522522522522523,0.6458234887727093,1.0,8/38,8.21%,CTNNA3;SCN1B;KCNA5;KCNJ3;CACNA2D1;PKP2;CACNA1D;SCN5A
prerank,bile acid biosynthetic process (GO:0006699),0.38541957052478565,1.1768231667838347,0.2210065645514223,0.6445296178346598,1.0,6/24,16.99%,AKR1D1;CYP46A1;OSBPL6;CYP27A1;OSBPL9;ACOX2
prerank,covalent chromatin modification (GO:0016569),-0.45162967973418544,-1.1768070104759667,0.2715827338129496,0.4952690718378742,1.0,3/14,7.41%,CHD1;HDAC1;SETD5
prerank,response to calcium ion (GO:0051592),0.28048272273297375,1.1767557321652036,0.14352941176470588,0.6430035877323784,1.0,19/102,9.78%,NLGN1;SYT1;SYT5;KCNMA1;RYR3;SLC25A13;ADCY8;SYT12;SYT11;HPCA;CALM2;HOMER1;RYR2;CPNE9;DPEP1;SCN5A;ACER1;PPP3CA;CPNE1
prerank,positive regulation of protein transport (GO:0051222),-0.3124872418587252,-1.176416930960425,0.20104895104895104,0.49576387748289336,1.0,27/67,25.29%,UNC13B;CD2AP;GOLPH3L;ADAM9;IER3IP1;BMP6;TGFB2;EZR;MYO18A;CNST;MYOM1;BCAS3;ICE1;CHP1;TPR;IGF1;RIPOR1;GOLPH3;PCM1;OAZ2;ARHGEF5;VAMP2;PCNT;CEP131;SYTL4;APBB1;PLK3
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.3728322412699363,-1.1761245225948076,0.22323049001814882,0.4960182713925981,1.0,13/30,28.41%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,vesicle transport along actin filament (GO:0030050),-0.40966183370687537,-1.176121933539626,0.25609756097560976,0.49561960393455406,1.0,5/19,12.83%,MYO1D;FNBP1L;WASL;MYO1F;ACTN4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.383539759116567,-1.176046447977202,0.23159784560143626,0.49537447473058027,1.0,11/27,21.38%,SLC47A1;SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC7A2;SLC1A4;SLC3A2
prerank,regulation of mitotic nuclear division (GO:0007088),-0.32825993594108904,-1.1757998955988604,0.2226027397260274,0.4955630940278086,1.0,32/55,41.40%,INSR;LRP5;CDK13;CUL9;BMP4;CUL7;EDN1;RGCC;EDN3;CCDC8;BMP7;IGF1;IGF2;PDGFRB;CHEK1;TOM1L2;BORA;DUSP1;CAV2;BTC;OBSL1;AURKA;PHIP;IL1A;DRD3;FBXO5;TOM1L1;AURKAIP1;CCNB1;CD28;PDXP;CDC25C
prerank,protein homooligomerization (GO:0051260),0.27916626890254653,1.1752826738230961,0.1334841628959276,0.6453482548568035,1.0,23/114,15.30%,KCNC2;MPP2;GLRA3;HCN1;SYCP1;RYR3;C9;ADCY8;ATL1;AQP4;GNMT;SLC1A2;ACACA;CARD11;ALDH1A2;P2RX3;GLS;SIGMAR1;GOLGA2;RNF112;ASIC1;CBY1;TDO2
prerank,DNA metabolic process (GO:0006259),-0.2556437282730299,-1.1752152055101643,0.10097719869706841,0.4964907183323675,1.0,90/270,27.65%,SP100;MNAT1;PDS5B;STN1;ATM;NT5E;PARP4;DMC1;TOP3A;KMT5B;SAMHD1;TRRAP;TOP3B;MRE11;INIP;UHRF2;NABP1;RBBP8;MCM4;DOT1L;AXIN2;ORC5;NSMCE3;ENDOV;PDS5A;POLD3;RAD18;INTS3;OGG1;RPA3;DNA2;KAT5;RPA1;CTC1;PNKP;XPC;PTGES3;ERCC3;BTG2;UBE2V2;TOP1MT;TERF2;SRPK2;ORC2;DNMT1;SUMO1;POLE2;FANCC;FANCG;PRIM2;WRN;ORC4;RPA2;USP7;SMARCAD1;PRKDC;RAD54L;TCF7L2;TIMELESS;NSMCE4A;LIG4;FANCL;BRCA1;TRIM28;CHRNA4;DCLRE1B;TERT;BLM;RFC4;CHEK1;PWWP3A;GADD45A;MCM3;TOP1;NTHL1;RFC1;MSH3;SMARCB1;LIG1;HMGB1;INO80;POLA2;MCM7;RAN;MMS19;MCM5;GTF2H3;MCM10;POLL;EXO1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.43983580540332584,-1.1752001640260399,0.26296296296296295,0.49612097689685547,1.0,6/16,21.30%,LRRK2;SEC16B;UBAC2;BCAP31;VAPA;BCAP29
prerank,cellular response to estrogen stimulus (GO:0071391),-0.4408311086529454,-1.1748826109109196,0.24956369982547993,0.4964775066807662,1.0,11/14,43.66%,NCOA4;BCAS3;RARA;WBP2;PELP1;TRIM24;AR;CRHBP;SERPINB9;SFR1;OCSTAMP
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3278546201339576,-1.174469842102143,0.2112676056338028,0.49700540487796185,1.0,11/49,13.15%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;ZCCHC9;GPATCH2;RASA4;BCAS3;ARFGEF1;CHP1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.462107698382904,-1.1744022831845276,0.2449725776965265,0.4967313649674943,1.0,4/13,9.93%,ATG7;ATG10;UBA2;UBA7
prerank,regulation of microtubule nucleation (GO:0010968),0.47639173416911723,1.1742828614581773,0.27292576419213976,0.6464176545244492,1.0,3/10,7.35%,EML2;ARHGEF7;PAK1
prerank,energy reserve metabolic process (GO:0006112),-0.4149732784033169,-1.1738926144472819,0.2323049001814882,0.4974722698660527,1.0,5/19,13.73%,GBE1;GSK3B;GFPT2;PPP1R3C;PHKB
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.4155819264939209,-1.1737868528295825,0.2581227436823105,0.4973191931670626,1.0,12/20,34.66%,PUM1;ZC3H7B;SNIP1;DICER1;AGO2;DROSHA;TERT;ZC3H7A;TSN;PUM2;TARBP2;MRPL44
prerank,anterograde axonal transport (GO:0008089),0.3487079686448952,1.1735898022513054,0.22799097065462753,0.6466926902316535,1.0,13/37,19.50%,DLG2;RAB27B;AP3S2;KIF5A;KIF3A;AP3M2;KIF1C;SNAPIN;NEFL;TRAK2;MAP1A;HAP1;MAPK8IP3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.37825747331737625,-1.173514331968953,0.22634508348794063,0.4975370226744211,1.0,7/29,12.85%,VTI1A;COG5;COG1;TRAPPC3;COPG1;COPA;COPE
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5033582431655357,-1.1733825075876994,0.2849364791288566,0.49739755259116614,1.0,3/10,15.36%,IL15;ROCK1;ROCK2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.45243891668968195,-1.1719851319149495,0.2737226277372263,0.5001394081981577,1.0,6/14,27.63%,NOL9;RPL7L1;BOP1;PES1;ZNHIT3;WDR12
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4018774279088221,1.1714322944643187,0.2281449893390192,0.6510675680822782,1.0,5/21,8.21%,SCN1B;KCNA5;CACNA2D1;CACNA1D;SCN5A
prerank,acyl-CoA biosynthetic process (GO:0071616),0.4309401056631849,1.1710061947735495,0.2505643340857788,0.650660623158903,1.0,7/16,22.56%,ACLY;ACACA;ACSS1;SCD5;SCD;ACAT1;HSD17B8
prerank,RNA splicing (GO:0008380),-0.2926759239611079,-1.170858824361317,0.18647166361974407,0.5021723331636876,1.0,30/95,24.22%,MBNL1;SRSF11;PRPF3;SMU1;CDK12;IVNS1ABP;RSRC1;PPIG;FUS;PRPF6;DDX39B;SF3B1;DBR1;SFPQ;SLU7;YJU2;SCNM1;SYNCRIP;SRPK2;USB1;ZMAT5;PPP2CA;SRRM1;NONO;RNPS1;SRSF10;TRA2B;USP39;RNPC3;PDCD7
prerank,cardiac muscle tissue development (GO:0048738),-0.33672578423111976,-1.170648374674301,0.2112676056338028,0.5022363169802978,1.0,15/50,12.19%,AKAP13;BMPR2;BMP5;SIK1;RBP4;BMP4;SMAD1;TBX2;MAML1;NOTCH2;ADAMTS9;SMAD4;KDM6B;ZFPM1;NOTCH1
prerank,positive regulation of macrophage activation (GO:0043032),-0.4323827592120473,-1.1706060220555412,0.25140712945590993,0.5019176658327671,1.0,11/17,48.47%,THBS1;LBP;CEBPA;TREM2;TLR6;TNIP2;STAP1;TLR4;TAFA3;WNT5A;CCL3
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.3291846545180744,-1.1705946373504963,0.2117039586919105,0.501547126612989,1.0,15/50,22.73%,CREBBP;FBXL17;TTC23;SMO;HERC4;WDR11;GLI3;GLIS2;MOSMO;FUZ;ZIC1;KIF7;GPC3;TUBD1;TULP3
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4080827199283321,-1.1698284998180823,0.26868327402135234,0.502873218628802,1.0,12/22,30.14%,MED1;PTPRK;STXBP4;NOTCH2;PRKD1;FGF7;KLF9;CRNN;ZFP36L1;FGF10;SNAI2;SRSF6
prerank,intracellular protein transport (GO:0006886),-0.25101045842106784,-1.1691770473151433,0.10847457627118644,0.5039058414134284,1.0,86/304,23.09%,TBC1D4;SEC31A;RASSF9;KIF13B;TRAK1;NUP42;ARF3;RAB7A;ARCN1;RAB1A;SMURF1;CSE1L;TLK1;SYNRG;TBC1D1;RAB5B;XPO7;STX3;TBC1D2B;COX18;HPS4;TBC1D8B;WDR11;SNX9;USP6NL;SEC13;RAB5A;TBC1D30;ARHGEF2;STX8;TBC1D14;SCFD1;SRPRA;AKT1;FUT10;PPP1R10;TBC1D22B;COPA;GABARAP;RAB3GAP2;EHD1;TBC1D22A;VPS26A;NUP153;ARL4A;SLU7;CHP1;VPS45;RAB23;VPS36;RAB24;RAB32;TPR;SNX8;HERC2;SIL1;AP4M1;HDAC6;LAMP2;TMED5;XPO4;GIPC1;FAM91A1;NUP214;NXT1;IPO8;STX12;TBC1D8;VPS26C;AP3B1;TBC1D17;AP4B1;TBC1D25;ARL5C;KIF13A;CTSA;TECPR2;SNX13;PREB;NUP188;TBC1D12;EVI5;SAR1A;ARL4C;HOMER3;COPZ1
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3169683826790666,-1.1691562540085543,0.18938053097345134,0.5035520226454697,1.0,21/63,18.65%,GAB1;PARVB;MYH9;PARVA;PTPN1;RICTOR;EZR;CDC42BPA;S1PR1;BCAR1;FGF7;FLNA;PHACTR1;RHOA;NEDD9;GRB2;ANXA1;CDC42BPB;RAP2A;TRPV4;MKLN1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2764671669055941,-1.1688355537862,0.15630252100840336,0.5038788287311837,1.0,26/138,11.47%,PTPRG;FLT1;TEK;IGF1R;TIE1;ROR1;INSR;ABI1;LYN;BMPR2;KDR;MERTK;EGFR;IL6ST;YES1;PTK2;NGF;EPHA4;FLT4;LIFR;ACVR2A;BCAR1;MPZL1;FRK;RAPGEF1;JAK2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3238434267455884,1.1688348829187973,0.1895424836601307,0.6553722628066105,1.0,13/51,13.10%,CNTNAP2;EPB41L3;SHTN1;NBL1;TNIK;MAP1S;GPM6A;PAK1;NYAP2;MINK1;SRGAP2;SGK1;BDNF
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.29485116857414145,-1.1682080720006942,0.17900172117039587,0.5049122516322383,1.0,29/86,22.06%,GHR;PECAM1;APP;PAK2;IL15;PTPRJ;EGFR;BMP6;IL6R;ABL1;PRKCD;ARHGEF2;PLCG2;HAX1;CSPG4;FGF7;TP53;JAK2;HGF;MIF;ANGPT1;IGF1;FYN;PTPRC;RAP2C;ITGB3;IGF2;PTPN11;PTK2B
prerank,positive regulation of filopodium assembly (GO:0051491),0.38346326797845603,1.1679826030717848,0.22528735632183908,0.6562145811975577,1.0,6/24,8.92%,NLGN1;TENM1;TENM2;FSCN1;GPM6A;PLPPR5
prerank,platelet degranulation (GO:0002576),-0.28384181957942684,-1.1679687479488878,0.14770797962648557,0.505060543557046,1.0,34/118,23.75%,ABCC4;VWF;PECAM1;PHACTR2;LYN;THBS1;TMSB4X;APP;PROS1;SRGN;GAS6;FAM3C;TGFB2;APOOL;VEGFC;FLNA;TIMP3;ACTN1;ACTN4;HGF;F5;IGF1;LAMP2;SOD1;NHLRC2;FERMT3;ITGB3;IGF2;VCL;LHFPL2;SERPINE1;SYTL4;TLN1;ITIH3
prerank,extracellular transport (GO:0006858),0.4472821306064705,1.1676815112408534,0.275,0.6553920797130158,1.0,6/13,16.82%,ADCY10;TSG101;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,RNA metabolic process (GO:0016070),-0.27950459176907627,-1.167314010736209,0.14285714285714285,0.506098515480971,1.0,45/127,26.52%,RBPMS;RBFOX2;RBMS1;METTL14;DDX3X;HNRNPA0;RBM5;HNRNPR;FTO;RBMS2;HNRNPM;POLR2G;RNASE3;DDX39B;NOL9;HNRNPA3;WTAP;DICER1;HNRNPUL1;RBM39;HNRNPF;XRN2;APOBEC1;TENT2;PARN;AGO2;HNRNPA1;SYNCRIP;THOC1;ADARB1;WDR74;TFIP11;RNASEH2C;DROSHA;RBM3;RBM6;PCBP1;POLR2C;DHX9;POLR2L;EXOSC7;POLR2H;ATXN1;HNRNPL;HNRNPD
prerank,negative regulation of protein modification process (GO:0031400),-0.3022832784408309,-1.1656067137718964,0.19607843137254902,0.5095798842361517,1.0,17/79,14.35%,DAB2IP;MFHAS1;LYN;CORO1C;GSK3B;LRRK2;NIBAN1;CDYL;LRP6;SLIT2;OCLN;PRKAA1;PTPN13;CHP1;PNKP;TRAF3IP1;DNAJC10
prerank,positive regulation of DNA recombination (GO:0045911),-0.3801484230400223,-1.1655500642345136,0.25183823529411764,0.5093109518486653,1.0,9/27,16.00%,ARID2;SHLD1;TFRC;KMT5B;MRNIP;FUS;ERCC2;PRDM9;MAD2L2
prerank,regulation of cell aging (GO:0090342),-0.47751058360685356,-1.1654266122829544,0.26855123674911663,0.5091494726844623,1.0,4/11,15.38%,NEK6;LMNA;MIF;NUAK1
prerank,negative regulation of blood coagulation (GO:0030195),0.34219443848984027,1.1651621271300359,0.22802850356294538,0.6608380848136373,1.0,9/38,16.65%,VTN;CPB2;C1QTNF1;F8;PDGFA;SERPING1;APOE;PDGFRA;KLKB1
prerank,visual perception (GO:0007601),0.29697804717601817,1.1649547058841936,0.1897810218978102,0.6597294830536605,1.0,11/84,8.07%,COL2A1;EML2;COL1A1;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2;TRPM1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3745375191870776,-1.1649510639214327,0.23290203327171904,0.5098121817122929,1.0,10/27,21.42%,VPS13A;VPS13C;GAK;CSNK1D;VPS13D;RIPOR1;GBP5;GOLPH3;ARL5C;IFT20
prerank,skeletal system development (GO:0001501),-0.27398066308914665,-1.1648897575309998,0.16323024054982818,0.5095559195325189,1.0,43/148,21.04%,TLL1;ZBTB16;AKAP13;EXT1;CDH11;TEAD4;PLS3;DYM;BMP5;ANKRD11;SH3PXD2B;BMP6;KIAA1217;TGFB2;ALPL;RBP4;CREB3L2;SLC10A7;TGM2;PCSK5;ADAMTS4;ETS2;PKDCC;RPL13;COMP;WWOX;NOTUM;WNT11;MYOC;RPS6KA3;EBP;TRPS1;BMP7;IGF1;TNFRSF11B;ANKH;CMKLR1;HYAL2;SOX4;COL13A1;HAPLN3;IGF2;HAPLN1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2785955707118116,-1.1643998704052667,0.17200674536256325,0.5102924929704963,1.0,36/141,15.81%,CTNNA1;RAPGEF2;GNB1;PKD2;ESR1;NRIP1;LRRK2;NR3C1;DIAPH1;TIPARP;EGFR;MSN;PDE3A;LARP1;PDE2A;MED1;KCNQ1;SPIDR;RAP1A;MEF2C;EZR;TGM2;RAP1B;CDH1;ARL6IP5;RAPGEF1;NCOA4;ACTB;KAT5;PDE12;P2RY6;IGFBP5;ROCK2;RUVBL2;ADCY1;UBE2L3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.36856361552686945,-1.1642770112374174,0.23487544483985764,0.5101764673044611,1.0,15/31,36.48%,DCUN1D3;RAB1A;MAGEC2;UBE2L3;DCUN1D2;PTEN;DCUN1D5;FZR1;TRIB3;RPS2;PLK1;BMI1;TOPORS;CDC20;UBE2C
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4999145229034415,-1.1639016588975337,0.27440147329650094,0.5106738142528616,1.0,5/10,28.45%,SLC44A1;SMOX;ALDH7A1;CHDH;DMGDH
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.27094477972990405,-1.1635119563724026,0.1632996632996633,0.511246450180747,1.0,58/172,25.93%,RUFY1;MTMR3;ARF3;PLA2G4A;PIP4K2A;LPCAT1;PLD1;PIK3R1;BMX;PIP4K2B;PI4KB;SLC44A1;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLD2;STARD7;PLCG2;MFSD2A;PIK3CD;DGKA;AGPAT4;DGKZ;INPP4A;PIK3R6;MTMR12;FGF2;ACP6;AGPAT3;PTPN13;AGK;PLEKHA4;PLSCR1;PIK3CB;AGPAT1;PI4K2B;CEPT1;PIK3R3;PTDSS1;PCTP;PLA2G12A;LCLAT1;PTEN;LPIN2;DDHD2;LPCAT3;INPP5D;LCAT;MTMR4;GPD1;PIP5K1A;DGKH;CHAT;INPP5J;PIK3CA;DGKE;INPP5E
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4859707488544347,-1.163499232296397,0.2727272727272727,0.5108674210937983,1.0,10/10,51.44%,SMAD7;RC3H1;NFKBID;IL4;FOXP3;MALT1;RC3H2;TBX21;NFKBIZ;ZC3H12A
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3754911363239266,-1.1632023025721474,0.25140712945590993,0.511190859388917,1.0,11/26,25.24%,ITGB1;NEDD4L;YWHAE;DLG1;NEDD4;CASQ2;WWP2;VAMP2;FHL1;AKAP9;CAB39
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4285117193739152,-1.162833434650042,0.27355072463768115,0.5116240910685501,1.0,9/18,28.03%,DAB2IP;MSN;VGLL4;EZR;CDK5RAP3;AMER1;HSP90AA1;VPS35;RDX
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3491230775779466,-1.1625060760446324,0.23172905525846701,0.5119585505563827,1.0,14/38,21.87%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;PHC3;CHEK1
prerank,cellular lipid catabolic process (GO:0044242),0.37488469588124085,1.1624444773508704,0.2515991471215352,0.6654021428107191,1.0,4/27,7.62%,ENPP2;NUDT19;LPIN1;SMPDL3B
prerank,AMP metabolic process (GO:0046033),0.4483119497703846,1.161515193606026,0.2775423728813559,0.6663673197541581,1.0,4/13,10.48%,AK9;AK3;ADSS2;ADSS1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.3426227611137114,-1.1607697774844388,0.21557971014492755,0.515601490902212,1.0,9/40,14.91%,FLT1;EDNRA;ESR1;PLCG1;EGFR;HTR2A;FGF2;P2RY6;LPAR2
prerank,protein dephosphorylation (GO:0006470),-0.27828994951657055,-1.160537315448446,0.16981132075471697,0.5157010766246743,1.0,38/135,20.31%,PTPRG;PTPRB;PTPRM;PPP2R5A;PTPN14;PPM1H;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;NCK1;PPEF2;PPM1L;ILKAP;PTPRK;MTMR6;PPM1F;PPP2R2D;PPM1B;PPP1R12A;UBLCP1;PTPN3;DUSP3;PTPN13;CTTNBP2NL;FBXW11;PPP2CB;UBASH3B;TNS2;PPM1D;DUSP16;DUSP22;PPP2CA;PTPRC;PTEN;PPP3CC
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.300402672639607,-1.1605098161336247,0.17785843920145192,0.5153536124445024,1.0,18/76,14.72%,TEK;BAIAP2L1;PRKCE;NCK1;ABL1;SNX9;NES;HAX1;EDN1;NCK2;CFL2;FCHSD2;BCAS3;SYNPO2;LMOD1;CDC42EP3;SORBS3;NCKAP1
prerank,T cell mediated immunity (GO:0002456),-0.4542688353994248,-1.1604068111212065,0.24818840579710144,0.5151709997955856,1.0,6/13,32.75%,CD55;JAG1;CTSH;GNL1;EMP2;MYO1G
prerank,cell-matrix adhesion (GO:0007160),-0.294794901226547,-1.1602067534435352,0.1826086956521739,0.5152273802897988,1.0,33/95,23.09%,SORBS1;ITGB1;THSD1;BCR;FERMT2;CD34;RAC1;ITGBL1;ITGA3;ITGA1;ITGB4;ADAM9;ITGB5;PPFIA1;PTPRK;ADAMTS9;BCAM;FBLN5;ILK;ACTN1;MSLN;ITGA4;ITGA2;VCAM1;MKLN1;COL13A1;LYVE1;FERMT3;ITGB3;VCL;ITGA7;PIP5K1A;HPSE
prerank,mitotic metaphase plate congression (GO:0007080),-0.33022106861889033,-1.15991321718254,0.22968197879858657,0.5154799193364158,1.0,28/51,39.58%,MAD1L1;CUL3;CHMP4B;CHMP4A;CHMP2B;CHMP5;RAB11A;CENPE;PDCD6IP;RRS1;BECN1;EML4;PINX1;CHMP3;KIF14;SPDL1;CDCA8;CHMP6;CHMP1A;NUDC;BOD1;NUF2;PSRC1;MIS12;CHMP1B;RMDN1;KIF2C;CCNB1
prerank,keratan sulfate catabolic process (GO:0042340),0.4643534772643942,1.1591901423050974,0.2431818181818182,0.6711985682276127,1.0,5/11,21.58%,FMOD;PRELP;HEXB;OGN;ACAN
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.4242793682358281,-1.1590257612129473,0.2892416225749559,0.5171348776468635,1.0,10/16,41.59%,MCM4;RPA1;WRN;BLM;MCM7;MCM2;MCMDC2;HMGA1;TWNK;RECQL4
prerank,membrane repolarization during action potential (GO:0086011),-0.46045905991101455,-1.1589391228139878,0.2846441947565543,0.5169273214551872,1.0,7/13,28.17%,KCNJ2;YWHAE;KCNQ1;KCNE4;KCNH2;KCND3;ATP1A1
prerank,lymphocyte differentiation (GO:0030098),-0.31228670937712155,-1.1588612520078139,0.21723518850987433,0.5167140680013808,1.0,19/68,19.36%,PBX1;ITGB1;PTPRJ;JAG2;ZBTB7A;PLCG2;TPD52;PIK3CD;HDAC4;ITGA4;NHEJ1;LMBR1L;TCF3;VCAM1;CEBPG;CLCF1;SOX4;PTPRC;DNAJB9
prerank,endocytic recycling (GO:0032456),-0.3282045788298815,-1.158357501551428,0.24621212121212122,0.517429138266893,1.0,14/50,18.79%,EPS15;RAB7A;EHD2;RAB11FIP3;ANKRD50;SNX12;EHD1;VPS26A;VPS52;EHD4;ANKRD27;VPS35L;WASHC1;VPS26C
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.40083600451286233,-1.158234338725479,0.26287744227353466,0.5173240893141031,1.0,8/20,24.52%,DCUN1D3;ZMIZ1;DCUN1D2;EPAS1;WASHC1;DCUN1D5;HSP90AA1;HSPA1B
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.40006609213989786,-1.1581795372062882,0.2558139534883721,0.517057939065941,1.0,5/22,12.95%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,xenobiotic transport (GO:0042908),-0.42783584412519754,-1.1578855075989714,0.2608695652173913,0.517295643259591,1.0,3/17,2.43%,ABCG2;SLC47A1;SLC7A5
prerank,cellular response to insulin stimulus (GO:0032869),-0.2780415689453519,-1.15749579135221,0.16974169741697417,0.5177629936841017,1.0,43/124,26.79%,IGF1R;TBC1D4;SORBS1;FOXO1;GAB1;INSR;GSK3B;KAT2B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;AKT1;SLC27A4;RAB8B;INSIG2;CEACAM1;ATP6V1E1;GRB2;DENND4C;FOXO4;PIK3R3;ATP6V0A1;PRKDC;PPARG;LPIN2;IGF2;VAMP2;ATP6V1H;SYAP1;TRIB3;SH2B2;PTPN2;ZFP36L1;APC;HDAC5;ATP6V0E2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.45457708612168735,-1.1566088025385806,0.30341113105924594,0.5193947945450766,1.0,6/14,10.16%,LIMS2;LIMS1;LOXL3;PHACTR4;PRKD1;FLNA
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2938199636917746,-1.156017995101278,0.20503597122302158,0.520331069107342,1.0,45/95,33.67%,SMC5;NIPBL;SAMHD1;ZFYVE26;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;MCM4;RAD54B;NSMCE2;SFPQ;RPA3;RPA1;FANCM;PALB2;RFWD3;WRN;RPA2;RAD54L;BRCA1;RAD51AP2;BLM;YY1;MCM3;MORF4L1;INO80;MCM7;MCM5;POLL;XRCC2;AP5Z1;KDM4D;RAD51AP1;SWI5;RAD51D;MCM2;HUS1B;RMI1;MEIOB;RAD50;GINS2;FAN1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4482275919388137,-1.155613104438547,0.2902033271719039,0.5208598001305799,1.0,3/13,9.00%,SEMA7A;TGFB2;PLCG2
prerank,MAPK cascade (GO:0000165),-0.25072489404014847,-1.1538133826757735,0.11705685618729098,0.5245500467081031,1.0,66/295,17.04%,SPTBN1;TEK;DAB2IP;KITLG;RAPGEF2;SPTAN1;SHANK3;MAP3K20;MEF2A;RASAL2;BRAP;IL17RD;JAK1;RANBP9;PSMA2;LRRK2;MAP3K5;KDR;YWHAE;EGFR;NFKB1;RASGRF2;RBX1;PIK3R1;IRS1;DLG1;SHOC2;CUL3;PTK2;FGF1;MEF2C;PSME2;MAPKAPK2;MAPK1;RAF1;PSMB4;FGF7;PDE6D;MAP3K3;TAOK3;RASA4;PTPN3;PEBP1;BRAF;JAK2;RASA1;FGF2;ABHD17A;FBXW11;MAP3K8;HGF;KSR1;MAPK8;ABHD17C;PIK3CB;PSMC2;GRB2;MAP4K4;PSMB2;MAPK12;PSMB1;ANGPT1;IGF1;FYN;MARK3;CTSH
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.34769421511928456,-1.1534650005434244,0.2536231884057971,0.5249461487482512,1.0,14/38,19.62%,CAV1;PTPN1;APP;ACE;GAS6;IL34;SH3BP5L;EPHA4;NCK2;NEDD9;NOX4;HYAL2;PTPRC;RAP2C
prerank,regulation of T cell migration (GO:2000404),-0.4082496524254167,-1.1530784080625185,0.26120857699805067,0.5254381860471197,1.0,3/18,3.19%,CD200;APP;LRCH1
prerank,response to X-ray (GO:0010165),-0.44760882400801266,-1.1530521515609937,0.2773722627737226,0.5250999406784908,1.0,7/14,21.31%,ATM;NIPBL;XRCC4;ANXA1;BRCC3;LIG4;BLM
prerank,myotube differentiation (GO:0014902),0.41803749709551624,1.1527305293493297,0.2762557077625571,0.6883232823550033,1.0,4/17,10.41%,ADAM12;ADGRB3;ADAMTS15;PLD3
prerank,cellular response to superoxide (GO:0071451),-0.4927131502986461,-1.151832127082786,0.2920353982300885,0.5273820036452121,1.0,3/10,18.07%,NOS3;CCS;SOD1
prerank,positive regulation of viral life cycle (GO:1903902),0.3895281190819218,1.1516578128004715,0.26146788990825687,0.6898089531308679,1.0,6/22,18.33%,LGALS1;TYRO3;DDB1;TSG101;P4HB;CHMP2A
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.282164925553761,-1.1515350903229165,0.19320214669051877,0.527660462740294,1.0,29/119,16.18%,RUFY1;MTMR3;ARF3;EFR3B;PIP4K2A;PIK3R1;BMX;PIP4K2B;PI4KB;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLCG2;ITPKB;PIK3CD;TTC7A;SOCS2;INPP4A;PIK3R6;MTMR12;PIGV;FGF2;PTPN13;PLEKHA4;PIK3CB;PIGG;PI4K2B;PIK3R3
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.28191126046842,-1.1508432234888526,0.18232044198895028,0.5288256049013922,1.0,21/102,12.67%,TBC1D4;SORBS1;FOXO1;INSR;CAV1;PRKACB;KAT2B;ADCY9;SLC30A10;NFKB1;PIK3R1;IRS1;RHOQ;PRKCD;ADCY4;GSK3A;AKT1;CYSLTR2;RAB8B;INSIG2;CEACAM1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3745604465496424,1.1507270890698809,0.26576576576576577,0.6890088147546072,1.0,6/24,18.82%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,canonical glycolysis (GO:0061621),0.3745604465496424,1.1507270890698809,0.26576576576576577,0.6890088147546072,1.0,6/24,18.82%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4092734227842303,1.150502419112433,0.26048565121412803,0.6879059004511573,1.0,4/18,5.12%,NLGN1;RIMS2;RIMS1;SYN1
prerank,positive regulation of lipid storage (GO:0010884),-0.3991045501321364,-1.1504690505570738,0.2573913043478261,0.5292859411882492,1.0,6/21,15.73%,NFKB1;SCARB1;EHD1;IKBKE;LPL;PLIN2
prerank,response to amino acid starvation (GO:1990928),-0.3031754847976901,-1.1502274335623937,0.22281639928698752,0.52939285217101,1.0,21/72,19.30%,SESN1;MAP3K5;MTOR;LARP1;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;DAP;CASTOR1;GCN1;RNF152;ITFG2
prerank,defense response to symbiont (GO:0140546),-0.29426270475934097,-1.1499896407574797,0.21206581352833637,0.5295896861454221,1.0,41/92,31.08%,IRF2;IFIH1;ATG7;TRIM56;SETD2;ABCC9;SAMHD1;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;CD40;PLSCR1;PDE12;CGAS;MOV10;NLRC5;MAVS;ZMYND11;SERINC5;MAP3K14;PTPRC;EXOSC5;ABCE1;IFNAR2;RELA;IRF7;NCBP3;IFITM2;AGBL5;OASL;BST2;RSAD2;IFNLR1;SHFL;LILRB1;RTP4;PMAIP1
prerank,innate immune response in mucosa (GO:0002227),-0.4808235515661289,-1.149988556060429,0.30594405594405594,0.5291798222352094,1.0,9/10,51.95%,RNASE3;DEFA6;RPL39;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.44825188295814844,-1.1493008565644114,0.26195028680688337,0.5304460235939022,1.0,2/13,6.02%,ENTPD1;ENTPD6
prerank,pre-miRNA processing (GO:0031054),-0.44999170225483165,-1.1492050143021857,0.29701230228471004,0.5302800903909642,1.0,5/14,21.03%,TUT7;DICER1;TUT4;AGO2;DROSHA
prerank,mammary gland epithelium development (GO:0061180),0.43087622968062883,1.1490526599608466,0.25601750547045954,0.6904708714128875,1.0,2/14,1.29%,ERBB4;WNT7B
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3938251012116909,-1.1490502899263293,0.2687385740402194,0.5302032372156865,1.0,7/22,14.14%,SP100;LRRK2;MDFIC;GDI1;CHP1;UFM1;RAB23
prerank,defense response to virus (GO:0051607),-0.29058637893737616,-1.1485480491753355,0.19736842105263158,0.5309558641275354,1.0,45/100,31.08%,IRF2;IFIH1;ATG7;TRIM56;SETD2;ABCC9;CLPB;SAMHD1;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;CD40;PLSCR1;PDE12;CGAS;MOV10;NLRC5;MAVS;ZMYND11;SERINC5;MAP3K14;PTPRC;ZDHHC1;EXOSC5;ABCE1;IFNAR2;RELA;AKAP1;IRF7;NCBP3;IFITM2;AGBL5;CXCL10;OASL;BST2;RSAD2;IFNLR1;SHFL;LILRB1;RTP4;PMAIP1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2856266311245942,-1.1481190514123938,0.19444444444444445,0.5311579090516249,1.0,27/104,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,cellular response to lectin (GO:1990858),-0.2856266311245942,-1.1481190514123938,0.19444444444444445,0.5311579090516249,1.0,27/104,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.35491629368326627,-1.1479304869232754,0.25181159420289856,0.5311603098658828,1.0,15/33,24.02%,NET1;MAP3K5;ABL1;PRKCD;ANKZF1;TNFAIP3;ANXA1;HDAC6;PPIF;RPS3;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,regulation of protein localization (GO:0032880),-0.3120692940121099,-1.1478277846670362,0.22641509433962265,0.530997542916291,1.0,21/58,28.79%,DVL3;TRIM25;AFDN;DLG1;AAK1;DNAJB6;PPM1F;MMD;PICALM;TRIM14;MAPK8;TPR;DZIP1L;SUMO1;ITGB3;HSP90AA1;TRIM68;TMEM231;TRIM67;TRIM6;BORA
prerank,nuclear migration (GO:0007097),-0.45600814952119156,-1.1476025120240874,0.29044117647058826,0.5310924056083329,1.0,5/13,17.98%,SYNE2;DCTN1;PAFAH1B1;FBXW11;PCM1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.33683084931501184,-1.1473655409187353,0.24006908462867013,0.5312401289564292,1.0,14/49,23.39%,SGMS1;CAV1;MCL1;DDX3X;TP53;BCAP31;BBC3;BCL2L11;GSDME;PPIF;SIAH1;HERPUD1;BECN1;EIF2AK3
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.4733750463281388,-1.147197817200515,0.29338103756708406,0.5308194237436661,1.0,8/11,45.94%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.4733750463281388,-1.147197817200515,0.29338103756708406,0.5308194237436661,1.0,8/11,45.94%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.49185493938672675,-1.1469664658195016,0.30035971223021585,0.5309454708109853,1.0,4/10,14.79%,MLLT3;ACE;TP53;LMBR1L
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.31197038537973504,1.1465279864917224,0.2356828193832599,0.6960838843706287,1.0,14/59,16.99%,AKR1D1;CYP46A1;ELOVL4;ACLY;OSBPL6;ACACA;CYP27A1;OXSM;ALDH1A2;LIPC;OSBPL9;NDUFAB1;ALOX5;ACOX2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.44263668848625903,-1.145867584631582,0.2857142857142857,0.533139090121882,1.0,4/14,9.84%,PPARA;IRS1;MFSD2A;AKT1
prerank,regulation of stem cell differentiation (GO:2000736),-0.29317415493222515,-1.1455793781092298,0.20253164556962025,0.5334205975315336,1.0,32/89,28.40%,CBFB;TCF12;PSMA2;LMO2;HES1;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;NOTCH1;PSMC2;JAG1;TCF3;PSMB2;PSMB1;PSMA8;NELFB;PSME1;GATA2;PRKDC;PSMD4;PSMA7;PTN;RBM24;PSMD5;SP7;PSMB10;PSMA3;HNRNPU;LMO1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3027777381876316,-1.145145381871358,0.2375,0.5339908929305275,1.0,23/71,20.26%,SGMS1;CERT1;ACER2;DEGS2;SGMS2;A4GALT;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;AGK;SPTLC1;ASAH1;CERS5;SMPD2;VAPA;LARGE1;DEGS1;ELOVL7
prerank,regulation of macrophage migration (GO:1905521),-0.48343192689530384,-1.1449124544952995,0.28368794326241137,0.5341307234147905,1.0,2/10,3.25%,CD200;MTUS1
prerank,protein polyubiquitination (GO:0000209),-0.25020770952750926,-1.1448935091049948,0.14093959731543623,0.5337610780527734,1.0,93/297,26.35%,FBXL7;WWP1;PELI1;UBR5;CBFB;NEDD4L;ZNRF1;SMURF2;TRAF5;FBXL12;UBE2K;TRIM56;PSMA2;FBXL17;DTX3L;SMURF1;RNF125;FBXL3;RNF213;RBX1;LMO7;UBE4B;CUL3;NEDD4;PSME2;RNF115;RNF144B;SPSB1;PSMB4;HECTD1;TRIP12;UBE2J2;ZNRF2;UBE2D3;TPP2;UBR2;FBXW8;AREL1;TRIM14;RMND5A;CDC16;HERC6;UBE2E2;UBE4A;FBXW11;RNF168;PSMC2;RC3H1;RNF167;MYLIP;TNFAIP3;UBE2V2;ERCC8;PSMB2;UBE2L3;PSMB1;PELI2;MIB2;CTNNB1;PSMA8;SPOP;SASH1;KLHL3;SIAH1;RNF152;AKTIP;PSME1;TRIM3;NPEPPS;RNF4;WWP2;PSMD4;HUWE1;BRCA1;UBE2R2;MDM2;PSMA7;RNF216;HACE1;FZR1;PSMD5;THOP1;TRIM68;RNF146;FBXO32;FBXL22;FBXO17;ANAPC7;FBXO40;DTL;FBXO38;PSMB10;ARIH2
prerank,osteoclast differentiation (GO:0030316),-0.39406821965654015,-1.1447433723076852,0.27706422018348625,0.5336912773362691,1.0,2/22,2.79%,FOXP1;ANXA2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.40937141710896086,-1.1444666408602746,0.291958041958042,0.5339079706843797,1.0,5/18,12.94%,RALBP1;KDR;MIEF1;BNIP3;MIEF2
prerank,organic substance transport (GO:0071702),-0.2811885599567417,-1.1444072406191155,0.1906474820143885,0.5336357048422712,1.0,22/121,9.94%,ABCG2;SLC47A1;PLTP;RUFY1;SLCO2A1;CALCRL;MYH9;RAMP1;RAB7A;SPNS2;SCAMP2;SLC19A2;SLC22A5;ABCB9;ABCD3;TAP2;ARRDC1;SLCO2B1;ARL6IP5;MFSD2A;RAMP2;ABCA9
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.28414718248622556,-1.1443880147397947,0.19827586206896552,0.5332695101376022,1.0,27/105,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2767993678555341,-1.14387623426569,0.19343696027633853,0.534088594746122,1.0,33/121,16.83%,GHR;PECAM1;LYN;PTPN1;PAK2;IL15;PTPRJ;ACE;IL6ST;BMP6;IL6R;HES1;GAS6;ABL1;IL34;PARP14;EPHA4;ARHGEF2;PLCG2;HAX1;CSPG4;FGF7;TP53;JAK2;NEDD9;STAP2;CD40;HGF;MIF;TNFRSF1A;ANGPT1;IGF1;NOX4
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3201903187979988,-1.1438501725195611,0.24027072758037224,0.5337536893694895,1.0,17/51,15.36%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;RHOA;LIMCH1;SYNPO2;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2
prerank,sensory organ development (GO:0007423),-0.3229140213547999,-1.1430301711491597,0.21532846715328466,0.5352698469507636,1.0,17/51,23.57%,PBX1;SH3PXD2B;SMOC1;PBX3;TGFB2;RBP4;ECE1;SIPA1L3;SHROOM2;FOXC1;FREM2;HIPK1;SIX4;PBX2;CHRDL1;ATF6;MYO7A
prerank,brain development (GO:0007420),0.2664566489647355,1.1429923749456237,0.18509615384615385,0.704753136720832,1.0,19/136,7.58%,CNTNAP2;ROBO2;CTNNA2;CNTN4;GRIN2B;DSCAML1;ADGRL3;GRIN2A;POMK;MEIS1;NDRG4;MEIS3;MDGA1;PITPNM1;SMG9;PAX2;MAP1S;PROX1;BBS4
prerank,protein destabilization (GO:0031648),-0.3599227793176328,-1.14275768791772,0.2668977469670711,0.5355221679792345,1.0,11/32,18.31%,CREBBP;RNF139;SOX17;FBXL3;CUL3;IRGM;CDC73;FBXW11;SENP2;CTSH;RAD23A
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.39224523382073984,-1.1424493948524623,0.28186714542190305,0.5358322410676067,1.0,12/22,44.16%,GSK3B;ROCK1;ROCK2;IKBKB;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B;MASTL;STYXL1;TNF
prerank,negative regulation of nervous system development (GO:0051961),0.40894265752828357,1.1416202636729207,0.2926829268292683,0.7070029332004141,1.0,3/17,9.89%,ROBO2;SORL1;SLIT1
prerank,spermatid development (GO:0007286),0.3411838504540805,1.1415893431021806,0.25339366515837103,0.7053170488264632,1.0,13/32,23.59%,DDX25;CCDC63;ZMYND15;BBS4;RNF8;MKKS;YTHDC2;NME5;SYCP3;IQCG;ACRBP;CIB1;TDRD5
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3842041389776084,-1.1414253887800692,0.27191413237924866,0.5377228971159186,1.0,12/24,30.86%,DTX3L;SIN3A;CGAS;MAVS;ZDHHC1;HSP90AA1;EIF2AK4;TRIM44;PARP9;TRIM6;TOMM70;LILRB1
prerank,regulated exocytosis (GO:0045055),0.2558060719325499,1.141390108978343,0.1724137931034483,0.7041899680685217,1.0,31/173,13.29%,ABCA12;SYT1;PCLO;SYT5;BLK;RIMS2;SNAP25;RIMS1;CDK5;F8;SYT12;SYT11;CLEC3B;PLEK;CD63;RAB27B;ECM1;LY6G6F;PF4;STXBP2;TIMP1;VEGFA;PDGFA;RAB3A;VTI1B;CHID1;SYT4;SERPING1;SYNGR1;CDC37L1;CLU
prerank,regulation of cell motility (GO:2000145),-0.2773468926570529,-1.1411628553565507,0.21403508771929824,0.5379340844201793,1.0,34/121,17.05%,RAC1;NTN1;TMSB4X;SPOCK2;CRK;DIAPH1;EGFR;ABL1;LMO4;ROBO4;MACF1;FGF1;PRAG1;PLXND1;ROCK1;PLXNA4;RAF1;LDB1;FGF7;AKT1;FLNA;LMNA;FRMD5;ABI3;RHOA;FGF2;CEACAM1;CDK6;PKN2;TBCCD1;ROCK2;CAVIN1;SLK;TMSB10
prerank,lipid biosynthetic process (GO:0008610),0.2939627318947234,1.1410923804551139,0.2422062350119904,0.7033933621762425,1.0,18/77,15.88%,IDI2;FADS1;ACSS2;LSS;ELOVL4;CYP51A1;ACLY;ACACA;OXSM;ACSL6;GNPAT;LIPC;FDFT1;OLAH;SCD5;NDUFAB1;CLN8;ALOX5
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.4535218942250175,-1.1408653515339338,0.3036053130929791,0.5382290562862887,1.0,6/12,30.69%,JAM2;APP;RHOA;CXCL12;CXCL10;TNFRSF14
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.37171334942396195,-1.1408079672559424,0.25678119349005424,0.5379401236856316,1.0,14/29,34.60%,BIRC3;CASP8;UBE2D3;IKBKE;CD40;IKBKG;IKBKB;RIPK1;IRF7;CD300LF;TICAM1;TLR6;CD14;TBK1
prerank,ion transport (GO:0006811),0.2751391310193189,1.1406154809130833,0.18340611353711792,0.7030803204993864,1.0,23/111,14.47%,TRPM3;SLC24A4;SLC24A2;GABRB1;SLC5A12;GLRA1;SLC9A7;KCNN2;SLC9A9;SLC4A2;SLC8A2;SLC1A2;SLC36A2;SLC12A5;PANX2;VDAC2;SLC17A6;KCNN3;SLC8A3;SLC8A1;SLC12A4;SLC1A3;SLC26A8
prerank,DNA replication (GO:0006260),-0.27882986705607365,-1.1394409210614398,0.20302013422818793,0.5407018439620385,1.0,48/105,33.69%,MCMBP;RBMS1;ATM;TOP3A;BAZ1A;MRE11;MCM9;RBBP8;CLSPN;MCM4;ORC5;RPA3;DNA2;KAT5;REV1;RPA1;PNKP;TBRG1;TOP1MT;ORC2;POLE2;PTMS;WRN;ORC4;RPA2;TIMELESS;BRCA1;BLM;RFC4;CHEK1;MCM3;TOP1;RFC1;POLA2;MCM7;MCM5;MCM10;POLL;EXO1;SET;ING5;MCM2;RMI1;RAD50;GRWD1;ORC3;CDC6;PIF1
prerank,phospholipid metabolic process (GO:0006644),0.3016886123910026,1.139157008055594,0.22453703703703703,0.7056523009881702,1.0,14/71,12.25%,ENPP2;IDI2;FADS1;PIP4P1;PLPPR4;PLPPR1;PLPP2;SMPD3;PLA2G3;PLA2G4E;PLPPR5;ABCA2;GNPAT;FDFT1
prerank,electron transport chain (GO:0022900),-0.4288871767367976,-1.138679650163532,0.2983425414364641,0.5420212750479737,1.0,5/15,19.79%,ENOX2;PDIA5;UQCRFS1;ETFRF1;POR
prerank,RNA transport (GO:0050658),-0.3025684843567031,-1.1385879274497825,0.23777403035413153,0.5418457871070408,1.0,21/71,20.24%,SRSF11;RAE1;SARNP;RTRAF;TGFBR2;THOC2;UPF3B;THOC7;DDX39B;DHX38;NUP153;SLU7;FLOT1;HNRNPA1;TPR;THOC3;THOC1;NUP214;SRRM1;RNPS1;SRSF3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.40591365632567117,-1.1385718379900118,0.3,0.5414760239303283,1.0,6/18,16.22%,NCK1;PIK3R1;ERN1;USP13;ATXN3;BCL2L11
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3173032179610254,1.1384373491379038,0.2643171806167401,0.7060269065705785,1.0,13/52,11.29%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;CELF6;FXR2;DDX17;RBFOX3;ZC3H10;RBM8A
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.36959618449628767,-1.1383501752428562,0.28390596745027125,0.5416053131105574,1.0,9/29,18.94%,MNAT1;RBX1;ERCC2;RPA3;RPA1;XPC;ERCC3;CETN2;RPA2
prerank,negative regulation of kinase activity (GO:0033673),-0.3054757705820491,-1.1379992606875806,0.24036697247706423,0.5420296241062059,1.0,18/62,21.49%,RB1;PPP2R5A;CEP85;PAK2;CDKN1B;RTRAF;LRP6;PPM1F;PRKRIP1;AKT1;CEACAM1;CHP1;TAF7;UBASH3B;PTPRC;AKT1S1;NF1;WARS1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.36714980346986853,1.1375284207928669,0.2743362831858407,0.7070574754801977,1.0,6/25,18.82%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,nitrogen compound transport (GO:0071705),-0.27213887637308176,-1.1373266269102955,0.1986062717770035,0.5432104797986109,1.0,29/141,13.74%,ABCG2;SLC6A6;CERT1;RUFY1;CALCRL;MYH9;SLC7A1;SLC7A5;RALBP1;RAMP1;RAB7A;SLC12A2;SCAMP2;SLC19A2;SLC38A5;SLC22A5;SLC44A1;SLC1A5;LRRC8D;ARRDC1;ARL6IP5;RAMP2;SLC52A1;SEC14L1;EDN1;TXNIP;SLC52A3;CHMP2B;SLC7A7
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.40877808723433134,1.1370657711435106,0.27230046948356806,0.706786639119252,1.0,3/16,6.86%,CLDN18;CLDN14;CLDN11
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3837387763030648,-1.1369306722344499,0.2912801484230056,0.5438105745287399,1.0,6/23,19.32%,CAV1;CBL;SH3BP5L;HYAL2;DUSP22;PTPRC
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4111043080055433,-1.1368522390935276,0.2975352112676056,0.5435903979178429,1.0,12/17,48.62%,CD55;BACH2;JAG1;GNL1;STAT3;MYO1G;IL18;TLR4;BTN3A3;EBI3;SLA2;IL12B
prerank,regulation of epidermal cell differentiation (GO:0045604),0.38368153363981494,1.1367195945954607,0.2686230248306998,0.7060241917328702,1.0,6/21,8.12%,ABCA12;CTSK;SULT2B1;MAFG;SGPP1;MAFF
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4289186144470258,-1.1367140541733036,0.2894248608534323,0.5435239485958594,1.0,7/15,28.27%,PPARA;LPL;PLIN2;PPARG;PNPLA2;PLIN3;TREM2
prerank,cellular response to glucose starvation (GO:0042149),-0.33305753040906916,-1.1363618755622351,0.2735191637630662,0.5439557622017502,1.0,19/41,34.07%,SESN1;MTMR3;SIK1;FOXO3;TP53;PRKAA1;KPTN;ATF4;HNRNPA1;NUAK1;ITFG2;BECN1;EIF2AK3;PMAIP1;CPEB4;NIM1K;TBL2;NUAK2;SZT2
prerank,protein modification process (GO:0036211),-0.294253799891533,-1.1360940370855146,0.23035714285714284,0.5442021711061902,1.0,22/76,21.35%,ST3GAL6;ST3GAL1;PLOD2;ST8SIA4;PARP4;YES1;CSNK1G3;ABL1;PHKA2;UBE2D3;UBA7;ERO1A;STK38;MSRA;UBE2M;UBE2L3;PLAT;BAP1;PRKDC;WWP2;UBL4A;LOX
prerank,neurogenesis (GO:0022008),-0.3301630598201522,-1.1359618402255067,0.25528169014084506,0.5440875839602792,1.0,15/43,19.71%,TRAK1;METTL14;THOC2;SIX1;TGFB2;BTBD3;CDK6;BTBD1;FAT4;SIX4;ANXA1;NDUFS2;DAGLB;CLN5;RITA1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3443524892597807,-1.134603797150752,0.265625,0.5468139592236473,1.0,6/36,11.78%,SHANK3;ITGB1;HDAC1;EDN1;JAK2;HFE
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2826854500391237,-1.1340063845480906,0.2231686541737649,0.5478198715510582,1.0,41/109,26.42%,RUFY1;MTMR3;ARF3;PLA2G4A;PLCG1;PIP4K2A;PLCB3;PIK3R1;BMX;PLCB1;PIP4K2B;PI4KB;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLCG2;PIK3CD;INPP4A;PIK3R6;MTMR12;FGF2;PTPN13;PLEKHA4;PIK3CB;PI4K2B;PIK3R3;PIP4P2;PLA2G12A;LCLAT1;PTEN;PIGW;INPP5D;PDGFRB;MTMR4;PIP5K1A;INPP5J;PIK3CA;PLA2G4F;INPP5E;TPTE
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.3705165636960523,1.133709081569152,0.2803532008830022,0.7132034551385535,1.0,5/25,9.34%,ANK3;ATP1B1;WNK2;WNK3;STAC
prerank,amino acid import across plasma membrane (GO:0089718),-0.38224882975317004,-1.1333034821192896,0.2786259541984733,0.5491039232486874,1.0,5/24,7.64%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC1A5
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3348581884628542,-1.1327758633318612,0.2638146167557932,0.5499397194071122,1.0,15/41,21.17%,ENG;TGFBR3;TGFBR2;TGFB2;BMP4;MEF2C;GSK3A;SMAD7;NOTCH1;TPM1;JAG1;HEY1;HEY2;SOX4;DLL4
prerank,vesicle organization (GO:0016050),-0.32505658094997275,-1.1327055130400265,0.2634315424610052,0.549701195076123,1.0,15/46,18.82%,DNAJC13;CAV1;CD34;EPS15;FNBP1L;SRGN;ALS2CL;WASL;CHMP2B;EXOC8;PI4K2B;ALS2;ZFYVE16;WASHC4;AKTIP
prerank,cellular response to interferon-gamma (GO:0071346),-0.2829998282744754,-1.1326853933846042,0.2454212454212454,0.5493344689188943,1.0,25/88,23.93%,SP100;DAPK1;IRF2;TRIM25;JAK1;CCL25;ICAM1;MID1;CAMK2G;PRKCD;GBP6;IRF1;JAK2;GBP4;PDE12;SYNCRIP;VCAM1;GBP5;CCL19;IFNGR2;FCGR1A;CASP1;RPL13A;GBP3;TRIM68
prerank,calcium ion homeostasis (GO:0055074),0.2766640306878724,1.1325920599252053,0.21244635193133046,0.7147431866662043,1.0,16/95,12.58%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;CCL13;ATP13A2;CIB2;SLC8A3;SLC8A1;CCL5
prerank,eye morphogenesis (GO:0048592),-0.39002149520392365,-1.1325436987215458,0.29422382671480146,0.54925756786635,1.0,7/19,10.69%,COL5A1;NIPBL;RARG;COL5A2;NKD1;SHROOM2;AGTPBP1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.37021035477995706,-1.132537733752277,0.2822429906542056,0.5488574884412554,1.0,9/24,19.32%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2;CCL19;PTPRC
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.38238310328865155,1.1323993702546957,0.29493087557603687,0.7136062952432702,1.0,5/22,9.55%,RELL2;GADD45B;SPHK1;VEGFA;MINK1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.30103809509542123,-1.1323594475687113,0.22743682310469315,0.5488751226084181,1.0,21/70,21.85%,CBFB;TCF12;PSMA2;LMO2;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;PSMC2;TCF3;FOXC1;PSMB2;PSMB1;PSMA8;PSME1;GATA2;PRKDC;PSMD4;PSMA7
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3950188360883037,-1.1322940124320753,0.297153024911032,0.5477968630827073,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3950188360883037,-1.1322940124320753,0.297153024911032,0.5477968630827073,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3950188360883037,-1.1322940124320753,0.297153024911032,0.5477968630827073,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,cellular response to interleukin-4 (GO:0071353),-0.4887676537190476,-1.1322462214907452,0.3235831809872029,0.5474959826931385,1.0,2/10,6.72%,LEF1;STAT6
prerank,histone methylation (GO:0016571),-0.3677548025315407,-1.1320870526393851,0.2980251346499102,0.5474852167508631,1.0,8/26,18.02%,CREBBP;NSD1;NSD3;SUV39H1;EHMT1;SMYD1;N6AMT1;CARM1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4258882964244022,-1.131814321120678,0.28596802841918295,0.5477364877974958,1.0,5/15,15.58%,PRKCH;MED1;BMP4;FOXC1;TRIM16
prerank,sensory perception of sound (GO:0007605),0.28337123685653565,1.1318021954606423,0.2119205298013245,0.7137079841115362,1.0,11/88,6.43%,PCDH15;COL2A1;SLC26A5;LHFPL3;EML2;COL1A1;ATP2B2;COL11A2;DCDC2;TMC1;CACNA1D
prerank,positive regulation of dendrite development (GO:1900006),-0.48012842911167053,-1.1313200802922403,0.3123877917414722,0.5484902449722538,1.0,2/10,3.14%,DAB2IP;BMP5
prerank,polyol biosynthetic process (GO:0046173),0.40411077934894235,1.1310267961619926,0.28475336322869954,0.7143246107509076,1.0,5/16,10.42%,ITPKA;ISYNA1;CYP27A1;IP6K2;IPPK
prerank,metal ion homeostasis (GO:0055065),-0.34545285862595804,-1.131017321392833,0.2595281306715064,0.5488235173131485,1.0,8/40,11.02%,SLC12A7;CAV1;FAM20A;CNNM2;TMTC2;SLC12A2;CNNM4;COX11
prerank,regulation of protein secretion (GO:0050708),0.26876816117883423,1.130955241170298,0.2037914691943128,0.7128483953148895,1.0,31/119,18.05%,KCNC2;STXBP5L;SNAP25;GIP;GCK;KCNA5;CACNA1A;EXOC1;MTNR1B;CYP51A1;ANG;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;IL12A;FRMD4A;EIPR1;ATP13A2;LLGL1;CCL5;PPID;PPIA;APOE;ALOX5;SLC8B1;ADAM8;GLP1R;ABCC8;KCNG2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.4647948066350944,1.1307680814733858,0.29504504504504503,0.7117049992790143,1.0,4/10,14.60%,DGKQ;GNMT;SIRT7;SELENOS
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4163810554565601,1.1298082509284422,0.28153153153153154,0.7129341661519221,1.0,4/14,9.70%,AK7;AK3;AK5;NME2
prerank,metanephros development (GO:0001656),0.35852133293888166,1.1297769297104008,0.28211009174311924,0.7113074850211915,1.0,5/26,6.07%,ROBO2;WNT7B;OSR1;WT1;PAX2
prerank,regulation of intracellular protein transport (GO:0033157),-0.3512896311929798,-1.1296851316543397,0.2640845070422535,0.5514752712277327,1.0,15/32,25.29%,PTPN14;PTPN1;BMP4;BCAS3;ICE1;LCP1;TPR;RIPOR1;PCM1;OAZ2;NDEL1;VAMP2;PCNT;CEP131;PLK3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.4710783217339265,-1.1296494394502377,0.32194244604316546,0.55115319975139,1.0,5/11,24.28%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4343722471542461,1.1295550829174048,0.2816593886462882,0.7102290950696775,1.0,6/12,24.40%,GMNN;WRNIP1;NUGGC;KAT7;WDR18;TIPIN
prerank,macrophage differentiation (GO:0030225),-0.4479965460554916,-1.1287924729265368,0.32037037037037036,0.5527824315400629,1.0,3/13,9.60%,IL15;BMP4;CASP8
prerank,positive regulation of DNA binding (GO:0043388),-0.35488863796232833,-1.1286945540895632,0.2846975088967972,0.5526152562624503,1.0,14/31,30.81%,RB1;HES1;NGF;FOXC1;IGF1;SKI;CEBPG;TXN;PPARG;HMGB1;PINX1;TRIM6;PLAUR;TGFB1
prerank,positive regulation of macrophage migration (GO:1905523),-0.39961963006479745,-1.128590766844822,0.31103074141048825,0.5524295069869971,1.0,4/19,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.34910833185218626,-1.1282006825870523,0.2664233576642336,0.5529427069508306,1.0,13/33,28.93%,LYN;ACER2;ADAM9;TGFB2;PTK2;EPHA2;FERMT3;PTPN11;SERPINE1;CYP1B1;ADA;SNAI2;FOXC2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3361582355145271,1.1278315228503089,0.26339285714285715,0.7137282967046312,1.0,16/33,25.83%,DDAH2;OAT;PYCR2;RIMKLA;GLS2;GLS;GLUD1;ART4;NIT2;RIMKLB;DDAH1;MTHFS;ALDH4A1;SIRT4;GCLM;FPGS
prerank,DNA catabolic process (GO:0006308),0.45712153516778226,1.1277959093021273,0.3243847874720358,0.71212533644507,1.0,6/11,23.78%,MUS81;REXO4;DNASE1L1;FBH1;ISG20;DNASE1L2
prerank,regulation of histone acetylation (GO:0035065),-0.3484880150164481,-1.127688067050365,0.2867383512544803,0.5537191923625353,1.0,16/33,30.97%,RPS6KA5;IWS1;SETD5;RUVBL2;TAF7;BRCA1;CHEK1;NOS1;MYOCD;ARRB1;RAPGEF3;HDAC5;GLYR1;SET;SPI1;RPS6KA4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4475290126780158,-1.12700698822395,0.3253424657534247,0.5548973474740346,1.0,5/12,31.57%,RAB27A;PLCG2;ADGRB1;SLC5A3;TLR6
prerank,prostanoid biosynthetic process (GO:0046457),-0.418058684420881,-1.1269753992666964,0.29180887372013653,0.5545706637832418,1.0,10/15,30.65%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,neuromuscular junction development (GO:0007528),-0.3798770085743355,-1.1269503503996199,0.2912280701754386,0.5542238337968531,1.0,7/24,11.74%,UNC13B;PPFIBP1;LRRK2;NEDD4;AGRN;PDZRN3;DCTN1
prerank,gliogenesis (GO:0042063),-0.4266024461369683,-1.1257509094557263,0.3003533568904594,0.5566497679274374,1.0,6/15,18.34%,NFIB;METTL14;TGFB2;CDK6;ANXA1;NDUFS2
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3664591479465233,-1.1254722953628118,0.2772963604852686,0.5569151324404481,1.0,11/25,20.17%,ACVRL1;CORO1C;THBS1;ACE;ROCK1;FAM107A;BCAS3;ROCK2;IKBKB;DUSP22;PTEN
prerank,regulation of synapse maturation (GO:0090128),0.4591398294309578,1.1251199417369668,0.32790697674418606,0.718251019039987,1.0,3/10,6.81%,NRXN1;ANAPC2;CAMK2B
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.29891150019176266,-1.1248319185634268,0.26014760147601473,0.5580389096241487,1.0,22/69,25.92%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E1;GTF2E2;TAF11;ICE1;INTS3;SNAPC1;TAF8;INTS9;PHAX;INTS7;SNAPC3;TAF13;POLR2C;CCNK;TAF9;POLR2L;POLR2H
prerank,ncRNA catabolic process (GO:0034661),-0.36619662018098703,-1.1243620292444014,0.2774774774774775,0.5586954945180161,1.0,10/28,25.26%,TENT4B;XRN1;EXOSC2;EXOSC3;TUT4;PARN;EXOSC8;EXOSC5;DIS3L2;EXOSC7
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.4371179018593719,-1.1241978932219798,0.3037300177619893,0.5586654560516081,1.0,4/13,19.36%,PTPN1;NCK1;ABCA7;DNAJB9
prerank,glycolipid metabolic process (GO:0006664),-0.32165783401182035,-1.123773123822077,0.24954128440366974,0.5592478110955718,1.0,14/47,21.99%,ESYT2;ST3GAL6;ST3GAL4;ST6GALNAC3;ST3GAL2;ARSA;ASAH1;SMPD2;GBA2;GBGT1;GLTP;PIGW;CTSA;GLA
prerank,regulation of postsynapse organization (GO:0099175),0.35547699046136244,1.1233395272111728,0.29148936170212764,0.7218146503626017,1.0,7/28,10.54%,IL1RAPL1;PPFIA2;CDK5;CDKL5;HOMER1;TANC2;ABI2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3538285731165969,-1.1219848382088067,0.30353817504655495,0.5630371335252253,1.0,10/29,25.37%,RPS21;RPS14;NOL10;UTP3;RPS16;DCAF13;UTP4;RRS1;RPS8;WDR46
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3841717462903904,-1.121636854813063,0.3079710144927536,0.5635296887675403,1.0,8/22,17.05%,KANK3;TMSB4X;SLIT2;PRKCD;KANK4;ARFGEF1;HIP1R;TMSB10
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3939750288860107,-1.121613791468169,0.31539888682745826,0.5627600695395897,1.0,13/20,48.73%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4;GSTP1;AKR1A1;GSTA2
prerank,glutathione derivative metabolic process (GO:1901685),-0.3939750288860107,-1.121613791468169,0.31539888682745826,0.5627600695395897,1.0,13/20,48.73%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4;GSTP1;AKR1A1;GSTA2
prerank,regulation of vacuole organization (GO:0044088),-0.3934897620523332,-1.1215457362869357,0.29775280898876405,0.5624918938505475,1.0,4/20,8.79%,ANXA2;MTMR3;RAB5A;TBC1D14
prerank,membrane fusion (GO:0061025),-0.34408620782335586,-1.1214496423631173,0.2800687285223368,0.5622993886627997,1.0,12/33,22.30%,MYOF;DNM3;DYSF;DNM2;RABEP1;CHP1;VAPA;VAMP3;HUWE1;RABIF;VAMP2;HACE1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3217092566206028,-1.1213700931651092,0.2715827338129496,0.5620765167716926,1.0,15/47,22.58%,SPTBN1;EXOC6;STXBP6;EXOC4;GOLPH3L;MACF1;RABEP1;EXOC2;GOLGA4;EXOC8;GOLPH3;VPS35L;KIF13A;VAMP2;ARFGEF2
prerank,regulation of myotube differentiation (GO:0010830),-0.3750206546227233,-1.1213363112411858,0.297153024911032,0.5617453904087163,1.0,11/24,26.59%,SIK1;HDAC1;MAML1;NOTCH1;HDAC4;SMYD1;CCN3;PIEZO1;RBM24;DMPK;HDAC5
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.39542555286633174,-1.1209223504834025,0.3009009009009009,0.5623207663722187,1.0,6/19,15.97%,TENT4B;STN1;XRN1;CTC1;HNRNPA1;TERF2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.27902518561331496,-1.120844672314617,0.24190800681431004,0.5621104116427561,1.0,21/95,10.57%,ST3GAL6;ST3GAL4;ST3GAL1;EXT1;GCNT2;CSGALNACT1;B3GNT2;GPC6;CHST15;NDST1;B4GALT4;SLC10A7;DSE;HS3ST3B1;AGRN;HSPG2;ST3GAL2;CHST11;CSPG4;HS3ST1;BGN
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2871096133663367,-1.120401491430217,0.26881720430107525,0.5627522850326819,1.0,23/86,14.72%,RB1;CLIP1;BAIAP2L1;RAC1;PRKCE;APP;NCK1;TOGARAM1;SNX9;OCLN;EDN1;NCK2;CFL2;PSEN1;FCHSD2;DCTN1;SYNPO2;LMOD1;SLAIN2;DRG1;CDC42EP3;GPX1;NCKAP1
prerank,icosanoid metabolic process (GO:0006690),-0.33165989384975203,-1.1201875361150955,0.28321678321678323,0.5627954631060619,1.0,17/40,32.41%,PLA2G4A;PON2;GGT5;MAPKAPK2;PTGS1;EPHX1;MGLL;GPX1;DAGLB;PTGR1;PNPLA8;CYP1B1;PTGIS;GPX4;TBXAS1;ALOX5AP;ALOXE3
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.36750177396590333,-1.1197976993481886,0.31066176470588236,0.5632740933288393,1.0,5/24,9.39%,WASF2;RAC1;PIK3R1;PLCE1;OCLN
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2947504943611998,-1.1197120306448896,0.23801065719360567,0.5630497976600572,1.0,28/80,29.94%,VTI1A;ERC1;RAB7A;TMEM87B;HEATR5A;VPS54;TBC1D14;BET1L;SNX12;DCTN1;VPS26A;ANKFY1;VPS52;TBC1D23;SNX8;WASHC1;VAMP3;TBC1D17;CLN5;SPAG9;EVI5;RAB9B;RAB6B;VPS35;RBSN;PHETA2;GOSR2;STX5
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.397338697816169,1.1196526497777424,0.31965442764578833,0.731176537551156,1.0,4/16,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,alanine transport (GO:0032328),-0.47381223482199336,-1.119451001577842,0.3241252302025783,0.5632570175872038,1.0,3/10,20.54%,SLC6A6;SLC36A4;SLC1A4
prerank,synaptic vesicle localization (GO:0097479),0.44289202723445686,1.1194227111128636,0.3363431151241535,0.7300911877551551,1.0,4/13,10.15%,NLGN1;CDK5;SYNDIG1;KIF5A
prerank,modulation by symbiont of host process (GO:0044003),0.45699464638299064,1.1194011708586153,0.31494252873563217,0.7284409291524033,1.0,6/10,29.71%,HGS;UBB;MRC1;PGK1;RPS27A;UBC
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.45447870492225895,-1.1189553923702307,0.332703213610586,0.5639843136918371,1.0,3/11,17.00%,SMAD7;RC3H1;ANXA1
prerank,toxin transport (GO:1901998),0.4649830357946387,1.1184515824549675,0.314410480349345,0.7295835622162234,1.0,4/10,12.77%,SLC22A1;SLC29A4;ANTXR1;ANTXRL
prerank,sterol metabolic process (GO:0016125),0.2966778762169029,1.118339470087427,0.2681318681318681,0.7282113674755026,1.0,13/60,9.92%,CYP46A1;INSIG1;PIP4P1;SULT2B1;CYP26B1;CYP51A1;SC5D;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5
prerank,negative regulation of protein transport (GO:0051224),-0.3649625356325816,-1.117897894982086,0.3126050420168067,0.5660124014901843,1.0,12/25,30.35%,RHBDF2;PPM1F;DPH3;SNX12;PKDCC;CSK;WWP2;NDFIP2;SERGEF;HMGCR;RSAD2;RHBDF1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3716846016790955,-1.117469694300678,0.3076923076923077,0.5665634476802035,1.0,6/23,15.68%,CBFA2T3;SIK1;PPARA;GSK3A;HDAC4;C1QTNF3
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.4477867162624943,-1.1173525129378639,0.33269961977186313,0.5664453032837123,1.0,5/12,17.12%,RB1;CTCF;WAPL;AXIN2;CTNNB1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3965697345197098,-1.1167377915654373,0.30601092896174864,0.5674202772681465,1.0,12/19,31.65%,ADK;POLD3;AMPD2;HPRT1;AMPD3;TERT;ADA;PNP;POLL;GMPR2;APRT;DCK
prerank,negative regulation of nuclear division (GO:0051784),-0.45322734558412175,-1.1164530505691805,0.3260135135135135,0.5676740127139008,1.0,7/11,38.89%,BMP4;BMP7;CHEK1;TOM1L2;FBXO5;TOM1L1;AURKAIP1
prerank,positive regulation of translational initiation (GO:0045948),-0.40243995022819784,-1.1159866163548815,0.27863247863247864,0.5683554800543721,1.0,5/18,12.82%,DDX3X;MTOR;LARP1;POLR2G;CDC123
prerank,regulation of chemotaxis (GO:0050920),-0.35764765030421475,-1.1159146318522335,0.30412371134020616,0.5680986853072642,1.0,11/30,30.81%,ADGRA2;THBS1;STX3;PPM1F;DUSP3;CCL19;ZSWIM6;PDGFRB;PTPN2;TREM2;TGFB1
prerank,tRNA metabolic process (GO:0006399),-0.40565663494611637,-1.1158860892017874,0.33810375670840787,0.5677569472094505,1.0,8/17,36.94%,FARS2;DARS2;TRPT1;RPP30;SSB;DTD2;SARS1;THG1L
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3831501963173432,-1.1155815866879844,0.30996309963099633,0.5676685277952672,1.0,8/23,14.96%,PPP1R13B;YWHAE;YWHAZ;NMT1;CASP8;TP53;MAPK8;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3831501963173432,-1.1155815866879844,0.30996309963099633,0.5676685277952672,1.0,8/23,14.96%,PPP1R13B;YWHAE;YWHAZ;NMT1;CASP8;TP53;MAPK8;BBC3
prerank,regulation of pseudopodium assembly (GO:0031272),-0.46511837638358927,-1.1155291915025602,0.3339382940108893,0.5669830563990655,1.0,9/10,50.28%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2;F2RL1;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.46511837638358927,-1.1155291915025602,0.3339382940108893,0.5669830563990655,1.0,9/10,50.28%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2;F2RL1;CDC42
prerank,cell junction maintenance (GO:0034331),0.4291783150256188,1.1154316016386943,0.3258426966292135,0.7354625282749848,1.0,7/14,24.93%,CD177;CBLN1;CSF1R;NLGN2;PARD6A;CBLN2;CLDN1
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.29960728839155276,-1.1154292979212064,0.2620817843866171,0.5668188413468696,1.0,29/68,32.11%,SLC2A1;PANK2;SLC25A32;SLC5A6;SLC19A2;MTHFD1;PDXK;RFK;AOX1;SLC52A1;SLC52A3;LMBRD1;MTHFD1L;PCCA;PCCB;GSTO2;CUBN;ALDH1L1;MTRR;PNPO;MTR;SHMT1;SLC19A3;SLC2A3;VNN1;HLCS;SLC25A19;SLC23A1;SLC23A2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.311286553896507,-1.1152055431595083,0.2805755395683453,0.5669343618461277,1.0,14/51,17.12%,NEK7;TENT4B;STN1;ATM;XRN1;TCP1;MAPK1;HMBOX1;CTC1;PNKP;PARN;HNRNPA1;TERF2;CTNNB1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.3646625710809325,-1.1150512256605438,0.32094594594594594,0.566875382514064,1.0,12/24,27.93%,MTHFD1;TXN2;MSRA;NOX4;CDO1;CTH;ADO;GCLC;MTRR;MPST;AHCY;MTR
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.37616404928435887,-1.1147835670782689,0.28842832469775476,0.5671001484522412,1.0,5/22,7.85%,PDGFD;DDX3X;ACE;RASSF2;MRE11
prerank,negative regulation of heart contraction (GO:0045822),0.4602680895174289,1.1145229061039483,0.32142857142857145,0.7364681676556539,1.0,3/11,12.08%,ATP1A2;SPTBN4;SRI
prerank,toll-like receptor signaling pathway (GO:0002224),-0.28320970185565286,-1.1144662575524171,0.23885918003565063,0.5674676892950018,1.0,34/84,36.11%,TAB3;BIRC3;NMI;LBP;MAPKAPK2;PLCG2;CASP8;UBE2D3;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;IKBKG;IKBKB;ITGAM;RIPK1;HMGB1;MAP3K7;TNIP1;LGALS9;PIK3AP1;TICAM1;TLR6;RFTN1;TNIP2;SCARA3;TLR1;TLR5;CD14;S100A9;TLR2;TLR8
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3218598403921417,-1.1144637048844457,0.26666666666666666,0.5670678199707119,1.0,8/43,8.09%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2
prerank,nucleic acid-templated transcription (GO:0097659),-0.32395327598421997,-1.1142571031834627,0.2804232804232804,0.567110849430887,1.0,16/42,26.97%,MEF2A;THRB;POLR2G;PWP1;TAF1B;DRG1;CREBL2;RNPS1;TERT;PTMA;MED20;POLR2C;POLR2L;MLF1;POLR2H;MMS19
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.4121663305290605,1.1141981491037931,0.3049040511727079,0.73574859359541,1.0,4/15,4.83%,KCNA5;KCNJ3;KCNN2;ATP1B1
prerank,negative regulation of autophagy (GO:0010507),-0.3105225103834331,-1.1140872987159625,0.2824156305506217,0.5671228948262336,1.0,13/54,16.41%,MCL1;TAB3;TLK2;ATG7;LRRK2;MTOR;RASIP1;TBC1D14;DAPL1;AKT1;HGF;DAP;TAB2
prerank,spindle assembly (GO:0051225),-0.30417611314083604,-1.113974986697905,0.27140255009107467,0.5669813286857591,1.0,21/67,22.31%,NEK7;NEK6;STAG1;CCDC61;TOGARAM1;WRAP73;HAUS8;FLNA;RHOA;CSNK1D;ARHGEF10;HAUS6;STAG2;KIF11;TUBGCP4;RAB11A;TUBGCP5;RPS3;KIF3B;STARD9;MISP
prerank,regulation of cytoplasmic transport (GO:1903649),-0.46055050773050876,-1.113612613184466,0.3285968028419183,0.5674384647590741,1.0,3/11,8.04%,DNAJC13;LRRK2;MAPK1
prerank,response to UV-B (GO:0010224),0.44194944137822023,1.1136067927009152,0.32894736842105265,0.7357595794211833,1.0,3/12,9.74%,MME;STK11;IL12A
prerank,embryonic axis specification (GO:0000578),-0.4193234257422838,-1.113596470774831,0.30280373831775703,0.567079063850485,1.0,9/15,33.99%,SMAD2;TASOR;SMAD6;TBX3;FZD5;RIPPLY2;PTCH1;WNT7A;HOXD8
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.40741175224543413,-1.1131620112136436,0.3120567375886525,0.5676778639466143,1.0,7/19,12.27%,TGFBR3;VGLL4;RBP4;MEF2C;TBX2;NOTCH1;FGF2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.46432917600509516,-1.113114031746692,0.32899628252788105,0.5673985545235958,1.0,6/10,35.09%,TNFRSF1B;NOTCH1;TNFRSF1A;EMILIN1;TGFB1;FAP
prerank,positive regulation of immune effector process (GO:0002699),-0.3654662249103583,-1.1130785563224252,0.2906764168190128,0.5670725498683402,1.0,5/27,11.08%,ANKRD17;PTPRJ;LBP;MYO18A;DDX60
prerank,regulation of cell growth (GO:0001558),-0.2504726635069532,-1.112971655947483,0.1989795918367347,0.5668999482672198,1.0,67/204,25.54%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;NET1;DDX3X;MTOR;PTPRJ;SOX17;EGFR;TFRC;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;PLCE1;RASGRP2;EXOSC2;SMAD4;MFSD2A;FAM107A;BCAR1;ADAM10;AKT1;SOCS2;TP53;AGTR1;RPTOR;ARHGEF11;DCBLD2;LTBP4;RPS6KA1;CEACAM1;WNT11;ST7L;RPS6KA3;H3-3A;CCN3;N6AMT1;RERG;MAD2L2;NPR1;KIF26A;OSGIN2;HYAL2;BAP1;BRAT1;PPP2CA;CDK11B;BCL6;DCUN1D5;CDKN2C;CAPRIN2;FHL1;MTPN;MSX1;SERTAD2;HSPA1B;GNG4;INO80;APBB1;SIPA1;SERTAD3
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3562019715493446,1.1129515643405665,0.31346578366445915,0.7360667754972788,1.0,9/27,19.08%,HPCA;CALM2;CACNB3;CACNB4;ADRA2A;HRC;SELENON;CACNB1;PDE4D
prerank,macrophage chemotaxis (GO:0048246),0.4524813375309197,1.1128891624269828,0.3238512035010941,0.7345583739981975,1.0,4/10,18.23%,CXCL17;CCL5;CCL2;EDNRB
prerank,cellular response to oxygen levels (GO:0071453),0.45506628079757133,1.1125267996676589,0.3333333333333333,0.7340032986118784,1.0,4/10,19.06%,CCDC115;ATP6V0A2;ATP6V0D1;ATP6V1A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3638947810894484,-1.11244784485015,0.30902111324376197,0.5676536258333426,1.0,15/26,36.90%,RB1;NEK6;CUL3;CDC16;NSMCE2;CENPE;ANAPC7;DUSP1;ANAPC11;ANAPC5;PLK1;CDC6;ESPL1;UBE2C;FBXO5
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4497375658297488,-1.1123396914172525,0.3387096774193548,0.567504352992077,1.0,3/11,11.47%,JAK1;IL6ST;JAK2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.31971171664493575,1.1122637153388408,0.2693156732891832,0.7331175284565927,1.0,9/44,13.40%,AKR1D1;CYP46A1;INSIG1;SC5D;OSBPL6;SQLE;CYP27A1;ALOX12;OSBPL9
prerank,negative regulation of protein processing (GO:0010955),-0.45040925350628813,-1.1119817930883868,0.34,0.567956722546514,1.0,6/12,22.81%,THBS1;LRRK2;SNX12;CTSZ;SERPINE2;SERPINE1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.41340716004756445,1.111942476728966,0.3196125907990315,0.7323436536332416,1.0,5/14,9.22%,PPP2R2B;PPP5C;PPP2R2C;PPP3CA;PPTC7
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3179023825564473,-1.111437243859604,0.27387387387387385,0.5688172437111353,1.0,17/49,25.59%,MAP3K20;ACER2;ATM;ABL1;CLSPN;TP53;DOT1L;NDRG1;GRB2;USP10;MAD2L2;ATRX;CHEK1;GADD45A;INTS7;E2F7;ERCC6
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.4554434364727932,-1.1112178590079842,0.3152804642166344,0.5689118449112561,1.0,10/11,50.72%,SMAD7;HFE;CEACAM1;PTPRC;LILRB1;AHR;KLRD1;FOXP3;XCL1;KLRC1
prerank,negative regulation of bone remodeling (GO:0046851),0.45038697336603184,1.1111733373364234,0.32882882882882886,0.7330212408881605,1.0,2/11,3.45%,CARTPT;CALCA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.47080708302811336,-1.1110606533570724,0.33212996389891697,0.5688630319505632,1.0,4/10,17.32%,SP100;TP53;KAT5;TFAP4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.4037332397828175,1.1108446776160423,0.31839622641509435,0.7323077711259199,1.0,3/17,6.22%,ANK3;AKAP6;RNF207
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.42801648930039243,-1.110214447880004,0.3370165745856354,0.5705081256204771,1.0,4/13,15.78%,SHANK3;APP;LGMN;ADCY1
prerank,neuron projection fasciculation (GO:0106030),0.4527032278433706,1.1101833820947429,0.32873563218390806,0.7327116401111814,1.0,3/10,8.65%,CNTN4;NRCAM;RTN4
prerank,negative regulation of inflammatory response (GO:0050728),-0.2549260613425144,-1.1098841615429451,0.22950819672131148,0.5709036872233216,1.0,37/182,16.68%,TEK;GNB1;RB1;CALCRL;KLF4;MYH9;MFHAS1;LYN;CD200;PRKACB;ADCY9;RAMP1;PLCG1;YES1;PPARA;TNFRSF1B;GGT5;OTULIN;PRKCD;CDH5;PLK2;RHBDF2;ADCY4;PPARD;PLCG2;RAMP2;FEM1A;ADM;CYSLTR2;TNFAIP3;IAPP;CCN3;C1QTNF3;ADCY1;TNFRSF1A;IGF1;FYN
prerank,B cell differentiation (GO:0030183),-0.31740015166743535,-1.1097241006052632,0.2828096118299446,0.5708616659054375,1.0,18/46,26.59%,ITGB1;PTPRJ;ZBTB7A;PLCG2;TPD52;HDAC4;ITGA4;NHEJ1;TCF3;VCAM1;CEBPG;CLCF1;PTPRC;DNAJB9;GPS2;PTPN2;ADAM17;HDAC5
prerank,ephrin receptor signaling pathway (GO:0048013),-0.28685491906037963,-1.1094528878346777,0.2712765957446808,0.5710749047094485,1.0,32/82,22.47%,ANKS1A;RAC1;LYN;ARHGEF28;CRK;MMP2;YES1;AP2B1;AP2A2;PSEN2;CHN1;PTK2;AP2S1;WASL;ITSN1;ROCK1;EPHA4;NCK2;PSEN1;RASA1;RHOA;ACTB;ROCK2;ARPC4;FYN;APH1A;EPHA2;AP2M1;PTPN11;VAV2;EPHB6;EPHB3
prerank,acute inflammatory response (GO:0002526),-0.3754361952011624,-1.109434190791817,0.3087971274685817,0.5707122496066842,1.0,13/23,37.59%,IL6R;LBP;ANO6;PLSCR1;CTNNBIP1;F3;IL22;AHSG;VNN1;CEBPB;HPR;HP;CRP
prerank,regulation of mitotic spindle organization (GO:0060236),-0.33464548229976315,-1.1093585195138982,0.29009009009009007,0.5704882937410414,1.0,23/35,40.84%,RAE1;CHMP4B;DCTN1;DRG1;CHMP2B;TPR;CHMP5;TACC3;PDCD6IP;HSPA1B;CHMP3;HNRNPU;CCSAP;BORA;CHMP1A;MAP9;PARP3;PLK1;PSRC1;CHMP1B;TPX2;CEP97;CLTC
prerank,regulation of chemokine production (GO:0032642),-0.33703580469294236,-1.1092292990666894,0.30241187384044527,0.5703937775087748,1.0,24/36,48.16%,FOXP1;APP;IL6R;LPL;ACKR1;IL7;ADAM17;LGALS9;SNAI2;HMOX1;TREM2;TSLP;CD74;TLR2;HIF1A;IL18;SIGIRR;TLR4;TNF;IL6;TLR3;AGER;F2RL1;WNT5A
prerank,protein N-linked glycosylation (GO:0006487),-0.29976897307886435,-1.1082507807740407,0.286231884057971,0.5722250459368824,1.0,18/66,16.93%,ST3GAL1;ALG14;ST6GAL1;ALG10B;MAN1C1;DAD1;MGAT4B;GFPT2;FUT8;SLC39A8;ALG12;ALG8;OST4;ALG11;DOLPP1;ALG13;UGGT1;MGAT2
prerank,regulation of transmembrane transport (GO:0034762),-0.35298041923031287,-1.1082404960615246,0.2920517560073937,0.5718375295381228,1.0,13/31,26.89%,SLC2A1;NEDD4L;KCNJ2;NEDD4;OCLN;ACTB;CTTNBP2NL;KCNJ8;WWP2;PIM1;TRIB3;ACE2;KCNJ13
prerank,visual system development (GO:0150063),-0.33180742322401646,-1.1080036021010566,0.30892857142857144,0.5719972866315508,1.0,14/37,23.20%,PBX1;SH3PXD2B;SMOC1;PBX3;TGFB2;RBP4;SIPA1L3;FOXC1;FREM2;HIPK1;PBX2;ITGAM;CHRDL1;ATF6
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.3790863937693717,-1.1078692878753436,0.3432282003710575,0.5719270144643046,1.0,5/21,11.89%,MITF;MED1;JUN;MED13;MED17
prerank,cellular response to leucine starvation (GO:1990253),-0.4694281009639658,-1.107074554514164,0.3452830188679245,0.5733312098855213,1.0,4/10,16.82%,SESN1;MTOR;LARS1;GCN1
prerank,cardiac muscle cell differentiation (GO:0055007),0.365466555757477,1.1070741406684235,0.3296943231441048,0.7404627077504505,1.0,8/21,14.85%,NRG1;WT1;CXADR;ALPK3;IRX3;VEGFA;SLC8A1;CBY1
prerank,mRNA catabolic process (GO:0006402),-0.3152259797227049,-1.106665605621195,0.2761061946902655,0.5738914044404528,1.0,15/44,29.28%,TUT7;XRN1;ERN1;XRN2;TUT4;PDE12;RC3H1;NUDT12;DIS3L2;METTL16;THRAP3;HSPA1B;DXO;LSM2;NBDY
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.39011754130597676,-1.1066080807742196,0.3363148479427549,0.5736281084342844,1.0,3/19,6.73%,PPARA;IRS1;PRKCD
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4449349385394035,-1.1061109741609387,0.31910946196660483,0.574354948176667,1.0,3/12,8.54%,PRKD2;NIPBL;PRKD1
prerank,cellular response to metal ion (GO:0071248),0.2574198403141929,1.106102351058844,0.23234624145785876,0.741528850654946,1.0,23/123,12.35%,NLGN1;SYT1;SYT5;DLG2;ANK3;RYR3;ADCY8;SYT12;SYT11;GLRA1;HPCA;HSF1;CPNE9;DPEP1;SCN5A;ACER1;ADCY7;CPNE1;CYP11B1;ATP13A2;SYT4;GPLD1;DLG4
prerank,androgen receptor signaling pathway (GO:0030521),-0.45169496867399167,-1.1054077549837005,0.35701906412478335,0.5756207540159589,1.0,5/11,29.32%,ZMIZ1;KDM3A;PMEPA1;PLPP1;RNF14
prerank,regulation of muscle contraction (GO:0006937),0.3527946605343622,1.1052285608890398,0.3053097345132743,0.7425236891452627,1.0,6/26,12.61%,CHRM2;ATP1A2;TNNC1;NMUR2;SRI;MYL2
prerank,cellular response to cAMP (GO:0071320),-0.35789946566821945,-1.1050401696360916,0.32264150943396225,0.5760896316682269,1.0,14/30,26.05%,RAPGEF2;PKD2;PDE2A;KCNQ1;RAP1A;EZR;RAP1B;RAPGEF1;IGFBP5;SLC5A5;AKAP9;RAPGEF3;DMTN;ZFP36L1
prerank,midbody abscission (GO:0061952),-0.40477589401927294,-1.1048581479608492,0.3486238532110092,0.576107608182099,1.0,11/17,36.37%,CHMP4B;CHMP4A;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A;CHMP1B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3389388264362081,-1.1047332893347481,0.31663685152057247,0.5759806208105424,1.0,13/32,28.41%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,positive regulation of interferon-beta production (GO:0032728),-0.3448541058308057,-1.1045829881273335,0.31841652323580033,0.5759222307404598,1.0,18/33,36.11%,IFIH1;TRIM56;DDX3X;IRF1;FLOT1;POLR3F;MAVS;PTPN11;HSP90AA1;DHX9;IRF7;RIOK3;TOMM70;IRF5;POLR3A;TBK1;TLR2;TLR8
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.35770466418622654,-1.103917420155512,0.31204379562043794,0.5770715431626611,1.0,14/30,34.60%,BIRC3;CASP8;UBE2D3;IKBKE;CD40;IKBKG;IKBKB;RIPK1;IRF7;CD300LF;TICAM1;TLR6;CD14;TBK1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.29284250149270985,-1.1038688425871426,0.2558983666061706,0.5767924151657774,1.0,23/73,24.95%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,macromolecule catabolic process (GO:0009057),-0.36849286338544834,-1.1038653434141215,0.3129496402877698,0.5763984015579094,1.0,15/26,36.35%,SMURF1;MTOR;NEDD4;USE1;LGMN;SIAH1;CLN5;SNX25;KIF16B;BECN1;PPT1;TGFB1;CLPX;CLN6;TRIM24
prerank,aminoglycan metabolic process (GO:0006022),0.4549701015952257,1.1037698964666127,0.3400447427293065,0.7453005288409299,1.0,4/10,17.72%,B4GALT7;CHST9;B3GAT1;GAL3ST3
prerank,sensory perception of pain (GO:0019233),0.38705834095880776,1.1033448224876827,0.3159041394335512,0.7448734760850133,1.0,3/21,4.61%,OPRM1;MME;KCNA2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3362808182767022,-1.1026574085502572,0.30915371329879104,0.5788936396531418,1.0,8/36,12.19%,GHR;CAV1;CENPJ;CRLF3;HES1;DOT1L;JAK2;NOTCH1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.42070285534501645,1.102654571628087,0.3393665158371041,0.745278879203459,1.0,6/12,18.37%,EML2;ARHGEF7;MAP2;STMN2;MAPRE1;TUBB4A
prerank,regulation of interleukin-12 production (GO:0032655),-0.31909711256076373,-1.1015606438658716,0.30824372759856633,0.5809621478264807,1.0,9/47,18.45%,FOXP1;THBS1;MAST2;PLCB1;PLCG2;CD40;IL16;CMKLR1;CCL19
prerank,zinc ion transmembrane transport (GO:0071577),-0.38033711971904216,-1.1012931362879255,0.32124352331606215,0.5811837041099513,1.0,7/22,20.73%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,CENP-A containing chromatin organization (GO:0061641),0.33809399173082993,1.1012417074714216,0.311804008908686,0.7462230210783093,1.0,10/29,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.33809399173082993,1.1012417074714216,0.311804008908686,0.7462230210783093,1.0,10/29,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.45908183794645957,-1.1010987514293196,0.3244206773618538,0.5812334062647332,1.0,2/10,1.62%,ENG;CAV1
prerank,regulation of programmed cell death (GO:0043067),-0.2563741927523462,-1.100924451570343,0.2339688041594454,0.5812441589648416,1.0,30/161,13.04%,MECOM;HIP1;PPP1R13B;CREBBP;DAPK1;ACER2;ATM;LRRK2;BIRC3;RARG;ABL1;ZBTB7A;FAS;STEAP3;BNIP3;TGM2;RAF1;HAX1;BCAR1;AKT1;TP53;CRADD;PERP;JAK2;ACER3;TM7SF3;ACTN1;ACTN4;NDRG1;RTKN
prerank,C-terminal protein amino acid modification (GO:0018410),0.45104846249797487,1.100904332465403,0.33649289099526064,0.7455251597778549,1.0,3/11,12.14%,AGBL4;AGBL1;GPLD1
prerank,response to tumor necrosis factor (GO:0034612),-0.27786764801692265,-1.1008726364324248,0.2639138240574506,0.5809546640852443,1.0,30/91,26.05%,DAB2IP;CCL25;MAP4K3;ADAM9;GGT5;GCH1;ARHGEF2;CASP8;ADAM10;AKT1;JAK2;CD40;ZFAND6;ASAH1;GSDME;IGBP1;RPS3;CCL19;IKBKB;HYAL2;BRCA1;NFE2L2;RELA;RIPK1;HAS2;GBP3;ADAMTS7;DHX9;ERBIN;ZFP36L1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.32590864209958137,-1.1002634649703773,0.3142857142857143,0.5819530297390747,1.0,15/41,26.42%,PLA2G4A;ELOVL5;PTGS1;GSTM2;EPHX1;MGLL;GPX1;ACOX1;ACSL1;DAGLB;DEGS1;PTGR1;PNPLA8;CYP1B1;GPX4
prerank,macrophage migration (GO:1905517),0.42358919496608155,1.100194902423086,0.33185840707964603,0.7460054867399878,1.0,4/13,18.23%,CXCL17;CCL5;CCL2;EDNRB
prerank,regulation of viral transcription (GO:0046782),-0.32571568856680033,-1.0997621849490171,0.3193430656934307,0.5827657149914308,1.0,20/39,33.94%,UBP1;POLR2G;MDFIC;TRIM14;IFITM3;TRIM13;NELFB;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;LARP7;TRIM32;TRIM62;NELFA;NELFCD;POLR2E;TARBP2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4427401518509008,1.0993492972474002,0.3192389006342495,0.7468203282756161,1.0,2/11,0.95%,ANK3;BLK
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2759879027819343,-1.0991752071383003,0.27164685908319186,0.5836971210657448,1.0,20/91,11.99%,HIP1;RUFY1;DNAJC13;PTPN1;STON1;RNF139;LRRK2;PLD1;RAB5B;ABL1;AP2S1;MAPK1;RAB5A;SCFD1;SCARB1;PICALM;RAB4B;BET1L;SNX12;RAB8B
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.46566787292335693,-1.0987599265222878,0.3672014260249554,0.5838752950708077,1.0,3/10,3.58%,NFAT5;NFATC1;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.46566787292335693,-1.0987599265222878,0.3672014260249554,0.5838752950708077,1.0,3/10,3.58%,NFAT5;NFATC1;NFATC4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.44755936856923073,-1.0986270663384194,0.3594306049822064,0.5837979942991303,1.0,3/12,16.34%,GCNT2;FLOT1;BMP7
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3253171615648601,-1.0985855792321182,0.31835205992509363,0.5834861665331005,1.0,13/40,20.28%,MCL1;ABL1;PRKCD;IER3;WDR76;KMT5A;FEM1B;UBE2V2;RFWD3;ARMT1;RPA2;USP1;NSMCE4A
prerank,protein targeting to membrane (GO:0006612),-0.2836425038206609,-1.098517607923824,0.27964601769911507,0.5832318494680533,1.0,35/83,36.63%,PARD3;ZDHHC6;ZDHHC3;AQP11;ABCD3;SRPRA;CHMP4B;CHMP4A;RAB8B;SGTA;PEX14;SRP14;SIL1;ZDHHC1;ZDHHC4;PEX3;ZDHHC12;RAB3IP;SEC61A1;ATG3;VPS37B;PEX11B;PEX19;RTP4;GOLGA7B;ZDHHC9;SEC63;PEX26;ZDHHC22;SRP19;NCF1;VPS37C;ICMT;YIF1B;RABGEF1
prerank,organelle assembly (GO:0070925),-0.23305538436580173,-1.0979129523202384,0.19063545150501673,0.5843196834882612,1.0,95/385,21.53%,ABCC4;ABLIM1;PGM5;EXOC6;ASAP1;NEK7;CD34;PARVA;ATG7;CENPJ;FNBP1L;RAB7A;SH3PXD2B;EXOC4;DDX3X;RAB1A;NEK6;MAP1LC3B;EHD2;PTPDC1;LIMD1;CCDC61;SSX2IP;TMOD3;AMBRA1;CEP250;HPS4;IRGM;E2F4;IFT140;CDC14A;OGFOD1;WDR11;RAB11FIP3;EXOC2;PDE6D;HAUS8;CHMP4B;CHMP4A;FLNA;WIPI1;POGZ;GABARAP;PRRC2C;EHD1;WDR35;GALNT11;RAB8B;NOTCH1;IFT52;LMOD1;CSNK1D;VTA1;CHMP2B;CFAP44;ULK2;HAUS6;RAB23;ZFYVE1;TRAF3IP1;VPS36;CEP41;RC3H1;RAB32;EXOC8;ATG5;FUZ;TUBGCP4;DZIP1L;NUDCD3;EHD4;CHMP5;RAB11A;TUBGCP5;HDAC6;DBNL;CFAP298;EDC3;PLK4;PCM1;STX12;RPS3;TMEM17;CENPE;KIF3B;IFT43;EMC6;GORASP2;WDR45B;PDCD6IP;KIF27;ATG16L2;IFT20;STARD9;LSM3
prerank,regulation of endopeptidase activity (GO:0052548),0.29351163740333275,1.0976705986890314,0.26401869158878505,0.750156619570884,1.0,11/59,12.71%,VTN;SPOCK3;SPOCK1;PRELID1;SERPIND1;TIMP1;A2ML1;ATP13A2;SERPINA2;SERPING1;FETUB
prerank,snRNA transcription (GO:0009301),-0.29055957016302086,-1.0975764866704758,0.2987249544626594,0.5846711252136272,1.0,22/70,25.92%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E1;GTF2E2;TAF11;ICE1;INTS3;SNAPC1;TAF8;INTS9;PHAX;INTS7;SNAPC3;TAF13;POLR2C;CCNK;TAF9;POLR2L;POLR2H
prerank,neutrophil mediated immunity (GO:0002446),-0.22910149148031866,-1.0974433754932313,0.1901639344262295,0.584560241383682,1.0,102/432,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;KMT2E;DDX3X;DIAPH1;ANXA3;PTPRJ;ACE;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,insulin secretion (GO:0030073),0.376312426373111,1.0972925732663372,0.3378684807256236,0.7495761376764444,1.0,2/19,1.46%,RIMS2;PTPRN2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.3126744786133052,-1.0970286904909412,0.2962962962962963,0.5851282235055143,1.0,16/48,25.53%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;AGPAT4;DGKZ;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3837573295716976,-1.0968593986832673,0.3414179104477612,0.5851685805725215,1.0,7/20,15.61%,THBS1;PRKD2;DSTYK;FGF2;SPRY4;FGFBP3;SMOC2
prerank,regulation of phagocytosis (GO:0050764),-0.30437537613663607,-1.0965534955155072,0.2864864864864865,0.585472998861796,1.0,14/53,19.32%,IL15;MERTK;DYSF;GAS6;TGM2;RAB27A;SCARB1;PLSCR1;ABCA7;PIP4P2;LMAN2;TULP1;GATA2;PTPRC
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.38453788526666344,-1.096252799089834,0.3532608695652174,0.5858381769695238,1.0,4/19,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,phagosome acidification (GO:0090383),0.3502277950852978,1.0956815565370717,0.33182844243792325,0.7527388204479465,1.0,10/26,19.06%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3818624037973192,-1.0955699827744203,0.34183673469387754,0.587022066694094,1.0,11/18,30.65%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;HPGDS;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3512364188906034,-1.0955537315186503,0.325,0.5866525641964346,1.0,11/29,27.03%,CBFB;ESR1;STRN3;YAP1;UFM1;CARM1;WBP2;BRCA1;SRARP;CNOT2;CNOT1
prerank,regulation of cell division (GO:0051302),-0.2895995713446342,-1.0954901208868213,0.298932384341637,0.5864135198255416,1.0,22/72,25.29%,MLLT3;SETD2;AHCTF1;ZFYVE26;FGF1;RAB11FIP3;PLK2;BIRC6;TAL1;KLHL13;TXNIP;RAB11A;PLK4;CETN2;CDK2AP2;PRC1;BLM;KIF13A;BECN1;KIF18B;TLE6;PLK3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3753700790032817,-1.095345603479114,0.33562822719449226,0.5863587033628707,1.0,12/21,36.90%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13;PLK1;CDC20;FBXO5
prerank,keratinocyte differentiation (GO:0030216),-0.35869506239147475,-1.0948926960966572,0.31896551724137934,0.5869963860864582,1.0,9/29,19.29%,BCR;ADAM9;MED1;WNT16;TXNIP;JAG1;ASAH1;ANXA1;EPHA2
prerank,epithelial cell migration (GO:0010631),-0.3308326649995318,-1.0943395772806521,0.32051282051282054,0.5879526275083715,1.0,11/37,15.17%,NOS3;ADGRA2;PLEKHG5;PXN;ABL1;PLXND1;ROCK1;STARD13;RHOA;PKN2;PKN3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3651938118633541,-1.0934699168941857,0.3259668508287293,0.5896312260998123,1.0,6/25,15.35%,HIP1;AFAP1L2;CBL;AKT1;ARAP1;HIP1R
prerank,regulation of plasminogen activation (GO:0010755),0.4309474309995752,1.0932569346254708,0.33175355450236965,0.7584319057545493,1.0,3/12,7.09%,MELTF;CLEC3B;PLGRKT
prerank,negative regulation of ossification (GO:0030279),-0.36708246156046753,-1.0926321247969661,0.36,0.5912223553159527,1.0,6/23,15.62%,SRGN;TRPM4;MEF2C;NOTCH1;BCOR;SMAD6
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.43534226944089616,-1.0926257168519973,0.37163375224416517,0.5908369873066293,1.0,4/13,14.14%,GNAI3;LRRK2;RHOQ;RAB23
prerank,brain morphogenesis (GO:0048854),0.4207247302717825,1.0926176791466267,0.3142857142857143,0.7587469355256096,1.0,6/12,16.59%,CTNNA2;PAX2;BBS4;SLC6A4;MKKS;BBS2
prerank,cell junction organization (GO:0034330),-0.29056652372150343,-1.0923019707007742,0.289198606271777,0.5912194643178813,1.0,18/71,12.61%,TJP1;APBB2;FERMT2;PPFIBP1;LIMS2;LIMS1;APP;TGFB2;PPFIA1;TJP2;AGRN;OCLN;FLNA;ILK;PSEN1;RAB8B;RHOA;ACTB
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4207697693770761,1.0916906750619706,0.3405639913232104,0.7599255005567324,1.0,4/13,8.21%,KCNA5;KCNJ3;KCNN2;SCN5A
prerank,macroautophagy (GO:0016236),-0.26436008005525574,-1.0916414479596057,0.27545909849749584,0.5923673519000877,1.0,51/118,36.25%,LIX1L;MTMR3;ATG7;ATG10;MAP1LC3B;PIP4K2A;AMBRA1;PIP4K2B;TECPR1;CHMP4B;CHMP4A;TOMM40;PRKAA1;WIPI1;GABARAP;FUNDC1;VTA1;CHMP2B;ZFYVE1;VPS36;ILRUN;ATG5;TOMM5;LAMP2;HDAC10;KLHL3;PRKAB1;PLEKHM1;BECN1;STAM2;VPS39;TOMM20;CHMP3;DYNLL1;ATG3;VPS37B;TOMM70;LIX1;CHMP6;ARL8B;VAMP8;TCIRG1;YOD1;WIPI2;TOMM6;GABARAPL2;VPS37C;VCP;MTMR14;CSNK2A1;CSNK2A2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.2874164802901305,-1.0915945051768234,0.3026086956521739,0.5920686743704306,1.0,25/72,26.54%,RBFOX2;SPRED2;CEP57;CBL;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;GRB2;HNRNPA1;FLRT2;FGFR4;PTPN11;KIF16B;FRS2;POLR2C;POLR2L;POLR2H;FLRT3;FGF10
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3339246260895225,-1.0915570650523994,0.325,0.591750479123237,1.0,12/35,18.65%,HIP1;RAC1;LDLRAP1;CBL;AAK1;PICALM;HFE;FLOT1;PIK3CB;HIP1R;CCL19;MKLN1
prerank,hyaluronan metabolic process (GO:0030212),-0.3543579513436851,-1.091408526349591,0.33815551537070526,0.5917192468341261,1.0,11/23,31.99%,CEMIP2;FGF2;CHP1;HAS1;HYAL2;LYVE1;HAS2;HEXA;HYAL3;TGFB1;CEMIP
prerank,cellular response to amino acid starvation (GO:0034198),-0.28922237328573863,-1.0912886371110762,0.27927927927927926,0.5916102010682497,1.0,26/71,27.17%,SESN1;MAP3K5;MTOR;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;DAP;CASTOR1;GCN1;RNF152;ITFG2;ATP6V1H;EIF2AK3;RHEB;EIF2AK4;ATP6V0E2;WDR24
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.36353512600574955,-1.0911508073201637,0.3430034129692833,0.5915505784391695,1.0,11/24,26.84%,GHR;CENPJ;CRLF3;HES1;JAK2;NOTCH1;IL10RB;PTK2B;OCIAD2;CYP1B1;F2R
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.34675834760944063,-1.0908963384977317,0.3432574430823117,0.5917286071398037,1.0,10/30,16.38%,LYN;SHOC2;NGF;TGM2;NOTCH2;RAPGEF1;JAK2;NOTCH1;GRB2;IGF1
prerank,negative regulation of defense response (GO:0031348),-0.2810653895636857,-1.0906591683412183,0.2998204667863555,0.5918943084607888,1.0,18/77,15.91%,TEK;RB1;KLF4;MFHAS1;PPARA;OTULIN;NMI;PRKCD;CDH5;PPARD;PPM1B;FEM1A;TRAF3IP1;TNFAIP3;ILRUN;CCN3;C1QTNF3;TNFRSF1A
prerank,organophosphate biosynthetic process (GO:0090407),0.32075601638046486,1.0905140011766434,0.31756756756756754,0.7618176184481525,1.0,8/37,11.40%,ITPKA;FADS1;TKT;TPI1;GK;IP6K2;IPPK;GNPAT
prerank,axonal transport of mitochondrion (GO:0019896),0.439977861183894,1.0903835181586279,0.35320088300220753,0.7605791283082564,1.0,7/11,25.16%,SYBU;MAPT;NEFL;TRAK2;HAP1;SPAST;ACTR10
prerank,organophosphate catabolic process (GO:0046434),0.44159306630494694,1.0902799127392415,0.3511777301927195,0.7592279569820214,1.0,1/11,1.48%,ENPP2
prerank,cellular response to organic substance (GO:0071310),-0.26183618795728275,-1.0900893825610145,0.30067567567567566,0.5928664323775245,1.0,21/116,10.11%,LEF1;GHR;ACVRL1;NFAT5;PTPN14;KLF4;BMPR2;RAMP1;LRRK2;PTPN9;LDLRAP1;TIPARP;EMD;PTPN12;TGFBR2;SLIT2;ARL6IP5;ACVR2A;HAX1;RAMP2;SOCS2
prerank,regulation of multicellular organismal development (GO:2000026),-0.3683718824184481,-1.0900238680384815,0.3542039355992844,0.5926052428713839,1.0,5/25,10.19%,INSR;SOX17;NIPBL;TRIP12;EHMT1
prerank,negative regulation of translational initiation (GO:0045947),-0.4268095667308004,-1.089965224399114,0.35634328358208955,0.5923599143685399,1.0,9/13,36.89%,EIF3E;LARP1;AGO2;TPR;EIF2AK4;PAIP2B;EIF4EBP1;EIF4EBP3;PAIP2
prerank,cellular response to nitrogen compound (GO:1901699),-0.3807168230190959,-1.088502388293283,0.35304990757855825,0.5954512002800417,1.0,9/20,21.31%,DDI2;SPIDR;RTF2;NSMCE3;PDE12;ROCK2;ATRX;TIMELESS;BLM
prerank,negative regulation of coagulation (GO:0050819),0.40731598435391103,1.088384650531821,0.3333333333333333,0.7634230848210838,1.0,2/14,2.07%,VTN;HS3ST5
prerank,positive regulation of RNA splicing (GO:0033120),-0.3445734814859608,-1.0882322973990195,0.33212341197822143,0.59569900982135,1.0,9/29,24.13%,DYRK1A;PIK3R1;NUP98;ERN1;ZPR1;RBM20;RBM3;TRA2B;THRAP3
prerank,photoreceptor cell development (GO:0042461),0.3920008442175525,1.0881383228484922,0.35251798561151076,0.7625418678665993,1.0,4/14,9.43%,AHI1;ARL3;VEGFA;DCX
prerank,nucleoside catabolic process (GO:0009164),-0.4462817232671198,-1.0877592816724788,0.3611111111111111,0.5964477574002889,1.0,7/11,36.67%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DERA;DPYS
prerank,negative chemotaxis (GO:0050919),-0.33749298300314945,-1.0875596057083456,0.3304042179261863,0.5965605206520352,1.0,13/33,21.05%,SEMA6A;SEMA3C;NTN1;SEMA7A;SLIT2;RHOA;SEMA3G;SEMA6B;SEMA4C;SEMA4A;SEMA3E;ITGB3;SEMA4G
prerank,mitochondrial fission (GO:0000266),-0.4113239249865831,-1.0872919318538659,0.35701598579040855,0.596791626722056,1.0,3/16,6.07%,DNM3;MIEF1;DNM2
prerank,negative regulation of complement activation (GO:0045916),-0.45966114630222643,-1.0872433059270075,0.3614678899082569,0.596486980246876,1.0,2/10,7.02%,CR1L;CD55
prerank,sterol transport (GO:0015918),-0.38785841359490464,-1.0869305726609708,0.3246268656716418,0.5968052901690645,1.0,5/19,21.54%,CAV1;LDLRAP1;STARD3;OSBPL2;LCAT
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.36372440178581616,-1.08680580882093,0.32867132867132864,0.5967135616294384,1.0,7/23,25.29%,PLK2;NABP1;INTS3;CDK5RAP3;BUB1B;CHEK1;PLK3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.3944797209202452,-1.0863073399958147,0.3545966228893058,0.5974791631397898,1.0,8/17,34.35%,RB1;CTCF;BUB3;TTK;MTBP;SPDL1;BOD1;MIS12
prerank,protein localization to chromosome (GO:0034502),-0.32863864309081703,-1.0861162611526842,0.33212341197822143,0.5975668183714484,1.0,12/34,19.64%,RB1;ESR1;CTCF;MRNIP;XRCC4;MCM9;WAPL;RPA1;SLF2;TERF2;RPA2;ATRX
prerank,sphingolipid metabolic process (GO:0006665),-0.2695724479053827,-1.0860907458920113,0.27472527472527475,0.597224189519381,1.0,34/108,21.99%,SGMS1;ESYT2;CERT1;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ST6GALNAC3;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;PDXDC1;ARSA;AGK;ORMDL1;SPTLC1;ASAH1;CERS5;SMPD2;GBA2;VAPA;SERINC1;GLTP;PPP2CA;DEGS1;ORMDL3;ELOVL7;TEX2;CTSA;GLA
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3734829568442003,-1.085932361835809,0.34111310592459604,0.5971854131107593,1.0,7/22,20.85%,RNF139;MAN1C1;MAN1A2;MAN1B1;TRIM13;UGGT1;EDEM2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3613442032292846,1.0858597654874238,0.33620689655172414,0.7677377792112916,1.0,4/21,6.31%,HS6ST3;HS3ST5;HS6ST2;GPC1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.4004746929455152,1.08543871382712,0.35714285714285715,0.7673785139479455,1.0,2/15,8.37%,MAGI2;ACVR1B
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4320432189995119,-1.0854032744669964,0.367816091954023,0.5980331989645409,1.0,6/12,25.35%,LIMA1;CFL2;PLEKHH2;MTPN;SEMA5A;PIK3CA
prerank,integrated stress response signaling (GO:0140467),0.4155683435651884,1.0851352508590266,0.3506787330316742,0.7666746033120043,1.0,4/14,15.10%,OMA1;IMPACT;CCL2;EIF2AK1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.35837249136374333,-1.0848793877196357,0.34870848708487084,0.5988576592998317,1.0,11/24,28.79%,LYN;MOSPD2;SLIT2;ANO6;CCN3;LGMN;CXCL12;SERPINE1;HMGB1;CXCL10;DUSP1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3826430032017521,-1.0848586522408168,0.35241502683363146,0.5985022900372347,1.0,8/19,26.27%,GFPT2;GNPDA2;GNPNAT1;UAP1;NANS;SLC35D1;UAP1L1;PMM2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2908618725226554,1.0848574372998405,0.3080357142857143,0.765893677088848,1.0,10/54,8.47%,GPC5;HS3ST6;HS3ST5;HPSE2;HS6ST2;GPC1;GALNT5;B4GALT7;HS3ST2;CHST9
prerank,positive regulation of protein secretion (GO:0050714),-0.2886998035396397,-1.0842938946261078,0.31444241316270566,0.5994557431453325,1.0,11/69,7.78%,UNC13B;MYRIP;CD2AP;GOLPH3L;ADAM9;IER3IP1;BMP6;TGFB2;RBP4;EZR;MYO18A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4055876731640662,-1.0841116769916133,0.3592592592592593,0.5994948205612882,1.0,5/15,7.20%,TBX1;TGFBR2;NIPBL;SIX1;MTHFD1
prerank,positive regulation of cell cycle process (GO:0090068),-0.27555804774840253,-1.0837363560573108,0.30472854640980734,0.600022437777727,1.0,27/91,27.04%,MAP3K20;INSR;LRP5;PRKCE;SVIL;PKP4;CUL3;CDC14A;EDN1;RGCC;EDN3;KIF23;RHOA;PLSCR1;PKN2;TPR;IGF1;GIPC1;PLK4;ATRX;IGF2;PDGFRB;E2F7;INO80;CEP295;KIF14;USP19
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.3609227444509457,-1.0834698785425252,0.3345388788426763,0.6002354657315309,1.0,10/25,27.75%,PRPF3;PRPF6;SF3B1;DBR1;SLU7;SRRM1;SRSF10;TRA2B;SCAF11;TXNL4A
prerank,negative regulation of phosphatase activity (GO:0010923),-0.3541440318558741,-1.0832321096177182,0.3379073756432247,0.6004023058363305,1.0,11/25,35.33%,GSK3B;TGFB2;ZCCHC9;GPATCH2;CHP1;SH3RF2;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B
prerank,negative regulation by host of viral process (GO:0044793),-0.4609506887938317,-1.0831725356286488,0.3707052441229656,0.600135676467611,1.0,9/10,51.95%,VAPA;CCNK;EIF2AK4;CRP;CCL8;PTX3;PSMC3;ZC3H12A;LTF
prerank,barbed-end actin filament capping (GO:0051016),-0.39537092900618687,-1.0831469214837153,0.3432282003710575,0.5994100528833596,1.0,3/18,2.67%,EPS8;ADD3;SVIL
prerank,actin filament capping (GO:0051693),-0.39537092900618687,-1.0831469214837153,0.3432282003710575,0.5994100528833596,1.0,3/18,2.67%,EPS8;ADD3;SVIL
prerank,muscle cell development (GO:0055001),-0.3377378957848029,-1.083008268643772,0.33217391304347826,0.5993404591527223,1.0,8/30,10.09%,ENG;MYOF;HES1;DYSF;MYH11;RAMP2;CHRNB1;NEBL
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.24020352308309392,-1.08277979890336,0.24790619765494137,0.5994446434241842,1.0,76/241,28.11%,SRSF11;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;FUS;PRPF6;SF3B6;SPEN;RBM19;HNRNPM;POLR2G;PHF5A;DDX39B;SF3B1;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SFPQ;SLU7;CTNNBL1;SNRPE;SF3A1;HNRNPA1;SYNCRIP;SRSF12;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;RBM15;PCBP1;POLR2C;GEMIN7;USP39;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;HNRNPL;HNRNPD;PABPC1;HNRNPU;TXNL4A;LSM2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3701608758175353,-1.0825131616618617,0.34306569343065696,0.5996943189593035,1.0,7/22,10.76%,LYN;RANBP9;SP1;EPHA4;GSK3A;PICALM;SLC2A13
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.37901563684638384,-1.082340170341616,0.3447653429602888,0.5997135179510741,1.0,11/21,38.31%,RAB1A;RPL5;MAD2L2;PTEN;RPS7;FZR1;PLK1;CDC20;UBE2C;FBXO5;BAG2
prerank,regulation of platelet activation (GO:0010543),0.36471343579108273,1.0821218735806037,0.34140969162995594,0.7725427408145671,1.0,7/21,15.31%,BLK;C1QTNF1;PLEK;PDGFA;TXK;APOE;PDGFRA
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3477342380585863,-1.0821089219484183,0.3523809523809524,0.5998561433756756,1.0,7/26,12.27%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.32940987903055746,1.0818372193771004,0.34557235421166305,0.7717581864321675,1.0,6/32,10.68%,RIMS2;RIMS1;SYT11;SYN1;GPER1;MCTP2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3514699587875701,-1.0817673673282127,0.34798534798534797,0.6002943299716889,1.0,11/27,22.04%,UTRN;NEDD4L;SLMAP;DLG1;FXYD5;PTPN3;FXYD6;SCN3B;SCN4B;SNTA1;NOS1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4140663483338026,1.081645652262349,0.35650224215246634,0.7706853746165047,1.0,2/13,4.15%,BPNT2;SULT2B1
prerank,platelet aggregation (GO:0070527),-0.3429814665647393,-1.0809193095599987,0.33093525179856115,0.6019496200828458,1.0,14/33,27.58%,MYH9;FLNA;ILK;ACTN1;ACTB;PIK3CB;CLIC1;UBASH3B;FERMT3;ITGB3;VCL;TLN1;MYL9;RAP2B
prerank,ethanol metabolic process (GO:0006067),0.42477253263431514,1.0806040838450022,0.3552036199095023,0.7722499567201236,1.0,2/12,7.60%,ACSS2;ACSS1
prerank,actin crosslink formation (GO:0051764),-0.4398677919152686,-1.0797717868828562,0.36331569664902996,0.6043875295782063,1.0,4/12,12.71%,EPS8;BAIAP2L1;FLNA;LCP1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.40493806239226793,-1.0796791507520116,0.3482758620689655,0.6041977900510265,1.0,5/15,15.65%,EGFR;PTPN12;RHBDF2;CEACAM1;LGMN
prerank,positive regulation of phosphatase activity (GO:0010922),0.3621282755314805,1.079668399153977,0.3303964757709251,0.7733591284186511,1.0,3/21,5.75%,MAGI2;PLEK;CALM2
prerank,autophagy of mitochondrion (GO:0000422),-0.32630276783407386,-1.0790093029549634,0.3415061295971979,0.6053794826112114,1.0,16/38,27.26%,ATG7;MAP1LC3B;AMBRA1;BNIP3;WIPI1;GABARAP;FUNDC1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B;ATG3
prerank,negative regulation of receptor internalization (GO:0002091),0.4290402432197116,1.0788123522701398,0.35496957403651114,0.7743845667568303,1.0,4/12,12.35%,ANKRD13B;WDR54;MTMR2;DLG4
prerank,positive regulation of insulin secretion (GO:0032024),0.3164955514840675,1.0785145420657043,0.33263157894736844,0.7737137129169931,1.0,10/36,15.32%,BLK;GCK;ADCY8;TRH;GPER1;PLA2G6;GPLD1;NLGN2;GLUD1;MCU
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.36543506902256895,-1.0784404767515483,0.3327272727272727,0.6063726435394258,1.0,6/22,14.55%,ESR1;MED1;TP53;MED13;MED17;PSMC2
prerank,negative regulation of cell development (GO:0010721),-0.3565211288351207,-1.0783740053458413,0.32838589981447125,0.6061196870283467,1.0,13/25,38.82%,GSK3B;GSK3A;NOTCH1;IGF1;PCM1;FBN1;RFLNB;RFLNA;LILRB1;WNT7A;CCL11;PAX6;APPL2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.45704403108395963,-1.0780145379033979,0.36767317939609234,0.6066005024444786,1.0,8/10,30.86%,RAPGEF2;LYN;GAS6;CCL19;CXCL12;LGALS9;AXL;LILRB1
prerank,regulation of filopodium assembly (GO:0051489),-0.3188636334550388,-1.0778481444418684,0.34501845018450183,0.6066167034391232,1.0,11/38,11.65%,MYO10;FNBP1L;PIK3R1;PALM;RHOQ;PRKCD;WASL;AGRN;RAB5A;ARAP1;BCAS3
prerank,microtubule anchoring (GO:0034453),0.42305255042708,1.077820396735334,0.35777777777777775,0.774234319224339,1.0,4/12,17.24%,BICD1;BCCIP;CLASP2;CAMSAP3
prerank,cardiac muscle cell development (GO:0055013),0.36496856335652744,1.077721602859741,0.3611738148984199,0.7728736788190886,1.0,8/20,15.31%,FHOD3;CXADR;ALPK3;VEGFA;MYLK3;SLC8A1;MYL2;PDGFRA
prerank,regulation of sensory perception of pain (GO:0051930),-0.4426046752028716,-1.0775465249170546,0.38204225352112675,0.6069697193589818,1.0,5/11,26.84%,MGLL;CCN3;ACP3;SPX;F2R
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4415180573183107,-1.0771479067961633,0.3779385171790235,0.6075321299059134,1.0,3/11,10.97%,P3H2;OGFOD1;P4HA1
prerank,cellular response to drug (GO:0035690),-0.35357480903386185,-1.0767669072991413,0.35231316725978645,0.6079704842780637,1.0,7/25,10.11%,ACER2;TFRC;GAS6;KCNQ1;MEF2C;PPM1F;TP53
prerank,cell proliferation in forebrain (GO:0021846),-0.45222649358264155,-1.0763932831287852,0.3527204502814259,0.6085046706473362,1.0,6/10,33.22%,NUMB;PCM1;AKNA;KIF14;NUMBL;WNT7A
prerank,cristae formation (GO:0042407),-0.3475269963358297,-1.0759185880098243,0.35951134380453753,0.6092140895148788,1.0,11/27,24.75%,CHCHD3;APOOL;AFG3L2;SAMM50;DMAC2L;ATP5F1E;UQCC3;ATP5F1C;ATP5MF;ATP5PO;IMMT
prerank,early endosome to late endosome transport (GO:0045022),-0.3724592614840012,-1.0756165053741429,0.35879218472468916,0.6095366123554444,1.0,7/20,23.00%,RAB7A;RAB5A;STX8;ANKRD27;AKTIP;KIF16B;BECN1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.3836659345995811,-1.075325366686315,0.3623931623931624,0.6098101842860326,1.0,3/19,3.89%,IFIH1;SETD2;DDX3X
prerank,regulation of cell differentiation (GO:0045595),-0.25245965163025036,-1.0751753658552463,0.2706896551724138,0.6097765358872075,1.0,38/148,20.89%,SLC6A6;CREBBP;CBFB;KLF4;ZFHX3;SPOCK2;TBX1;SIK1;SMOC1;NREP;SIX1;PTK2;SUZ12;NGF;ROCK1;RAF1;NOTCH4;MOSMO;SMAD7;EDN3;LTBP4;RPS6KA1;PA2G4;CDK6;ATF4;RPS6KA3;TAF8;NR1D2;TRPS1;MCRIP1;CDK5RAP3;HEY1;HEY2;UQCC2;PPP2CA;BCL6;NF1;IGF2
prerank,anion transmembrane transport (GO:0098656),-0.2835487160605019,-1.075090509467247,0.32387312186978295,0.6095766497599341,1.0,20/67,21.38%,LRRC8C;SLC7A1;SLC7A5;SLC13A4;SLC16A12;SLC5A6;SLC38A5;SLC39A8;LRRC8D;ARL6IP5;SLC13A3;SLC35A3;SLC25A11;SLC36A4;SLC35B4;PRAF2;SLC25A1;SLC1A1;SLC7A2;SLC3A2
prerank,mismatch repair (GO:0006298),-0.34623893025232094,-1.0750500914450012,0.3290676416819013,0.6092693052918267,1.0,11/27,27.65%,SETD2;ABL1;MCM9;POLD3;RPA3;RPA1;XPC;RPA2;MSH3;LIG1;EXO1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.353100882218047,1.0749164924955397,0.34186046511627904,0.7796845000872639,1.0,5/24,11.50%,AGBL4;TTLL8;TPGS1;TTLL10;TTLL5
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3867554176760264,-1.0744456141218268,0.36685288640595903,0.6104077056376053,1.0,5/18,19.59%,COX16;COX18;SCO1;COX17;COA8
prerank,innate immune response (GO:0045087),-0.2421581107308901,-1.0744395276858094,0.2905982905982906,0.6100268322718462,1.0,77/217,32.08%,SP100;ANKHD1;MFHAS1;LYN;ANKRD17;IFIH1;TRIM25;APP;TRIM56;SETD2;DDX3X;RNASE7;YES1;CLPB;OTULIN;GCH1;PTK2;IRGM;LBP;RNASE3;PLCG2;ALPK1;PIK3CD;SERINC3;FRK;PGLYRP1;TRIM14;IFITM3;IRAK1;CD40;NCF2;TRIM59;TRIM13;SRPK2;FYN;NRROS;NLRC5;MAVS;IKBKG;SERINC5;IKBKB;DEFA6;NOD2;TKFC;ZDHHC1;PPARG;KYNU;TRIM28;PTK2B;RELA;TRIM39;AKAP1;TRIM68;HMGB1;IRF7;LCN2;IFITM2;RPL39;FCER1G;TRIM6;TIFA;CXCL10;TREM2;BST2;TRIM35;RNF187;IFNLR1;MASP2;SHFL;SRMS;TRIM32;MFAP4;TRIM62;VNN1;CORO1A;JCHAIN;IRF5
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4460672808693792,-1.0742357867636,0.3694390715667311,0.6101198294207265,1.0,6/11,24.95%,SETD2;IWS1;NUP153;TPR;KHDRBS1;DHX9
prerank,response to steroid hormone (GO:0048545),-0.33832898945487194,-1.0742176333782172,0.33451957295373663,0.6097587973732052,1.0,7/31,8.80%,ABHD2;CAV1;THBS1;NR3C1;TGFB2;MED1;YAP1
prerank,protein localization to vacuole (GO:0072665),0.41297277875458804,1.074183464410136,0.3702127659574468,0.7802921676747313,1.0,5/13,11.95%,MFSD1;CD81;RTN4;ATP13A2;RNF128
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.31942834859105523,-1.0738714415526847,0.3419593345656192,0.6101980909237086,1.0,11/42,21.87%,SETD2;ARID2;SHLD1;MRNIP;FUS;SPIDR;CGAS;MAD2L2;RPA2;TIMELESS;CHEK1
prerank,peptide hormone secretion (GO:0030072),-0.3532431354243884,-1.0737894295639099,0.3508771929824561,0.6099838706424808,1.0,7/26,17.00%,RAB1A;CAMK2G;EDN1;EDN3;LTBP4;SNX19;ANXA1
prerank,neutrophil degranulation (GO:0043312),-0.2246901760036004,-1.0737635812281694,0.22148760330578512,0.6096452452493524,1.0,100/425,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;DDX3X;DIAPH1;ANXA3;PTPRJ;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,C4-dicarboxylate transport (GO:0015740),0.4050103013622561,1.0735903881882924,0.3698630136986301,0.780518091420626,1.0,3/14,6.54%,SLC25A13;LRRC8E;SLC1A2
prerank,polyamine metabolic process (GO:0006595),-0.42869370591117206,-1.073562202596781,0.36395147313691506,0.6097456642576536,1.0,5/13,23.10%,SMOX;HDAC6;HDAC10;OAZ2;SRM
prerank,regulation of establishment of planar polarity (GO:0090175),-0.2705074141000038,-1.0729985602291658,0.29930795847750863,0.6107084753055487,1.0,27/88,23.89%,RAC1;SMURF2;FZD6;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1;PSMD4;ROR2;PSMA7;FZD7;PSMD5;FZD5
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.384809220360151,1.0728142182154667,0.35697940503432496,0.781249883566038,1.0,9/17,22.38%,ATP1A2;PKP2;ATP1B1;RYR2;SLC8A1;GJC3;GJA1;ATP1B2;ATP1A3
prerank,cell-cell junction maintenance (GO:0045217),-0.43933790884405666,-1.0727580883380219,0.3675373134328358,0.6108586779122209,1.0,2/11,1.30%,TJP1;FERMT2
prerank,regulation of proteolysis (GO:0030162),-0.30797420374000345,-1.0726403301823277,0.3215547703180212,0.6107408963804513,1.0,16/48,22.36%,CAV1;RNF139;DNAJC1;ASPH;CASP8;AKT1;PERP;SPOPL;LTBP4;FBXW11;PLAT;HDAC6;SPOP;FGFR4;OGT;SERPINE2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.4159438154518895,-1.072134025600473,0.38095238095238093,0.6116166739876868,1.0,3/13,16.55%,PLA2G4A;MGLL;DGAT2
prerank,positive regulation of myelination (GO:0031643),0.4231603195202977,1.0721041441689534,0.3522975929978118,0.7817359665716205,1.0,2/11,1.02%,TENM4;MYRF
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2237255860976465,-1.071332960130261,0.2262295081967213,0.6131553628687619,1.0,100/428,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;DDX3X;DIAPH1;ANXA3;PTPRJ;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.3486716264798905,-1.071229066201468,0.3713235294117647,0.6130007397449976,1.0,11/27,35.99%,TAB3;IRAK1;TAB2;IRAK2;MAP3K7;TNIP1;TLR6;TLR1;TLR5;CD14;TLR2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2689903804021336,1.070484117004055,0.3168103448275862,0.7851298827214869,1.0,12/85,9.75%,PCDH15;COL2A1;SLC26A5;LHFPL3;EML2;COL1A1;ATP2B2;COL11A2;DCDC2;CACNA1D;GRM7;SPTBN4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.39499380404385764,-1.070471024476295,0.381651376146789,0.6143198831108582,1.0,6/17,11.05%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,regulation of phospholipase activity (GO:0010517),0.44511405688812145,1.0702438015518414,0.37777777777777777,0.7842347481089976,1.0,6/10,24.84%,FGFR2;RASGRP1;FGFR3;ANGPTL3;PDPK1;SNCA
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4229158047474121,-1.0701711244239454,0.3914590747330961,0.6146150833386161,1.0,6/12,24.23%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,heart process (GO:0003015),0.40214293111097227,1.07002095644735,0.37276785714285715,0.7833108140381835,1.0,1/14,0.03%,SGCZ
prerank,chromatin remodeling at centromere (GO:0031055),0.32436175995343075,1.0699858261119164,0.3370044052863436,0.7817850397663457,1.0,10/31,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4508698242068455,-1.0698352950138288,0.38095238095238093,0.6149982666809208,1.0,4/10,18.14%,MSN;EZR;RHOA;RAP2A
prerank,phagosome maturation (GO:0090382),0.31856774033109975,1.0698265848700756,0.3534675615212528,0.7806406312165561,1.0,12/35,19.06%,MREG;ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;RAB39A;RAB34;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,response to interleukin-4 (GO:0070670),-0.46069040208846224,-1.069298157377351,0.38404452690166974,0.6159363884643485,1.0,1/10,0.16%,LEF1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.33208193692737764,-1.0691800852190538,0.36952714535901926,0.6158513974206802,1.0,9/33,18.44%,PRKD2;PTPRJ;EZR;DGKZ;CEACAM1;DUSP3;RC3H1;RPS3;IKBKG
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.30735708936366113,1.0691055194687065,0.33410672853828305,0.7812027384997882,1.0,8/41,13.10%,GRM5;DOCK3;NTRK2;ADRA2A;LILRA5;CSF1R;DLG4;BDNF
prerank,mesonephros development (GO:0001823),-0.43787468937096075,-1.0688146443127629,0.3767605633802817,0.6163500811967649,1.0,3/11,7.18%,ZBTB16;FGF1;BMP4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3606198950614664,1.06871263384745,0.3501144164759725,0.7807897750147377,1.0,6/20,17.17%,FAR1;ACLY;ACACA;ACSL3;SCD5;SCD
prerank,peptidyl-lysine methylation (GO:0018022),-0.34844873574164237,-1.0673415156353163,0.36414048059149723,0.6194708190807325,1.0,8/26,16.06%,SETD2;SUV39H1;SETD3;EHMT1;KMT5A;SMYD1;N6AMT1;ANTKMT
prerank,androgen metabolic process (GO:0008209),0.3715629073680068,1.0672788918932756,0.36729857819905215,0.7835857701977678,1.0,3/18,13.05%,AKR1D1;HSD17B7;SPP1
prerank,metal ion transport (GO:0030001),0.2665097984987788,1.067044747617462,0.3325635103926097,0.7826972732268859,1.0,21/86,12.58%,RYR3;CACNA1B;ATP2B2;CACNA2D1;TUSC3;CACNA1A;CACNB3;CACNG8;CACNA1D;SLC8A2;SELENOK;RYR2;CACNG3;CACNA1E;NIPA1;SLC39A2;NMUR2;NIPAL1;SLC8A3;SLC8A1;CCL5
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4060843003670479,-1.0666437407756457,0.3625,0.6206728108342717,1.0,10/15,38.31%,DTX3L;ABL1;SMAD7;RPL5;MAD2L2;RPS7;BAG5;PARK7;FBXO5;BAG2
prerank,dopaminergic neuron differentiation (GO:0071542),0.364268634435068,1.066336471350368,0.3544600938967136,0.7832305465096491,1.0,3/19,9.25%,PHOX2A;LMX1B;VEGFA
prerank,organic cation transport (GO:0015695),-0.3692901512187701,-1.0662167890555427,0.34363636363636363,0.6212422798816278,1.0,5/20,10.06%,SLC47A1;RALBP1;SLC22A5;SLC44A1;SEC14L1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3603210019005755,1.066180341923453,0.37276785714285715,0.7820932032527947,1.0,3/20,5.98%,GCK;CDA;BCKDK
prerank,positive regulation of response to wounding (GO:1903036),-0.3564074315013572,-1.0660394583633523,0.37732342007434944,0.6212741711864402,1.0,7/24,11.88%,ITGB1;PRKCE;SCARF1;PTK2;OCLN;MYLK;ARFGEF1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3931669043703225,-1.0657805526781208,0.4017857142857143,0.6215130617821787,1.0,6/16,21.78%,CHMP4B;CHMP4A;VTA1;VPS36;CHMP5;TMEM50B
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.361142949804528,1.0654980738780635,0.35172413793103446,0.7825843075530001,1.0,8/21,19.13%,TOX;PROX1;INSM1;VEGFA;FZD9;FZD3;DISP3;CX3CL1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4282680603923395,-1.0652912098274512,0.4121739130434783,0.6223001126790252,1.0,2/12,1.62%,GJD3;CAV1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.42550236059710583,-1.0652101447135662,0.40111940298507465,0.6220998718311462,1.0,6/13,29.25%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2;SPI1
prerank,wound healing (GO:0042060),-0.2900566922470298,-1.0650405911109373,0.33212341197822143,0.6221065294809024,1.0,16/62,13.27%,MYOF;MYH9;DYSF;TGFB2;MACF1;AHNAK2;FGF1;RAF1;DST;SCARB1;CFLAR;FUT10;DCBLD2;FGF2;TPM1;PRCP
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.28388451890956734,-1.0646010831781176,0.3188405797101449,0.6227318835478819,1.0,28/68,36.91%,IFIH1;APP;IL6R;LBP;ARHGEF2;PLCG2;LPL;IL17RA;IL16;MAVS;HYAL2;NOD2;PTPN11;HMGB1;DHX9;F2R;LGALS9;STAT3;TLR6;TLR1;NOS2;RAB7B;IL1A;TSLP;CD74;TLR2;TLR8;SYK
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2967662423935804,-1.064423696180018,0.34014869888475835,0.6227618762930434,1.0,17/56,15.75%,SPTBN1;STAMBP;SNX9;BIN3;ROCK1;CHMP4B;CECR2;CUL7;KIF23;RASA1;DCTN3;RHOA;SON;RTKN;RHOC;ROCK2;MITD1
prerank,histone H4 acetylation (GO:0043967),-0.30555328846562196,-1.0641041235481359,0.35634328358208955,0.6231633954083529,1.0,16/47,25.05%,LEF1;KANSL3;EP400;PHF20;TRRAP;ZZZ3;HCFC1;TADA3;TRIM16;RUVBL2;JADE2;OGT;WDR5;MORF4L1;BEND3;APBB1
prerank,regulation of receptor binding (GO:1900120),-0.45677589198259283,-1.0640883398315322,0.3979416809605489,0.6228004809563047,1.0,3/10,11.78%,ATP2A3;GREM2;HFE
prerank,nitric oxide biosynthetic process (GO:0006809),-0.4154469842114663,-1.0637027081053518,0.391304347826087,0.6233355101496045,1.0,7/13,24.02%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1;CYP1B1
prerank,regulation of viral life cycle (GO:1903900),0.35732349430317495,1.0635683443608202,0.389010989010989,0.7870882033174638,1.0,5/21,14.05%,HS3ST5;TYRO3;TRIM27;TSG101;PPIA
prerank,nitric oxide metabolic process (GO:0046209),-0.4063877747196652,-1.0635515566596687,0.4017543859649123,0.623280903597282,1.0,7/14,24.02%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1;CYP1B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.44992152097437876,-1.0634930747378393,0.39664804469273746,0.6226220463948847,1.0,5/10,20.03%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.44992152097437876,-1.0634930747378393,0.39664804469273746,0.6226220463948847,1.0,5/10,20.03%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,protein complex oligomerization (GO:0051259),0.2621537467259597,1.0633557700197445,0.3252747252747253,0.786173798424907,1.0,7/85,4.27%,KCNC2;MPP2;GLRA3;MS4A1;C9;ADCY8;ATL1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.35670003426960994,-1.063325976874871,0.36822429906542054,0.6226340388577858,1.0,9/24,29.13%,ZBTB16;ACVRL1;PKDCC;TRPS1;PTPN11;ADAMTS7;SNAI2;TGFBR1;WNT9A
prerank,respiratory electron transport chain (GO:0022904),0.41105551654839856,1.0631767427471035,0.3595505617977528,0.7850965450851082,1.0,3/14,11.51%,SLC25A13;SDHA;NDUFA5
prerank,hyaluronan catabolic process (GO:0030214),-0.3696765455416676,-1.0630596744290544,0.3743119266055046,0.6228676318413451,1.0,9/18,31.99%,CEMIP2;FGF2;CHP1;HYAL2;LYVE1;HEXA;HYAL3;TGFB1;CEMIP
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2491692764594596,-1.062543038694084,0.3008695652173913,0.6236765969016745,1.0,53/160,26.82%,HIP1;FCHO2;STXBP6;EPS15;EIF4H;NCK1;PXN;AHCTF1;AP2S1;NUP98;PSMG2;TCP1;PIK3C2A;SNX9;SMAD1;SMAD2;PICALM;SMAD4;CHMP4B;CHMP4A;SAMM50;VBP1;NCK2;POGZ;NUP153;RPL38;PTGES3;TTC12;HIP1R;TPR;ANGPT1;CASQ2;DNAJB12;CENPE;VAMP3;PFDN6;ADRM1;TCF4;AP2M1;PSMD4;HIGD2A;VAMP2;HSP90AA1;NDUFAF1;ARL2;HIGD1B;DHX9;DRC1;PSMG1;CCT2;GPX4;IMMP2L;CHMP3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.43096448676759835,-1.062381537252872,0.38503649635036497,0.6236585993584315,1.0,5/11,19.59%,SLC30A10;PPARA;ABCB7;FYN;COA8
prerank,mitotic spindle organization (GO:0007052),-0.2496386081078569,-1.0623712363253743,0.31951640759930916,0.6232885068843314,1.0,74/153,39.97%,CLIP1;MAD1L1;MAP4;NEK6;RANBP2;STAG1;CCDC61;AHCTF1;TOGARAM1;NUP98;PLK2;SEC13;WRAP73;FLNA;KIF23;RHOA;PAFAH1B1;ARHGEF10;MECP2;STAG2;KIF11;RAB11A;RPS27;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;PRC1;BUB3;TTK;MISP;PCNT;CENPI;CENPH;EML4;CENPN;RAN;DYNLL1;SPC25;SPDL1;TUBG2;CDCA8;STMN1;BIRC5;EFHC2;WDR62;NUDC;CEP192;MAP9;PLK1;NUF2;CKAP5;AURKA;MIS12;SPC24;TNKS;CDC20;NUP43;VCP;LSM14A;RMDN1;TPX2;TUBG1;SPICE1;KIF2C;NSL1;DYNC1LI1;SMC3;CCNB1;CENPT;CENPM
prerank,acylglycerol catabolic process (GO:0046464),-0.3396014596991595,-1.0620795179511842,0.37707948243992606,0.6235804133729166,1.0,12/30,42.17%,ABHD2;MGLL;LPL;LIPE;PNPLA2;FABP3;LIPH;ABHD12;FABP4;LYPLA2;FABP12;DAGLA
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.38176639147296576,1.0619031284975204,0.359375,0.7873716696589163,1.0,5/15,13.29%,PSMD10;PRELID1;TRIAP1;GHITM;CLU
prerank,translational termination (GO:0006415),-0.2657902964161315,-1.0618068395728866,0.32326820603907636,0.623808598796705,1.0,34/95,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;GSPT1;MRPS24;MRPL46;MRPS27;MRPL12;N6AMT1;MRPL58;MRPL24;MTRF1L;MRPL57;MRPS14;ABCE1;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;MRPL11;TRMT112;MRPS31
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.35410820884048716,-1.0616952400482043,0.3567467652495379,0.6236428423214778,1.0,9/26,27.80%,SLC30A10;PPARA;RAB27A;PLCG2;ABCB7;COA8;ADGRB1;SLC5A3;SLC25A33
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.40998727061580814,-1.0614344902458768,0.40867992766726946,0.6238609640872679,1.0,5/14,14.99%,PRKG1;SLIT2;MEF2C;TPM1;IGFBP5
prerank,regulation of cellular respiration (GO:0043457),-0.39124395930223,-1.0610783090060463,0.36155202821869487,0.6243357751861094,1.0,3/17,3.95%,CBFA2T3;PRDM16;IFNAR1
prerank,ether lipid metabolic process (GO:0046485),0.4058961765473805,1.0607820398302774,0.38064516129032255,0.7891334010962778,1.0,6/14,12.68%,FAR1;PLA2G7;PLA2G6;GNPAT;DHRS7B;PEDS1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3467307072637935,1.0605575705599641,0.3681917211328976,0.7882839914841924,1.0,4/25,3.86%,B3GALT1;NDST4;FUT9;B3GALT5
prerank,membrane raft organization (GO:0031579),-0.40475871558039456,-1.060159737964991,0.38204225352112675,0.6261069616941077,1.0,10/15,35.54%,ANXA2;NAXE;FLOT1;ABCA7;PPT1;EMP2;RFTN1;MYADM;NPC1;S100A10
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2955218065468883,-1.0601166206256418,0.3563636363636364,0.6257936309321885,1.0,20/54,29.10%,UBE2K;BIRC3;TAX1BP1;GAS6;OTULIN;CASP8;CFLAR;TNFAIP3;TNFRSF1A;HIPK1;IKBKG;IKBKB;RIPK1;CASP1;HSPA1B;GPS2;PTPN2;ADAM17;NLRP2B;RNF31
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.414000442930064,-1.0597093403643936,0.39444444444444443,0.6263302290008863,1.0,2/13,5.04%,OGDH;IDH1
prerank,regulation of isotype switching (GO:0045191),-0.41101925506549175,-1.0596976461561702,0.37406015037593987,0.625960554537328,1.0,3/14,5.29%,SHLD1;TFRC;KMT5B
prerank,regulation of T cell activation (GO:0050863),0.31367217271646275,1.0596379844302124,0.3495762711864407,0.7894375917508961,1.0,8/42,15.73%,TNFSF18;PAG1;PRELID1;VTCN1;CCL5;CCL2;CD47;SIRPA
prerank,regulation of phosphatase activity (GO:0010921),-0.3578794292454658,-1.059411840189956,0.36936936936936937,0.6262321337574969,1.0,8/24,24.99%,PPP1R2;ZCCHC9;GPATCH2;PPP6R3;CHP1;CDK5RAP3;SH3RF2;BMP2
prerank,mitochondrion organization (GO:0007005),-0.2474968732561002,-1.0593478367145515,0.30612244897959184,0.6259792754377639,1.0,66/165,34.86%,MEF2A;NOS3;ALAS1;DNM3;TRAK1;LRRK2;MIEF1;DNM2;CHCHD3;SIRT5;BNIP3;PYROXD2;AKT3;AFG3L2;HAX1;VPS13C;SAMM50;TOMM40;AGTPBP1;BCAP31;MTX1;GABPB1;MIEF2;SIRT3;AFG1L;HCFC1;RAB32;TIMM17B;VPS13D;TOMM5;FANCG;NRF1;DNAJC19;WASF1;HIGD2A;TERT;ATPAF1;GABPA;BIK;HIGD1B;TIMM50;TMEM11;STOML2;TIMM10;IMMP2L;TOMM20;RAB38;MTFR1;SLC25A33;RHOT2;CAV2;YME1L1;HIGD1A;TOMM70;PID1;MTM1;ATP5F1D;SPG7;TIMM10B;AIFM1;TIMM13;PARK7;ATP2A1;IFIT2;WDR81;NUBPL
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3739529914323373,-1.0592523107174583,0.36379613356766255,0.6258098611828596,1.0,12/19,40.15%,ZMIZ1;GAS6;PPP2R3C;PRKDC;IL7;AXL;MMP14;SYK;ZAP70;MDK;GATA3;IL4
prerank,protein processing (GO:0016485),0.25934992811059315,1.0592406084773967,0.33183856502242154,0.7891261880518005,1.0,24/102,16.86%,OMA1;MYRF;C1RL;MME;MMP16;CLN3;CPE;TYSND1;METAP2;BACE1;KLK1;KLK6;SPCS3;ADAM19;CPN1;PCSK2;AEBP1;HTRA2;SPCS1;PCSK6;ECE2;EEF1AKMT4-ECE2;KLKB1;CASP4
prerank,defense response to bacterium (GO:0042742),-0.2635504612812897,-1.0589168219522973,0.3225806451612903,0.6262455501788102,1.0,38/105,33.07%,ANKRD17;NOD1;RAB1A;ANXA3;RNASE7;IL6R;IRGM;PRKCD;LBP;GBP6;RNASE3;PGLYRP1;STAB1;GBP4;MAVS;DEFA6;NOD2;DROSHA;SERPINE1;RPL30;ADGRB1;LCN2;ADAM17;RPL39;LYZL4;FCER1G;TREM2;SELP;MPEG1;NLRC4;TNFRSF14;TLR6;JCHAIN;CEBPB;FGR;LPO;NOS2;AQP1
prerank,regulation of protein modification process (GO:0031399),-0.2967189964419977,-1.058725570333291,0.351985559566787,0.6263236264797692,1.0,11/50,11.30%,LYN;CORO1C;ATG7;KAT2B;SPRED2;ATG10;PTK2;CDH5;ASPSCR1;STAT2;FNIP2
prerank,negative regulation of cell projection organization (GO:0031345),0.2957148349285918,1.0585252964735532,0.35514018691588783,0.7897367369455878,1.0,12/48,15.52%,DCC;GRIN2B;SPOCK1;ITM2C;TSKU;PTPRS;STMN2;MAG;PAQR3;DENND5A;APOE;PTPRO
prerank,response to peptide (GO:1901652),0.31953032495212186,1.0582856296613807,0.3572984749455338,0.7888707476531993,1.0,5/33,4.32%,MMP12;CACNA1B;GNAI1;CACNA1A;INAVA
prerank,dephosphorylation (GO:0016311),-0.24884717292000313,-1.0582269774470432,0.31724137931034485,0.6271120547926309,1.0,29/147,13.71%,PTPRG;PTPRB;PTPRM;PPP2R5A;PTPN14;PPM1H;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PPEF2;ALPL;PPM1L;ILKAP;PTPRK;MTMR6;PPM1F;PPM1B;PPP1R12A;UBLCP1;PTPN3;DUSP23;ACP6;DUSP3;PTPN13;CTTNBP2NL;FBXW11;PNKP
prerank,positive regulation of protein deacetylation (GO:0090312),-0.40117552533194567,-1.0581397224377613,0.3754646840148699,0.6269576480436688,1.0,2/14,5.18%,DYRK1A;NIPBL
prerank,regulation of heart contraction (GO:0008016),0.2661680635125109,1.0579664882473956,0.32045454545454544,0.7882215338605294,1.0,17/90,12.89%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;CELF2;CALM2;NPPC;RNF207;SLC8A2;RYR2;SLC8A3;SLC8A1;SRI;HRC;CASQ1;FXYD4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2687525842279482,-1.0578699511489675,0.3266423357664234,0.6272056777327041,1.0,26/88,22.58%,CLINT1;VPS13A;EXOC6;STXBP6;EPS15;APP;EXOC4;SCAMP2;DNM2;RABEP1;PUM1;SCFD1;EXOC2;VPS13C;AP1G1;ACBD3;EXOC8;CORO7;AP4M1;VPS35L;SCAMP1;AP4B1;RABIF;VAMP2;KIF16B;ARFGEF2
prerank,regulation of macrophage activation (GO:0043030),-0.3386193149388712,-1.0572780972961375,0.34953271028037386,0.6282388791662564,1.0,7/30,15.33%,MFHAS1;CD200;THBS1;LBP;MYO18A;GPR137B;MIF
prerank,positive regulation of intracellular transport (GO:0032388),0.31369555536897487,1.0570620527573575,0.3811659192825112,0.7892923912928553,1.0,9/38,11.79%,ABCA12;TENM1;PGAP1;STK11;ZFAND1;SORL1;PLA2G4E;EIPR1;PRR5L
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.38968907478525744,-1.0570386764472843,0.3732394366197183,0.628407852421138,1.0,4/17,12.67%,KLF7;CAV1;APOLD1;CEACAM1
prerank,regulation of neuron projection arborization (GO:0150011),0.3891582864094942,1.0567368467134777,0.375,0.7887550433654629,1.0,6/15,15.82%,GRIP1;NTNG2;NTNG1;DLG4;MYO9A;DVL2
prerank,regulation of TOR signaling (GO:0032006),-0.2775276766740466,-1.0559745890276362,0.34275618374558303,0.6305687650622801,1.0,18/67,20.40%,SH3BP4;RICTOR;GNA12;GAS6;DDIT4;SEC13;MIOS;GSK3A;UBR2;PRKAA1;TTI1;RPTOR;LARS1;GOLPH3;UBR1;ITFG2;TMEM127;AKT1S1
prerank,regulation of protein transport (GO:0051223),-0.34089512345653816,-1.0559670286601126,0.387719298245614,0.6301944001784654,1.0,11/27,22.24%,PTPN1;DNAJC1;RHBDF2;PPM1F;SCFD1;SNX12;LCP1;CHP1;NDEL1;WWP2;NDFIP2
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2867190058705483,-1.0558225061380675,0.3625,0.6301324660604708,1.0,35/61,40.59%,MNAT1;RB1;CDKN1B;CRLF3;CUL3;MAX;PLK2;CUL2;LATS2;CDK6;GSPT1;CACUL1;CCND1;CDKN2C;CDC25A;CCNE2;E2F3;KHDRBS1;PLK3;CDKN3;CCNH;HINFP;CDC34;CUL5;CDK4;CCNE1;EIF4EBP1;NASP;CCNA2;PPP6C;TRIM71;CDKN1A;ACVR1;USP37;CDKN2D
prerank,DNA strand elongation (GO:0022616),-0.38022756139174724,-1.055769731069233,0.3836589698046181,0.6298638358713388,1.0,10/18,26.13%,MRE11;MCM4;POLD3;GINS3;GINS1;DCLRE1B;TERT;RFC4;MCM3;MCM7
prerank,positive regulation of viral process (GO:0048524),-0.2868425913376837,-1.055605080337053,0.38581314878892736,0.6298758742242218,1.0,28/60,33.94%,RAB7A;DDX3X;LARP1;PPARA;POLR2G;MDFIC;PKN2;PDE12;TBC1D20;SRPK2;ADARB1;RAD23A;NELFB;STAU1;PPIH;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;PABPC1;AXL;PPIE;NELFA;NELFCD;POLR2E;TARBP2
prerank,camera-type eye development (GO:0043010),0.33372779502642486,1.0555284073261573,0.348993288590604,0.7907890880181044,1.0,6/25,9.25%,TENM3;EFEMP1;WT1;PAX2;TSKU;VEGFA
prerank,stem cell development (GO:0048864),0.37798258230060877,1.0551521914694215,0.4066193853427896,0.7903618875115739,1.0,3/16,11.59%,NRG1;NOLC1;CDH2
prerank,regulation of cilium movement (GO:0003352),0.4256930526927457,1.0546477691135272,0.3912037037037037,0.7903549514913226,1.0,3/10,9.18%,ODAD2;DNAAF1;CFAP43
prerank,response to amino acid (GO:0043200),0.32964307354717576,1.054559712655159,0.39285714285714285,0.7890922060697011,1.0,5/31,10.51%,GLRA3;RRAGA;GLRA1;CPEB1;CPEB3
prerank,kidney development (GO:0001822),0.2727543676811529,1.054519786596911,0.3536036036036036,0.7876535368622929,1.0,11/65,9.25%,ROBO2;MME;LHX1;OSR1;WT1;PAX2;HNF1B;VANGL2;PROX1;ARL3;VEGFA
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.24056574690428026,1.0543088396609148,0.2968036529680365,0.7867441767929773,1.0,25/142,12.48%,ATP1A2;HCRTR1;C1QTNF1;ATP2B4;ATP2B2;ADCY8;CALCA;CLN3;CACNA1A;PTGER3;SLC8A2;RYR2;C3AR1;CCR6;GPER1;TMEM178A;ADRA1D;ADRA1A;CIB2;TACR1;NMUR2;SLC8A1;HRC;DLG4;FZD9
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.34433821382326274,-1.0543011778617033,0.348294434470377,0.6326110049386906,1.0,10/24,21.05%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,negative regulation of catalytic activity (GO:0043086),-0.3524977389038467,-1.0541514681441237,0.37305699481865284,0.6325229120060075,1.0,14/24,36.42%,NES;TP53;PPP1R12A;NOTCH1;APBA3;HDAC6;PLN;NOS1;PARP9;NOSIP;PHPT1;HP;MT3;ATP5IF1
prerank,positive regulation of protein polymerization (GO:0032273),-0.28440141619006704,-1.0536311955180475,0.3666061705989111,0.6333934574041902,1.0,23/65,23.71%,CLIP1;BAIAP2L1;RAC1;PRKCE;NCK1;TOGARAM1;SNX9;OCLN;NCK2;FCHSD2;DCTN1;LMOD1;SLAIN2;DRG1;CDC42EP3;NCKAP1;RPS3;FCHSD1;CDC42EP1;PTK2B;HSP90AA1;AKAP9;ARL2
prerank,cellular response to organonitrogen compound (GO:0071417),-0.26570806118338597,-1.0534675628075882,0.35664335664335667,0.6333952646582266,1.0,24/99,15.21%,CTNNA1;RAPGEF2;PKD2;SH3BP4;DIAPH1;MTOR;PDE3A;LARP1;PDE2A;SLIT2;KCNQ1;RAP1A;MEF2C;EZR;RAP1B;CDH1;CAPN2;RAPGEF1;RPTOR;ACTB;LARS1;P2RY6;IGFBP5;HTR1B
prerank,neuron apoptotic process (GO:0051402),0.3700038012329314,1.0534200644802385,0.3634361233480176,0.7878995552436671,1.0,4/19,5.95%,CDK5;BCL2;SCN2A;NAE1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.39424169218419497,-1.0534028064596073,0.3901098901098901,0.6331415694097121,1.0,4/15,9.10%,STOX2;RICTOR;TGFB2;CELF1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3617242765522943,-1.0531060081540928,0.3981651376146789,0.633504998214303,1.0,5/21,10.70%,PDZD8;MCUB;TGM2;AFG3L2;BCAP31
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2695701273635881,-1.0529657077395311,0.33158813263525305,0.6334493166715683,1.0,23/80,18.73%,WASF2;EPS8;RAC1;FNBP1L;EPS8L2;PIK3R1;PALM;RHOQ;WASL;PLCE1;AGRN;OCLN;CROCC;ARAP1;BCAS3;CDC42EP3;FAM98A;NCKAP1;FUZ;ARHGAP35;CCL19;WASHC1;NDEL1
prerank,Fc receptor signaling pathway (GO:0038093),-0.2585867741877524,-1.0529377578818164,0.3732876712328767,0.6331171661427213,1.0,38/110,27.30%,RAC1;TAB3;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;PSME2;JUN;MAPK1;PSMB4;PLCG2;FBXW11;MAPK8;PIK3CB;PSMC2;GRB2;GAB2;PSMB2;PSMB1;MAP2K4;TAB2;PSMA8;IKBKG;IKBKB;PSME1;PSMD4;VAV2;PSMA7;RELA;PSMD5;MAP3K7;PIK3CA;PSMB10;PSMA3;FCER1G
prerank,negative regulation of cell communication (GO:0010648),0.3528605975605262,1.0513452527465326,0.3695652173913043,0.7927272797307494,1.0,3/21,3.44%,OPRM1;IGFBP3;GLRA1
prerank,neural tube closure (GO:0001843),-0.31947737966953865,-1.0512640153813737,0.38256227758007116,0.6366760565457723,1.0,10/34,18.68%,DVL3;LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,cellular response to heat (GO:0034605),-0.31842390541935384,-1.0509727291799023,0.39421338155515373,0.6370124932287663,1.0,11/35,18.49%,THBS1;YWHAE;ANO1;CLPB;FGF1;SLU7;ATXN3;TCIM;TPR;SUMO1;TRPV4
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.40632905980454215,-1.0506742200778252,0.3929236499068901,0.6372904423242917,1.0,3/14,5.29%,SHLD1;TFRC;KMT5B
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.3950629164611371,-1.0503831906990373,0.3921200750469043,0.6375823540181182,1.0,2/14,6.02%,ENTPD1;ENTPD6
prerank,striated muscle cell development (GO:0055002),-0.40640329032802136,-1.0500736020531067,0.40142095914742454,0.6379517588913809,1.0,3/14,12.75%,PGM5;TMOD3;LMOD1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3909486078695561,-1.0497620226275743,0.3974358974358974,0.6382976787831313,1.0,4/15,12.40%,CUL3;STXBP4;PLCG2;CDC73
prerank,protein targeting to peroxisome (GO:0006625),-0.3356794107109762,-1.0497067851223358,0.39649122807017545,0.6380504462584343,1.0,13/29,33.89%,PEX1;ABCD3;PEX7;RAB8B;ZFAND6;PEX14;PEX3;PEX6;PEX11B;HACL1;PEX19;LONP2;PEX26
prerank,cellular component disassembly (GO:0022411),-0.29707241520855726,-1.049368040318687,0.385146804835924,0.638469621324205,1.0,12/53,15.16%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;CAPN2;ADAM10;ADAMTS4;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3586797305805703,1.0487947265216337,0.40311804008908686,0.799096724555825,1.0,5/20,8.29%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4134693018099268,-1.0487777751598875,0.3894927536231884,0.6394517310895306,1.0,5/12,18.81%,STARD3;FDX1;FDXR;STARD3NL;STAR
prerank,carbohydrate homeostasis (GO:0033500),-0.27468077044777056,-1.0487050854338709,0.37122557726465366,0.6392264181983419,1.0,9/67,10.64%,KLF7;IGF1R;INSR;TENT4B;ADIPOR2;IRS1;RBP4;HECTD4;PRKAA1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2770455347086059,-1.0486836435646025,0.3752244165170557,0.6388779110851021,1.0,25/72,29.19%,MNAT1;RBX1;POLR2G;ERCC2;POLD3;TCEA1;RPA3;RPA1;ERCC3;ERCC8;RPA2;USP7;COPS7A;RFC4;RFC1;COPS8;POLR2C;COPS4;LIG1;POLR2L;ERCC6;POLR2H;GTF2H3;CCNH;PPIE
prerank,regulation of cytokine production (GO:0001817),-0.25647791676611326,-1.0481035128660097,0.35335689045936397,0.6398603128470698,1.0,26/126,20.24%,FOXP1;AFAP1L2;LYN;IFIH1;TRIM56;RPS6KA5;IL15;SRGN;TNFRSF1B;MAST2;MAPKAPK2;CASP8;PIK3CD;RGCC;FLOT1;ASB1;ICOSLG;AGPAT1;N4BP1;MIF;C1QTNF3;ANXA1;SOD1;LURAP1;PTPRC;BCL6
prerank,histone H2B ubiquitination (GO:0033523),-0.44095452317744493,-1.0479248757651438,0.42226148409893993,0.6398865504997243,1.0,3/10,12.40%,DTX3L;RNF40;CDC73
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3672222105125492,1.047843809503381,0.3923766816143498,0.8005503599871318,1.0,4/18,7.39%,TENM4;OPALIN;PTPRZ1;SOX1
prerank,mesenchymal to epithelial transition (GO:0060231),0.43248711032962683,1.0478239380927297,0.39344262295081966,0.7990554859533759,1.0,2/10,6.07%,WT1;PAX2
prerank,regulation of protein dephosphorylation (GO:0035304),-0.31247390266075903,-1.0477657881776938,0.37455197132616486,0.639870884133158,1.0,6/37,7.57%,PPP2R5A;MFHAS1;PPP1R2;PRKCD;SPPL3;CDH5
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.38234849764072276,1.0476867284879672,0.3895216400911162,0.7979080835080232,1.0,6/15,15.13%,APOM;PLA2G3;LIPC;ABCA5;APOE;APOC1
prerank,extracellular matrix disassembly (GO:0022617),-0.29636747414970716,-1.0476642675790995,0.38030560271646857,0.6396965397793225,1.0,12/53,15.16%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;CAPN2;ADAM10;ADAMTS4;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,regulation of cytoplasmic translation (GO:2000765),0.39894102386191754,1.0475421117077974,0.3769063180827887,0.7968105886392608,1.0,4/14,17.25%,CPEB1;PKM;CPEB3;DHX36
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3753762324101404,-1.047524155524903,0.41788321167883213,0.6396139410758316,1.0,5/18,15.76%,ESR1;NRIP1;EGFR;KAT5;RUVBL2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3015590728518145,-1.0473044803543032,0.3641207815275311,0.6397199110198822,1.0,22/48,37.75%,NUP42;PRDM16;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188;NOA1;NUP88;NUP35;NOS2;NUP43;HIF1A;GCGR;PGAM1;JMJD8;PRKAG2
prerank,GPI anchor biosynthetic process (GO:0006506),0.3279860098868674,1.047270447406179,0.3874458874458874,0.7960879435570305,1.0,6/30,11.22%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3
prerank,positive regulation of growth (GO:0045927),-0.2814542832716018,-1.0472225921128375,0.356401384083045,0.6395444070828651,1.0,16/64,15.48%,INSR;DDX3X;EGFR;PLCB1;TGFB2;PPM1F;EXOSC2;MFSD2A;ADAM10;AKT1;RPTOR;RPS6KA1;ZPR1;RPS6KA3;H3-3A;N6AMT1
prerank,exit from mitosis (GO:0010458),-0.4247811718415827,-1.0472097949652086,0.4099264705882353,0.6391879745820056,1.0,3/12,10.03%,EPS8;PPP2R2D;CHMP4B
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3453653519833668,-1.0470272104635883,0.37943262411347517,0.6392334043432104,1.0,14/24,38.66%,TENT4B;STN1;XRN1;CTC1;HNRNPA1;TERF2;PINX1;HNRNPU;TNKS2;PIF1;TNKS;DCP2;SLX4;ERCC4
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.36860947808003064,1.0467361699922804,0.39211136890951276,0.7961192031811362,1.0,3/18,5.19%,CHRM2;OPRM1;CHRM3
prerank,early endosome to Golgi transport (GO:0034498),0.4163095310179683,1.0466240850688084,0.3856812933025404,0.7949511129467958,1.0,4/11,14.67%,LMAN1;RAB6A;SURF4;TMED9
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.406396928307005,-1.0457089384167366,0.4116575591985428,0.6419933927332746,1.0,6/14,17.16%,DYRK1A;PSEN2;ADAM10;PSEN1;ABCA7;APH1A
prerank,DNA methylation (GO:0006306),-0.35875910824582224,-1.0456599629554006,0.40310077519379844,0.6416966417766347,1.0,9/23,24.04%,KMT2E;METTL4;EHMT1;N6AMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,phospholipid transport (GO:0015914),-0.29363705369827603,-1.0455351625639513,0.3761467889908257,0.6415715276555283,1.0,14/52,20.94%,ATP10A;PITPNC1;ATP8B1;PLTP;SCARB1;MFSD2A;ATP10B;ABCA7;TNFAIP8L3;ATP9B;PCTP;PRELID2;OSBPL2;ATP11C
prerank,positive regulation of calcium ion import (GO:0090280),0.40692312669646263,1.0453327224568947,0.3933649289099526,0.7972604774853808,1.0,3/12,12.95%,STC1;SPHK2;CCL2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.28255059272472216,-1.044595432048023,0.3788927335640138,0.6434565867393286,1.0,18/61,21.85%,CAV1;PSMA2;PANK2;PPARA;SIRT5;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;NQO1;PSMD4;FGFR4;PSMA7
prerank,inner dynein arm assembly (GO:0036159),0.41975380888147906,1.0445325685421463,0.38823529411764707,0.798113671836138,1.0,2/11,8.26%,DNAAF5;DNAAF1
prerank,rRNA catabolic process (GO:0016075),-0.38777979644418425,-1.0443954639886408,0.39107142857142857,0.643558885599627,1.0,7/16,25.26%,XRN1;EXOSC2;EXOSC3;EXOSC8;EXOSC5;PELO;EXOSC7
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3254159638745028,-1.0440933787394533,0.3724007561436673,0.6439182755616456,1.0,10/33,18.69%,SH3BP4;SESN1;MTOR;CAPN2;UBR2;RPTOR;LARS1;CASTOR1;FYN;UBR1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.31370153639294585,-1.044040309141875,0.37056737588652483,0.643649467250173,1.0,6/36,7.85%,ENG;PPP2R5A;PDGFD;DDX3X;RASSF2;MRE11
prerank,positive regulation of ossification (GO:0045778),-0.31347568893769945,-1.043480488075042,0.39705882352941174,0.6446012686315328,1.0,10/39,12.16%,ZBTB16;BMPR2;BMP6;TGFB2;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,response to fatty acid (GO:0070542),-0.3817068033972913,-1.043335090948767,0.40530973451327434,0.6445554559000283,1.0,4/17,12.72%,FOXO1;IRS1;FOXO3;LPL
prerank,cellular response to copper ion (GO:0071280),-0.3849791038632722,-1.0431404758603375,0.4159132007233273,0.6446512908924541,1.0,10/16,35.95%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F;AQP1;MT3
prerank,cellular response to alcohol (GO:0097306),-0.3065363302245168,-1.0430138230122705,0.36767317939609234,0.6445585960336134,1.0,14/42,21.31%,CTNNA1;GNB1;SMO;LARP1;LRP6;SPIDR;CDH1;PTGFR;KLF9;ADCY1;CTNNB1;GOLPH3;BRCA1;BLM
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2408363654935224,-1.0416709858296533,0.3781942078364566,0.6473279711707837,1.0,53/152,26.87%,XIAP;RSPO3;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;LRRK2;DDX3X;EGFR;CSNK1G3;TRPM4;NFKB1;LRRK1;MACF1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CDC73;CSNK1G1;DKK2;CSNK1D;PLEKHA4;PSMC2;TNFAIP3;LYPD6;USP34;PSMB2;PSMB1;DAAM2;SKI;PSMA8;PSME1;SOX4;TBL1X;GPC3;PSMD4;TERT;CAPRIN2;PSMA7;AMER1;RSPO2;SFRP4;PSMD5;RNF146;SEMA5A;BMP2;WNT5B;PSMB10;FGF10;PSMA3
prerank,negative regulation of macroautophagy (GO:0016242),-0.34596416670140334,-1.0415583895677514,0.4118705035971223,0.6471759688252385,1.0,6/26,10.04%,LRRK2;MTOR;SCFD1;AKT1;CHMP4B;CHMP4A
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3484769481133476,-1.0409270717286747,0.40176991150442476,0.6482329279332222,1.0,14/23,51.44%,GAS6;CEACAM1;TNFAIP3;IGF1;NLRP2B;CARD16;NLRP3;CD33;GIT1;NLRP12;GSTP1;APOA1;FFAR4;ZC3H12A
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.4154392444850856,-1.0407487085251783,0.4147727272727273,0.6482700691822473,1.0,7/13,27.52%,LSG1;ABCE1;RRS1;RPS15;NUP88;RAN;NMD3
prerank,inflammatory response (GO:0006954),-0.23416159003106152,-1.040598831798601,0.34915254237288135,0.6482510478970653,1.0,91/195,41.26%,AFAP1L2;RAC1;MFHAS1;ADGRE5;NOD1;THBS1;F11R;NFATC4;CCL25;PARP4;LOXL3;HNRNPA0;NFKB1;GGT5;MAPKAPK2;HSPG2;PXK;PIK3CD;PTGFR;ADM;AGTR1;MGLL;HDAC4;CD40;ADCY1;TNFRSF1A;NOX4;ANXA1;NRROS;AOC3;IL10RB;CMKLR1;IKBKG;CCL19;IKBKB;LY75;CDO1;RELA;ACKR1;HMGB1;PTGDR;BMP2;HDAC5;F2R;LGALS9;IL22;CXCL10;IL2RA;HYAL3;NLRC4;TGFB1;STAT3;TLR6;VNN1;CEBPB;TLR1;C5AR2;NOS2;TLR5;LAT;CD14;IL1A;NLRP3;PTGER1;S100A9;TBK1;CCRL2;SIGLEC1;HPR;HP;PROK2;CXCL5;TLR2;CCL11;ITCH;CXCL1;CRP;PTGER4;TNFRSF4;CCL4;IL18;PTGER2;CRHBP;CCR1;IL4;PPBP;ABCF1;CD44;CCL8;TUSC2;CRH
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.25769389571976176,-1.0405266464801808,0.39649122807017545,0.6480100552413003,1.0,38/109,27.30%,RAC1;TAB3;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;PSME2;JUN;MAPK1;PSMB4;PLCG2;FBXW11;MAPK8;PIK3CB;PSMC2;GRB2;GAB2;PSMB2;PSMB1;MAP2K4;TAB2;PSMA8;IKBKG;IKBKB;PSME1;PSMD4;VAV2;PSMA7;RELA;PSMD5;MAP3K7;PIK3CA;PSMB10;PSMA3;FCER1G
prerank,positive regulation of potassium ion transport (GO:0043268),0.3140769296302872,1.040452626973594,0.39816933638443935,0.8088994430057713,1.0,9/38,12.02%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;ADRA2A;KCNN3;GABBR1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2377376888310376,1.0401279243737052,0.3591549295774648,0.8082729096849354,1.0,34/140,19.46%,HTR2C;C1QTNF1;ADCY8;CACNA2D1;CALCA;CACNA1A;PTGER3;CACNB3;GRM1;RYR2;TRPM1;C3AR1;CCR6;GPR65;GPER1;ADRA1D;ADRA1A;CIB2;TACR1;NMUR2;P2RX3;SLC8A1;DLG4;BDKRB2;P2RX5;TAC4;PDGFRA;LPAR4;GLP1R;CCKBR;CXCR4;F2RL2;CD24;PTGIR
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3866395767078676,-1.039617016887456,0.39855072463768115,0.6498174664679659,1.0,5/15,20.29%,KDR;VEGFC;IL16;CXCL12;F3
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3873888401349335,-1.0386578198584853,0.3912248628884826,0.6516732407573779,1.0,6/14,26.17%,JAK1;JAK2;SUMO1;IFNGR2;PTPN2;PARP9
prerank,acute-phase response (GO:0006953),-0.4216830710058973,-1.0385301581043214,0.4176991150442478,0.6515969880063314,1.0,10/12,45.31%,IL6R;LBP;PLSCR1;IL22;AHSG;CEBPB;CRP;SIGIRR;ITIH4;IL6
prerank,mitotic nuclear membrane organization (GO:0101024),-0.29269215591618675,-1.0383768905943613,0.3989169675090253,0.6511799553488973,1.0,13/51,19.25%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.29269215591618675,-1.0383768905943613,0.3989169675090253,0.6511799553488973,1.0,13/51,19.25%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA
prerank,signal transduction by p53 class mediator (GO:0072331),-0.325346967090479,-1.038006879020343,0.398876404494382,0.6516893093405649,1.0,8/30,19.64%,PPP1R13B;ACER2;FHIT;TP53;NDRG1;USP10;HINT1;ATRX
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.4396960566831989,-1.0379127237736454,0.44101633393829404,0.6515038710743943,1.0,6/10,26.59%,SMAD4;BRCA1;CHEK1;SMARCB1;RAPGEF3;HDAC5
prerank,T cell activation (GO:0042110),-0.2753425623848494,-1.0376567618030754,0.3929824561403509,0.6517504114419641,1.0,35/69,40.99%,KIF13B;MSN;JAG2;NCK1;CTPS1;CASP8;PIK3CD;NCK2;LCP1;NHEJ1;ICOSLG;LMBR1L;CCL19;SOX4;PTPRC;DLL4;CD276;ADA;PTPN2;EIF2AK4;LFNG;PPP3CB;LAT;CD74;ZAP70;MDK;TNFRSF4;GATA3;GPR89B;GPR89A;CRTAM;LCK;IL4;CD28;CD44
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.22360130247412563,-1.0374637122886892,0.3501683501683502,0.6518424930299805,1.0,59/291,16.45%,DAB2IP;RAPGEF2;GNB1;FOXO1;PKD2;DAPK1;ESR1;LYN;NRIP1;SH3BP4;ATM;TBX1;MTOR;EGFR;PDE3A;ADAM9;FZD4;NFKB1;TNFRSF1B;PXN;IRS1;PDE2A;PDCD4;SLIT2;KCNQ1;IRGM;PRKCD;LBP;RAP1A;PTPRK;MEF2C;EZR;JUN;TGM2;MAPK1;RAP1B;PRKD1;CAPN2;AKT1;NFKBIL1;RAPGEF1;RPTOR;RHOA;IRAK1;CDC73;ACTB;LPL;TPM1;KAT5;WNT11;LARS1;MAPK8;P2RY6;TNFAIP3;IGFBP5;ROCK2;RUVBL2;AGAP3;CHMP5
prerank,intracellular protein transmembrane transport (GO:0065002),-0.3015265837065438,-1.0372122860634987,0.4129263913824057,0.6520467216669558,1.0,20/42,37.61%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;SEC61A1;TOMM70;SEC63;AIFM1;PEX26;DNLZ;TIMM23;PAM16;AKT2;ZFAND2B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3807262144055851,1.0366804830899143,0.4121475054229935,0.8171835685531929,1.0,3/14,12.34%,LPIN1;ETNK1;CHKA
prerank,GTP metabolic process (GO:0046039),-0.3985351742234784,-1.0366067620497497,0.43392857142857144,0.6531745352342612,1.0,4/15,14.14%,GNAI3;LRRK2;RHOQ;RAB23
prerank,transcription by RNA polymerase I (GO:0006360),-0.3169512156312888,-1.0365640420455322,0.42124542124542125,0.6528828219284772,1.0,13/34,28.41%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.35147998115663653,1.03645638396073,0.40582959641255606,0.816240763226707,1.0,4/19,6.12%,HS6ST3;HS3ST5;NDST4;HS6ST2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.26907586937266464,-1.0362818067286828,0.37881508078994613,0.6531455536794298,1.0,32/78,28.41%,MNAT1;PKD2;EGFR;CDKN1B;CCND3;LATS2;AKT1;CCNY;RGCC;ACTB;TFAP4;CDK5RAP3;CCND1;CNPPD1;PTEN;NR2F2;BLM;CDKN2C;CDC25A;GADD45A;MYOCD;CEBPA;CCNYL1;CCNG1;CCNK;CCNE2;ADAM17;CDKN3;APC;CCNJ;CDKN2B;CCNH
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.33131816061241254,1.0361385169176012,0.41280353200883,0.8155877583536897,1.0,8/26,14.47%,ABCA12;NR1D1;ADCY8;EPHA5;ADRA2A;PLA2G6;GPLD1;BRSK2
prerank,skin development (GO:0043588),-0.28089303928327425,-1.0359141004390395,0.40418118466898956,0.6536527936683713,1.0,12/65,11.42%,ITGA6;BCR;ITGA3;LSR;COL5A1;ITGB4;ADAM9;MED1;COL5A2;HRNR;WNT16;TXNIP
prerank,cranial nerve development (GO:0021545),0.4263623978346247,1.0357829697876102,0.4014084507042254,0.815072028537562,1.0,2/11,8.55%,PAX2;POU4F1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.37005655884861643,-1.0352517951836466,0.3897707231040564,0.6548702988127865,1.0,4/18,13.15%,MFHAS1;ZCCHC9;GPATCH2;CHP1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.33587368496683756,-1.0352327633172078,0.4074766355140187,0.6545304394241195,1.0,7/29,12.82%,ENG;TGFBR3;S1PR1;SMAD7;ZFPM1;NOTCH1;TPM1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.41810948838307155,1.0351483859341974,0.4034229828850856,0.8154951381675314,1.0,3/11,8.53%,PTPRT;SOCS3;HGS
prerank,neuron remodeling (GO:0016322),-0.4418227291184964,-1.0347906039515862,0.41312056737588654,0.6551854810668039,1.0,3/10,5.32%,ANKS1A;APP;SCARF1
prerank,negative regulation of transposition (GO:0010529),-0.38114781285790283,-1.034632723555642,0.41480206540447506,0.6551755974206059,1.0,7/16,30.80%,TUT7;UBR2;TUT4;MOV10;TDRD9;DDX4;MYBL1
prerank,protein localization to cell surface (GO:0034394),-0.3407654169471758,-1.033623495624004,0.4080560420315236,0.6572008131777775,1.0,9/26,17.12%,SMURF1;RIC3;PTPRK;FGF7;FLNA;FBLN5;WNT11;ANGPT1;CTNNB1
prerank,regulation of immune response (GO:0050776),-0.24591273959415968,-1.0332025739436903,0.3885819521178637,0.6578168895367502,1.0,25/135,18.01%,FOXP1;ITGB1;XIAP;CD34;LYN;CD200;IL15;ICAM1;CLEC2D;BIRC3;SAMHD1;TGFB2;IRF1;CASP8;PVR;CSK;ITGA4;CD40;PLSCR1;ICAM2;N4BP1;GPR108;VCAM1;ZMPSTE24;ERAP1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4201717499775326,1.0331294163835743,0.4116279069767442,0.8201302439113766,1.0,2/11,4.84%,CD177;CAMK4
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.31703000381255303,-1.0331227862876506,0.41831238779174146,0.6575900991328087,1.0,17/34,30.26%,PTPRB;PTPN1;PTPN9;PTPRJ;PTPN12;DUSP3;PTPN13;UBASH3B;TNS2;DUSP16;DUSP22;PTPN11;PTPRQ;PTPN2;PTPN18;DUSP1;DUSP6
prerank,negative regulation of axon extension (GO:0030517),-0.32551107635357274,-1.0328421670776502,0.4091710758377425,0.6578777749226596,1.0,10/30,18.35%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4137850924994726,-1.0323757357448757,0.4241379310344828,0.6586236813508536,1.0,5/12,21.30%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.41273546457224514,1.0316570131913796,0.4332552693208431,0.8232119658165823,1.0,2/11,5.71%,GMNN;DONSON
prerank,respiratory system development (GO:0060541),0.30899976736462514,1.031344271573618,0.37748344370860926,0.8226428229990779,1.0,7/32,9.25%,WNT7B;PDPN;WT1;PROX1;FGFR2;DNAAF1;VEGFA
prerank,post-translational protein modification (GO:0043687),-0.22066338784585174,-1.0310426605506642,0.36610169491525424,0.6613638733738981,1.0,109/332,30.54%,FBXL7;IGFBP7;ZBTB16;KLHL5;DCAF10;DCUN1D3;PTP4A2;FBXL12;APP;PSMA2;IGFBP4;RAB1A;CUL9;FBXL3;RAB2A;RBX1;GAS6;LMO7;CUL3;DCAF5;BMP4;PSME2;PDIA6;CUL2;WSB2;RAB5A;SPSB1;PSMB4;ADAM10;FEM1A;SOCS2;CUL7;FBXW8;KLHL13;ITIH2;LRRC41;PRKCSH;ANO8;CCDC8;NOTUM;FEM1C;MSLN;ASB1;FBXW11;KLHL25;BTBD1;PSMC2;HIF3A;IGFBP5;SERPINC1;FEM1B;UBE2M;ATG5;ERCC8;PSMB2;PSMB1;F5;DCAF13;RAB11A;PSMA8;KLHL3;EPAS1;PSME1;GPC3;ELOC;PSMD4;COPS7A;MFGE8;LAMB1;FN3KRP;PSMA7;KEAP1;CCN1;ASB7;CHRDL1;KTN1;WDR5;COPS8;PSMD5;RBBP5;FBN1;COPS4;FBXO32;PNPLA2;FBXL22;FBXO17;UBXN7;FBXO40;DTL;RABGGTB;PSMB10;RHBDD1;PSMA3;RAB38;TMEM132A;DNAJC3;ASB4;SCG3;KLHL41;NEURL2;FBXO31;DSCC1;ASB5;SUMF1;MBTPS1;OBSL1;LTBP1;AHSG;COPS5
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.40564430565564047,-1.0309144790873854,0.40669014084507044,0.6612551796578542,1.0,4/12,20.64%,PPARA;NFKBIA;PPARG;ITGB3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2967632538290381,-1.030524801097807,0.411660777385159,0.6617891534800494,1.0,21/47,31.57%,THBS1;TGFBR2;PRKCD;RAB27A;PLCG2;DHRS4;TP53;AGTR1;GRB2;SOD1;PDGFRB;ITGAM;GADD45A;RIPK1;ACE2;ADGRB1;SLC5A3;MAPK14;PID1;TGFB1;TLR6
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.36252056067583044,-1.0304409299108015,0.4028776978417266,0.6616021732900976,1.0,6/20,11.05%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,regulation of cellular localization (GO:0060341),0.28865234813449653,1.030360330462081,0.38636363636363635,0.8241977064596878,1.0,7/46,7.81%,ABCA12;BLK;NR1D1;EPHA5;MAP2;GSN;STXBP2
prerank,oxoacid metabolic process (GO:0043436),0.3297574058097776,1.0302220008788379,0.40492170022371365,0.8230712452721023,1.0,4/27,5.77%,BPNT2;SULT2B1;GNMT;HAO1
prerank,prostaglandin metabolic process (GO:0006693),-0.3378930459423535,-1.0302129355949645,0.39752650176678445,0.6617860791103587,1.0,11/26,24.18%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;ACOX1;HPGDS;DAGLB;PTGR1;PNPLA8;PTGIS
prerank,positive regulation of cellular component movement (GO:0051272),-0.3388295992992176,-1.0300211088545046,0.3948339483394834,0.6618228131773906,1.0,4/24,3.35%,ETS1;LYN;NTN1;SPOCK2
prerank,microtubule nucleation (GO:0007020),-0.36475297505511883,-1.0299906794363514,0.42994241842610365,0.6615007601259241,1.0,10/20,30.18%,CENPJ;RANBP9;SLAIN2;CSNK1D;TUBGCP4;TUBGCP5;NDEL1;AKAP9;TUBG2;TUBGCP3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.2925655239741819,-1.029851148966073,0.3940972222222222,0.6614191311469275,1.0,22/52,28.11%,PAN3;TUT7;CNOT4;SAMD4A;EXOSC2;EXOSC1;EXOSC3;TUT4;PARN;PDE12;RC3H1;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;CNOT2;EXOSC7;CNOT8;CNOT1;LSM2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3509391654308993,-1.0298077268052692,0.42077464788732394,0.6611160417439261,1.0,6/23,8.04%,GNB1;LRRK2;ABL1;KCNQ1;TGM2;MAPK1
prerank,iron ion homeostasis (GO:0055072),-0.28419737691563773,-1.0297527401324809,0.4174397031539889,0.6608476744627639,1.0,13/58,18.25%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;BDH2;PICALM;SMAD4;HFE;HMOX2;ABCB7;SOD1;FLVCR1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.33780250672048895,-1.0296998724807302,0.39572192513368987,0.6605819176257709,1.0,13/25,33.18%,MTHFD1;ADK;AMPD2;HPRT1;AMPD3;PRPS2;ADA;PNP;GMPR2;APRT;SHMT1;DCK;GART
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.4130874169045242,1.0294931279751336,0.43013100436681223,0.8238249501160247,1.0,3/11,12.40%,ST18;GSN;HTRA2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.39536635901299677,1.0293885282186637,0.3854875283446712,0.8225998360675525,1.0,14/14,60.50%,POU4F1;IL23A;TYROBP;ATP6AP1;IFNG;POU4F2;CSF1;TRAF6;IL12B;IL23R;TNF;OCSTAMP;TNFSF11;CCR1
prerank,protein autoubiquitination (GO:0051865),-0.28158111392873436,-1.0288363348307006,0.4074074074074074,0.6622199860242968,1.0,20/61,24.35%,CNOT4;DTX3L;RNF213;CUL3;RNF115;UHRF2;SH3RF1;UBE2D3;RAD18;OBI1;ERCC8;TRIM13;RNF10;RNF4;WWP2;BRCA1;MDM2;SH3RF2;TRIM68;RNF146
prerank,negative regulation of lymphocyte activation (GO:0051250),0.353248057392571,1.0283469209598124,0.4170305676855895,0.82428305579523,1.0,3/21,5.71%,PAG1;SAMSN1;VTCN1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.38832684634654846,-1.0279179644798342,0.41589648798521256,0.6635867333302199,1.0,7/15,27.32%,TNRC6B;AGO2;TOB1;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.38832684634654846,-1.0279179644798342,0.41589648798521256,0.6635867333302199,1.0,7/15,27.32%,TNRC6B;AGO2;TOB1;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,regulation of lipid storage (GO:0010883),-0.36119059757887056,-1.0267803849175312,0.44041450777202074,0.6659455521073291,1.0,9/22,28.13%,NFKB1;NFKBIA;FTO;IKBKE;LPL;ITGB3;PTPN2;HILPDA;ALKBH7
prerank,male meiosis I (GO:0007141),-0.38262876323570366,-1.0264827272576396,0.418848167539267,0.6662245637878224,1.0,7/16,30.91%,ZSCAN21;FOXJ3;HSF2BP;TDRD9;DDX4;MYBL1;FOXJ2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2671118937952066,1.025951728095884,0.407158836689038,0.8300757572955084,1.0,19/69,17.26%,BCL2;TYRO3;CLN3;PTPRZ1;NTRK2;VSTM2L;GRN;PLA2G3;POU4F1;MAG;FZD9;NRBP2;CCL2;BDNF;FGF20;APOE;ADAM8;MSH2;RETREG1
prerank,muscle cell differentiation (GO:0042692),-0.32235314562080997,-1.0258180680018885,0.4014336917562724,0.6674171826514693,1.0,8/32,12.80%,MRTFB;TBX1;SYNE1;MEF2C;TMEM204;CHRNB1;NEBL;SEMA4C
prerank,amino acid transport (GO:0006865),0.28579080274449686,1.0256482689965092,0.41418764302059496,0.8294964257461933,1.0,9/49,9.62%,SLC7A11;SLC7A4;PDPN;SLC6A15;SLC7A8;SLC36A2;SLC7A14;SLC25A45;SLC7A6
prerank,regulation of viral genome replication (GO:0045069),-0.2931277175400937,-1.0253177238435491,0.4110320284697509,0.6682086746191849,1.0,24/56,29.19%,IFIH1;ZC3HAV1;DDX3X;LARP1;PPARA;IFITM3;PLSCR1;PKN2;PDE12;N4BP1;SRPK2;ADARB1;MAVS;RAD23A;STAU1;PPIH;IFITM2;TNIP1;PABPC1;TRIM6;OASL;BST2;RSAD2;PPIE
prerank,regulation of gluconeogenesis (GO:0006111),0.3183181706608941,1.0252282167931244,0.44731182795698926,0.8292094548347949,1.0,7/27,17.18%,DGKQ;GCK;GNMT;DDB1;SIRT7;SELENOS;PGP
prerank,protein insertion into ER membrane (GO:0045048),-0.3075384692520694,-1.025180638921371,0.40555555555555556,0.6681501657772501,1.0,12/37,21.65%,APP;EMD;UBE2J2;SGTA;TRAM2;VAPA;EMC9;EMC2;EMC6;WDR83OS;UBL4A;VAMP2
prerank,response to interleukin-6 (GO:0070741),-0.43700984016252103,-1.0249493657876911,0.4436229205175601,0.6683133521347611,1.0,6/10,31.27%,ST3GAL6;NFKB1;RELA;PTGIS;PID1;SBNO2
prerank,intermediate filament organization (GO:0045109),0.36248543731149824,1.024514767028159,0.4217391304347826,0.8299688014873943,1.0,5/17,16.91%,PKP2;BFSP2;TCHH;NEFL;VIM
prerank,amino acid transmembrane transport (GO:0003333),-0.2989413429854374,-1.024259377177236,0.42533081285444235,0.6695936738823192,1.0,7/45,7.79%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC38A11;SLC38A5;LRRC8D
prerank,type I interferon signaling pathway (GO:0060337),-0.30745628935712827,-1.024253839933917,0.41964285714285715,0.6688123546095818,1.0,10/41,14.94%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1;IFI35
prerank,cellular response to type I interferon (GO:0071357),-0.30745628935712827,-1.024253839933917,0.41964285714285715,0.6688123546095818,1.0,10/41,14.94%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1;IFI35
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.37941504838515394,-1.024249947477228,0.4160958904109589,0.6684280698384268,1.0,5/16,12.27%,PKD2;SIX1;FGF1;BMP4;FGF2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.2950425379674445,1.0241886178890278,0.42596810933940776,0.8294374502818705,1.0,8/40,10.11%,MAGI2;VTN;BICD1;CD63;ATAD1;AHI1;VEGFA;SGIP1
prerank,fatty acid transmembrane transport (GO:1902001),-0.3726411874875628,-1.0238217336958162,0.42363636363636364,0.6690544882846522,1.0,4/19,10.87%,SLC2A1;ABCD3;ACACB;CPT1A
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.37583343790379903,-1.023467181509718,0.4128113879003559,0.6695568882874791,1.0,6/16,19.55%,DTX3L;SHLD1;KMT5B;PNKP;MAD2L2;PRKDC
prerank,negative regulation of bone mineralization (GO:0030502),-0.40087355436154765,-1.0233743107572455,0.41304347826086957,0.6693822138600105,1.0,7/13,30.46%,SRGN;TRPM4;BCOR;PTK2B;RFLNB;RFLNA;AHSG
prerank,carbohydrate biosynthetic process (GO:0016051),0.3458484088201796,1.0232683139820022,0.4230769230769231,0.830770803332261,1.0,5/21,8.29%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,ganglioside biosynthetic process (GO:0001574),-0.38853244327721154,-1.0232115084925402,0.44265232974910396,0.6693595806831506,1.0,5/15,14.37%,ST3GAL1;ST8SIA4;ST6GALNAC3;ST3GAL2;B4GALT5
prerank,chondrocyte differentiation (GO:0002062),-0.31592481307268466,-1.023155402909814,0.42882882882882883,0.6691059604527847,1.0,15/32,33.22%,NFIB;BMPR2;BMP4;CREB3L2;MEF2C;SNX19;CCN3;EIF2AK3;BMP2;WNT2B;WNT5B;RUNX1;TGFB1;SULF1;WNT7A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.3164471228524943,-1.023087628711252,0.39219330855018586,0.6688594308693974,1.0,18/33,37.96%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;MTURN;ARNT;PRKDC;MAPK11;HSPA1B;MAPK14;STAT3;RAB7B;SCIN;HOXA5;HIF1A;FES
prerank,protein homotetramerization (GO:0051289),0.28305457616034235,1.023061487977626,0.42424242424242425,0.8299374462721801,1.0,11/49,15.30%,HCN1;SYCP1;RYR3;AQP4;GNMT;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.38423517992706496,-1.0222509168955543,0.42350746268656714,0.6704900341057084,1.0,3/15,6.02%,ENTPD1;CMPK1;ENTPD6
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3309448729555251,1.0222088610198492,0.4227467811158798,0.8310265599594532,1.0,5/26,6.42%,ATP2B4;AKAP6;EFHB;CAMTA1;FHL2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.35630052572862075,-1.0213114574566502,0.4405594405594406,0.6723342419966434,1.0,10/20,28.16%,BMP5;SIK1;ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3;BMP2;PRMT3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4311318129439983,-1.0212993449877024,0.4537037037037037,0.6719672425833307,1.0,6/10,36.67%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DPYS
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4248688617426043,-1.0212824598295032,0.42857142857142855,0.6716172362799463,1.0,5/10,29.45%,PODXL;FERMT3;PIEZO1;ADA;WNK1
prerank,negative regulation of secretion by cell (GO:1903531),0.301459031394058,1.0211845086701803,0.40617577197149646,0.8327311815495275,1.0,8/38,11.30%,IL1RAPL1;SYT11;CHGA;CYP51A1;TRH;GRM7;IL12A;SYT4
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.41723422550757905,-1.021097132196066,0.4359430604982206,0.6716746236606176,1.0,5/11,20.96%,STX18;ATL2;VCPIP1;MOSPD3;LPCAT3
prerank,regulation of adaptive immune response (GO:0002819),0.3651892759498918,1.0210248156196655,0.42592592592592593,0.8317149729490685,1.0,4/18,8.27%,SASH3;SAMSN1;TRIM27;ADCY7
prerank,transcription by RNA polymerase III (GO:0006383),-0.3297519455317224,-1.0209780587679351,0.4067495559502664,0.6715620294941367,1.0,16/27,41.24%,IVNS1ABP;BRF1;ICE1;SNAPC1;SNAPC3;GTF3C4;POLR2L;POLR3GL;POLR3K;RO60;GTF3C3;GTF3C6;ELL;GTF3A;SNAPC5;POLR3G
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3091962945378188,-1.0209600350415413,0.41323792486583183,0.6712143834993924,1.0,17/39,29.20%,MYH9;TJP2;FLNA;ILK;ACTN1;ACTB;PIK3CB;CLIC1;UBASH3B;FERMT3;ITGB3;VCL;TLN1;PLPP3;MYL9;RAP2B;MEGF11
prerank,peptidyl-arginine modification (GO:0018195),0.373293578028142,1.020861159360286,0.4111111111111111,0.8306583848254743,1.0,4/15,15.90%,PADI1;PADI2;PRMT5;ART4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.38051240435879474,1.0207045288463037,0.4376417233560091,0.8296151610837135,1.0,4/14,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3100924578314266,-1.0201044983079348,0.4218181818181818,0.6728939495576743,1.0,12/36,24.54%,EIF3H;TLK2;FHIT;RYBP;AQP11;HFE;N4BP1;GIPC1;USP7;OGT;TRIM39;TAF9
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.36233645694958566,-1.0199595407273245,0.4267631103074141,0.6724435879558784,1.0,5/20,12.25%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.36233645694958566,-1.0199595407273245,0.4267631103074141,0.6724435879558784,1.0,5/20,12.25%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,myotube cell development (GO:0014904),-0.4246989584046731,-1.0198550197520109,0.4567669172932331,0.6723203779893955,1.0,6/10,36.45%,SIX1;IGF1;SKI;CAV2;MYORG;ACTA1
prerank,regulation of lipase activity (GO:0060191),-0.40525234204057214,-1.0198546018788623,0.4351005484460695,0.6719276076836699,1.0,4/13,13.34%,PCSK5;RHOA;LPL;RHOC
prerank,JNK cascade (GO:0007254),-0.30527292375766596,-1.0198095864601049,0.43485915492957744,0.6716393736422623,1.0,15/40,24.79%,TAB3;NOD1;MAP3K5;MAP4K3;IRAK1;MAPK8;TNFRSF19;MAP2K4;TAB2;IRAK2;IKBKG;NOD2;SH2D3C;MAP3K7;GPS2
prerank,glycoprotein biosynthetic process (GO:0009101),-0.26396144351844847,-1.0196619111032525,0.3982142857142857,0.6716036555340317,1.0,18/79,18.59%,ST3GAL6;ST3GAL4;BMPR2;ST8SIA4;GCNT2;CSGALNACT1;ALG10B;DAD1;B3GNT2;ST3GAL2;CHST11;FUT10;B4GALT5;GAL3ST2;IGF1;GOLPH3;ST6GALNAC2;LARGE1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4186446020742309,1.0192164576786569,0.44130434782608696,0.8324805732437944,1.0,2/10,9.31%,ATP1A2;ADRA2A
prerank,Golgi ribbon formation (GO:0090161),-0.39867912300403596,-1.019153785088787,0.44148936170212766,0.6724713974498567,1.0,8/13,34.06%,VTI1A;MYO18A;TMED5;GOLPH3;TRIP11;FHDC1;STX6;VAMP4
prerank,catecholamine biosynthetic process (GO:0042423),-0.4114590346192877,-1.0188320270102613,0.4288256227758007,0.6728851829483349,1.0,2/11,6.59%,TGFB2;GCH1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3203116750979368,-1.018727149497868,0.42730496453900707,0.6727748461305287,1.0,5/33,9.60%,LEF1;IL34;ACIN1;HAX1;CASP8
prerank,peptidyl-proline modification (GO:0018208),-0.3331048563154656,-1.0187105766699105,0.4065180102915952,0.6724182773061389,1.0,7/25,17.30%,P3H2;NKTR;PPIG;OGFOD1;FKBP5;FKBP10;PPIF
prerank,negative regulation of viral release from host cell (GO:1902187),-0.39832086069625994,-1.0185782409799249,0.4473684210526316,0.6723314722973456,1.0,9/13,46.25%,TRIM13;TRIM28;CHMP3;TRIM35;TRIM32;TRIM5;TRIM21;PML;MID2
prerank,apoptotic cell clearance (GO:0043277),-0.3264752921015924,-1.0178938314808175,0.433392539964476,0.6735780374207512,1.0,14/30,28.27%,RAC1;RHOBTB1;THBS1;GAS6;TGM2;SCARB1;RHOG;RARA;ANXA1;ITGB3;HMGB1;ADGRB1;LRP1;TREM2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.2980353406631179,-1.0172543466659763,0.444253859348199,0.6747344618485753,1.0,11/41,22.54%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188
prerank,response to cholesterol (GO:0070723),-0.36725269058030224,-1.0172307030962298,0.43795620437956206,0.6743842847371018,1.0,4/17,7.68%,SMO;TGFBR2;LRP6;SMAD2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.29107814270396803,-1.0170076272400272,0.40925925925925927,0.6745295225499662,1.0,15/46,26.25%,ZNF423;RB1;ID1;IL15;LAMA4;NOVA2;ADAMTS5;NOTCH1;ATF4;PCTP;ALDH1A1;ACVR2B;RHEB;ACOT11;ADAM17
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3796417803669919,-1.0167989036337897,0.4261992619926199,0.6746894696055398,1.0,6/16,23.02%,SMAD4;BCOR;DNMT1;CTNNB1;BRCA1;WDR5
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3432904562298271,1.0167511847366832,0.42953020134228187,0.8384156292155855,1.0,5/20,10.48%,ATIC;PAICS;AK3;ADSS2;ADSS1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.25056658025654593,-1.0163684936415338,0.42780748663101603,0.6753391979332812,1.0,38/101,34.17%,DAB2IP;LYN;PRKCE;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;LBP;MEF2C;NFKBIL1;RHOA;IRAK1;MTDH;CDC73;MAPK8;TNFAIP3;CHMP5;DEFA6;NOD2;RELA;SERPINE1;CASP1;SHPK;HMGB1;CXCL10;AXL;CACTIN;MAPK14;TGFB1;LILRB1;SBNO2;TICAM1;TNIP2;CD14;IL1A;CARD16;NLRP3
prerank,regulation of leukocyte migration (GO:0002685),0.36770960681874465,1.01617981941848,0.44565217391304346,0.8386676236510383,1.0,4/16,9.25%,TNFSF18;HOXA7;CD81;VEGFA
prerank,cholesterol efflux (GO:0033344),0.3411788225639767,1.016132108561785,0.45161290322580644,0.8372785723182505,1.0,8/20,22.90%,APOM;TSKU;ABCA5;APOE;APOC1;SOAT2;SOAT1;ABCG1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3345674636634648,1.0157207335018898,0.4521158129175947,0.8370260596644723,1.0,6/23,12.61%,PKP2;PROX1;FGFR2;IRX3;TNNC1;MYL2
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.3131220004683681,-1.0153637252810563,0.42526690391459077,0.6773398109589904,1.0,7/34,14.35%,FOXO1;FERMT2;ASXL1;YAP1;ANKRD26;ZFPM1;TRIO
prerank,cardiac conduction system development (GO:0003161),-0.3407553624082426,-1.0149514616695543,0.43992932862190814,0.6779048062926432,1.0,11/24,30.26%,BMP4;SMAD1;MAML1;NOTCH2;SMAD4;HEY1;HEY2;MSX1;GJA5;MSC;HCN4
prerank,regulation of cell communication (GO:0010646),-0.3123980518077335,-1.014839680059964,0.4340659340659341,0.6777803788971584,1.0,9/35,17.80%,GRK5;IGFBP7;PTPN1;CRK;SOCS2;MGLL;NCLN;ANXA1;CASQ2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.29760155991746096,-1.014711649068218,0.42408376963350786,0.6776968937228901,1.0,11/41,22.54%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188
prerank,mitotic nuclear division (GO:0140014),-0.27058775077142444,-1.014394739823679,0.4493783303730018,0.6780820329017778,1.0,35/71,39.50%,EPS8;STAG1;CCDC61;TOGARAM1;PPP2R2D;WRAP73;SMC4;CHMP4B;FLNA;RHOA;ARHGEF10;STAG2;KIF11;RAB11A;DSN1;NDEL1;KIF3B;MISP;KIF18B;INO80;RAN;TUBG2;CDCA8;CEP192;MAP9;PLK1;MIS12;ESPL1;UBE2C;LSM14A;TPX2;TUBG1;SPICE1;NSL1;SMC3
prerank,negative regulation of biosynthetic process (GO:0009890),-0.37648082928431925,-1.0143759817702789,0.4384057971014493,0.677732482826232,1.0,5/16,19.59%,SLC30A10;PPARA;CEACAM1;ABCB7;COA8
prerank,maturation of LSU-rRNA (GO:0000470),-0.3312279030432436,-1.0132771153268132,0.4208566108007449,0.6800179651701813,1.0,8/26,22.80%,RPF1;RRP15;NOP2;RPL7A;RPL7L1;BOP1;PES1;ZNHIT3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.36497798466239284,-1.0129808172943409,0.45719489981785066,0.680314500822015,1.0,4/18,7.39%,CTSC;MSN;VGLL4;EZR
prerank,nuclear membrane reassembly (GO:0031468),-0.282079055775311,-1.012885293178104,0.4238178633975482,0.6801462107401723,1.0,20/54,31.35%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA;NUP188;RAN;UBXN2A;CHMP3;UBE2I;CHMP6;NUP35
prerank,cellular response to ketone (GO:1901655),-0.30921889891679094,-1.01252636199567,0.42935779816513764,0.6805931233676253,1.0,10/35,17.78%,GNB1;NR3C1;MSN;LARP1;PTGFR;NCOA4;KLF9;ROCK2;ADCY1;GOLPH3
prerank,organophosphate ester transport (GO:0015748),-0.33193887514129666,-1.012342103712724,0.4491682070240296,0.680630981894441,1.0,8/24,23.47%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PCTP;PRELID2;OSBPL2;PITPNA
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2662542737632537,-1.0118977429981255,0.4126712328767123,0.6812949053143782,1.0,22/74,23.69%,CREBBP;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;NOTCH1;PSMC2;HIF3A;PSMB2;PSMB1;ARNT;PSMA8;EPAS1;CITED2;PSME1;ELOC;PSMD4;PSMA7;NFE2L2;PSMD5
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.33861430954198807,-1.0116011576962436,0.44074074074074077,0.6812170204984228,1.0,4/23,3.33%,CREBBP;DAB2;THBS1;RNF111
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.33861430954198807,-1.0116011576962436,0.44074074074074077,0.6812170204984228,1.0,4/23,3.33%,CREBBP;DAB2;THBS1;RNF111
prerank,regulation of inclusion body assembly (GO:0090083),-0.4156863228599813,-1.0112304706363384,0.45207956600361665,0.6817180387178382,1.0,2/11,8.03%,SNCAIP;DNAJB6
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3473655807887709,-1.011039832920089,0.45108695652173914,0.6817927061366066,1.0,10/23,34.01%,COX18;SAMM50;AGK;BCL2L11;HSP90AA1;TIMM10;TOMM70;PMAIP1;TIMM10B;TIMM13
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.42330706695020887,-1.010993350244516,0.4660714285714286,0.6815183264868717,1.0,4/10,19.26%,RNF125;SEC14L1;GPATCH3;TKFC
prerank,regulation of telomerase activity (GO:0051972),-0.29181643242789485,-1.0108189578123812,0.4187725631768953,0.6815459330868173,1.0,11/45,14.30%,KLF4;NEK7;ATM;PARP4;TCP1;MAPK1;TP53;HMBOX1;PNKP;PARN;PTGES3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.2593914521997195,-1.0104313919260655,0.4365217391304348,0.6820772261432781,1.0,36/86,33.05%,CREBBP;KLF2;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;TP53;ATF4;PSMC2;HIF3A;PSMB2;PSMB1;GCN1;ARNT;PSMA8;EPAS1;PSME1;ELOC;PSMD4;PSMA7;CHEK1;MAPK7;NFE2L2;PSMD5;INO80;PSMB10;PSMA3;HMOX1;HIGD1A;DDIT3;STOX1;PSMD13;PSMB6;ATF3
prerank,vitamin transport (GO:0051180),0.31437881694792386,1.0099736627952338,0.42857142857142855,0.8529096246838944,1.0,8/29,12.08%,CBLIF;PDPN;SLC46A1;SLC19A1;SLC2A10;GC;SLC2A8;SLC35F3
prerank,sister chromatid segregation (GO:0000819),-0.3165122799017464,-1.0096526635328427,0.4421052631578947,0.6835162818990853,1.0,15/31,39.08%,RB1;WRAP73;SMC4;DSN1;KIF18B;INO80;RAN;TUBG2;CDCA8;PLK1;MIS12;ESPL1;TOP2A;TUBG1;NSL1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.42052418419769394,-1.009491049570848,0.45269016697588127,0.683480991224115,1.0,3/11,9.84%,NOS3;GCH1;AKT1
prerank,cellular response to amyloid-beta (GO:1904646),0.29993358836764394,1.009397071065777,0.42725173210161665,0.8530597487154417,1.0,5/35,4.29%,GRM5;CDK5;CACNA2D1;GRIN2A;CACNA1A
prerank,regulation of protein metabolic process (GO:0051246),-0.29186611130796086,-1.0093519184023398,0.45072992700729925,0.6834127073520716,1.0,14/44,22.90%,KLF4;NEDD4L;KLF2;APP;ACE;SPOPL;LTBP4;MAPK8;ROCK2;ABCA7;SPOP;MDM2;MAPK7;MTPN
prerank,aorta development (GO:0035904),-0.39212242340644715,-1.0078063656867229,0.46788990825688076,0.6867230190794802,1.0,6/14,9.23%,PKD2;TBX1;PDE2A;TBX2;HECTD1;ADAMTS9
prerank,relaxation of muscle (GO:0090075),0.3912030744525767,1.007558905158406,0.43648960739030024,0.8572409510258523,1.0,4/13,11.91%,ATP1A2;ATP1B1;GSN;SLC8A1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3947818756995032,1.007196227155709,0.42038216560509556,0.8567520252835111,1.0,4/12,14.66%,GINS4;CDC45;MUS81;CDC7
prerank,L-amino acid transport (GO:0015807),-0.32539355161609435,-1.007042826761993,0.4444444444444444,0.6880820358991251,1.0,10/28,21.38%,SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC7A2;SLC1A4;SLC3A2
prerank,glycogen catabolic process (GO:0005980),0.37649530752245164,1.0070349089283859,0.45011600928074247,0.8556983066437998,1.0,7/15,18.43%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.27822663193774827,-1.0066471700003794,0.4482758620689655,0.6886106718075253,1.0,13/56,18.97%,TAB3;NOD1;LBP;MAPKAPK2;PLCG2;ALPK1;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;NOD2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2377770317226521,-1.0065609044271187,0.42857142857142855,0.688428273840665,1.0,48/146,26.92%,FBXL7;CENPJ;PSMA2;YWHAE;CEP57;RBX1;CEP250;PSME2;CEP78;PSMB4;HAUS8;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;MECP2;CEP41;PSMC2;PSMB2;PSMB1;ALMS1;RAB11A;PSMA8;PLK4;PCM1;CETN2;CNTRL;CEP152;PSME1;CCND1;PSMD4;ODF2;PSMA7;CDC25A;HSP90AA1;FHL1;PCNT;CEP131;AKAP9;PSMD5;PINX1;BRD4;DTL;PSMB10;PSMA3;KIF14;DYNLL1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4287524215617586,-1.0063153080326523,0.46221441124780316,0.6886347656665639,1.0,5/10,30.27%,ATF4;HERPUD1;NFE2L2;EIF2AK3;DDIT3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2625743694835609,-1.0057204273879623,0.4347048300536673,0.6896852386763688,1.0,21/80,19.16%,ARF3;STX18;ARCN1;RAB1A;GOLPH3L;COPG1;SCFD1;KDELR3;COPA;KIF23;COPE;ERGIC2;KIF11;USE1;KIF15;ATP9B;KIF26A;LMAN2;GOLPH3;CENPE;KIF3B
prerank,regulation of centrosome cycle (GO:0046605),-0.3489265504599047,-1.005389882849431,0.45161290322580644,0.6900918361037085,1.0,14/21,42.29%,CHMP4B;CHMP2B;CHMP5;PDCD6IP;CEP131;ATF5;CHMP3;CHMP1A;AURKA;PKHD1;CHMP1B;MARK4;SIRT1;NAT10
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.31893072373200493,-1.0050899860694218,0.44609665427509293,0.6904446249784975,1.0,12/30,29.10%,HPS4;GSK3A;UBE2J2;UBE2D3;UBE2L3;BAP1;NPEPPS;HUWE1;FZD5;SAE1;ARIH2;RNF31
prerank,positive chemotaxis (GO:0050918),-0.3616256131629059,-1.004854490087789,0.4561717352415027,0.6905749981799119,1.0,8/17,32.78%,PTPRJ;FGF7;ANGPT1;SEMA5A;FGF10;MET;CORO1A;TSC2
prerank,cellular response to radiation (GO:0071478),-0.3047397750117333,-1.0047535952094717,0.4584070796460177,0.6904315159423174,1.0,23/40,40.42%,NET1;SPIDR;TP53;NSMCE3;GRB2;LIG4;BLM;GADD45A;INTS7;INO80;KDM4D;RAD51AP1;GPR52;SWI5;MAPK14;EEF1D;RRH;OPN1MW;OPN1MW3;GPR88;RAD1;CDKN1A;SIRT1
prerank,regulation of interleukin-4 production (GO:0032673),-0.34425313703129734,-1.0047280868965205,0.43853211009174314,0.6901058314702327,1.0,2/21,2.43%,LEF1;SLC7A5
prerank,negative regulation of reproductive process (GO:2000242),0.3582453652284027,1.0037763861725633,0.44642857142857145,0.8641294409997642,1.0,6/17,22.57%,SPINK13;NPPC;TIMP1;ACVR1C;GJA1;WDR77
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3262618315695048,-1.0032911672477325,0.4404332129963899,0.6931589303163926,1.0,6/26,13.89%,ADIPOR2;ELOVL5;ACADL;CEACAM1;ERLIN2;ACADVL
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.21947802333426195,-1.0030363337550514,0.459866220735786,0.6933683326347774,1.0,82/264,27.75%,SRSF11;CDK13;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;FUS;PRPF6;SF3B6;SPEN;RBM19;HNRNPM;POLR2G;PHF5A;DDX39B;SF3B1;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SFPQ;SLU7;CTNNBL1;SNRPE;SCNM1;SF3A1;TGS1;HNRNPA1;SYNCRIP;SRSF12;SRPK2;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;STRAP;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;COIL;RBM15;PCBP1;POLR2C;GEMIN7;USP39;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;HNRNPL;HNRNPD;PABPC1;HNRNPU;SCAF11;TXNL4A
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3137096194640762,-1.002741964314763,0.44424778761061945,0.6936772613387261,1.0,8/31,14.78%,PARD3B;PARD3;MSN;DLG1;EZR;RHOA;MTCL1;MARK2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.35458030281485775,-1.0026622851580116,0.4681647940074906,0.6934851108738112,1.0,5/20,15.33%,LRRK2;ADGRV1;TCIM;IAPP;MIF
prerank,regulation of cilium assembly (GO:1902017),-0.2768958721787584,-1.0025122661565684,0.4256505576208178,0.6934481126357528,1.0,19/62,19.31%,LIMK2;TBC1D1;TBC1D2B;IFT140;CDK10;USP6NL;TBC1D30;TBC1D14;YAP1;CROCC;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;TBC1D20;FUZ;ARHGAP35;TBC1D8;TBC1D17
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4087831897167262,-1.0024355508744365,0.4694589877835951,0.6928315052741554,1.0,6/11,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.4087831897167262,-1.0024355508744365,0.4694589877835951,0.6928315052741554,1.0,6/11,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,negative regulation of signaling (GO:0023057),0.323124542120015,1.002200185395817,0.4282511210762332,0.8674463241083793,1.0,3/25,3.44%,OPRM1;IGFBP3;GLRA1
prerank,catecholamine metabolic process (GO:0006584),-0.38062528969569553,-1.0020948822418299,0.4716981132075472,0.6932981590726361,1.0,1/14,1.18%,SNCAIP
prerank,negative regulation of ATPase activity (GO:0032780),-0.3714671170187642,-1.001953509781569,0.45652173913043476,0.6932395795985561,1.0,4/16,18.24%,PXK;TP53;PPIF;PLN
prerank,positive regulation of TOR signaling (GO:0032008),0.29150473765253365,1.0015304174572082,0.45308924485125857,0.8679779655937908,1.0,7/40,8.52%,GPR137C;PIP4P1;RRAGA;HDAC3;FLCN;KLHL22;SEH1L
prerank,protein targeting to mitochondrion (GO:0006626),-0.27997831524063593,-1.0015232868733424,0.44703770197486536,0.6939042070202436,1.0,22/52,36.31%,SAMM50;TOMM40;BCAP31;AGK;IMMP1L;TIMM17B;TOMM5;DNAJC19;TOMM40L;HSP90AA1;TIMM50;TIMM10;PMPCA;IMMP2L;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;DNLZ;TIMM23;PAM16
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3681895341048874,-1.000812481537768,0.45569620253164556,0.6952052692429295,1.0,3/15,7.57%,ADAM9;TNFRSF1B;SNX9
prerank,regulation of myoblast differentiation (GO:0045661),-0.3058128762422573,-1.0003205991700919,0.44153577661431065,0.6960020555530156,1.0,16/32,31.54%,BOC;PLCB1;BMP4;MEF2C;NOTCH1;SMYD1;TBX3;RBM24;EID2B;ZFP36L1;LRRC8A;KLHL41;MAPK14;TGFB1;XKR8;SOSTDC1
prerank,response to growth factor (GO:0070848),-0.29316508776648986,-1.0003049189846769,0.43079584775086505,0.6956430284312212,1.0,12/41,22.04%,ACVRL1;KLF4;BMPR2;EMD;TGFBR2;ACVR2A;AKT1;HDAC6;CTNNB1;EPHA2;MAPK7;NOS1
prerank,leukotriene biosynthetic process (GO:0019370),-0.380667402878628,-1.0002571704076662,0.43392857142857144,0.6953415787321726,1.0,2/14,5.88%,PLA2G4A;GGT5
prerank,amyloid-beta metabolic process (GO:0050435),-0.37415425573711447,-1.0000432545006614,0.47574626865671643,0.6954433263532427,1.0,6/16,17.16%,DYRK1A;ACE;PSEN2;PSEN1;ABCA7;APH1A
prerank,glucose import (GO:0046323),-0.39093446428185563,-0.9998752965122674,0.49536178107606677,0.6954618309631961,1.0,3/13,11.66%,SLC2A1;RAB4B;SLC27A4
prerank,cellular response to peptide (GO:1901653),-0.2739082260663239,-0.9998486659723432,0.4524647887323944,0.6951328211605716,1.0,16/56,16.68%,IGF1R;CAV1;NOD1;GSK3B;APP;ICAM1;EPHA4;ARHGEF2;TP53;PSEN1;ITGA4;LGMN;IGF1;CHMP5;VCAM1;FYN
prerank,regulation of centrosome duplication (GO:0010824),-0.3140452572663349,-0.9997370981293433,0.45863309352517984,0.6949976881392809,1.0,10/30,26.82%,CENPJ;PLK2;CHMP4B;CHMP2B;CHMP5;ALMS1;PDCD6IP;CEP131;CEP295;CHMP3
prerank,regulation of amyloid fibril formation (GO:1905906),-0.37599889461618496,-0.9995103192008705,0.43727598566308246,0.6951275433039192,1.0,5/15,19.65%,APP;VBP1;PSEN1;IAPP;PFDN6
prerank,cellular respiration (GO:0045333),0.2872664327797139,0.9992142929130642,0.4598698481561822,0.87351006053586,1.0,17/41,27.04%,SLC25A13;UQCR10;NR4A3;UQCRH;SDHA;NDUFA5;NDUFS8;LYRM7;NDUFS7;MDH2;UQCRB;ME3;MTLN;PPARGC1A;OXA1L;MTFR1L;NDUFS1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2295166164919151,-0.9991679730145893,0.46048109965635736,0.6955630461967296,1.0,47/171,21.85%,TTC28;AFAP1L2;RB1;NEK7;BTG3;IQGAP1;CDK13;APP;PSMA2;SIK1;NEK6;CUL9;CDKN1B;RNF40;CDK10;PSME2;PSMB4;USP2;ERCC2;TAL1;CUL7;PTPN3;CDC16;ANAPC16;DUSP3;CCDC8;XPC;PKN2;ERCC3;PSMC2;FOXC1;BTG2;PSMB2;SMOC2;LGMN;PSMB1;TFAP4;PSMA8;CDK5RAP3;PSME1;BUB1B;CDK11B;ANGEL2;PSMD4;MDM2;BUB3;PSMA7
prerank,monocyte chemotaxis (GO:0002548),-0.31022468189381186,-0.9989428815261088,0.4737827715355805,0.6957147799447136,1.0,3/32,5.33%,FLT1;CCL25;IL6R
prerank,mitochondrial translational termination (GO:0070126),-0.2525074932402394,-0.9981598006379133,0.4511545293072824,0.6972070044146711,1.0,30/88,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MTRF1L;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;MRPL11;MRPS31
prerank,ceramide metabolic process (GO:0006672),-0.2824305666754688,-0.9978253945913069,0.4504672897196262,0.6976326754980603,1.0,16/49,20.08%,SGMS1;ACER2;DEGS2;SGMS2;ST6GALNAC3;CERS4;ACER3;AGK;ORMDL1;SPTLC1;ASAH1;CERS5;SMPD2;PPP2CA;DEGS1;ORMDL3
prerank,ureteric bud morphogenesis (GO:0060675),-0.37108667878354473,-0.9976690735756277,0.444633730834753,0.6976304322271877,1.0,5/16,13.26%,PKD2;SIX1;BMP4;FGF2;WNT11
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3911182553013792,0.9970448084855487,0.47368421052631576,0.8785953200789921,1.0,3/11,6.16%,ENPP2;PDPN;ARHGEF7
prerank,secretory granule organization (GO:0033363),-0.41406962502404576,-0.9966064575203978,0.47338403041825095,0.6998792244303692,1.0,7/10,45.10%,SRGN;F2R;BLOC1S2;BLOC1S1;F2RL3;BLOC1S3;DTNBP1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.4094909709666652,0.9964856243453987,0.4339622641509434,0.8787969835515085,1.0,3/10,6.03%,HECW1;OSR1;HECW2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.38831201558877937,-0.9961016622289627,0.48877374784110533,0.7006599002430804,1.0,3/15,9.30%,SIK1;SCARB1;MFSD2A
prerank,diol biosynthetic process (GO:0034312),0.36493099972251203,0.9957459795273691,0.4475374732334047,0.8795401646902508,1.0,5/15,9.92%,QDPR;SPHK1;ACER1;ABCA2;SPHK2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3634680010795955,-0.9955472984210344,0.469811320754717,0.7015582273903351,1.0,9/15,36.48%,NEK6;CDC16;TPR;CENPE;TACC3;ANAPC7;PLK1;CDC6;UBE2C
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3337735436003749,0.9955066292470728,0.4703296703296703,0.8787294562893054,1.0,5/22,15.13%,PDE3B;BSCL2;ADRA2A;GPER1;APOC1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3688676696666017,0.9953835410029597,0.46258503401360546,0.8775468266552601,1.0,6/14,21.60%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,glucose homeostasis (GO:0042593),-0.2534476457729975,-0.9952260527309605,0.47368421052631576,0.7019615829718601,1.0,10/83,8.48%,KLF7;IGF1R;FOXO1;INSR;ADIPOR2;PIK3R1;IRS1;RBP4;LRRC8D;HECTD4
prerank,negative regulation of transferase activity (GO:0051348),-0.32201284601541946,-0.9947180764028186,0.44922547332185886,0.7027892806865639,1.0,7/28,11.55%,GSK3B;DTX3L;CDKN1B;ABL1;GSK3A;TP53;SMAD7
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.23761538184121905,0.9940758116557464,0.45454545454545453,0.8800464077932985,1.0,20/110,10.78%,ADGRB3;ADGRL3;ADCY8;CALCA;GNAL;GPR101;ADGRG4;CNR1;PTGER3;ADRA2C;PF4;ADCY7;ADRB3;ADRA2A;GPR65;TSHR;GPER1;LGR5;ADRA1D;ADRA1A
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.33079417565960373,0.9940053242298211,0.4634146341463415,0.8787086720972267,1.0,4/23,10.33%,NRG1;AKAP6;PROX1;MYLK3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.26451524550257394,-0.9938861206555992,0.4719710669077758,0.7043963146237616,1.0,15/63,19.32%,SLC7A1;IL15;IL6ST;TFRC;CD38;NCK1;MEF2C;NCK2;CD40;MIF;VCAM1;ANXA1;CCL19;CLCF1;PTPRC
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.30861355153020914,-0.9937625117117393,0.476280834914611,0.7042956666802742,1.0,17/34,34.14%,DAB2IP;MFHAS1;LYN;NFKBIL1;OTUD4;TNFAIP3;GPR108;GPS2;CD300LF;NLRP2B;TREM2;CACTIN;TICAM1;TLR6;RAB7B;CD14;LRRC14
prerank,iron ion transport (GO:0006826),-0.2874503784388692,-0.9936302742875965,0.4681647940074906,0.7042166223729278,1.0,11/47,14.16%,SLC40A1;TFRC;DNM2;STEAP3;SCARA5;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15;ABCB7
prerank,positive regulation of T cell activation (GO:0050870),-0.26740961266915114,-0.9927911635119633,0.46629213483146065,0.7058452061486168,1.0,12/62,19.32%,ZMIZ1;SLC7A1;IL15;IL6ST;TFRC;NCK1;NCK2;VCAM1;ANXA1;CCL19;NOD2;PTPRC
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3647089944500275,-0.9922526819682789,0.44964028776978415,0.7067592766664601,1.0,4/17,11.32%,SLC9A2;SLC12A2;TRPM4;SLC9A5
prerank,response to muscle stretch (GO:0035994),0.36421652424847306,0.9922205598577354,0.4611872146118721,0.8826109271606077,1.0,4/15,11.91%,GSN;RYR2;CDH2;SLC8A1
prerank,regulation of interleukin-6 production (GO:0032675),-0.247668583115588,-0.9920628900779442,0.4697508896797153,0.7068227280434144,1.0,36/96,36.11%,AFAP1L2;CD200;IFIH1;APP;IL6R;GAS6;LBP;MAPKAPK2;ARHGEF2;PLCG2;LPL;IL17RA;TNFAIP3;C1QTNF3;IL16;MAVS;HYAL2;NOD2;PTPN11;ARRB1;HMGB1;DHX9;F2R;LGALS9;TREM2;STAT3;TLR6;TLR1;C5AR2;NOS2;RAB7B;IL1A;TSLP;CD74;TLR2;TLR8
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3936880235574183,0.9920476977490293,0.47333333333333333,0.8815918862138802,1.0,7/12,24.08%,ACLY;ACO1;IDH3A;GLUD1;ACO2;SIRT4;IDH2
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4034424017153307,-0.9919671438555869,0.4593128390596745,0.7062607889048944,1.0,3/11,19.10%,NOTCH4;AGO2;TNRC6A
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4034424017153307,-0.9919671438555869,0.4593128390596745,0.7062607889048944,1.0,3/11,19.10%,NOTCH4;AGO2;TNRC6A
prerank,ceramide biosynthetic process (GO:0046513),-0.29968576416722864,-0.9918941805371979,0.46654275092936803,0.7060495439600516,1.0,11/40,16.85%,SGMS1;ST8SIA4;DEGS2;SGMS2;ST6GALNAC3;CERS4;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,phospholipid biosynthetic process (GO:0008654),0.29658189654614914,0.9917557698768154,0.4818181818181818,0.8809843744759018,1.0,10/36,13.87%,IDI2;FADS1;CLN3;HDHD5;FAR1;CPNE1;SPHK2;GNPAT;NUS1;IDI1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.329156002989248,-0.9914517384138012,0.45774647887323944,0.7067276131831906,1.0,8/24,24.65%,POLD3;RPA3;RPA1;RPA2;LIG4;RFC4;RFC1;LIG1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.39797576268080725,-0.9911222544933345,0.47302158273381295,0.7071496175047594,1.0,7/12,35.02%,TIPARP;PARP11;PARP16;PARP6;TNKS2;PARP3;TNKS
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3552366187548596,-0.9911130417305951,0.4575971731448763,0.7067799999498279,1.0,9/18,26.59%,HDAC1;GSK3A;NOTCH1;HDAC4;CCN3;FRS2;FZD7;BMP2;HDAC5
prerank,fatty acid beta-oxidation (GO:0006635),-0.2776963621590574,-0.9909859457959449,0.474169741697417,0.7066985846358003,1.0,10/51,17.47%,HADHB;ABCD3;BDH2;PPARD;ACADL;ACAD11;CRAT;ACADVL;ACOX1;ACOX3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.283348750032289,-0.9906582292058214,0.4757630161579892,0.70711277877131,1.0,12/47,16.68%,RAPGEF2;CAV1;CD34;SIK1;NFKB1;ACADL;CEACAM1;ERLIN2;ACADVL;ROCK2;C1QTNF3;FYN
prerank,positive regulation of heart contraction (GO:0045823),-0.3499526062772541,-0.9906194977337897,0.4547038327526132,0.7068234946706873,1.0,7/19,11.69%,TRPM4;TGFB2;KCNQ1;GSK3A;EDN1;ADM;EDN3
prerank,translational elongation (GO:0006414),-0.24455368526301355,-0.9904139745701726,0.4710017574692443,0.7068886898211333,1.0,35/101,27.22%,DAP3;LTN1;PTCD3;MRPL32;MRPL47;EEF2;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;NEMF;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;EEF1B2;MRPL11;MRPS31;EEF1G
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3210077509965865,0.9901287516356385,0.4613733905579399,0.8845016499369831,1.0,4/22,10.42%,RASL11A;DDX11;DHX33;IPPK
prerank,negative regulation of cell cycle (GO:0045786),-0.2587453209394033,-0.9900310166162251,0.46567717996289426,0.707440683822469,1.0,31/73,30.86%,PPP1R13B;RB1;BTG3;CDKN1B;PDCD4;BMP4;PTPRK;LATS2;PTPN3;CDK6;NUDT6;RNF167;FOXC1;BTG2;BMP7;TFAP4;ANGEL2;PTEN;NR2F2;MYOCD;CEBPA;BMP2;SIPA1;NUPR2;APC;NLRP2B;DUSP1;TRIM35;TGFB1;CHMP1A;LILRB1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.40093223836054315,0.9897076654409984,0.4790794979079498,0.8842261998391983,1.0,4/11,13.72%,DDX11;NOP53;IPPK;SIRT7
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.35661496783001323,-0.9893301953593554,0.46703296703296704,0.7086875105090095,1.0,3/18,11.38%,SLC2A1;OCLN;BRAF
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.28975118732529465,-0.9892338993023184,0.47882136279926335,0.7085307582594431,1.0,16/42,33.07%,RNASE7;IL6R;IRGM;LBP;RNASE3;DEFA6;DROSHA;SERPINE1;RPL30;ADGRB1;TREM2;SELP;MPEG1;TNFRSF14;NOS2;AQP1
prerank,proteasome assembly (GO:0043248),-0.4095719444336056,-0.9890345365172335,0.4918032786885246,0.708655172083085,1.0,7/11,32.21%,PSMG2;ADRM1;PSMD4;PSMD5;PSMG1;OTUD6B;PSMD13
prerank,histone H2A ubiquitination (GO:0033522),-0.3578055820859474,-0.9889413568108678,0.48440366972477067,0.7084872653000491,1.0,6/17,19.05%,DTX3L;RYBP;UBR2;RNF168;BCOR;RNF2
prerank,positive regulation of viral transcription (GO:0050434),-0.32119153883655766,-0.9888905143760421,0.48956356736242884,0.7082025955059658,1.0,12/25,33.72%,POLR2G;MDFIC;NELFB;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;NELFA;NELFCD;POLR2E
prerank,regulation of bone mineralization (GO:0030500),-0.2779129664880349,-0.9886405516587936,0.47048300536672627,0.7084289927563924,1.0,21/55,24.99%,BMPR2;SGMS2;SRGN;TRPM4;BMP6;BMP4;MEF2C;ACVR2A;S1PR1;ADGRV1;ANO6;PKDCC;NOTUM;BCOR;BMP7;ANKH;PTK2B;CCN1;PTN;ACVR2B;BMP2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3365162780476969,-0.9883226527614551,0.4946236559139785,0.7088470062752107,1.0,10/20,34.93%,SP100;SYNE1;TAF8;SUN1;TAF3;ARL2;HNRNPU;MORC3;PARK7;TOPORS
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.34482220985919293,-0.9882802778523565,0.4742857142857143,0.7085442130158051,1.0,8/20,18.83%,DLG1;RHOQ;ROCK1;LCP1;NCKAP1;ROCK2;FMNL2;IKBKB
prerank,regulation of calcium-mediated signaling (GO:0050848),0.31780299361490916,0.9881527986459686,0.46153846153846156,0.8875091067973035,1.0,8/25,16.74%,RIT2;PLEK;SLC8A2;MAPT;P2RX3;P2RX5;HTT;CDH13
prerank,protein targeting (GO:0006605),-0.24055131410329708,-0.9878771225670818,0.489247311827957,0.7090981911424015,1.0,58/118,39.53%,PARD3;RASSF9;PEX1;KIF13B;TRAK1;ZDHHC6;ZDHHC3;HPS4;AQP11;SRPRA;FUT10;TOMM40;BCAP31;GABARAP;ZFAND6;TIMM17B;TOMM5;SRP14;AP4M1;LAMP2;GIPC1;DNAJC19;ZDHHC1;AP4B1;ZDHHC4;HOMER3;PEX6;ZFAND2A;ZDHHC12;RAB3IP;TIMM10;TOMM20;SEC61A1;ATG3;VPS37B;TOMM70;HACL1;PEX19;RTP4;GOLGA7B;LONP2;ZDHHC9;SEC63;TIMM10B;ZDHHC22;TIMM13;NCF1;VPS37C;TIMM23;ICMT;YIF1B;RABGEF1;ZFAND2B;CDC37;TAOK2;AIP;LTBP2;RTP3
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.316471979167982,-0.9878342354614745,0.4808362369337979,0.7087998352648919,1.0,12/28,24.03%,EGFR;NOTCH3;ZBTB7A;ARRDC1;AKT1;TCIM;HEY1;GATA2;RITA1;WWP2;DLL4;ARRB1
prerank,response to cAMP (GO:0051591),-0.3003845934306868,-0.9877944967261763,0.496309963099631,0.7085018099756122,1.0,8/37,11.03%,RAPGEF2;PKD2;PDE2A;KCNQ1;RAP1A;EZR;RAP1B;RAPGEF1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.2787267197656055,-0.9877203113054303,0.45960502692998206,0.7082937816395569,1.0,12/49,16.38%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1
prerank,positive regulation of calcium ion transport (GO:0051928),0.284222850095087,0.9876944433977802,0.4663677130044843,0.8873606749825931,1.0,9/36,14.37%,STC1;WNK3;CACNA1D;SPHK2;LILRA5;P2RX3;CCL5;CCL2;P2RX5
prerank,ether lipid biosynthetic process (GO:0008611),0.4122768257375153,0.9872567578017405,0.48497854077253216,0.8870930054418531,1.0,6/10,17.55%,FAR1;GNPAT;DHRS7B;PEDS1;CHPT1;LPCAT2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.34459110676805316,-0.9872362837123226,0.49217391304347824,0.7091091731069233,1.0,7/21,27.01%,KDR;MAPK1;IGF1;CTSH;ZFP36L1;FGF10;LGALS9
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3191032297837385,-0.987228768780528,0.4665461121157324,0.7087402402092359,1.0,9/27,23.29%,DYRK1A;ATM;SPRED2;YJU2;KMT5A;MIF;HIC1;MDM2;MSX1
prerank,neural crest cell development (GO:0014032),-0.2891028629398168,-0.9871682106712909,0.49475524475524474,0.7084788551057866,1.0,13/44,18.35%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;KLHL12;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,cellular response to hormone stimulus (GO:0032870),0.25397663654534247,0.9870453048999636,0.4841628959276018,0.886284926879228,1.0,11/69,9.96%,ROBO2;NCOA2;ATP1A2;GCK;AKR1C1;WT1;NR4A3;ADRA2A;CYP11B1;SLIT3;GPER1
prerank,vesicle transport along microtubule (GO:0047496),0.32517183886714823,0.9869767459615418,0.47558386411889597,0.8849617511921556,1.0,11/23,19.74%,CLN3;KIFAP3;KIF5A;KIF3A;DYNC1I1;KIF1C;HTT;TRAK2;BICDL1;HAP1;FYCO1
prerank,mesoderm development (GO:0007498),-0.3577502540631085,-0.9869017195091737,0.47289719626168225,0.7087623206192278,1.0,4/18,11.47%,TIE1;TBX1;BMX;JAK2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3910052375849623,0.9862749410998778,0.49023861171366595,0.8857088514796934,1.0,3/12,11.87%,LPIN1;VRK1;PRKCB
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3876078706617767,-0.9861620443478234,0.48566308243727596,0.7101790569985535,1.0,5/13,22.46%,NOS3;GCH1;AKT1;MTHFD1L;HSP90AA1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.34050649817635614,0.9859279592459668,0.46875,0.885269711260429,1.0,6/20,16.03%,SLC25A23;PHB2;PMPCB;SLC8A3;MCU;SLC8B1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.3839442997852589,-0.9848672905218067,0.47377938517179025,0.7129059279751612,1.0,6/13,35.95%,ABL1;HDAC6;NOD2;SZT2;HP;MT3
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.32935708191167085,0.9846802380288245,0.48873873873873874,0.8876433794428232,1.0,7/22,18.98%,CYP24A1;GC;CBR1;ALDH1A2;LRAT;CYP1A1;RBP1
prerank,histone exchange (GO:0043486),0.28793712926645987,0.984512087120918,0.4881720430107527,0.8866433692171795,1.0,12/37,20.27%,SMARCA5;CENPS;ACTR6;MIS18BP1;OIP5;RUVBL1;RNF8;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3308161749769625,-0.9844745309397498,0.4565972222222222,0.7134431917110633,1.0,7/25,11.85%,LIMK2;SLIT2;PRKCD;CDK10;TBC1D30;YAP1;ABI3
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.40970315459149464,-0.9841289042616611,0.48794063079777367,0.71386388047568,1.0,3/11,7.39%,DAB2;MSN;EZR
prerank,cGMP metabolic process (GO:0046068),-0.39510592503333786,-0.9837878151148635,0.47058823529411764,0.714291833585843,1.0,5/12,24.28%,PDE2A;PDE9A;NPR1;GUCY1A1;GUCY2C
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2681390432599332,-0.9831607503065904,0.4782608695652174,0.7153666984341569,1.0,21/65,26.87%,FBXL7;PSMA2;RBX1;PSME2;NABP1;PSMB4;INTS3;PSMC2;PSMB2;PSMB1;PSMA8;CDK5RAP3;PSME1;PSMD4;PSMA7;CHEK1;FHL1;PSMD5;PINX1;PSMB10;PSMA3
prerank,L-glutamate transmembrane transport (GO:0015813),0.4050579521061858,0.9831567713782051,0.46621621621621623,0.8892889756470884,1.0,3/10,13.80%,SLC25A13;SLC1A2;SLC1A3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3930511672687662,0.9830589235497363,0.48717948717948717,0.8880823092118548,1.0,3/11,10.42%,ITPKA;IP6K2;IPPK
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2980309940765092,-0.9821837795113109,0.4855595667870036,0.7173217962254601,1.0,15/38,29.10%,LRRK2;HPS4;GSK3A;HAX1;UBE2J2;UBE2D3;UBE2L3;BAP1;NPEPPS;HUWE1;FZD5;SAE1;ARIH2;BAG4;RNF31
prerank,DNA recombination (GO:0006310),-0.29717851473357515,-0.9821348586517906,0.48014440433212996,0.7170710123472824,1.0,18/37,35.32%,DMC1;MRE11;RAD54B;RPA1;HDAC10;WRN;RAD54L;LIG4;BLM;MSH3;HMGB1;EXO1;XRCC2;RAD51D;TSN;RAD50;ENDOG;RAD52
prerank,histone H4 deacetylation (GO:0070933),-0.4121898876369613,-0.9820677776059553,0.47079646017699117,0.7168373280342017,1.0,4/10,19.54%,RCOR1;HDAC1;HDAC4;SMARCAD1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.37444523025581467,-0.9818521578682525,0.49245283018867925,0.7169612104069277,1.0,3/15,8.91%,PPARA;ELOVL5;PPARD
prerank,protein O-linked glycosylation (GO:0006493),-0.24865854684112795,-0.9816268791276582,0.5089605734767025,0.7171115651897308,1.0,14/96,6.30%,EOGT;ST3GAL4;ST3GAL1;PLOD1;TMTC1;PLOD2;ST6GAL1;TRAK1;TMTC2;GALNT10;GXYLT2;B3GNT2;TET2;C1GALT1
prerank,microtubule anchoring at centrosome (GO:0034454),0.4111875607003391,0.9815125981170959,0.49318181818181817,0.8912192588565356,1.0,6/10,19.05%,NINL;BBS4;KIF3A;CEP19;HOOK3;CCDC120
prerank,regulation of neuron migration (GO:2001222),-0.3224812261441979,-0.980882693641365,0.455026455026455,0.7185144659759586,1.0,6/26,11.61%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2;PHACTR1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.33970485412618556,-0.9808498279679809,0.4786476868327402,0.7182000653201769,1.0,4/21,5.78%,PLTP;CAV1;RXRA;NFKBIA
prerank,acylglycerol metabolic process (GO:0006639),0.2855383616980536,0.9808475165829954,0.48514851485148514,0.89179579283604,1.0,9/37,16.51%,DGKK;DGKI;DGKQ;GK;PGS1;APOE;APOC1;ABHD6;SEL1L
prerank,phosphate ion transport (GO:0006817),0.35266467078056296,0.9805467033910025,0.4822546972860125,0.8911907857367759,1.0,2/16,4.64%,SLC34A1;SLC25A3
prerank,ncRNA 3'-end processing (GO:0043628),-0.3776985130910493,-0.9805433942164785,0.496415770609319,0.7185522242621687,1.0,8/14,30.25%,INTS8;INTS7;ELAC2;TOE1;TRNT1;INTS5;INTS12;SSB
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3012128619137238,-0.9805300366162527,0.4981684981684982,0.7181871432303207,1.0,5/36,6.54%,SPTBN1;RAB7A;GOLPH3L;AFDN;MACF1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3320821020509384,-0.9804765252217839,0.4972677595628415,0.7179293028128904,1.0,9/22,23.29%,ATM;SPRED2;RPL37;EIF5A;HIC1;CDK5RAP3;RPS7;RPS15;MSX1
prerank,nuclear body organization (GO:0030575),-0.38460845045556935,-0.9803381066519044,0.49557522123893805,0.7178532047107381,1.0,4/12,16.59%,ETS1;SERBP1;ZPR1;SRPK2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.30968871444438834,-0.979721409111034,0.48073394495412847,0.7189658006010393,1.0,8/30,19.48%,UBR5;RNF169;SHLD1;TRIP12;OGG1;CGAS;MAD2L2;TFIP11
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.23275594293502355,-0.9796850991054602,0.5118243243243243,0.7186640362871354,1.0,41/129,24.42%,XIAP;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;LRRK2;DDX3X;EGFR;CSNK1G3;TRPM4;NFKB1;LRRK1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CSNK1G1;DKK2;CSNK1D;PLEKHA4;PSMC2;LYPD6;USP34;PSMB2;PSMB1;DAAM2;PSMA8;PSME1;SOX4;TBL1X;GPC3;PSMD4;CAPRIN2;PSMA7;AMER1;SFRP4;PSMD5;RNF146;SEMA5A
prerank,defense response to fungus (GO:0050832),-0.35477137764789,-0.9796301891942286,0.4849023090586146,0.7184051052996776,1.0,12/17,53.00%,RNASE7;PLCG2;S100A9;GAPDH;CARD9;CLEC4D;BCL10;HRG;S100A8;CLEC6A;LTF;CLEC4E
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3471812413005221,0.9795434668716283,0.4892703862660944,0.8927548498998192,1.0,4/18,6.65%,MELTF;PDPN;DDR2;FSCN1
prerank,respiratory tube development (GO:0030323),-0.3159530307555433,-0.9789890704972121,0.49452554744525545,0.719512094844994,1.0,9/28,14.01%,ITGA3;LOXL3;RBP4;FGF1;BMP4;PCSK5;FGF7;FGF2;ZIC3
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2768130070865442,0.978670562247927,0.4901098901098901,0.8939302280008495,1.0,7/44,7.86%,TENM1;PFN2;SPIRE1;PFN1;BAIAP2L2;GSN;CARMIL1
prerank,positive regulation of response to stimulus (GO:0048584),-0.2926199371412504,-0.9784512470340151,0.4945652173913043,0.7204473513553502,1.0,13/40,25.38%,IFIH1;IL15;TGFB2;PRKCD;YPEL3;ILK;ABI3;CGAS;MAVS;NSMCE4A;TAF9;DHX9;FXR1
prerank,engulfment of apoptotic cell (GO:0043652),-0.3734181948613573,-0.9784128123711996,0.49635036496350365,0.7201454372904922,1.0,3/15,2.75%,RAC1;RHOBTB1;THBS1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.24964927465978834,-0.9783806689239789,0.5181347150259067,0.7198396809098442,1.0,21/88,16.79%,DAB2IP;TRABD2B;MPP7;GSK3B;RAB7A;STX18;TFRC;SPIDR;CDH5;TAL1;RGCC;FNIP2;ICE1;SYNPO2;FLOT1;RHOC;SLF2;TPR;BCL2L11;BMP7;SUMO1
prerank,protein-DNA complex assembly (GO:0065004),-0.23732344985080284,-0.9782323179809318,0.4991212653778559,0.7198031765667354,1.0,38/116,27.24%,MNAT1;KAT6B;PSMA2;DMC1;RBX1;BRD2;PSME2;PSMB4;ERCC2;SPTY2D1;MCM4;ORC5;RPA3;RPA1;XPC;ERCC3;PSMC2;H3-3A;PSMB2;PSMB1;ORC2;PSMA8;CETN2;ORC4;RPA2;PSME1;ATRX;TCF4;PSMD4;PSMA7;MCM3;PSMD5;MCM7;PSMB10;RSF1;PSMA3;MCM5;GTF2H3
prerank,melanosome organization (GO:0032438),-0.3211422400210956,-0.9781213041171796,0.4804270462633452,0.7196743432075333,1.0,7/26,21.54%,HPS4;BLOC1S5;SHROOM2;AP1G1;RAB32;AP3B1;KIF13A
prerank,B cell activation (GO:0042113),-0.2598095445755342,-0.9780953806302706,0.49635036496350365,0.7193381070220727,1.0,19/68,19.36%,ITGB1;PTPRJ;ZBTB7A;MEF2C;PLCG2;TPD52;CTPS1;CASP8;PIK3CD;HDAC4;ITGA4;CD40;NHEJ1;TCF3;VCAM1;CEBPG;CLCF1;PTPRC;DNAJB9
prerank,T cell migration (GO:0072678),-0.38555602740850775,-0.9780509067732894,0.5105633802816901,0.7190424739995585,1.0,4/13,9.65%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3382338468191965,0.9779416025944448,0.5044843049327354,0.8945898372164128,1.0,3/19,6.49%,BPNT2;SULT2B1;SLC35B2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3312530309118031,-0.977776125660802,0.5053956834532374,0.7193240456314304,1.0,7/24,20.39%,ABCG2;ALAS1;ABCB10;SUCLA2;FLVCR1;COX10;RSAD1
prerank,cellular response to osmotic stress (GO:0071470),-0.34345128370012373,-0.9775990087034353,0.5061511423550088,0.7193613779081196,1.0,6/21,9.43%,PKD2;RCSD1;DDX3X;LRRC8D;ARHGEF2;MYLK
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.3091407469115408,-0.977547541198076,0.47947761194029853,0.7190856072391427,1.0,9/31,19.36%,SHLD1;TFRC;KMT5B;RBP4;MAD2L2;CLCF1;VAMP3;PTPRC;DNAJB9
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.31802091292550455,-0.9772233828057153,0.5125448028673835,0.7194643026935716,1.0,14/26,35.99%,BIRC3;IRF1;NFKBIL1;OTUD4;FLOT1;GPR108;GPS2;IRF7;NLRP2B;TREM2;CACTIN;TLR5;LRRC14;TLR2
prerank,mitotic chromosome condensation (GO:0007076),-0.32400869714383324,-0.9771179109074227,0.5,0.7193209215199341,1.0,14/26,36.25%,RB1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;SET;TTN;CHMP1A;PLK1;CSNK2A1;CSNK2A2
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.2788789049214416,-0.9766701601435707,0.4965635738831615,0.7199936529832082,1.0,16/45,21.97%,BTG3;CDKN1B;BMP4;PLK2;NABP1;RGCC;PTPN3;FOXC1;BTG2;BMP7;CTNNB1;BUB1B;ANGEL2;BCL6;CHEK1;TOM1L2
prerank,negative regulation of response to external stimulus (GO:0032102),-0.24209196286592338,-0.9766189347245786,0.49107142857142855,0.7197374886948718,1.0,24/105,15.91%,TEK;RB1;KLF4;MFHAS1;CRK;PPARA;OTULIN;NMI;PRKCD;CDH5;EPHA4;PPARD;PPM1B;FEM1A;NFKBIL1;FGF2;DUSP3;RTN4RL1;TRAF3IP1;TNFAIP3;ILRUN;CCN3;C1QTNF3;TNFRSF1A
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3018334585320185,-0.9764036184138342,0.5084427767354597,0.719899499589015,1.0,5/33,11.25%,HIP1;AFAP1L2;CBL;AKT1;ARAP1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.30853249128741056,-0.9762524412845947,0.4934086629001883,0.7198825302746658,1.0,9/32,17.12%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,amide biosynthetic process (GO:0043604),-0.2807425860482943,-0.9761656188802297,0.49256505576208176,0.7197151609908746,1.0,11/47,16.85%,SGMS1;DEGS2;SGMS2;CERS4;PAM;PCSK5;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,intracellular cholesterol transport (GO:0032367),-0.36099344853941384,-0.9755769266290792,0.5055762081784386,0.7207361866082819,1.0,5/15,20.56%,LDLRAP1;LRP6;STARD4;STAR;OSBPL2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.27349946706982864,-0.9751216384062855,0.48736462093862815,0.7214500830026614,1.0,16/54,19.18%,CLIP1;LIMK2;DLG1;EZR;DST;DCTN1;RHOA;SLAIN2;CHP1;TUBGCP4;RAB11A;SLK;TUBGCP5;PCM1;TRPV4;CLIP2
prerank,detection of mechanical stimulus (GO:0050982),-0.34901610550683737,-0.9750183909299969,0.49016100178890876,0.7212883379803812,1.0,9/19,31.64%,PIEZO2;PKD2;PTK2;CTNNB1;PKD2L1;PIEZO1;TTN;JUP;LHFPL5
prerank,cilium organization (GO:0044782),-0.21758609576743201,-0.9749866698803783,0.5242070116861436,0.7209787396781503,1.0,45/210,19.26%,ABCC4;ABLIM1;EXOC6;ASAP1;PKD2;PARVA;CENPJ;FNBP1L;EXOC4;RAB1A;EHD2;PTPDC1;SSX2IP;CEP250;IFT140;CDC14A;WDR11;RAB11FIP3;CEP78;EXOC2;PDE6D;FLNA;EHD1;WDR35;GALNT11;RAB8B;NOTCH1;IFT52;CFAP44;RAB23;TRAF3IP1;CEP41;EXOC8;FUZ;DZIP1L;NUDCD3;EHD4;RAB11A;HDAC6;CFAP298;PLK4;PCM1;TMEM17;KIF3B;IFT43
prerank,primary alcohol metabolic process (GO:0034308),-0.32675224717425433,-0.9746353807701462,0.4938704028021016,0.7214339885593527,1.0,9/25,26.69%,RBP4;RDH10;NAPEPLD;GDPD1;GDPD3;IGF1;RETSAT;CYP1B1;GDE1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3804561040292469,0.9745677391180696,0.4625267665952891,0.9032900425952002,1.0,2/11,6.48%,BCL2;TRIAP1
prerank,fibrinolysis (GO:0042730),0.3779816599910393,0.974260104333695,0.48951048951048953,0.9027279411132796,1.0,1/13,1.24%,CPB2
prerank,activation of protein kinase activity (GO:0032147),-0.2395333068008549,-0.9742443677384535,0.51138353765324,0.7219561467601991,1.0,25/106,16.38%,GHR;INSR;PRKACB;ADCY9;PAK2;MTOR;TGFBR2;RICTOR;GAS6;STK3;ABL1;TGFB2;PRKCD;FGF1;ADCY4;CLSPN;AKT1;TAOK3;JAK2;IRAK1;MAP4K4;MARK2;ADCY1;ANGPT1;IGF1
prerank,secondary alcohol metabolic process (GO:1902652),0.27535149577967755,0.9741262212995804,0.5032397408207343,0.9016277828853795,1.0,12/42,15.42%,PIP4P1;SULT2B1;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5;IDH3A;ABCA5;APOE;CLN8
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2968712314510936,0.9737810748236313,0.49311926605504586,0.9011360932877169,1.0,8/31,13.75%,NRG1;PKP2;PROX1;RYR2;FGFR2;TNNC1;MYL2;ZFPM2
prerank,histone deubiquitination (GO:0016578),-0.3470306049071475,-0.9734065606504865,0.4954627949183303,0.7235053879671774,1.0,7/18,23.18%,UIMC1;TRRAP;USP15;BRCC3;USP7;ATXN7;USP16
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4054744245308948,-0.9734007308675239,0.4864864864864865,0.7231306826554451,1.0,6/10,27.31%,CSGALNACT1;DSE;PXYLP1;XYLT2;CSGALNACT2;XYLT1
prerank,regulation of response to oxidative stress (GO:1902882),0.3963800560273809,0.9733520950412649,0.5066964285714286,0.9009446514651985,1.0,6/11,27.56%,ALOX5;SELENON;ACOX2;GGT7;AIFM2;PINK1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.387969770740076,-0.9731869323256968,0.49730700179533216,0.7232432145438075,1.0,5/13,21.30%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,phospholipid catabolic process (GO:0009395),-0.32800786718276087,-0.9726096836663256,0.5182481751824818,0.7242471013709394,1.0,4/24,13.54%,GPCPD1;PLA2G4A;GDPD1;GDPD3
prerank,lytic vacuole organization (GO:0080171),0.29668378162601566,0.9723890631658733,0.48623853211009177,0.902438722502481,1.0,11/32,18.94%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2
prerank,potassium ion import across plasma membrane (GO:1990573),0.28029497295659167,0.9718408800697055,0.48590021691973967,0.9026872450234569,1.0,7/41,8.79%,ATP1A2;KCNJ3;ATP12A;ATP1B1;SLC12A5;ATP4A;KCNJ6
prerank,peptidyl-threonine modification (GO:0018210),-0.26282261045266603,-0.9713987007115552,0.5089605734767025,0.7267884033236501,1.0,21/66,19.55%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;MAPK1;ROCK1;PRKD1;GSK3A;AKT1;GALNT11;MAPK8;MARK2;ROCK2;HIPK1;CDC42BPB;GALNT1;PRKDC
prerank,epidermis development (GO:0008544),0.26192727768375024,0.9708936167144605,0.5,0.9040210686444575,1.0,10/56,14.33%,OVOL3;ZNF750;POU2F3;SCEL;FGFR2;ACER1;LAMB3;CERS3;GATA6;COL7A1
prerank,L-serine metabolic process (GO:0006563),-0.4163413569517798,-0.970577578857355,0.5043630017452007,0.7283795553128785,1.0,5/10,29.63%,SRR;SERINC3;SERINC5;PSAT1;SHMT1
prerank,snRNA 3'-end processing (GO:0034472),-0.345782913262405,-0.9701678458684876,0.5095320623916811,0.7289309610826634,1.0,11/19,29.96%,INTS8;EXOSC2;EXOSC3;EXOSC8;USB1;EXOSC5;INTS7;EXOSC7;TOE1;INTS5;INTS12
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4113181758151524,-0.9699161527449663,0.4805194805194805,0.7291496444227786,1.0,8/10,50.60%,DNMT1;ATRX;BRCA1;DNMT3B;MYB;SIRT1;RIF1;PRDM12
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.37996854947891034,0.9697463698203074,0.49217002237136465,0.9060621080028648,1.0,3/12,9.25%,LHX1;PAX2;VEGFA
prerank,fatty acid transport (GO:0015908),-0.3459553894763222,-0.9692450009963685,0.49012567324955114,0.7303228824263132,1.0,8/17,31.15%,PPARD;MFSD2A;SLC27A4;ACSL1;PPARG;SLC27A3;FABP3;SLC27A6
prerank,positive regulation of telomerase activity (GO:0051973),-0.2979007825091725,-0.9692049287082419,0.48128342245989303,0.7300336887566737,1.0,9/33,17.12%,KLF4;NEK7;TCP1;MAPK1;HMBOX1;PNKP;PARN;PTGES3;CTNNB1
prerank,positive regulation of immune system process (GO:0002684),-0.3552944267770722,-0.9687798113761183,0.4964788732394366,0.730675324841458,1.0,5/16,17.00%,IL15;TGFB2;PIK3CD;PIK3CB;ANXA1
prerank,regulation of embryonic development (GO:0045995),-0.29661489104910693,-0.9686985105147514,0.4918625678119349,0.7304887527297729,1.0,7/34,10.19%,INSR;SOX17;NIPBL;PLCB1;RBM19;TRIP12;EHMT1
prerank,positive regulation of transmembrane transport (GO:0034764),0.373152975190431,0.9681789372617989,0.5042372881355932,0.9092515618669049,1.0,4/13,10.50%,CA2;NR4A3;C2CD5;AZIN2
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.24380506893413306,-0.9677285523220812,0.5413793103448276,0.7323697321164215,1.0,30/98,24.59%,INSR;KLF4;SLCO1C1;THBS1;ANXA2;IFNAR1;RAB1A;TGFBR2;PPARA;NFKBIA;ECE1;PPARD;DHRS4;ACACB;AKT1;TP53;AGTR1;STARD4;GRB2;AGPAT1;ANGPT1;IL10RB;VAMP3;PPARG;PDGFRB;GADD45A;RIPK1;SFRP4;ARRB1;ACE2
prerank,melanocyte differentiation (GO:0030318),-0.40314202329916393,-0.9674395786324647,0.5258126195028681,0.7326643717227533,1.0,3/11,9.66%,MITF;MEF2C;USP13
prerank,regulation of amyloid-beta formation (GO:1902003),0.2907841702875571,0.967317911999672,0.5143487858719646,0.9102754827030718,1.0,9/34,14.63%,LRRTM3;GGA3;NTRK2;SORL1;RTN4;ABCA2;CLU;GSAP;APOE
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3614551582205147,-0.9672256319922722,0.5036101083032491,0.7328113322763261,1.0,6/16,15.36%,CDH5;RAP1B;ROCK1;BCAS3;ARFGEF1;ROCK2
prerank,response to chemokine (GO:1990868),-0.38389552119847015,-0.966890933818142,0.4981203007518797,0.7331933824598424,1.0,7/13,29.45%,LRCH1;SLC12A2;RHOA;FOXC1;CXCL12;DUSP1;WNK1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.40585994872483044,-0.9668077229256073,0.5080213903743316,0.7330168672680095,1.0,3/10,14.55%,ESR1;TP53;PSMC2
prerank,negative regulation of platelet activation (GO:0010544),-0.3629509101928443,-0.966451492097595,0.5055147058823529,0.7334910353812905,1.0,4/16,12.67%,PRKG1;NOS3;PRKCD;CEACAM1
prerank,apoptotic mitochondrial changes (GO:0008637),0.2972690061993367,0.966298735326617,0.5225225225225225,0.9118192648898511,1.0,3/32,3.75%,ERBB4;BCL2;GGCT
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2782597508912727,-0.9661140893570358,0.5052264808362369,0.7339150000425839,1.0,12/45,20.79%,DAB2IP;EMD;GAS6;TP53;CDC73;CDK6;MIF;IGF1;SKI;CTNNB1;LIG4;NF1
prerank,glucan catabolic process (GO:0009251),0.36173651789476996,0.965846213362447,0.47540983606557374,0.9116774551058818,1.0,7/15,18.43%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.3430654125921385,0.9656383173696473,0.5124716553287982,0.9107936946111581,1.0,2/17,5.75%,MAGI2;CALM2
prerank,regulation of mast cell degranulation (GO:0043304),0.3547765085786865,0.9653821774987211,0.5218295218295218,0.9100602245350649,1.0,3/14,9.92%,BLK;STXBP2;SPHK2
prerank,positive regulation of histone acetylation (GO:0035066),-0.320097753386499,-0.9653549627540386,0.5165794066317626,0.735314233596452,1.0,12/23,36.26%,RPS6KA5;SMAD4;RUVBL2;WBP2;BRCA1;NOS1;ARRB1;SMARCB1;GLYR1;RPS6KA4;MUC1;LIF
prerank,protein localization to lysosome (GO:0061462),0.3057220237727624,0.9652516577767678,0.52,0.9089833435998248,1.0,8/28,11.95%,MFSD1;GGA3;CD81;SORL1;HGS;RTN4;ATP13A2;RNF128
prerank,regulation of interferon-beta production (GO:0032648),-0.2811541030705988,-0.96515066783609,0.5204262877442274,0.7353647827672419,1.0,23/46,36.11%,IFIH1;TRIM56;DDX3X;IRF1;PPM1B;FLOT1;POLR3F;MAVS;PTPN11;RNF216;HSP90AA1;YY1;DHX9;IRF7;RIOK3;CACTIN;TOMM70;LILRB1;IRF5;POLR3A;TBK1;TLR2;TLR8
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3280904093651016,-0.9651393793925698,0.51138353765324,0.7350013444219615,1.0,4/23,5.40%,GHR;CENPJ;CRLF3;HES1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.321012999161038,-0.9649713206393707,0.5116279069767442,0.7350146431757845,1.0,3/23,6.37%,RAC1;MOSPD2;SLIT2
prerank,regulation of smooth muscle contraction (GO:0006940),0.32917141507118125,0.9649088412103268,0.5022421524663677,0.9085286717628548,1.0,4/20,11.23%,CHRM2;CHRM3;SPHK1;NMUR2
prerank,in utero embryonic development (GO:0001701),0.31165830902954433,0.964631859759491,0.5011547344110855,0.9078795955514981,1.0,7/25,11.41%,WNT7B;FLCN;FGFR2;LMX1B;VEGFA;ZNF568;ARNT2
prerank,ruffle organization (GO:0031529),-0.3551389562411227,-0.9646112856082865,0.5109489051094891,0.7354733321642863,1.0,2/16,1.85%,LIMA1;RAC1
prerank,protein oxidation (GO:0018158),-0.39845713931341586,-0.9644112595592648,0.5459363957597173,0.7355650841895298,1.0,5/11,35.05%,LOXL3;LOXL1;LOX;SUMF1;LOXL4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.31257532375454367,-0.9637170386404639,0.5238095238095238,0.7368402810334378,1.0,11/26,24.02%,NOS3;ACER2;GCH1;AKT1;ACER3;SPTLC1;ASAH1;CYB5B;NQO1;NOS1;CYP1B1
prerank,amyloid fibril formation (GO:1990000),-0.27669186141052504,-0.9636891306472055,0.5158450704225352,0.7364993946219947,1.0,17/51,23.22%,SNCAIP;USP9X;APP;HSPG2;TSPAN14;ADAM10;TSPAN5;H3-3A;IAPP;APH1A;SIAH1;TGFBI;MFGE8;MDM2;CALB1;TSPAN33;RIPK1
prerank,response to alcohol (GO:0097305),0.30298106001708175,0.9636805231565029,0.5203619909502263,0.9093337338284637,1.0,5/27,9.89%,GRIN2B;GLRA1;GRIN2A;ABCA2;SLIT3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.27226334205121294,-0.9634119112051862,0.5017421602787456,0.7367693223295818,1.0,22/47,34.01%,CHCHD3;APOOL;AFG3L2;SAMM50;MTX1;DMAC2L;AGK;ATP5F1E;UQCC3;ATP5F1C;ATP5MF;ATP5PO;TMEM11;IMMT;TIMM10;TOMM70;ATP5F1D;SPG7;MICOS10;TIMM10B;ATP5MC2;TIMM13
prerank,tRNA aminoacylation (GO:0043039),-0.2895582168191511,-0.9630625331489622,0.49280575539568344,0.7371933574644426,1.0,10/37,21.49%,YARS1;WARS2;FARS2;LARS1;AIMP2;HARS2;DARS2;FARSA;IARS2;WARS1
prerank,embryonic eye morphogenesis (GO:0048048),-0.3963854343317029,-0.9624713774800132,0.5111524163568774,0.7381976435419889,1.0,3/11,8.09%,RARG;LRP6;TBX2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.34008561578772917,-0.9619149144320597,0.5,0.739131189843437,1.0,8/20,26.50%,CDKN1B;LATS2;TFAP4;PTEN;NR2F2;MYOCD;CEBPA;APC
prerank,inositol phosphate catabolic process (GO:0071545),-0.3808019077112831,-0.9618416087936945,0.5026269702276708,0.738919801763111,1.0,6/12,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,positive regulation of integrin activation (GO:0033625),-0.39235271845249525,-0.9617846606557898,0.512589928057554,0.7386626879680112,1.0,3/11,8.05%,FERMT2;RASIP1;RAP1B
prerank,actin filament network formation (GO:0051639),0.3800016355591117,0.9616828112654322,0.48868778280542985,0.913903997865595,1.0,6/11,20.85%,SPIRE1;FHOD3;CARMIL1;SPIRE2;FHOD1;PLS1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.40358327602737787,-0.9612353851356461,0.5318761384335154,0.739585049330015,1.0,5/10,21.21%,MECP2;KDM1B;PCGF3;IGF2;PCGF5
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3731537904134544,0.9611413009968417,0.4954545454545455,0.9140876623601301,1.0,4/12,15.38%,CDA;DPYSL5;DPYD;DPYSL2
prerank,epithelium development (GO:0060429),-0.23780985045434494,-0.9611335247726592,0.5437392795883362,0.7394216828602436,1.0,17/107,11.52%,PKD2;CD34;TBX1;KDR;SOX17;SMO;LOXL3;MEOX2;SIX1;MTHFD1;TBX2;BDH2;ANXA4;MFSD2A;CPT1A;JAK2;ALDOC
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.24277584968835844,0.9607517284472348,0.535632183908046,0.9137389829374176,1.0,20/84,16.07%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;QKI;CELF6;SRPK1;FXR2;DDX17;RBFOX3;ZC3H10;RBM8A;TIA1;NOVA1;U2AF2;SF3B4;HNRNPK
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3981434674828473,-0.9594696755286093,0.5374771480804388,0.7429151421102761,1.0,5/10,25.17%,SETD5;DIP2B;PRKAA1;MYOCD;DIP2A
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.387532944963371,-0.9593134191357122,0.5169340463458111,0.7429059512612217,1.0,4/11,15.43%,RIN3;SLIT2;MIF;CCN3
prerank,positive regulation of reproductive process (GO:2000243),0.28932876433738375,0.9589266876967977,0.4910313901345291,0.9176554739004145,1.0,5/31,10.93%,CFAP69;GLRA1;ACVR1B;VEGFA;TACR1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4105111706040578,-0.9588899417622824,0.5149253731343284,0.7434763637101324,1.0,3/10,8.34%,SHANK3;APP;RAB5A
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4100171027318749,-0.9588347490490313,0.5170556552962298,0.7432169842071308,1.0,3/10,13.32%,LRRK2;KDR;MYOC
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.252482637853697,-0.9582838006865954,0.5159574468085106,0.7441144952338795,1.0,19/77,20.26%,ITGA6;RB1;MCL1;THBS1;DDX3X;BMP4;BIRC6;CAAP1;SH3RF1;CFLAR;AKT1;MAZ;HGF;GPX1;IGF1;PPIF;ZMYND11;TCF7L2;HERPUD1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.21857202594055344,-0.9580287972087184,0.5551601423487544,0.7443428900799743,1.0,37/198,14.94%,PTPRB;PLCB4;LIMK2;PAK2;PANK2;PLA2G4A;LRRK2;INPP1;MTOR;PLCG1;PIP4K2A;INPP5A;LIMD1;GFPT2;PLCB3;ACYP2;PLCB1;ALPL;PIP4K2B;MINPP1;PLCE1;PLCG2;ITPKB;PIK3CD;AKT1;INPP4A;PFKFB3;ALDOC;DUSP23;ACP6;LPL;DUSP3;PNKP;AGK;PIK3CB;GK5;AGPAT1
prerank,negative regulation of JNK cascade (GO:0046329),-0.29822438622498093,-0.9577327960841143,0.5427046263345195,0.7446376238989447,1.0,8/31,24.93%,MECOM;PDCD4;TAOK3;DUSP3;ZMYND11;SH3RF2;GPS2;AIDA
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.40693591686659947,-0.957713790215395,0.5211267605633803,0.7438993241402633,1.0,2/10,17.55%,CEP250;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.40693591686659947,-0.957713790215395,0.5211267605633803,0.7438993241402633,1.0,2/10,17.55%,CEP250;TULP1
prerank,peptide metabolic process (GO:0006518),-0.2500114870981842,-0.9575699513355669,0.5355871886120996,0.7438500375027709,1.0,20/75,19.51%,CPQ;GSTT1;ACE;PSEN2;GSTT2;SPPL3;ABCB9;PCSK5;ENPEP;GSTM2;PSEN1;CPXM2;GPX1;HPGDS;ERAP1;SOD1;DNPEP;CPXM1;NPEPPS;CLN5
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.24291465367834716,-0.9573839933256817,0.5706896551724138,0.7438786513155543,1.0,27/85,23.89%,RAC1;SMURF2;FZD6;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1;PSMD4;ROR2;PSMA7;FZD7;PSMD5;FZD5
prerank,mitochondrial membrane organization (GO:0007006),0.28566176668608084,0.956762321522209,0.5123595505617977,0.922794193753707,1.0,8/32,12.01%,BCL2;HSPA9;MFN1;SLC25A4;MTX3;CHCHD6;DNAJC11;GHITM
prerank,actin nucleation (GO:0045010),0.3265721458573566,0.9566536561292048,0.5221445221445221,0.9216150169697434,1.0,7/21,19.43%,SPIRE1;TRIM27;ARPC5L;ARPC5;SPIRE2;WHAMM;ARPC1A
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2993544508343109,-0.9563514891652476,0.519298245614035,0.7458946830658062,1.0,13/29,29.38%,UBE2K;PTPN1;SAMHD1;STAT2;USP18;NLRC5;MAVS;ABCE1;PTPN11;IFNAR2;PTPN2;TRIM6;CACTIN
prerank,nerve growth factor signaling pathway (GO:0038180),0.39665607453748786,0.9560487578833362,0.5104895104895105,0.9219622282529302,1.0,2/10,4.54%,MAGI2;KIDINS220
prerank,negative regulation of protein polymerization (GO:0032272),-0.3087187291443326,-0.9555087628595258,0.5244122965641953,0.7475311582047227,1.0,8/27,15.35%,KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARFGEF1;HIP1R
prerank,mitochondrial gene expression (GO:0140053),-0.28132467840918796,-0.9553359625927544,0.5121107266435986,0.7475269702136766,1.0,20/42,29.86%,FOXO3;PTCD3;MRPL47;MRPS18A;MRPL2;MRPS24;MRPL12;MRPL57;NDUFA7;MRPS14;IARS2;MRPS21;GFM2;FASTKD5;MRPS2;NOA1;MRPS28;SLC25A33;GATB;MRPS17
prerank,O-glycan processing (GO:0016266),0.2582901387387585,0.9551424044776927,0.5349344978165939,0.9232113128818511,1.0,12/54,17.24%,MUC20;GALNT15;GALNT13;GALNT12;GALNT5;GALNT14;POFUT1;C1GALT1C1;MUC16;GALNT3;GALNT2;GALNT6
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3379766675064703,-0.954713561664605,0.5196428571428572,0.7485882768830184,1.0,4/20,9.17%,MCL1;GSK3B;FAS;GSK3A
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.30101820325809847,-0.9543313620302568,0.5177304964539007,0.7490714922751142,1.0,14/29,41.40%,LARP1;FUS;AXIN2;RBM24;THRAP3;TAF15;PABPC1;HNRNPU;TENT5C;TENT5B;VIP;TENT5D;DND1;NOCT
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.3145403033643307,-0.9543100972315666,0.5449438202247191,0.7487192939364435,1.0,12/28,24.52%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;MECP2;RPS3;AKAP9;ARL2;HSPA1B
prerank,oligodendrocyte development (GO:0014003),0.3601937200082765,0.9541485728954366,0.5599128540305011,0.9246354121156926,1.0,5/15,16.50%,MYRF;PLP1;TPPP;EIF2B1;B4GALT6
prerank,cAMP-mediated signaling (GO:0019933),-0.32160855386036497,-0.9533655507608509,0.5438282647584973,0.7505592830524602,1.0,5/24,6.05%,RAPGEF2;ADGRG6;PDE7B;PDE3A;PDE2A
prerank,B cell proliferation (GO:0042100),0.3389137290042161,0.9532874187534431,0.5061475409836066,0.9258109760669816,1.0,2/17,3.49%,MS4A1;BCL2
prerank,regulation of T cell proliferation (GO:0042129),-0.25641881913670056,-0.9530380507082666,0.5348399246704332,0.7509424663602166,1.0,13/61,23.62%,SLC7A1;IL15;IL6ST;TFRC;TNFRSF1B;NCK1;NCK2;VCAM1;ANXA1;CCL19;PTPRC;TNFSF8;CD276
prerank,regulation of chromosome segregation (GO:0051983),-0.3540017350301009,-0.9530080806178292,0.5253623188405797,0.7506232386422916,1.0,13/16,48.27%,SMC5;PUM1;RAD18;PUM2;CDC6;CSNK2A1;CSNK2A2;IHO1;KIF2C;SMC6;AURKB;RMI2;HORMAD1
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2916836508571687,-0.9528428579313328,0.5310834813499112,0.7502299972927423,1.0,10/31,28.41%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2L;POLR2H;GTF2H3;CCNH
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2916836508571687,-0.9528428579313328,0.5310834813499112,0.7502299972927423,1.0,10/31,28.41%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2L;POLR2H;GTF2H3;CCNH
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.2934171758037938,0.9526367690811272,0.5534591194968553,0.9262321437905057,1.0,6/31,10.54%,NLGN1;PPFIA2;CDK5;CAMK2B;TANC2;ABI2
prerank,substantia nigra development (GO:0021762),0.27892734684830833,0.9524660910682687,0.5387931034482759,0.925276815665493,1.0,8/37,13.71%,PLP1;CALM2;MAOB;CNP;PADI2;CCDC14;MBP;GLUD1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3108032769084816,0.9524496114340986,0.5206971677559913,0.9238285330461401,1.0,9/25,24.84%,NPSR1;AKAP6;GPER1;CASQ1;CX3CL1;TRPC1;PDPK1;CAPN3;SNCA
prerank,connective tissue development (GO:0061448),-0.2885492026131736,-0.9518863501901631,0.5191956124314442,0.7520577156411069,1.0,5/35,9.54%,ZBTB16;LRP5;SH3PXD2B;CREB3L2;NAMPT
prerank,actin polymerization or depolymerization (GO:0008154),-0.26670191331269316,-0.9511856283912943,0.5355285961871751,0.7533502849346565,1.0,15/50,20.38%,ABI1;RAC1;SVIL;MICAL2;DIAPH1;WASL;FAM107A;CFL2;JAK2;PREX1;CORO7;CFL1;PSTPIP1;WASF1;DSTN
prerank,regulation of organelle organization (GO:0033043),-0.24098174185507817,-0.9511212385879858,0.5365853658536586,0.7531205700767167,1.0,13/80,9.73%,TJP1;F11R;PAK2;STX18;DIAPH1;MSN;PDE2A;PTK2;EZR;ARMH3;USP6NL;MAPK1;CAPN2
prerank,mRNA metabolic process (GO:0016071),-0.2404661190404172,-0.9506453420586475,0.564748201438849,0.7538772214016239,1.0,26/90,28.11%,SRSF11;PRPF3;HNRNPA0;HNRNPR;ERN1;CELF1;TP53;SON;SFPQ;LSM11;SNRPE;SF3A1;LSM10;NUDT12;NONO;LSM3;DIS3L2;METTL16;ALKBH5;SUPT4H1;USP39;HSPA1B;PRPF18;DXO;SCAF11;LSM2
prerank,cellular response to zinc ion (GO:0071294),-0.3538146772066941,-0.9505817088187896,0.5340699815837937,0.7536288371953378,1.0,9/15,25.53%,HVCN1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F
prerank,regulation of fibrinolysis (GO:0051917),-0.37243706580442076,-0.9504161008018003,0.5196428571428572,0.7536367975549219,1.0,9/13,49.66%,THBS1;SERPINE1;USF1;FAP;APOH;PLG;F11;HRG;F2
prerank,dendritic spine organization (GO:0097061),-0.3087396368091995,-0.9501779662615729,0.5601436265709157,0.7537963263296532,1.0,4/26,2.92%,IGF1R;SHANK3;INSR;ITGA3
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3257846569805609,-0.9497829601991309,0.5379061371841155,0.7543556960022932,1.0,3/22,5.58%,SLC7A5;TRPM4;TNFRSF1B
prerank,lung epithelium development (GO:0060428),0.38194178416976265,0.9496235446826143,0.507177033492823,0.9307744191541877,1.0,3/10,14.58%,WNT7B;FOXJ1;RCN3
prerank,cellular response to inorganic substance (GO:0071241),0.32821051856173417,0.948923368104685,0.5262008733624454,0.9313184843155491,1.0,4/21,8.05%,KCNC2;DDX11;ADCY10;DPEP1
prerank,negative regulation of endocytosis (GO:0045806),-0.31815165084793223,-0.9483263910830029,0.5467625899280576,0.7573730465258728,1.0,4/24,9.18%,CAV1;RAC1;PRKD1;PICALM
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.28844689451437594,0.9482808599270115,0.5426695842450766,0.9317243852162923,1.0,4/32,5.75%,MAGI2;PPP1R7;CAMTA1;CALM2
prerank,negative regulation of transport (GO:0051051),-0.2661638310775397,-0.9481859345277381,0.5487804878048781,0.7573013799000851,1.0,15/51,22.24%,RAB7A;DYSF;PPM1F;PRKD1;ARL6IP5;PXK;SNX12;CTTNBP2NL;PLSCR1;ABCA7;PIP4P2;WWP2;PTEN;ITGB3;NDFIP2
prerank,regulation of mRNA processing (GO:0050684),0.2856192404545715,0.9476203099441008,0.5263157894736842,0.9322360910795454,1.0,8/32,16.07%,KHDRBS2;KHDRBS3;QKI;SRPK1;PTCD2;SAFB;TIA1;HNRNPK
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.31255619454254946,0.947304887214572,0.5653206650831354,0.9316571716898951,1.0,7/23,12.18%,PIP4P1;MTMR2;MTMR10;MTMR11;MTMR7;OCRL;INPP5F
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.22950865111529523,-0.947293864774152,0.5778546712802768,0.7590774308669639,1.0,50/125,35.67%,CLIP1;MAD1L1;SETD2;MAP4;NEK6;RANBP2;AHCTF1;NUP98;PLK2;SEC13;PAFAH1B1;MECP2;KIF11;RPS27;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;TACC3;BUB3;TTK;PCNT;CENPI;CENPH;EML4;CENPN;RAN;DYNLL1;SPC25;SPDL1;TUBG2;CDCA8;STMN1;BIRC5;EFHC2;WDR62;NUDC;PLK1;NUF2;CKAP5;AURKA;MIS12;SPC24;ESPL1;TNKS;CDC20;NUP43
prerank,dicarboxylic acid transport (GO:0006835),0.30189829026628784,0.9470289312774277,0.5389755011135857,0.9309961350959827,1.0,8/28,14.47%,PDPN;SLC25A13;SLC46A1;SLC1A2;SLC19A1;SLC1A3;SLC13A5;SLC26A8
prerank,regulation of protein localization to membrane (GO:1905475),0.2965755263845087,0.9469574618721427,0.5114155251141552,0.9297193945730116,1.0,5/28,6.96%,GPC5;CDK5;CLN3;GPC1;GSN
prerank,positive regulation of cell aging (GO:0090343),-0.39187766417078596,-0.9469217884515231,0.542608695652174,0.759601062804015,1.0,4/11,15.17%,YPEL3;LMNA;ABI3;CGAS
prerank,positive regulation of lipid localization (GO:1905954),-0.39701470881172984,-0.9468789721273193,0.5215889464594128,0.7593063330354576,1.0,5/11,27.14%,NFKB1;IKBKE;LPL;LRP1;HILPDA
prerank,histone monoubiquitination (GO:0010390),-0.3141326837290658,-0.9467828639962429,0.54,0.7591384264787939,1.0,7/24,19.05%,DTX3L;RYBP;RNF40;CDC73;RNF168;BCOR;RNF2
prerank,glycoprotein catabolic process (GO:0006516),0.33934763971602877,0.9462324760290247,0.5310344827586206,0.9303942801632102,1.0,2/17,5.88%,MMP12;FBXO2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.28447337392581074,0.9461465239252899,0.5565819861431871,0.9291606924551797,1.0,5/35,5.39%,HTR2C;RIMS2;DGKQ;AKAP6;EPHA5
prerank,mitochondrial translational elongation (GO:0070125),-0.23827301020315772,-0.9461181761032855,0.5541958041958042,0.760367617130326,1.0,30/88,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;MRPL11;MRPS31
prerank,positive regulation of cholesterol transport (GO:0032376),-0.30511089545106085,-0.9458035701839554,0.5621621621621622,0.7607571515633278,1.0,11/27,28.27%,PLTP;CAV1;RXRA;NFKBIA;ABCA7;EEPD1;PPARG;LPCAT3;GPS2;LRP1;TREM2
prerank,regulation of cell cycle process (GO:0010564),-0.23424967281467374,-0.9457598224344733,0.5709342560553633,0.7604670631700221,1.0,38/104,33.27%,DCUN1D3;CDK13;MAD1L1;SETD2;CEP85;CUL9;AHCTF1;ZFYVE26;CEP250;RAB11FIP3;PLK2;BIRC6;CUL7;KLHL13;CCDC8;KIF11;RAB11A;CTNNB1;PLK4;CETN2;PRC1;KIF13A;CHEK1;BECN1;ATF5;PLK3;APC;USP19;CDKN2B;BORA;CAV2;OBSL1;MAP9;PLK1;SND1;KIF20A;E4F1;AURKA
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.25192589524160264,-0.9456627438643451,0.5711743772241993,0.7603094793661813,1.0,24/66,36.11%,FOXP1;APP;CASP8;JAK2;LPL;PANX1;TNFAIP3;TRIM16;IGF1;GBP5;CCL19;NOD2;CASP1;FZD5;F2R;LGALS9;NLRP2B;NLRC4;STAT3;TLR6;CARD16;NLRP3;CD33;TLR8
prerank,bone morphogenesis (GO:0060349),-0.3663619571143273,-0.9456579924924845,0.5355191256830601,0.7599287501632087,1.0,3/14,6.37%,LRP5;BMPR2;LRP6
prerank,regulation of calcium ion import (GO:0090279),0.3145232919396918,0.9454116692738431,0.5162790697674419,0.9297982823078443,1.0,6/21,12.95%,STC1;WNK3;TRIM27;PLPP4;SPHK2;CCL2
prerank,glycogen metabolic process (GO:0005977),-0.309079265614988,-0.9443690801491359,0.5677655677655677,0.7626024622653311,1.0,6/27,13.73%,GBE1;GSK3B;PHKA2;PPP1R3C;GYS1;PHKB
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.2892383383983074,-0.9442021608316276,0.5559701492537313,0.7625944962116395,1.0,9/35,17.12%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,B cell homeostasis (GO:0001782),-0.3943112592967166,-0.9438325118712289,0.5385996409335727,0.7630542311419413,1.0,4/10,14.90%,LYN;MEF2C;PPP2R3C;TNFAIP3
prerank,negative regulation of viral genome replication (GO:0045071),-0.28507172406804715,-0.9436129199231728,0.535042735042735,0.7631858134905761,1.0,16/40,30.71%,RESF1;IFIH1;ZC3HAV1;TASOR;IFITM3;PLSCR1;N4BP1;SRPK2;MAVS;IFITM2;TNIP1;TRIM6;OASL;BST2;RSAD2;SHFL
prerank,renal absorption (GO:0070293),-0.39755374742876265,-0.9433977696519482,0.5280289330922242,0.7632612474337219,1.0,5/10,23.34%,KCNQ1;WNK4;KLHL3;HYAL2;HAS2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.37515606524302253,-0.9433630214939813,0.540796963946869,0.7629592089915577,1.0,4/13,16.35%,ATM;SPRED2;RPL26;HIC1
prerank,primary neural tube formation (GO:0014020),-0.2963567615723904,-0.9433553696884828,0.5348432055749129,0.7625837540383771,1.0,9/30,18.68%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,autonomic nervous system development (GO:0048483),0.3394856808374097,0.943310341704192,0.530751708428246,0.9346561489781099,1.0,1/17,0.37%,PHOX2A
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.34927299962705954,-0.943269262496675,0.5333333333333333,0.7623975180211533,1.0,6/16,24.23%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,negative regulation of developmental growth (GO:0048640),0.2916315733796881,0.9425722847171026,0.5097613882863341,0.9353344283706986,1.0,10/30,19.84%,DCC;MAP2;RTN4;PTPRS;MAG;TRIM46;SLC6A4;BBS2;RTN4R;FGFR3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3892388617171304,0.942555777074862,0.5196304849884527,0.933901963692776,1.0,2/10,14.86%,RCC2;RACGAP1
prerank,positive regulation of viral genome replication (GO:0045070),-0.30331772943997826,-0.9414409775468444,0.546572934973638,0.7663478412955181,1.0,9/29,18.77%,DDX3X;LARP1;PPARA;PKN2;PDE12;SRPK2;ADARB1;RAD23A;STAU1
prerank,response to organonitrogen compound (GO:0010243),0.27248587806826746,0.9413701839472634,0.5533333333333333,0.9359589572184336,1.0,3/38,4.32%,GLRA3;GLRA1;INAVA
prerank,maturation of 5.8S rRNA (GO:0000460),-0.34806964138509433,-0.9412585535181034,0.5549132947976878,0.7663576956159724,1.0,5/17,20.70%,RPF1;RRP15;NOL9;PRKDC;PES1
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2886208945982204,-0.9411759059448509,0.5788497217068646,0.7661612629939135,1.0,16/36,40.15%,LEF1;ZMIZ1;GLI3;VSIR;SOX4;BCL6;NKAP;IL7;PNP;SHH;VNN1;ZAP70;MDK;GATA3;TESPA1;IL4
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2709514345043465,0.9407222428534191,0.5522727272727272,0.9364450086634989,1.0,11/38,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;HIRA;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3050865679534115,0.9401475409042002,0.5577777777777778,0.9367244635131844,1.0,5/26,5.58%,PFN2;SHANK1;PLEK;LIMK1;PFN1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2908717393090232,0.9392468122740096,0.5435779816513762,0.9378954234913016,1.0,10/30,17.77%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1
prerank,anterior/posterior axis specification (GO:0009948),-0.3586216700065091,-0.93907281355576,0.5805860805860806,0.7706708430997831,1.0,8/15,33.99%,TASOR;SKI;TBX3;FZD5;RIPPLY2;DDIT3;SHH;HOXD8
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.24010314012993794,-0.9388570478680067,0.5910714285714286,0.7707604893247232,1.0,29/88,27.03%,DAB2IP;DAPK1;RNF139;DDX3X;GIGYF2;LARP1;NFKB1;DNAJC1;SAMD4A;AKT1;EDN1;IGFBP5;SYNCRIP;BTG2;PLAT;HDAC6;CDK5RAP3;RPS3;CAPRIN1;TOB1;SERPINE2;RPL13A;MRPL13;EIF2AK3;FXR1;IGF2BP2;CNOT8;NANOS1;CNOT1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.34784256422379584,-0.9387812021144513,0.5408695652173913,0.7705516003292354,1.0,6/16,24.66%,CECR2;DICER1;KPNA1;EXOG;FOXL2;HMGB1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.28113928515367687,-0.938388515773995,0.5504761904761905,0.7710916001227518,1.0,16/39,24.03%,UTRN;NEDD4L;YWHAE;TCAF1;NEDD4;TRPC6;FXYD5;PTPN3;FXYD6;SCN3B;PPIF;SCN4B;WWP2;FHL1;RIPK1;AHCYL1
prerank,regulation of interferon-alpha production (GO:0032647),-0.32187567314822907,-0.9383156510524688,0.5609756097560976,0.7708578563706852,1.0,3/23,3.89%,IFIH1;SETD2;DDX3X
prerank,intestinal absorption (GO:0050892),-0.375197482101856,-0.938289606921195,0.53125,0.7705202223527493,1.0,3/13,7.60%,F11R;KCNQ1;TJP2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.27237734525500806,-0.9380709095632593,0.5714285714285714,0.7706129886593269,1.0,10/41,16.92%,CD34;GAS6;LBP;NFKBIL1;DICER1;TNFAIP3;ILRUN;VSIR;IGF1;RARA
prerank,heterochromatin assembly (GO:0031507),-0.3285249033387231,-0.9377095483789961,0.5314685314685315,0.7710753030882284,1.0,4/20,14.82%,ZNFX1;HDAC1;SUV39H1;H3-3A
prerank,digestive tract development (GO:0048565),-0.294599083705786,-0.9374726109251384,0.5754884547069272,0.7712141165251827,1.0,8/33,14.01%,CLMP;SMO;NIPBL;TGFB2;GLI3;PCSK5;PKDCC;ZIC3
prerank,cardiac cell development (GO:0055006),0.3671000339648554,0.9374140126432494,0.5616740088105727,0.9418618182770411,1.0,4/11,11.91%,CXADR;ALPK3;VEGFA;SLC8A1
prerank,regulation of cell projection organization (GO:0031344),0.35673060645431964,0.9371765952771063,0.5547785547785548,0.9410693040824113,1.0,3/13,7.70%,NTNG2;NTNG1;ERMN
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.35839322227619586,0.9366603928198671,0.5331858407079646,0.9410417413629917,1.0,5/12,24.80%,CDA;UCK2;UCK1;TK1;TK2
prerank,lipoprotein catabolic process (GO:0042159),-0.3826911083830033,-0.9366277286187614,0.535593220338983,0.7728010883457517,1.0,8/11,39.93%,ABHD17A;NOTUM;ABHD17C;LYPLA1;ABHD10;PPT1;ABHD17B;LYPLA2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.38751178272837405,-0.9365087828393189,0.527972027972028,0.7726867284823099,1.0,2/10,7.02%,TGFBR2;CD55
prerank,response to insulin (GO:0032868),-0.2402453615528508,-0.9363193134720635,0.5787476280834914,0.7727187344341129,1.0,13/80,12.67%,TBC1D4;SORBS1;FOXO1;INSR;KAT2B;PIK3R1;IRS1;RHOQ;GSK3A;AKT1;RAB8B;INSIG2;CEACAM1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3698274408251767,-0.935733963670212,0.5521885521885522,0.7736917018337947,1.0,3/12,4.94%,PKD2;ABCC9;TRPM4
prerank,glycolytic process (GO:0006096),0.2944840390010737,0.9356254039348298,0.5417607223476298,0.9425773754119864,1.0,5/28,15.04%,GCK;TPI1;PKM;ENO2;HK1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.371326604260654,-0.9354645750234157,0.5575221238938053,0.7739142638152711,1.0,5/12,15.57%,LAMA3;LAMA5;ACTB;TRAF3IP1;FUZ
prerank,sympathetic nervous system development (GO:0048485),-0.353925881457529,-0.934936927452669,0.5678119349005425,0.7747083098121225,1.0,4/15,20.79%,NRP2;CTNNB1;SOX4;NF1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.3300683488675082,0.934777276785196,0.5595238095238095,0.9435209741950934,1.0,3/17,12.58%,VTN;NR4A3;CCL5
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.32276380879798716,-0.9347117927131867,0.566003616636528,0.7748336937647807,1.0,5/22,22.01%,KLF4;GCNT2;FLOT1;BMP7;MAPK7
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.2116254591085033,0.9345855119320879,0.609271523178808,0.9426268426629103,1.0,29/163,14.60%,PDE4B;BLK;MS4A1;BLNK;PSMC5;PAG1;NFATC2;BCL2;CD3G;PSMD10;GRAP2;VTCN1;PAK3;PAK1;PIK3R2;PSMD14;VAV3;RIPK2;MOG;CARD11;PSMB7;RBCK1;PRKCB;PSMA4;TXK;PSMD1;PSMF1;EIF2B1;PSMB8
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3071464289707887,-0.9341958653845288,0.5833333333333334,0.7756251566494227,1.0,7/24,24.01%,ACVRL1;BMPR2;DACH1;TERF2;RPS3;BLM;MSH3
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.2729378193655449,-0.9335579515606697,0.5784832451499118,0.7767367033900056,1.0,9/40,14.12%,SLC7A5;SLC38A11;SLC5A6;SLC38A5;SLC16A1;SLC13A3;SLC25A11;SLC7A7;SLC36A4
prerank,protein prenylation (GO:0018342),-0.39715161666538357,-0.9334536282804599,0.5608465608465608,0.7765850213022695,1.0,6/10,39.12%,PTAR1;PGGT1B;RABGGTB;RCE1;RABGGTA;CHML
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.35488836011705194,-0.933323826694364,0.5478424015009381,0.776480960883846,1.0,3/15,11.78%,TGFB2;SMAD7;HFE
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.35003800882281394,-0.9331844342457106,0.556350626118068,0.7763939039688651,1.0,4/16,15.40%,ESR1;RBFOX2;NCOA4;TADA3
prerank,centromere complex assembly (GO:0034508),0.27610652193185586,0.9329621523322829,0.547085201793722,0.9458891724898393,1.0,11/36,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;DLGAP5;RBBP7;ITGB3BP;CENPA
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.22663621774493425,-0.9328852509893137,0.5914529914529915,0.7767109682826644,1.0,17/116,11.72%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;PLK2;RHBDF2;ADCY4;PLCG2;RAMP2;ADM;CYSLTR2
prerank,cardiolipin metabolic process (GO:0032048),-0.36874813572192655,-0.9327601505588248,0.5454545454545454,0.7766037564919738,1.0,2/13,3.63%,HADHB;PLA2G4A
prerank,negative regulation of metabolic process (GO:0009892),-0.25601561898476494,-0.9325430271809537,0.5627306273062731,0.7767231230097866,1.0,9/54,14.04%,ZNF423;RB1;ID1;IL15;LAMA4;NOVA2;ADAMTS5;NOTCH1;ATF4
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3597275045257525,-0.9322567798582281,0.56,0.7770174843673542,1.0,4/13,18.14%,MSN;EZR;RHOA;RAP2A
prerank,regulation of microtubule polymerization (GO:0031113),-0.27626317725212923,-0.9319501854281581,0.5818181818181818,0.7773737783339223,1.0,10/40,13.02%,DYRK1A;CLIP1;RAC1;ABL1;TOGARAM1;CDH5;OCLN;DCTN1;SLAIN2;DRG1
prerank,cellular amide metabolic process (GO:0043603),0.22654474970839714,0.931816186858331,0.6141552511415526,0.9478133465275167,1.0,24/102,16.64%,ABCA12;MME;PLPP2;SLC46A1;SMPD3;CPE;SLC19A1;PLA2G4E;OXSM;ALDH1L2;ABCA2;CPN1;AEBP1;ACSL6;MCCC2;NAAA;ACOT2;ACOT7;ACBD6;AASDHPPT;NSMAF;CLN8;MIPEP;ASAH2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.31320811382308694,0.9317810087142493,0.5553191489361702,0.9464546265845017,1.0,9/22,17.71%,MAP2;MAP1S;MAPT;MAP1B;AEBP1;MAPRE3;APOE;CAMSAP3;MAP1A
prerank,cellular defense response (GO:0006968),-0.27629551178064443,-0.9317686090693257,0.5669565217391305,0.7773908482334508,1.0,9/40,23.00%,ITGB1;ZNF148;LBP;CCR9;NCF2;RAB23;PTK2B;RELA;BECN1
prerank,negative regulation of hormone secretion (GO:0046888),-0.3972943444198237,-0.9312431772841023,0.5528756957328386,0.7782458830241954,1.0,5/10,36.26%,RAB11FIP3;RAB11FIP1;RAB11FIP5;IL11;LIF
prerank,positive regulation of endocytosis (GO:0045807),-0.2668906513245552,-0.9309352235838937,0.5918727915194346,0.7785628224082446,1.0,10/45,13.06%,HIP1;DAB2;NEDD4L;CBLL1;LDLRAP1;CBL;HFE;ANO6;ANKFY1;FLOT1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3554121008151685,0.9307249633607613,0.5570469798657718,0.9481252709976312,1.0,4/13,16.40%,TOX;CAMK4;FOXJ1;ADAM8
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.238295799082959,-0.9306770282131139,0.6039426523297491,0.7787629921639682,1.0,25/83,24.25%,CENPJ;YWHAE;CEP57;CEP250;CEP78;HAUS8;TP53;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;ODF2;HSP90AA1;PCNT;CEP131;AKAP9;ATF5
prerank,tube closure (GO:0060606),-0.29025417339158194,-0.9306123286194563,0.5587188612099644,0.77851356814326,1.0,9/31,18.68%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,negative regulation of neuron death (GO:1901215),0.23177291667814182,0.9305930134343476,0.6022988505747127,0.9470666870706388,1.0,21/93,13.39%,CDK5;BCL2;TYRO3;CLN3;CHGA;PTPRZ1;NTRK2;VSTM2L;GRN;PLA2G3;SORL1;POU4F1;KIR3DL2;MAG;ATP13A2;HTRA2;FZD9;NRBP2;CCL2;BDNF;FGF20
prerank,establishment of spindle orientation (GO:0051294),-0.30365300131518014,-0.9303977792801513,0.56353591160221,0.7786437619636344,1.0,7/28,22.31%,ITGB1;MAP4;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,regulation of chromatin binding (GO:0035561),-0.3956528109586094,-0.930299519670877,0.551594746716698,0.7784883138451821,1.0,4/10,10.43%,BTAF1;DTX3L;WAPL;HMBOX1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.27950986592422117,-0.9300070349982114,0.568904593639576,0.7787649450841629,1.0,12/39,22.47%,PTPRG;PODXL;AFDN;PTK2;CDH1;SMAD7;CEACAM1;JAG1;CITED2;MAGI1;FERMT3;EPHB3
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3920728357483402,-0.9299829402124956,0.5681818181818182,0.7784334270302242,1.0,7/10,47.14%,AKT1;TREM2;TICAM1;TLR6;MIA3;TLR4;MYD88
prerank,negative regulation of cellular component organization (GO:0051129),0.23754289044767618,0.929344600292293,0.6053811659192825,0.9492512643479896,1.0,15/74,13.93%,TMEFF2;SYT11;APOM;IMPACT;MTMR2;HSF1;CARMIL1;SORL1;XRCC5;VEGFA;PRKCZ;NOP53;RUBCN;CLU;LRSAM1
prerank,nuclear pore organization (GO:0006999),-0.35645600988902176,-0.9291088333585354,0.5706618962432916,0.7800255451799316,1.0,4/14,15.78%,AHCTF1;NUP98;NUP153;TPR
prerank,heme biosynthetic process (GO:0006783),-0.31670082829675317,-0.929001760584702,0.5658362989323843,0.7799006557528683,1.0,3/22,8.14%,ABCG2;ALAS1;ABCB10
prerank,camera-type eye morphogenesis (GO:0048593),-0.38746248658019233,-0.9288294160719021,0.5719489981785064,0.7798931584679367,1.0,5/10,20.79%,LRP6;TBX2;SHROOM2;SKI;NF1
prerank,negative regulation of immune system process (GO:0002683),0.3322048294061508,0.9286216795082146,0.5588865096359743,0.9499584500290059,1.0,6/16,17.74%,FCRLB;HOXA7;GPER1;COL3A1;SOX9;FCGR2B
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2919097257608284,-0.9278754990588353,0.5886654478976234,0.7816991526763128,1.0,11/31,26.71%,DAB2IP;PTPN1;ERN1;TM7SF3;ATXN3;HDAC6;DNAJB12;HSPA14;HSPA13;HSPA1B;RHBDD1
prerank,lymphocyte mediated immunity (GO:0002449),-0.3655858215240838,-0.9278447770462023,0.5740402193784278,0.7813721395338982,1.0,7/12,45.62%,CD55;JAG1;GNL1;MYO1G;BTN3A3;KLRD1;SLA2
prerank,negative regulation of immune effector process (GO:0002698),0.3558915209344459,0.92757223605324,0.5438972162740899,0.9514809521069804,1.0,4/13,15.25%,GRN;ENPP3;HAVCR2;CD47
prerank,negative regulation of histone acetylation (GO:0035067),-0.3874135130079737,-0.9270958461718299,0.5394265232974911,0.7827104281308841,1.0,5/11,29.25%,SIN3A;TAF7;BRCA1;SET;SPI1
prerank,transepithelial transport (GO:0070633),-0.35009505532096397,-0.9269768452744348,0.5588752196836555,0.7825980030445644,1.0,2/15,4.55%,ABCG2;SLC12A2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.28198973230400387,-0.9266061778265329,0.5909090909090909,0.7830127007772802,1.0,12/33,24.03%,NEDD4L;KCNJ2;YWHAE;NEDD4;KCNQ1;ANO6;KCNJ8;CASQ2;WWP2;KCNH2;AKAP9;AHCYL1
prerank,positive regulation of organelle assembly (GO:1902117),-0.2696857552726854,-0.9265501714793608,0.5659050966608085,0.7827544185334975,1.0,11/44,17.97%,ASAP1;RAB3GAP1;STX18;PIP4K2A;PIP4K2B;CROCC;RAB3GAP2;LCP1;FUZ;ARHGAP35;PLK4
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2969821267805146,-0.9262031117782921,0.5609318996415771,0.7831628414606305,1.0,10/29,27.81%,JAM2;GAS6;MOSPD2;ANO6;LGMN;CXCL12;SERPINE1;HMGB1;LGALS9;CXCL10
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.22557266605930507,-0.9253438434544372,0.6295025728987993,0.7847586846900887,1.0,17/117,11.72%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;PLK2;RHBDF2;ADCY4;PLCG2;RAMP2;ADM;CYSLTR2
prerank,cellular response to light stimulus (GO:0071482),-0.2480092697386095,-0.9248445431300477,0.608318890814558,0.7855146108805522,1.0,13/66,15.76%,GNB1;CREBBP;NEDD4;PRKCD;PTPRK;RPL26;TP53;NSMCE3;SAG;ATF4;COPS9;N4BP1;RUVBL2
prerank,regulation of establishment of protein localization (GO:0070201),-0.35852158348911467,-0.9244960564530117,0.5626072041166381,0.7859037209268768,1.0,3/14,8.85%,CENPJ;SPIDR;SCFD1
prerank,skeletal system morphogenesis (GO:0048705),0.26695117382354605,0.9240622810005338,0.5786163522012578,0.9601537615524369,1.0,14/42,19.99%,DSCAML1;HOXD3;CYP26B1;MEGF8;FGFR2;RAB33B;HOXA4;HOXA9;PDGFRA;HOXD4;FBN2;HHIP;FGFR3;DYNC2I1
prerank,histone H3-K36 demethylation (GO:0070544),-0.39278154984964686,-0.9240362504709106,0.5953237410071942,0.7865455388139464,1.0,3/10,14.06%,KDM2A;RIOX2;KDM7A
prerank,cognition (GO:0050890),-0.27266383771858826,-0.9238096594680454,0.575591985428051,0.7866641171053141,1.0,8/42,9.33%,SHROOM4;ST3GAL4;SOBP;APP;NIPBL;SETD5;MFSD2A;FAM107A
prerank,intestinal lipid absorption (GO:0098856),-0.37756290146031735,-0.9236052767438493,0.5416666666666666,0.7867467299920916,1.0,1/11,0.85%,LIMA1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3025938193225363,0.9233484498815097,0.5627615062761506,0.9607874538201244,1.0,6/24,15.33%,SLC25A13;ADRB3;NR4A3;LYRM7;MRAP2;GFPT1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3899202992181816,-0.923198465338459,0.5778175313059034,0.7873084643437144,1.0,5/10,32.71%,LYN;CD40;BTLA;LILRB1;FGR
prerank,cellular response to purine-containing compound (GO:0071415),0.3735305136402261,0.9231087266268052,0.5275779376498801,0.9599822589416518,1.0,3/10,11.91%,RYR3;RYR2;SLC8A1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3136458959838939,-0.9229263554602799,0.5803571428571429,0.78752112338235,1.0,8/23,30.86%,GAS6;VSIR;RARA;HMGB1;LGALS9;AXL;DDIT3;LILRB1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2627448046724712,-0.9210766408988605,0.6049382716049383,0.7912872477757806,1.0,18/49,28.27%,GSK3B;DDX3X;LDLRAD4;RAF1;TRAF3IP1;IAPP;SMAD6;HDAC6;ANKRD27;PMEPA1;TFIP11;RPL13A;HMGB1;AIDA;KIF14;NLRP2B;RIOK3;TREM2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3263653015098522,-0.9207128420893816,0.5947467166979362,0.7913471836076242,1.0,7/21,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3263653015098522,-0.9207128420893816,0.5947467166979362,0.7913471836076242,1.0,7/21,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,cellular response to acid chemical (GO:0071229),-0.29911371469286796,-0.9204540848378778,0.5901639344262295,0.791524209582569,1.0,6/27,13.63%,SH3BP4;KLF2;MTOR;CAPN2;RPTOR;LARS1
prerank,triglyceride biosynthetic process (GO:0019432),0.3226788894234632,0.9203460370699571,0.5664488017429193,0.9665605022505512,1.0,3/18,12.65%,LPIN1;GK;MOGAT1
prerank,phosphate ion homeostasis (GO:0055062),0.38420661452301824,0.9202841096965748,0.5504385964912281,0.9652632200359834,1.0,1/10,1.56%,SLC34A1
prerank,zymogen activation (GO:0031638),0.27395524122016046,0.9202605525713987,0.5771971496437055,0.963853294086296,1.0,5/39,10.27%,OMA1;C1RL;GRIN2A;KLK1;RIPK2
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3318495047044162,-0.9198082290859266,0.5905096660808435,0.7925781322733975,1.0,6/18,25.24%,CAV1;NEDD4L;SLC43A1;PPIF;KCNH2;CAB39
prerank,response to retinoic acid (GO:0032526),-0.2471906391724867,-0.9193751755107565,0.5958188153310104,0.7931655873948038,1.0,9/59,6.79%,LYN;ACER2;ASXL1;RXRA;ATM;TBX1;FZD4;RARG;RBP4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2626359134890871,-0.9192025554760224,0.5828877005347594,0.7931814934007544,1.0,10/43,16.92%,CD34;GAS6;LBP;NFKBIL1;DICER1;TNFAIP3;ILRUN;VSIR;IGF1;RARA
prerank,cellular response to unfolded protein (GO:0034620),-0.2986001247773949,-0.9190082466516399,0.590990990990991,0.7932247709056514,1.0,5/26,12.34%,DAB2IP;PTPN1;ERN1;ABCB10;TM7SF3
prerank,long-chain fatty acid import into cell (GO:0044539),-0.3876995692540297,-0.9186681551338652,0.5555555555555556,0.7936168609257893,1.0,4/10,23.42%,SLC2A1;SLC27A4;ACSL1;SPX
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.329492357795387,-0.918448914971952,0.5964285714285714,0.7937120529814569,1.0,4/18,8.54%,CD200;RPS6KA5;PRKD2;PRKD1
prerank,SNARE complex assembly (GO:0035493),-0.38960159261171323,-0.9181702487662657,0.5905096660808435,0.7939553294691784,1.0,5/10,34.06%,STXBP6;VAMP3;VAMP2;VAMP8;VAMP4
prerank,phagosome-lysosome fusion (GO:0090385),0.37651528928207234,0.9180269636627781,0.5502283105022832,0.9687052235287784,1.0,4/10,15.85%,CLN3;RAB39A;RAB34;RAB20
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3377896438019899,0.9180180070751583,0.5462962962962963,0.967271706664975,1.0,7/16,18.43%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.3687905145891073,-0.91697584708104,0.5974955277280859,0.7962756545449464,1.0,2/12,5.85%,PPARA;IRS1
prerank,regulation of telomere capping (GO:1904353),-0.31041870346761363,-0.9165680927132214,0.5687732342007435,0.7968420645408318,1.0,13/23,38.34%,NEK7;ATM;MAPK1;PNKP;TERF2;USP7;SMG6;HNRNPD;TNKS2;RAD50;TNKS;MAPKAPK5;MAPK15
prerank,positive regulation of interferon-gamma production (GO:0032729),0.2579090433791291,0.9165181277623868,0.6300448430493274,0.9701144369497279,1.0,9/48,15.02%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;TXK;SLAMF6;IL23A
prerank,negative regulation of receptor binding (GO:1900121),-0.39022465613251034,-0.9164327865846424,0.5873015873015873,0.7967646423266045,1.0,2/10,11.78%,ATP2A3;HFE
prerank,arachidonic acid metabolic process (GO:0019369),-0.279530528501511,-0.9163371387807897,0.580110497237569,0.7965914579701812,1.0,12/35,26.42%,PLA2G4A;PTGS1;EPHX1;MGLL;PTGES3;GPX1;HPGDS;DAGLB;PNPLA8;CYP1B1;PTGIS;GPX4
prerank,regulation of platelet aggregation (GO:0090330),0.33468061293492324,0.9160919511399269,0.567032967032967,0.969911507145295,1.0,3/17,1.83%,BLK;C1QTNF1;PDPN
prerank,proteoglycan biosynthetic process (GO:0030166),-0.2858661512855229,-0.9160029046841696,0.5952813067150635,0.7969652823891448,1.0,6/31,12.14%,EXT1;BMPR2;CSGALNACT1;HS3ST3B1;CHST11;EXTL3
prerank,positive regulation of cyclase activity (GO:0031281),-0.34695678999689045,-0.9159617843334248,0.5630397236614854,0.796653944202037,1.0,7/14,35.15%,NOS3;MAPK8;NF1;NOS1;MAPK14;NOS2;STIM1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3377614111336866,-0.9156605119740395,0.5641952983725136,0.7969532171681178,1.0,8/16,33.12%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,diol metabolic process (GO:0034311),0.31468324092908223,0.915591189872567,0.5751633986928104,0.9698386069269973,1.0,6/19,11.24%,PLPP2;SPHK1;SGPP1;PRKG2;SPHK2;NAAA
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3800838981069449,-0.9155380144155639,0.5769980506822612,0.7968341252918277,1.0,3/11,6.70%,KCNJ2;YWHAE;KCNQ1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.30010316406013793,-0.9154802485146674,0.5932504440497336,0.7965606701328551,1.0,9/26,19.01%,LYN;PSME2;EPHA4;PICALM;ROCK2;VSIR;FYN;APH1A;PSME1
prerank,peptidyl-asparagine modification (GO:0018196),0.28206696438881323,0.9152752428217247,0.5763888888888888,0.9692979699846042,1.0,10/31,17.77%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1
prerank,positive regulation of dendritic spine development (GO:0060999),0.31624176377175645,0.915201162340685,0.575,0.9680570920199063,1.0,6/20,17.25%,NLGN1;SHANK1;CAMK2B;CPEB3;APOE;DHX36
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3274149764857442,-0.915020207547012,0.583180987202925,0.7972189781340913,1.0,7/17,30.81%,BMP4;RGCC;VSIR;F2R;LARP6;RUNX1;TGFB1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3802844825537293,-0.9141403699672543,0.5662878787878788,0.7987994403342566,1.0,2/11,3.17%,LYN;ATM
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2219425154243744,-0.9136065290822403,0.6724738675958188,0.7995659848437573,1.0,48/117,35.11%,BSG;DLD;PANK2;SLC5A6;PPARA;GGT5;ACSF2;SLC16A1;PPARD;SCPEP1;THEM4;CPT1A;ACADSB;ABAT;SLC27A4;PDHB;LPL;IGF1;HOGA1;GBA2;MTHFD1L;PCCA;PPARG;PCCB;KYNU;GAMT;PTGR1;PNPLA8;ACOT6;ACSF3;CKMT1A;ACOT11;GLO1;SGPL1;ALKBH7;ME2;HACL1;HAGH;LDHA;VNN1;HLCS;NPC1;FASN;ADH1A;ME1;CYP4B1;ECHDC3;ALDH8A1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.26925387643391635,-0.9135333724681963,0.6221441124780316,0.799322047545733,1.0,9/39,13.47%,MYO1D;TRAK1;FNBP1L;RAB1A;WASL;MYO1F;ACTN4;PAFAH1B1;FBXW11
prerank,negative regulation of cyclase activity (GO:0031280),0.3441290864732248,0.913484052685818,0.5912087912087912,0.971476702630632,1.0,2/14,4.62%,GNAI2;GABBR2
prerank,cellular iron ion homeostasis (GO:0006879),-0.25531527937938603,-0.9133481206954661,0.6142322097378277,0.7993391833550081,1.0,11/55,18.25%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;SMAD4;HFE;HMOX2;ABCB7;SOD1;FLVCR1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2380102870130988,0.9132818778339548,0.6388888888888888,0.9706066258880179,1.0,15/70,17.55%,ENPP2;PCYT1B;LPIN1;PLA2G7;PLA2G3;PLA2G4E;PLA2G6;LIPC;MBOAT7;GPLD1;CHKA;CHPT1;SLC44A2;MBOAT2;LPCAT2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.34551096606046927,-0.9131155460057174,0.5863309352517986,0.7994629818486135,1.0,4/15,10.57%,CSGALNACT1;DSE;CSPG4;BGN
prerank,fatty acid elongation (GO:0030497),0.3468414124415712,0.9130618541918435,0.5432372505543237,0.9698092093211088,1.0,5/13,19.35%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,nucleotide metabolic process (GO:0009117),0.29869316431560805,0.9130019059529925,0.5808656036446469,0.9685496925127202,1.0,7/23,17.00%,AK7;AK5;ENPP3;NME2;RNASEH2B;GUK1;AK1
prerank,mesenchymal cell development (GO:0014031),0.31930316598578595,0.9125006809743591,0.6081730769230769,0.9685814511380522,1.0,3/18,11.59%,NRG1;NOLC1;CDH2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.29290800897178126,-0.9123319473080141,0.5932504440497336,0.8007961471793111,1.0,13/28,32.37%,DTX3L;SHLD1;KMT5B;MRNIP;PNKP;MAD2L2;TFIP11;PRKDC;ERCC6;PARP9;KDM4D;CYREN;PARP3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.21994500046509102,0.9119161770891628,0.6637744034707158,0.9688233491397352,1.0,15/107,12.58%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;CCL13;ATP13A2;SLC8A3;SLC8A1;CCL5
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.356935182835336,-0.9116595082101122,0.559322033898305,0.8019463763950134,1.0,7/14,36.67%,NT5E;NT5C1A;NT5C;UPB1;UPP1;CAD;DPYS
prerank,negative regulation of RNA splicing (GO:0033119),-0.321247373738205,-0.9116534559915156,0.5479930191972077,0.8015625680614663,1.0,8/19,30.51%,SRSF12;SFSWAP;RNPS1;PTBP3;SRSF10;RPS26;SRSF6;RPS13
prerank,regulation of ATP metabolic process (GO:1903578),-0.25408920205675845,-0.9116116758812388,0.5871080139372822,0.8012629280574155,1.0,24/54,39.21%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;UQCC2;OGT;NUP188;BEND3;NUP88;SLC25A33;NUP35;NUP43;HIF1A;ATP5IF1;PGAM1;JMJD8;PRKAG2;COX7A1;NUP50
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.3925677161393318,-0.9114126683037026,0.5825771324863884,0.8012929076365792,1.0,5/10,38.32%,HDAC6;AOC3;HP;MT3;ETFBKMT
prerank,protein K48-linked deubiquitination (GO:0071108),0.30118710141370364,0.9112010993760119,0.5906040268456376,0.9693276586419957,1.0,11/23,24.60%,OTUD7A;USP25;OTUD7B;USP50;USP5;USP33;USP20;OTUB2;USP8;OTUB1;OTUD5
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.303671387813471,-0.9108637596023221,0.6153846153846154,0.8021649561743952,1.0,8/24,21.91%,MCL1;FOXO3;TGFB2;ATF4;SRPK2;CTNNB1;NF1;ITGAM
prerank,positive regulation of proteolysis (GO:0045862),-0.2544701802356654,-0.9106320410581633,0.6178571428571429,0.8022819005933455,1.0,12/55,21.12%,CTSC;ADAM9;TNFRSF1B;SNX9;ASPH;CASP8;PERP;FBXW11;MAPK12;CTSH;FGFR4;OGT
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3586980528470292,-0.9105853043368811,0.5859649122807018,0.8020045031599727,1.0,5/13,12.27%,TGFBR3;MEF2C;TBX2;NOTCH1;FGF2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2985122374253272,-0.9104680639201912,0.5901639344262295,0.801856837913119,1.0,4/27,12.29%,NFAT5;ETS1;RHOA;IRAK1
prerank,ceramide transport (GO:0035627),-0.3602444058996449,-0.9101252500848777,0.5971479500891266,0.8022338075142992,1.0,2/12,1.27%,CERT1;PLTP
prerank,regulation of interleukin-2 production (GO:0032663),-0.26526145015995234,-0.9100397040509459,0.6179159049360147,0.8020328099317563,1.0,14/43,24.75%,SPTBN1;CD34;PRKD2;EZR;PLCG2;KAT5;TNFAIP3;ANXA1;RPS3;PTPRC;HDAC7;HOMER3;STOML2;MAP3K7
prerank,regulation of lipid metabolic process (GO:0019216),-0.22988138728429655,-0.9094638521744627,0.657672849915683,0.8029081945253265,1.0,25/88,20.44%,CREBBP;CAV1;RXRA;PANK2;SP1;PPARA;MED1;NFYC;GGPS1;PPARD;ACACB;HELZ2;SIN3A;C1QTNF2;SMARCD3;NR1D2;TGS1;DHCR7;ABCA7;TNFAIP8L3;CARM1;NCOA6;TBL1X;PPARG;FGFR4
prerank,bicarbonate transport (GO:0015701),-0.29792173872736083,-0.9094283014992202,0.5862676056338029,0.8025904029999421,1.0,4/25,7.50%,SLC26A7;SLC4A10;CA4;SLC39A8
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3507449830700622,0.9092907357803408,0.6195652173913043,0.9731552835013608,1.0,2/13,4.62%,GNAI2;GABBR2
prerank,regulation of primary metabolic process (GO:0080090),-0.217678787408911,-0.9085724442635634,0.666098807495741,0.8041291621618936,1.0,37/126,20.44%,CREBBP;RXRA;PSMA2;SP1;PPARA;MED1;NFYC;PSME2;GGPS1;PSMB4;PPARD;ACACB;HELZ2;SIN3A;AZIN1;C1QTNF2;SMARCD3;PSMC2;NR1D2;TGS1;DHCR7;ROCK2;PSMB2;ABCA7;PSMB1;TNFAIP8L3;PSMA8;CARM1;OAZ2;PSME1;NCOA6;PRKAB1;TBL1X;PPARG;NQO1;PSMD4;FGFR4
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23603867776326404,-0.9081319757751406,0.6384892086330936,0.8047472049373984,1.0,14/75,15.36%,GRK5;RGS3;RGS5;GIT2;ZDHHC3;RGS12;PLCB1;PLCE1;ROCK1;NMT1;EDN1;MGLL;SAG;ROCK2
prerank,modified amino acid transport (GO:0072337),-0.3407216345395847,-0.908110674083487,0.6038461538461538,0.8043982907086608,1.0,3/15,5.23%,SLC16A12;SLC25A32;SLC5A6
prerank,embryonic organ morphogenesis (GO:0048562),0.2598716074027522,0.9080029233481687,0.6242299794661191,0.9753733822235194,1.0,8/42,10.01%,DSCAML1;EFEMP1;HOXD3;MEGF8;RYR2;FGFR2;MFAP2;HOXA4
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3335838120493434,-0.9076789638269492,0.6133567662565905,0.8049774102279716,1.0,11/17,40.99%,DYRK1A;YJU2;MIF;MDM2;SNAI2;RNF34;ARMC10;CD74;SIRT1;PTTG1IP;CD44
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3885493377004192,-0.9075599426295123,0.5830324909747292,0.8048620986081397,1.0,7/10,34.66%,DICER1;AGO2;DROSHA;TERT;TSN;TARBP2;MRPL44
prerank,leukotriene metabolic process (GO:0006691),-0.31951456577596127,-0.90753003948896,0.5951972555746141,0.8045374050132966,1.0,3/19,7.48%,PLA2G4A;GGT5;MAPKAPK2
prerank,nucleus organization (GO:0006997),-0.26075237342885366,-0.9074114758110382,0.6189591078066915,0.8044111711986551,1.0,16/47,31.35%,SYNE1;NUP98;REEP3;CHMP4B;CHMP4A;CHMP2B;TPR;SUN1;CHMP5;PDCD6IP;ATXN7;DMPK;CHMP3;CHMP6;CHMP1A;NUP35
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2514796194238285,-0.9068384172319847,0.6065857885615251,0.8053021470080406,1.0,18/55,26.87%,FBXL7;PSMA2;RBX1;PSME2;PSMB4;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;PSMD4;PSMA7;FHL1;PSMD5;ATF5;PINX1;PSMB10;PSMA3
prerank,mitotic cytokinesis (GO:0000281),-0.2608423166961036,-0.9067775319713252,0.6022727272727273,0.8050326656315876,1.0,13/47,15.75%,SPTBN1;STAMBP;SNX9;ROCK1;CHMP4B;CUL7;KIF23;RASA1;SON;RTKN;RHOC;ROCK2;MITD1
prerank,RNA biosynthetic process (GO:0032774),0.2782341004270322,0.9063515666359359,0.623608017817372,0.9784199479759559,1.0,5/31,10.43%,TBPL1;SMARCA5;TAF5;POLA1;PRMT5
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.29834229360823483,-0.9060004101032383,0.6254826254826255,0.8063225349426673,1.0,5/25,11.34%,RIN3;RAC1;APP;PICALM;PSEN1
prerank,regulation of pH (GO:0006885),0.36052459077537047,0.9052686377777595,0.5603644646924829,0.9799794312011659,1.0,1/11,3.49%,SLC9A7
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.35150633481567295,0.905053849041952,0.5607476635514018,0.9791691824387643,1.0,2/12,6.82%,FADS1;FADS2
prerank,lipid droplet organization (GO:0034389),0.30488634888891125,0.9036964251902923,0.5965665236051502,0.9815063741213005,1.0,6/22,17.75%,BSCL2;SQLE;PPID;PPIA;AUP1;CDS1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3494073589002813,0.9035389250058886,0.5565819861431871,0.9805038142686524,1.0,3/12,7.41%,CTNNA3;PKP2;RYR2
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.30291608323680735,-0.9034491544079377,0.6190476190476191,0.8116217369216806,1.0,7/24,15.58%,PRKCH;CBFB;MED1;ROCK1;FOXC1;ROCK2;TRIM16
prerank,regulation of neurotransmitter transport (GO:0051588),0.33425835366512247,0.9031911090436019,0.5665137614678899,0.9800500959923536,1.0,3/16,10.68%,RIMS1;SYN1;MCTP2
prerank,positive regulation of DNA repair (GO:0045739),-0.2611224194712654,-0.9031126395321037,0.6390845070422535,0.8119687196012185,1.0,20/46,26.54%,EYA4;UIMC1;EGFR;SPIDR;BABAM2;RNF168;SLF2;ERCC8;HDAC10;CEBPG;BRCC3;RPS3;TIMELESS;BRCA1;TRIM28;FAM168A;HMGB1;DHX9;ERCC6;FGF10
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3250182954489452,-0.9030793737615391,0.6043956043956044,0.8116391705863584,1.0,7/17,27.81%,MOSPD2;ANO6;LGMN;CXCL12;SERPINE1;HMGB1;CXCL10
prerank,regulation of cholesterol transport (GO:0032374),0.31240675287288294,0.9030427841530974,0.608786610878661,0.9790019999747889,1.0,9/20,27.51%,OSBPL6;ABCA2;NUS1;ABCA5;APOC1;LAMTOR1;NR1H2;ARV1;TTC39B
prerank,maturation of SSU-rRNA (GO:0030490),-0.2768646190200117,-0.9028214791838096,0.6177024482109228,0.8118238479761052,1.0,15/34,42.29%,RPS14;NOL10;UTP3;RPS16;DCAF13;UTP4;RPS8;WDR46;RIOK3;SRFBP1;RRP36;DHX37;TSR2;RPS28;NAT10
prerank,replicative senescence (GO:0090399),-0.3618883886017107,-0.9024555184111125,0.5849387040280211,0.8122324847225633,1.0,6/12,22.81%,ATM;WNT16;TP53;TERT;CHEK1;SERPINE1
prerank,protein kinase B signaling (GO:0043491),-0.30331134862117304,-0.9023226849553967,0.6270903010033445,0.812172748166753,1.0,10/23,26.05%,KDR;GAS6;AKT1;THEM4;PIK3R3;IGF1;EPHA2;PTEN;PLK3;ZFP36L1
prerank,metanephric mesenchyme development (GO:0072075),0.36987838370560433,0.9023164085229797,0.6155507559395248,0.9795508162087434,1.0,3/10,6.07%,OSR1;WT1;PAX2
prerank,transferrin transport (GO:0033572),-0.2828459793411473,-0.9022443326304608,0.6219739292364991,0.8119600571847349,1.0,8/33,13.99%,TFRC;DNM2;STEAP3;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15
prerank,positive regulation of peptidase activity (GO:0010952),-0.31686415628172915,-0.901854543314889,0.5873873873873874,0.8124134138775109,1.0,6/20,19.01%,PSME2;MAPK12;VSIR;CTSH;APH1A;PSME1
prerank,fat cell differentiation (GO:0045444),-0.24874146031440714,-0.9017483748000609,0.6524163568773235,0.812261709782742,1.0,24/57,35.17%,FOXO1;KLF4;PRDM16;TMEM120A;ZBTB7A;MED1;CTBP2;SMAD6;C1QTNF3;SENP2;ERAP1;TCF7L2;PPARG;CEBPA;ATF5;WNT5B;SDF4;STEAP4;PID1;TRIM32;ALOXE3;IL11;NR4A2;ADIG
prerank,zinc ion transport (GO:0006829),-0.31364937637776064,-0.9016899077460477,0.6045296167247387,0.8119927667189498,1.0,6/21,20.73%,SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3174030824977222,-0.9015445454642533,0.5967741935483871,0.8119606071152169,1.0,3/19,5.88%,PARD3B;PARD3;DLG1
prerank,T cell receptor signaling pathway (GO:0050852),-0.21564367345929836,-0.9015022369227496,0.7028985507246377,0.8116591863760366,1.0,43/138,25.35%,PSMA2;PAK2;PLCG1;PRKD2;PTPRJ;NFKB1;NCK1;PIK3R1;SPPL3;PSME2;PSMB4;PLCG2;THEMIS;BCAR1;PIK3CD;EIF2B2;CSK;FBXW11;PIK3CB;ICOSLG;PSMC2;RC3H1;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;PTPRC;PSMD4;INPP5D;PSMA7;RELA;FYB2;CD276;PSMD5;CD247;STOML2;MAP3K7;KHDRBS1;PIK3CA
prerank,negative regulation of histone modification (GO:0031057),0.349310464835671,0.9014836078350581,0.6017699115044248,0.9804111980341738,1.0,4/14,15.43%,PRMT6;SPHK2;THAP7;TWIST1
prerank,activation of protein kinase B activity (GO:0032148),0.27964338751906825,0.9008262227312982,0.6167800453514739,0.9807738720619735,1.0,5/29,9.31%,NRG1;CCDC88A;ANG;ADRA2C;ADRA2A
prerank,protein import into peroxisome matrix (GO:0016558),-0.36259523783037273,-0.9007971861257321,0.6007130124777184,0.8128154999086944,1.0,3/12,15.77%,PEX1;PEX7;PEX14
prerank,chromosome organization (GO:0051276),-0.22589514579084996,-0.9002122610912838,0.6737588652482269,0.8137041381102432,1.0,36/99,30.82%,RAE1;HDAC1;RBX1;ABL1;ZBTB7A;SUV39H1;LDB1;EHMT1;DOT1L;AXIN2;HMG20A;HMGN3;XPC;H3-3A;TCF7L1;RFWD3;HDAC10;CETN2;HMGN2;TCF7L2;LIG4;COPS7A;PWWP3A;CENPH;COPS8;SUPT4H1;SETD7;MSH3;COPS4;HDAC5;CDCA8;PHF19;CDAN1;BRWD1;COPS5;BAHD1
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.22452354095628752,-0.9002052763814051,0.6743362831858407,0.8133217635161715,1.0,40/95,37.54%,DAB2IP;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;LBP;MEF2C;NFKBIL1;RHOA;IRAK1;CDC73;MAPK8;TNFAIP3;CHMP5;DEFA6;NOD2;RELA;SERPINE1;CASP1;FZD5;SHPK;HMGB1;CXCL10;AXL;CACTIN;MAPK14;LILRB1;SBNO2;TICAM1;TNIP2;CD14;IL1A;CARD16;NLRP3;CXCL5;TLR2;CD274;CTR9;CXCL1
prerank,cilium-dependent cell motility (GO:0060285),0.29970443981955297,0.9000802787880159,0.6138392857142857,0.9814325614115845,1.0,2/22,4.01%,TEKT1;CFAP54
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3517997117445554,-0.8999248777911716,0.6053571428571428,0.8135726686501406,1.0,3/13,11.47%,JAK1;IL6ST;JAK2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3286412559421165,0.8994665762356324,0.5910064239828694,0.9816619140196102,1.0,9/15,21.99%,SCN1A;TMC1;TMC2;KIT;WHRN;MKKS;COL11A1;PDZD7;KCNK4
prerank,regulation of DNA replication (GO:0006275),-0.2540366399679626,-0.8985133312985696,0.6121739130434782,0.816337021926985,1.0,10/49,13.51%,ACVRL1;ANKRD17;STN1;EGFR;WAPL;ORC5;PDS5A;OBI1;DNA2;CTC1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.34119499299009676,0.8984919739062089,0.5668934240362812,0.9829372684196072,1.0,5/13,22.04%,ASPA;GLUD1;GAD1;DDO;MTHFS
prerank,axon extension (GO:0048675),-0.29737104424049216,-0.8979574298007266,0.6199649737302977,0.8171727321589362,1.0,6/23,16.15%,NRP2;USP9X;SLIT2;SPG11;ULK2;SEMA5B
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3123101654414203,-0.8978834031691543,0.612280701754386,0.8169409210203853,1.0,4/20,6.52%,NEDD4L;PRKCE;YWHAE;NEDD4
prerank,positive regulation of cellular protein localization (GO:1903829),-0.24353325613646035,-0.8975203926814188,0.6696588868940754,0.8173515231795124,1.0,17/69,17.82%,FERMT2;GSK3B;LIMK2;DTX3L;TFRC;RIC3;STX3;CEP250;YAP1;AKT1;CROCC;PRKAA1;GPR137B;TRAPPC12;ABCA7;FYN;CDK5RAP3
prerank,tRNA methylation (GO:0030488),0.26652382431607213,0.8974256794384315,0.6266968325791855,0.9843525689981935,1.0,12/34,25.66%,GTPBP3;TRMT13;TRMT10A;PRORP;FTSJ1;NSUN6;METTL2A;METTL2B;TRMT5;THUMPD3;TRMT1L;THUMPD2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2691694955919269,0.8971020171487,0.6244635193133047,0.9838001100053556,1.0,16/33,29.41%,MED18;CPSF1;CSTF2T;SNRPD3;CLP1;CPSF2;SCAF8;CSTF2;NCBP2;SETX;CPSF4;CSTF3;PCF11;SNRPF;TTF2;PABPN1
prerank,multivesicular body organization (GO:0036257),-0.2841811211482718,-0.8963654466089922,0.6438848920863309,0.81951314470376,1.0,14/31,30.84%,RAB27A;CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,neurotrophin signaling pathway (GO:0038179),-0.31121957348360485,-0.8962464550160937,0.6035714285714285,0.8193719246990234,1.0,7/21,14.62%,RAPGEF2;DDIT4;RAP1A;NGF;BCAR1;RAPGEF1;GRB2
prerank,response to UV-A (GO:0070141),0.3308873897506365,0.8955604154174587,0.6032110091743119,0.9865933133088236,1.0,4/14,13.12%,MME;CERS1;TIMP1;PPID
prerank,glucose transmembrane transport (GO:1904659),-0.32629674971498723,-0.8954590958053054,0.6073943661971831,0.8206960405135438,1.0,4/18,13.25%,SLC2A1;PPARD;RAB4B;SLC2A9
prerank,negative regulation of protein depolymerization (GO:1901880),0.29225343787883523,0.8954470279404051,0.625531914893617,0.9854803238725685,1.0,6/24,17.24%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.24508926387066865,-0.8953678967950274,0.6371681415929203,0.8205081183332342,1.0,14/57,19.25%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1;CLCF1;PPP2CA
prerank,protein polymerization (GO:0051258),-0.24544398748483107,-0.895099442960267,0.6510791366906474,0.8206897146574471,1.0,15/56,18.92%,RAC1;UBE2K;CENPJ;DIAPH1;WASL;FAM107A;CHMP4B;CHMP4A;JAK2;PREX1;CORO7;CASQ2;TRPV4;PSTPIP1;WASF1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.29053413889680163,0.8949470780822183,0.6383928571428571,0.985390882993293,1.0,6/24,11.98%,PDE3B;GNAI1;PEX5L;PDE11A;RNF157;PRKAR1B
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.35515870961316687,-0.8946998126342792,0.6190476190476191,0.8211829786391603,1.0,3/12,2.83%,PODXL;IQGAP1;PROM1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2968712980435125,-0.8943983013759388,0.6142857142857143,0.8214349127041524,1.0,11/26,23.71%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;RPS3;TRPV4;AKAP9;ARL2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.326528139938162,0.8937897168751585,0.6150537634408603,0.9871330556345448,1.0,4/17,8.21%,PKP2;GPD1L;RYR2;SCN5A
prerank,central nervous system neuron development (GO:0021954),-0.33245208870809556,-0.8935880298862755,0.61101243339254,0.8228317975520406,1.0,7/15,22.46%,RAPGEF2;LHX6;B4GALT5;GBA2;ARHGAP35;PTEN;HSP90AA1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3262538187433464,-0.8930819451538299,0.6083788706739527,0.8235479340105354,1.0,5/17,15.78%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1
prerank,anterior/posterior pattern specification (GO:0009952),-0.2510057599738734,-0.89300415405712,0.6311030741410488,0.823338881654392,1.0,12/53,18.39%,LRP5;BMPR2;TBX1;HES1;HOXB6;SMAD2;PCSK5;HOXC6;SKI;HEY1;HEY2;HOXB9
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3624847309321401,-0.8928680929549296,0.6216216216216216,0.8232480734804819,1.0,6/12,36.48%,RAB1A;PTEN;FZR1;PLK1;CDC20;UBE2C
prerank,selective autophagy (GO:0061912),-0.2502036114774773,-0.8928449830936445,0.6655231560891939,0.822892499514495,1.0,16/56,26.92%,ATM;RAB7A;MAP1LC3B;AMBRA1;WDFY3;UFM1;ULK2;ATG5;LGALS8;HDAC6;KLHL3;PCNT;BECN1;ATG2A;ATG2B;DYNLL1
prerank,organonitrogen compound catabolic process (GO:1901565),-0.2506674570173554,-0.8925555360532179,0.6567944250871081,0.823121998740742,1.0,18/57,22.25%,CPQ;PLA2G4A;MTOR;ACE;GNPDA2;TXN2;ENPEP;PDXDC1;GGACT;USE1;SMPD2;ERAP1;SIAH1;NPEPPS;CLN5;CTH;ADO;PNPLA8
prerank,regulation of adenylate cyclase activity (GO:0045761),0.2995831571880265,0.8921353158883175,0.6405228758169934,0.9901696386177461,1.0,3/22,6.43%,GNAI2;GABBR2;CACNA1D
prerank,non-motile cilium assembly (GO:1905515),-0.2782969469281752,-0.8918591180116263,0.6127819548872181,0.8242813614296528,1.0,9/30,18.62%,TOGARAM1;CEP250;DCTN1;CSNK1D;FUZ;RPGRIP1;TBC1D32;PCM1;TMEM17
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.2719222354580228,-0.8907734356619591,0.6365217391304347,0.8262986786463117,1.0,11/35,27.41%,POLD3;OGG1;RPA3;RPA1;PNKP;RPA2;RFC4;NTHL1;RFC1;LIG1;POLL
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3677234555708414,-0.8906866903098611,0.6022514071294559,0.8261085329557323,1.0,6/11,29.00%,ITGB5;CCN3;VCL;KIFC3;THBS4;JUP
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3206418312271275,-0.8905164642050085,0.6225749559082893,0.8260889929028578,1.0,2/17,5.85%,RAC1;MOSPD2
prerank,protein localization to cilium (GO:0061512),-0.27845146999630743,-0.8903802582707864,0.634011090573013,0.8259751101178168,1.0,9/32,22.73%,ZNF423;RABEP1;IFT140;EHD1;WDR35;CSNK1D;TULP1;IFT20;TULP3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3127685062892304,0.8902332976168948,0.6275862068965518,0.9938243102750774,1.0,7/17,24.12%,TERF1;UNG;ACD;ERCC5;TERF2IP;NEIL2;TDG
prerank,positive regulation of ruffle assembly (GO:1900029),0.34774230982909027,0.8900513458340589,0.6035634743875279,0.9929163227350859,1.0,2/13,5.58%,NLGN1;PFN1
prerank,regulation of lymphocyte activation (GO:0051249),0.35129736546876034,0.8900470321735637,0.593952483801296,0.9915109305189124,1.0,2/12,12.58%,PAG1;CCL5
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3672176920918386,-0.8899872867002716,0.6211293260473588,0.8264554062331515,1.0,5/11,34.01%,AGK;TIMM10;TOMM70;TIMM10B;TIMM13
prerank,regulation of interleukin-13 production (GO:0032656),-0.35648220528662167,-0.8899716855694887,0.6082289803220036,0.8260910880408731,1.0,1/13,0.16%,LEF1
prerank,regulation of microtubule-based process (GO:0032886),0.2645815647534465,0.8899632843888221,0.6696230598669624,0.9903396292464133,1.0,11/36,18.69%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT;TPPP;CLASP2;CAMSAP3;MAP6;MAP6D1
prerank,negative regulation of proteolysis (GO:0045861),-0.27135729089063826,-0.8897970952444088,0.6193895870736086,0.8260611923282776,1.0,10/34,17.07%,LRRK2;DNAJC1;ROCK1;EPHA4;AKT1;SNX12;PTPN3;TIMP3;PLAT;HDAC6
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.36271559400594544,-0.8883821519294339,0.5854545454545454,0.8287252540253883,1.0,2/11,7.35%,TGFB2;MEF2C
prerank,positive regulation of cation channel activity (GO:2001259),0.26313983844317457,0.8883530397864384,0.6612903225806451,0.9932142106559697,1.0,7/40,12.95%,ANK3;STAC2;AKAP6;CALM2;STAC;CASQ1;CCL2
prerank,carbohydrate transport (GO:0008643),-0.3664236568906053,-0.8878221920825754,0.6336996336996337,0.8295431759996493,1.0,6/11,33.07%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3060441787694586,-0.8877048082430139,0.6117216117216118,0.8293992496770832,1.0,8/22,26.50%,CDKN1B;LATS2;TFAP4;PTEN;NR2F2;MYOCD;CEBPA;APC
prerank,cellular response to UV (GO:0034644),0.22602863986744579,0.8875055779574136,0.7056179775280899,0.9940919397107164,1.0,14/76,14.11%,MME;TMEM161A;CERS1;RHNO1;USP28;STK11;IMPACT;TRIAP1;DDB1;TIMP1;BMF;ATR;PPID;TAF1
prerank,mitotic cytokinetic process (GO:1902410),-0.3093420630082532,-0.8874326106202927,0.6172161172161172,0.8295888940747852,1.0,11/20,32.65%,CHMP4B;CHMP4A;RHOA;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.3305442287470574,-0.8873523212469724,0.6018348623853211,0.8293791614809757,1.0,7/16,42.75%,PDE12;PPIF;UQCC2;SLC25A33;VCP;COX7A1;ABCD1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3009663529681394,-0.8869823555145844,0.6233766233766234,0.829777897800563,1.0,12/23,32.44%,UBE2K;APP;IRGM;MAPK1;RPTOR;BMP7;CAB39;TRIM6;STOX1;TGFB1;CEMIP;PLK1
prerank,chordate embryonic development (GO:0043009),0.2382346019014271,0.8867915304145995,0.684931506849315,0.9946156399729207,1.0,12/55,11.41%,WNT7B;COL1A1;UCMA;FLCN;PROX1;DEAF1;FGFR2;LMX1B;VEGFA;ZNF568;ALDH1A2;ARNT2
prerank,regulation of cellular protein localization (GO:1903827),-0.25670938458906345,-0.886754889658426,0.6559139784946236,0.829857933621461,1.0,17/45,23.85%,DVL3;PTPN1;SETD2;GPC6;SPIDR;PPM1F;PRKAA1;HFE;LCP1;VCPIP1;CTNNB1;NDEL1;KCNAB2;GPC3;HSP90AA1;RALB;RAB11FIP5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2909439686486932,0.8863113394086202,0.6065217391304348,0.9944617154388448,1.0,3/24,6.48%,TMEM161A;BCL2;TRIAP1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3099083851291315,-0.885690236791788,0.6321428571428571,0.831775581373978,1.0,11/19,51.44%,TNFAIP3;IGF1;NLRP2B;CARD16;NLRP3;CD33;GIT1;GSTP1;APOA1;FFAR4;ZC3H12A
prerank,cardiocyte differentiation (GO:0035051),-0.3753821168294024,-0.8855262886904077,0.6184448462929476,0.8317412705875344,1.0,4/10,10.26%,AKAP13;SIK1;TGFB2;KDM6B
prerank,base conversion or substitution editing (GO:0016553),0.3523833497170254,0.8852214799496736,0.6117136659436009,0.996003579744118,1.0,2/11,14.01%,ADARB2;NUDT16
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.34940746110856546,-0.8848962138582985,0.6127819548872181,0.832720866159351,1.0,7/13,30.31%,GREM2;NRROS;DAND5;CHRDL1;FBN1;BMP2;LTBP1
prerank,negative regulation of hemostasis (GO:1900047),0.3437293956470959,0.8846372296897306,0.6076233183856502,0.9962027890707199,1.0,1/12,0.27%,VTN
prerank,regulation of protein polymerization (GO:0032271),0.2642410402516121,0.8843130787605744,0.648870636550308,0.9956267092681257,1.0,8/35,12.81%,PFN2;PFN1;PAK3;MAP2;MAPT;TPPP3;MAPRE3;TPPP
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.26568400079485505,0.8842295234216886,0.6518847006651884,0.9944333475639109,1.0,10/35,17.32%,FAR1;ACLY;ACACA;HMGCLL1;ALOX12;HMGCL;SCD5;ALOX5;SCD;GGT7
prerank,phosphatidylserine metabolic process (GO:0006658),-0.277492482755618,-0.8839605173829441,0.6418439716312057,0.8342978220606793,1.0,8/32,20.96%,PLA2G4A;MBOAT1;PLSCR1;PTDSS1;PLA2G12A;SERINC1;SERINC5;LPCAT3
prerank,positive regulation of telomere maintenance (GO:0032206),-0.27717602601543245,-0.8835344759527173,0.6461824953445066,0.8348196074951738,1.0,6/31,13.71%,NEK7;ATM;MRE11;MAPK1;PPP1R10;PNKP
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.27035911457463335,-0.8830621927013419,0.6586206896551724,0.8354819656495673,1.0,12/33,24.82%,STN1;MRE11;PPP6R3;RPA1;CTC1;PTGES3;TERF2;DCLRE1B;TERT;HSP90AA1;RFC1;PINX1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.3586513034247509,-0.8827389879001943,0.6140035906642729,0.8357601881855115,1.0,3/11,7.28%,ZDHHC6;TFRC;BNIP3
prerank,mitochondrial translation (GO:0032543),-0.217040572959249,-0.8824675876402405,0.7100694444444444,0.83594277086035,1.0,34/104,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MTRF1L;MRPL57;NDUFA7;MRPS14;IARS2;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;NOA1;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;MRPL11;MRPS31
prerank,determination of bilateral symmetry (GO:0009855),-0.2964263161417612,-0.8824332646509049,0.6532846715328468,0.8356048150086375,1.0,8/25,21.59%,PKD2;TBX1;GALNT11;NOTCH1;ZIC3;CITED2;KIF3B;CFAP53
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.20159882024970724,-0.8823198361769478,0.7785234899328859,0.835466245468596,1.0,55/185,26.92%,CENPJ;PSMA2;NEK6;YWHAE;CEP57;CUL3;CEP250;CDC14A;PSME2;CEP78;PSMB4;ERCC2;HAUS8;RGCC;CDC16;DCTN1;DCTN3;ANAPC16;CSNK1D;PAFAH1B1;HAUS6;XPC;CEP41;ERCC3;PSMC2;PSMB2;PSMB1;ALMS1;TFAP4;PSMA8;PLK4;PCM1;CETN2;CNTRL;CEP152;CENPE;PSME1;BUB1B;PSMD4;BUB3;ODF2;PSMA7;HSP90AA1;PCNT;CEP131;AKAP9;FZR1;PSMD5;INO80;ANAPC7;ZFP36L1;PSMB10;PSMA3;KIF14;DYNLL1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.36585069642976964,-0.8822988208971053,0.6422338568935427,0.8351130658700602,1.0,3/11,13.26%,NEDD4L;PICALM;TAX1BP3
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3084515033063906,-0.8814658502110554,0.6377816291161178,0.8364834037581121,1.0,2/20,7.02%,IL1R1;CD55
prerank,replication fork processing (GO:0031297),-0.2676449012352212,-0.8811538424797579,0.6542553191489362,0.8367573267205146,1.0,11/38,21.31%,SAMHD1;MMS22L;MRE11;ZGRF1;DNA2;FANCM;THOC1;RFWD3;WRN;ATRX;BLM
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.26657877001143965,0.8804585642352629,0.6933333333333334,1.0,1.0,6/32,10.53%,CDK5;CDC45;TYMS;NPAT;POLA1;TFDP2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.27043417199544406,0.8798972074757884,0.6353211009174312,1.0,1.0,11/32,23.19%,NPSR1;AKAP6;CALM2;GPER1;CASQ1;HTT;CX3CL1;HAP1;TRPC1;PDPK1;CAPN3
prerank,megakaryocyte differentiation (GO:0030219),-0.3651297200647715,-0.8798061810164064,0.628158844765343,0.8392619704028583,1.0,3/11,11.57%,MED1;TAL1;ZFPM1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3064762055668149,0.8794118591498836,0.6384439359267735,1.0,1.0,4/17,17.62%,SULT2B1;AHI1;FOXJ1;SOX9
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.338604267815152,0.8793666335763547,0.6533333333333333,1.0,1.0,3/13,15.02%,IL12A;IL12RB1;IL23A
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.3180659996023389,-0.8791252380350306,0.615819209039548,0.8403250490483621,1.0,8/16,46.16%,CEBPG;VAMP2;ARL8B;CORO1A;RAET1E;TUBB4B;SLAMF7;KLRK1
prerank,actin filament depolymerization (GO:0030042),-0.36533994925872587,-0.8790992188664164,0.6304728546409807,0.8399909775155039,1.0,4/11,20.38%,MICAL2;CFL2;CFL1;DSTN
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3150053815288114,-0.8790587001523951,0.6523297491039427,0.839683233162896,1.0,4/18,12.61%,SPTBN1;LDLRAP1;STX8;ACTB
prerank,protein alkylation (GO:0008213),0.292825457815088,0.8787742415587818,0.6493506493506493,1.0,1.0,9/22,25.30%,METTL21A;EEF1AKMT2;SNRPD3;PCMT1;PRMT2;VCPKMT;PRMT8;EEF1AKMT1;FAM98B
prerank,negative regulation of wound healing (GO:0061045),-0.2822852364097438,-0.8786473849073135,0.6446428571428572,0.8401545081863054,1.0,9/28,22.81%,CD34;CRK;SLC12A2;EDN1;FGF2;TFPI;PTEN;SERPINE2;SERPINE1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2809079349611563,-0.8780671898733811,0.6576576576576577,0.8409969905874629,1.0,14/31,28.11%,POLR2G;EXOSC2;EXOSC1;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;DIS3L2;NT5C3B;EXOSC7;CNOT8;LSM2
prerank,response to nitric oxide (GO:0071731),0.3440040345609602,0.8775596749902002,0.6224719101123596,1.0,1.0,2/13,8.05%,KCNC2;DPEP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3496312635031204,0.8772206539057111,0.6140350877192983,1.0,1.0,2/12,6.42%,ATP2B4;FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3496312635031204,0.8772206539057111,0.6140350877192983,1.0,1.0,2/12,6.42%,ATP2B4;FHL2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3713315488573252,-0.8770619342259625,0.6308851224105462,0.8427380744536535,1.0,5/10,28.47%,RUVBL2;ZNHIT3;TAF9;NAF1;NUFIP1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.29963531768275453,-0.8766862215961144,0.6370106761565836,0.8431215020805062,1.0,6/23,16.91%,SMO;SIX1;BMP4;PIK3CD;FGF2;SIX4
prerank,regulation of double-strand break repair (GO:2000779),-0.26400036378285124,-0.8766400842579328,0.6648550724637681,0.842823866626651,1.0,7/39,9.15%,UBR5;SETD2;DEK;RNF169;MRNIP;SPIDR;TRIP12
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.34745648648505023,-0.876015274842478,0.6358595194085028,0.8437702536886281,1.0,5/12,25.33%,MTHFD1;AMPD2;HPRT1;PRPS2;ADA
prerank,protein localization to nucleus (GO:0034504),-0.21744963995456007,-0.8756678100064399,0.7433628318584071,0.8440965809329319,1.0,33/102,26.64%,YWHAE;CSE1L;SIX1;ZBTB7A;TOR1B;BMP4;SEC13;AKT1;PPP1R10;LMNA;NUP153;TBRG1;TAF8;ABCA7;TPR;BMP7;SIX4;TAF3;NUP214;NXT1;IPO8;WRN;RRS1;MDM2;NUP188;MSX1;ARL2;E2F3;PINX1;NOL8;RANBP6;NUP88;RAN
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.36332070468259736,-0.8754831595948527,0.6385542168674698,0.8437159385654786,1.0,3/11,17.80%,PKD2;GSTM2;CASQ2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.36332070468259736,-0.8754831595948527,0.6385542168674698,0.8437159385654786,1.0,3/11,17.80%,PKD2;GSTM2;CASQ2
prerank,regulation of extracellular matrix organization (GO:1903053),-0.32753713476638935,-0.8752762475358921,0.6261343012704175,0.843748037133314,1.0,2/15,1.37%,RB1;TIE1
prerank,histone H4-K5 acetylation (GO:0043981),-0.334163070958167,-0.8752289355007793,0.629695885509839,0.8430615150560302,1.0,6/15,23.02%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,histone H4-K8 acetylation (GO:0043982),-0.334163070958167,-0.8752289355007793,0.629695885509839,0.8430615150560302,1.0,6/15,23.02%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.29569234376842635,-0.8752286699272747,0.6389380530973451,0.8426646332035199,1.0,9/22,26.87%,PSMA2;PSMB4;PSMB2;PSMB1;PSMA8;PSMA7;NFE2L2;PSMB10;PSMA3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.36962779431591275,-0.8747577020820193,0.6451016635859519,0.8428491919479778,1.0,1/10,1.54%,KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.36962779431591275,-0.8747577020820193,0.6451016635859519,0.8428491919479778,1.0,1/10,1.54%,KLF4
prerank,regulation of protein kinase C signaling (GO:0090036),0.3222215107743553,0.8741128766280779,0.6274089935760171,1.0,1.0,4/14,10.78%,GPD1L;VEGFA;SPHK2;ADRA1A
prerank,regulation of integrin activation (GO:0033623),-0.32790591958707527,-0.873898866702903,0.6276978417266187,0.8442503656405446,1.0,3/15,8.05%,FERMT2;RASIP1;RAP1B
prerank,acidic amino acid transport (GO:0015800),-0.32171657443352314,-0.8738169036672284,0.6408839779005525,0.844014484754178,1.0,6/17,20.01%,SLC6A6;LRRC8D;ARL6IP5;GIPC1;PRAF2;SLC1A1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3033268817671647,0.873755723748358,0.6407982261640798,1.0,1.0,3/18,11.67%,CARTPT;TMEM178A;TCTA
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3066482021607071,-0.8736632722144406,0.6514886164623468,0.8439485599949161,1.0,2/19,5.85%,RAC1;MOSPD2
prerank,piRNA metabolic process (GO:0034587),0.29914583595025757,0.87365176723498,0.6316964285714286,1.0,1.0,19/19,70.12%,TDRKH;PIWIL2;EXD1;TEX15;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;MYBL1;DDX4;TDRD9
prerank,cAMP biosynthetic process (GO:0006171),0.35873854050775855,0.8732087690590454,0.6327944572748267,1.0,1.0,4/10,14.39%,ADCY8;ADCY10;ADCY7;ADCY3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.31878807862950176,-0.8730948464593148,0.6368515205724508,0.8447837240881915,1.0,5/17,16.18%,KDR;SLIT2;AKT1;FGF2;PIK3R3
prerank,regulation of autophagosome maturation (GO:1901096),0.3409240645736003,0.8730639426670498,0.6231263383297645,1.0,1.0,6/13,23.94%,CLN3;RUBCN;FYCO1;CLEC16A;SMCR8;UBQLN4
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.29640075414071,-0.8727144051540543,0.6395563770794824,0.8451842796352447,1.0,6/23,22.31%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.2999782714992112,-0.8726100458775429,0.6557093425605537,0.8450238674903595,1.0,9/20,27.89%,SMAD1;SMAD4;NOTCH1;ATF4;SMAD9;NFE2L2;RELA;BMP2;CARF
prerank,modulation by host of viral genome replication (GO:0044827),-0.34312170765023603,-0.8721867862128108,0.6426056338028169,0.8455119344505948,1.0,7/13,41.08%,TBC1D20;VAPA;CCNK;EIF2AK4;IFI27;FBXL2;CCL8
prerank,lysosome organization (GO:0007040),0.2595343252376858,0.8719015079266162,0.6659090909090909,1.0,1.0,15/36,24.38%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2;LAMTOR1;GAA;NAGPA;VPS33A
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.3340152851082846,-0.8715237709459971,0.6386404293381037,0.8465356742103909,1.0,7/14,29.13%,PTPN11;ADAMTS7;RFLNB;SNAI2;RFLNA;TGFBR1;WNT9A
prerank,regulation of p38MAPK cascade (GO:1900744),0.2600718062806368,0.8710674166572019,0.670995670995671,1.0,1.0,8/35,12.19%,RELL2;GADD45B;SPHK1;CYLD;VEGFA;MINK1;PHLPP1;RASGRP1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.25880244438500305,-0.870988549480808,0.6991150442477876,0.8472881215977958,1.0,10/40,17.82%,DAB2IP;EGFR;ROCK1;FLNA;SNX12;PTPN3;TIMP3;AZIN1;MAD2L2;CDK5RAP3
prerank,B cell activation involved in immune response (GO:0002312),0.3282364842644648,0.8707300981990537,0.6557017543859649,1.0,1.0,5/13,17.74%,BATF;RNF8;GPR183;MSH2;FCGR2B
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.35496830079718783,0.8706125016720411,0.6081081081081081,1.0,1.0,10/10,64.53%,CBARP;CALM1;CALM3;GNB5;DRD4;FMR1;DRD2;GPR35;CRHR1;DRD3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2422565506149835,0.8705516049829259,0.6950354609929078,1.0,1.0,10/48,14.39%,ADCY8;ADCY10;AK5;NPPC;SLC35B2;ADCY7;ADSS2;ADSS1;ACOT7;ADCY3
prerank,global genome nucleotide-excision repair (GO:0070911),-0.28760422160175053,-0.8705385903076914,0.6470588235294118,0.8478431874897607,1.0,6/26,18.21%,RNF111;RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,negative regulation of viral transcription (GO:0032897),-0.34221753945208816,-0.8703038770620838,0.6408934707903781,0.8479191203251042,1.0,7/13,31.52%,UBP1;TRIM14;IFITM3;TRIM13;LARP7;TRIM32;TRIM62
prerank,protein maturation (GO:0051604),0.21689487346960512,0.8702390156531048,0.7385321100917431,1.0,1.0,22/95,15.48%,MME;MMP16;DNAJB11;TSPAN15;CLN3;CPE;TYSND1;METAP2;SORL1;BACE1;ADAM19;TESC;CPN1;PCSK2;AEBP1;TSPAN32;PCSK6;NAA40;NFU1;NDUFAB1;ECE2;EEF1AKMT4-ECE2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.32285841323173725,-0.8700559929254162,0.6270270270270271,0.84804992804355,1.0,4/15,33.41%,SMOX;SRM;DDC;AANAT
prerank,mRNA methylation (GO:0080009),-0.3329572754191604,-0.8692293679174372,0.6666666666666666,0.8494401982125737,1.0,3/15,10.78%,CBLL1;METTL14;WTAP
prerank,linoleic acid metabolic process (GO:0043651),0.3057690460392136,0.8678973684209205,0.639344262295082,1.0,1.0,4/17,15.88%,FADS1;FADS2;ALOX12;ALOX5
prerank,translesion synthesis (GO:0019985),-0.2551253637775116,-0.867379874097263,0.7100175746924429,0.8528745874369517,1.0,13/42,25.94%,TRIM25;POLD3;RPA3;REV1;RPA1;USP10;MAD2L2;POLE2;RPA2;RFC4;RFC1;RCHY1;DTL
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.2813114572004545,0.8672927221989871,0.6997578692493946,1.0,1.0,4/25,7.41%,CTNNA3;PKP2;CXADR;RYR2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3332823564396027,0.866906234797088,0.6447368421052632,1.0,1.0,5/12,20.99%,ACSL3;APOC1;P4HB;SOAT2;SOAT1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2313812997889732,-0.86670658145547,0.724561403508772,0.8539070381048921,1.0,22/72,26.87%,PSMA2;BIRC3;PSME2;PSMB4;AKT1;DICER1;IRAK1;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;MAP3K14;PSME1;PSMD4;PSMA7;RELA;COPS8;PSMD5;MAP3K7;PSMB10;PSMA3
prerank,ERBB2 signaling pathway (GO:0038128),0.262059971465258,0.8665403999880749,0.6846846846846847,1.0,1.0,2/31,0.56%,NRG1;ERBB4
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.27785243232483153,-0.8662914613849224,0.6873889875666075,0.8543292862893432,1.0,19/30,40.99%,DYRK1A;DDX39B;ACKR3;YJU2;MIF;THOC1;RPS3;CXCL12;MDM2;SNAI2;TRIM32;CD74;FBXO5;DDIAS;SIRT1;PTTG1IP;CDKN2D;SFRP2;CD44
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.32784106970268656,-0.8662231302747232,0.6602112676056338,0.8540784321202746,1.0,7/16,16.38%,TGFBR3;MEF2C;TBX2;EDN1;NOTCH1;FGF2;IGF1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2256327105782081,-0.8661470763886899,0.7363636363636363,0.853831385678262,1.0,12/72,11.88%,SHANK3;LIMA1;KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARHGEF2;SMAD4;VBP1;ARFGEF1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3519150213644066,0.8661264373267578,0.6152019002375297,1.0,1.0,3/10,8.61%,TERF1;MAPT;CORO2B
prerank,lung development (GO:0030324),-0.27188200909034893,-0.8657511703700836,0.6649214659685864,0.8542459343469783,1.0,9/33,14.01%,ITGA3;LOXL3;RBP4;FGF1;BMP4;FGF7;FGF2;WNT11;ZIC3
prerank,cellular response to decreased oxygen levels (GO:0036294),0.22511019265044355,0.8656953356780901,0.7002237136465325,1.0,1.0,12/65,16.40%,KCND2;FMN2;SCN2A;CPEB1;VEGFA;NOP53;SLC8A3;GATA6;HIPK2;TWIST1;P4HB;ADAM8
prerank,eye photoreceptor cell development (GO:0042462),0.31223395554656386,0.8652000344027316,0.6393088552915767,1.0,1.0,3/15,9.25%,BBS4;RPGRIP1L;VEGFA
prerank,peroxisomal membrane transport (GO:0015919),-0.28282440157902405,-0.865117931730477,0.6713286713286714,0.855138483963596,1.0,9/27,30.08%,PEX1;ABCD3;PEX7;RAB8B;PEX14;PEX3;PEX6;PEX11B;PEX19
prerank,aminoglycan catabolic process (GO:0006026),0.26776726313656585,0.865059034233989,0.6877637130801688,1.0,1.0,3/28,6.31%,GPC5;HPSE2;GPC1
prerank,isotype switching (GO:0045190),0.3514259022510426,0.8648891812798541,0.6211453744493393,1.0,1.0,4/10,17.14%,CCR6;BATF;RNF8;MSH2
prerank,positive regulation of B cell activation (GO:0050871),-0.2404262053340176,-0.8644304949615228,0.7124060150375939,0.8561324949199419,1.0,12/50,19.32%,SHLD1;TFRC;CD38;KMT5B;MEF2C;PPP2R3C;CD40;MIF;MAD2L2;CLCF1;NOD2;PTPRC
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.31575774090433406,0.8642734119149751,0.6896551724137931,1.0,1.0,3/17,8.21%,SCN1B;CACNA2D1;SCN5A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.36989661496001874,-0.8641751373334118,0.65,0.8563022589449458,1.0,3/10,12.67%,PRKG1;PRKCD;CEACAM1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.3316809014308881,-0.8635526221663784,0.6527272727272727,0.8571664587795356,1.0,3/15,7.18%,SMO;SIX1;BMP4
prerank,positive regulation of lymphocyte activation (GO:0051251),0.2782197652245053,0.8633331890926405,0.6681514476614699,1.0,1.0,7/28,19.15%,IL12A;CCL2;XRCC6;IL23A;CD47;SIRPA;PRKCQ
prerank,transport along microtubule (GO:0010970),-0.3383594171187556,-0.8631709616672602,0.6284658040665434,0.8575618594365492,1.0,3/13,13.33%,APP;COPG1;SPG11
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.31047008016858757,-0.8621679976294329,0.6573556797020484,0.8592426830627987,1.0,6/18,15.36%,SP1;EPHA4;GSK3A;PICALM;SLC2A13;ROCK2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3350494122001161,0.8620473279707364,0.63718820861678,1.0,1.0,2/12,5.75%,MELTF;RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3350494122001161,0.8620473279707364,0.63718820861678,1.0,1.0,2/12,5.75%,MELTF;RCC2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2409507079107325,0.8620403919846361,0.7023255813953488,1.0,1.0,11/48,19.69%,NPSR1;AKAP6;CALM2;GPER1;SRI;HRC;CASQ1;SELENON;PDE4D;CX3CL1;TRPC1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2872351143792562,-0.8618400400433383,0.6607142857142857,0.859513926463852,1.0,6/25,17.30%,TNFSF10;BNIP3;TP53;BBC3;BCL2L11;PPIF
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3021192938335141,-0.8610789813019875,0.6806569343065694,0.8606602925598944,1.0,5/19,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,synaptic vesicle transport (GO:0048489),-0.34883646127451506,-0.8608654766880569,0.6471631205673759,0.8607053619343311,1.0,4/11,13.33%,DNM2;RAB27A;TMEM230;SPG11
prerank,glucan biosynthetic process (GO:0009250),-0.34567875864477005,-0.8605675396583597,0.6628787878787878,0.8605205728869935,1.0,4/12,20.66%,GBE1;PPP1R3C;GYS1;GYG1
prerank,glycogen biosynthetic process (GO:0005978),-0.34567875864477005,-0.8605675396583597,0.6628787878787878,0.8605205728869935,1.0,4/12,20.66%,GBE1;PPP1R3C;GYS1;GYG1
prerank,cilium assembly (GO:0060271),-0.18492659914292775,-0.8604086426376297,0.8835274542429284,0.8604360026716024,1.0,61/297,19.26%,ABCC4;ABLIM1;EXOC6;ASAP1;PARVA;CENPJ;FNBP1L;EXOC4;RAB1A;YWHAE;EHD2;PTPDC1;CEP57;SSX2IP;TOGARAM1;CEP250;E2F4;IFT140;CDC14A;WDR11;RAB11FIP3;CEP78;EXOC2;PDE6D;HAUS8;FLNA;EHD1;DCTN1;WDR35;GALNT11;RAB8B;DCTN3;NOTCH1;IFT52;DYNC2LI1;CSNK1D;PAFAH1B1;CFAP44;HAUS6;RAB23;TRAF3IP1;CEP41;EXOC8;FUZ;RPGRIP1;DZIP1L;NUDCD3;EHD4;ALMS1;RAB11A;HDAC6;TBC1D32;CFAP298;PLK4;PCM1;CETN2;CNTRL;CEP152;TMEM17;KIF3B;IFT43
prerank,import into nucleus (GO:0051170),0.22035401724741865,0.8603255951090069,0.7438202247191011,1.0,1.0,6/73,4.18%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;DDX20
prerank,negative regulation of insulin secretion (GO:0046676),-0.3186325027655163,-0.8600259332705126,0.659217877094972,0.8608449857952204,1.0,2/17,5.85%,KLF7;IRS1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2721032953509325,0.8592248073371571,0.668235294117647,1.0,1.0,4/26,12.08%,ATP1A2;CALM2;ADRA2A;SRI
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3486728908747736,0.8590399225202068,0.6523929471032746,1.0,1.0,2/11,7.35%,MUC20;PAK1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.34612051060074683,-0.8588904145471886,0.6855670103092784,0.8628143522467208,1.0,3/12,19.75%,PLK2;NABP1;BUB1B
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.2663785676069486,0.8587126714954767,0.6891891891891891,1.0,1.0,10/32,23.19%,NPSR1;AKAP6;GPER1;P2RX3;CASQ1;P2RX5;CX3CL1;TRPC1;PDPK1;CAPN3
prerank,base-excision repair (GO:0006284),-0.24549125870120744,-0.8584481082477078,0.7228070175438597,0.863288062093983,1.0,15/48,27.41%,POLD3;OGG1;RPA3;DNA2;RPA1;PNKP;WRN;RPA2;HUWE1;RFC4;NTHL1;RFC1;LIG1;ERCC6;POLL
prerank,negative regulation of innate immune response (GO:0045824),0.2625360122501085,0.858318573593228,0.6983758700696056,1.0,1.0,8/34,15.63%,TYRO3;TTLL12;GRN;SUSD4;SERPING1;OAS3;CNOT7;LYAR
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.270635736225311,-0.8582903613080086,0.7018518518518518,0.863194093968172,1.0,13/33,27.85%,CDKN1B;PSME2;STXBP4;PLCG2;CDC73;TCIM;PSME1;PTEN;TRIM39;INO80;CRNN;KIF14;MN1
prerank,negative regulation of catabolic process (GO:0009895),0.24096656614918655,0.8582620699326279,0.7305122494432071,1.0,1.0,10/47,15.71%,PDE3B;FMN2;BSCL2;CYP51A1;SF3B3;ADRA2A;AZIN2;CST3;APOC1;ZDHHC7
prerank,mitochondrial fusion (GO:0008053),-0.31066703040242655,-0.85819378626975,0.6478632478632479,0.86299095184893,1.0,4/18,12.94%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,organelle fusion (GO:0048284),-0.2929894516942463,-0.8581001680912776,0.6836734693877551,0.8627980333797914,1.0,4/22,12.94%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,positive regulation of hormone secretion (GO:0046887),-0.3182040332240008,-0.8579347111586015,0.6666666666666666,0.8627433660042201,1.0,4/17,15.68%,EDN1;EDN3;HFE;C1QTNF3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3088767173597523,-0.8576888142149575,0.6784386617100372,0.8628367841563992,1.0,11/18,45.94%,TCP1;PARN;RUVBL2;CCT5;CCT2;NAF1;CCT3;DCP2;CCT7;DKC1;CCT6A
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.28074350433681755,-0.8575182666374155,0.6758747697974218,0.8628045507186318,1.0,12/25,44.16%,PPARA;CBL;HFE;PPARG;ACE2;CHMP6;RAMP3;SNX6;CRHBP;SLC6A9;VPS25;TNF
prerank,embryonic heart tube development (GO:0035050),-0.32286860938347733,-0.8575129776349409,0.6504504504504505,0.8624182164639146,1.0,3/14,8.09%,SOX17;HES1;TBX2
prerank,estrogen metabolic process (GO:0008210),0.3116999020952931,0.8573406250220121,0.6498855835240275,1.0,1.0,5/15,24.55%,HSD17B7;HSD17B14;CYP1A1;HSD17B8;HSD17B2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.323783973954063,0.8570908170036655,0.6681514476614699,1.0,1.0,4/14,15.61%,ATP2B4;PKIB;PRKAR1B;HTT
prerank,response to organic cyclic compound (GO:0014070),-0.23774384957559538,-0.8570174925005567,0.7153153153153153,0.8629904826422864,1.0,22/52,31.88%,ESR1;LRRK2;TIPARP;STRN3;GGT5;ALPL;ARL6IP5;SOCS2;IGFBP5;ANXA1;CTNNB1;SLC1A1;FGFR4;KYNU;PAQR7;CYP1B1;GLDC;TGFB1;PMAIP1;STAT3;HLCS;CHRNB2
prerank,postreplication repair (GO:0006301),-0.24743139325289992,-0.8568835611320282,0.710801393728223,0.8628793382228533,1.0,12/45,23.23%,TRIM25;POLD3;RAD18;RPA3;REV1;RPA1;UBE2V2;USP10;RPA2;BRCA1;RFC4;RFC1
prerank,pinocytosis (GO:0006907),0.34580901422264904,0.8568474137296441,0.658256880733945,1.0,1.0,5/10,21.22%,CARMIL1;RAB34;SNX33;SNX5;MAPKAPK3
prerank,histone H3 deacetylation (GO:0070932),-0.3241891150403984,-0.85536805901792,0.6513274336283186,0.8654509026185544,1.0,5/15,19.54%,HDAC1;HDAC4;SFPQ;ELK4;SMARCAD1
prerank,membrane repolarization (GO:0086009),0.3203790589070682,0.8552925227079369,0.6666666666666666,1.0,1.0,2/15,4.83%,ATP1A2;ATP1B1
prerank,regulation of trophoblast cell migration (GO:1901163),0.31542418901813996,0.8552213037251715,0.6727272727272727,1.0,1.0,5/14,19.15%,ACVR1B;TIMP1;VEGFA;ACVR1C;GJA1
prerank,calcium-mediated signaling (GO:0019722),-0.21536964634751252,-0.8545205535060881,0.7810344827586206,0.8666879384393991,1.0,16/93,11.79%,LRRK2;KDR;PLCG1;PTPRJ;EGFR;TRPM4;IRGM;STIMATE;PLCE1;CCR9;PLCG2;EDN1;PRKAA1;BCAP31;PTGFR;AGTR1
prerank,response to zinc ion (GO:0010043),-0.2831599935589499,-0.8540205396896745,0.6860902255639098,0.8672789322023374,1.0,11/25,25.53%,PAM;SLC30A5;HVCN1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1X;MT1F
prerank,RNA catabolic process (GO:0006401),-0.2444436346132344,-0.8539798550018113,0.714527027027027,0.8669515400784741,1.0,14/46,28.11%,ERN1;RNASE3;XRN2;DNA2;ZPR1;NUDT12;RNASEH2C;DIS3L2;METTL16;HSPA1B;EXOSC7;HNRNPD;DXO;LSM2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.299491983618389,0.8535879980616387,0.6784869976359338,1.0,1.0,3/20,7.36%,CHRM2;CHRM3;LY6G6D
prerank,regulation of feeding behavior (GO:0060259),0.34347845135666133,0.8531607805134794,0.6417910447761194,1.0,1.0,4/11,23.48%,NR4A3;SGIP1;CFAP20;AGRP
prerank,regulation of stem cell proliferation (GO:0072091),-0.3087308397433408,-0.8530269128704994,0.6638370118845501,0.868357677314548,1.0,6/17,27.56%,ACE;YAP1;PTPRC;TERT;ZFP36L1;HNRNPU
prerank,regulation of ruffle assembly (GO:1900027),0.28185917556368373,0.8529920352005292,0.7037037037037037,1.0,1.0,3/23,5.58%,NLGN1;PFN2;PFN1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3306202719536444,-0.8529871030565259,0.6546112115732369,0.8680441795646675,1.0,7/14,45.34%,LRRK2;HERPUD1;TXNDC12;PARK7;CREB3L1;TMBIM6;BCL2L1
prerank,regulation of Golgi organization (GO:1903358),-0.30696863438419175,-0.852975480818586,0.6817325800376648,0.8676664228863651,1.0,4/17,8.04%,STX18;ARMH3;USP6NL;MAPK1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2594578015589401,0.8524857141394907,0.7090909090909091,1.0,1.0,6/33,9.96%,IGFBP3;TAFA5;NDRG4;ANG;IL12A;GPER1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.22853007254190474,-0.8519661991891256,0.7704347826086957,0.8692697094808468,1.0,20/67,23.69%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;PDIA3;NCF2;PSMC2;PSMB2;PSMB1;PSMA8;IKBKG;VAMP3;IKBKB;PSME1;PSMD4;PSMA7;SEC22B;FCGR1A;PSMD5
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3059570332526737,-0.85163895694113,0.6470588235294118,0.8695213751934062,1.0,4/17,18.16%,BMP6;CD55;NFKBIL1;SASH1
prerank,phasic smooth muscle contraction (GO:0014821),0.34992318282498114,0.8515879886185789,0.6698564593301436,1.0,1.0,4/10,22.64%,PTGER3;HTR1D;EDNRB;TIFAB
prerank,protein catabolic process (GO:0030163),-0.23429829793763945,-0.8515812861136103,0.7236614853195165,0.8692325303571936,1.0,27/59,38.36%,DAB2IP;MTOR;DDI2;DENND3;ADAMTS9;CEACAM1;MAGEC2;USE1;LAMP2;PSMA8;SIAH1;CLN5;HSP90AA1;RIPK1;FBXO17;MANBA;ATE1;PPT1;PMAIP1;CLPX;UBE2G2;VCP;CLN6;TRIM24;RNF5;DDI1;HSPA8
prerank,neuron maturation (GO:0042551),0.30048614471255275,0.8515392563125544,0.6596736596736597,1.0,1.0,8/18,20.83%,ADGRB3;SRRM4;ACTL6B;B4GALT6;LGI4;C3;CX3CL1;MTCH1
prerank,negative regulation of T cell activation (GO:0050868),0.2560731587025033,0.8513063716642902,0.6951754385964912,1.0,1.0,5/35,13.29%,PAG1;VTCN1;SDC4;HAVCR2;CD86
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3442171261398434,-0.8512769365668043,0.6383363471971067,0.8694377103017528,1.0,4/12,22.06%,DIAPH1;UBASH3B;CASQ2;PTK2B
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3191234063826657,-0.8511732602124464,0.6744604316546763,0.869241084463682,1.0,5/15,20.75%,DDX3X;MKNK2;HNRNPA1;PPIF;GSTO2
prerank,response to interferon-gamma (GO:0034341),-0.22661807539340129,-0.8510485656381869,0.7616279069767442,0.8690762387859026,1.0,21/67,30.71%,SP100;DAPK1;CCL25;GCH1;GBP6;IFITM3;GBP4;CD40;PDE12;SYNCRIP;GBP5;CCL19;KYNU;CASP1;RPL13A;GBP3;IFITM2;LGALS9;BST2;SLC26A6;SHFL
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.35166691456504956,0.8510158325444979,0.6331096196868009,1.0,1.0,1/10,0.27%,VTN
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.36173576709024374,-0.8509196865612778,0.6630434782608695,0.8689454691780681,1.0,6/10,41.64%,EMC9;EMC2;EMC6;EMC3;MMGT1;EMC8
prerank,regulation of cholesterol efflux (GO:0010874),-0.2695368186388483,-0.8505372217715946,0.6996402877697842,0.8693053347714059,1.0,8/30,20.11%,PLTP;CAV1;RXRA;NFKBIA;NAXE;ABCA7;EEPD1;PPARG
prerank,retinol metabolic process (GO:0042572),-0.3311980107531107,-0.8502275803052707,0.6703096539162113,0.8695281268049604,1.0,6/14,33.86%,RBP4;RDH10;RETSAT;CYP1B1;RDH12;ADH1A
prerank,nuclear membrane disassembly (GO:0051081),0.3243830935233822,0.8502057299354648,0.6528384279475983,1.0,1.0,6/14,23.84%,LPIN1;VRK1;PRKCB;AKAP8L;CDK1;CTDNEP1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.21548437684682348,-0.8498930815613241,0.7880910683012259,0.8697939386512317,1.0,25/88,26.91%,FBXL7;FBXL12;PSMA2;FBXL17;FBXL3;RBX1;PSME2;CUL2;PSMB4;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;DMAC2;PSME1;PSMD4;PSMA7;PSMD5;FBXL22;FBXO17;FBXO38;PSMB10;PSMA3;KIF14
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.34960686490944126,0.8498331572811282,0.6215596330275229,1.0,1.0,3/11,19.15%,IL12RB1;IL23A;PRKCQ
prerank,nucleoside salvage (GO:0043174),0.3458470621031004,0.8497350758095473,0.6269315673289183,1.0,1.0,5/10,24.80%,CDA;UCK2;UCK1;TK1;TK2
prerank,aerobic respiration (GO:0009060),0.28746252346104867,0.8497014559865379,0.6845637583892618,1.0,1.0,9/20,26.14%,UQCR10;UQCRH;NDUFS8;NDUFS7;MDH2;UQCRB;ME3;OXA1L;MTFR1L
prerank,positive regulation of leukocyte activation (GO:0002696),-0.3013931504246231,-0.8495134818352681,0.6976744186046512,0.870156424468487,1.0,2/18,6.78%,THBS1;LBP
prerank,"wound healing, spreading of cells (GO:0044319)",-0.28268377702452563,-0.8493807836411075,0.6834532374100719,0.8700272104579069,1.0,7/24,13.34%,ACVRL1;COL5A1;FLNA;RHOA;CEACAM1;LCP1;RHOC
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2620560798445216,0.8493591474770447,0.7284768211920529,1.0,1.0,11/30,21.68%,ACSBG1;HACD1;ELOVL4;ACSL6;TECR;ACOT2;HACD2;ACOX2;HACD3;PEX2;ABCD4
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.2870391918585057,-0.8492517008360475,0.6872727272727273,0.86990628094429,1.0,9/25,27.28%,SPTBN1;PRKD2;PLCG2;ANXA1;RPS3;PTPRC;STOML2;MAP3K7;PNP
prerank,error-free translesion synthesis (GO:0070987),-0.29085453390114413,-0.8488806087463086,0.6737967914438503,0.8702618047293363,1.0,7/22,24.16%,RPA3;REV1;RPA1;RPA2;RFC4;RFC1;RCHY1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.34333440372886886,0.8474297353903768,0.6613995485327314,1.0,1.0,2/11,6.22%,AKAP6;RNF207
prerank,regulation of macroautophagy (GO:0016241),-0.20957968949203734,-0.8469094246468938,0.8076923076923077,0.8737027830823616,1.0,24/105,19.78%,GNAI3;SESN1;LRRK2;EXOC4;KDR;MTOR;LARP1;NEDD4;BNIP3;ERN1;AKT1;PRKAA1;RPTOR;VPS26A;ATP6V1E1;MAPK8;EXOC8;TRIM13;HDAC6;ATP6V0A1;IKBKG;PRKAB1;TBC1D25;UCHL1
prerank,neural crest cell differentiation (GO:0014033),-0.3110218418606707,-0.8469058174002049,0.688663282571912,0.8733094748483425,1.0,4/18,7.81%,FBXL17;LRP6;MEF2C;KLHL12
prerank,lymphocyte chemotaxis (GO:0048247),-0.2536603055249132,-0.8468995686323425,0.7094972067039106,0.8729252594018531,1.0,5/34,9.65%,CCL25;SLC12A2;CYP7B1;GAS6;PIK3CD
prerank,peptidyl-amino acid modification (GO:0018193),0.3378172110575403,0.84672984801221,0.6637362637362637,1.0,1.0,3/10,19.08%,METAP2;METAP1;FKBP7
prerank,cytoplasmic translational initiation (GO:0002183),-0.31431193616637143,-0.8463325164157057,0.6419294990723562,0.8736343425752936,1.0,5/17,31.00%,EIF4H;EIF3A;EIF3I;EIF4A2;DHX29
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.37110774872842367,-0.8462089834354642,0.6532846715328468,0.8734719605704102,1.0,3/10,21.93%,TUT7;TUT4;DIS3L2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2797481379138153,-0.8459517882576516,0.6913357400722022,0.8735411412216278,1.0,13/25,38.61%,CHMP4B;CHMP4A;VTA1;CHMP2B;CHMP5;TMEM50B;CHMP3;CHMP6;CHMP1A;LEPROTL1;VCP;CHMP1B;RILP
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3537265463812519,-0.8457905774477997,0.6715063520871143,0.8734550841191301,1.0,8/10,51.26%,ANO6;TREM2;RAB31;APPL2;STAP1;F2RL1;NCKAP1L;CD300A
prerank,phagolysosome assembly (GO:0001845),0.32945736437503825,0.8457272938820866,0.6393805309734514,1.0,1.0,4/12,15.85%,CLN3;RAB39A;RAB34;RAB20
prerank,regulation of Rac protein signal transduction (GO:0035020),0.30727612111394553,0.8455563541470283,0.6623376623376623,1.0,1.0,3/16,11.64%,RASGRF1;ARHGAP24;AUTS2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2257226590241708,-0.8450249929133813,0.7591240875912408,0.8745652070276221,1.0,21/71,24.08%,USP9X;CTSC;FBXL17;DDI2;CASP8;CAPN2;CHMP4B;ATXN3;ZER1;TNFAIP3;CTSZ;LGMN;ZYG11B;CTSH;HDAC6;PSMA8;PDCD6IP;MDM2;CTSF;CTSO;ADAMTS7
prerank,skeletal muscle contraction (GO:0003009),0.2873676733021244,0.8450033075269893,0.6606334841628959,1.0,1.0,4/19,13.30%,STAC2;STAC;TNNC1;TNNI2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3452238821400626,-0.8449869152390412,0.6745886654478976,0.8742395344539219,1.0,2/11,14.71%,CAT;GPX1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.3574425831691573,-0.8445995575328437,0.6809269162210339,0.874592628434873,1.0,8/10,41.17%,TXN2;CTH;ADO;MTRR;MPST;BLMH;CBS;TST
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2636024488341065,0.8444764577228694,0.7113163972286374,1.0,1.0,6/29,13.86%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2636024488341065,0.8444764577228694,0.7113163972286374,1.0,1.0,6/29,13.86%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3030902245517433,-0.8441175834865416,0.6702127659574468,0.8751165368139441,1.0,9/18,37.73%,RNF139;MAN1B1;TRIM13;UGGT1;EDEM2;RNF103;RNF185;OS9;RNF5
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3605853908438477,-0.8440954249589209,0.6710526315789473,0.874763224679364,1.0,1/10,0.53%,RAPGEF2
prerank,regulation of metal ion transport (GO:0010959),0.30590457075942407,0.8436962772220167,0.6698113207547169,1.0,1.0,4/16,12.08%,CACNA2D1;BCL2;CAMK2B;SRI
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.2395349242958034,-0.8435818584581165,0.7508650519031141,0.8753717794909673,1.0,25/55,37.07%,RAC1;THBS1;TGFBR2;SIRT5;AATF;DHRS4;TP53;AGTR1;GRB2;BRCA1;PDGFRB;GADD45A;RIPK1;CYP1B1;ACE2;SLC25A33;MAPK14;PID1;PDK3;BST1;TFAP2A;RAC2;MT3;PARL;FOXM1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.26344112401834807,-0.8434815806218334,0.7235188509874326,0.8751866782092788,1.0,9/33,19.39%,NEDD4L;RIC3;STX3;PICALM;HFE;TAX1BP3;ABCA7;CTNNB1;KCNAB2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.3442401251900671,-0.8430664261184923,0.6575091575091575,0.8756346654521105,1.0,3/12,21.22%,ESR1;PPARG;TERT
prerank,regulation of viral entry into host cell (GO:0046596),0.26200996751876765,0.8414169021809875,0.7169373549883991,1.0,1.0,4/30,7.21%,HS3ST5;LGALS1;GSN;TRIM27
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3141994335054892,-0.8411893663519161,0.6902173913043478,0.8788732403417395,1.0,9/17,24.99%,HES1;TNFRSF1B;IL34;DICER1;NOTCH1;CLCF1;SERPINE2;PTN;BMP2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.2962301744155087,0.8411735311281845,0.6747787610619469,1.0,1.0,4/17,13.56%,HSF1;CPEB1;CPEB3;CCNT1
prerank,digestive tract morphogenesis (GO:0048546),-0.32451939926854323,-0.841068200691954,0.7012522361359571,0.8787064727456062,1.0,6/14,26.96%,SOX17;NIPBL;EPHB3;FOXF1;RBPMS2;STRA6
prerank,positive regulation of B cell proliferation (GO:0030890),0.26422750291244734,0.8409259839117554,0.6856540084388185,1.0,1.0,5/29,10.26%,NFATC2;BCL2;SASH3;CD81;VAV3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3040241620721606,0.8409014011755249,0.6909871244635193,1.0,1.0,2/17,3.34%,GET1;CAMLG
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3202351927036964,-0.8402487920312353,0.6949152542372882,0.8798889820459028,1.0,4/15,14.62%,DDIT4;NGF;BCAR1;GRB2
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.22436351464470894,-0.839939223376779,0.7787307032590052,0.8800831659318175,1.0,17/68,22.13%,GNAI3;NT5C2;LRRK2;RHOQ;ACSF2;TPST2;SULT1A1;PDE9A;THEM4;AMPD2;RAB23;HPRT1;HINT1;ACOT9;EPHA2;AMPD3;BPNT1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.27801679344562225,0.8391305303247147,0.6883720930232559,1.0,1.0,4/21,8.27%,ADCY8;ADCY10;NPPC;ADCY7
prerank,ERAD pathway (GO:0036503),-0.21779744281826918,-0.838643673568109,0.7624113475177305,0.8821681668463829,1.0,24/83,27.19%,ECPAS;TRIM25;RNF139;UBE4B;ANKZF1;UBE2J2;USP13;ATXN3;SGTA;MAN1B1;UBE4A;ERLIN2;DNAJC10;TRIM13;UGGT1;DNAJB12;DNAJB9;HERPUD1;FBXO17;TMUB1;RHBDD1;RNF103-CHMP3;USP19;RNF103
prerank,positive regulation of actin nucleation (GO:0051127),-0.3464844496985876,-0.8386403894398209,0.6893382352941176,0.8817738316045743,1.0,4/11,18.92%,WASF2;FCHSD2;NCKAP1;WASF1
prerank,acetyl-CoA metabolic process (GO:0006084),0.32033953306122875,0.8383886592230787,0.6820276497695853,1.0,1.0,7/15,21.28%,ACLY;ACACA;ACSS1;TDO2;HMGCS1;ACAT1;MVK
prerank,vasodilation (GO:0042311),0.3137910548229972,0.8382518506553116,0.6689342403628118,1.0,1.0,3/13,9.96%,KCNMA1;ADRB3;GPER1
prerank,positive regulation of rRNA processing (GO:2000234),0.3414929076088515,0.8380924690389484,0.6555323590814196,1.0,1.0,3/10,13.72%,BUD23;DIMT1;SIRT7
prerank,ganglioside metabolic process (GO:0001573),0.2858626100879138,0.8380580793112671,0.6751054852320675,1.0,1.0,6/20,17.68%,B3GALT4;ST6GALNAC5;ABCA2;HEXB;ST8SIA3;ST8SIA2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3084059206357177,-0.8379977222435303,0.7087542087542088,0.882605317302926,1.0,7/17,35.88%,PLA2G4A;PLA2G12A;LCLAT1;PLA2G4F;PLA2G5;LPGAT1;PLBD1
prerank,response to metal ion (GO:0010038),0.21935421267787997,0.837834668215059,0.7839080459770115,1.0,1.0,10/67,10.02%,KCNMA1;SLC34A1;SLC25A13;BCL2;PPP5C;CALM2;HOMER1;MAPT;PPP3CA;HAAO
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3091469495181127,0.8377548659232396,0.6958424507658644,1.0,1.0,6/15,21.88%,ATL1;RTN4;ZFYVE27;RTN3;REEP4;ARL6IP1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.26403539988674724,-0.837714492404272,0.7237762237762237,0.8827523399058381,1.0,20/31,48.62%,PLCB1;PLCG2;CD40;IL16;CCL19;MAPK11;HMGB1;LGALS9;MAPK14;IRF5;TLR2;SYK;MDK;ISL1;TLR4;SCIMP;TLR3;IL23R;AGER;IL12B
prerank,protein heterotetramerization (GO:0051290),0.32300383390532056,0.8375331279801899,0.6943231441048034,1.0,1.0,1/13,0.90%,GRIN2B
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3076176571507512,-0.8373639490788877,0.7076648841354723,0.883034756374393,1.0,3/18,9.23%,BPGM;SAMHD1;ADAMTS9
prerank,thyroid hormone generation (GO:0006590),-0.35957977740156355,-0.8372188654061983,0.6818181818181818,0.8829226261630867,1.0,1/10,0.41%,CPQ
prerank,regulation of DNA recombination (GO:0000018),-0.26451102042584995,-0.8371777547764339,0.7454545454545455,0.8826020169329533,1.0,10/32,24.01%,SETD2;SPIDR;MRE11;KPNA1;THOC1;RPA2;SMARCAD1;BLM;CHEK1;MSH3
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.27882970408458935,-0.8370673217666232,0.7299270072992701,0.8824158886824222,1.0,7/26,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,endosome organization (GO:0007032),0.2398725141090067,0.8370008554109695,0.762114537444934,1.0,1.0,9/41,12.09%,TMEM9;RNF26;DNM1;LAPTM4B;ANXA8;ANXA8L1;USP50;SNX10;PHETA1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.25815475711308655,0.8364192382950829,0.7361419068736141,1.0,1.0,2/32,1.40%,GRM5;DDX25
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3200024781859485,-0.8364028189616458,0.6740331491712708,0.8832747669471701,1.0,4/14,18.76%,RPUSD4;MRPS27;MPV17L2;UQCC2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.28805857427642795,0.8361686920792644,0.7027027027027027,1.0,1.0,4/18,15.63%,RASL11A;DHX33;SIRT7;LYAR
prerank,regulation of catabolic process (GO:0009894),-0.29820170555099945,-0.8358532521606553,0.7107142857142857,0.8839596720048569,1.0,2/18,2.03%,ITGB1;NEDD4L
prerank,regulation of steroid biosynthetic process (GO:0050810),0.33274424554979914,0.8357659379599258,0.6642512077294686,1.0,1.0,2/11,5.11%,DGKQ;EGR1
prerank,peptide cross-linking (GO:0018149),-0.27640741100603045,-0.835344223608164,0.7272727272727273,0.8845640134506187,1.0,18/25,49.29%,THBS1;TGM2;ABCA7;ANXA1;CD247;EVPL;FCGR3A;KRT10;TGM7;TGM4;DSP;TGM1;SPRR1A;LORICRIN;TGM6;TGM5;NDNF;EPB42
prerank,magnesium ion transport (GO:0015693),0.32052804967214577,0.8353311216001669,0.6783369803063457,1.0,1.0,4/12,16.15%,TUSC3;NIPA1;NIPAL1;NIPAL2
prerank,antibacterial humoral response (GO:0019731),0.3025433361444846,0.8352392999442418,0.697986577181208,1.0,1.0,3/16,10.06%,RNASE6;ANG;PLA2G6
prerank,positive regulation of neutrophil migration (GO:1902624),-0.29559010846638656,-0.8337751727514857,0.6909722222222222,0.8871368079897504,1.0,2/18,5.85%,RAC1;MOSPD2
prerank,retinoic acid metabolic process (GO:0042573),0.30881096872675956,0.8331658775950361,0.6979405034324943,1.0,1.0,4/14,22.31%,CYP26B1;ALDH1A2;BCO2;CYP26C1
prerank,protein K63-linked deubiquitination (GO:0070536),0.2570465987035676,0.8329952587072772,0.7173447537473233,1.0,1.0,6/31,10.37%,OTUD7A;USP25;CYLD;OTUD7B;PSMD14;USP50
prerank,morphogenesis of an epithelium (GO:0002009),-0.2736371017435216,-0.8324034883385076,0.7230769230769231,0.889292974800352,1.0,8/25,21.11%,LAMA3;LRP6;LAMA5;ACTB;TRAF3IP1;ARHGAP12;TIMELESS;VCL
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3432038903929149,0.8323772988801258,0.6714975845410628,1.0,1.0,3/10,14.63%,APOM;ZDHHC8;APOE
prerank,proteolysis (GO:0006508),0.17685016157415673,0.8322144142352903,0.9528301886792453,1.0,1.0,46/252,17.46%,CPB2;TMPRSS11D;MMP12;MME;TRHDE;MMP16;CELA3A;MMP24;MMP25;PAPPA2;CLN3;CTSK;CPA2;CPE;FBXO2;TYSND1;METAP2;PRSS57;USP25;BACE1;SPCS3;TMPRSS7;ADAM19;CPN1;CPNE1;PCSK2;AEBP1;UFSP2;HTRA2;SPCS1;PCSK6;CPA4;CPA3;CLPP;ATG4D;ECE2;EEF1AKMT4-ECE2;MIPEP;TPP1;LONP1;ATG4B;KLKB1;CASP4;PSMB5;PGPEP1;NAPSA
prerank,regulation of cholesterol esterification (GO:0010872),0.3448022982673049,0.8320765974687505,0.6666666666666666,1.0,1.0,5/10,22.90%,ABCA2;APOE;APOC1;LAMTOR1;ABCG1
prerank,negative regulation of lyase activity (GO:0051350),0.30369228828633543,0.8318821681546216,0.7133333333333334,1.0,1.0,2/16,4.62%,GNAI2;GABBR2
prerank,defense response to protozoan (GO:0042832),-0.3300630498056024,-0.8318371967227973,0.6992753623188406,0.8899383238252757,1.0,3/12,13.55%,GBP6;GBP4;CD40
prerank,actin filament polymerization (GO:0030041),-0.2613314689444316,-0.8317932928780941,0.7636363636363637,0.8896070989211021,1.0,9/29,18.92%,RAC1;DIAPH1;WASL;FAM107A;JAK2;PREX1;CORO7;PSTPIP1;WASF1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.31274997673969346,-0.8316134283621472,0.6934046345811051,0.8895602303900741,1.0,6/15,20.71%,RTRAF;ERN1;TSEN15;TSEN34;TRPT1;RTCB
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.22240623485398947,-0.8315278224918269,0.8088495575221238,0.889325837843673,1.0,23/70,27.30%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;PDIA3;NCF2;PSMC2;PSMB2;PSMB1;PSMA8;IKBKG;VAMP3;IKBKB;PSME1;PSMD4;PSMA7;SEC22B;FCGR1A;PSMD5;PSMB10;PSMA3;FCER1G
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.24854386373274345,-0.8312247730640305,0.7472324723247232,0.8895291137202234,1.0,14/38,29.38%,DAB2IP;ESR1;PPM1B;CASP8;TRIM59;TNFAIP3;USP10;ZMYND11;TRIM39;RIPK1;TNIP1;RIOK3;TREM2;CACTIN
prerank,TOR signaling (GO:0031929),0.26790851468233373,0.8310771903184074,0.7011494252873564,1.0,1.0,6/26,11.79%,CCDC88A;FLCN;RHEBL1;RPS6KB1;CARD11;PRR5L
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.24690004106269198,0.8310151802693593,0.7276688453159041,1.0,1.0,7/39,15.32%,BLK;GCK;TRH;GPER1;NLGN2;GLUD1;MCU
prerank,cellular response to alkaloid (GO:0071312),-0.30412469568342104,-0.8306917887406803,0.6911262798634812,0.8900984058244127,1.0,6/17,21.31%,SPIDR;TGM2;GSTM2;HTR1B;CASQ2;BLM
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.33833647194010785,-0.8306563659132652,0.6983842010771992,0.8897672801729977,1.0,7/11,47.26%,H3-3A;ATRX;ASF1B;ASF1A;NASP;HAT1;CABIN1
prerank,lipid homeostasis (GO:0055088),-0.23002872498630283,-0.8306345318138463,0.8014571948998178,0.8894066784306385,1.0,18/57,28.27%,ZBTB20;DDX3X;PRKAA1;ORMDL1;NR1D2;ACOX1;TLCD1;DGAT2;ACOX3;ORMDL3;PPARG;PNPLA8;CEBPA;PNPLA2;TLCD3B;USF2;FABP3;TREM2
prerank,interstrand cross-link repair (GO:0036297),-0.23214012747280427,-0.8303436744582973,0.7882136279926335,0.8895380143703506,1.0,17/53,25.04%,MCM9;RPA3;RPA1;RNF168;FANCM;RFWD3;FANCD2;FANCC;FANCG;RPA2;USP1;FANCL;RAD51AP2;ERCC6L2;DCLRE1B;FANCI;DCLRE1A
prerank,glucose metabolic process (GO:0006006),0.22402404193693767,0.8303202807356131,0.7757847533632287,1.0,1.0,4/58,5.09%,OMA1;SLC25A13;DCXR;TPI1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.26931276193288295,0.8302781051040549,0.7184684684684685,1.0,1.0,9/22,23.76%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;CIAPIN1;LYRM4
prerank,fatty acid metabolic process (GO:0006631),0.19877383039230356,0.8301636039926595,0.8454545454545455,0.9991073041433577,1.0,23/115,16.99%,NUDT19;LPIN1;ACSBG1;ELOVL4;ACLY;ACACA;ACSL3;CPT1B;OXSM;CPT1C;ACSL6;ALOX12;NAAA;GNPAT;LIPC;AASDH;ACOT2;ACOT7;NDUFAB1;MECR;ALOX5;CYP1A1;ACOX2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2715891402003655,-0.8299452465527527,0.7267657992565055,0.889891761039541,1.0,4/27,7.57%,PPP2R5A;PRKCD;SPPL3;CDH5
prerank,diterpenoid metabolic process (GO:0016101),0.2220674208855995,0.8295257871263179,0.775175644028103,0.9992103969804553,1.0,8/55,14.63%,GPC5;AKR1C1;APOM;GPC1;SDC4;LRAT;AKR1B10;APOE
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.3418167393418885,-0.8291842876574153,0.6952554744525548,0.8908970382968574,1.0,8/12,52.73%,TREM2;IL18;STAP1;TNF;TAFA3;IL6;CCL3;IL1B
prerank,positive regulation of lyase activity (GO:0051349),-0.3162424057511832,-0.8286548909360099,0.6949458483754513,0.8914773316372958,1.0,8/14,41.70%,NOS3;NF1;NOS1;NOS2;PARK7;STIM1;FXN;CACNA1C
prerank,glycolipid biosynthetic process (GO:0009247),0.24529716343100452,0.8285561483781065,0.746606334841629,1.0,1.0,10/38,16.86%,DPM1;ST8SIA5;ST6GALNAC5;PIGP;MPPE1;PIGB;PGAP3;ST8SIA3;B4GALT6;PIGQ
prerank,tRNA processing (GO:0008033),0.2236047091625277,0.8281974174599565,0.811816192560175,0.9995843271296343,1.0,17/61,22.06%,QTRT2;TRMT10B;CPSF1;PTCD1;TRMT6;DDX1;TRMT10A;CLP1;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;CSTF2;NSUN6;ADAT2;THUMPD1
prerank,DNA replication checkpoint signaling (GO:0000076),0.30045839411811176,0.8278410344520728,0.68,0.9990642096252516,1.0,4/16,15.81%,CDC45;NAE1;RAD9B;ORC1
prerank,cardiac myofibril assembly (GO:0055003),0.29672169239227913,0.8273986452392955,0.6896551724137931,0.9987579224932086,1.0,5/15,15.31%,FHOD3;PROX1;MYLK3;MYL2;PDGFRA
prerank,glycosphingolipid metabolic process (GO:0006687),-0.24431361415577701,-0.8273558973505502,0.7839388145315488,0.8935195920341168,1.0,11/42,21.99%,ESYT2;A4GALT;ST6GALNAC3;ARSA;ASAH1;SMPD2;GBA2;LARGE1;GLTP;CTSA;GLA
prerank,ribosomal small subunit assembly (GO:0000028),0.3064065274150546,0.8271258030512599,0.7011764705882353,0.9981069327189852,1.0,5/16,16.89%,RRP7A;ERAL1;XRCC5;ABT1;PWP2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3178162684927178,0.8260955121584036,0.6748329621380846,0.9989997204075436,1.0,2/12,6.48%,BCL2;TRIAP1
prerank,histone ubiquitination (GO:0016574),-0.285246575295862,-0.8260879853317022,0.7148148148148148,0.895438965298084,1.0,6/21,20.37%,DTX3L;RNF40;UBR2;CDC73;PHC1;HUWE1
prerank,nuclear membrane organization (GO:0071763),-0.29217483096001906,-0.8259256303304515,0.7148148148148148,0.8953412223516894,1.0,4/19,11.74%,EMD;TOR1B;CHMP4B;DCTN1
prerank,carnitine metabolic process (GO:0009437),-0.3373215108493323,-0.825912359762621,0.6899641577060932,0.894961731387601,1.0,7/12,32.48%,ACADL;CPT1A;CRAT;TMLHE;BBOX1;SHMT1;CPT2
prerank,regulation of B cell proliferation (GO:0030888),0.2366192428745917,0.8252879533934888,0.7398720682302772,0.99944827429644,1.0,5/44,6.52%,BLK;NFATC2;BCL2;SASH3;CD81
prerank,chromosome condensation (GO:0030261),-0.25335748979955336,-0.8250119520625757,0.7743119266055046,0.8962448936553423,1.0,17/36,36.25%,RB1;ACIN1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;SET;TTN;CHMP1A;PLK1;AIFM1;TOP2A;CSNK2A1;CSNK2A2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.23122778911984515,-0.8247755587838701,0.783068783068783,0.8962803031795525,1.0,23/50,33.59%,MNAT1;CDKN1B;CCND3;ACTB;CDK5RAP3;CCND1;CNPPD1;BLM;CDKN2C;CDC25A;GADD45A;CCNG1;CCNK;CCNE2;CDKN3;CCNJ;CDKN2B;CCNH;CCND2;STOX1;CDK5R1;CCNE1;CDC6
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.2909673827196623,-0.8244507070139727,0.7220149253731343,0.8964678049518862,1.0,7/18,22.95%,CD34;EZR;KAT5;TNFAIP3;PTPRC;HDAC7;HOMER3
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.30411816990989493,0.8243789897285265,0.7047619047619048,1.0,1.0,5/15,19.43%,TRIM27;ARPC5L;ARPC5;WHAMM;ARPC1A
prerank,establishment of skin barrier (GO:0061436),0.3101896030609426,0.8243091730597323,0.7133620689655172,0.9977357878839117,1.0,1/15,0.47%,ABCA12
prerank,regulation of water loss via skin (GO:0033561),0.3101896030609426,0.8243091730597323,0.7133620689655172,0.9977357878839117,1.0,1/15,0.47%,ABCA12
prerank,negative regulation of cartilage development (GO:0061037),-0.3222679427186664,-0.823924902919923,0.703971119133574,0.8970395503447816,1.0,6/13,29.13%,WNT11;PTPN11;ADAMTS7;SNAI2;TGFBR1;WNT9A
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.34457008788747434,0.8235318029435684,0.6823027718550106,0.9980458835216609,1.0,2/10,7.86%,PLEK;CARMIL1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.23479344820071085,-0.8233750943061333,0.7859712230215827,0.8976574632338796,1.0,17/46,36.31%,AKT1;TOMM40;BCAP31;TIMM17B;TOMM5;DNAJC19;TOMM40L;TIMM50;TIMM10;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;DNLZ;TIMM23;PAM16
prerank,positive regulation of metabolic process (GO:0009893),-0.20327610565920584,-0.82323081908501,0.8520499108734403,0.8975254652476292,1.0,15/103,11.47%,IGF1R;INSR;CAV1;ADIPOR2;PRDM16;STAT6;UCP2;GRB10;ACADL;ACACB;EHMT1;KDM6B;IL4R;KDM3A;JAK2
prerank,sphingosine biosynthetic process (GO:0046512),0.33309791696518737,0.822942801639387,0.7004310344827587,0.99678157403543,1.0,4/11,9.92%,SPHK1;ACER1;ABCA2;SPHK2
prerank,sphingoid biosynthetic process (GO:0046520),0.33309791696518737,0.822942801639387,0.7004310344827587,0.99678157403543,1.0,4/11,9.92%,SPHK1;ACER1;ABCA2;SPHK2
prerank,intracellular lipid transport (GO:0032365),-0.2907868565060994,-0.8228859112996887,0.7271095152603232,0.8977621258729562,1.0,4/21,10.87%,CERT1;ABCD3;ACACB;CPT1A
prerank,mitochondrial protein processing (GO:0034982),0.32785571785961876,0.82172824426492,0.6960556844547564,0.9980759640436031,1.0,3/11,15.79%,OMA1;PMPCB;MIPEP
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3001882330664805,-0.8216166038045234,0.699812382739212,0.8996949267698002,1.0,9/16,36.67%,NT5E;TET2;NT5C1A;CRMP1;NT5C;UPB1;UPP1;DPYSL4;DPYS
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.27331562731825,-0.8211871494943462,0.7042735042735043,0.9000781492250761,1.0,14/24,36.28%,KLF2;TP53;NOTCH1;ATF4;GCN1;MAPK7;NFE2L2;ATF6;DDIT3;CEBPB;ATF3;MUC1;MT3;HIF1A
prerank,regulation of peptidase activity (GO:0052547),0.2813118413629693,0.8210000504310532,0.7340909090909091,0.9983051977249682,1.0,6/19,14.60%,ECM1;A2ML1;ATP13A2;CST3;RCN3;PSMB8
prerank,establishment of protein localization to organelle (GO:0072594),0.21314551332025397,0.8207554142662506,0.8135198135198135,0.9975504151834323,1.0,17/72,22.11%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;RYR2;RANBP17;RPAIN;LRSAM1;HK1;HIKESHI;POM121;NUP107;FAM53B;FAM53C;PRICKLE1;NUP93
prerank,regulation of actin nucleation (GO:0051125),0.3191035218783353,0.820336311307263,0.7199124726477024,0.9972532078055617,1.0,12/12,68.11%,GSN;WHAMM;CORO1B;PICK1;ARFIP2;WASHC5;ARFIP1;ARF1;ARPIN;VIL1;SCIN;CORO1A
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3147165721282512,0.8202581970107536,0.7084282460136674,0.9961972924276177,1.0,5/13,19.35%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,activation of phospholipase C activity (GO:0007202),0.25610248852951484,0.820037730263275,0.7734204793028322,0.9954573434911738,1.0,7/29,13.29%,PHB2;ANG;NTRK2;ADRA1A;TXK;BDNF;CD86
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32786233111957147,0.8198842824566502,0.6948356807511737,0.9945828881302393,1.0,3/12,12.14%,ADCY8;PLA2G6;GPLD1
prerank,Golgi to lysosome transport (GO:0090160),-0.33588914611441634,-0.8192078454154412,0.7181663837011885,0.9032270728820351,1.0,4/11,16.96%,GAK;ANKFY1;AP1G1;AP4M1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2629623484945539,-0.8187927374433043,0.7372013651877133,0.9035760212383501,1.0,7/28,16.68%,MIEF1;TCAF1;GDI1;MTCL1;MIEF2;CHP1;FYN
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3106548134558274,0.8184670556755119,0.6814345991561181,0.9962512527682522,1.0,3/12,13.45%,INSIG1;RER1;KDELR2
prerank,DNA methylation or demethylation (GO:0044728),-0.28913830385532,-0.8182891644598809,0.7264325323475046,0.9036649289852071,1.0,7/19,24.04%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,DNA alkylation (GO:0006305),-0.28913830385532,-0.8182891644598809,0.7264325323475046,0.9036649289852071,1.0,7/19,24.04%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3479834523771564,-0.8181873558299438,0.726078799249531,0.9034394478825605,1.0,4/10,24.98%,ATRX;STOML2;E2F7;INO80
prerank,regulation of receptor recycling (GO:0001919),-0.309225972836325,-0.818021052243332,0.7222222222222222,0.9033365773721802,1.0,4/16,22.11%,ANXA2;ECE1;VAMP3;KIF16B
prerank,regulation of myelination (GO:0031641),0.26544727219719355,0.8179545425630693,0.7444444444444445,0.9960949707636293,1.0,3/25,5.85%,TENM4;MYRF;PTPRZ1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.3433930654352539,-0.8174514128600604,0.6956521739130435,0.9039333787874413,1.0,6/10,45.84%,RC3H1;LGALS9;CD274;CRTAM;PDCD1LG2;FOXP3
prerank,positive regulation of double-strand break repair (GO:2000781),-0.24179405976348928,-0.8169476398837084,0.7793345008756567,0.9043892299978038,1.0,7/39,6.93%,DTX3L;ARID2;SHLD1;KMT5B;MRNIP;FUS;SPIDR
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.28954474097331273,0.8165223741386689,0.7196652719665272,0.9976927266071485,1.0,16/16,71.07%,BCKDK;SCARB2;PDK2;PDK1;MLYCD;PRKN;ADIPOQ;FOXK2;ADIPOR1;SIRT1;GNB3;RORA;PDK3;FOXK1;PDK4;RORC
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.32177033382617204,-0.8161850208283333,0.7156488549618321,0.9053359290566718,1.0,5/13,27.03%,ZC3HAV1;RC3H1;MOV10;CNOT8;CNOT1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2741335780639541,-0.8161595867005075,0.7531083481349912,0.9049761339839882,1.0,5/22,10.11%,CDKN1B;BMP4;ROCK1;PRKRIP1;TP53
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.31268657507708136,0.8161219517523628,0.7108167770419426,0.9973055905463677,1.0,4/14,13.14%,NR1D1;SYT11;GRN;LDLR
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3237520113235123,0.8159713474055271,0.710239651416122,0.9964066111820743,1.0,2/10,8.45%,ATP5MC1;VPS9D1
prerank,renal system development (GO:0072001),-0.2269724954652611,-0.8159181554874724,0.7971274685816876,0.9049825087984208,1.0,11/52,14.92%,SOX17;ACE;SIX1;C1GALT1;TGFB2;RBP4;BMP4;PCSK5;AGTR1;TRAF3IP1;FOXC1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26357065123403617,-0.8157703351950619,0.7217068645640075,0.90481705518307,1.0,4/28,10.47%,MAP3K20;ATM;CLSPN;DOT1L
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.26741971663973324,-0.8155499323942723,0.7437275985663082,0.9048121957093073,1.0,3/25,2.50%,ITGB1;CD200;PARVA
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.18729872271238432,-0.8153557896599548,0.9138513513513513,0.9047356228927644,1.0,47/170,26.52%,FOXP1;AFF1;PRDM5;MTMR3;APP;HMG20B;CTCF;NOVA2;KDM6A;HNRNPAB;PRDM2;CDH1;KDM6B;POGZ;HMG20A;PSEN1;TRIM14;PRDM6;EDN3;RASA1;FLOT1;CDK6;MARF1;ROCK2;ZNF462;PRDM9;IGF1;FUBP1;ZNF507;MKLN1;PTPRC;CAVIN4;PRDM1;TOB1;NKAP;KIF16B;MTMR4;TRIM39;RFXANK;PCBP1;TRIM68;UBAP2;IGF2BP2;CRNN;TRIM44;ZFP36L1;HNRNPD
prerank,positive regulation of cilium assembly (GO:0045724),0.2837642283279449,0.8150581770491919,0.722972972972973,0.9970730252103002,1.0,6/18,20.53%,CCDC88A;BBS4;CEP135;HTT;HAP1;SEPTIN9
prerank,response to axon injury (GO:0048678),-0.2952333529472925,-0.8149545951476116,0.70817843866171,0.9050779441486753,1.0,6/18,28.27%,NREP;RTN4RL1;SOD1;FLRT3;MTR;TREM2
prerank,detection of visible light (GO:0009584),-0.3036964128805141,-0.8148788823058363,0.7357512953367875,0.9048055419765256,1.0,11/16,54.27%,CEP250;TULP1;GNA11;PDE6B;RP1;GNAQ;RHO;GNAT1;REEP6;GNAT2;CACNA1F
prerank,aromatic amino acid family catabolic process (GO:0009074),0.306055162642761,0.8146017024337484,0.6926315789473684,0.9967799688116737,1.0,3/15,15.30%,QDPR;HAAO;TDO2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.24193600314893005,0.8139118726485036,0.7817796610169492,0.9969553792177933,1.0,10/37,16.39%,KIF17;DYNC2H1;KIFAP3;KIF3A;DYNC2I2;DYNLRB2;KIF3C;IFT172;IFT22;IFT81
prerank,regulation of viral release from host cell (GO:1902186),-0.2805359807375598,-0.8131494801105792,0.7299651567944251,0.9074276060529274,1.0,10/21,33.32%,TRIM25;CHMP2B;TRIM13;TRIM28;CHMP3;VPS37B;TRIM35;TRIM32;TRIM62;TRIM5
prerank,neuron projection extension (GO:1990138),0.24857003347919396,0.8127303631371517,0.7793427230046949,0.998142375578605,1.0,7/32,11.64%,SH3GL2;TMEM108;CDK5;IMPACT;CPNE1;MAP1B;AUTS2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3178366078598463,-0.8125816499755454,0.6935201401050788,0.9080349167584408,1.0,5/13,17.95%,TGFBR2;GSK3A;SMAD4;NOTCH1;HEY2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.30022646044175727,-0.812251632722159,0.7140255009107468,0.9082027568041817,1.0,9/16,34.42%,BOC;PLCB1;MEF2C;SMYD1;RBM24;LRRC8A;MAPK14;XKR8;HIF1AN
prerank,regulation of neutrophil migration (GO:1902622),-0.34300692742431904,-0.8121045978040148,0.7233644859813084,0.9080618098785759,1.0,2/10,13.44%,RAC1;RHOG
prerank,cellular response to lipid (GO:0071396),-0.18364346917034377,-0.8118662429376853,0.9284497444633731,0.9080645423762029,1.0,34/191,16.45%,DAB2IP;ESR1;LYN;NRIP1;ATM;TBX1;NR3C1;EGFR;MSN;ADAM9;FZD4;NFKB1;TNFRSF1B;IRS1;PDCD4;MED1;IRGM;LBP;MEF2C;NFKBIL1;NCOA4;RHOA;IRAK1;CDC73;LPL;KAT5;WNT11;MAPK8;TNFAIP3;ROCK2;RUVBL2;ADCY1;UBE2L3;CHMP5
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.31523992888656666,-0.811762832207861,0.7174311926605504,0.9078450011367734,1.0,8/14,42.75%,CRAT;ACOX1;ACOX3;ECI2;EHHADH;ACOXL;SCP2;ABCD1
prerank,mitochondrial transport (GO:0006839),-0.22579426747807058,-0.8117094408537968,0.8062730627306273,0.907540721518155,1.0,22/53,34.01%,COX18;BNIP3;ABCB10;STARD3;TOMM40;BCAP31;TMEM14C;TIMM17B;TOMM5;PPIF;FLVCR1;DNAJC19;SLC25A24;HSP90AA1;TIMM10;TOMM20;TOMM70;PMAIP1;SPG7;SLC25A5;TIMM10B;TIMM13
prerank,response to hexose (GO:0009746),-0.2681618816271747,-0.8116573296781533,0.75139146567718,0.9072215303917932,1.0,10/25,33.43%,THBS1;EIF2B2;LPL;TCF7L2;VAMP2;PFKL;SELENOT;MAFA;EIF2B4;EIF2B5
prerank,ribosome assembly (GO:0042255),-0.23361338627849,-0.8115089197824742,0.8043478260869565,0.9070751448572603,1.0,15/47,24.41%,DDX3X;RPS14;RPSA;NOP2;RPL3;RPL10;RPL5;NLE1;MPV17L2;RPS27;MDN1;BOP1;RRS1;RPS15;MRPS2
prerank,tRNA modification (GO:0006400),0.21670392742134809,0.8114698660973023,0.8417582417582418,0.9993500140466713,1.0,19/62,23.10%,QTRT2;TRMT6;GTPBP3;TRMT13;TRMT10A;PUS1;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;NSUN6;TPRKB;METTL2A;METTL2B;ADAT2;THUMPD1;TRMT5;THUMPD3
prerank,regulation of mast cell activation (GO:0033003),-0.3416686386867457,-0.8111290907036005,0.7201426024955436,0.9073091731785927,1.0,4/10,26.84%,LYN;PLSCR1;MILR1;CD300LF
prerank,T cell differentiation in thymus (GO:0033077),-0.3138178352926049,-0.8109560876681683,0.7319778188539742,0.9072021811006798,1.0,6/14,31.26%,GLI3;PTPRC;LIG4;ZFP36L1;ADAM17;SHH
prerank,glycerolipid metabolic process (GO:0046486),0.32579226193603483,0.8106113064826984,0.7414529914529915,0.9997664874623818,1.0,3/11,17.18%,DGKQ;GAL3ST1;PGP
prerank,membrane lipid catabolic process (GO:0046466),0.3385442786502516,0.8103382186591715,0.6936936936936937,0.9991189133601853,1.0,3/10,15.24%,ENPP2;SMPDL3B;FUCA1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.2952465035767101,-0.8089841033383318,0.7513611615245009,0.910184833328035,1.0,8/16,40.37%,TGFB2;FOXC1;PTN;RBM24;SP7;TCF15;LTBP3;GATA4
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3371215012221453,-0.8088002620030906,0.7238938053097345,0.9101052801959915,1.0,2/10,4.84%,PTPRJ;PTPN12
prerank,epithelial cell differentiation (GO:0030855),-0.20623860169398953,-0.8083383395444272,0.8395061728395061,0.9105108307111435,1.0,15/88,14.85%,DAB2;TBX1;KDR;HDAC1;SIX1;E2F4;BMP4;BDH2;ANXA4;AKT1;KDM6B;CPT1A;ALDOC;ACADVL;JAG1
prerank,second-messenger-mediated signaling (GO:0019932),0.19894122995563132,0.8082729465363437,0.8658536585365854,1.0,1.0,21/82,22.18%,PPP1R9A;KSR2;DDAH2;CHRM3;SPHK1;RYR2;CCR6;RCAN2;MCTP2;NMUR2;RCAN3;APOE;MCU;HRH1;EDNRB;CXCR4;PPP2R1A;SAMD14;DDAH1;BTK;PDPK1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2390560108724386,-0.8081167189267038,0.7806122448979592,0.910482768941726,1.0,10/40,17.30%,TNFSF10;BNIP3;AKT1;TP53;HGF;GPX1;BBC3;BCL2L11;IGF1;PPIF
prerank,mitochondrion morphogenesis (GO:0070584),0.3203402161586224,0.8077392495671324,0.7466960352422908,1.0,1.0,5/11,23.29%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.2138774022896088,-0.8074739865763307,0.8312159709618875,0.9112099351388029,1.0,20/69,27.19%,ECPAS;TRIM25;UBE4B;ANKZF1;UBE2J2;SGTA;MAN1B1;UBE4A;ERLIN2;DNAJC10;TRIM13;DNAJB12;DNAJB9;HERPUD1;EDEM2;FBXO17;TMUB1;RNF103-CHMP3;USP19;RNF103
prerank,cyclooxygenase pathway (GO:0019371),0.3381002909537847,0.8071728066161844,0.6850574712643678,1.0,1.0,2/10,10.63%,PTGDS;CBR1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.31803381057024116,-0.8068639939961831,0.7546125461254612,0.9118967030706284,1.0,4/13,19.32%,HES1;DOT1L;JAK2;PTPRC
prerank,multivesicular body assembly (GO:0036258),-0.2568296772563747,-0.806824057187577,0.7675675675675676,0.9115551707679428,1.0,13/30,30.84%,CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.29647926060569413,0.8063981313988273,0.7465753424657534,1.0,1.0,7/15,25.41%,NYNRIN;ZC3H12B;ZC3H12C;NUDT16;RNASEH1;LACTB2;POP7
prerank,response to glucagon (GO:0033762),-0.29043659378612646,-0.8060618391817572,0.7355679702048417,0.9125080671481938,1.0,5/19,15.78%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1
prerank,retinoid metabolic process (GO:0001523),0.20736086013621557,0.8058220863943772,0.8682352941176471,1.0,1.0,10/71,14.63%,GPC5;AKR1C1;APOM;CYP26B1;GPC1;ALDH1A2;SDC4;LRAT;AKR1B10;APOE
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.20147293743749684,-0.8056303268128984,0.8655913978494624,0.9128661967570121,1.0,21/90,21.69%,IGF1R;CAV1;ADIPOR2;PRDM16;STAT6;UCP2;GRB10;ACADL;EHMT1;KDM6B;IL4R;KDM3A;JAK2;ALMS1;ACSL1;CMKLR1;EPAS1;PRKAB1;G0S2;OGT;DIO2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2966726923384545,0.8055707138366849,0.7341176470588235,1.0,1.0,2/15,6.48%,BCL2;TRIAP1
prerank,protein targeting to lysosome (GO:0006622),-0.28184850229746666,-0.8052728738284615,0.7401709401709402,0.9130535137603671,1.0,7/20,20.43%,RAB7A;NEDD4;NCOA4;AP4M1;LAMP2;ZFYVE16;M6PR
prerank,microtubule polymerization (GO:0046785),-0.26027844861759264,-0.8050127988152047,0.7588235294117647,0.9131071213247762,1.0,8/29,18.73%,CENPJ;RANBP9;SLAIN2;CSNK1D;TUBGCP4;TUBGCP5;TRPV4;NDEL1
prerank,pseudouridine synthesis (GO:0001522),-0.30959748531196696,-0.8049892236090634,0.7277882797731569,0.9127501682067506,1.0,5/13,29.47%,PUS10;TRUB1;PUSL1;RPUSD2;GAR1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.32768930694222664,-0.8048777256437433,0.7171171171171171,0.9125409129253887,1.0,7/12,31.42%,PROM1;NKD1;AGTPBP1;TULP1;MYO7A;SDK2;STAT3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2982888928194239,-0.8048512587268782,0.7254901960784313,0.9121850780657949,1.0,2/17,4.87%,PLA2G4A;LPCAT1
prerank,mononuclear cell differentiation (GO:1903131),-0.26674169830087724,-0.8041404487795725,0.776595744680851,0.9129908714279464,1.0,4/24,7.18%,MYH9;LYN;GAS6;BMP4
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.2901601133295443,0.803664157206604,0.745958429561201,1.0,1.0,7/16,19.31%,B3GALT4;ST8SIA5;ST6GALNAC5;ST8SIA3;B4GALT6;ST8SIA2;ST8SIA1
prerank,aerobic electron transport chain (GO:0019646),0.20653515456503888,0.8033715835820717,0.8539325842696629,1.0,1.0,15/68,17.30%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;COX6A1;NDUFS7;NDUFB6;NDUFA11
prerank,positive regulation of T cell migration (GO:2000406),-0.2764597906591407,-0.802884128640895,0.7490636704119851,0.914728175698305,1.0,8/20,30.69%,APP;ADAM10;RHOA;CXCL12;ADAM17;CXCL10;WNK1;TNFRSF14
prerank,nucleocytoplasmic transport (GO:0006913),-0.2358278156862328,-0.8027383740749824,0.7820738137082601,0.9145852979166847,1.0,12/40,26.21%,RSRC1;NUP98;BACH2;SNRPE;HNRNPA1;LSG1;NXT1;PHAX;RITA1;GEMIN7;NEMF;ATXN1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.332729695555467,0.8027307614642615,0.711943793911007,1.0,1.0,1/10,0.75%,ANK3
prerank,DNA replication initiation (GO:0006270),0.23610167662395537,0.8027125318412602,0.8131868131868132,1.0,1.0,9/37,16.00%,GMNN;MCM8;CDC45;POLA1;PURA;POLE4;CDC7;ORC1;CDK2
prerank,regulation of neuroblast proliferation (GO:1902692),0.29675529581541105,0.8020226955041468,0.730593607305936,1.0,1.0,3/15,12.48%,TAFA1;VEGFA;FZD3
prerank,negative regulation of viral process (GO:0048525),-0.22125806831918063,-0.8019046104918216,0.8458961474036851,0.9155600034263547,1.0,23/57,31.52%,IFIH1;ZC3HAV1;UBP1;TRIM14;IFITM3;PLSCR1;N4BP1;TRIM13;SRPK2;MAVS;TRIM28;IFITM2;TNIP1;CHMP3;TRIM6;OASL;BST2;TRIM35;RSAD2;LARP7;SHFL;TRIM32;TRIM62
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.28982930460671136,-0.8015904156525006,0.7553571428571428,0.9156797037687004,1.0,8/16,39.64%,BMP4;RGCC;F2R;LARP6;RUNX1;TGFB1;HDAC2;CREB3L1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2921954752062536,0.8011788130410019,0.7195652173913043,1.0,1.0,5/16,18.78%,IL12A;RASGRP1;CD226;SLAMF6;CADM1
prerank,DNA-dependent DNA replication (GO:0006261),0.1889026079631798,0.8004159469501579,0.9137055837563451,1.0,1.0,25/128,17.13%,GMNN;GINS4;WRNIP1;PSMC5;MCM8;PSMD10;CDC45;POLD4;PSMD14;POLA1;PSMB7;RPAIN;PSMA4;PURA;SIRT7;POLE4;PSMD1;PSMF1;PSMB8;CDC7;ORC1;CDK2;PSMD7;PSMB5;PSMD2
prerank,negative regulation of neuron differentiation (GO:0045665),-0.2721025290462368,-0.8003439696859658,0.7710196779964222,0.9173582570893407,1.0,7/22,25.91%,GSK3B;HES1;MED1;BMP7;HEY1;NEPRO;EIF2AK4
prerank,acyl-CoA metabolic process (GO:0006637),-0.24754433164837608,-0.8000653556342366,0.7884615384615384,0.9173908374203544,1.0,8/35,18.88%,OGDH;ACSF2;SUCLG2;ACACB;THEM4;HMGCS2;SUCLA2;ACOT9
prerank,regulation of membrane depolarization (GO:0003254),-0.2859895603057896,-0.7999156874048121,0.7592920353982301,0.9172598999625281,1.0,9/18,30.27%,NEDD4L;LRRK2;PTPN3;SMAD7;SCN3B;FHL1;GJA5;HCN4;RANGRF
prerank,nuclear envelope organization (GO:0006998),-0.27502827353692444,-0.7990950999622533,0.7854609929078015,0.9182068579620069,1.0,4/20,15.90%,EMD;TOR1B;REEP3;SUN1
prerank,positive regulation of cell killing (GO:0031343),-0.3090478462343431,-0.798667625186545,0.7275985663082437,0.9184857130945459,1.0,3/13,23.43%,RAC1;MAPK8;FZD7
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.23749705447655314,0.7986037198239884,0.7960088691796009,1.0,1.0,5/34,13.29%,PHB2;INAVA;SASH3;SPHK2;CD86
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2766013768781279,-0.7984280524087053,0.7643884892086331,0.9184883115487971,1.0,8/23,22.06%,DIAPH1;PSEN2;NOS1AP;FYN;UBASH3B;CASQ2;NOS1;PTK2B
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.26036895502033136,0.7976744483540691,0.7669902912621359,1.0,1.0,6/24,19.08%,AKAP6;CALM2;SRI;HRC;SELENON;PDE4D
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2413835267297833,0.7976307756166657,0.7981220657276995,1.0,1.0,9/31,23.02%,PYCR2;LSS;CYP51A1;FDFT1;ALOX5;NOXRED1;NFS1;LIAS;PRLR
prerank,negative regulation of telomere maintenance (GO:0032205),-0.30132435893012377,-0.7974353432125375,0.8035019455252919,0.9197793364523082,1.0,10/15,42.06%,ATM;TERF2;SMG6;PINX1;TNKS2;RAD50;TNKS;SLX4;ERCC4;ERCC1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3064583479752131,-0.7972496579626703,0.7583774250440917,0.9196715041908091,1.0,6/13,31.54%,BMP4;NOTCH1;TBX3;EID2B;TGFB1;SOSTDC1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.24006067825640826,-0.7971978778640418,0.7949640287769785,0.9193613239596673,1.0,11/39,23.23%,RBX1;ERCC2;POLD3;OGG1;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.27837188548107206,-0.7971714552000325,0.7485928705440901,0.9186060048448109,1.0,6/21,18.94%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.27837188548107206,-0.7971714552000325,0.7485928705440901,0.9186060048448109,1.0,6/21,18.94%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,dendritic cell migration (GO:0036336),-0.29772759990280995,-0.7969506736412115,0.7775831873905429,0.9185753095391302,1.0,2/16,4.94%,EPS8;TRPM4
prerank,response to acidic pH (GO:0010447),-0.3077168419295805,-0.7964621425972358,0.7206703910614525,0.9189709680846578,1.0,5/13,23.85%,CHP1;LGMN;PKD2L1;GPR4;RAB11FIP5
prerank,negative regulation of immune response (GO:0050777),-0.18709695799132503,-0.7964150023706194,0.9393414211438474,0.9186545704319894,1.0,25/154,15.78%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;NMI;PLK2;RHBDF2;ADCY4;PLCG2;PPM1B;RAMP2;ADM;CYSLTR2;TRAF3IP1;RC3H1;TNFAIP3;ILRUN;IAPP;ADCY1
prerank,positive regulation of bone mineralization (GO:0030501),-0.2431882970243707,-0.7961750937173645,0.800718132854578,0.918669808882704,1.0,8/35,12.16%,BMPR2;BMP6;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3038414698128819,-0.7958913643137554,0.7199248120300752,0.9187148934915698,1.0,7/13,33.46%,RNF168;NELFB;SUPT4H1;HNRNPU;LARP7;NELFA;NELFCD
prerank,lipid oxidation (GO:0034440),0.31809603421305005,0.7954932861485737,0.7387173396674585,1.0,1.0,3/12,15.88%,PLA2G7;ALOX12;ALOX5
prerank,histone H2A acetylation (GO:0043968),0.28885697595118387,0.7953651698828225,0.7258426966292135,1.0,1.0,4/16,14.00%,MEAF6;SPHK2;RUVBL1;NAA40
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.34170480952239424,-0.7953386836442704,0.728440366972477,0.9192214532811023,1.0,4/10,14.75%,MTOR;ADAM9;FGF7;MAP4K4
prerank,negative regulation of chemokine production (GO:0032682),-0.3009287940585653,-0.795208779919035,0.7408088235294118,0.9190226195592325,1.0,1/14,1.54%,KLF4
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3086321509025265,-0.7949318608262907,0.7463503649635036,0.91905865706606,1.0,2/14,7.02%,TGFBR2;CD55
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.2685314585280552,-0.794911186403129,0.7735191637630662,0.9187005397354967,1.0,11/23,35.89%,HERC4;GLI3;GLIS2;MOSMO;KIF7;GPC3;TULP3;SUFU;PTCH1;MGRN1;VCP
prerank,endoderm development (GO:0007492),0.3068143995027488,0.7941931066605274,0.7054794520547946,1.0,1.0,2/13,6.44%,LHX1;DUSP4
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.30355144305476534,-0.7938880711179451,0.769090909090909,0.9199538570256653,1.0,4/14,29.64%,DAGLB;NOS1;CHAT;SLC22A2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3169417533902139,-0.7937122999401498,0.7567567567567568,0.9198162688418511,1.0,9/13,40.99%,DYRK1A;YJU2;MIF;MDM2;SNAI2;CD74;SIRT1;PTTG1IP;CD44
prerank,DNA duplex unwinding (GO:0032508),-0.22430714915522654,-0.7935438508507655,0.8449197860962567,0.919679902183385,1.0,19/50,33.69%,RBX1;MRE11;MCM9;ERCC2;MCM4;RPA1;XPC;ERCC3;ANXA1;WRN;CETN2;BLM;DHX9;MCM7;GTF2H3;CHD1L;MCM2;RAD50;PIF1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.26678534566258316,-0.7933324933680916,0.7917448405253283,0.9196566165270864,1.0,10/24,30.94%,SUZ12;TASOR;H3-3A;DNMT1;PPHLN1;PPM1D;AEBP2;PHF19;SPI1;DNMT3B
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.29790124501507875,0.7930234608322458,0.7348314606741573,1.0,1.0,5/15,15.11%,SMPD3;SPHK1;SPHK2;PLA2G6;NSMAF
prerank,protein import (GO:0017038),0.19948797838100069,0.7928265158727013,0.8926014319809069,1.0,1.0,22/84,22.11%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;ATAD1;RANBP17;RPAIN;CLU;APOE;HIKESHI;POM121;SNX33;NUP107;GDAP1;FAM53B;FAM53C;FIS1;PEX2;ACBD5;PRICKLE1;NUP93
prerank,glial cell development (GO:0021782),-0.2630737901654697,-0.7927215225613498,0.7874306839186691,0.9202392328323058,1.0,14/25,37.42%,APP;EIF2B2;CDK6;NRROS;SOX4;NF1;NSUN5;EIF2B4;EIF2B5;PRDM8;S100A9;MT3;TLR2;MDK
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.2740493549263959,-0.7918487361266242,0.8120437956204379,0.9212628982240177,1.0,5/21,10.57%,CSGALNACT1;CHST15;CHST11;CSPG4;BGN
prerank,regulation of osteoblast proliferation (GO:0033688),0.28134841062148497,0.7915876078485736,0.7505720823798627,1.0,1.0,4/17,15.09%,NELL1;FGFR2;ATRAID;EIF2AK2
prerank,gastrulation (GO:0007369),-0.3000961115167088,-0.7912664714714887,0.7625482625482626,0.9217650713867092,1.0,4/15,13.61%,LRP5;SMAD2;TASOR;LMBRD1
prerank,negative regulation of response to wounding (GO:1903035),-0.28276913941269266,-0.7912018287869743,0.7662565905096661,0.9214796341686031,1.0,4/19,13.05%,CRK;EPHA4;FGF2;RTN4RL1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.20176579421169263,-0.7903526536896196,0.8805704099821747,0.922400817553494,1.0,29/83,29.97%,MNAT1;RB1;CDK17;CDKN1B;CRLF3;CUL3;MAX;PLK2;CUL2;LATS2;CDK6;GSPT1;CACUL1;CCND1;CDK14;CDKN2C;CDC25A;CDK18;CCNE2;E2F3;TFDP1;KHDRBS1;BRD4;PLK3;CDKN3;CDK16;CCNH;HINFP;CDC34
prerank,regulation of nuclear division (GO:0051783),-0.2774677910153608,-0.7901628392305508,0.7642725598526704,0.9222934275051557,1.0,4/20,13.19%,CDK13;CUL9;CUL7;CCDC8
prerank,regulation of axon regeneration (GO:0048679),-0.3300550425568687,-0.7897525218974282,0.7545454545454545,0.9225531143671616,1.0,4/12,13.05%,SCARF1;STK24;EPHA4;RTN4RL1
prerank,lysosome localization (GO:0032418),0.23608687539625808,0.7897039808959854,0.8281938325991189,1.0,1.0,11/37,19.88%,PIP4P1;CHGA;FLCN;NR4A3;RAB3A;RAB34;KIT;SNAPIN;BORCS5;MAP6;VPS33B
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.24092055868115164,-0.7891621562787685,0.8172413793103448,0.9230915412869004,1.0,7/35,15.38%,PPP1R2;GSK3B;ITGA1;MTOR;PPP1R12A;PPP6R3;NUAK1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3397589741506527,-0.7890373368891064,0.7321100917431193,0.9228835430035665,1.0,3/10,18.61%,NCK1;JUN;CITED2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3244462284468234,0.7887838004760136,0.7631027253668763,1.0,1.0,3/10,18.89%,ADRA2A;TGFA;HBEGF
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2299204813966616,0.7887108238959668,0.8105726872246696,1.0,1.0,10/38,17.30%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,neutrophil migration (GO:1990266),-0.21293669345803706,-0.7883135613411121,0.8303886925795053,0.9236446725099131,1.0,7/58,11.69%,PECAM1;BSG;CCL25;TGFB2;PIK3CD;EDN1;EDN3
prerank,glycerophospholipid catabolic process (GO:0046475),0.2511455758309504,0.7882866337107904,0.7702702702702703,1.0,1.0,6/27,12.18%,ENPP2;PLA2G7;PLA2G4E;PLA2G6;LIPC;INPP5F
prerank,cholesterol transport (GO:0030301),-0.2257931637642429,-0.7880788098810134,0.8318425760286225,0.9236230823405742,1.0,11/45,21.54%,LIMA1;CAV1;LDLRAP1;SCARB1;STARD3;STARD4;ABCA7;STX12;STAR;OSBPL2;LCAT
prerank,striated muscle cell differentiation (GO:0051146),-0.2946228888311691,-0.7879952603026753,0.7536764705882353,0.9233597559230052,1.0,4/16,10.26%,AKAP13;SIK1;MEF2C;KDM6B
prerank,establishment of protein localization to extracellular region (GO:0035592),0.22719768470327967,0.7879509817520414,0.8400900900900901,1.0,1.0,8/39,16.51%,RAB15;PDIA4;RAB3C;TANGO2;RAB3A;RCN3;COPG2;SEL1L
prerank,cartilage development (GO:0051216),-0.2226054134536634,-0.7875689252593957,0.848987108655617,0.923660507977655,1.0,19/49,33.22%,ZBTB16;NFIB;BMP4;CREB3L2;MEF2C;FGF2;SNX19;CCN3;TRPV4;HYAL2;BMP2;WNT2B;WNT5B;TRIP11;HYAL3;RUNX1;TGFB1;SULF1;WNT7A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3297803238395287,0.7873050214776719,0.7259100642398287,1.0,1.0,4/10,15.11%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3297803238395287,0.7873050214776719,0.7259100642398287,1.0,1.0,4/10,15.11%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,cAMP metabolic process (GO:0046058),0.30309500955704816,0.7872831930375924,0.7443946188340808,1.0,1.0,3/13,8.27%,ADCY8;ADCY10;ADCY7
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.2685585761405904,0.7872694295917352,0.75,1.0,1.0,3/21,12.21%,GRIN2B;USP50;PCID2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.2774058493761054,-0.7871224410459138,0.7697715289982425,0.9239648357355096,1.0,7/19,19.32%,KDR;PTPRJ;STIMATE;BCAP31;PTGFR;VCAM1;PTPRC
prerank,positive regulation of histone modification (GO:0031058),-0.24191834857485614,-0.7867779673902616,0.8190127970749543,0.9241396943462886,1.0,10/33,30.97%,RPS6KA5;NIPBL;RUVBL2;BRCA1;SAP30BP;NOS1;ARRB1;GLYR1;APLNR;RPS6KA4
prerank,chromatin assembly (GO:0031497),-0.23476762660652706,-0.7865453960647663,0.8136531365313653,0.924086744474704,1.0,7/38,15.56%,KAT6B;CTCF;BRD2;SPTY2D1;TP53;H3-3A;PRDM9
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3205405516498583,0.7865296759251876,0.75054704595186,1.0,1.0,3/10,10.58%,PDE3B;PDE11A;RNF157
prerank,protein import into nucleus (GO:0006606),0.20733440667567055,0.7863392104636442,0.852017937219731,1.0,1.0,5/66,3.44%,MMP12;SPRN;PHB2;NUP62CL;TNPO3
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2922165715459034,-0.7862733934122664,0.7754010695187166,0.9240945593618429,1.0,7/16,28.27%,HDAC1;ROCK1;ABCA7;MYOCD;LRP1;HMGCR;TREM2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3085704858283159,-0.7857686267693408,0.7576853526220615,0.924497147326442,1.0,5/13,28.90%,RPS21;NOL9;RRS1;RCL1;UTP20
prerank,activation of protein kinase A activity (GO:0034199),-0.29505159887934373,-0.7857252223187772,0.7495327102803738,0.9241670104487436,1.0,3/16,8.02%,PRKACB;ADCY9;ADCY4
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.28280648307668793,-0.7853225153149532,0.7654545454545455,0.9243791037801966,1.0,2/18,3.07%,ESR1;KAT2B
prerank,prostanoid metabolic process (GO:0006692),-0.30798237702414444,-0.7852504801915394,0.7473498233215548,0.924097355611222,1.0,4/13,21.13%,PTGS1;ACOX1;HPGDS;PTGR1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2504874922196366,-0.7839219574727833,0.8256880733944955,0.9257836383493472,1.0,3/30,6.54%,SPTBN1;GOLPH3L;MACF1
prerank,intraciliary retrograde transport (GO:0035721),-0.31089837524324015,-0.7838668768775545,0.7616387337057728,0.9254715213905944,1.0,4/12,19.26%,IFT140;WDR35;DYNC2LI1;IFT43
prerank,ribosomal large subunit assembly (GO:0000027),-0.2593736227829922,-0.7833135945833058,0.7978142076502732,0.925965747770896,1.0,8/24,20.95%,NOP2;RPL3;RPL10;RPL5;NLE1;MDN1;BOP1;RRS1
prerank,arachidonate transport (GO:1903963),-0.3337672348888828,-0.7826826049625499,0.7715289982425307,0.9261431865579415,1.0,5/10,35.49%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,arachidonic acid secretion (GO:0050482),-0.3337672348888828,-0.7826826049625499,0.7715289982425307,0.9261431865579415,1.0,5/10,35.49%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.22038338985567396,-0.7824941588359318,0.8578680203045685,0.9260525911316525,1.0,17/51,31.57%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;IL16;GBP5;CCL19;NOD2;CASP1;FZD5;HMGB1;LGALS9;NLRC4;STAT3;TLR6
prerank,potassium ion export across plasma membrane (GO:0097623),-0.304617650060402,-0.781566558964651,0.7467411545623837,0.9270890880902762,1.0,5/13,27.46%,KCNK5;KCNQ1;KCNE4;KCNH2;KCND3
prerank,ncRNA transcription (GO:0098781),0.29718567011363506,0.7804170063697945,0.7718550106609808,1.0,1.0,6/13,24.11%,ANG;SIRT7;RPAP2;USPL1;NIFK;SPIN1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2653507638133695,0.7803826107843947,0.7974137931034483,1.0,1.0,3/20,7.48%,BCL2;SELENOK;TMCO1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.29366686773284945,-0.7802948703018118,0.7513416815742398,0.9286232051912372,1.0,4/16,11.39%,CAV1;TRIM25;EXOC2;TRIM14
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3128253790394264,-0.7798750667267299,0.7508833922261484,0.9288847153471624,1.0,4/12,15.43%,HDAC1;NOTCH1;HDAC4;CCN3
prerank,cholesterol homeostasis (GO:0042632),0.2047745698302531,0.7792699027655187,0.9090909090909091,1.0,1.0,21/64,23.56%,NR1D1;INSIG1;AKR1C1;APOM;TSKU;ABCA2;LIPC;ABCA5;LDLR;GRAMD1B;APOE;SOAT2;DISP3;CD24;SOAT1;ANGPTL3;LAMTOR1;ABCG1;CNBP;NR1H2;TMEM97
prerank,female gamete generation (GO:0007292),-0.24953365386663587,-0.7785917401766945,0.8046594982078853,0.9305021278689889,1.0,6/29,15.56%,USP9X;DMC1;MCM9;PARN;MARF1;PRDM9
prerank,neutrophil chemotaxis (GO:0030593),0.20753006817990804,0.7782460877440639,0.8617511520737328,1.0,1.0,8/53,14.71%,PDE4B;CXADR;PF4;CCL13;CCL5;CCL2;PPIA;CCL7
prerank,mRNA splice site selection (GO:0006376),0.24328931515671992,0.7779029171939429,0.7986425339366516,1.0,1.0,4/30,6.47%,CELF5;CELF4;CELF2;CELF6
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.28760271383130037,-0.7773433886841244,0.8042704626334519,0.9319474951769107,1.0,8/17,31.62%,AKT1;SFPQ;SOD1;MAPK7;NFE2L2;BAG5;TREM2;VNN1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3290606067506622,-0.7768821719171676,0.7862190812720848,0.9322387655887672,1.0,7/10,45.94%,TCP1;CCT5;CCT2;CCT3;CCT7;DKC1;CCT6A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2738004007996008,0.7768557401572441,0.7679324894514767,1.0,1.0,2/18,5.71%,PAG1;VTCN1
prerank,response to iron ion (GO:0010039),0.3107833360570904,0.7767588900106837,0.7649572649572649,1.0,1.0,2/12,8.02%,BCL2;ACO1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2318000606612161,-0.7764954044851973,0.8336283185840708,0.9324293217208567,1.0,13/38,28.11%,PRPF3;PRPF6;PRPF31;SNRPE;TGS1;SRSF12;CD2BP2;STRAP;SRSF10;COIL;GEMIN7;AAR2;LSM2
prerank,basement membrane organization (GO:0071711),-0.3076860886188283,-0.7764078172718963,0.7871198568872988,0.9321637390480562,1.0,5/14,15.07%,NTN4;COL4A1;RAMP2;NID1;FLRT2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.30871038556295793,0.7763695324467856,0.7427293064876958,1.0,1.0,3/12,14.60%,TMEFF2;PF4;SELENOS
prerank,regulation of glucose metabolic process (GO:0010906),0.22847821022958095,0.7756218474299403,0.8295964125560538,1.0,1.0,6/34,14.60%,DGKQ;GNMT;BCKDK;GPLD1;SIRT7;SELENOS
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.2795858519501102,0.7754291539999435,0.7599118942731278,1.0,1.0,5/17,18.78%,IL12A;RASGRP1;CD226;SLAMF6;CADM1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.32003370076904114,-0.7753539078448215,0.7607476635514019,0.9333406085447257,1.0,4/11,26.45%,CDC73;AHCYL1;ZFP36L1;LEO1
prerank,protein localization to microtubule organizing center (GO:1905508),0.28602046577261664,0.7750800240371998,0.7661469933184856,1.0,1.0,3/15,10.63%,BBS4;SNX10;CCDC14
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.2561198573051422,-0.7750137073844867,0.8218181818181818,0.9334127591099806,1.0,6/27,14.28%,KHNYN;XRN1;ERN1;DICER1;PARN;PDE12
prerank,programmed necrotic cell death (GO:0097300),-0.2765909741343737,-0.7749272084731009,0.7703984819734345,0.9331465549255932,1.0,14/18,49.59%,TRPM7;PPIF;RIPK1;ALKBH7;IPMK;TICAM1;CD14;MLKL;TLR4;TICAM2;TLR3;ITPK1;RIPK3;LY96
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.19873076314170354,0.774711680183534,0.9054054054054054,1.0,1.0,15/69,17.30%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;COX6A1;NDUFS7;NDUFB6;NDUFA11
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.27578519750324165,-0.7745700296303669,0.7445255474452555,0.9332712915609671,1.0,5/19,15.60%,MTOR;RPTOR;ICE1;POLR3F;NAB2
prerank,placenta development (GO:0001890),-0.3123765289931275,-0.774547671131756,0.7728119180633147,0.9329008301296794,1.0,5/12,24.40%,PTK2;CUL7;SOD1;PPARG;E2F7
prerank,rRNA modification (GO:0000154),0.26586572939513214,0.7745393681225159,0.7910112359550562,1.0,1.0,7/21,22.43%,MTERF4;BUD23;TFB1M;DIMT1;TSR3;THUMPD1;NOP10
prerank,protein localization to condensed chromosome (GO:1903083),-0.31256622954050717,-0.7744070436485523,0.774074074074074,0.9327196480510418,1.0,8/12,47.05%,BUB3;TTK;MTBP;SPDL1;MIS12;AURKB;CHAMP1;KNL1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.27126444065520766,-0.7743346496971293,0.783001808318264,0.9324200933816225,1.0,7/21,31.44%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PLA2G4F;OSBPL10;PLA2G5
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2728433081226345,-0.7742300091928903,0.8137931034482758,0.9321716456541613,1.0,8/18,26.13%,MCM4;POLD3;GINS3;GINS1;RFC4;MCM3;LIG1;MCM7
prerank,serine family amino acid catabolic process (GO:0009071),-0.33448166630127407,-0.773336327419541,0.7486136783733827,0.933114156385742,1.0,6/10,40.10%,DLD;GLDC;SHMT1;GCSH;DAO;CBS
prerank,mucosal immune response (GO:0002385),-0.28740373325592805,-0.773314764725013,0.7866894197952219,0.9327440062458704,1.0,13/15,54.26%,RNASE3;DEFA6;RPL39;IFNLR1;NOS2;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19564670476649312,0.7723245779940308,0.8870967741935484,1.0,1.0,23/84,20.80%,PATL2;GGA3;TYMS;ENC1;SPHK1;NTRK2;SORL1;RTN4;FXR2;CPEB3;EIF4A3;CNOT7;CLU;EIF4E2;APOE;EIF2AK2;DHX36;IGF2BP3;RTN3;HAP1;SAMD4B;RTN1;RBM4
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.24079473661839285,-0.7722798343354315,0.8087431693989071,0.9338697177077567,1.0,6/32,17.21%,PPP1R13B;FHIT;DDIT4;TP53;HIPK1;HINT1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.3225386357777127,-0.7721562718567111,0.7644991212653779,0.9336529410576313,1.0,2/10,9.17%,GRB10;GSK3A
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2545485886090857,-0.771155042794785,0.8315972222222222,0.9347756949939547,1.0,6/26,15.01%,NMI;PPM1B;NFKBIL1;TRAF3IP1;TNFAIP3;ILRUN
prerank,steroid hormone biosynthetic process (GO:0120178),-0.24745652261665116,-0.7711203666916916,0.8280701754385965,0.9344216566773563,1.0,7/29,18.81%,MED1;STARD3;FDX1;FDXR;STARD3NL;DHCR7;STAR
prerank,regulation of T cell differentiation (GO:0045580),-0.24012820830637005,-0.770362516230702,0.844559585492228,0.9351725781415763,1.0,3/33,5.93%,CBFB;ZMIZ1;ABL1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.2938801687011897,-0.769759835703759,0.7820069204152249,0.9356527470097972,1.0,11/15,48.62%,CD55;GLI3;NKAP;PNP;SHH;HSPH1;SYK;EBI3;IHH;IL23R;IL12B
prerank,negative regulation of cellular metabolic process (GO:0031324),0.22864323460724004,0.7696719430115104,0.8427947598253275,1.0,1.0,9/37,18.23%,ANKRD13B;WDR54;PAX2;MTMR2;ABCA2;DLG4;APOE;OPTN;EDNRB
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3102718927378777,0.769584360671576,0.7857142857142857,1.0,1.0,3/11,15.70%,STK26;LANCL1;P4HB
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.22763597814506115,0.7690456548639836,0.8622222222222222,1.0,1.0,5/38,11.70%,MAGI2;FLCN;GPER1;NOP53;PHLPP1
prerank,axonal transport (GO:0098930),0.2282882204319952,0.7688188422864153,0.8466666666666667,1.0,1.0,8/36,16.69%,TMEM108;SYBU;AP3S2;MAPT;KIF3A;AP3M2;SNAPIN;NEFL
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2081419169012026,-0.7686938481089144,0.8774080560420315,0.9367350325465436,1.0,22/64,32.80%,PLA2G4A;ELOVL5;ACADL;GSTM2;EPHX1;CPT1A;ACAD9;SLC27A4;MGLL;GPX1;ACOX1;ACSL1;DAGLB;PNPLA8;CYP1B1;SLC27A3;GPX4;HACL1;ELOVL2;ALOXE3;CPT2;ELOVL6
prerank,ear morphogenesis (GO:0042471),-0.2656070942587753,-0.7680728557968534,0.8076923076923077,0.9372469963732044,1.0,3/20,5.59%,TBX1;NIPBL;SIX1
prerank,oligosaccharide metabolic process (GO:0009311),-0.22149486335123647,-0.7678403477655245,0.8715277777777778,0.9371667451274949,1.0,6/46,9.03%,ST3GAL6;ST3GAL4;ST8SIA4;ST6GALNAC3;FUT8;ST3GAL2
prerank,monocyte differentiation (GO:0030224),-0.32761240031314814,-0.767836523056138,0.7847222222222222,0.9367759934212077,1.0,5/10,25.48%,MYH9;BMP4;PIR;PPARG;MT1G
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2647077343417553,-0.767728514955428,0.8106194690265487,0.9365319127289156,1.0,13/24,39.61%,CTSC;PSME2;EPHA4;GPX1;PSME1;PTK2B;RHBDF1;ATP5IF1;DNAAF4;UBE3A;NUDT15;PSME3;EFNA1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.25655133268960784,-0.7676769032922992,0.8281535648994516,0.9362095202283958,1.0,7/25,17.07%,FBXL17;CUL3;ATXN3;ZER1;ZYG11B;UGGT1;HDAC6
prerank,positive regulation of cell development (GO:0010720),-0.23777242890170716,-0.7675824883897375,0.8471223021582733,0.9359540577086102,1.0,4/31,7.84%,PDE3A;SPEN;BMP4;TGM2
prerank,establishment of vesicle localization (GO:0051650),-0.2774036342977873,-0.7674163862607712,0.8028419182948491,0.9357885461400436,1.0,7/18,18.44%,LIMK2;DNM2;RAB27A;TMEM230;SPG11;RAB11A;IKBKG
prerank,pre-replicative complex assembly (GO:0036388),0.2038914037189454,0.7672437398621764,0.8997668997668997,1.0,1.0,14/64,17.13%,GMNN;PSMC5;MCM8;PSMD10;PSMD14;PSMB7;PSMA4;PSMD1;PSMF1;PSMB8;ORC1;PSMD7;PSMB5;PSMD2
prerank,regulation of intracellular transport (GO:0032386),0.2212504052781304,0.7672248948042808,0.8506787330316742,1.0,1.0,12/38,20.80%,ATP9A;MAP2;PLA2G3;NEFH;ATP13A2;INPP5F;MLC1;NUMA1;AAAS;HAP1;REEP5;RBM4
prerank,negative regulation of neurogenesis (GO:0050768),-0.23732441918144798,-0.7668667065780923,0.85,0.9362000331981917,1.0,9/34,22.67%,RAPGEF2;ARHGDIA;GDI1;NOTCH1;RHOA;PCM1;PTEN;NF1;PTN
prerank,sterol homeostasis (GO:0055092),0.2014497903857478,0.7666907364142643,0.9359823399558499,1.0,1.0,21/65,23.56%,NR1D1;INSIG1;AKR1C1;APOM;TSKU;ABCA2;LIPC;ABCA5;LDLR;GRAMD1B;APOE;SOAT2;DISP3;CD24;SOAT1;ANGPTL3;LAMTOR1;ABCG1;CNBP;NR1H2;TMEM97
prerank,activation of adenylate cyclase activity (GO:0007190),0.23154813231865232,0.7666764742361744,0.8532110091743119,1.0,1.0,8/35,14.39%,ADCY8;GIPR;ADCY7;ADRB3;TSHR;LGR5;ACR;ADCY3
prerank,chondroitin sulfate metabolic process (GO:0030204),0.23756330983400603,0.7666376142412672,0.8147321428571429,1.0,1.0,8/30,13.61%,DSEL;CHSY3;NCAN;CHST9;HEXB;CHST12;CHSY1;UGDH
prerank,regulation of steroid metabolic process (GO:0019218),-0.26112878808914075,-0.766197620288267,0.815742397137746,0.936727141265299,1.0,6/23,19.85%,PANK2;ACADL;ACADVL;ASAH1;STAR;FMO5
prerank,lymphocyte proliferation (GO:0046651),-0.2549784813097187,-0.7661118917647457,0.8162878787878788,0.9364606210879088,1.0,7/22,21.96%,MSN;MEF2C;CTPS1;CD40;LMBR1L;PTPRC;ELF4
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3050079643693328,-0.7660358059611363,0.7759562841530054,0.9361669669771576,1.0,9/12,46.50%,MAD1L1;CENPE;BOD1;NUF2;MIS12;RMDN1;KIF2C;CDT1;CHAMP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.29933813779649904,-0.7659804898037447,0.7807486631016043,0.9358408510705496,1.0,4/13,18.07%,BMP5;NFKB1;ERLIN2;SOD1
prerank,positive regulation of neuron death (GO:1901216),0.2203387809290649,0.7655016795661862,0.8738938053097345,1.0,1.0,6/46,8.61%,GRIN2B;CDK5;EGR1;GRN;MAPT;BACE1
prerank,peptidyl-methionine modification (GO:0018206),-0.30956045947006067,-0.7654440904010054,0.7821428571428571,0.9362166123521042,1.0,2/12,10.04%,NAA16;NAA15
prerank,regulation of interferon-gamma production (GO:0032649),0.20039865395322976,0.765174999552459,0.8995433789954338,1.0,1.0,12/71,15.73%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;HAVCR2;TXK;SLAMF6;IL23A;CD47;SIRPA
prerank,inorganic anion transport (GO:0015698),0.20623347670096015,0.76482363542904,0.8891213389121339,1.0,1.0,10/53,16.03%,SLC34A1;CLCNKA;GLRA1;ANO4;CLCN2;ENPP3;SLC26A8;RACGAP1;SLC4A11;SLC13A1
prerank,glutamate metabolic process (GO:0006536),0.26246411444101453,0.764620743606395,0.7901785714285714,1.0,1.0,9/19,27.42%,OAT;GLS2;GLS;GLUD1;GAD1;MTHFS;GCLM;FPGS;ALDH5A1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.25127441424782965,-0.7644357484964452,0.8193202146690519,0.9372483623656841,1.0,14/26,40.42%,LRRK2;AKT1;ATF4;FYN;TXN;MAPK7;NFE2L2;BAG5;PYCR1;VNN1;PARK7;PDE8A;GATA4;SIRT1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.27196513806663963,-0.764253542563542,0.7869718309859155,0.9371203506709491,1.0,8/20,32.02%,PLOD2;PLSCR1;PTDSS1;GAMT;GCLC;CNDP2;HAGH;MGST2
prerank,extracellular matrix assembly (GO:0085029),0.25303935514465575,0.7641211641146021,0.8163265306122449,1.0,1.0,4/23,8.37%,GPM6B;NTNG2;NTNG1;LAMB3
prerank,natural killer cell activation (GO:0030101),-0.2597932375734421,-0.7638364716990571,0.7939068100358423,0.9373259439248022,1.0,3/23,9.65%,PBX1;CASP8;PIK3CD
prerank,acylglycerol biosynthetic process (GO:0046463),0.2582771353749884,0.7627783561252932,0.7977272727272727,1.0,1.0,4/23,12.65%,LPIN1;ANG;GK;MOGAT1
prerank,fatty acid oxidation (GO:0019395),-0.2095990222975408,-0.762765291263744,0.8921389396709324,0.9384303062488767,1.0,9/57,15.50%,HADHB;ADIPOR2;ABCD3;BDH2;PPARD;ACADL;ACAD11;ACADVL;ACOX1
prerank,retina homeostasis (GO:0001895),-0.2578873658984993,-0.7619875472877785,0.8091743119266055,0.9391192257110484,1.0,10/23,33.71%,ACTB;POTEF;TULP1;SOD1;CCDC66;POC1B;PRDX1;JCHAIN;CRB2;ACTG1
prerank,determination of left/right symmetry (GO:0007368),0.22276011443628083,0.7598296018843284,0.8725274725274725,1.0,1.0,10/37,16.20%,ODAD2;MEGF8;BBS7;DNAAF1;PKD1L1;ENKUR;LEFTY1;ARL6;FOXJ1;MKKS
prerank,ESCRT III complex disassembly (GO:1904903),-0.31998146671779726,-0.7589603741885137,0.802536231884058,0.942461966616525,1.0,3/10,16.45%,VTA1;CHMP2B;CHMP5
prerank,ESCRT complex disassembly (GO:1904896),-0.31998146671779726,-0.7589603741885137,0.802536231884058,0.942461966616525,1.0,3/10,16.45%,VTA1;CHMP2B;CHMP5
prerank,histone H2A monoubiquitination (GO:0035518),-0.2758871862668617,-0.7579893615944285,0.8,0.943370553287717,1.0,6/17,21.21%,RYBP;RNF168;BCOR;PCGF3;RNF2;PCGF5
prerank,negative regulation of protein metabolic process (GO:0051248),-0.21491708953886263,-0.7578096180280226,0.8871252204585538,0.9432179266197495,1.0,12/48,20.64%,EGFR;NFKB1;ROCK1;FLNA;VBP1;EDN1;SNX12;AZIN1;IAPP;MAD2L2;PFDN6;ITGB3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.24574171570122944,-0.7574976762955892,0.8511029411764706,0.9432250161141472,1.0,11/27,27.31%,CSGALNACT1;CHST15;CHST11;CSPG4;BGN;CHST7;CHPF2;PXYLP1;XYLT2;CSGALNACT2;XYLT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.29523269851611916,-0.7571280865303748,0.8072727272727273,0.9433366690285352,1.0,8/14,46.43%,IRAK1;COPS8;MAP3K7;TLR6;ZFP91;CARD14;MALT1;TLR3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.24801173904850413,0.7570496384701585,0.815068493150685,1.0,1.0,2/23,6.19%,PPEF1;METAP2
prerank,regulation of keratinocyte migration (GO:0051547),-0.3099407668187772,-0.7568476772319276,0.7947761194029851,0.9433378366968797,1.0,5/12,20.17%,MTOR;ADAM9;FGF7;MAP4K4;PTEN
prerank,microtubule polymerization or depolymerization (GO:0031109),0.24266437558729487,0.7560364316510311,0.8203463203463204,1.0,1.0,6/25,15.06%,MAPT;STMN2;TPPP3;TPPP;HDGFL3;STMN4
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.2640413888208691,-0.7559237557643804,0.818018018018018,0.944179656388518,1.0,7/19,30.81%,BMP4;RGCC;EMILIN1;F2R;LARP6;RUNX1;TGFB1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3006166480340615,-0.7557096190140995,0.7950530035335689,0.9440776310949663,1.0,4/12,21.42%,PTPRJ;CBL;F3;IFT20
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.31561678674364807,-0.755434143258992,0.7794392523364486,0.9440641068987031,1.0,4/10,33.52%,LRP6;CTNNB1;FZD1;WNT3
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.21145834522438153,-0.7549762533907002,0.8989547038327527,0.9442853838473728,1.0,9/47,14.25%,KLF4;APP;NFKB1;NFKBIA;FOXO3;AKT1;EDN1;AGTR1;RPL10
prerank,cobalamin metabolic process (GO:0009235),0.2724356296181008,0.7545709974621527,0.8181818181818182,1.0,1.0,3/17,13.46%,CBLIF;MMAB;MMAA
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.28553358626725533,0.754508929986592,0.7978494623655914,1.0,1.0,2/14,6.31%,SHISA2;GPC1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.2846818089039813,-0.7544618363105053,0.7948717948717948,0.9446304742837227,1.0,10/16,42.54%,PSEN1;IGBP1;IKBKB;SMG6;MCM7;SMG7;PGAM1;GNB3;IL4;SRPX2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.30795380111816684,-0.7543902765110878,0.7900763358778626,0.9443358619873309,1.0,3/12,13.13%,NFIB;EPHA4;PAFAH1B1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.201810893266207,0.7543347325450863,0.9173913043478261,1.0,1.0,8/55,11.97%,GPC5;HPSE2;GPC1;NCAN;FMOD;PRELP;HEXB;SDC4
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.28672080016308576,-0.7539985702895667,0.822550831792976,0.9444679486657179,1.0,5/15,26.33%,TCP1;RUVBL2;CCT5;CCT2;NAF1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.30062760944782735,0.7536505588420985,0.796875,1.0,1.0,1/11,1.95%,GCK
prerank,sulfur compound catabolic process (GO:0044273),0.21742918892071866,0.7531871914673001,0.8449438202247191,1.0,1.0,6/38,10.65%,GADL1;DPEP1;NCAN;FMOD;PRELP;HEXB
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.23823612726103077,0.7531271237093345,0.8461538461538461,1.0,1.0,4/27,9.60%,DDR2;SPHK1;S100A6;PDGFA
prerank,regulation of rRNA processing (GO:2000232),-0.2825749221748717,-0.7513586860159005,0.781651376146789,0.947612024029746,1.0,2/16,5.92%,KAT2B;WDR75
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.31229968870941766,-0.7511981421697571,0.7710622710622711,0.947448298627414,1.0,4/10,25.04%,TERF2;TFIP11;DCLRE1B;DCLRE1A
prerank,regulation of tau-protein kinase activity (GO:1902947),0.31180347517956175,0.7509831571181628,0.8033826638477801,1.0,1.0,4/10,17.06%,EGR1;SORL1;CLU;HSP90AB1
prerank,sarcomere organization (GO:0045214),0.2392286639126916,0.7508494161296487,0.841304347826087,1.0,1.0,4/27,12.82%,FHOD3;MYPN;MYLK3;CASQ1
prerank,regulation of mitochondrion organization (GO:0010821),0.2110862629128708,0.7508374599818148,0.8881431767337807,1.0,1.0,16/47,23.29%,OMA1;PRMT6;FLCN;MAPT;ATP13A2;INF2;HTRA2;SIRT7;RHOT1;MFF;VDAC1;FIS1;PISD;SQSTM1;USP36;DNM1L
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2483893711401286,-0.7506354371156189,0.8574181117533719,0.9477982570393979,1.0,11/25,36.25%,EPHA4;HFE;SGTA;RPL5;RPS7;TRIM39;PRKCG;OPHN1;GABARAPL2;CSNK2A1;CSNK2A2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3002664718497868,-0.7505902159153782,0.7765567765567766,0.9474604710578312,1.0,3/12,13.36%,CHMP4B;CHMP4A;SGTA
prerank,response to purine-containing compound (GO:0014074),0.26935930795188257,0.7505763517793925,0.7664233576642335,1.0,1.0,2/17,7.41%,DGKQ;RYR2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.27759869619784927,-0.7504354679660126,0.7974910394265233,0.947262522121119,1.0,2/16,6.14%,PPARA;PDCD4
prerank,regulation of defense response to virus (GO:0050688),-0.28685217863597856,-0.7489461797639404,0.8095238095238095,0.9488246385806395,1.0,8/14,29.57%,PPM1B;TRAF3IP1;TNFAIP3;ILRUN;ZMPSTE24;RNF216;DHX9;IFNLR1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3048494451730006,-0.7487882221583805,0.7963636363636364,0.9486321191221173,1.0,1/12,2.01%,ESR1
prerank,epiboly involved in wound healing (GO:0090505),-0.27442172358732,-0.7483721432645435,0.8160714285714286,0.948778939980739,1.0,7/16,22.42%,FLNA;RHOA;CEACAM1;LCP1;RHOC;ARHGAP35;CCN1
prerank,positive regulation of cellular senescence (GO:2000774),-0.31880676704630007,-0.7482831296491276,0.7923875432525952,0.9485076668708583,1.0,3/10,15.17%,YPEL3;ABI3;CGAS
prerank,cell part morphogenesis (GO:0032990),0.28480874178680116,0.7481530769435544,0.811816192560175,1.0,1.0,5/13,23.29%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.22347564653853402,-0.747510599447132,0.8706739526411658,0.9491267573543939,1.0,8/40,12.16%,BMPR2;BMP6;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,negative regulation of defense response to virus (GO:0050687),0.30404211479170445,0.7466436526966373,0.7842227378190255,1.0,1.0,3/10,14.02%,RNF26;TSPAN6;PCBP2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2711041163248293,0.7463403251860421,0.8088888888888889,1.0,1.0,2/16,9.74%,TNFSF18;IL12A
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.25448072909888175,-0.7452638834570016,0.8405545927209706,0.9515481610181998,1.0,14/21,43.00%,MECP2;RAB11A;CCND1;CDC25A;BRD4;DTL;STOX1;CDK4;DYRK3;FBXO5;ATAD5;CCNB1;CDC25C;RAD51C
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3041395637030617,-0.744245834442745,0.82842287694974,0.9524755226102078,1.0,2/12,11.64%,LY6E;IFITM3
prerank,genitalia development (GO:0048806),-0.2985341131370748,-0.7441696158608349,0.8117001828153565,0.9521672031750974,1.0,6/12,31.26%,FOXF2;DNAJC19;PTPN11;TBX3;STRA6;SHH
prerank,chemical homeostasis (GO:0048878),-0.2020846173554893,-0.7439733446296125,0.9211409395973155,0.9520261930672713,1.0,18/61,24.90%,ZBTB20;NEDD4L;SLC4A10;TENT4B;DDX3X;AQP11;WNK4;NR1D2;ACOX1;TLCD1;ACOX3;KLHL3;PPARG;SLC66A1;PNPLA8;CEBPA;PNPLA2;TLCD3B
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.18891528238045807,-0.7437342244595845,0.9658273381294964,0.9519397283079764,1.0,25/95,23.44%,CENPJ;YWHAE;CEP57;CEP250;CEP78;HAUS8;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;CEP41;ALMS1;RAB11A;PLK4;PCM1;CETN2;CNTRL;CEP152;ODF2;HSP90AA1;PCNT;NPHP1;CEP131;AKAP9
prerank,tRNA wobble base modification (GO:0002097),-0.2858977088654904,-0.7432303690750209,0.8156934306569343,0.9521755450388251,1.0,8/14,40.12%,DPH3;TRMT9B;MOCS3;KTI12;CTU2;ALKBH1;ELP4;ELP3
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.25378503709183314,-0.7424932499989877,0.824468085106383,0.9526983952959887,1.0,8/20,30.49%,PSMG2;PTGES3;PFDN6;HSP90AA1;NDUFAF1;PSMG1;CCT2;PSMG3
prerank,ganglion development (GO:0061548),-0.3085958713928805,-0.742034648312113,0.8464285714285714,0.9529020362597276,1.0,1/11,0.76%,NRP2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.23468464091118452,-0.7417970300483503,0.8607142857142858,0.952784753906192,1.0,10/32,24.21%,LPCAT1;SLC44A1;STARD7;MFSD2A;CEPT1;PCTP;LPIN2;LPCAT3;LCAT;CHAT
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2774202195308579,0.7415894316421987,0.8135964912280702,1.0,1.0,6/14,22.89%,XRCC5;ATR;ACD;TPP1;TERF2IP;BRCA2
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2528697979518433,-0.7414647714453494,0.8429602888086642,0.9528015126852439,1.0,4/22,20.24%,CBFB;IRF1;VSIR;BCL6
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.20108799291136617,-0.7409933924296781,0.9130434782608695,0.9529626887830066,1.0,27/62,40.78%,MCL1;LRRK2;DDX3X;ARHGEF2;AKT1;ACKR3;PPIF;CXCL12;HERPUD1;MDM2;MAPK7;NFE2L2;TXNDC12;SNAI2;BAG5;PLAUR;TRIM32;VNN1;ARMC10;PARK7;DDIAS;CREB3L1;SIRT1;PTTG1IP;CDKN2D;TMBIM6;SFRP2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2059281234580774,0.7409353071857316,0.9006622516556292,1.0,1.0,8/48,13.26%,ROBO1;TTLL12;PELI3;TRAIP;PADI2;SLIT3;OAS3;CNOT7
prerank,positive regulation of chemokine production (GO:0032722),-0.21416613120086148,-0.740713663258359,0.8884892086330936,0.9529308850853938,1.0,17/44,38.50%,APP;DDX3X;IL6R;LPL;IL17RA;MAVS;HMGB1;IL7;ADAM17;LGALS9;HMOX1;TSLP;CD74;TLR2;HIF1A;SYK;IL18
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.19935418795414211,0.7404557431414733,0.9191011235955057,1.0,1.0,12/56,17.30%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.19935418795414211,0.7404557431414733,0.9191011235955057,1.0,1.0,12/56,17.30%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.28734860066243817,-0.7403425538295145,0.8037383177570093,0.9529986512427956,1.0,5/13,30.12%,ITGB1;LPL;PPARG;FCER1G;CD9
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.2733400735520129,-0.739955001596457,0.8066298342541437,0.9530774172726977,1.0,2/16,5.48%,TMSB4X;PPARA
prerank,negative regulation of interleukin-6 production (GO:0032715),0.23182113312863709,0.7393647611291572,0.8640350877192983,1.0,1.0,6/27,19.13%,SYT11;PTPN6;FOXJ1;SELENOS;SIRPA;CX3CL1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3104404055978499,0.7392415251172352,0.7757847533632287,1.0,1.0,2/10,6.83%,PHB2;MTMR2
prerank,regulation of aerobic respiration (GO:1903715),-0.2795738168271612,-0.7392101764408457,0.8308823529411765,0.9535886965103987,1.0,1/15,1.76%,CBFA2T3
prerank,tyrosine metabolic process (GO:0006570),0.29993722536095424,0.7391324738654008,0.7830802603036876,1.0,1.0,11/11,70.03%,THAP4;GSTZ1;FAH;IL4I1;TAT;PAH;TH;IYD;DCT;HGD;TYR
prerank,epithelial structure maintenance (GO:0010669),-0.3048009489856557,-0.7389533324148742,0.783001808318264,0.9535193386417792,1.0,6/11,37.71%,RBP4;NOD2;STRAP;MUC13;PIWIL4;MUC6
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.28009702390008373,-0.7386271380613213,0.8253676470588235,0.9535257556031254,1.0,3/15,16.62%,GGT5;GGACT;HOGA1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.2705097191487805,-0.7385979789506966,0.8228980322003577,0.9531663495935664,1.0,5/17,28.06%,FERMT2;PTPRC;TERT;HNRNPU;N4BP2L2
prerank,DNA packaging (GO:0006323),0.26614527604894245,0.7384811017545895,0.8405172413793104,1.0,1.0,2/16,6.57%,M1AP;H1-0
prerank,apoptotic nuclear changes (GO:0030262),0.2468962311599001,0.7384370598233454,0.8594470046082949,1.0,1.0,6/24,15.22%,BLCAP;H1-0;GPER1;HMGB2;ACVR1C;DEDD2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.27192896928166377,-0.7382372490588551,0.842756183745583,0.9532149373936608,1.0,4/16,16.38%,BMP5;IGFBP4;IGFBP5;IGF1
prerank,positive regulation of mRNA processing (GO:0050685),0.246601271430258,0.7381672963441462,0.8418803418803419,1.0,1.0,8/21,21.60%,CELF4;SF3B4;DHX36;DAZAP1;PRDX6;RBMX;PAF1;NCBP2
prerank,immunoglobulin mediated immune response (GO:0016064),0.3059080453954957,0.7381332535617935,0.7956989247311828,1.0,1.0,2/10,17.74%,CD81;FCGR2B
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2247632975592864,-0.7380753391345117,0.8641304347826086,0.9530129804322006,1.0,10/37,23.23%,RBX1;ERCC2;POLD3;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1
prerank,tRNA wobble uridine modification (GO:0002098),-0.2821564616093668,-0.7369254094752746,0.8241758241758241,0.9540206767703686,1.0,8/14,40.12%,DPH3;TRMT9B;MOCS3;KTI12;TRMU;CTU2;ELP4;ELP3
prerank,negative regulation of interferon-beta production (GO:0032688),0.30789837931772757,0.7367406496204639,0.793859649122807,1.0,1.0,3/10,15.73%,REL;PTPRS;SIRPA
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2668222885138492,-0.7363116023335856,0.8151571164510166,0.9543406657046265,1.0,6/18,24.21%,ERC1;CHRNB1;FCHSD2;STAC3;FCHSD1;CHAT
prerank,regulation of immunoglobulin production (GO:0002637),0.2459757129237497,0.7357976009781066,0.863013698630137,1.0,1.0,2/23,4.82%,PHB2;SASH3
prerank,cellular response to hypoxia (GO:0071456),-0.17582397992844656,-0.7354722712880035,0.9651741293532339,0.9549677595622346,1.0,38/126,28.31%,CREBBP;PSMA2;MTOR;LIMD1;RBX1;BNIP3;PSME2;SUV39H1;CUL2;PSMB4;TP53;RGCC;LMNA;NDRG1;PSMC2;HIF3A;PSMB2;PSMB1;BMP7;ARNT;PSMA8;EPAS1;PSME1;NPEPPS;ELOC;PSMD4;TERT;MDM2;PSMA7;PSMD5;PTGIS;PLK3;ZFP36L1;PSMB10;PSMA3;HILPDA;HMOX1;ANGPT4
prerank,protein lipidation (GO:0006497),0.19517879613031353,0.7354036234031889,0.9409090909090909,1.0,1.0,10/59,12.14%,DPM1;SELENOK;PIGP;ZDHHC8;ZDHHC13;MPPE1;ZDHHC20;PIGB;PGAP3;GPLD1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.24324305900566162,-0.7353937292371636,0.8590381426202321,0.9546463971610486,1.0,6/24,16.68%,MIEF1;TCAF1;MTCL1;MIEF2;CHP1;FYN
prerank,regulation of spindle organization (GO:0090224),-0.26484446831810377,-0.7351980405085707,0.8445229681978799,0.9544809530383643,1.0,9/18,34.16%,RAE1;DCTN1;RNF4;TACC3;SENP6;BORA;MAP9;PARP3;PSRC1
prerank,neuron projection regeneration (GO:0031102),-0.3129079156813686,-0.7350416340985878,0.8039568345323741,0.9542716395624357,1.0,4/10,27.93%,NREP;RTN4RL1;PTN;MTR
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2775658505033602,0.7349371571493222,0.8024096385542169,1.0,1.0,2/14,7.07%,PELI3;TRAIP
prerank,positive regulation of type 2 immune response (GO:0002830),0.2766646017734178,0.7349305901267008,0.8438228438228438,1.0,1.0,3/14,13.29%,CD81;PRKCZ;CD86
prerank,protein localization to centrosome (GO:0071539),0.263179373644178,0.7344724885357043,0.8415178571428571,1.0,1.0,5/17,18.81%,BBS4;SNX10;CCDC14;GOLGB1;HOOK3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2005706755992882,0.7342777269527385,0.9197247706422018,1.0,1.0,13/53,18.51%,PSMC5;PSMD10;BCKDK;PSMD14;PSMB7;PSMA4;PSMD1;PSMF1;PSMB8;PSMD7;PSMB5;PSMD2;PSMB3
prerank,cellular amino acid catabolic process (GO:0009063),0.1834888567941008,0.7341426920205141,0.963963963963964,1.0,1.0,24/87,21.71%,OTC;QDPR;BCKDK;ASPA;HMGCLL1;HAAO;AMT;MCCC2;SDSL;HMGCL;GLS2;GLS;GLUD1;CARNS1;TDO2;SARDH;GAD1;DDO;BCAT2;DLST;SLC25A21;ACAT1;DDAH1;GSTZ1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.254274775709606,-0.7335944676633199,0.8485401459854015,0.9555936723798657,1.0,4/20,13.68%,ZBTB16;LDB1;CDC73;CDK6
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21023220033152284,-0.7334620547035138,0.8940972222222222,0.9553432454592969,1.0,12/49,27.55%,DAB2IP;DENND3;RNASE3;ADAMTS9;XRN2;MAGEC2;RNASEH2C;RIPK1;EXOSC7;FBXO17;HNRNPD;MANBA
prerank,snRNA processing (GO:0016180),-0.27043680816798976,-0.7331418040412602,0.8493870402802102,0.9553232442431523,1.0,7/16,29.96%,INTS8;INTS3;INTS9;INTS7;TOE1;INTS5;INTS12
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2603557630992918,-0.7328419548651646,0.8592870544090057,0.9552635104410527,1.0,4/19,18.07%,CAT;GPX1;ACOX1;SOD1
prerank,protein secretion (GO:0009306),-0.20056559211483058,-0.7327845797682649,0.928695652173913,0.9549351071205178,1.0,9/56,12.56%,CAMK2G;TANGO6;STEAP3;MON1A;COPG1;PCSK5;TVP23A;RAB8B;SNX19
prerank,glutathione biosynthetic process (GO:0006750),0.29820163745304124,0.7320721561899243,0.7853881278538812,1.0,1.0,1/11,3.75%,GGCT
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.17456837742341993,-0.7320185012896357,0.9712746858168761,0.9554321337153351,1.0,39/132,26.36%,EIF4H;RBM5;RPS14;PRPF6;RPSA;NOP2;CELF1;DDX39B;RPL3;SF3B1;PUF60;CPSF7;DICER1;CDC73;RPL38;SNRPE;RPL10;PTGES3;TGS1;RPL5;NLE1;SRPK2;RPS27;MDN1;PRKDC;BOP1;STRAP;RRS1;SRSF10;HSP90AA1;RPS15;COIL;EIF3A;GEMIN7;USP39;GCFC2;DHX9;NAF1;PRPF18
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.2892164252858177,-0.7314297298919474,0.8249097472924187,0.9557511471791058,1.0,8/13,37.00%,LRRK2;HGF;TXN;NFE2L2;MET;PYCR1;PARK7;PDE8A
prerank,tetrapyrrole metabolic process (GO:0033013),0.2599633304476305,0.7311489189728317,0.8530020703933747,1.0,1.0,3/18,13.46%,CBLIF;MMAB;MMAA
prerank,lipoxygenase pathway (GO:0019372),-0.2795674192161175,-0.730470394778575,0.8294010889292196,0.9564771813474662,1.0,5/14,32.41%,PON2;GPX1;GPX4;ALOX5AP;ALOXE3
prerank,natural killer cell mediated immunity (GO:0002228),-0.2717219180917848,-0.7303937824828114,0.8208955223880597,0.9561691746997729,1.0,9/15,53.22%,CEBPG;ARL8B;RAET1E;TUBB4B;SLAMF7;KLRD1;KLRK1;KIF5B;KLRC2
prerank,response to unfolded protein (GO:0006986),0.1997596950622696,0.7300318791563462,0.9170403587443946,1.0,1.0,6/48,7.99%,PACRG;HSPA4L;DNAJB4;HSPA9;HSF1;HSPA1L
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2299561197910275,0.729751496647335,0.8909512761020881,1.0,1.0,4/26,11.67%,CARTPT;HOXA7;TMEM178A;TCTA
prerank,negative regulation of locomotion (GO:0040013),-0.29738047169781895,-0.7293275017528412,0.8098720292504571,0.9570660925584531,1.0,3/12,12.95%,CRK;FRMD5;DUSP3
prerank,granulocyte chemotaxis (GO:0071621),0.1946082347009714,0.7289608271412703,0.9166666666666666,1.0,1.0,8/55,14.71%,PDE4B;CXADR;PF4;CCL13;CCL5;CCL2;PPIA;CCL7
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.2949710902369518,-0.7287885397564214,0.8142076502732241,0.9573004733213113,1.0,3/12,10.57%,DSE;CSPG4;BGN
prerank,regulation of dephosphorylation (GO:0035303),-0.27378537202647424,-0.7280392121763971,0.8173913043478261,0.9578250279249075,1.0,5/15,24.30%,MTMR3;IGBP1;CDK5RAP3;MTMR4;SMG6
prerank,regulation of protein sumoylation (GO:0033233),-0.26744022116919874,-0.7277197566818955,0.85431654676259,0.9578046153215857,1.0,5/17,19.68%,ZMIZ1;UBA2;HDAC4;CTNNB1;PIAS4
prerank,fatty acid catabolic process (GO:0009062),-0.19304477137850887,-0.727539150386984,0.9462962962962963,0.9576362904449278,1.0,13/67,20.49%,ABHD2;HADHB;ABCD3;BDH2;PPARD;ACADL;SLC27A4;ACAD11;ACADVL;ACOX1;PCCA;LPIN2;PCCB
prerank,myofibril assembly (GO:0030239),-0.2132539904614235,-0.7271624412415876,0.8931159420289855,0.9576779305825532,1.0,6/42,12.82%,PGM5;TMOD3;CSRP2;CFLAR;LMOD1;TPM1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.26978116099880356,-0.7268282142690781,0.8681732580037664,0.9576711347498723,1.0,5/17,18.92%,WASF2;FCHSD2;NCKAP1;GMFB;WASF1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.28934028694378744,0.7268131705082754,0.8270509977827051,1.0,1.0,1/11,3.11%,CACNA2D1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.23661713763874528,-0.7262666345735963,0.8669064748201439,0.9578968913124081,1.0,12/29,28.11%,EXOSC2;EXOSC1;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;EXOSC7;CNOT8;LSM2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.2905199385552847,-0.7256912637484402,0.8208955223880597,0.9577817738446216,1.0,4/12,16.38%,SPPL3;STIMATE;LMCD1;IGF1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.2905199385552847,-0.7256912637484402,0.8208955223880597,0.9577817738446216,1.0,4/12,16.38%,SPPL3;STIMATE;LMCD1;IGF1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.25984530294131775,-0.7250391084757538,0.8327402135231317,0.9581147671670103,1.0,8/17,33.12%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.19130999793883174,-0.7245265579973055,0.9564489112227805,0.9582958269236026,1.0,17/72,23.23%,RBX1;MRE11;ERCC2;DICER1;XRN2;POLD3;OGG1;RPA3;DNA2;RPA1;PDE12;ERCC3;EDC3;RPA2;DCP1A;RFC4;RFC1
prerank,icosanoid biosynthetic process (GO:0046456),0.2911014743260243,0.7237977287983948,0.8236658932714617,1.0,1.0,1/10,2.26%,FADS1
prerank,regulation of exit from mitosis (GO:0007096),0.2071041214125169,0.7235899108152336,0.9230769230769231,1.0,1.0,3/38,5.70%,ANAPC2;PHB2;ANLN
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20875617688229905,-0.7235763756383005,0.9063604240282686,0.958986573918011,1.0,20/45,32.99%,GCNT2;APP;LARP1;FOXO3;PUM1;ZC3H7B;RPL10;RC3H1;RBM4B;RBM3;METTL16;MTPN;PARP9;NANOS1;TDRD7;ZC3H7A;METTL18;ATXN2;EIF2B4;PUM2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2707398832029062,-0.7225733471283224,0.8388214904679376,0.9596866190474453,1.0,2/14,7.48%,HNRNPA0;MAPKAPK2
prerank,positive regulation of chromosome organization (GO:2001252),0.26218363579374615,0.7224638830596578,0.8305084745762712,1.0,1.0,4/15,17.25%,DDX11;GNL3;RAD21;DHX36
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2028517432115009,-0.7224049420363676,0.9322916666666666,0.9594715251373089,1.0,9/53,19.01%,DAB2IP;GNA12;PSME2;FOXF2;ECSCR;PSMC2;GPX1;RAD23A;PSME1
prerank,glycerophospholipid metabolic process (GO:0006650),0.18639262743560492,0.7223834279197,0.9587155963302753,1.0,1.0,13/75,12.14%,CLN3;HDHD5;PLEK;FAR1;PLA2G7;PLA2G3;PIGP;PLA2G4E;CPNE1;PLA2G6;PIGB;CSF1R;GPLD1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.24934625075307498,0.7221092298316438,0.8558139534883721,1.0,1.0,3/18,12.14%,BLK;C3AR1;GPLD1
prerank,cellular response to fatty acid (GO:0071398),-0.29248820800421194,-0.7214406214136578,0.8324125230202578,0.9601552472826352,1.0,6/12,32.39%,IRS1;LPL;DGAT2;PID1;PDK4;PDK3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.30474967789288443,-0.7214050604760941,0.8214285714285714,0.9598001871007882,1.0,2/11,9.30%,SCARB1;MFSD2A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2619074401181982,-0.7211856342682305,0.8535714285714285,0.9596485205093087,1.0,10/18,40.42%,AKT1;NONO;MAPK7;NFE2L2;BAG5;VNN1;PARK7;HIF1A;TRAP1;SIRT1
prerank,meiosis I (GO:0007127),-0.24330035489399704,-0.7206823854833354,0.8717504332755632,0.9598009930265201,1.0,9/23,32.33%,ZSCAN21;FOXJ3;BCL2L11;HSF2BP;TDRD9;DDX4;MYBL1;FOXJ2;MEIOB
prerank,negative regulation of centrosome duplication (GO:0010826),-0.30075912898044,-0.7206449258211328,0.8380782918149466,0.959453239304787,1.0,1/11,3.07%,KAT2B
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.24914779743924764,-0.7205343039618067,0.8641114982578397,0.9591813220141157,1.0,9/20,35.33%,NKTR;PPIG;FKBP5;PPIF;PPIH;CWC27;PPIE;PPIC;FKBP1B
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.20897050600918826,0.720215273341717,0.9094922737306843,1.0,1.0,12/40,24.40%,DDX11;CENPS;DONSON;TRAIP;ATR;ETAA1;PCNA;GEN1;CDK9;FBH1;RTEL1;TIPIN
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3019268459225284,-0.719942323968221,0.8410351201478743,0.959451222042903,1.0,5/10,44.42%,PDCD4;AIDA;DUSP19;HIPK3;GSTP1
prerank,renal water homeostasis (GO:0003091),0.23859462981042856,0.7193371721714925,0.8650442477876106,1.0,1.0,5/23,14.39%,ADCY8;AQP4;ADCY7;PRKAR1B;ADCY3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.271733099358245,-0.7192346306970211,0.8590831918505942,0.9598300059082391,1.0,4/15,16.34%,RAB3GAP1;SRPRA;RAB3GAP2;SRP14
prerank,dermatan sulfate metabolic process (GO:0030205),-0.2830279910251445,-0.7183192172999372,0.8232044198895028,0.9604483080391871,1.0,3/13,10.57%,DSE;CSPG4;BGN
prerank,histone H4-K16 acetylation (GO:0043984),-0.2551268431813978,-0.7178662726252485,0.8641975308641975,0.9605401537716003,1.0,6/19,23.02%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,regulation of cell cycle phase transition (GO:1901987),0.17859955282792803,0.7177947360089262,0.9761336515513126,1.0,1.0,19/91,17.13%,ANAPC2;PSMC5;ATP2B4;PSMD10;DDB1;PSMD14;NEK10;NEK11;PSMB7;PSMA4;CDC26;PSMD1;TAF1;PSMF1;PSMB8;CDC27;PSMD7;PSMB5;PSMD2
prerank,ncRNA metabolic process (GO:0034660),-0.22053935543186293,-0.7177735872356945,0.9089285714285714,0.9602611166711461,1.0,6/37,14.23%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2
prerank,nuclear transport (GO:0051169),-0.2682189721098239,-0.7177423386099994,0.8693284936479129,0.9599028049830225,1.0,2/16,6.96%,RSRC1;NUP98
prerank,protein K11-linked ubiquitination (GO:0070979),-0.23385893238619265,-0.7171546728890741,0.9085923217550275,0.9601382158311395,1.0,15/27,36.48%,UBE2D3;CDC16;UBE2E2;UBE2L3;RNF4;FZR1;ANAPC7;ANAPC11;UBE2H;ANAPC10;ANAPC5;ANAPC13;UBE2A;UBE2T;UBE2C
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.255032124387738,-0.7169566153603117,0.873015873015873,0.9599618122314012,1.0,3/18,6.39%,SARNP;THOC2;IWS1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.22616045531881143,-0.7168756779444456,0.8745583038869258,0.9596674763875652,1.0,11/30,27.87%,DNAJC7;GAK;ERO1A;PTGES3;UGGT1;DNAJB12;HSPA14;HSPA13;HSPA1B;CCT2;SDF2L1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2022514432140335,-0.7166422814500498,0.9180035650623886,0.9595403689096464,1.0,16/50,26.87%,PSMA2;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;NQO1;PSMD4;PSMA7;PSMD5;PSMB10;PSMA3
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.26136580324707137,0.7164714237268243,0.8279816513761468,1.0,1.0,5/16,19.57%,CELF4;SF3B4;DAZAP1;PRDX6;RBMX
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.20636606853767164,-0.7164573763117158,0.9369527145359019,0.9593262963088953,1.0,15/45,31.57%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;GBP5;CCL19;NOD2;CASP1;FZD5;LGALS9;NLRC4;STAT3;TLR6
prerank,DNA geometric change (GO:0032392),-0.23860332192507455,-0.7159863847963641,0.8752293577981651,0.9594332330414835,1.0,8/24,24.95%,MRE11;MCM9;DNA2;ANXA1;WRN;BLM;HMGB1;DHX9
prerank,protein methylation (GO:0006479),-0.21304544769134343,-0.7157089128269883,0.9009009009009009,0.9593491006761771,1.0,8/40,18.02%,NSD1;NSD3;SETD3;EHMT1;GSPT1;FAM98A;N6AMT1;CARM1
prerank,negative regulation of cell division (GO:0051782),-0.29473221011743295,-0.7155441251791786,0.8422018348623853,0.9591261021594331,1.0,3/11,24.40%,TXNIP;BLM;E2F7
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.3010696590459257,0.7153156087898126,0.8278867102396514,1.0,1.0,2/10,12.58%,OXSR1;CCL5
prerank,tRNA 5'-end processing (GO:0099116),0.2610825065929926,0.7151796803922171,0.8410596026490066,1.0,1.0,15/15,73.92%,RPP25L;PRORP;POP7;POP5;RPP21;POP1;HSD17B10;RPP38;RPP25;RPP14;TRMT10C;RPP40;SSB;POP4;RPP30
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.2387390910731863,-0.7149491447675913,0.8785714285714286,0.959387299137438,1.0,2/22,3.85%,SLC7A5;IL15
prerank,regulation of histone methylation (GO:0031060),-0.27638277031642416,-0.7149279998593946,0.8411214953271028,0.9590241005775226,1.0,1/13,1.14%,NSD1
prerank,hexose transmembrane transport (GO:0008645),-0.24828110180193202,-0.7148695569050625,0.8589743589743589,0.9586976851351819,1.0,3/21,13.25%,SLC2A1;PPARD;SLC2A9
prerank,negative regulation of B cell activation (GO:0050869),-0.2507131564661369,-0.7148463958641539,0.8707360861759426,0.9583407082415911,1.0,4/21,14.90%,LYN;ATM;RC3H1;TNFAIP3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.27646852620390533,0.7146013152619862,0.8340909090909091,1.0,1.0,4/12,17.06%,EPHB1;SPTBN4;B4GALT6;HSP90AB1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2776060327906381,-0.7143658326660804,0.84,0.9584610923297401,1.0,4/13,15.65%,ASPH;CASP8;PERP;LGMN
prerank,DNA integrity checkpoint signaling (GO:0031570),0.21103809284103692,0.7142035528893285,0.9163090128755365,1.0,1.0,4/36,5.71%,RHNO1;CDC45;USP28;DONSON
prerank,triglyceride homeostasis (GO:0070328),-0.23613612482450602,-0.7139107635556579,0.8658318425760286,0.9585675196437442,1.0,15/26,48.35%,SCARB1;LPL;C1QTNF3;DGAT2;PNPLA8;RORA;IL18;SIRT1;APOC4;PLA2G12B;NR1H3;HNF4A;ACSM2A;ANGPTL8;APOA1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.2792899647712246,0.7137718590981759,0.8389423076923077,1.0,1.0,4/12,18.93%,DOCK10;GPR183;FCGR2B;POU2AF1
prerank,cellular response to pH (GO:0071467),0.2534096447290287,0.7137002345606742,0.871331828442438,1.0,1.0,4/17,15.20%,IMPACT;GPLD1;ASIC1;GPR68
prerank,regulation of mitochondrial translation (GO:0070129),-0.24667724776554587,-0.7135321392269827,0.8576576576576577,0.9585681583596767,1.0,10/21,40.76%,RPUSD4;MRPS27;MPV17L2;UQCC2;MTG2;TSFM;ALKBH1;NSUN3;RCC1L;TRMT10C
prerank,iron-sulfur cluster assembly (GO:0016226),0.22670354221346561,0.7135274328680765,0.8799126637554585,1.0,1.0,9/24,23.76%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;CIAPIN1;LYRM4
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2933606745067684,-0.7134801003546939,0.8298611111111112,0.9582405311699119,1.0,4/11,18.37%,UQCR11;UQCRFS1;UQCRC1;UQCC3
prerank,spliceosomal complex assembly (GO:0000245),0.20032904620513486,0.7134676559289624,0.9343891402714932,1.0,1.0,8/46,13.59%,CELF5;CELF4;CELF2;CELF6;SRPK1;DDX1;SNRPD1;SNRPD2
prerank,establishment of mitotic spindle localization (GO:0040001),-0.23103312361481018,-0.7132436830346661,0.8858695652173914,0.9580921026962741,1.0,6/28,22.31%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2852331370030654,0.7113169379608356,0.8367816091954023,1.0,1.0,1/11,5.45%,GNAT3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.22735346813571083,-0.7112504015612418,0.8954128440366973,0.959683226561305,1.0,7/30,19.32%,CAV1;PRKCD;PARP14;SH3BP5L;HYAL2;PPP2CA;PTPRC
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2230074351564001,0.71087953836288,0.865934065934066,1.0,1.0,7/29,18.78%,IL12A;IL12RB1;RASGRP1;CD226;SLAMF6;IL23A;CADM1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2724923946145229,-0.7103299288953084,0.8664192949907236,0.9602300363152977,1.0,1/14,2.75%,THBS1
prerank,lipoprotein localization (GO:0044872),-0.29184761842349716,-0.7094437216733328,0.8252788104089219,0.9607595078710592,1.0,3/11,26.11%,ZDHHC3;PPARG;LRP1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.27172111051385384,0.7088855623779349,0.8608490566037735,1.0,1.0,2/13,11.60%,CHST2;EXTL2
prerank,dendritic cell differentiation (GO:0097028),-0.24228879744732473,-0.7085975031051532,0.8807829181494662,0.961216378514578,1.0,3/22,5.73%,LYN;TGFBR2;GAS6
prerank,response to muramyl dipeptide (GO:0032495),-0.2887206586207316,-0.7077859240732179,0.8576576576576577,0.9616135276398237,1.0,5/12,25.07%,NOD1;ARHGEF2;CHMP5;NOD2;ERBIN
prerank,triglyceride catabolic process (GO:0019433),-0.2521899936083695,-0.7070292558628614,0.8738574040219378,0.9619806926337519,1.0,6/19,40.16%,LPL;PNPLA2;FABP3;LIPH;FABP4;FABP12
prerank,positive regulation of transporter activity (GO:0032411),-0.27866399537419867,-0.7069889301928689,0.8523364485981308,0.9616317860302359,1.0,2/13,7.87%,RXRA;TRPC6
prerank,defense response to Gram-positive bacterium (GO:0050830),0.20261955142022628,0.7064686723833584,0.9424778761061947,1.0,1.0,6/40,11.74%,RNASE6;CHGA;ANG;IL12A;MBL2;HMGB2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.27752911928703805,0.7062111358685444,0.8533333333333334,1.0,1.0,2/13,8.43%,CD177;MAPT
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.24369969380355877,-0.7054242962763297,0.8882882882882883,0.9627754673974844,1.0,5/22,18.21%,RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.28385604384784946,0.7029373859481676,0.8609406952965235,1.0,1.0,4/10,21.75%,TSKU;WHRN;PLS1;PDZD7
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.25113185285202866,-0.7027804324904664,0.8793418647166362,0.9649532341626075,1.0,5/18,17.16%,LDLRAP1;PSEN2;ADAM10;PSEN1;APH1A
prerank,negative regulation by host of viral transcription (GO:0043922),-0.27865794792306586,-0.7018136923517068,0.8421052631578947,0.9654956708322932,1.0,3/12,17.32%,HDAC1;JUN;TFAP4
prerank,membrane lipid metabolic process (GO:0006643),-0.23373870050209483,-0.7001719679839604,0.8724584103512015,0.9667124890479937,1.0,10/22,32.41%,ST3GAL6;B4GALT4;AGK;SPTLC1;SERINC1;TEX2;CYP1B1;CERKL;MGST2;ALOXE3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.21482867038223444,0.6991343317948859,0.9299363057324841,1.0,1.0,4/31,13.29%,BLK;VTCN1;SDC4;CD86
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2516373773373831,0.6983103465029453,0.8853932584269663,1.0,1.0,4/18,16.23%,MPV17L;TMEM14A;FZD9;SLC35F6
prerank,positive regulation of interleukin-13 production (GO:0032736),0.28505932011047563,0.6982326634483879,0.8494117647058823,1.0,1.0,2/10,10.14%,SPHK2;PRKCZ
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.2934080577566083,-0.6966874088711525,0.8681898066783831,0.9696004110400444,1.0,1/10,5.52%,ELOVL5
prerank,regulation of B cell differentiation (GO:0045577),-0.25665889776751855,-0.6960130910382142,0.8653500897666068,0.9698572644092922,1.0,5/17,36.91%,PPP2R3C;ZFP36L1;IKZF3;MMP14;SYK
prerank,glutathione metabolic process (GO:0006749),0.20394199275924466,0.6955356673532488,0.9251101321585903,1.0,1.0,4/38,8.05%,NAT8;GGCT;GLRX2;DPEP1
prerank,tRNA 5'-leader removal (GO:0001682),0.26104972375690605,0.6937969605206239,0.8634453781512605,1.0,1.0,13/13,73.92%,RPP25L;PRORP;POP7;POP5;RPP21;POP1;RPP38;RPP25;RPP14;RPP40;SSB;POP4;RPP30
prerank,homocysteine metabolic process (GO:0050667),-0.2810444275859715,-0.6937191504369234,0.8571428571428571,0.9716291521539692,1.0,7/11,41.17%,NOX4;CTH;MTRR;MPST;BLMH;CBS;TST
prerank,mRNA polyadenylation (GO:0006378),-0.2255883334145763,-0.6935091228382343,0.9025270758122743,0.9710555340303222,1.0,8/26,27.32%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,RNA polyadenylation (GO:0043631),-0.2255883334145763,-0.6935091228382343,0.9025270758122743,0.9710555340303222,1.0,8/26,27.32%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,regulation of lamellipodium organization (GO:1902743),0.26002928158673116,0.6932590208388542,0.8656387665198237,1.0,1.0,2/14,7.86%,PDPN;CARMIL1
prerank,calcium import into the mitochondrion (GO:0036444),0.2803938648477895,0.6927845150211452,0.8552915766738661,1.0,1.0,1/10,1.91%,SLC25A23
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.19940708513275426,0.6927305520767325,0.9223529411764706,1.0,1.0,5/42,10.09%,SYCP1;WRNIP1;POLD4;PCLAF;POLA1
prerank,hexose metabolic process (GO:0019318),-0.20282345998316464,-0.6923855648788189,0.9352380952380952,0.9716928074350105,1.0,12/39,26.52%,CHST15;HECTD4;PPARD;GALK2;ALDOC;GALK1;BRAT1;FPGT;FUOM;GALM;PMM2;SLC37A4
prerank,regulation of coagulation (GO:0050818),-0.28368304647606635,-0.6922073822194469,0.8486486486486486,0.9714616856003013,1.0,1/11,1.62%,CAV1
prerank,regulation of biosynthetic process (GO:0009889),0.2780916509730068,0.6922034796823814,0.8556034482758621,1.0,1.0,11/11,72.21%,SPHK2;ALOX5;SNCA;PCK1;UCP1;PIKFYVE;CCN6;GSTP1;THRSP;MID1IP1;SLC25A33
prerank,sphingolipid catabolic process (GO:0030149),0.2560330448461139,0.6917746018616057,0.8586956521739131,1.0,1.0,3/15,8.23%,ENPP2;SPHK1;ACER1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.28312971091794104,-0.6917531058233906,0.8625,0.971469894175789,1.0,4/11,25.72%,NOVA2;RASA1;PCBP1;IGF2BP2
prerank,development of primary male sexual characteristics (GO:0046546),-0.2075814480650897,-0.6916581828914071,0.9306569343065694,0.9711871665800188,1.0,9/34,25.39%,KITLG;TGFB2;MAMLD1;NCOA4;SIX4;LHFPL2;COL9A3;BIK;WNT2B
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.23959827120155372,-0.6908844200080211,0.9023090586145648,0.9715005273208744,1.0,7/21,31.26%,TTC23;SMO;KIF7;TUBD1;TEDC2;ARMC9;SHH
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.26700269440583735,0.6896816843124977,0.8454545454545455,1.0,1.0,2/11,9.47%,ITM2C;ABCA2
prerank,carbohydrate catabolic process (GO:0016052),0.2076748406565143,0.6890051361914333,0.9376443418013857,1.0,1.0,4/38,10.95%,GCK;TPI1;PKM;ENO2
prerank,ketone body metabolic process (GO:1902224),-0.2908802545061199,-0.6885928861452363,0.8646209386281588,0.9731370243685571,1.0,4/10,24.62%,BDH2;HMGCS2;OXCT1;ACSS3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.24950120944374599,0.6883277706666353,0.8681818181818182,1.0,1.0,5/16,23.17%,DCPS;PSIP1;SNRPC;NCBP2;WBP11
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.26407452768791917,-0.6878675216572251,0.8843416370106761,0.9734219260269947,1.0,2/16,6.99%,CAV1;PARP14
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.24966727707226044,-0.6871489882147124,0.8899082568807339,0.9736542965388348,1.0,16/18,49.09%,BNIP3;THEM4;PPIF;ALKBH7;PMAIP1;NAIF1;SPG7;SLC25A5;HEBP2;SLC25A31;BAK1;MUL1;BCL2L1;BAD;TMEM102;CAMK2A
prerank,myeloid dendritic cell activation (GO:0001773),0.2645403410409572,0.6869782086298327,0.8790496760259179,1.0,1.0,2/12,11.00%,CAMK4;BATF
prerank,mRNA modification (GO:0016556),-0.23612365355502668,-0.6868722668279845,0.891588785046729,0.9735083156881319,1.0,13/22,44.39%,CBLL1;METTL14;WTAP;TRUB1;METTL16;RPUSD2;TRMT61A;PCIF1;PUS7;TRMT10C;VIRMA;DKC1;NSUN2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.18309884960644152,-0.6865100992950279,0.966131907308378,0.9734096395762576,1.0,23/68,32.20%,MNAT1;ERCC2;CPSF7;TAF1B;MAZ;LSM11;TAF1C;SNRPE;ERCC3;CAVIN1;LSM10;FIP1L1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH;POLR3K;MTERF2;POLR1H;SMN1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2433169331124642,-0.6859075477067006,0.8894927536231884,0.9735803662389565,1.0,7/19,32.19%,DDIT4;TP53;HIPK1;PHLDA3;TMEM109;CDIP1;RPS27L
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.2670700453803311,-0.6858503180221577,0.8792792792792793,0.9732363517791891,1.0,4/14,21.18%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2570544009208981,0.6858177139708487,0.8558139534883721,1.0,1.0,3/13,14.64%,ISCA2;CISD3;NFU1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.26283800899481735,-0.685769206094003,0.8752260397830018,0.9729220051135568,1.0,4/14,18.14%,MSN;EZR;RHOA;RAP2A
prerank,glycerol metabolic process (GO:0006071),0.28448337265233803,0.6857561230244424,0.8418708240534521,1.0,1.0,4/10,21.15%,TPI1;GK;PGP;ANGPTL3
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.20440675388242097,-0.6855240830265047,0.9372693726937269,0.9727512753163325,1.0,4/37,11.81%,ENTPD1;ENTPD6;RNASE3;XRN2
prerank,cellular response to interleukin-2 (GO:0071352),-0.28167644494830163,-0.6844859128713562,0.8745519713261649,0.9728976884263799,1.0,4/11,29.51%,JAK1;PTK2B;IL2RA;IL2RG
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.28167644494830163,-0.6844859128713562,0.8745519713261649,0.9728976884263799,1.0,4/11,29.51%,JAK1;PTK2B;IL2RA;IL2RG
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2407110883917975,-0.6831710546281711,0.8975694444444444,0.9736404914157057,1.0,7/19,28.27%,CENPJ;TCP1;CHP1;CCT5;CEP295;CCT2;TREM2
prerank,cellular response to misfolded protein (GO:0071218),-0.2398518175455883,-0.6829253947850312,0.9053571428571429,0.9734667127480324,1.0,11/20,43.32%,CUL3;ATXN3;UGGT1;DNAJB12;KLHL15;RNF185;VCP;RNF5;POMT2;RNF126;DNAJB14
prerank,ceramide catabolic process (GO:0046514),-0.26415241578451465,-0.6828880304967356,0.8764044943820225,0.9731070136176152,1.0,5/14,27.88%,ACER2;ACER3;ASAH1;GLA;HEXA
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.19040054843173482,-0.6826388413103658,0.9682242990654205,0.9729452081843482,1.0,11/52,21.81%,DGLUCY;SLC25A32;OGDH;IDH1;MTHFD1;ALDH18A1;HOGA1;MTHFD1L;ALDH1L1;GCLC;MTRR
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.2575470100624844,0.6813506201209201,0.8989010989010989,1.0,1.0,1/14,4.83%,ATP1B1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.2619250074444274,0.6808469788240855,0.8810068649885584,1.0,1.0,3/14,14.71%,OXSR1;CCL5;CCL7
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2584548625538076,-0.6806122661068087,0.8809946714031972,0.9742541463452904,1.0,4/15,17.56%,SAMHD1;STAT2;USP18;NLRC5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.17525613480850633,-0.6799346388266251,0.9789103690685413,0.974465709161693,1.0,30/84,33.27%,RB1;PSMA2;CUL3;PSME2;PSMB4;CDC16;ANAPC16;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;BUB1B;ECRG4;PSMD4;BUB3;PSMA7;FZR1;PSMD5;ANAPC7;PSMB10;PSMA3;FBXO31;ANAPC11;ANAPC10;ANAPC5;PSMD13;PLK1;PSMB6;AURKA
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2721366277242119,-0.6793575930386889,0.8791208791208791,0.9745589830224768,1.0,2/12,9.84%,PPARA;AKT1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19266770343262826,0.6792364529749857,0.9409282700421941,1.0,1.0,11/42,22.67%,OXSR1;PF4;CCL13;CCL5;THPO;CCL2;CCL7;CX3CL1;CCL14;CIB1;STK39
prerank,activin receptor signaling pathway (GO:0032924),-0.2557003554085395,-0.6789094720636967,0.903169014084507,0.9745608517735395,1.0,7/15,40.22%,SMAD2;ACVR2A;ACVR2B;TGFBR1;SMAD3;INHBB;ACVR1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2669375312712377,0.6787448313291977,0.8779443254817987,1.0,1.0,6/13,27.39%,PCID2;CDK5RAP2;ANAPC15;GEN1;MAD2L1;NDC80
prerank,autophagosome maturation (GO:0097352),-0.20998089569019374,-0.6780442885638835,0.9393382352941176,0.9748830086959717,1.0,4/32,10.83%,LIX1L;MAP1LC3B;TECPR1;GABARAP
prerank,negative regulation of inclusion body assembly (GO:0090084),0.280674921618243,0.6776288982935522,0.8835164835164835,1.0,1.0,4/10,20.35%,SORL1;DNAJB2;DNAJB1;DNAJA4
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.24548765198383565,-0.677147761653367,0.8994413407821229,0.9752069276230227,1.0,9/16,38.66%,ATM;TERF2;SMG6;PINX1;NAF1;TNKS2;TNKS;SLX4;ERCC4
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.2602327119199265,0.6771397720720682,0.8789954337899544,1.0,1.0,2/13,9.92%,CD177;SPHK2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.22952177015545153,0.6767652273680909,0.9168591224018475,1.0,1.0,3/23,7.88%,OTC;SLC9A7;SLC12A5
prerank,P-body assembly (GO:0033962),-0.2666990970031299,-0.675662840874848,0.8822463768115942,0.9760623046003037,1.0,4/12,21.53%,LIMD1;RC3H1;EDC3;LSM3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2905594149098405,-0.6749852309419069,0.8568904593639576,0.9762388971957617,1.0,2/10,6.46%,GSK3B;CEP250
prerank,regulation of histone modification (GO:0031056),-0.2624288072687127,-0.6745654567551009,0.8845437616387337,0.9761862139771387,1.0,4/13,22.61%,SETD5;HPF1;IGF2;MYOCD
prerank,receptor recycling (GO:0001881),0.27804646845002284,0.6736094318281746,0.8478260869565217,1.0,1.0,3/10,18.61%,SORL1;PHETA1;NSG1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.23898060222780776,-0.6733879385075549,0.8980322003577818,0.9767608056478686,1.0,2/19,5.58%,CD200;TNFRSF1B
prerank,positive regulation of telomere capping (GO:1904355),-0.24627048843260854,-0.6732498914358376,0.8954954954954955,0.9764961113329125,1.0,3/17,13.71%,NEK7;MAPK1;PNKP
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2661287485577447,-0.6731323750210043,0.878095238095238,0.9762039608306389,1.0,6/12,33.46%,RNF168;NELFB;HNRNPU;LARP7;NELFA;NELFCD
prerank,positive regulation of macrophage differentiation (GO:0045651),0.2662293705794608,0.6708707455611512,0.8881278538812786,1.0,1.0,2/11,7.80%,HSF1;PF4
prerank,regulation of protein processing (GO:0070613),0.22762930782030538,0.6708483688140869,0.9191011235955057,1.0,1.0,2/21,3.86%,TMEM59;CLN3
prerank,protein palmitoylation (GO:0018345),0.20466699212607892,0.6700304945901351,0.9354838709677419,1.0,1.0,6/30,15.71%,SELENOK;ZDHHC8;ZDHHC13;ZDHHC20;ZDHHC24;ZDHHC7
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2041530138311599,-0.6700054649437072,0.9282051282051282,0.9782098458880092,1.0,6/33,18.02%,CBFB;ESR1;UFM1;H3-3A;HDAC6;CARM1
prerank,mitotic DNA replication (GO:1902969),-0.27838877277428503,-0.6698176709161289,0.8987108655616943,0.9779785678666134,1.0,5/10,24.65%,MCM4;GINS3;GINS1;MCM3;LIG1
prerank,microtubule depolymerization (GO:0007019),0.23693795528761602,0.6696033595711891,0.9217758985200846,1.0,1.0,17/17,76.33%,STMN2;STMN4;STMN3;NCKAP5;KIF18A;KIF2A;KIF24;STMND1;KATNB1;KIF2C;CKAP5;KIF19;NCKAP5L;STMN1;CCSAP;KIF14;KIF18B
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.2881653899595191,-0.6684673830545578,0.8956692913385826,0.9786266822205487,1.0,4/10,30.86%,CEACAM1;PTPRC;LGALS9;LILRB1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.24278626892281235,-0.6682552504716814,0.8927911275415896,0.9784059685722214,1.0,7/17,29.89%,FGF1;PRKAA1;ERLIN2;SOD1;LPCAT3;RAN;MBTPS1
prerank,ovarian follicle development (GO:0001541),0.25608334800943144,0.6678841413445452,0.8752783964365256,1.0,1.0,3/13,13.54%,ANG;VEGFA;KIT
prerank,lipid catabolic process (GO:0016042),-0.2409333144387728,-0.6669364543196816,0.8968531468531469,0.9790082234148401,1.0,3/18,14.81%,ACADL;LPL;LIPE
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.2839071059274215,-0.6666184671209311,0.8866906474820144,0.9784666938456481,1.0,2/10,7.77%,FTO;ASCC1
prerank,DNA dealkylation (GO:0035510),-0.2839071059274215,-0.6666184671209311,0.8866906474820144,0.9784666938456481,1.0,2/10,7.77%,FTO;ASCC1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2386900501011477,0.6657063130756408,0.9158878504672897,1.0,1.0,2/16,11.48%,CENPS;MUS81
prerank,stabilization of membrane potential (GO:0030322),0.24060498156162372,0.6650767268805128,0.8870588235294118,1.0,1.0,5/16,23.51%,KCNK12;KCNK10;KCNK9;KCNK4;KCNN4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.17098669376035058,-0.664082906723066,0.9802513464991023,0.9800013531536963,1.0,27/87,28.33%,COX16;COX18;SAMM50;NDUFV3;ACAD9;SCO1;NDUFB2;NDUFB11;UQCRFS1;COX17;DMAC2;NDUFS2;UQCC3;NDUFA7;NDUFV1;UQCC2;COA8;TMEM126B;NDUFC2;NDUFV2;NDUFAF1;NDUFB3;IMMP2L;SDHAF4;NDUFB4;SLC25A33;NDUFS5
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.1957174300706463,-0.6630905937067432,0.9566003616636528,0.9803098221736574,1.0,18/40,36.42%,LRRK2;ABL1;ARL6IP5;AKT1;SOD1;STOML2;RNF122;SLC25A33;PID1;STOX1;PYCR1;PMAIP1;PIP5KL1;HEBP2;PARK7;VCP;AKT2;ATP5IF1
prerank,vitamin D metabolic process (GO:0042359),0.2590483221330854,0.6627382474041813,0.8941441441441441,1.0,1.0,3/13,16.35%,CYP24A1;GC;CYP1A1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.2711933160342794,-0.6626681366320086,0.8971119133574007,0.9802342644575733,1.0,1/10,5.37%,GFPT2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.2154914110923209,-0.6621711619056072,0.9259927797833934,0.9802253761042801,1.0,8/25,30.69%,SLC7A5;CD55;PLCG2;NOD2;FZD5;MAP3K7;TRIM6;TNFRSF14
prerank,dendritic cell chemotaxis (GO:0002407),0.24656969257064337,0.6614186053478613,0.8938679245283019,1.0,1.0,6/14,25.09%,CCR6;CCL5;GPR183;CXCR4;TRPM2;CCR5
prerank,protein homotrimerization (GO:0070207),-0.2516001786427459,-0.6612566038291998,0.8843416370106761,0.9801350573950677,1.0,7/14,31.67%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;STEAP4;ALOX5AP
prerank,protein trimerization (GO:0070206),-0.2516001786427459,-0.6612566038291998,0.8843416370106761,0.9801350573950677,1.0,7/14,31.67%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;STEAP4;ALOX5AP
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2177092501057828,-0.6611144714379564,0.9218472468916519,0.9798475860273185,1.0,9/25,27.87%,DNAJC7;GAK;ERO1A;PTGES3;DNAJB12;HSPA14;HSPA13;HSPA1B;SDF2L1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.21241962981902018,-0.6609660533656152,0.930841121495327,0.9795708409992736,1.0,3/26,10.77%,APP;CBL;NCK2
prerank,negative regulation of protein secretion (GO:0050709),-0.2016452222058106,-0.6606318875185003,0.9562841530054644,0.9794152755531058,1.0,15/38,32.22%,CD200;IRS1;RAB11FIP3;RHBDF2;DPH3;CCN3;RAB11FIP1;RAB11FIP5;SERGEF;F2R;HMGCR;MIDN;RSAD2;RHBDF1;KCNB1
prerank,B cell mediated immunity (GO:0019724),0.27305253907475996,0.660078002668643,0.8972162740899358,1.0,1.0,10/10,72.71%,MSH2;FCGR2B;CD70;CD27;CD19;SLA2;CARD9;TLR8;CD74;FCER1G
prerank,microtubule bundle formation (GO:0001578),0.18949369826372253,0.658475060605846,0.9608695652173913,1.0,1.0,10/42,18.60%,CFAP74;MAP1S;DCX;TPPP3;TPPP;FOXJ1;GAS8;NUMA1;AAAS;CDK5RAP2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.27054259128047137,-0.6576658364158404,0.8975265017667845,0.9803786868590667,1.0,1/11,3.56%,PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),-0.27054259128047137,-0.6576658364158404,0.8975265017667845,0.9803786868590667,1.0,1/11,3.56%,PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.27054259128047137,-0.6576658364158404,0.8975265017667845,0.9803786868590667,1.0,1/11,3.56%,PANK2
prerank,positive regulation of histone methylation (GO:0031062),-0.2173054608572192,-0.6574165465283882,0.9343339587242027,0.9801736415434902,1.0,8/24,30.94%,SMAD4;DNMT1;CTNNB1;BRCA1;OGT;WDR5;PHF19;DNMT3B
prerank,positive regulation of cellular respiration (GO:1901857),-0.27251675968157696,-0.6568850171922863,0.8968531468531469,0.9801847663911771,1.0,6/11,40.15%,IFNAR1;IL10RB;IFNLR1;PARK7;VCP;IL4
prerank,RNA interference (GO:0016246),-0.2410948492397395,-0.6559282668639789,0.9355992844364938,0.980421781232843,1.0,9/17,34.66%,CELF1;DICER1;AGO2;DROSHA;TERT;DHX9;TSN;TARBP2;MRPL44
prerank,signal peptide processing (GO:0006465),-0.2648126495523532,-0.6557187951015275,0.8791208791208791,0.9801810691534308,1.0,4/11,25.86%,SPPL3;PCSK5;CLN5;SEC11A
prerank,regulation of ERAD pathway (GO:1904292),0.26323663785426066,0.6556278009275833,0.9002217294900222,1.0,1.0,2/11,7.01%,TMEM259;USP25
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.22474551240002244,-0.6554321360717897,0.9166666666666666,0.9799973494517616,1.0,6/23,25.78%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.22246022390054943,-0.6550760679087068,0.9253996447602132,0.9794799765622894,1.0,2/22,4.27%,ZDHHC6;ZDHHC3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.22246022390054943,-0.6550760679087068,0.9253996447602132,0.9794799765622894,1.0,2/22,4.27%,ZDHHC6;ZDHHC3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2525989196251338,-0.6550201570987487,0.8892921960072595,0.979138477228065,1.0,5/14,20.71%,RTRAF;TSEN15;TSEN34;TRPT1;RTCB
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2244544679638847,-0.6539985624415761,0.927536231884058,0.9794534537644252,1.0,2/24,4.87%,PLA2G4A;LPCAT1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.2825338172282378,-0.65369369744831,0.9163636363636364,0.979290765870493,1.0,7/10,37.00%,LRRK2;TXN;NFE2L2;RIPK1;PYCR1;PARK7;PDE8A
prerank,regulation of macrophage differentiation (GO:0045649),0.23240288405026208,0.6534214049301927,0.9211136890951276,1.0,1.0,2/15,7.80%,HSF1;PF4
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23842906263889063,0.6528030693325831,0.9183673469387755,1.0,1.0,4/15,17.75%,NEK11;MUS81;RAD9B;CHEK2
prerank,response to light stimulus (GO:0009416),-0.18188081040347523,-0.6522998972272196,0.9689119170984456,0.9798813375423281,1.0,21/55,34.18%,MAP4K3;UBE4B;ERCC2;REV1;MAPK8;ERCC3;ERCC8;USP1;ERCC6;DTL;CRY2;GPR52;TYR;TRIM32;USF1;FECH;UBE2A;RRH;AANAT;OPN1MW;OPN1MW3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.23417165820612026,-0.6512518782853689,0.931740614334471,0.9802130486523155,1.0,12/18,43.00%,MECP2;RAB11A;CCND1;CDC25A;BRD4;DTL;STOX1;CDK4;FBXO5;CCNB1;CDC25C;RAD51C
prerank,regulation of mRNA metabolic process (GO:1903311),-0.2681720922385,-0.6512454537758718,0.9029982363315696,0.979832687245612,1.0,5/11,27.71%,IWS1;SRPK2;CDK11B;DHX9;SLTM
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2741395362832337,-0.651011898005139,0.9067961165048544,0.9796249202562288,1.0,1/10,5.38%,NFKB1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.22806027254019587,-0.6502736182029213,0.9250936329588015,0.9797483759826531,1.0,7/19,29.63%,SLC25A32;MTHFD1;MTHFD1L;ALDH1L1;MTRR;GGH;SHMT1
prerank,male gonad development (GO:0008584),-0.1952142540631245,-0.6493632505811181,0.9521178637200737,0.9799481427574398,1.0,4/34,11.06%,KITLG;TGFB2;MAMLD1;NCOA4
prerank,protein depolymerization (GO:0051261),-0.20925645347981836,-0.6484547908133128,0.92573402417962,0.980130891588423,1.0,14/27,40.52%,MICAL2;CFL2;CFL1;DSTN;KIF18B;KIF14;MICAL1;STMN1;NCKAP5L;CKAP5;TWF2;KIF2C;VIL1;KATNB1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.25421338517359193,0.6472322679695602,0.8937093275488069,1.0,1.0,3/12,17.75%,NAE1;ORC1;CHEK2
prerank,nucleosome assembly (GO:0006334),-0.20212866993403686,-0.6449627687186001,0.9689320388349515,0.9819544782770875,1.0,4/31,14.82%,KAT6B;BRD2;SPTY2D1;H3-3A
prerank,pancreas development (GO:0031016),0.2495263746147452,0.6442199852663264,0.9202733485193622,1.0,1.0,2/12,8.26%,PROX1;DNAAF1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.23508924622099336,0.6441558133420467,0.9287356321839081,1.0,1.0,3/15,15.09%,DHX33;USP50;EIF2AK2
prerank,folic acid metabolic process (GO:0046655),0.22871318223855797,0.6441400884710602,0.9410480349344978,1.0,1.0,3/18,9.28%,SLC46A1;SLC19A1;ALDH1L2
prerank,T cell activation involved in immune response (GO:0002286),-0.2577557269229045,-0.6434268466809211,0.9233511586452763,0.9825273113316567,1.0,7/12,37.42%,ICAM1;LCP1;EIF2AK4;FCER1G;LILRB1;CD74;MDK
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2618206092508035,-0.6428521586940606,0.9080882352941176,0.9824814661398522,1.0,4/11,34.54%,LRP6;CTNNB1;FZD1;NR4A2
prerank,regulation of T cell chemotaxis (GO:0010819),0.2628339145034384,0.6425166311607385,0.907725321888412,1.0,1.0,2/11,12.58%,OXSR1;CCL5
prerank,retinal metabolic process (GO:0042574),0.25059952044784767,0.6416964210154303,0.9114470842332614,1.0,1.0,1/12,2.73%,AKR1C1
prerank,stress granule assembly (GO:0034063),0.216162393607144,0.6414737950441605,0.9331683168316832,1.0,1.0,2/20,8.43%,BICD1;MAPT
prerank,regulation of cellular metabolic process (GO:0031323),-0.18829785273290117,-0.640740934982877,0.9752212389380531,0.9833898814233675,1.0,19/45,37.78%,PANK2;PPARA;ACACB;FLOT1;AGPAT1;MKLN1;KIF16B;CYP1B1;VPS35;RNF34;PID1;PDK4;PDK3;FASN;TBC1D16;PM20D2;PARL;FOXM1;GNB3
prerank,gonad development (GO:0008406),0.18424177401211936,0.6400678450718751,0.9869281045751634,1.0,1.0,11/41,20.75%,ADAM29;WT1;GATA6;KIT;WNT4;MKKS;MSH2;SOX9;NUP107;ADAM21;IRX5
prerank,regulation of histone deacetylation (GO:0031063),0.25003844883034243,0.6369401589693657,0.9155844155844156,1.0,1.0,2/13,9.92%,PRMT6;SPHK2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.23591052386868303,-0.6337036517726806,0.9239332096474954,0.9872041992322482,1.0,3/16,16.00%,SHLD1;CGAS;MAD2L2
prerank,phospholipid homeostasis (GO:0055091),0.2502861888360909,0.6334657253724955,0.9104803493449781,1.0,1.0,4/11,22.90%,RCN3;TLCD2;ANGPTL3;ABCG1
prerank,regulation of neurogenesis (GO:0050767),-0.17522193176444772,-0.6328683996682221,0.979890310786106,0.9873154241357569,1.0,11/55,20.39%,HES1;SPEN;TGM2;YAP1;NOTCH1;NUMB;CTNNB1;HEY1;HEY2;PCM1;LIG4
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20992794749433133,0.6326885158102383,0.9415730337078652,1.0,1.0,8/22,23.71%,VPS37D;TSG101;UBAP1;MVB12B;VPS4B;UBAP1L;PTPN23;VPS28
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.2699210180923922,-0.6320571437810986,0.9215686274509803,0.9866102104138099,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,t-circle formation (GO:0090656),-0.2699210180923922,-0.6320571437810986,0.9215686274509803,0.9866102104138099,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.2699210180923922,-0.6320571437810986,0.9215686274509803,0.9866102104138099,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,reticulophagy (GO:0061709),-0.2545582705657879,-0.6320186410464349,0.8990990990990991,0.9862496890842363,1.0,4/12,26.64%,UFM1;ULK2;ATG2A;ATG2B
prerank,epithelial cell development (GO:0002064),0.21721717316991823,0.6313909812907067,0.9403341288782816,1.0,1.0,1/20,1.29%,WNT7B
prerank,cellular response to sterol (GO:0036315),-0.24645064883679996,-0.6310076635369302,0.9306049822064056,0.9864450218055133,1.0,3/13,12.41%,SMO;LRP6;INSIG2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.24084713579319636,-0.6308991535426959,0.9113475177304965,0.9861263104354091,1.0,1/13,1.34%,NOS3
prerank,positive regulation of immune response (GO:0050778),-0.17037594924847285,-0.6307370686864129,0.9858657243816255,0.9858295580751827,1.0,17/64,29.06%,IL15;IL6ST;NMI;TGFB2;AKIRIN2;PLSCR1;POLR3F;IFI35;GBP5;NOD2;PTPRC;ITGAM;DHX9;EIF2AK4;LGALS9;RIOK3;RSAD2
prerank,pyruvate metabolic process (GO:0006090),-0.1767302520918111,-0.6303783136767797,0.9782214156079855,0.9856381020621402,1.0,6/52,12.06%,BSG;SRR;DLD;SLC16A1;ALDOC;PDHB
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.2614341068614421,-0.6299112514197258,0.891941391941392,0.9855197700175747,1.0,9/11,51.44%,TP53;PTGIS;FAP;DLC1;CIDEA;DFFA;BCL2L1;SIRT2;ZC3H12A
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.25043502784193034,-0.6294779345830865,0.924908424908425,0.9853689987290638,1.0,3/13,15.49%,RIC3;STX3;ABCA7
prerank,snRNA metabolic process (GO:0016073),-0.23337983585109534,-0.629388021543627,0.9283018867924528,0.9850321036072403,1.0,6/17,29.96%,INTS8;INTS3;INTS9;INTS7;INTS5;INTS12
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.21883699333306428,-0.6289258349361536,0.9353680430879713,0.9848978899483452,1.0,3/20,16.38%,RB1;FOXC1;IGF1
prerank,regulation of transport (GO:0051049),-0.1914790946192053,-0.6286344529458802,0.9571183533447685,0.9846815626775253,1.0,6/36,16.66%,LRRK2;SCFD1;ARL6IP5;ACTB;ICA1;RAB11A
prerank,necroptotic process (GO:0070266),-0.23465550794534462,-0.6279560976972984,0.9272030651340997,0.9846573326465006,1.0,12/16,49.59%,TRPM7;RIPK1;IPMK;TICAM1;CD14;MLKL;TLR4;TICAM2;TLR3;ITPK1;RIPK3;LY96
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.22662742809623027,-0.6279064593493607,0.9274047186932849,0.9843123770851336,1.0,9/17,40.88%,SLC7A5;RARA;LGALS9;FCER1G;CEBPB;NLRP3;SYK;GATA3;CD28
prerank,alpha-amino acid catabolic process (GO:1901606),0.19670060876933637,0.62786881270249,0.9680851063829787,1.0,1.0,8/29,23.60%,OTC;HAAO;TDO2;SARDH;DDO;ACAT1;GSTZ1;ALDH4A1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.20636709481482324,0.6273904240933004,0.9437229437229437,1.0,1.0,6/23,16.96%,LMAN1;SURF4;SELENOS;TMED9;SEL1L;AUP1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.26308821885372036,-0.6270168801450343,0.9341637010676157,0.9844210804261286,1.0,4/10,24.70%,UBA2;HDAC4;PIAS4;SAE1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.2095456379905734,0.626952545374295,0.9438444924406048,1.0,1.0,6/23,18.78%,IL12A;RASGRP1;CD226;SLAMF6;ARRB2;CADM1
prerank,neural tube development (GO:0021915),-0.23727570181272584,-0.6269456151736464,0.9454545454545454,0.9840818890621554,1.0,1/15,1.73%,PKD2
prerank,proteoglycan metabolic process (GO:0006029),-0.20438424747268297,-0.6267453342980275,0.958029197080292,0.9838063458837064,1.0,11/26,35.56%,BMPR2;CSGALNACT1;CHST11;IGF1;HPSE;CSGALNACT2;XYLT1;SULF1;CHST14;CHST13;CNMD
prerank,protein O-linked mannosylation (GO:0035269),-0.22723482675734968,-0.6263184600086785,0.9252669039145908,0.9836346541795811,1.0,2/18,3.65%,TMTC1;TMTC2
prerank,regulation of tissue remodeling (GO:0034103),-0.22539149130391423,-0.6261824062658544,0.9473684210526315,0.9833270899510989,1.0,3/18,12.67%,IL15;FLT4;CEACAM1
prerank,negative regulation of mRNA processing (GO:0050686),-0.2401299989414587,-0.6246678402919957,0.9225225225225225,0.9837378071056136,1.0,4/15,21.18%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,response to sterol (GO:0036314),-0.25352517240118355,-0.624557075380439,0.9180327868852459,0.9834191557437176,1.0,6/11,30.81%,TGFBR2;SMAD2;PMVK;TGFBR1;RORC;TGFB1
prerank,T cell proliferation (GO:0042098),0.2424739131414141,0.6230965523196542,0.9117647058823529,1.0,1.0,4/13,18.78%,TNFSF18;RASGRP1;DOCK8;CADM1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.18624443614897623,-0.621435694175334,0.9838420107719928,0.9846745244111733,1.0,12/39,32.46%,RPS14;RPSA;RPS16;RPS27;UTP4;RPS7;RPS15;RPS17;EMG1;RIOK3;RPS27L;SRFBP1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.23307754560868268,-0.6201272700687219,0.9460370994940978,0.9849915950460731,1.0,4/16,24.84%,SCARB1;MFSD2A;DAGLB;PNPLA2
prerank,cellular response to chemokine (GO:1990869),-0.17905783423278726,-0.6188214949070289,0.9905660377358491,0.9852750986782025,1.0,20/46,41.08%,LRCH1;CCL25;SLC12A2;RHOA;ACKR3;FOXC1;CCL19;CXCL12;PTK2B;CXCL10;DUSP1;WNK1;GPR75;CXCL5;CCL11;CXCL1;CCL4;CCR1;PPBP;CCL8
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.22884147584865838,0.6182043116763319,0.9172259507829977,1.0,1.0,3/14,12.46%,CD81;CARD11;CD226
prerank,negative regulation of viral life cycle (GO:1903901),-0.23463665358347524,-0.618061512845724,0.9458041958041958,0.9852610393916581,1.0,2/15,11.64%,LY6E;IFITM3
prerank,UV-damage excision repair (GO:0070914),0.2385428461604713,0.6172154052940068,0.9101123595505618,1.0,1.0,2/12,10.09%,DDB1;POLA1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.1951163260224245,0.6168154272650798,0.966183574879227,1.0,1.0,12/29,23.85%,TERF1;ANKRD28;WRAP53;PPIA;CDK2;ACD;HSP90AB1;TERF2IP;TELO2;NOP10;SHQ1;RTEL1
prerank,long-chain fatty acid transport (GO:0015909),-0.19400789406114466,-0.616673779291556,0.9760589318600368,0.9855750711416529,1.0,18/30,42.75%,ABCD3;MFSD2A;ACACB;CPT1A;SLC27A4;ACSL1;PPARG;SPX;FABP3;SLC27A6;CPT2;MID1IP1;FABP4;PRKAG2;THRSP;SLC25A20;SLC27A2;ABCD1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.23629250901054769,-0.6155246509256246,0.9229390681003584,0.9857723645948008,1.0,8/14,40.42%,IRS1;AKT1;PTPN2;ARPP19;PMAIP1;AKT2;NNMT;SIRT1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.19005600241497211,0.6153037940741151,0.9789227166276346,1.0,1.0,4/32,9.94%,RNASE6;ANG;PF4;CCL13
prerank,RNA methylation (GO:0001510),0.1672651808591327,0.6144346613525702,0.9954853273137697,1.0,1.0,17/60,23.10%,MTERF4;TRMT6;GTPBP3;TRMT13;TRMT10A;BUD23;ZC3H13;TFB1M;DIMT1;FTSJ1;METTL8;NSUN6;CMTR1;METTL2A;METTL2B;TRMT5;THUMPD3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.22406976810810064,0.6132713321619098,0.9353448275862069,1.0,1.0,14/15,64.25%,SELENOS;SEL1L;AUP1;NPLOC4;DERL2;SYVN1;UFD1;TMEM129;FAF2;DERL1;HSP90B1;SEC61B;VCP;OS9
prerank,regulation of chromosome organization (GO:0033044),-0.2048628388119048,-0.6117491833120475,0.9538745387453874,0.9871604535692674,1.0,9/22,33.69%,RB1;WAPL;TERF2;LIG4;SMG6;HNRNPD;SMG1;HDAC8;PIF1
prerank,triglyceride metabolic process (GO:0006641),0.1696624031772817,0.6075601898442136,0.9882629107981221,1.0,1.0,7/48,16.51%,LPIN1;GK;LIPC;MOGAT1;APOE;APOC1;SEL1L
prerank,monosaccharide transmembrane transport (GO:0015749),0.2197702744765036,0.6073574323112577,0.9295454545454546,1.0,1.0,2/16,9.94%,SLC2A10;SLC2A8
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.24818543460101278,0.6037031341013691,0.9241071428571429,1.0,1.0,5/10,28.05%,VEGFA;FZD3;CX3CL1;CX3CR1;KDM1A
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.20374400066031464,-0.6036524393288484,0.9529190207156308,0.9905063572262355,1.0,5/24,23.05%,LRRK2;AQP11;HERPUD1;LPCAT3;TXNDC12
prerank,telomere maintenance via telomerase (GO:0007004),-0.19184470164958542,-0.601771255926438,0.9606837606837607,0.9909450155423132,1.0,9/28,24.82%,MRE11;PPP6R3;RPA1;PTGES3;TERF2;TERT;HSP90AA1;RFC1;PINX1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.212528694091839,0.6011227955014521,0.9377682403433476,1.0,1.0,6/17,25.17%,SELENOS;SEL1L;AUP1;HM13;NPLOC4;DERL2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.21266643151033632,0.5998451134664212,0.9617117117117117,1.0,1.0,7/17,28.30%,LIPC;PCSK6;APOC1;ANGPTL3;NR1H2;SORT1;HDAC9
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.256398602825222,-0.5996266516184806,0.9312977099236641,0.9915035660508806,1.0,4/10,29.47%,RPUSD4;NAF1;RPUSD2;GAR1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.23503001090804182,0.5995898212897929,0.9426048565121413,1.0,1.0,2/12,8.28%,TRH;SLC29A4
prerank,positive regulation of protein depolymerization (GO:1901881),0.23989936244800636,0.5985884357427693,0.9397321428571429,1.0,1.0,2/11,9.80%,PLEK;STMN2
prerank,regulation of nervous system development (GO:0051960),0.17674386332846065,0.5985831944962561,0.9887640449438202,1.0,1.0,2/37,5.85%,TENM4;PTPRZ1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.19352407211427897,-0.5980511317224665,0.9719789842381786,0.9917846827909415,1.0,7/29,25.78%,PLA2G4A;LPCAT1;TMEM86B;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.2101174206790563,-0.5973743027903557,0.9546313799621928,0.9912991410734509,1.0,6/19,25.92%,POLR2G;TERF2;ATRX;POLR2C;POLR2L;POLR2H
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.2101174206790563,-0.5973743027903557,0.9546313799621928,0.9912991410734509,1.0,6/19,25.92%,POLR2G;TERF2;ATRX;POLR2C;POLR2L;POLR2H
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.2536071984068286,-0.59734285221286,0.9322344322344323,0.9909373365080696,1.0,5/10,29.45%,ACER2;SERPINE1;CYP1B1;SNAI2;WNK1
prerank,regulation of telomere maintenance (GO:0032204),-0.19098051896280827,-0.5952708326723027,0.9765342960288809,0.991409456793698,1.0,11/26,33.69%,MRE11;PPP1R10;TERF2;USP7;ATRX;SMG6;HNRNPD;SMG1;RAD50;HDAC8;PIF1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.20245444056527415,-0.594709072290869,0.9705340699815838,0.9912478077559678,1.0,6/23,24.47%,RBX1;XPC;CETN2;COPS7A;COPS8;COPS4
prerank,organelle disassembly (GO:1903008),0.18209333387792154,0.5946300493580802,0.9754464285714286,1.0,1.0,6/33,17.26%,VRK1;ZFAND1;UBA5;GOLGA2;UFL1;RETREG1
prerank,regulation of microtubule-based movement (GO:0060632),0.23925224586947624,0.5932308861419762,0.9337748344370861,1.0,1.0,2/11,8.67%,MAP2;NEFH
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.23133526891131667,-0.5928645346523868,0.9341421143847487,0.9915922302790274,1.0,5/14,30.41%,FOXO3;MRPL12;FASTKD5;SLC25A33;MTERF2
prerank,regulation of superoxide anion generation (GO:0032928),0.22662169354442566,0.5912083519246046,0.9426048565121413,1.0,1.0,2/14,8.43%,CD177;MAPT
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.2153085056179237,0.5911238195261409,0.9693654266958425,1.0,1.0,3/16,15.02%,IL12A;IL12RB1;IL23A
prerank,epithelial cell morphogenesis (GO:0003382),0.2067975922287162,0.5904938961013994,0.967032967032967,1.0,1.0,1/17,2.77%,STC1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.2232230221469347,0.5902770178691534,0.9450800915331807,1.0,1.0,3/14,19.45%,RASGRP1;IL23A;CD84
prerank,protein localization to kinetochore (GO:0034501),0.21667608463615257,0.5889396123621409,0.9583333333333334,1.0,1.0,14/14,78.35%,RCC2;CDK1;IK;ZWILCH;ZW10;KNL1;CHAMP1;AURKB;CENPT;MIS12;SPDL1;MTBP;TTK;BUB3
prerank,heterocycle biosynthetic process (GO:0018130),0.221240032072594,0.5871036166978018,0.9426048565121413,1.0,1.0,5/14,22.46%,PYCR2;ALOX5;NOXRED1;NFS1;LIAS
prerank,negative regulation of T cell proliferation (GO:0042130),0.18241059010452493,0.5862577225153786,0.968944099378882,1.0,1.0,27/28,73.00%,VTCN1;SDC4;CD86;PRNP;IL4I1;TNFRSF21;PRKAR1A;SCRIB;PLA2G2F;DLG5;VSIG4;IL10;BTN2A2;PLA2G2D;CD80;GLMN;SPN;FOXP3;PDCD1LG2;CRTAM;ARG1;GPNMB;CD274;CEBPB;LILRB1;TNFRSF14;LGALS9
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.19723306784111405,0.5862542300198406,0.9756637168141593,1.0,1.0,10/19,29.22%,ATP13A2;HTRA2;HTT;VDAC1;FBXO7;USP36;DNM1L;SREBF1;PINK1;SREBF2
prerank,lipoprotein transport (GO:0042953),0.2484716172744067,0.5860185115000048,0.9426048565121413,1.0,1.0,4/10,26.23%,PRKCB;VMP1;UNC119;CD36
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.2255500115887255,0.5856330671142108,0.9509803921568627,1.0,1.0,1/13,2.30%,UBE2J1
prerank,inner ear morphogenesis (GO:0042472),-0.20099094379438748,-0.585611096968818,0.9613152804642167,0.994002772480424,1.0,2/22,5.59%,TBX1;SIX1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.23331609413178997,0.5845675113661002,0.9507829977628636,1.0,1.0,1/12,3.75%,GGCT
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.19792323378197785,-0.5836422740186477,0.9789473684210527,0.9943780250945476,1.0,9/22,30.26%,PPM1F;PPM1B;PPP2CB;PPM1D;DUSP16;PPP2CA;PPP1CA;DUSP1;DUSP6
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.22904380095333685,0.5829511061190964,0.958904109589041,1.0,1.0,3/11,16.74%,P2RX3;P2RX5;CDH13
prerank,chromatin assembly or disassembly (GO:0006333),0.23208335508006925,0.582138217619506,0.9337748344370861,1.0,1.0,1/11,5.61%,M1AP
prerank,phosphate ion transmembrane transport (GO:0035435),-0.23212949370667718,-0.5820731993383347,0.9540229885057471,0.9945718764512717,1.0,5/12,31.12%,SLC25A11;SLC20A2;SLC37A4;SLC20A1;SLC25A10
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.19640145555484287,0.5803775532623262,0.9778270509977827,1.0,1.0,4/23,12.58%,H1-0;MUS81;HMGB2;REXO4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2334313899073504,0.5801760908895789,0.9614512471655329,1.0,1.0,3/10,19.57%,SOCS3;INPP5F;PPP2R1A
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.20762184128551528,-0.5800540026269124,0.9621212121212122,0.9948614561117871,1.0,4/19,21.05%,RIC3;CHRNB1;NQO1;CHRNA4
prerank,endocrine system development (GO:0035270),-0.20119664306559365,-0.5782280046883175,0.9674502712477396,0.9951162735911104,1.0,6/21,28.59%,TBX1;SIX1;WNT11;NF1;STRA6;TGFBR1
prerank,regulation of DNA metabolic process (GO:0051052),0.1621304785126572,0.5762620262266146,0.9931818181818182,1.0,1.0,11/44,22.35%,WRNIP1;XRCC5;PDGFA;SMG5;SIRT7;UPF1;KAT7;WDR70;WDR18;TERF2IP;CDK9
prerank,lymphocyte migration (GO:0072676),-0.17807471757300275,-0.5753328149244239,0.9886792452830189,0.9957263896075754,1.0,3/32,9.20%,CCL25;MSN;S1PR1
prerank,protein mannosylation (GO:0035268),-0.19775195167380122,-0.5748369075872435,0.9751332149200711,0.9955140030401386,1.0,2/22,3.65%,TMTC1;TMTC2
prerank,regulation of small molecule metabolic process (GO:0062012),-0.18243427043996682,-0.5742754031219474,0.9839857651245552,0.9953114971475355,1.0,4/28,13.89%,PANK2;PPARA;ACADL;ACADVL
prerank,regulation of interleukin-17 production (GO:0032660),-0.17834540231649854,-0.5737398755457124,0.980072463768116,0.9950853435686826,1.0,2/31,3.85%,SLC7A5;IL15
prerank,carboxylic acid catabolic process (GO:0046395),0.22486470581751788,0.5736620797446446,0.9598108747044918,1.0,1.0,3/12,20.48%,BCKDK;NPL;GNPDA1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.23414978848289164,-0.5736006118340556,0.9613259668508287,0.9947520513406887,1.0,4/11,24.39%,ADM;SAG;ARRB1;GRK3
prerank,Golgi inheritance (GO:0048313),-0.23851475233947828,-0.5725092833050935,0.9612546125461254,0.9947524722170025,1.0,5/11,33.57%,YWHAZ;VCPIP1;PLK3;STX5;PDCD10
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.2302326229746754,-0.5721897352794904,0.9512635379061372,0.994479725112718,1.0,3/12,20.88%,RBP4;NOD2;STRAP
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.23921412472574283,-0.5710489380839479,0.9490909090909091,0.99447442906773,1.0,6/11,32.94%,CASP8;RIPK1;TICAM1;RFTN1;TNIP2;SCARA3
prerank,oogenesis (GO:0048477),0.21188035441011482,0.5708544406878876,0.9548693586698337,1.0,1.0,1/15,3.69%,FMN2
prerank,rRNA methylation (GO:0031167),0.19009762130008073,0.5691434242418887,0.9803921568627451,1.0,1.0,4/22,13.07%,MTERF4;BUD23;TFB1M;DIMT1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.19657922482055817,-0.5687164220306021,0.9718574108818011,0.9948172458041014,1.0,5/20,20.96%,LDLRAP1;ACADL;ACADVL;FMO5;LPCAT3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.23169728202902634,-0.5639112898363073,0.9602888086642599,0.995893557284316,1.0,2/11,16.25%,JAK2;TAF7
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.22091364884030879,-0.56348428103979,0.9617486338797814,0.9956435608942329,1.0,1/13,5.60%,CBL
prerank,actin-myosin filament sliding (GO:0033275),-0.1660649355766387,-0.5624955432105485,0.9928698752228164,0.9951852856456781,1.0,13/38,36.59%,TPM3;TPM1;MYL6;TNNI1;TNNT3;ACTN2;TTN;TPM2;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,muscle filament sliding (GO:0030049),-0.1660649355766387,-0.5624955432105485,0.9928698752228164,0.9951852856456781,1.0,13/38,36.59%,TPM3;TPM1;MYL6;TNNI1;TNNT3;ACTN2;TTN;TPM2;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,regulation of fatty acid oxidation (GO:0046320),-0.20806212311817282,-0.5603037204403101,0.9817184643510055,0.9954429815609365,1.0,3/16,13.89%,PPARA;ACADL;ACADVL
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.21493027735291698,-0.5602177322725624,0.9657039711191335,0.9950895340315403,1.0,2/14,9.00%,SEMA7A;PLCG2
prerank,coenzyme A metabolic process (GO:0015936),0.2082059359334698,0.5585022456570309,0.9776286353467561,1.0,1.0,6/14,25.87%,ACLY;ACOT7;ACAT1;CROT;DCAKD;COASY
prerank,nucleotide biosynthetic process (GO:0009165),-0.1984168384683324,-0.5571831902487995,0.9675675675675676,0.9955695011129925,1.0,7/18,35.84%,MTHFD1;HPRT1;PRPS2;PNP;GART;ME1;NMNAT3
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.22159530238035474,0.5569927024300145,0.9636363636363636,1.0,1.0,4/12,19.63%,LDLR;CLU;APOE;PFDN4
prerank,cochlea morphogenesis (GO:0090103),-0.2370953693826971,-0.5565478723400262,0.9708029197080292,0.9953651487265059,1.0,1/10,3.63%,TBX1
prerank,establishment of spindle localization (GO:0051293),-0.21571975560491807,-0.5560016742682083,0.9708029197080292,0.9951372755050748,1.0,6/14,39.72%,MAP4;CFL1;TLE6;ESPL1;NLRP5;ZBED3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.21534557399826626,-0.5551853401547387,0.9774590163934426,0.9949728472142928,1.0,4/13,32.09%,IRAK1;IRAK2;PIK3AP1;TNIP2
prerank,protein polyglutamylation (GO:0018095),0.21871336841214656,0.5539146376191958,0.9621380846325167,1.0,1.0,5/11,26.94%,TPGS1;TTLL5;CFAP20;TTLL11;TTLL2
prerank,glycine metabolic process (GO:0006544),-0.22446207432244927,-0.5509286991364893,0.9647887323943662,0.995681467121259,1.0,1/12,3.50%,DLD
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.22937956588394331,-0.5500230808974111,0.9664902998236331,0.9955285404224984,1.0,5/11,37.64%,SLC19A2;SLC19A3;DCK;SLC25A19;THTPA
prerank,anterograde synaptic vesicle transport (GO:0048490),0.201766231586788,0.5493522263760483,0.98,1.0,1.0,3/15,15.41%,AP3S2;AP3M2;SNAPIN
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.201766231586788,0.5493522263760483,0.98,1.0,1.0,3/15,15.41%,AP3S2;AP3M2;SNAPIN
prerank,positive regulation of bone resorption (GO:0045780),0.22328939108600115,0.5492095655375123,0.9772209567198178,1.0,1.0,11/11,77.69%,SPP1;ADAM8;DEF8;ATP6AP1;PRKCA;TNFRSF11A;DCSTAMP;TNFSF11;SYK;MC4R;PLEKHM1
prerank,positive regulation of leukocyte migration (GO:0002687),-0.17676626159377995,-0.5482531286445067,0.9874551971326165,0.9956130930832054,1.0,3/27,11.69%,ICAM1;IL6R;EDN3
prerank,carnitine shuttle (GO:0006853),0.22216194049046928,0.5480230973450518,0.9553571428571429,1.0,1.0,2/11,9.05%,ACACA;CPT1B
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.2009791380741032,-0.5466945574005069,0.9719298245614035,0.9956372987921339,1.0,5/17,29.29%,AFG1L;COX10;COX6C;COX5A;COX4I2
prerank,negative regulation of phagocytosis (GO:0050765),0.19249433833556984,0.5426474119707505,0.9823008849557522,1.0,1.0,4/17,17.74%,SYT11;CD47;SIRPA;FCGR2B
prerank,negative regulation of cation channel activity (GO:2001258),-0.17723268718229956,-0.5420969787013112,0.9823943661971831,0.9963966606665827,1.0,2/26,10.36%,PKD2;GSTM2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.23080972442959918,-0.5417364574595284,0.9736379613356766,0.996104907822467,1.0,3/10,28.54%,TAF7;BRCA1;SET
prerank,ATP transport (GO:0015867),0.2249698878218701,0.5402763754052695,0.9646017699115044,1.0,1.0,2/10,15.25%,SLC25A4;CD47
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.21470359583681428,0.5398255136720919,0.9725400457665904,1.0,1.0,2/12,15.02%,RASGRP1;IL23A
prerank,regulation of transposition (GO:0010528),-0.21216463292799467,-0.5381925101369633,0.9734513274336283,0.9965176462153653,1.0,6/13,40.02%,UBR2;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,mitochondrial transcription (GO:0006390),-0.23157706370300518,-0.536937269571857,0.9646017699115044,0.9964196452913722,1.0,4/10,30.41%,FOXO3;MRPL12;SLC25A33;MTERF2
prerank,tetrahydrofolate metabolic process (GO:0046653),0.22280778373054627,0.5358691037293658,0.975,1.0,1.0,1/10,5.28%,TYMS
prerank,acylglycerol homeostasis (GO:0055090),-0.18772300977808304,-0.5355188963345343,0.982363315696649,0.9963583012374576,1.0,12/20,48.35%,SCARB1;LPL;PNPLA8;RORA;IL18;APOC4;PLA2G12B;NR1H3;HNF4A;ACSM2A;ANGPTL8;APOA1
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.19255568136079915,-0.5344200489607192,0.9853479853479854,0.9962060619671329,1.0,4/18,26.05%,ABL1;PRKDC;PRDM1;ZFP36L1
prerank,N-terminal protein amino acid modification (GO:0031365),-0.2059396986320299,-0.5342050201343608,0.9763636363636363,0.9958716421421,1.0,2/14,10.04%,NAA16;NAA15
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.2093475479197872,-0.5325710331267521,0.9774011299435028,0.9958437499513574,1.0,2/13,10.57%,CSPG4;BGN
prerank,protein deneddylation (GO:0000338),-0.22195785952197827,-0.5320058085155999,0.9692028985507246,0.9955880611517084,1.0,4/10,30.54%,COPS7A;COPS8;COPS4;COPS5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.19414826678735378,0.5311691864359911,0.9861431870669746,1.0,1.0,1/16,2.91%,TMEM161A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.211223949084954,0.5282068827806959,0.9839449541284404,1.0,1.0,2/11,13.38%,TERF1;WRAP53
prerank,regulation of activated T cell proliferation (GO:0046006),-0.16903251660732796,-0.5256633340078055,0.9896013864818024,0.9964270229080334,1.0,19/30,49.56%,ICOSLG;RC3H1;IGF1;RPS3;IGF2;HMGB1;LGALS9;IL27RA;CD274;IL18;CRTAM;PDCD1LG2;TNFSF9;FOXP3;IL23R;AGER;IL12B;IL2;RIPK3
prerank,negative regulation of DNA recombination (GO:0045910),0.15368863882426834,0.5239743116390349,0.9977477477477478,1.0,1.0,15/43,25.96%,SHLD3;TERF1;H1-0;POLR2D;FANCB;ACD;MSH2;TERF2IP;FBH1;RTEL1;UBQLN4;POLR2J;POLR2K;ZRANB3;POLQ
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.15676785301260804,-0.523722564063313,0.9928057553956835,0.9964013543802713,1.0,18/37,45.31%,PPARA;PDCD4;IL17RA;GBP5;NOD2;TREM2;MAPK14;STAT3;TICAM1;TLR6;NOS2;HIF1A;APPL2;ABCD1;CARD9;TLR4;TNF;IL6
prerank,hexose biosynthetic process (GO:0019319),-0.15302704938648426,-0.5220244122109946,0.9981481481481481,0.9963368182925159,1.0,5/42,14.04%,CHST15;RBP4;SLC25A11;ALDOC;ATF4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.2094433500509793,-0.5198899574747362,0.986013986013986,0.996344796341108,1.0,4/13,22.63%,SEC16B;BCAP31;EDEM2;SAR1A
prerank,cGMP biosynthetic process (GO:0006182),-0.21826214081194972,-0.5193591183585897,0.9724137931034482,0.9960668529971324,1.0,3/10,24.28%,NPR1;GUCY1A1;GUCY2C
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.204601520032627,-0.5156272783645086,0.9745454545454545,0.9963228505078947,1.0,7/14,39.87%,RARA;ANXA1;CCL19;NFKBID;NLRP3;IL18;MYB
prerank,intracellular sterol transport (GO:0032366),-0.20086967185703844,-0.5152840842017803,0.9869158878504672,0.996005337255784,1.0,3/13,20.56%,STARD4;STAR;OSBPL2
prerank,tryptophan metabolic process (GO:0006568),0.20502197112366602,0.5135906647700248,0.9754601226993865,1.0,1.0,11/11,79.51%,HAAO;TDO2;IL4I1;ACMSD;IDO1;ATP7A;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.1975216453415956,0.5134120314133338,0.9841628959276018,1.0,1.0,3/13,18.00%,BMF;VDAC2;RHOT1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.20001934047399525,-0.5121040279848341,0.9780621572212066,0.9961298693434726,1.0,5/13,32.76%,AQP11;LPCAT3;EIF2AK3;USP19;MANF
prerank,kinetochore organization (GO:0051383),-0.19960907273430695,-0.5120121832127875,0.9859154929577465,0.9957681198632226,1.0,6/13,39.76%,POGZ;CENPE;CENPH;NUF2;MIS12;CENPT
prerank,tryptophan catabolic process (GO:0006569),0.20502197112366605,0.5110365386219908,0.9744136460554371,1.0,1.0,11/11,79.51%,HAAO;TDO2;IL4I1;AFMID;ACMSD;IDO1;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,maintenance of protein localization in organelle (GO:0072595),-0.17921938973472587,-0.5109453516415895,0.9929203539823008,0.9955526831102743,1.0,8/19,37.84%,AKT1;TAF8;TAF3;ARL2;HNRNPU;MORC3;TOPORS;ARL2BP
prerank,female gonad development (GO:0008585),-0.17785253841686122,-0.5091404817223788,0.9928057553956835,0.9954451028501313,1.0,8/19,33.43%,EIF2B2;SOD1;NR2F2;FOXL2;COL9A3;CEBPB;EIF2B4;EIF2B5
prerank,protein localization to phagophore assembly site (GO:0034497),-0.20868994597962792,-0.5077442728008686,0.9827882960413081,0.9952873646323777,1.0,5/11,34.25%,WIPI1;WDR45B;ATG9A;PACS2;WIPI2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.17969042962634346,0.5068352839468793,0.9867549668874173,1.0,1.0,3/18,15.69%,CHGA;ADRA2A;BMP8A
prerank,superoxide anion generation (GO:0042554),0.1995781328691274,0.506815243025321,0.997716894977169,1.0,1.0,2/13,11.54%,ALOX12;NOX3
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.16899195489052035,0.5016583051676615,0.9977324263038548,1.0,1.0,4/22,19.03%,IL12A;IL12RB1;IL23A;ZBTB1
prerank,indolalkylamine catabolic process (GO:0046218),0.20500910175130255,0.4997245727548208,0.9835051546391752,1.0,1.0,10/10,79.51%,HAAO;TDO2;IL4I1;ACMSD;IDO1;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.18109846141549985,0.4974572297838609,0.980561555075594,1.0,1.0,7/16,29.33%,PIGP;PIGB;PIGQ;DPM2;PIGA;PIGM;PIGC
prerank,gluconeogenesis (GO:0006094),0.14467307461251394,0.4925376248282661,1.0,1.0,1.0,2/39,5.09%,SLC25A13;TPI1
prerank,rRNA transcription (GO:0009303),-0.17968467887557038,-0.4873684088940854,0.9964664310954063,0.9975417323548401,1.0,5/17,25.09%,TAF1B;BRF1;CAVIN1;GTF3C4;POLR1E
prerank,microglial cell activation (GO:0001774),0.16161403124340623,0.48594849900471626,0.9886621315192744,1.0,1.0,7/21,26.03%,GRN;MAPT;CLU;CX3CL1;SNCA;CX3CR1;TYROBP
prerank,DNA modification (GO:0006304),0.16111327791355826,0.4856971999146866,0.997737556561086,1.0,1.0,2/22,6.89%,TERF1;UNG
prerank,protein import into peroxisome membrane (GO:0045046),-0.1641927360596273,-0.483020035062256,0.9880546075085325,0.9976802294574144,1.0,7/22,33.89%,ABCD3;RAB8B;PEX14;PEX3;PEX11B;PEX19;PEX26
prerank,RNA modification (GO:0009451),0.13315697171817134,0.48220917687903747,1.0,1.0,1.0,13/54,22.43%,QTRT2;TRMT6;TFB1M;TSR3;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;NSUN6;ADAT2;THUMPD1;NOP10
prerank,positive regulation of protein maturation (GO:1903319),0.19064657878217206,0.47617828529286055,0.9930232558139535,1.0,1.0,11/11,80.95%,NKD2;ADAM8;ASTL;TNP2;ANGPTL8;TFR2;CCBE1;BAG2;NLRC4;RHBDD1;SOX4
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.18828884998073545,-0.46808980078047313,0.9963833634719711,0.9987161672838151,1.0,2/13,13.29%,GAS6;AP1G1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.1878448076357494,0.46716554320177817,0.9907621247113164,1.0,1.0,3/11,21.50%,UGGT2;AUP1;TOR1A
prerank,regulation of B cell activation (GO:0050864),0.14909525006283003,0.4653391396904426,0.9955849889624724,1.0,1.0,25/25,85.11%,SAMSN1;FOXJ1;FCGR2B;IL4I1;MZB1;IGLL1;TNFSF4;TLR9;ZFP36L2;SH3KBP1;LAPTM5;IL10;CD19;SLAMF8;IL6;CD22;IL4;AHR;THEMIS2;IKZF3;TNIP2;BANK1;ZFP36L1;NOD2;TNFAIP3
prerank,aggrephagy (GO:0035973),0.14802968658568727,0.46498242085426544,0.997624703087886,1.0,1.0,7/27,21.97%,DYNC1I1;DYNC1LI2;VIM;UBB;DYNC1I2;ACBD5;SQSTM1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.17222579213592676,-0.45884947182846936,0.9962756052141527,0.9990662401009761,1.0,8/16,42.83%,RC3H1;MOV10;RBM24;ZFP36L1;ZC3H12D;TRIM71;DND1;PLEKHN1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.16791505063023823,0.45464035967935484,0.9879807692307693,1.0,1.0,2/15,11.60%,CHST2;EXTL2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.1415676006022321,0.45235311185063465,0.995260663507109,1.0,1.0,4/30,15.02%,INAVA;PRKCZ;LILRA5;IL23A
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.16875761639570686,-0.4518594833755007,0.9982014388489209,0.9991624622182544,1.0,10/16,50.07%,VSIR;LILRB1;TRIB2;CD274;PDCD1LG2;FOXP3;IL23R;AGER;IL12B;DLL1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.16150200870669862,-0.44287316084191514,0.9966386554621849,0.9993244919609187,1.0,5/18,24.66%,ICOSLG;IGF1;RPS3;IGF2;HMGB1
prerank,regulation of interleukin-10 production (GO:0032653),-0.12739000971657588,-0.4381634549935773,1.0,0.9991848035237307,1.0,25/44,50.07%,CD34;PLCG2;VSIR;NOD2;HMGB1;LGALS9;LILRB1;STAT3;TSLP;TRIB2;CD274;SYK;PDCD1LG2;IL4;CD28;TLR4;IL6;FOXP3;IRF4;IL23R;AGER;F2RL1;IL12B;XCL1;DLL1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.17881628382219883,0.4343216876564978,0.993421052631579,1.0,1.0,1/10,9.74%,IL12A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.16648277289547941,0.4319492762609991,0.9978768577494692,0.9993996352926229,1.0,1/13,6.89%,UNG
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.16556991995456172,0.42577550450203777,0.9977876106194691,0.9987174823450893,1.0,2/12,13.38%,GNL3;WRAP53
prerank,regulation of stem cell population maintenance (GO:2000036),-0.14649118558854013,-0.4100307847717698,1.0,0.9998833643983992,1.0,4/18,27.03%,TAF5L;PTN;CNOT2;CNOT1
prerank,smoothened signaling pathway (GO:0007224),-0.12195052812741043,-0.3874859447987315,1.0,0.9999705536366076,1.0,5/32,20.33%,SMO;GLI3;HIPK1;TMEM17;PKD2L1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.1552730221568135,-0.3754478836009471,1.0,0.999744502148613,1.0,4/11,36.28%,ATF4;NONO;PARK7;HIF1A
